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Giving Due Credit? 
To the editor: 
I have read the Spring 1992 copy of Yale 
Medicine, and in particular, the article on 
the humanitarian service of Drs. Gaudio 
and Kini. Credit was given to Alcon Labs 
and Johnson & Johnson for their donation 
of supplies. 
On Page 6, mention was given to the 
treatment of river blindness by oral 
ivermectin. To be even-handed, Merck & 
Co. gave ivermectin to areas in Africa and 
■elsewhere, where this disease was preva¬ 
lent. You did not credit Merck. 
Thank you for your attention. 
! Elizabeth Tishler 
Middletown, Conn. 
1 
'Editor’s reply: The cited article, “The 
■ Gift of Sight: India’s Cataract Camps, ” 
| dealt only with the authors' experience in 
' Mangalore, India, and in no way was 
meant to slight the many humanitarian 
\ contributions that a wide array of Ameri¬ 
can pharmaceutical companies make 
\ worldwide. For the record. Dr. Gaudio 
informs us that Merck & Co. did not do¬ 
nate medicines to the Mangalore cataract 
camp. 
More on Wilbur Downs 
To the editor: 
Upon receiving the Spring 1992 Yale 
Medicine, you can imagine how I was 
“blown away” by the tribute to my father, 
Wilbur G. Downs, M.D. He and I were 
fortunate enough to become good friends 
and mutual admirers and irascible fishing 
partners before he died, peacefully, last 
year. 
I thought Marty Gordon and Herb Sacks 
did very good jobs describing my dad’s 
talents, and will of course be writing them 
to thank them. Drs. Sack and Gordon 
offered up many more compliments than 
my father would or could tolerate, and I 
will not add any more, but rather will 
repeat Dr. Sacks’ most key sentence: 
“Wilbur Downs had a great capacity to 
approach people unthreateningly, with 
warmth and gentleness.” This capacity 
was based on profound, non-discrimi¬ 
nating respect and interest. It was quite 
inspiring to witness, pertaining, as it did, 
even in the most random situations such 
as airplane-seating arrangements. It was 
not unusual for him to disembark from 
an airplane with a new address in hand, 
establishing life-long written contact. 
Also, Tom Mcguane, in his Esquire 
article (October 1991), wrote a beauti¬ 
ful sentence that could be my father’s 
epitaph (or that of any helplessly ad¬ 
dicted naturalist): “He rhapsodized the 
burgeoning life that he saw.” 
Sadness played a key role in my 
father’s life, both professionally and per¬ 
sonally, and my observation was that 
he learned at least as much from it as he 
did from his joys or successes or 
achievements. Dr. Sacks’ article hinted 
at the professional sadness when he 
noted that their (his and my father’s) 
$6-million proposal for the Senegal 
Health Project was turned down. In¬ 
deed, my father witnessed a steady and 
major decline in funding (and other) 
support for most international health 
projects over the last three decades. And 
of course he concurrently and with sad¬ 
ness witnessed a resurgence of malaria, 
kala azar. Rift Valley fever, and many 
other communicable and preventable 
diseases (some devastating, and some 
apparently new, like AIDS) to Dark Age 
proportions. 
His prayer was to immediately have 
every penny taken from the defense bud¬ 
get, to be put into support programs for 
the famine-ravaged and disease-infested 
children who seemingly have no chance 
at the kind of life we try to provide for 
our own children. 
He once told me that he was inca¬ 
pable of standing around (much less 
sitting in lotus position) enjoying a glo¬ 
rious sunset. I later came to understand 
what he meant, namely that his fascina¬ 
tion was in what insects (or fish, or birds 
or people) might be appearing or disap¬ 
pearing during that climactic period of 
the day. Nevertheless I saw him, on 
more than one occasion, sneak a glance 
at the glorious sky and enjoy a deep 
breath even as he so intently and invol¬ 
untarily focused on life here on Earth. 
Similarly, he was not unaware of the 
inevitability of his own sunset, and of 
the forces and questions that surrounded 
it. But “rhapsodizing the burgeoning 
life on earth” was his love and his glory, 
and his way, as Dylan Thomas put it, of 
“singing in his chains like the sea.” 
Thank you for the excellent edition, 
which is an enormous honor and remem¬ 
brance for me and for my family. 
Mont}'Downs, M.D. '70 
Lihue, Hawaii 
Senatorial Salute 
To the editor: 
I recently received a copy of the article 
in the summer edition of Yale Medicine 
about the cooperative venture between 
the veterans medical center at West Ha¬ 
ven and the Yale School of Medicine. 
While I was aware of the cooperation 
between the two institutions, I did not 
realize how close the association was— 
nor how mutually beneficial. Clearly 
the $90 million earmarked for capital 
improvement at West Haven will facili¬ 
tate the partnership between YSM and 
the veterans facility and will leverage an 
enormous dividend in improved patient 
care and expanded biomedical research. 
Thank you for a fine article. I am 
looking forward to continuing accounts 
of this fruitful partnership. 
Christopher J. Dodd 
United States Senator (Conn.) 
Washington, D.C. 
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Fetal Rights 
To the editor: 
I have taken the liberty to add a footnote 
to the Yale University School of Medi¬ 
cine Human Relations Code of Conduct 
featured on Page 37 of the Spring 1992 
edition of Yale Medicine: 
Respect for the dignity and worth of 
each individual ensures that Yale is free 
from intolerance based on age or physi¬ 
cal handicap. This makes certain that 
no unborn child will be aborted because 
of his sex, physical condition, genetic 
make-up, or even just because he is “un¬ 
wanted. ” 
(“Life Begins at Fertilization”: Brad¬ 
ley Patten. Jerome Lejeune, Isaac 
Azimov, Paul Weiss, Thomas Hilgers, 
A. E. A. Scheinfeld, B. Heffernan, etc.) 
Paul Bruch, M.D. '51 
President, Conn. Right to Life Corp. 
Soutlibury, Conn. 
Editor's reply: Our human relations 
code of conduct is meant to encourage 
mutual respect among students, faculty 
and patients. This includes respect for 
differing points of view without pre¬ 
judging their intent and without 
imposing one’s own opinions on others. 
The code encourages freedom of 
expression and respect for the dignity> 
and rights of individuals. In fact, it is 
in this spirit that we publish Dr. 
Bruch's letter. 
Military Women 
To the editor: 
I have just finished reading the article by 
Linda Spoonster Schwartz, “Our Un¬ 
known Veterans Emerge from the Shad¬ 
ows” (Summer 1992), and wish to com¬ 
ment on her statement that “in the late 
1970s women doctors began to serve in 
military hospitals.” 
I was a lieutenant colonel in the U.S. 
Army Medical Corps Reserves, and while 
on active duty served in the military hos¬ 
pitals in Fort Devens. Mass., and Fort 
Drum, N.Y.. in the 1960s. 
In addition to the monument dedi¬ 
cated to military women that is to be 
constructed at the entrance to Arlington 
National Cemetery, the Association of 
Military Women is also requesting pho¬ 
tographs, uniforms, memorabilia, etc., for 
a museum to be devoted to women in the 
military. 
I personally had the privilege of pre¬ 
senting a sabre (in honor of my late hus¬ 
band Col. Ronald B. Stevens U.S.A.F.) 
to two women in the A.F.R.O.T.C. at 
the University of Connecticut for their 
outstanding academic and military ex¬ 
cellence in the early 1970s. 
Both are now captains in the Air 
Force. One is a pilot who flies the larg¬ 
est Air Force transport plane, and the 
other is in N.O.R.D. So women are on 
their way as they were when 1 was in 
medical school. 
Sophie Trent, M.D. '43 
Meriden, Conn. 
Social Challenges 
To the editor: 
I liked your editorial, "A New Dean, A 
New Dawn." in the Summer 1992 issue 
of Yale Medicine. 1 hope you will con¬ 
tinue to follow that line you enunciated, 
helping students, faculty and alumni to 
face the challenges of change. There is a 
tendency in house organs to soften and 
blur the outlines of the problematic di¬ 
mensions of the institution's mission. 
Yale School of Medicine has a rich tra¬ 
dition of responding to social challenges. 
Social medicine once had a foothold here 
and it would be valuable for that view¬ 
point to return. 
You've touched on international and 
military issues recently. Perhaps it is 
time to reflect on Yale's response to 
today’s social and economic challenges. 
Thanks again for your very forthright 
editorial. 
George A. Silver, M.D. 
Professor emeritus of public health 
Tribute to a Friend 
To the editor: 
It is with deep sadness that I write that 
Mr. Leonard Berger of Atlanta, Ga., died 
suddenly on April 16, 1992, of an acute 
myocardial infarction, at the young age 
of 65. Lenny was a longtime friend of 
the Child Study Center and a personal 
friend of many members of the faculty. 
In the middle 1970s, he established the 
Berger Fellowship program for support 
of research concerning autism and asso¬ 
ciated disorders. The Berger Fellow¬ 
ships have provided support for over 20 
fellows from the United States, Europe. 
Asia and Israel who have become lead¬ 
ers in the field. Fenny took an active, 
enthusiastic interest in the work of the 
center, in the Berger Fellows and in ad¬ 
vances in scientific research. He was a 
remarkably devoted father, wonderful 
husband, and beloved friend. 
Mrs. Gloria Berger can be written to 
at 1585 Wesley Parkway, Atlanta. GA 
30339. 
The center will continue to provide 
Leonard Berger Fellowships in his 
memory. He will be deeply missed. 
Donald J. Cohen, M.D. 
Director 
Yale Child Study Center 
Bravo, Dr. Sphar 
To the editor: 
I am writing to applaud your providing 
Capt. Ray Sphar space in the Summer 
1992 edition of Yale Medicine. He truly 
made a great contribution to his profes¬ 
sion and to his country. I can personally 
attest to Ray as an outstanding Navy 
medical officer. 
My career ended with my retirement 
in October 1990 with many fond memo¬ 
ries and great personal satisfaction. 
William M. Nan’a 




To the editor: 
In the Summer 1992 Yale Medicine, on 
Page 33, it states that Harvey Cushing 
was professor of neurosurgery at Yale. 
Although offered that title, he refused 
because of ill health. He was then named 
Sterling Professor of Neurology. 
W.G. Cooper, M.D. '37 
Little Rock, Ark. 
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A Special Bond 1 
by Gerard N. Burrow, M.D. 
I am delighted to welcome you, the entering Class of 1996. 
You are a very special class to me because I am entering also, 
although as dean, and we will go through the next four years 
together. I have a slight edge because I have been through this 
process once already. Thirty-eight years ago I sat in your place 
and with a certain level of anxiety and apprehension listened to 
the inspirational words of Dean Vernon Lippard. Now it’s my 
turn to provide some inspiration with a minimum of perspiration. 
Medicine is not a trade to be learned blit a profession to 
be entered. It is an ever-widening field that requires continued 
study and prolonged experience in close contact with the sick. 
All that the medical school can hope to do is to supply the 
foundations on which to build. When one considers the 
amazing progress of science in its relation to medicine in the 
last 30 years, and the enormous mass of scientific material 
which must be made available to the modern physician, it is 
not surprising that the schools have tended to concern them¬ 
selves more and more with this phase of the educational 
problem. And while we have been absorbed in the difficult task 
of digesting and correlating new knowledge, it has been easy 
to overlook the fact that the application of principles of 
science to diagnosis and treatment of disease is only one 
limited aspect of medical practice. 
The practice of medicine in its broadest sense includes 
the whole relationship of the physician with his patient. It is 
an art, based to an increasing extent on the medical sciences, 
but comprising much that still remains outside the realm of 
any science. The art of medicine and the science of medicine 
are not antagonistic but supplementary to each other. There 
is no more contradiction between the science of medicine and 
the art of medicine than between the science of aeronautics 
and the art of flying. Good practice presupposes an under¬ 
standing of the sciences which contribute to the structure of 
modern medicine, but it is obvious that sound professional 
training should include a much broader equipment. 
Interestingly, these are not my inspirational words but rather 
were delivered in 1927 by Dr. Francis W. Peabody, in a talk to 
Harvard medical students. Amazingly, 65 years later the words 
are perhaps even more applicable. 
Even though Peabody’s words remain cogent, the medical 
world you are entering is very different from the one in which I 
found myself. In 1954, when I entered Yale School of Medicine, 
polio and smallpox were rampant. No one had heard of AIDS. 
Dean Gerard N. Burrow delivered this address to incoming 
Yale medical students on Sept. 10. 
Dr. Gerard N. Burrow also welcomed first-year medical students 
at this year's inaugural white coat ceremony on September 9. 
(See Student News, Page 37.) 
Watson and Crick had just unveiled the double helix. Medicare 
and Medicaid had not been promulgated, and physicians will¬ 
ingly devoted free care a half day or more a week. 
You are entering medicine in what is truly the best of times and 
the worst of times. Medicine goes through periods of quiescence 
punctuated by an advance that fundamentally changes how 
medicine is practiced. The invention of the X-ray, the introduc¬ 
tion of antibiotics, the ability to bank blood all changed the 
practice of medicine. 
Today, advances in cellular and molecular biology are causing 
a revolution in clinical medicine. We now understand what 
causes certain kinds of cancer. We are able to genetically 
engineer medically important proteins. 
At the same time there are 35 million Americans without 
health insurance. Fully one-half of the children in inner cities 
have not been immunized. Everyone is unhappy with our health 
care system. 
You will be reaching the peak of your medical careers in the 
year 2010. Our role is to educate you to deal with medicine in the 
21st century when the changes will be far greater than between 
when I entered and when you entered. 
I did not leave Southern California because of the weather, or 
the quality of the Yale football team. I came back because I 
believe in the Yale system of medical education, which treats the 
student as an adult and lets her or him learn at an individual pace, 
with support when and where it’s needed. 
I can’t think of anything more satisfying than to be a physician. 
We are here to help you become the leaders of American 
medicine in the first part of the 21st century. YM 












Gerard N. Burrow, M.D 
Welcome back to the School of Medicine, Dr. Burrow. How does 
it feel to be back? 
It’s enormously exciting. You know, Thomas Wolfe wrote that 
you can't go home again. I don't think that’s true; in a sense you 
never leave. There's something very special about Yale. I’ve 
been reacquainting myself with some of the people I served with 
on the house staff. And it's wonderful, the letters I’ve gotten from 
classmates, former house staff, graduate students that I taught as 
I went through my early career here. 
What have been your first impressions? 
In one sense, how little things have changed. And in another 
sense, how much they’ve changed. In April, when we had the 
press conference at Harkness auditorium to announce my ap¬ 
pointment, it was incredible to look out in the audience. I think 
I knew half of the people there. Some were people who had taught 
me as a first-year medical student. Ed Crelin taught my anatomy 
class and sent me a copy of a book he had written. John McLean 
Morris was there. It really took me back. 
What differences seem most striking? 
There are a lot more buildings. The number of students has 
increased somewhat, but especially the faculty. I think one of the 
truly exciting things about Yale is the breadth and the depth of the 
medical school and the University communities, and how well 
they relate to one another. 
Any surprises? 
Well, I was surprised to see my name on the door. For 22 years, 
it was always somebody else’s name, and serving as dean had not 
been something that I'd thought about doing. The big difference 
I see between San Diego and Yale is that in San Diego the sun 
goes into the ocean, and here it comes out of the ocean, but the 
problems are the same. 
Before commenting further on the problems, what do you see as 
our strengths at the School of Medicine? 
I think there are some very good medical schools across the 
country, but there really are very, very few that have the number 
of extraordinary individuals, both in the medical school and the 
On August 21, Gregory R. Huth and Rosalind D'Eugenio 
interviewed Dean Gerard N. Burrow. Mr. Huth is publications 
editor and Ms. D'Eugenio is media specialist at the School of 
Medicine’s Office of Public Information. 
main campus, as we do at Yale. Programmatically, we have 
enormous basic science strength at a time when science has never 
been more exciting. Our particular strength is in areas such as 
oncology, neuroscience, structural biology and genetics, areas 
that are really exploding with discovery. We boast a very good 
hospital, a strong clinical program, and the opportunity to build 
a bridge between the basic sciences and clinical care. 
And what are the school's major challenges? 
In the short term, and perhaps in the long term, we have to look 
at what’s going to happen with the U.S. health care system. 
Managed care is going to increase, and I think academic health 
centers are particularly ill-suited to practice in the kind of 
medicine that I see coming. 
Why is that? 
Take California as an example. In the five-year period that I was 
there, San Diego had 30 hospitals, which are collapsing into four 
channeled, managed systems of health care. By 1996, an esti¬ 
mated 70 to 80 percent of San Diegans will be in managed care. 
With channeled, managed care, if you're in one system, unless 
you are willing to pay the total cost, you can't be referred for care 
outside the system. So to be a part of the managed care system, 
which a university needs to do for medical education, you 
probably need access to 200,000 lives. To train residents inter¬ 
ested in doing surgery on the base of the skull, you probably need 
access to 400,000 lives. 
By and large medical schools do very well in specialized care, 
but to deliver primary care to huge numbers of people is not one 
of the things we’re designed for. Fortunately, Yale-New Haven 
Hospital does have a community practice. One of my goals, for 
the short term and the long term, is to build and solidify the 
bridges between University physicians and community physi¬ 
cians. Both groups face the same issues. The closer that we can 
get together, the better it will be. 
So you 'll emphasize closer ties with the New Haven community. 
New Haven is the city where redevelopment started in the United 
States. More recently, national policy with regard to cities seems 
to be going in the wrong direction, and I think that’s obviously 
unacceptable. In the long term, for the School of Medicine to be 
successful, the city has to be successful. One of New Haven's 
advantages is that it’s not a vast area like Los Angeles or New 
York, and I think that it’s possible to help. Although the 
University cannot solve the social ills of New Haven, I think it can 
use its academic strength to help solve those ills. 
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Have you been particularly impressed with any current town- 
gown programs ? 
For one. the needle exchange program. It's a wonderful example 
of the way that the University can contribute to the social well¬ 
being of the city. Also, the program that Jim Comer is directing 
to help strengthen the public schools, and the Child Study Center 
program working with children exposed to violence. These are 
perfect examples of using an academic approach to solve difficult 
social problems, and I think we need to do more of it. 
Will the department of epidemiology and public health (EPH) 
play a role in this approach? 
There's no question. I mean, the societal issues are not so much 
the care of individuals as the care of populations. The strength of 
EPH is that it is already playing that role. Another example of 
Yale’s breadth and the depth is that EPH, the Forestry School, and 
the Center for International and Area Studies are cooperating in 
Brazil. This is not our local community, but again, it's melding 
the different schools in an important way. 
Could we return to your encouraging cooperation between the 
bench and the bedside ? Would you cite any current efforts at the 
school as a good example ? 
I think Lyme disease is a perfect example of a disease that was 
identified and described here at Yale, the agent identified, and the 
treatment for the disease pursued. Now that the development of 
a vaccine is on the horizon, we’re successfully moving biotech¬ 
nology to the bedside. We need to be doing more of that. 
What's your perception about clinical care at the school? 
I think it’s been strong. I think that in order to become perhaps 
the premier medical academic institution in the country, we need 
to have a clinical program that’s as strong as our basic research 
program. We’ll start by building on areas in which we are really 
at the very forefront—transplantation, gene therapy—which 
again, feeds back on the basic science strength that we have 
already. 
Would you comment in more detail about the prospect of gene 
therapy at Yale? 
Gene therapy is clearly on the horizon, and we have the strength 
here to become leaders in this emerging field. We’ve had some 
meetings about setting up an active program; it would probably 
first happen in oncology and then develop from there. That’s one 
program that I’d like to focus on right away. 
Could you provide some background about gene therapy for our 
readers who may not be conversant with this concept? 
Dr. Gerard N. Burrow in his Sterling Hall of Medicine office. 
Turning to our physical plant, do you see any major new 
construction happening during the next few years? 
Yes. We're now drawing up plans for a new Center for the Study 
of Human Disease. We still need to secure funding. Perhaps our 
most pressing need is expanded space for laboratory research, 
and this center will help us address that need. 
Which laboratories would be located in the new building? 
Programs from the department of internal medicine, which are 
probably under the greatest stress in terms of space. As in the 
Boyer Center for Molecular Medicine, the new building would 
encourage an interdepartmental approach to diseases such as 
diabetes mellitus or heart disease, and would bring together 
investigators from a number of disciplines. As departmental 
boundaries blur and research becomes more programmatic, our 
challenge is to foster interdepartmental research collaboration 
while allowing individuals to feel as if they have a home. 
You've had extensive experience in the Canadian health care 
system and taught in Canada. From that perspective, would you 
comment on our struggles in the United States to reform our own 
health care system? 
Take, for example, a gene that makes a substance that could 
destroy a tumor cell. Insert that gene either directly into the tumor 
or into the bone marrow so that you’re really doing something to 
directly destroy the tumor without poisoning all cells, which is 
the price some patients now have to pay for life-saving cancer 
treatments. 
After being in Canada for almost 13 years and then returning to 
San Diego, I really felt like Rip Van Winkle. The American 
medical care system I left bore no resemblance to the one to which 
I came back. I returned to a system in which 10 percent of the 
women who delivered at the university hospital in San Diego had 
no prenatal care. Many of these were the working poor, that is, 





















they made too much money to qualify for Medicaid hut didn't feel 
they had enough money to pay for prenatal care. These women 
had a four-times higher incidence of low birth-weight babies, 
babies which ended up in an intensive care unit at $3,000 a day. 
With no medical insurance, these mothers very quickly qualified 
for Medicaid. At the same time, at a hospital in La Jolla, the 
Caesarean section rate of fee-for-service patients was 36 percent, 
which is almost twice the national average. It’s what Alain 
Enthoven, the Stanford health economist, has called “the paradox 
of deficiency and excess,” which means that with close to 35 
million Americans getting inadequate care, financially stable 
people may be getting too much care. 
How does this compare with the Canadian system ? 
There are problems with the Canadian health care system, but 
nevertheless, it delivers unquestionably better care to an entire 
population—for at the time I was there—3 percent less gross 
national product than did the United States. I think that the 
American system is in chaos at the present time. Everybody is 
dissatisfied. There are at least 50 proposals to change the system, 
but there’s no champion or leadership. And though health is 
being discussed, you don't hear it as the number one priority. At 
both of the political conventions it was mentioned in passing. 
There certainly are models that work. Ours does not work. 
What kind of model would work for the United States? 
I use the word “single” health plan and stay away from either 
“national" or “universal.” I think that the system could be broken 
up into individual states, but it’s got to offer a broad approach that 
simplifies things. It’s estimated that as much as 20 percent of our 
$800 billion in health care costs is spent on administration. 
Things like single insurance forms and tort reform could make an 
impact, but we also have to come to grips with the amount of 
technology that’s available. It's not that technology is bad; we’re 
just going to have to use technology in a more reasonable way. 
Returning to medical school issues, would you briefly share your 
thoughts about the Yale system of education? 
Sure. I believe in it; that's the short answer. I really think that the 
Yale system of medical education is one that is enormously 
important. I don’t think it's the best system of medical education 
for everyone, but it’s important to individuals who want to take 
responsibility for his or her own education, with the ability to get 
help when needed. 
Another thing we sometimes forget is that people are in 
medical school for four years, and then they are in house staff 
training for a few years. But after that, they practice for another 
40 years. A Yale medical education is not like taking a Berlitz 
course to master the language, only to take an exam and forget it. 
It’s really to develop a philosophy and attitude that allows the 
individual to learn for the rest of his or her life. 
That’s something that Yale gave me, and it’s what we need to 
pass on to today’s students. We, as faculty and alumni, need to 
be guideposts. We need to be teachers who will help students 
shape their lives to the benefit of the students and society. 
What do you see as the major differences in what medical students 
face today as compared to when you were a student at Yale? 
To begin with, the mass of material. It truly has reached the point. 
I think, where it" s just very difficult to get even an overview of the 
main issues. At the same time, when I graduated in 1958, the 
future of medicine and the shape of medical practice were very 
clear. I think it’s not at all clear now. 
Finally, there are concerns about personal safety. By the time 
I had graduated from medical school, there were, I think, one or 
two classmates who had developed tuberculosis, but by and large 
there were really no life-threatening diseases that put you at risk. 
Today's students are faced with the AIDS epidemic. That has 
returned them to the tradition of doctors throughout the centuries 
who have cared for patients despite the risk to themselves. 
“There clearly has been enormous growth of 
all medical schools since 1965 when Medicare 
came in. 1 think this rate of growth simply 
can ’tbe sustained. ” 
Given these challenges, do you favor professional rewards for 
good teachers? 
I firmly support promoting people on the basis of excellent 
teaching. One of the difficulties here is that it's easy to judge 
research. There are peer-review grants; there are published 
papers, so there are very clear, objective guidelines. And Yale 
is an academic institution, and that means that you need to be 
promoted on the basis of scholarship. 
We’ve not yet successfully, I think, been able to evaluate 
whether somebody is a really good teacher. We have to develop 
some way to objectively evaluate teaching performance. It’s one 
of the issues that we’ve been looking at and working on. 
Turning to the alumni, as both a medical school alumnus and 
former member of the house staff, you bring a particular 
perspective to the school. How do you view the alumni’s 
relationship to the School of Medicine? 
It's a very special relationship. I think that the people who have 
gone through the Yale system of medical education have a warm 
feeling about this institution. One of the difficulties, I think, has 
been that there are relatively few medical alumni. Until recently, 
they really have had little communication from the school except 
through Yale Medicine, and when they have a five-year reunion. 
And still the alumni have been enormously supportive. 
Obviously, the alumni’s financial support is important, but so 
is their direct contact with students as mentors, and with each 
other as colleagues. I think we really need to cultivate those 
relationships. What that means is contact in between the five- 
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year reunions, and that’s something that I’m interested in devel¬ 
oping. In fact, I am setting up a series of visits across the country 
to meet Yale medical alumni. We'll do that on a continuing basis. 
Speaking of finances, federal research support seems almost sure 
to be reduced in the coming years, especially reimbursements for 
overhead expenses. Is the medical school's fiscal health a 
particular concern ? 
Finances are a particular concern everywhere, and they’re always 
a concern. There tends to be a feeling that because Yale has a very 
large endowment, its medical school therefore is similarly en¬ 
dowed. The medical school’s endowment is really autonomous 
from the University’s. By and large, our money comes from 
research funds and from clinical practice. 
And if managed care is indeed the future of American medicine, 
that may further limit clinical income. 
I think that it is clear that clinical practice is not going to be a place 
that’s going to bring extra funds into the University, if in fact it 
will even support an academic position. Research funds are 
certainly under continuing pressure and particularly, as you 
mentioned, indirect costs. The cold, hard facts are that it costs 
money to heat a building and to light a building and to clean a 
building, and somebody has to pay for that. And if reimburse¬ 
ment for those indirect costs decreases significantly, that’s really 
a major issue. 
Does all this add up to a funding crisis on the horizon for 
American medical schools? 
We’ll have to wait and see what happens. There clearly has been 
enormous growth of all medical schools since 1965 when Medi- 
“ Research funds are certainly under continuing pressure... ” 
care came in. I think this rate of growth simply can't be 
sustained. One of the things that I will be doing to position the 
Yale School of Medicine for the 21 st century is to take a hard 
look at how much growth we can accommodate. We must 
have the resources to maintain the same level of excellence 
that we now have. 
Financial pressures have helped bring about increased 
cooperation with industry and other private funding sources. 
Do you see this trend continuing? 
Yes, and I think it’s going to grow. Part of our public 
responsibility tospeed the benefits of research tothe bedside is 
to embrace biotechnology. Again, take Lyme disease as an 
example. We can’t make our own vaccine here; we really do 
need to have a relationship with industry. From my experience 
in San Diego, which is one of the major biotechnology centers 
in the country, hospitals and universities have had those 
relationships without compromising academic integrity, even 
though the biotechnology companies benefit as well. I think 
it is an area where New Flaven could grow and provide jobs, 
which is one of the things this community needs to grow out 
of some of its problems. 
To touch briefly on another problem of the American health 
care system, what about increased specialization and a growing 
shortage of family practitioners? 
When 1 graduated from the School of Medicine in 1958, most 
people felt if they were going into internal medicine, it was the 
equivalent of becoming a family physician who would have an 
interest in a specialty. I think that as medicine has become 
more complex, it has pushed people more and more into a 
specialty. One of the things that American medicine in general 
has not looked at is how many specialists we really need. By 
contrast, when I began my work in Canada in 1976, one of the 
first things we were looking at was whether we were training 
too many endocrinologists. That’s not a question that's been 
asked until very recently in the United States, and it has to be 
handled on a national level. 
The individuals who come out of Yale School of Medicine 
will be leaders in many fields, including family practice. Our 
mission is to train good physicians, whether they be a family 
physician, clinical specialist or a researcher in molecular 
biology or some other branch of biomedical science. But Yale 
is after all, a research institution, and many of our students will 
go into research and academic careers. 
Any concluding words to your fellow alumni? 
My final message is that this truly is an enormously exciting 
school of which the alumni should be terribly proud. Yale is 
one of the best schools in the United States, and I look forward 
to working with the alumni and students as well as the faculty 
and staff in positioning our school to enter the 21st century 
successfully. YM 
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Reflections of a 
Physician-Journalist 
by Randi Hutter Epstein, M.D. '90 
Anyone can be a journalist. There are no prerequisites for the job. 
No minimum number of grueling courses are required. No 
professional degree is necessary. And best of all. there are no 
national exams. 
Yet those of us with the intention of being a good reporter— 
the kind that sniffs out news and packages it in proper perspec¬ 
tive—recognize the best way to prepare is a self-designed educa¬ 
tion. 1 chose medicine, specifically the Yale system of medical 
education. Now I'm a foreign correspondent. 
The foreign correspondent, as the name implies, is a person 
who lives in a foreign country reporting first-hand news as 
quickly and accurately as possible. Sometimes it requires sitting 
in an office, manning the phones, scanning the local papers, doing 
umpteen telephone interviews. Other times, it’s out in the field 
to observe, ask questions, assimilate facts and piece together a 
coherent story—a journalist's version of physical diagnosis and 
admission note. 
It’s this latter image of a journalist’s field work, getting right 
in the thick of things, that lured most of us to try our hand at it. We 
dream of editors offering us assignments to exotic destinations, 
begging us to enliven their prestigious publications with our 
mesmerizing prose. 
For beginning reporters, such thoughts border on the delu¬ 
sional. More often than not. we're spending hours rewriting 
query letters to editors of not-so-famous publications. Those of 
us who have remained employed during the recent magazine-o- 
cide. spend more time doing telephone interviews than gallivant¬ 
ing the globe. 
Rather than leading to fame or adventure, these crucial con¬ 
versations enable the office-bound journalist to become an essen¬ 
tial cog in the wheel of worldwide information transmission. The 
aim is to pass along vital and not-so-vital news. 
Many fledgling correspondents move abroad after journalism 
school—if they choose that dubious training—to learn another 
language or fall into the rhythm of day-to-day life. Such intimacy 
with the natives serves as a spice to transform bland reportage into 
a well-seasoned story. 
Among my classmates at the Graduate School of Journalism 
at Columbia University, one friend went to Ethiopia, another 
Nicaragua, a third to Spain. I moved to New Haven. Not 
surprisingly, my globe-trotting friends had more action-packed 
stories to send to the class notes section of our alumni magazine. 
Yet, in some key ways, their journeys to faraway places and my 
own into the world of medicine shared crucial common threads. 
Indeed, medical journalism is, in some respects, like foreign 
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correspondence, even if we’re stationed on native soil. We’re 
typically not island-hopping like travel writers or reporting 
from combat zones like war correspondents. But like our 
colleagues, we, too, try to bridge very different worlds, that of 
doctors and patients. 
Like my classmates, I, too, learned a new language—medi¬ 
cine. I, too, tried to assimilate my new surroundings—struggling 
to keep pace with the frenzied pace of a doctor’s life. I, too, 
I widened my horizons—observing firsthand a broad range of 
human diseases. 
At Yale, I discovered that some of the skills I learned in 
journalism school also applied to the wards: “Look. Listen. 
Ask lots of questions.” Moreover, the five basic questions that 
form the “lead” (first paragraph) of a straight news piece: 
"Who? What? When? Where? Why?” worked well for writing 
admission notes. 
In other ways, however, the worlds of medicine and journal¬ 
ism proved dramatically different. Doctors trust people. Journal¬ 
ists don't trust anyone. In medical school, our professors told us 
the only thing you never believe is a patient’s assessment of his 
average alcohol consumption. On the other hand, on my first day 
of journalism school we were taught the fundamental reporting 
skill, “If your mother says she loves you, check it out.” 
A Journalist’s Roots 
I I started free-lance writing my first year in medical school, 
reporting at night and squeezing in a few short articles here and 
there, primarily for health and women’s magazines. I’d try to 
pick topics touching on subjects we were covering in class. My 
journalism complemented my education. Writing helped so¬ 
lidify what I’d heard in class and read in texts. When I couldn't 
put words on paper, I knew I hadn't grasped the subject. 
During the spring semester, 1 discovered my knack for jour¬ 
nalism did not necessarily extend to fiction writing. Richard 
Selzer’s creative writing course brought together about 20 or so 
closet-fiction writers lurking in the medical school. Dr. Selzer 
provided me with the opportunity to humiliate myself every week 
as I read aloud my homework assignments. One week he told us 
to create horror stories, the next week, describe a plate of fruit and 
eggs. I must admit, though, that fiction writing made the chore 
of memorizing medical trivia seem a lot less onerous. At least the 
sentences in my textbooks were already written for me. 
I still talk about writing fiction, but I find myself drawn to non¬ 
fiction, primarily because it is just that, not fiction. I like to write 
about things that really did happen and report dialogue that was 
truly said. Moreover, the medical beat combines the thrill of 
delving into new health and science discoveries with the chal¬ 
lenge of writing about them in such a way as to intrigue even the 
most non-scientifically inclined readers. Plus, the vast selection 
of story ideas range from microscopic to macroscopic, from 
molecular biology to health policy. 
Many feature articles were inspired by patients I examined or 
the doctors with whom I worked. Days spent listening to the 
harrowing tales of in-patients at the Connecticut Mental Health 
Center and discussing the biology of mental illness with Dr. 
Lawrence Price lead to several articles about depression, one for 
In View, a magazine for college women, and a second for M, a 
men’s magazine. A seminar co-hosted by Yale's law and 
medical schools, an attempt to open the dialogue between 
doctors and lawyers while we were still in training, led to an 
article for Physician ’s Weekly, a publication distributed mostly 
in American hospitals. This piece was entitled “Yale Deans 
Seek a Cease-fire.” 
My third-year clerkship at the Indian Health Service (IHS) 
seeded more stories and involved a few trips out West. I wrote 
about native American patients who use both traditional and 
Western medicine, and covered the plight of doctors working 
for the IHS. My first story from this period was about a 
medicine man in Gallup, N.M., who sprinkled corn seed and 
chanted Navajo songs in the labor and delivery wing of the IHS 
hospital. I later wrote about a 27-year-old kidney transplant 
patient who was convinced that her operation was successful 
because she and her family had attended a nine-day native 
American healing ceremony. 
My IHS clerkship also provided me a first glimpse of social¬ 
ized medicine. I met a lot of disgruntled and disillusioned 
physicians. I listened to their complaints and watched them try 
to get by with understaffed and inadequately supplied clinics. 
The bureaucracy, many said, was the most maddening part of it 
all. Many doctors spent more time buried in stacks of paperwork 
than in seeing patients. Further reporting when I returned East 
uncovered administrative financial abuses which led to an article 
for Physician's Weekly entitled “The IHS Mess”. 
During my final year of medical school, I spent two weeks 
with a 1969 Yale medical graduate. Dr. Saundra Shepherd, who 
directed Montefiore Medical Center’s social pediatrics residency 
until her tragic death in October 1992. A day at Montefiore’s day¬ 
care center for AIDS-infected toddlers led to a story about efforts 
to make the lives of these pathetically sick children a bit brighter. 
Amid working on these features, I was researching and writing 
my Yale thesis, a partial biography of the late Dr. Wilbur Downs, 
former director of the International Health Fellowship program 
at Yale. Dr. Downs and I spent hours chatting about his experi¬ 
ences as malaria prevention officer in the South Pacific during 
World War II, including the medical and health policy aspects, a 
feast of knowledge which he served up with a generous side 
portion of personal anecdotes. His stories, combined with a bit 
of digging into the medical archives at Yale, Harvard and the 
library of the Rockefeller Foundation, where he had worked 
before coming to Yale, led to my medical school thesis, “Dr. 
Wilbur Downs: Crusader Against Malaria.” 
A Difference in Perception 
Today I am based in England, covering medical news for the 
London bureau of the Associated Press and writing magazine 
stories on health and medicine for British and American publica¬ 
tions. I also serve as London bureau chief for Physician's Weekly. 
Although the daily grind of journalism is no different here than 
it is in the United States, the title "journalist” goes over a lot better 
on the western shore of the Atlantic. Americans as a rule seem 
eager to discover what we reporters really do. The British already 
know, and they don’t like it. 
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Randi H utter Epstein keeps abreast of medical news as reported in a wide range of publications, from Lancet to the British tabloids. 
Here she works on deadline with AP London news editor, Robert Barr. 
To Americans, journalists are daily reminders of the First 
Amendment. We embody the independent spirit on which our 
nation was founded. Here in England we’re seen as professional 
parasites with a penchant for getting on the nerves of the smart, 
the rich or the famous. Worse, we’re the unwelcome guests at 
cocktail parties for fear we may be taking notes. 
This contrasts with my reception here at the Associated Press, 
where my colleagues were all too happy when I arrived to free 
them from the drudgery of weeding through medical journals. 
My responsibilities include reporting on medical news published 
in the British Medical Journal and Lancet. I read advance copies 
of both journals on Thursday morning, choose a few important 
news stories, interview the authors, get objective comments from 
experts, and ready a quick story by Thursday evening. AP sends 
my stories from London to the main bureau in New York, which 
relays them to newspapers and broadcast media worldwide. 
It wasn’t until I started choosing my own stories that I realized 
how much of the medical journalist’s job extends beyond trans¬ 
lating medical terminology into everyday language. This I 
learned my first week on the job in the spring of 1991. A few 
British doctors wrote a letter to Lancet casting doubt on the safety 
of chorionic villus sampling, because five women in one hospital, 
all of whom had CVS early in pregnancy, delivered malformed 
babies. Realizing that the controversy would be of interest to 
millions of women, I decided to cover the story. 
To balance the claims put forth in the Lancet letter, I got a 
comment from Dr. Laird Jackson of Jefferson Medical College in 
Philadelphia, who keeps a worldwide data base of chorionic 
villus sampling. Not surprisingly, he doubted that the unhappy 
experience of five women proved cause and effect, when eight 
million women who underwent CVS apparently did so with no ill 
effect to their babies. (While some subsequent studies have 
associated CVS with slightly increased risk of premature deliv¬ 
ery, none yet has tied the procedure to birth defects.) 
So, while I led my article with the five women and their babies, 
I concluded the piece with CVS’s apparent safety. Having 
carefully explained chorionic villus sampling in everyday lan¬ 
guage, I transmitted my piece to New York, confident in my 
balanced approach and smug in the knowledge that stories about 
babies always get wide coverage. The British journalists got their 
story splashed across every leading newspaper here. My story 
never made it out of the AP’s New York office. 
“I want to tell you why we didn’t run your CVS piece,” Paul 
Raeburn, the New York-based AP science editor called to tell me. 
The article’s fatal flaw, he explained, was that I didn’t put the 
news in proper perspective. Paul pointed out the harsh reality that 
some of my readers don’t finish my stories. Upon reading about 
CVS and birth defects, pregnant women worldwide might have 
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contacted their doctors immediately, without ever getting to my 
final paragraph. The potential for igniting unnecessary panic was 
too great. 
“You should have started your story with Dr. Jackson's com¬ 
ment,’’ Paul suggested. Then he added the sobering reminder, 
“People believe what they read in the newspaper more than they 
believe their own doctor.” 
This experience added a new twist to the job. Since then, I 
think I spend more time grappling with whether to write a 
particular story than with the writing itself. It’s an aspect of my 
job that I never considered when I decided to become a medical 
journalist. 
A Responsible Balance 
As a doctor, I want to inform the public about the latest in medical 
research and developments in health care. As a journalist, I long 
for that front-page article. 
It’s a lot easier to write about the most recent “breakthrough” 
in cancer—no matter how tenuous the evidence—than to do 
extensive research and decide to write nothing at all. My editors 
see the bottom line: how many of my stories “get on the budget,” 
the AP version of a front-page story. When I choose not to cover 
a story, that’s my own loss. 
[Despite the pressure to produce newsworthy copy. I can’t 
crank out a story about potential cures for AIDS or cancer when 
I picture the patients I helped care for at Yale-New Haven 
Hospital combing the newspapers and perusing television news 
reports, ready to grasp at any hopeful straw. Sometimes my stand 
seems a lonely one. Not too long ago, the London Times Sunday 
reported on its front page that the drug acyclovir cures AIDS. 
Prior to that, the same newspaper gave half a page to a new 
treatment for breast cancer that avoids surgery. I phoned the 
investigator, who confirmed that the procedure had proven effec¬ 
tive—on rats with minuscule tumors. 
“As a doctor, I want to inform the public about 
the latest in medical research and developments 
in health care. As a journalist, I long for that 
front-page article” 
On a positive note, one of the greatest thrills of my job is 
positive feedback from readers (ranking close behind positive 
feedback from editors). A few months ago, I wrote a feature story 
for the AP about autism and was inundated with letters from 
parents of autistic children in New Zealand, Thailand, Venezuela 
and the Philippines. It was the first time I truly realized the 
worldwide impact of Associated Press stories. These parents 
wrote to say how relieved they were to learn that scientists are 
interested in this terrible illness, and that parents have formed 
self-help groups. One parent even sent money; I returned the $7 
one grateful father sent me from Venezuela and put him and his 
fellow correspondents in touch with a British organization of 
parents with autistic children. 
As delightful as such surprises can be, on some level 1 have 
always known that there’s more to medical reporting than simply 
tossing out news briefs. A medical journalist not only provides 
the public with a condensed version of research findings, but also 
offers the reader an opportunity to peek into a world that is 
usually off-limits. An explosion of scientific advances, com¬ 
bined with a rapidly changing health-care delivery system, has 
dramatically whetted the public's appetite for medical news and 
analysis of health care issues. 
People don' t want to hear that butter is bad, they want to know 
why. They not only want to know why one treatment is better, but 
if they can afford it. Readers want the inside story of how 
medical research is shaped, and how it is funded. 
Doctors, too, rely on the lay press for medical news. A study 
in an October 1991 New England Journal of Medicine showed 
that NEJM articles picked up by the New York Times received a 
"disproportionate” number of scientific citations during the 10 
years following publication. During the first year after publica¬ 
tion, NEJM articles reported in the New York Times got 72.8 
percent more scientific citations than control articles. The effect, 
said the investigators, was not noted during a New York Times 
strike, when the newspaper suspended publication. 
The study’s author, David Phillips, Ph.D., of the University of 
California at San Diego, concluded, “Every medical researcher 
develops systematic and non-systematic mechanisms for reduc¬ 
ing and filtering what would otherwise be an overwhelming flow 
of scientific information. Our evidence suggests that a lay 
publication may serve as one of these filtering mechanisms, even 
for scientists.” He said further research is necessary to determine 
whether the lay press not only "amplifies but distorts the trans¬ 
mission of medical information to the biomedical community.” 
Unfortunately, a field like medical and health reporting lends 
itself naturally to sensationalized stories. People read emotion¬ 
ally wrought stories about cures for hopelessly fatal diseases and 
miraculous remedies for the ravages of aging. 
Medical reporting, compared to, say, political reporting, is a 
relatively young beat, still coping with the growing pains of any 
inchoate field. Remember, it wasn't until the past two decades 
that newspapers began dedicating entire sections to health and 
medicine. This relative youth is by no means an excuse for 
shoddy reporting, but perhaps, a reason to hope that as the field 
matures it will weed out more of its sloppy stories. 
Despite sporadic lapses into hysterical print and broadcast 
reports. I’d say the prognosis for medical journalism is good. As 
for myself, as long as I continue to love my work. I'll keep 
plugging away, sitting by the telephone, waiting for responses 
from quotable people, writing in-depth and investigative medi¬ 
cal stories. 
And, of course, waiting for my editors to assign me to a story 
in some exotic place. YM 
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Lerner Award 1992 
Cheme 
by Jan Geiger 
Of all the children who came to play at my house, 12-year-old 
Cheme was the best artist. She almost never spoke, and she rarely 
smiled. When she started throwing up uncontrollably, her 
mother took her to the doctor in town. Cheme wouldn't or 
couldn’t speak, but her brother Moreno said she had eaten a 
strange fruit from the forest, so the doctor gave her a shot of 
antihistamine and sent her home. Moreno came across the river 
in the late afternoon to take me back to his house, where I found 
Cheme sitting slumped and immobile, drooling out of one side 
of her mouth that drooped downward. Her father had stayed 
home from the rice swamp that day to sit and watch her. I 
couldn't get her to respond to me, but she often didn’t answer 
questions even when she was well, so I couldn’t tell exactly how 
out of it she was. When her mother Nuri came home from selling 
fish to tourists, however, she only had to take one look at Cheme 
to start freaking out. She grabbed the girl by the shoulders and 
lifted her up to a standing position, shaking her like a rag doll and 
shouting, “Ay! Ay! Cheme’s dying! I'm going to die, too!” 
Then she dropped the child back into the chair and threw herself 
on the wooden floor, pounding the planks with her fists and 
howling. The house was on stilts a couple of feet off the ground, 
and the corrugated tin roof seemed to amplify sound, so the 
effect was thunderous, especially since Nuri must have weighed 
over 200 pounds. It was like being trapped inside a giant drum 
with an enormous insane infant. While she rocked the place 
thrashing and screaming that if God took her daughter she would 
surely die, I cringed in a corner wondering, “Is this cultural?” 
I sent Cheme and Nuri in the back of a pickup truck first to the 
hospital in town, then to the big provincial hospital in San 
Francisco de Macons. For three days Nuri sent back word daily 
that no doctors had come to see Cheme since her admission and 
that they were doing nothing for her. On the fourth day Moreno 
came before dawn to tell me his father Rufo was going on the 
seven o'clock guagua to Macons to take Cheme out of the 
hospital and bring her home to see the curandero, the local healer. 
I went and asked Rufo to let me talk to the hospital doctors before 
he brought his daughter home, just to find out if there was any 
medicine I should continue giving her while she was under the 
care of the curandero. We agreed that I would start the ride to 
Macons on my motorcycle right away and arrive before him, so 
we could talk to the doctors together. 
I should have made better time on the Honda than Rufo could 
on the loaded-down pickup truck, but the bike started to wobble. 
Halfway there I had to stop and realign the back wheel, so I didn’t 
reach the hospital in Macoris until sunset. The first thing I saw 
inside was a black rat the size of a rabbit running alongside one 
wall of the main hallway. Somehow in trying to find Cheme's 
ward I ended up in the maternity unit, where the preemies were 
lying in bedpans instead of bassinets. I recalled a story that a 
Catholic Relief Services nurse in the capital had told me about a 
rat getting into a premature infant’s incubator and chewing the 
baby’s hands off. Suddenly it seemed possible that the CRS nurse 
had been telling the truth, and that maybe Rufo was right about 
getting Cheme out of that place. I finally found Cheme lying on 
a plastic mattress without sheets, drooling and moaning without 
words, but watching her parents who sat beside her looking 
stolidly hopeless. Nuri told me that Cheme couldn’t move the 
right side of her body or the left side of her face, and that she was 
unable to eat or speak. The mother was sure, however, that the girl 
understood the speech of those around her. 
I went and talked with the hospital director, who told me that 
Cheme had probably had a stroke, but there was no way to tell 
without a CT scan. If a CT scan confirmed a stroke, she could be 
taken care of for free in the big public Children’s Hospital in the 
capital. Since the only CT machine was privately operated and 
in the capital, and Cheme's parents didn’t have the 500 pesos a 
scan would cost, the hospital was, as Nuri had correctly per¬ 
ceived, doing nothing while waiting for Cheme either to die or go 
home. I offered to pay for a scan, and the director promised to 
send Cheme to the capital in an ambulance that was going to 
Santo Domingo for supplies at six o'clock the next morning. I 
went back and told Rufo what the doctor had said, and that I'd 
give Nuri 400 pesos for the CT scan plus bus fare to the capital if 
he’d give her the 100 pesos I figured he was saving for the 
curandero. He gave in immediately, not knowing what the best 
thing to do was, only wanting desperately for someone to do 
something for his daughter. 
After much searching throughout the town I found someone 
willing to change a check for cash at an outrageous surcharge, 
gave Nuri the money and went to a fellow Peace Coips volunteer’s 
house to collapse on the floor asleep. When I awoke the morning 
was already getting bright and hot outside; it was after seven. I 
took my time getting cleaned up; it would have been nice to see 
Cheme off, but since she had already left for the capital in the six 
o’clock ambulance, why not take advantage of the luxury of 
running water? It was almost eight when I went to the hospital to 
thank the director and found Cheme and her parents where I had 
left them; the ambulance had gone without her. 
I sent Cheme bouncing on the bumpy road to the capital in the 
back seat of a cab instead of in an ambulance, and wondered what 
additional damage she might have suffered because of it. The CT 
indeed showed a stroke, and she stayed in Children’s Hospital 
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Jan Geiger and Ramsey Alsarraf: 
From Harvard to Yale 
Fourth-year students Jan Geiger and Ramsey Alsarraf 
share the 1992 Marguerite Rush Lerner Prize for creative 
writing by a Yale medical student. Both honed their 
creative writing skills while Harvard undergraduates. 
Ms. Geiger, after having dropped out of high school in 
Los Angeles, was accepted into the Harvard-Radcliffe 
creative writing program, where she graduated with high¬ 
est honors. She then studied Spanish literature on a Henry 
Fellowship at Oxford. In the Dominican Republic, she 
worked with women and children as a Peace Corps volun¬ 
teer in health education and decided to become a physician. 
Ms. Geiger did neuroscience research at Princeton while 
finishing her pre-medical requirements there. She says, 
“My plans include taking an Indian Health Service elective 
in Alaska and becoming either a pediatrician or a pipe¬ 
smoking radical feminist obstetrician-gynecologist.'’ 
Mr. Alsarraf says his poems “she waits” and “he watches” 
reflect his “interest in the politics of relationships, espe¬ 
cially the way in which meaning and identity exist within 
a relationship between two people in the name of love.” 
The two works are part of a recently composed poetry 
¥ -A 
Jan Geiger and Ramsey Alsarraf 
collection entitled “Tornado Droppings.” While he was an 
undergraduate philosophy major at Harvard, Mr. Alsarraf 
published poems in The Harvard Advocate literary magazine, 
and his short story “Lucy” won the Iguana Press college 
writer’s prize. He is currently hard at work both on his medical 
school thesis, “Nietzsche and the notion of authenticity in the 
realm of existential psychotherapy,” and on editing his first 
short novel. 
there for three months getting anticoagulants and physical therapy. 
She came home to Villa Clara dragging one leg, with a useless 
arm, thick of speech and with a strange inappropriate laugh, a 
kind of disinhibition that made people think she was a little loony. 
Her father refused to put her back in school; though I argued with 
him then, I imagine he was right. I gave her a set of felt tipped 
pens and a sketch pad, but when she tried to scrawl with her non¬ 
dominant left hand, her face crumpled and she threw the pens 
back at me. The following week I invited all the children to my 
house and gave them all crayons and paper. Cheme sat motion¬ 
less in a corner, scowling with one side of her face. She could only 
stand it for about five minutes before she grabbed a crayon away 
from a younger cousin and started drawing. I tacked all her 
pictures up on my walls. 
One day I was boiling drinking water with nobody but elMello 
in the place. El Mello was four years old, supposedly, but he was 
the size of a two-year-old. He was so weird and precocious that 
if he hadn’t had a twin sister who looked exactly like him and 
acted like a normal kid I’d have thought he was actually an 
adolescent dwarf posing as a small child. He was lying in the 
doorway of my house so that every time I went from the front 
porch to the stove he’d get to look up my dress. Each time he 
caught a peek he’d explode into a lewd chuckle that sounded like 
Louis Armstrong laughing after a few drags of helium. Barbina’s 
grandsons were knocking down a palm tree that had become too 
tall so that it wouldn't fall on the houses when the next hurricane 
came. Barbina, who was about 90 years old. was standing in the 
courtyard between the houses squinting through her cataracts and 
telling them they were doing it all wrong, but they laughed and 
told her to stick to women’s business. 
At a certain moment it dawned on me that perhaps I ought to 
get off the porch, so I grabbed el Mello and ran into the courtyard. 
Within several seconds the palm tree tipped the wrong way, 
toward the houses, and started to fall. Everyone who had been 
idling around watching operations ran like hell, totally panicked, 
grown men pushing children out of their way as the tree crashed 
down and flattened the front half of my house. The palm also 
knocked down an orange tree, so the courtyard was awash in 
frantic chickens, rolling coconuts, green oranges, and children 
running after all the fruit. Only Barbina remained motionless 
exactly where she had stood while haranguing the men about their 
technique, about 10 feet out of range of the fallen tree, wearing 
an ancient-goddess-I-told-you-so look. El Mello, still in my 
arms, has stopped with the Louis-Armstrong-on-helium laugh 
and was now staring at the pile of rubble and dust where the porch 
used to be murmuring “ jCoho! ” I was wondering where my dog 
was when I became aware of Cheme laughing her head off from 
the rocking chair on Barbina’s porch across the way. It didn't 
sound inappropriate to me now; it sounded like exactly the right 
thing to be doing, and soon I was laughing like crazy, too. YM 
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she waits 
She waits like a rodeo for everything to become empty 
holding her head on hands of brazen silk, lost days 
with no one watching silence sprouts like weeds, 
a hiding that laughs she as a diamond 
wind bent trees in their faces, follows the shadows 
sunrise through hallowed tracts of woman thoughts 
as half bored wolves scoop breadcrumbs from the woods, 
torn blue from time, wrapped tight in moonlight's arms 
a voice awakens darkness depth speaks leavings left alone, 
her swollen eyes find home opening the breeze that blows 
their colors like blades of grass cut nothing to the floor, 
she pauses with the record, a skipped headless heart untold, 
stands and moves as windows shake december cold, 
with summer pressed lips the moss blankets her feet 
frozen, then spread wide to the browning soil would stop, 
the rush of voices root the earth beneath her 
and bury her treasure like snowflakes in the winter air. 
V J 
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he watches 
He watches her go and thinks of summer nights 
where the roundness of the world holds court in crickets 
and stars, a melody born to bathe them in faith. 
Rising water covers their heads with warmth 
like children under the blankets on cold Sunday mornings, 
buries them together in the sky. 
Her laughter pulls him from his blinded head 
to lift him up past doubt on moonbeams from her smiling 
eyes; tomorrow becomes perfume in her hair. 
But there he lays awake with empty lips 
the thirsty hollow man who dreams of tasting her tonight 
like raindrops in the desert of his soul. 
He closes, keeps her sweet scent in his heart, 
pulls sleep like sand across his face; her kiss again seals 
his life, and keeps him insane each time they part. 
Ramsey Alsarraf 
V 
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Rare Disease Research: 
The Road Less Traveled 
”Nature is nowhere accustomed more openly to display her secret mysteries than in cases where she 
shows traces of her workings apart from the beaten path. ” 
1657, William Harvey, the first physician to describe blood circulation 
by Sandra J. Ackerman 
It started with a single patient in 1986 at the University of 
Milan. A physician drew a vial of blood from a 49-year-old 
Type I diabetic woman who also suffered from stiff-man syn¬ 
drome—a neurological disorder so rare that during the past 30 
years, fewer than 100 cases had been reported in the literature. 
With its symptoms of rigidity and painful spasms of the skeletal 
muscles in the trunk and limbs, the virtually unknown disease 
resembles chronic tetanus and is often misdiagnosed as hysteri¬ 
cal paralysis. 
Analysis of this patient's blood, however, would provide a 
kind of Rosetta stone linking one of the world's rarest diseases 
with one of the most common. The lingua franca proved to be the 
antigen GAD (glutamic acid decarboxylase), an enzyme that 
synthesizes the neurotransmitter GABA, and that triggers an 
autoimmune reaction both in stiff-man syndrome and Type I 
diabetes—also known as insulin-dependent diabetes mellitus, or 
1DDM. Hence, the study of an extremely rare disease helped 
launch a biomedical research effort that may one day help 
millions of Type I diabetics lead longer, healthier lives. 
That effort has been led by Pietro De Camilli, M.D.. professor 
of cell biology, who with several of his Milan colleagues was 
recruited to Yale in 1988. Since 1992, when Dr. De Camilli also 
became a Howard Hughes Medical Institute investigator, his 
team has been based at the Boyer Center for Molecular Medicine. 
With their arrival from Milan, Dr. De Camilli and his colleagues 
joined the many YSM scientists whose research includes rare 
diseases. 
In explaining the tie between stiff-man syndrome and diabe¬ 
tes, Dr. De Camilli notes that scientists have come to understand 
Type I diabetes as an autoimmune disorder in which the body’s 
defenses destroy the insulin-secreting beta cells of the pancreas. 
Often, by the time physicians administer the classic blood test for 
IDDM. most of the beta cells already have been destroyed, 
leaving little chance to control further damage to the besieged 
pancreas. 
Sandra J. Ackerman is a free-lance writer living in New Haven. 
Her book. Discovering the Brain, was published in March 1992 
by the National Academy Press. 
Further research into stiff-man syndrome may lead to diagno¬ 
sis of IDDM before much—or perhaps any—such beta cell 
damage has occurred. The study of this rare disease, which is 
often associated with IDDM, led the De Camilli team to hypoth¬ 
esize that the same or similar autoimmune process could be 
involved in both conditions. Collaborating with colleagues at the 
University of California at San Francisco, the Yale researchers 
discovered that the immune system in about 80 percent of Type 
I diabetics reacted to the GAD antigen. This finding may provide 
the basis for a sensitive, highly specific assay. This assay could 
make it possible to detect even a pre-diabetic condition, in which 
the immune system is just gearing up for a devastating attack on 
the pancreas. 
Should biomedical science continue its progress toward 
discovering how to prevent autoimmune diseases, physicians 
may one day be able to prevent IDDM altogether. Short of 
prevention, with careful monitoring, early detection could allow 
treatment from the onset of Type I diabetes, minimizing the 
disease’s destructive impact. 
Research into stiff-man syndrome affirms William Harvey’s 
sage observation that coming to understand a medical anomaly 
can throw new light on the human body’s best kept secrets. This 
knowledge, in turn, often can be applied to treat not only the rare 
disease itself, but also common diseases. 
When Roads Diverge 
Deciding which of myriad rare diseases to investigate, and how 
to pursue their study, involves many factors, ranging from the 
availability of funds to the background, interests and even the 
intuition of the researchers. In the case of stiff-man syndrome, 
explains Dr. De Camilli, the team had stumbled onto the disorder 
because of “serendipity and a brilliant co-worker”—Michele 
Solimena, M.D., who today works at Yale with Dr. De Camilli as 
a postdoctoral fellow. Dr. De Camilli also credits an insightful 
team of clinicians at the St. Raffaele Hospital at the University of 
Milan. 
The Milan scientists already knew that nerve cells and hor¬ 
monal cells similarly dispensed some of their chemical signals, 
such as neuroactive peptides and peptide hormones; the research¬ 
ers wanted to find out if other common mechanisms also were at 
work. Their pursuit of this question led to the discovery that 
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Pietro De Camilli, M.D. (left) with postdoctoral fellows Maggie Butler, Ph.D., and Michele Solimena, M.D. 
!! endocrine cells contained organelles, specialized pouches which 
release neurotransmitter, much like the synaptic vesicles in nerve 
cells. The researchers came to the hypothesis that insulin- 
secreting beta cells of the pancreas also secrete the neurotrans¬ 
mitter GABA through the organelles. 
Says Dr. De Camilli, “This finding prompted us to hypoth¬ 
esize that if something went wrong with the organelles, one I should expect both a neuronal disease and an endocrine disease.” 
Their suspicions were confirmed when Dr. Sol imena came across 
the woman suffering from both stiff-man syndrome and Type I 
diabetes. Studies of this patient’s blood led to the discovery that 
GAD. the protein associated with synaptic vesicles of GABA- 
secreting neurons and with the organelles of pancreatic beta cells, 
was a major target to autoimmunity in both diseases. 
This research offers a new model in which to study the 
interplay between both humoral and cellular immunity, two 
kinds of “smart bombs” in the body’s biochemical arsenal. To 
do its job, humoral immunity uses antibodies circulating in the 
blood; cellular immunity uses white cells, or lymphocytes, 
which are summoned as needed from the lymph nodes, spleen 
and other parts of the lymphatic system. 
Humoral and cellular immunity address different challenges. 
While antibodies clean up invading proteins outside the cells, 
foreign proteins that insinuate their way inside cells become the 
responsibility of white cells. This is because only white cells can 
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“see” through other cells’ outer membranes. 
In rare instances, the body may produce an immune response 
in two phases, rendering a kind of “one-two punch.” This may be 
the case. Dr. De Camilli speculates, in the autoimmune reaction 
to GAD. The first punch, a cellular response, occurs when cells 
which express the antigen GAD are targeted by lymphocytes. 
This occurs both in people who develop stiff-man syndrome or 
1DDM. 
The lymphocyte raid sets up the second punch, a humoral 
response, as the debris from the white-cell attack makes its way 
to another class of lymphocytes, and thereby triggers the produc¬ 
tion of circulating antibodies to help destroy the violated cell. 
This model suggests the need for developing finely tuned therapy 
for autoimmune disorders, with the goal of treating the initial 
immune reaction without disabling the entire immune system. 
The Road Not Taken 
Must a disease be as scarcely reported as stiff-man syndrome 
before it is termed rare? Not according to the federal government. 
In 1983, in passing the Orphan Drug Act, Congress set the rare 
disease incidence level at fewer than 200,000 Americans, about 
one in 1,250. 
Continued on Page 19 
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YSM Faculty Member, Alumnus 
Lead in Treatment, Research 
Of Rare Genetic Disorder 
Hereditary hemorrhagic telangiectasia (HHT). 
Although able to twist the tongue of the most eloquent 
physician. HHT does offer a more descriptive name for the 
progressive, inherited malformations of arteries and veins than 
did its former moniker, Osler-Weber-Rendu syndrome. In this 
rare, progressive disor¬ 
der. blood vessel fistu¬ 
las—a kind of short cir¬ 
cuit—develop between 
the arteries and veins in 
the lung, brain, gastroi¬ 
ntestinal tract, skin and 
nose of patients. When 
fistulas appear in the 
lung, they lead to a re¬ 
duction in blood oxygen 
and predispose the pa¬ 
tient to stroke and other 
potentially fatal develop¬ 
ments. 
Robert I. White Jr., 
M.D., professor and 
chairman of diagnostic 
radiology at Yale and 
Yale-New Haven Hos¬ 
pital, first treated the lung 
fistulas of patients with 
HHT by blocking them 
with detachable balloons, a technique called balloon embolization, 
which he invented while at Johns Hopkins Medical School in the 
late 1970s. With this non-surgical technique, the physician uses 
an image-guided catheter to repair the damage caused by HHT, 
at much lower risk—and cost—to the patient than with surgery, 
which was the previous treatment of choice. 
Dr. White’s commitment to HHT patients led him to form, 
with his patients and their families, a non-profit foundation, HHT 
Foundation International, based in New Haven, and to chair its 
medical advisory board. Other medical faculty who serve on the 
board are David J. Leffell. M.D., assistant professor of dermatol¬ 
ogy, and Pierre Fayad, M.D., assistant professor of neurology. 
Dr. Leffell treats skin telangiectasias by tunable dye laser, and Dr. 
Fayad is studying brain-lung relationships in patients with HHT. 
Comments Dr. White, “The work of the foundation centers on 
patient and physician education and development of new diag¬ 
nostic and treatment methods. Approximately 10 percent of these 
patients die from the disorder and another 20 to 30 percent will 
have a serious complication. Many of these patients are walking 
around with a medical 'time bomb’ loose in the brain or lung. 
Many serious complications such as hemorrhage or stroke occur, 
but fortunately, if patients with HHT are screened, these compli¬ 
cations can be avoided by treatment using interventional radiol¬ 
ogy techniques.” 
Complementing this faculty commitment to clinical and vol¬ 
unteer work with HHT is the genetic research of a distinguished 
Yale alumnus. Francis S. Collins. M.D., Ph.D., director of the 
Human Genome Center at the University of Michigan and a 
Howard Hughes Medical Institute investigator, also serves on 
HHT International’s medical board. Having graduated from 
Yale in 1974 with a Ph.D. degree in physical chemistry. Dr. 
Collins returned to New Haven for a post-doctoral fellowship in 
human genetics after receiving his M.D. degree at the University 
of North Carolina and completing his internship and residency at 
North Carolina Memorial Hospital. 
In his search for the HHT gene. Dr. Collins hopes to repeat the 
success of his research team in identifying the genes for cystic 
fibrosis and neurofibromatosis—crucial discoveries which have 
helped biomedical scientists focus their research. As he did in his 
previous landmark efforts. Dr. Collins is using positional cloning 
in his hunt for the HHT gene. 
Positional cloning begins with using family genetic histories 
to approximate the position on a chromosome for a disease gene. 
Researchers then compare the patient's DNA in that chromo¬ 
somal area with that of healthy subjects to reveal any defects. 
Dr. Collins comments: "There are approximately 100.000 
genes scattered throughout the 24 chromosomes of man, so 
finding the right one is a difficult process which has been 
compared to trying to find a burned-out light bulb somewhere in 
the United States without initially knowing what state to look in. 
Though the process is laborious and difficult, the technology for 
achieving it is getting better and better, and the time is right to 
carry out such a strategy for HHT.” 
Gregory R. Huth 
Dr. Robert /. White Jr. 
Dr. Francis S. Collins 









Dr. Margretta R. Seashore 
Continued from Page 17 
Taken together, though, rare diseases are not so rare at all, 
notes Abbey Meyers, executive director of the National Organi¬ 
zation for Rare Disorders (NORD). She estimates that in the 
United States, rare diseases comprise more than 5,000 disorders 
affecting between 10 and 20 million people. NORD, based in 
New Fairfield, Conn., is a non-profit group of patients and 
families, biomedical scientists and voluntary agencies which 
works with government, industry and academia to advance rare 
disease research. 
While rare diseases cut across the full spectrum of society, 
their toll is not evenly distributed. Joseph B. Warshaw, M.D., 
chairman of pediatrics at Yale and Yale-New Haven Hospital, 
points out that children bear more than their share: “Most 
problems that affect children, and that have a genetic basis, can 
be described as orphan diseases.” Dr. Warshaw points out that the 
genetic disorders that affect metabolism, for example, usually 
appear as childhood diseases. Moreover, if these disorders are 
severe, they may be poorly represented among adults simply 
because few patients survive to adulthood. 
Margretta R. Seashore, M.D., professor of genetics and pedi¬ 
atrics, conducts research into such metabolic errors, in addition 
to her clinical work with patients with rare disorders. When we 
are healthy, she reminds us, it may be easy to take for granted the 
crucial processes of metabolism. Through metabolism’s intri¬ 
cate series of chemical reactions, the body breaks down every¬ 
thing we eat, breathe, or otherwise ingest, and uses the resulting 
products for energy and for building new tissues, eliminating the 
waste from the body. 
“It all works wonderfully, when it works,” says Dr. Seashore. 
“But there are several hundred inherited disorders of metabolism. 
Usually, these involve a single defective enzyme, resulting in 
very profound consequences.” Take, for instance, a group of 
disorders that involves the urea cycle—the breakdown of amino 
acids in proteins. One such disease makes it impossible for the 
body to detoxify itself of a by-product of this cycle: ammonia. 
The disorder can be quite serious, because excess ammonia in the 
blood can damage the brain. Another metabolic defect may result 
in abnormally high levels of lactic acid, which interfere with 
eating and breathing. 
With the possible problems so numerous and the clues that 
distinguish them so subtle, diagnosing a specific disorder of 
metabolism poses no small challenge. Dr. Seashore has begun a 
project to develop ways to help improve the physician’s odds for 
an accurate diagnosis. Funded by the New England Regional 
Genetics Group, this project will produce a computer program 
that will guide clinicians through the series of observations that 
leads to diagnosis of little-known metabolic disorders. 
“These disorders are so rare that no one can have all the 
expertise required to recognize them,” says Dr. Seashore. “The 
computer program will be as much an educational tool as a 
diagnostic one.” 
Dr. Seashore also is working on several clinical research 
projects directed at better understanding and treatment of meta¬ 
bolic disorders. These include studying the use of the drug 
betaine in disorders of sulfur metabolism and developing ways to 
diagnose a metabolic disorder in children whose ailments are 
suspected to arise from metabolic disorders but whose diagnosis 
is unclear. 
“We will be challenging these young patients with fats, 
proteins and carbohydrates to determine which of these causes 
difficulties, in order to adjust their diets accordingly," Dr. Sea¬ 
shore explains. 
Dr. Diane M. Komp 
















Other Yale researchers are looking to prevent rare childhood 
diseases that originate in the womb. One such disorder is being 
studied by Martina Brueckner, M.D., assistant professor of 
pediatrics (cardiology), a specialist in congenital heart disease. 
Dr. Brueckner’s research includes acondition called situs inversus, 
in which the internal organs of the trunk and abdomen are mirror- 
image reversed. 
In a case of complete situs inversus, for example, the heart and 
stomach are located on the right, while the liver resides on the left. 
When this occurs, a problem does not usually arise, says Dr. 
Brueckner. She explains, however, that such is not always the 
case: “The patients we see have an incomplete form of the 
condition; for instance, the stomach and liver are in normal 
position, but the heart instead of being on the left is on the right. 
These patients frequently have severe congenital heart disease.” 
Scientists believe that the genetic coding which determines 
"left” and “right” in the body expresses itself very early in 
development, probably in the first three weeks of gestation. 
Hence, a heart that is misplaced relative to the other organs cannot 
form the usual connections and fails to develop normally. Re¬ 
garding diagnosis, “this condition is usually picked up pretty 
early in life, often prenatally by ultrasound,” says Dr. Brueckner. 
Many of these patients require heart surgery before the age of 3. 
Even as the detection and treatment of incomplete situs 
inversus are now fairly standard, tracking down the mechanism 
by which the condition arises has become a research focus of Dr. 
Brueckner and other Yale researchers. She works closely with 
Arthur Horwich, M.D., associate professor of genetics and pedi¬ 
atrics, and David Ward, Ph.D., professor of genetics and of 
molecular biophysics and biochemistry. 
Dr. Brueckner comments: “Inherited defects have been iden¬ 
tified in both mice and humans that lead to loss of control over the 
development of left-right asymmetry of the heart and viscera.” 
Dr. Brueckner is studying the mouse mutation iv (inversus 
viscerum), which results in an inherited abnormality of develop¬ 
ment of left-right symmetry. In these studies, she uses positional 
cloning, a technique that led to the cloning of cystic fibrosis gene. 
[See “YSM Faculty Member, Alumnus Lead in Treatment, 
Research of Rare Genetic Disorder,” Page 18.] 
Dr. Martina Brueckner (left), postdoctoral fellow Jing Yao, 
M.D., and laboratory’ technician Aphakorn Nittarajarn. 
Pharmaceutical Safety Net 
Offered for Patients in Need 
For some patients in financial straits, an expensive pre¬ 
scription drug—even if vital to their health—may be be¬ 
yond their means. In such cases, the pharmaceutical 
industry has an informal tradition of providing the medi¬ 
cine free of charge, through the office of the attending 
physician. 
The PM A now hopes to begin formalizing this approach 
with a pilot program to help physicians find out what is 
available for patients in need. The program consists of two 
parts: 
• a directory that lists 59 "drug indigent programs” by 
name of the providing company; 
• a PMA hotline whereby physicians can learn which 
companies offer a specific drug, and under what 
circumstances. 
The hotline number, 1-800-PMA-INFCK 1-800-762-4636), 
is toll-free; (within area code 202, call 393-5200). For a 
copy of the directory, write to: 1992 Directory of Pharma¬ 
ceutical Indigent Programs, PMA, 11015th St. NW, Wash¬ 
ington, D.C. 20005. 
“So far, we have localized the iv gene to a small region on 
mouse chromosome 12 and we are isolating the DNA containing 
it," reports Dr. Brueckner. "Once the gene is identified and its 
DNA sequence known, the iv gene product can be analyzed and 
detailed studies of its function in the developing animal can be 
carried out to better understand the mechanism by which it helps 
direct left-right asymmetry and early cardiac development.” 
She adds that the location of iv on mouse chromosome 12 
corresponds to a position on human chromosome 14, and that 
researchers are studying human families with congenital heart 
disease, which may represent the equivalent of the mouse iv 
mutation. 
Like Dr. De Camilli, Diane M. Kornp, M.D., professor of 
pediatrics, and colleagues have focused much of their profes¬ 
sional attention on an extremely rare immune disorder. They are 
studying a blood disease called familial erythrophagocytic 
lymphohistiocytosis (FEL). [See “Laboratory Medicine’s Wid¬ 
ening Clinical Horizons,” Page 24.) In this condition, arising 
once in about a million live births, the histiocytes (a type of blood 
cell that carries out immune functions) proliferate abnormally 
and destroy other vital elements in the blood. 
FEL shows a clear pattern of inheritance: In a family in which 
both parents are carriers, children have a one-in-four chance of 
inheriting the condition. Just what goes wrong in FEL? To find 
out, the researchers studying some of the cell products that the 
disorder appears to affect. 
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A National Network for 
Information and Support 
To encourage people to form support groups on specific 
rare diseases, the National Organization for Rare Disorders 
(NORD) maintains a networking service for patients and 
their families. In this confidential service, NORD releases 
names and addresses only to other families affected by the 
same disorder, or to a voluntary agency dedicated to the 
specific disorder. Anyone may register for this service 
upon joining NORD; annual dues are $25. 
NORD also offers reprints and articles from its database 
on rare diseases. Each entry describes in non-technical 
language the symptoms, causes and treatments of a particu¬ 
lar disorder and includes a list of related resources. The 
continually updated database lists more than 850 rare 
diseases; reprints cost $3.25. 
NORD’s address and telephone number are: 
100 Route 37, P.O. Box 8923 
New Fairfield, CT 06812-1783; (203) 746-6518. 
"One particularly interesting product in the blood was soluble 
interleukin-2 receptor, which is produced normally in response to 
infections,” says Dr. Komp. "What we found, to our surprise, was 
that its level in the blood of children with FEL is far in excess of 
what is seen in most patients with benign or even infectious 
diseases. The levels are more in the range of those seen in, say, 
leukemia. This implies that FEL is a disease of regulation— 
affecting the orderly growth and multiplication of cells—that 
falls somewhere between benign and malignant. 
Dr. Komp, too echoes William Harvey as she reflects on this 
twilight zone of medical science: “To unravel the sequence of 
events that leads to the death of one in a million children, as in 
FEL, may lead to discovering the sequence of events in other 
borderline diseases.” 
Effective Funding: To Make All the Difference 
Scientists who study rare diseases at Yale cannot help but be 
affected by the national debate over how to allocate limited funds 
for biomedical research. Some advocates for increased funding, 
including NORD's Abbey Meyers, suggest that a more effective 
allocation would result from a national research policy on rare 
diseases. 
“In my opinion there has been a purposeful lack of policy,” 
Ms. Meyers says. “The National Commission on Orphan Dis¬ 
eases, created by Congress, submitted its report in 1989, a 
document which has been virtually ignored. The commission 
found that too many agencies and departments have control over 
research on rare diseases, and they're not talking to one another. 
“For example, although the National Institutes of Health 
(NIH) funds a project, the researchers may have to submit their 
findings to the Food and Drug Administration (FDA). But the 
FDA says, ‘We didn't order this study; you didn't set it up 
according to our criteria, you didn't do the protocol.”’ Ms. 
Meyers concludes, “A lot of money is wasted in this way.” 
Although the commission's report calls for establishing a 
central coordinating office on rare diseases in the U.S. Depart¬ 
ment of Health and Human Services above the level of the NIH 
and the FDA, such a step does not appear on the horizon. 
Ms. Meyers also protests that federal funding more often is 
distributed according to public pressure than scientific judgment. 
She observes, “Priority is given to the diseases that people fear 
most,” virtually guaranteeing an inequitable distribution of re¬ 
sources. 
Says Ms. Meyers, "The commission found that in 1987, the 
federal government spent slightly more than $1 billion on rare 
diseases. But over half this amount went to rare forms of cancer, 
numbering only 200 or so. Meanwhile, 4,000 other rare diseases 
have to share the rest of that pie.” 
Despite such funding inequities, back in the clinics, the 
laboratories and the research offices, the prospect of taking the 
road less traveled still holds its appeal. For some rare disease 
researchers, perhaps those with a taste for riddles that promise a 
germ of universal truth, the potential rewards offer great allure. 
Pediatrician Warshaw explains: “If you say to one person in 
the department, 'Here, you can work on this problem. It affects 
one in 3 million people, and you can spend 10 years on it and it 
will never relate to anything else in the world'—do you think 
anyone is going to want to do that? But if the problem has 
implications for some aspect of normal functioning of the body 
that we haven’t understood up to now, then it becomes exciting.” 
In yet another 20th-century paraphrase of William Harvey, 
Dr. Warshaw concludes, “The more you understand about rare 
diseases, the more you understand about normal function.” YM 
Dr. Joseph B. Warshaw 












by Michael B. Bracken, Plt.D., M.P.H. 70 
In the 1989 Turner Committee report, the department of epide¬ 
miology and public health (EPH) was invited to—and eagerly 
took advantage of—an offer to completely review its M.P.H. 
curriculum for the first time in 25 years and, possibly, longer. 
What was the philosophy underpinning this review? 
First, it should be obvious that profound changes have oc¬ 
curred in the science of public health. Molecular biology is 
advancing at such a rapid pace that even those of us within the 
academy have a hard time keeping up. Our students must know, 
for example, that p53 is not a school in the Bronx but an important 
tumor suppressor gene that plays a vital role in the development 
of several cancers. They must understand that PCR is not one of 
the new Baltic republics but polymerase chain reaction, a tech¬ 
nology which underpins many public health programs, including 
the needle exchange program for which New Haven is justifiably 
proud to be a leader. The faculty recognized that some grounding 
in the concepts of molecular biology was necessary for profes¬ 
sionals entering public health. Yale was the first school to 
implement such a requirement and other major schools are now 
following our lead. 
Those of you who recall computing as staggering over to the 
Yale Computer Center with boxes of IBM cards, and then 
returning the next day for the error messages, now realize that 
today's professionals have more computing power sitting on 
their desk than the big Yale computers had in 1968 when I first 
used them. Moreover, this increase in computing power has been 
accompanied, or perhaps driven, by enormous increases in our 
capacity to manage and analyze huge quantities of statistical and 
economic data; hence, the need to reflect these changes in the 
new M.P.H. program and to bring practical experience of data 
handling into our classrooms. 
EPH has preserved its traditional six divisions: biostatistics; 
chronic disease epidemiology; environmental health; health policy 
and resources; infectious disease epidemiology; and microbiol¬ 
ogy; as a way of administering the department, protecting profes¬ 
sional identity and organizing specialty research and training 
with some efficiency. However, the AIDS pandemic shows us 
once more—there have been numerous earlier examples—the 
ultimate futility of separating chronic from infectious disease 
epidemiology. Similarly, the need to understand the problems of 
addictive behaviors, or how to bring health care to the underserved, 
highlights the absurdity of delineating economics from health 
policy, or psychology from sociology. The resurgence of malaria 
This article is based on an address delivered on June 5 by Michael 
B. Bracken, professor and vice chairman of epidemiology and 
public health, to EPH graduates returning for alumni weekend. 
throughout the world is another 
example that highlights the 
need to consider economic and 
health policy along with agri¬ 
cultural policy. 
In the late '60s, when I 
worked on family planning pro¬ 
grams in Jamaica, we thought 
we understood the need to in¬ 
corporate family planning into 
general maternal and child 
health programs and to link 
them with reductions in infant 
mortality. But we were naive 
in ignoring at least two other 
major elements now under¬ 
stood to be critical. First was Michael B. Bracken 
the effect of the role and status 
of women in society generally; better educated women through¬ 
out the world have smaller families. Second, we didn't under¬ 
stand how overuse of agricultural land and decreased productiv¬ 
ity lead to the need to cultivate more land, requiring larger 
families to work unproductive fields. Again, this points to the 
importance of integrating policy in the health, economic and 
agricultural arenas. 
And so the M.P.H. degree core program must necessarily be 
integrated and interdigitated among many specialties; this is 
something the faculty is continuing to fine tune. It is also a 
University-wide tradition at Yale that professors, not teaching 
assistants, teach most of the introductory courses. To preserve 
that tradition in EPH, to upgrade the content of the introductory 
courses and to more efficiently organize our small department, all 
of the core courses are now taught by faculty from the relevant 
specialty. Each specialty core course for all students is also the 
introductory course for students in that specialty. The effect on 
streamlining the program is shown by having a single principles 
in epidemiology course replacing three or four previous introduc¬ 
tory courses. Similarly, one introduction to health policy course 
has replaced two or three courses. 
The philosophy that inter-specialty training is imperative also 
led to a conclusion that the department should construct well 
organized cross-divisional majors—the first of which is in inter¬ 
national health—and reconstruct our joint degree programs with 
the schools of organization and management, forestry, law and 
medicine, and the Center for International and Area Studies. 
But public health remains essentially an art. It is always 
community-based, requiring leadership skills and the ability to 
negotiate for competing demands on scarce resources. If John 
Snow—the 19th-century physician who stopped a cholera epi¬ 
demic in London by removing a neighborhood pump handle— 














wanted to do so today, he would need to network with community 
leaders; interface with governmental agencies; write an environ¬ 
mental impact statement; and obtain Human Investigation Com¬ 
mittee approval. Clearly, public health training must include 
practical training within health agencies and these components, 
the community project and the practicum, also were strengthened 
in the new M.P.H. program. 
It is also inconceivable that today’s leaders in public health 
will not be required to prepare major reports which generate 
data—or synthesize it—to draw conclusions about public health 
practice. Consequently, the thesis was maintained as an impor¬ 
tant integrating experience for the M.P.H. degree, a requirement 
which still sets the Yale degree apart from most others. 
What has been the impact of the new M.P.H. program? The 
need for more rigor in the introductory core has led to a necessary 
tightening of admission standards. Compared to recent class 
sizes of about 100, we expect in future years to matriculate 
between 60 and 80 students a year. 
C.P. Snow told the story about the Lucasian Chair of Math¬ 
ematics at Cambridge, the chair now held by Stephen W. Hawk¬ 
ing of “black hole” fame. An early incumbent of the chair had a 
student who was so brilliant that the professor simply turned over 
his chair to him. That student was Isaac Newton. The present 
EPH faculty will be pleased to learn that while the new M.P.H. 
class has been improved academically, their positions have not so 
far been threatened. However, it is encouraging that we have 
observed a 60 percent decrease in the proportion of students 
graded as failing or simply passing in the recent fall semester 
when most courses are required, and a 40 percent increase in 
students graduating this year with double honors in the thesis 
compared to the previous seven-year average. 
We are one of the oldest public health programs in the country 
and probably the smallest. But a school which is committed to 
training future leaders of public health, as we are, does not need 
to be large—it needs to be good. Small is better. Our very 
favorable student-faculty ratio leads to a collegiality between 
faculty and student which is not possible in most other schools. 
If William T. Sedgwick, C. E.-A. Winslow, Ira Hiscock and 
John Rodman Paul were to walk through our doors, they would 
still recognize the underlying values of our public health program 
(while being astonished at how quickly we could calculate a 
regression coefficient). Even when the human genome is fully 
described, as it will be; after our statistical models explain 80 
percent of the variance in breast cancer rates; and when the most 
sophisticated health management tools have been made opera¬ 
tional—all worthy goals—we will still need to deliver health care 
to the under served, understand the social and political barriers to 
health services, and appreciate why people engage in risk-taking 
behaviors. The most sophisticated, molecular-contrived de¬ 
signer drugs, some being created at Yale, will all need to be 
evaluated for their effectiveness and safety in human trials. 
And so the philosophy of the Yale M.P.H. program, after all 
our strategies to modernize it, remains essentially undisturbed. 
The timely has not displaced the timeless and innovation has not 
usurped the fundamentals. In restructuring the M.P.H. program, 
we have also rediscovered the foundations of our discipline: the 
new science and the old liberal art of public health. 
But perhaps above all else, the philosophy of the Yale M.P.H. 
program is one of preparing students for problems w hich cannot 
now be contemplated. None of us can know what will challenge 
the public’s health in the next 20 years. Just as a short time ago 
we could not anticipate that the fourth leading cause of death 
would be a disease called AIDS, we must recognize that the next 
disease to challenge us may already have mutated in some, as yet 
unknown, vector. Who, in the Class of 1980, could have 
predicted that we would be concerned about the health effects of 
electromagnetic fields and global warming, and who would have 
guessed the extent of the catastrophe of environmental pollution 
and its effect on health, not just in Eastern Europe but here at 
home. 
“If John Snow wanted to remove the pump 
handle today, he would need to network with 
community leaders, interface with 
governmental agencies, write an 
environmental impact statement and obtain 
Human Investigation Committee approval 
Even old problems need new solutions. As someone who has 
admired 2,000-year-old aqueducts and septic systems on the 
northern edges of the Roman Empire, it is depressing to realize 
that 40 percent of the world's 5 billion people still lack those most 
basic of all public health needs: clean water and adequate 
sanitation facilities. My own M.P.H. Class of 1970 worried that 
the United States ranked 14th on the world's infant mortality 
tables—now, 20 years later, we rank 24th. Little did the Class of 
1970 guess that 20 years on, 20 percent of our population would 
still be without health insurance coverage, or that all of our cities 
would have countless mentally ill homeless on their streets. 
And so, because we cannot predict what will engage public 
health specialists in the 21st century, we must prepare our 
students in the fundamentals rather than in short-lived facts; train 
them in values and methodologies, not give recipes for simplistic 
solutions; teach principles rather than particularities. We try to 
instill creativity and innovations, and the importance of scholar¬ 
ship and careful extrapolation from known data. 
I see no conflict between an academic program that insists on 
rigor but is nurturing; that insists on excellence and takes the time 
for excellence to grow, and this is surely best accomplished in a 
small program such as ours. We can be optimistic about the future 
of public health at Yale. I believe Yale will continue to set a 
standard for what education in public health ought to be and that 
the philosophy which has driven public health at Yale for the 
previous 75 years will continue to serve us well into Yale’s fourth 
century. YM 
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Laboratory Medicine’s 
Widening Clinical Horizons 
by John Dinolfo 
For some, laboratory medicine may conjure up images of white- 
coated clinicians hunched over batteries of blood tests in a 
sequestered world far removed from direct patient care. In 
reality, laboratory physicians increasingly find themselves at the 
bedside, using new transfusion products and helping primary 
physicians interpret faster, more accurate diagnostic tests for 
deadly infections, cancers and other diseases. 
Nowhere is this more evident than in Yale’s department of 
laboratory medicine, where research and practice regularly bridge 
the gap between basic and clinical science. Often this means 
helping to extend fragile lives that may have been lost just a few 
years—or months—ago. 
Consider the case of Katherine, who at 17 months of age, 
underwent a bone marrow transplant in March 1992 for the rare 
and usually fatal congenital disease, FEL (familial 
erythrophagocytic lymphohistiocytosis). Katherine had been 
referred to Diane M. Komp, M.D., professor of pediatrics, a 
specialist in the rare disease. Dr. Komp made the diagnosis after 
reviewing an autopsy report of the child’s elder brother, who had 
died as an infant from an undetected case of FEL. 
Recalls another member of the treatment team, Joel M. 
Rappeport. M.D., professor of medicine and pediatrics, “Without 
a transplant, Katherine, like her brother, surely would have died.” 
Dr. Rappeport is director of bone marrow transplantation at Y ale- 
New Haven Hospital (YNHH). 
Brian R. Smith, M.D., associate professor of laboratory medi¬ 
cine, internal medicine and pediatrics, explains the challenge 
posed by FEL: “For unknown reasons, blood-derived cells 
known as histiocytes, which normally consume invading germs, 
begin to attack the body’s own red blood cells and accumulate in 
the liver, spleen and sometimes, central nervous system. Chemo¬ 
therapy can stave off the disease for one to two years. The only 
way to cure FEL, however, is to replace all the abnormal cells 
from the bone marrow with a bone marrow transplant.” 
Director of research for bone marrow transplantation at Yale 
and director of the clinical immunology laboratory at YNHH, Dr. 
Smith identified a unique type of lymphocyte in Katherine’s 
blood, bone marrow and spinal fluid, which appeared only during 
the active stages of her disease and vanished when the illness was 
in remission. The same cell type has now been found in two other 
children with similar diseases and work is ongoing to determine 
what role this cell may play in the origin and course of FEL. 
John Dinolfo is a free-lance writer based in Westport, Conn. 
Katherine in a sterile environment during her hospitalization. 
“If we can understand the basic biology behind this devastat¬ 
ing illness, we can design both better diagnostics and better 
therapeutics for these children,” says Dr. Smith. 
In Katherine’s case, a computer search of international bone 
marrow donor registries carried out by the transplant team 
identified an adult donor in Great Britain who closely matched 
the baby genetically. Further laboratory tests revealed that the 
donor’s cells were immunologically compatible with Katherine’s 
and free of other pathogens that could cause opportunistic infec¬ 
tions—and death—during the critical months of immunosup¬ 
pression required for bone marrow transplantation. The donor, a 
mother of three, would allow Katherine to become the first 
YNHH bone marrow transplant patient to receive tissue from an 
unrelated person. 
After an operation in London to remove the bone marrow from 
the donor’s hip, a nurse escorted the potentially life-saving cells 
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Dr. Brian Smith introduces fourth-year medical student Joseph Choo to the 
interactive laser cytometer, which offers scientists a combination of microscopic 
visualization, laser-induced fluorescence and complex computer image processing 
when exploring the function and interaction of individual cells. 
to YNHH, where they were injected into the infant’s 
blood stream. Like homing pigeons undaunted by 
novel terrain, the marrow cells found their way 
directly to their new home in Katherine’s bones. 
Soon, her bone marrow began spawning new, 
healthy cells from the graft. 
"We are very pleased to see that at least in the 
laboratory, we can no longer tell the difference 
between Katherine’s blood cells and those of a 
normal 2-year old,” says Dr. Smith. 
Bridging the Gap 
Responsibility for Katherine’s case does not weigh 
just on the shoulders of Drs. Komp, Rappeportand 
Smith, however. For they are only the most visible 
members of a team of primary care and laboratory 
physicians working together to preserve 
Katherine’s life. [See “Rare Disease Research: 
The Road Less Traveled,” Page 16.] 
To maximize her chances of entering kinder¬ 
garten as a healthy, carefree child, a network of 
Yale laboratory clinicians keeps a high-technol¬ 
ogy vigil over the baby girl. Dr. Smith monitors 
her blood regularly, using among other technologies, mono¬ 
clonal antibodies and a florescence activated cell sorter to search 
for evidence of FEL recurrence. 
“We also check to make sure the cytopathic white blood cells 
which existed before the transplant have not returned,” explains 
Dr. Smith, an expert in the physiology of white blood cells, 
platelets and bone marrow. The presence of these or other 
abnormal cells could signal graft failure or graft versus host 
disease, a possibility that would require confirmation by Yale 
clinical and anatomic pathologists. 
Katherine’s blood is also routinely monitored in the clinical 
virology laboratory to rule out cytomegalovirus and other patho¬ 
gens that could spark an opportunistic infection. Explains Marie 
L. Landry, M.D., professor of laboratory medicine and chief of 
the clinical virology laboratory at YNHH, “Organ and bone 
marrow transplant recipients are susceptible to viral infections 
that don’t cause a problem in healthy people.” Dr. Landry adds, 
“Today we have a number of drugs available to treat viruses, so 
it is important to detect infection as early as possible so we can 
start the proper therapy.” 
Meanwhile, physicians and clinical scientists in the microbi¬ 
ology, hematology, transfusion medicine and clinical chemistry 
laboratories coordinated their efforts, helping to ensure success 
in Katherine’s transplant. The hematology and transfusion 
laboratory services monitored Katherine’s white cell and platelet 
counts and the blood bank selected and matched the appropriate 
blood constituents. The microbiology laboratory kept Katherine 
under surveillance for opportunistic bacterial or fungal infec¬ 
tions. Finally, the clinical chemistry laboratory monitored blood 
cyclosporine levels to assure that drug dosages were sufficient to 
prevent graft rejection, but not so strong as to be toxic. 
Given such an intensive, comprehensive effort to save this 
little girl’s life, it almost sounds like understatement when Dr. 
Rappeport observes, “Laboratory testing is an extremely impor¬ 
tant part of the success or failure of any bone marrow transplant." 
Communication between the basic and clinical sciences makes 
laboratory medicine at Yale possible, says Peter I. Jatlow, M.D., 
professor, chairman and chief of laboratory medicine. Such 
interventions account, in part, for the department’s national 
reputation as a major training site for clinical pathologists— 
laboratory medicine specialists. Adding to the department's 
depth and breadth, many of its faculty members specialize in 
internal medicine as well as in clinical pathology. 
“We think this gives us an unusually broad perspective in 
terms of linking the clinical laboratories to patient care,” notes 
Dr. Jatlow. 
Most of the department’s patient care falls into six categories: 
clinical chemistry, immunology, hematology, transfusion medi¬ 
cine, microbiology and virology. Employing more than 200 
people, the laboratories provide round-the-clock referral care for 
YNHH and other institutions. 
“These labs conduct almost all of the inpatient clinical labo¬ 
ratory testing done at Yale-New Haven Hospital, and on outpa¬ 
tients who are cared for at YNHH and School of Medicine 
clinics,” Dr. Jatlow states. “We are responsible for scientific 
oversight of technology of those laboratories, the quality of the 
data selection, developing new tests, and for following up on 
unusual results.” 
Adds Richard K. Donabedian, M.D., professor of laboratory 
medicine and director of clinical chemistry at YNHH, "Test 
results are often available to clinicians as soon as they are 
generated by instruments and verified and checked by technolo¬ 
gists, thanks to computers which link laboratories and hospital 
services.” This entire procedure often takes less than an hour. 
[See “A Model Computer System,” Page 29.] 






















From Trace Metals to Hormones 
Under Dr. Donabedian's supervision, clinical chemistry labora¬ 
tories detect and measure blood levels of numerous analytes, 
including trace metals, nutrients, enzymes, proteins, hormones 
and drugs to determine their possible role in diseases seen at 
YNHH and elsewhere. He is assisted by Petrie M. Rainey, M.D., 
Ph.D., an assistant professor, and Herbert Malkus, Ph.D., a 
clinical instructor in the department. 
"Today, we detect many diseases early because we can mea¬ 
sure hormonal and other abnormalities long before the classic 
changes in clinical appearance occur,” says Dr. Donabedian, an 
expert in endocrine disorders. In addition to routine tests for 
glucose, cholesterol and other blood constituents, technologists 
in clinical chemistry perform many specialized diagnostic assays 
unavailable in most hospital laboratories, such as liver tissue 
levels of iron to diagnose hemochromatosis, and copper, for the 
diagnosis of Wilson’s disease. 
Dr. Jatlow’s research laboratory has developed sensitive as¬ 
says to monitor drugs used to treat depression. Dr. Jatlow and 
colleagues in the department of psychiatry are using these assays 
to learn more about the relationship between blood levels of drugs 
and clinical response. Many of these assays have been transferred 
from the Jatlow research laboratory to the clinical chemistry 
laboratory at YNHH, where they are helping to manage patients 
at Yale and elsewhere. 
Other research by the Jatlow team deals with the neurochemi¬ 
cal and behavioral effects of cocaine and alcohol on the central 
nervous system. Dr. Jatlow, with colleagues in the departments 
of psychiatry and pharmacology, has found that a metabolite of 
cocaine formed only when individuals abuse cocaine and ethanol 
concurrently, has many neurochemical and behavioral properties 
in common with cocaine. These studies may help to better 
understand the consequences and management of this widely 
prevalent form of poly-drug abuse. 
Dr. Peter I. Jatlow 
Dr. Rainey, associate director of the clinical chemistry labo¬ 
ratory, and colleagues have established a highly sensitive and 
accurate assay to measure blood lead concentrations as an indi¬ 
cator of lead poisoning. The only hospital in Connecticut 
approved by the U.S. Occupational Safety and Health Adminis¬ 
tration (OSH A ) to conduct blood lead testing, the YNHH clinical 
chemistry laboratory recently enhanced its automated proce¬ 
dures to test blood lead levels faster and more accurately at lower 
concentrations. 
The department of laboratory medicine also instituted a method 
for measuring lead in specimens obtained from a finger stick; 
when used for lead screening in children, this represents a 
significant advance over the commonly used zinc protoporphyrin 
test, which produces many false negatives. 
“In 1992, our volume of blood lead testing increased approxi¬ 
mately eight-fold,” reports Dr. Rainey. “This occurred, in part, 
because the Centers for Disease Control is now recommending 
lead screening on at least an annual basis for all children under 6 
years of age.” Each week, YNHH tests as many as 100 patients, 
most of them inner-city children. 
The clinical chemistry laboratory also offers sophisticated 
tests to detect and measure: 
• pituitary hormones—including growth hormone, prolac¬ 
tin, thyroid stimulating hormone, luteinizing hormone and 
follicle stimulating hormone for the diagnosis of pituitary 
diseases including tumors; 
• status of the thyroid gland, including a high sensitivity TSH 
assay for the detection of thyroidal overactivity; 
• catecholamines, norepinephrine, epinephrine, 
vanilmandelic acid (VMA), to diagnose the adrenal tumor, 
pheochromocytoma; 
• dopamine, VMA and homovanillic acid (HVA) for the 
detection of the childhood tumor, neuroblastoma; 
• drugs and industrial poisons accidentally—or intention¬ 
ally—ingested in toxic amounts. 
In addition to providing assays for many therapeutic drugs which 
may be taken in overdose, the laboratory also provides testing for 
abused drugs and common poisons such as methanol and ethyl¬ 
ene glycol, the latter an ingredient in antifreeze, sometimes 
imbibed in a misguided—and potentially fatal—search for a 
substitute alcoholic beverage. 
Dr. Rainey also oversees therapeutic monitoring of medica¬ 
tions used to treat YNHH patients. “We are able to help 
physicians adjust drug dosages so that their patients achieve 
effective levels without experiencing unnecessary side effects,” 
he explains. 
An expert in diseases caused by the parasite, Leishmania, Dr. 
Rainey also participates with Dr. Jatlow in multicenter clinical 
trials of potential new AIDS therapies. As program director of an 
NIH-funded pharmacology core for the trials. Dr. Jatlow collabo¬ 
rates with the principal investigator for Yale’s AIDS clinical 
trials unit, Gerald H. Friedland, M.D., professor of medicine—a 
further illustration of bench and bedside partnership. 
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Clinical Immunology: 
To Dissect a Single Cell 
Several faculty members in laboratory medicine focus on disor¬ 
ders of the immune system, including infections that affect 
immunocompromised patients. For patient care, the clinical 
immunology and immunohematology laboratories headed by Dr. 
Smith characterize cell surface proteins on white blood cells and 
use recombinant DNA technologies to help diagnose and manage 
patients with leukemias and immune disorders. 
Funded by the National Institutes of Health, the Leukemia 
Society of America and the American Heart Association. Dr. 
Smith’s team uses flow cytometry and microscope-based interac¬ 
tive laser cytometry, among other state-of-the-art tools. These 
technologies, which permit the detailed functional dissection of 
individual cells, enable his research laboratory to investigate: 
• molecular mechanisms which enable the immune system to 
rebound after a bone marrow transplant and to form new 
marrow; 
• molecular and genetic factors which may help explain the 
control of cytomegalovirus (CMV) infection after trans¬ 
plant operations; 
• gene therapy strategies, using retroviruses to transfer genes 
into bone marrow cells, which could improve the success 
rate of bone marrow transplants for genetic disorders and 
widen their overall applicability; 
• factors which permit white blood cells and platelets to 
adhere in blood and regulate each other’s function, a pro¬ 
cess that may be pivotal in understanding bleeding and 
inflammation in certain patients, such as those undergoing 
heart and lung bypass procedures. 
Dr. Smith believes research on leukocyte-platelet “stickiness” 
may also lead to improved laboratory tests for atherosclerosis, and 
even metastatic cancers. 
When asked to summarize the significance of these kinds of 
research efforts, Dr. Smith says, “At an institution like Yale, what 
we learn in the research laboratory can be quickly transferred to 
patient care in the diagnostic laboratory and often to patient 
therapeutics. The ultimate benefactor of this research—the 
patient—is never far away.” 
Hematology: Cells Red, White and Blue 
Just as immunohematologists are helping to solve the mysteries of 
the immune system, hematologists explore abnormalities in red 
blood cells, platelets and blood coagulation. Under the supervi¬ 
sion of Peter McPhedran, M. D., professor of laboratory medicine 
and medicine, the clinical hematology laboratory does blood 
counts, clotting tests, and conducts a wide variety of follow-up 
tests to aid in the diagnosis of anemias, leukemias and bleeding 
disorders. Dr. McPhedran is assisted by Sally Lockwood Marchesi, 
M.D., professor of laboratory medicine and pathology, and by 
Stephen C. Wardlaw, M.D., a clinical professor in the department. 
Among the 600,000 tests this laboratory does annually is a 
highly specialized battery of up to 50 assays to distinguish 
various leukemias. Dr. McPhedran explains, “Results from 
these tests help referring physicians to know which chemo¬ 
therapy to use with which patients and, often, increase the odds 
for a cure.” 
Current research in clinical hematology focuses on: 
• diagnosis and classification of blood neoplasms, including 
special stains of blood cells, How cytometry, serum 
muramidase and other tests; 
• evaluating hypercoagulable states—using tests that mea¬ 
sure natural anticoagulants and the fibrinolytic system; 
• study of the usefulness of serum erythropoietin assays in 
anemic and polycythemic states (erythropoietin is a kid¬ 
ney-manufactured hormone that tells the bone marrow to 
make red blood cells); 
• microscopic review of white cell differentials and urine 
sediment; 
• re-evaluation of labor-intensive, commonly ordered tests, 
in an effort to control costs. 
Transfusion Medicine: The Gift of Life 
While clinical hematologists are concerned with the diagnosis 
and management of blood diseases, physicians in transfusion 
Dr. Marie Landry 








medicine strive to make the transfer of blood between donors and 
patients as safe and as productive as possible. This laboratory 
does so under the direction of Edward L. Snyder, M.D., professor 
of laboratory medicine, with the assistance of Gary Stault, M.D., 
assistant professor. The transfusion medicine service—includ¬ 
ing the YNHH blood bank and outpatient transfusion/apheresis 
service—handles a wide range of blood products and patient 
transfusion needs. This laboratory's tasks include irradiating 
blood to prevent graft versus host disease in transfusion patients 
whose immune systems are compromised, and providing platelets, 
red cells, plasma and other blood components for transfusion. 
As part of its varied role in patient care, the blood bank tests 
patients’ blood for hepatitis, HIV and other infectious agents. 
The blood bank also provides daily consultation on transfusion 
reactions, transfusion problems and other transfusion issues 
which affect Yale's patient population. 
The transfusion medicine laboratory performs the main clini¬ 
cal bedside service offered by the department of laboratory 
medicine: therapeutic apheresis. Depending on the disease, this 
process begins with the apheresis nursing staff, who under the 
direction of the blood bank physicians, remove some of the 
patient's blood—either plasma (plasmapheresis) or white blood 
cells (leukapheresis)—and replace the volume removed with a 
solution of salt water and protein (albumin). This procedure 
requires an automated apheresis device, a type of sterile centri¬ 
fuge. After separating out the undesired or harmful blood 
components, the normal cells are then reinfused. 
Transfusion medicine research at Yale centers on: 
• structural and biochemical changes in platelets which may 
occur during platelet storage; 
• ultraviolet B radiation of stored platelets to prevent rejec¬ 
tion of transfused platelets; 
• the safety and efficiency of new plastic containers, sy¬ 
ringes, infusion pumps and other devices used for platelet 
storage or transfusion. 
The expertise offered by the transfusion medicine service 
reveals why Yale has become a major site for evaluating and 
modifying new products used in transfusion medicine. In the past 
decade, more than two dozen manufacturers have turned to Dr. 
Snyder and his colleagues at Yale to evaluate the safety and 
efficacy of devices designed to improve the storage and transfu¬ 
sion of platelets. 
Clinical Microbiology: Fighting Hidden Invaders 
Two laboratory medicine clinical units, microbiology and virol¬ 
ogy, focus on legions of microscopic invaders. Microbiologists 
isolate harmful bacteria, fungi and parasites from the body and 
determine which antibiotics might best combat them. Virolo¬ 
gists, as their name implies, focus on identifying harmful viruses 
in biological fluids and tissues. 
Microbiology is headed by Stephen C. Edberg, Ph.D., 
A.B.M.M., professor of laboratory medicine and director of 
clinical microbiology at YNHH. "We identify the cause of 
infection—why patients have fevers and what to do about them,” 
explains Dr. Edberg. "The faster an organism and its susceptibil¬ 
ity to specific antibiotics are identified, the better the patient 
care.” 
Recent advances in Yale microbiology, developed in conjuction 
with Sheldon Campbell, M.D.. assistant professor of laboratory 
medicine, include a new genetic test that will allow physicians to 
detect tuberculosis faster than ever before. This disease, resur¬ 
facing after years of decline, has been on the steady increase for 
the past decade in Connecticut and other parts of the United 
States. “The microbiology laboratory at Y ale is one of the centers 
in the country for the rapid diagnosis of this very serious disease,” 
Dr. Edberg notes. 
This laboratory also plays a major role in diagnosing opportu¬ 
nistic infections in patients such as those with AIDS or cancer, 
whose immune systems have been ravaged by disease or inten¬ 
tionally suppressed as part of a life-saving therapy. Current 
microbiology research at Yale uses such advanced tools as: 
• polymerase chain reaction (PCR), used to develop faster 
genetic tests to detect tuberculosis in sputum or blood; 
• non-radioactive DNA probes, to pinpoint deadly bacteria 
with greater sensitivity and specificity; 
• molecular assays, to analyze bacterial virulence factors— 
the toxins and enzymes that microbes use to destroy cells. 
Some unexpected clinical benefits may arise from Dr. Edberg's 
research, which has revealed that bacteria with few virulence 
factors may pose a lower health risk than is now believed. This 
work could lead to a reduced use of antibiotics, which would not 
only save patients money, but also slow the development of drug 
resistance. 
Much of Dr. Edberg's research is supported by the U.S. 
Environmental Protection Agency. In fact. Dr. Edberg’s dis¬ 
coveries about the health risks posed by environmental mi¬ 
crobes—especially the identification of factors that allow an 
innocuous microbe to become a dangerous one—have led 
Congress to invite him to testify about legislation to improve air 
and water standards. 
Clinical Virology: The Smallest of the Small 
Although many hospitals have no diagnostic virology service, 
Yale’s laboratory medicine department offers two such laborato¬ 
ries, both under the direction of Dr. Marie Landry. Yale-New 
Haven Hospital houses one of these clinical virology laborato¬ 
ries; the other, at the Veterans Affairs Medical Center in West 
Haven, serves as the sole national virology reference laboratory 
for the VA hospital system, with its more than 100 institutions. 
VA hospitals across the nation ship samples to the West Haven 
laboratory by overnight mail, and the laboratory reports test 
results back via computer. 
Observes Dr. Landry: "Diagnostic virology remains a special¬ 
ized field. Most hospitals still lack in-house virology services, or 
provide very limited testing. Children and patients whose im¬ 
mune systems are compromised by either treatment or disease are 
the greatest beneficiaries of comprehensive and rapid viral diag¬ 
nosis. At a medical center like Yale, with its organ and bone 
28 Yale Medicine Fall/Winter 1992-93 
marrow transplant programs, comprehensive cancer center, new 
children’s hospital and AIDS care program, the clinical virology 
laboratory provides an important link in the chain of patient 
management.” 
Virology researchers and laboratory technologists use recom¬ 
binant DNA tests, advanced cell culturing, immunofluorescent 
and electron microscopy and a range of other techniques to detect 
and study a wide spectrum of viral diseases. Assisting Dr. Landry 
in this effort is research scientist Caroline K.Y. Fong-Cheng, 
Ph.D.. a protegee of noted virologist G.D. Edith Hsiung, Ph.D., 
professor emeritus of laboratory medicine and founder of the 
reference laboratory. Using research-supported electron micro¬ 
scope facilities at the West Haven VA Medical Center, Dr. Fong, 
an expert in viral morphology, has made important findings when 
cell cultures, serology tests and molecular studies fail to identify 
viral pathogens. 
Brigette Griffith, Ph.D., associate professor of laboratory 
medicine, heads the retrovirus diagnostic section of the virology 
reference laboratory. In 1986, Dr. Griffith introduced to the West 
Haven VA Medical Center the techniques used to isolate human 
immunodeficiency virus (HIV) from a patient's blood. Many 
Yale researchers have subsequently learned this methodology in 
her laboratory, which remains the only clinical laboratory in 
Connecticut and in the national VA system that provides culture, 
as well as antibody and antigen techniques, for HIV diagnosis. 
This laboratory also has been designated the core retrovirus 
laboratory for the recently established AIDS clinical trial unit at 
Yale. HIV cultures are performed to measure the amount of virus 
in a patient’s blood. Documenting a reduction in virus titer with 
treatment helps in evaluating the response of HIV infection to 
newly developed therapies. 
Finally, the Yale virology laboratory is studying a new, rapid 
monoclonal antibody test for quantifying CMV infection in the 
blood, with an eye to correlating test results with severity of 
clinical disease and response to treatment—a key step toward 
more effective management of CMV in immunosuppressed and 
other patients. 
A Model Computer System 
Since the mid-1960s, Yale has been a leader in developing 
computer services in laboratory medicine. Under the di¬ 
rection of Richard R. Rathbone, M.D., associate clinical 
professor of laboratory medicine, the department’s com¬ 
puter system provides comprehensive data, via an online 
system connected to all Yale-New Haven Hospital clinical 
services, enabling clinicians to make timely therapeutic 
decisions. Test results are available as soon as the test is 
completed; emergency data are often printed out within 
minutes of processing. 
“Doctors can examine a patient’s data chronologically 
and in graphic form over time,” explains Dr. Peter I. Jatlow, 
chairman and chief of laboratory medicine. 
"We are very interested in collaborating with basic scientists 
and clinicians to develop more rapid and sensitive diagnostic 
methods,” Dr. Fandry says, “and to develop faster ways to 
identify resistance of viruses to antiviral agents.” 
Toward this end. Dr. Landry works with John Gregory Howe, 
Ph.D.. associate research scientist in laboratory medicine. Direc¬ 
tor of the recently created molecular diagnostics development 
laboratory (MDDL), Dr. Howe and colleagues use the latest 
recombinant DNA technologies—including in situ hybridiza¬ 
tion. Northern and Southern blotting, and PCR. An example of 
Dr. Peter Tattersall (left) examines a Petri dish with research 
assistant Tony D’Abramo. 
industry-academia cooperation. MDDL receives support from 
Becton Dickinson and Co., a manufacturer of medical diagnostic 
reagents and equipment. 
Department chairman Jatlow says the laboratory’s goal "is to 
translate recent exciting advances in molecular biotechnology 
into useful clinical tools.” 
Adds Dr. Howe, “One of our aims is to develop DNA-based 
assays that will improve upon the sensitivity of current tests, and 
reduce both the time needed for those tests and the number of 
false negatives and false positives.” 
He cites as a hopeful example new, highly selective DNA 
probes to target cytomegalovirus DNA in blood. Researchers 
hope these “DNA bullets” will permit faster diagnosis of poten¬ 
tially fatal CMV infections in immunosuppressed patients. 
Dr. Howe also studies transcription—the process by which 
DNA creates messenger RNA—in the Epstein-Barr virus (EB V), 
a form of herpes which infects B-lymphocytes. A cause of 
infectious mononucleosis. EBV also has been associated with 
various lymphomas, especially in AIDS patients. In addition, 
EBV may cause other cancers in some transplant patients. Better 
understanding EB V's basic mechanisms could lead to improved 
diagnosis and treatment of EBV disease, notes Dr. Howe. 
Other research that may help AIDS patients is being advanced 
by molecular virologist Peter Tattersall. Ph.D., associate profes¬ 
sor of laboratory medicine and genetics. Dr. Tattersall is seeking 
insights into the replication of parvoviruses. In 1984, his labora¬ 
tory was the first to clone human parvovirus, the cause of fifth 
disease, a common and benign childhood infection. 









Dr. Stephen Edberg in a teaching laboratory with second- 
year medical student Andrea D. Toulson. 
Teaching Laboratory Medicine 
Under the supervision of Richard K. Donabedian, M.D., 
director of medical studies for the department of laboratory 
medicine, a required course in laboratory medicine is 
offered to second-year medical students in conjunction 
with the “Introduction to General Medicine” module. The 
semester-long course taught by clinical faculty in the 
department: 
• discusses the basic science underlying diagnostic 
laboratory tests including clinical chemistry, hema¬ 
tology, transfusion medicine and immunology; 
• uses representative case histories from YNHH to 
illustrate the clinical application of those tests; 
• emphasizes a problem-solving approach to the as¬ 
sessment and management of disease. 
The department also teaches the medical microbiology 
course to second-year medical students. In 1989, course 
director Stephen C. Edberg, Ph.D., professor of laboratory 
medicine and chief of clinical microbiology, received the 
first Bohmfalk Teaching Prize for excellence in basic 
science instruction at the medical school. 
Dr. Tattersall is trying to determine how this virus also causes 
bone marrow aplasia in bone marrow transplant patients and in 
patients with AIDS or sickle cell anemia. Human parvovirus is 
a major fetal threat, as well: Pregnant women infected for the 
first time are at increased risk of losing their developing fetus to 
non-immune hydrops, a fatal condition resembling that induced 
by Rhesus incompatibility. 
"We hope to uncover more about the intracellular trafficking 
of the virus—the chemical signals the virus uses to suborn the 
normal replication machinery of the cell,” Dr. Tattersall explains. 
He, Susan F. Cotmore, Ph.D., research scientist in laboratory 
medicine, and other colleagues also are looking for ways to 
harness this sophisticated viral invader as a clinical tool: "We are 
particularly interested in the use of viruses as vectors to introduce 
therapeutic molecules into cells.” 
In pursuit of this goal. Dr. Tattersall’s research team is 
evaluating the use of parvoviruses to program the synthesis of 
potentially therapeutic molecules in human T cells. T cells, 
principal warriors in the human immune network, are major 
targets for the AIDS virus. 
Related research is being done by an associate professor of 
laboratory medicine, Paula Kavathas, Ph.D., who is studying the 
molecular basis for immune recognition by cytotoxic T cells. She 
is focusing on a key molecule on the surface of T lymphocytes 
called CDS, also known as a T cell co-receptor molecule. Dr. 
Kavathas says this molecule is “critical for proper development 
of the T cells and for their function as cytotoxic cells.” She is 
performing a molecular analysis of how CD8 interacts with its 
ligand—or attachment molecule—on target cells. 
The second area of research in her laboratory is on the 
molecular mechanisms of gene regulation in T cells, again 
focusing on the CDS gene. She is defining both the sequences 
within the gene which are critical for that regulation and the 
proteins that bind to those sequences that ultimately regulate the 
expression of the gene. 
Dr. Kavathas explains the important clinical implications of 
this work: “If you know what are the key proteins regulating gene 
expression in T cells, you could potentially design drugs that 
specifically block expression of those genes and inhibit cancers 
arising from T cells.” She collaborates on this work with 
scientists from Pfizer Pharmaceutical. 
What’s in store for laboratory medicine tomorrow? Com¬ 
ments Dr. Jatlow: “Dramatic advances in biotechnology, espe¬ 
cially in the field of molecular biology, have made the present and 
future of laboratory medicine especially exciting.” He explains 
that recombinant DNA technologies, already employed by the 
clinical microbiology and hematology laboratories, will be used 
more and more by physicians to rapidly, specifically and sensi¬ 
tively detect and identify microorganisms in body fluids and to 
diagnose and manage neoplastic disorders. 
"In the future we can expect molecular techniques to be used 
to evaluate prognosis and predict behavior of neoplasms, and 
even to screen individuals for the risk of developing malignan¬ 
cies,” Dr. Jatlow adds. “Scientists have overcome many of the 
obstacles to the routine use of molecular techniques in the clinical 
laboratory, including the need for radioisotopes. PCR, well 
established as a powerful research tool, is already becoming an 
important technique in the clinical laboratory.” 
He says that “point of care” testing—performing laboratory 
tests at or near the bedside—also may be on the near horizon, an 
especially attractive prospect for physicians dealing with criti¬ 
cally ill and unstable intensive care patients. Despite such 
developments. Dr. Jatlow offers a caveat: "These breakthroughs 
are costly. Our challenge will be to incorporate these new, 
cutting-edge technologies into the clinical laboratories without 
having an excessive impact on the cost of patient care.” YM 
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Astrological Bloodletting Almanac, 
Bloodletting, or venesection, one of the oldest and most com¬ 
monly used therapeutic practices, dates back to the ancient 
Egyptians, who purged their blood monthly to “preserve their 
health.” The earliest records of bloodletting incisions, dated 
about 2500 B.C., were found in the tomb hieroglyphics of 
Egyptian royalty. 
Through history, bloodletting became popular among many 
cultures. About 300 B.C., the Hindus developed venesection into 
a more precise, less painful art. Hindu surgeons realized that 
without an anesthetic a swift incision was necessary; accord¬ 
ingly, they taught students to practice cutting on the veins of 
plants and animal cadavers. Only after perfecting the incising 
technique could a student proceed to a living human subject. 
The first record of bloodletting in European practice is found 
in Hippocrates’ treatise on ulcers, where he instructs how to 
check accidental hemorrhage after venesection; how to relieve 
the soreness after scarification, and points out the most common 
accident of venesection, phlebitis. He adds, “Venesection is to 
be practiced when the person has dined or drunk freely and when 
somewhat heated and rather in hot weather than in cold.” 
Leipzig, 1497 
During the second century A.D., Hebrews used sharp stones 
and primitive knives for incising; later, the Greeks developed 
metal instruments. By the medieval times, bloodletting had 
become an accepted part of personal hygiene. Astrology began 
to influence the practice as barber surgeons, bath keepers and 
itinerant “incisors” who had taken over the general practice of 
surgery scheduled incisions according to the positions of the stars 
and planets. During the 15th and 16th centuries, the northern 
countries were especially influenced by astrology, hence, the first 
medical publication to be set in type was an astrological blood¬ 
letting calendar in 1457. 
In 1514, physicians in Paris began questioning venesection; 
after a relative of the royal family died from bloodletting, many 
physicians in France gave up the practice. Although the advent 
of the scientific method during the first half of the 1800s brought 
about the general decline of venesection, English physicians 
continued letting blood well into the 19th century. 
Rosalind D'Eugenio 
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Dr. Ethan Nadel (right) celebrates with friends at a September reception marking 
the completion of a yearlong Pierce Laboratory renovation and expansion. Both 
public and laboratory spaces have been improved. 
Pierce Laboratory 
Begins Consortium 
To Study Aging 
Researchers at the John B. Pierce 
Laboratory and Yale University 
have organized a Health, Physical 
Activity and Aging Consortium to 
conduct a five-year study on the 
mechanisms by which physical 
activity helps older adults maintain a 
healthy, active lifestyle. 
"The consortium is the first of its 
kind in the country, representing a 
unique arrangement between an 
independent research institute, a 
major medical school and a retire¬ 
ment community to advance 
scientific knowledge about the 
biological process of aging,” states 
Ethan R. Nadel, Ph.D., director of 
the study and of the Pierce lab. 
Volunteers for the two-phase 
study will come from residents of 
Heritage Village, a retirement 
community of approximately 4,500 
men and women in Southbury, 
Conn. First, researchers will assess 
how subjects' cardiovascular, 
hormonal and kidney systems 
respond to various physical chal¬ 
lenges, such as dehydration, heat 
exposure and hypergravity. 
Second, subjects will undergo a 
six-month supervised physical 
conditioning program, through 
which the researchers will assess 
individuals' responses to these same 
challenges. 
As part of the project, the consor¬ 
tium will build an activity laboratory 
at Heritage Village, where a trained 
staff will conduct the supervised 
physical activity program, using 
exercise cycles and treadmills. 
32 
New Yale Center Opens 
For Older Americans 
The National Institute on Aging has 
awarded Yale a $4.5 million, five-year 
Claude Pepper Center Grant to estab¬ 
lish the Older American Independence 
Center, a project dedicated to research 
aiding the elderly. 
Mary E. Tinetti, M.D., associate 
professor of medicine, was named 
director of the center and of the primary 
clinical trial, which concentrates on 
rehabilitation after hip fracture. 
Through this research. Dr. Tinetti hopes 
to establish whether patients who return 
home to more intensive and longer 
therapy have a better functional level of 
recovery than those who receive the 
usual amount of therapy. 
Other aspects of the center’s 
program include training new investi¬ 
gators interested in health problems of 
elderly persons, increasing interaction 
between researchers and health care 
providers and consumers, and encour¬ 
aging more collaborative relationships 
among investigators involved in aging 
research. 
Working with Dr. Tinetti is Lisa F. 
Berkman, Ph.D., co-director of the 
Older American Independence Center, 
who began a pilot test post-stroke study 
to evaluate the effects that social 
supports, such as family and friends, 
have on recovering stroke patients. 
Mouse Model of Immune 
System Debuts at Yale 
Collaborating with researchers in the 
United Kingdom, Yale biologists have 
genetically engineered a new strain of 
mice which has enabled scientists to 
study how the immune system adapts to 
the loss of a specific T cell receptor. 
The new strain, which resulted from the 
biologists eliminating, or “knocking 
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out” a crucial gene, offers researchers a 
model to learn about failures in the 
immune system which can cause 
diseases such as AIDS. 
An estimated 40 or 50 different 
strains of knockout mice—each 
missing a specific gene—have been 
developed throughout the world within 
the past three years. While the mice 
can be used to study several abnormali¬ 
ties, they are particularly useful for 
observing the immune system because 
they can be protected in a germ-free 
environment and otherwise remain 
normal. 
Adrian Hayday, Ph.D., associate 
professor of biology and immuno¬ 
biology at Yale, led a group who 
worked with colleagues in London and 
Middlesex, England, to develop the 
first knockout mouse with missing T 
cells. Dr. Hayday is collaborating with 
Richard Flavell. professor and chair¬ 
man of immunobiology, to develop 
more strains of the mice. 
Calcium’s Role in Nerve 
Regeneration Studied 
A team of Yale researchers has 
discovered that calcium may play a role 
in allowing a cell to express the genes 
related to nerve regeneration. The 
researchers, based at the PVA/EPVA 
Center for Neuroscience and Regenera¬ 
tion Research at the Department of 
Veterans Affairs Medical Center in 
West Haven, published their findings 
this summer in the Proceedings of the 
National Academy of Sciences. 
“We are trying to discover how to 
stimulate regrowth of damaged cells in 
the spinal cord and brain,” says Jeffery 
Kocsis, Ph.D., associate director of the 
center and professor of neurology at 
Yale. "We’re testing the hypothesis 
that there is a critical time after injury 
during which a cell can express the 
genes for regeneration,” he explains. 
The study proved that the presence 
of calcium in a cell correlates with the 
expression of genes for regeneration 
and that there is a particular period 
during which gene expression must be 
put into motion to stimulate regrowth. 
These findings could help determine 
which drugs will be most effective to 
aid recovery from spinal and brain 
injuries, and when the drugs should be 
administered. 
If the findings can be replicated, 
they will enable scientists to know 
which genes are important in regenera¬ 
tion and which proteins are detrimental. 
The Yale/VA research center is 
named for the Paralyzed Veterans of 
America/Eastern Paralyzed Veterans 
Association. 
Body Temperature May 
Signal Febrile Seizures 
By studying how children's first febrile 
seizures occurred, Yale medical 
researchers and colleagues in New 
York have identified factors that can 
help predict the recurrence of such 
seizures. 
Febrile seizures occur in 2 to 4 
percent of all children under age 5; 
approximately one third of the 
children experience subsequent febrile 
seizures. 
Comments Ann Berg. Ph.D., 
research scientist in pediatrics and 
principal investigator: “Our results 
indicate that information about the 
acute illness during which the initial 
febrile seizure occurred provides 
equally strong, if not stronger, predic¬ 
tion of recurrence than do some of the 
factors traditionally studied, such as 
family history of epilepsy, type of 
seizure and history of neurologic 
abnormalities. 
Researchers identified 356 children 
and for two years collected information 
from medical records, interviewed 
parents and followed the children for 
approximately 20 months to ascertain 
whether febrile seizures occurred. 
Twenty-seven percent of the 
children experienced subsequent febrile 
seizures at intervals ranging from less 
than one month to two years after their 
first seizure. Children with low 
temperatures at the time of the initial 
febrile seizure were at increased risk of 
a recurrent seizure, compared to 
children with higher temperatures. 
Results of the research, conducted 
by a team at Yale, Albert Einstein 
College of Medicine and Columbia 
University School of Medicine, are 
reported in the Oct. 15 issue of The 
New England Journal of Medicine. 
The National Institute of Neurological 
Disorders and Stroke supported this 
research. 
New Studies Underway 
For General Anxiety 
Dr. Andrew Goddard, director of the 
Yale Anxiety Disorders Research 
Clinic at the Connecticut Mental Health 
Center, heads two studies to create 
better treatments for patients with 
general anxiety disorder (GAD), 
characterized by symptoms of over¬ 
whelming fear. 
One study will evaluate a medica¬ 
tion that alters the level of the chemical 
messenger serotonin, which is thought 
to be important in controlling anxiety. 
A second study involves biological 
testing of a single dose of a promising 
new anti-anxiety compound. The drug, 
thought to work on certain types of 
nerve receptors, may be effective in 
relieving specific anxieties. In this 
study, explains Dr. Goddard, subjects 
with GAD are given a medication that 
normally provokes mild anxiety in 
GAD patients equal to that of a strong 
cup of coffee. The same compound is 
then administered—with opposite 
affect—to other anxiety patients to 
relieve nervous response. 
"This type of study promises to help 
identify the biochemical abnormalities 
associated with general anxiety disor¬ 
der,” says Dr. Goddard, "and to help 
select treatments for these problems.” 
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Faculty 
News 
YSM faculty appointments, promotions announced 
The office of the dean at the School of Medicine has announced the following 
appointments or promotions to senior ranks. All, except where noted, were 
effective July 1. In recognition of their excellence in teaching, research and 
patient care, these faculty become members of the Board of Permanent 
Officers (BPO), the school’s governing board, which is responsible for all 
major academic decisions. 
Five faculty members were appointed to senior rank with tenure. They 
include: Gerard N. Burrow, M.D., professor of medicine: Jose Costa, M.D., 
professor of pathology, Nigel W. Daw, Ph.D., professor of ophthalmology 
and visual science: Peter Liggett, M.D., professor of ophthalmology and 
visual science (Jan. 1); and Thomas S. Renshaw, M.D., professor of 
orthopaedics and rehabilitation. 
Nineteen faculty members in various departments were promoted to 
professor, the highest academic rank. They are: G. Peter Beardsley, M.D., 
Ph.D., pediatrics: Lisa F. Berkman, Ph.D., epidemiology: David G. 
Brownstein, D.V.M., comparative medicine: Henry S. Cabin, M.D., medicine: 
Michael W. Cleman, M.D., medicine: Pietro De Camilli. M.D.. cell biology 
(Jan.l); Rosemarie L. Fisher, M.D., medicine: Cyrus R. Kapadia, M.D., 
medicine: Csaba Leranth, M.D., Ph.D., obstetrics and gynecology: John M. 
Leventhal, M.Dpediatrics: Kathryn E. McGoldrick, M.D., anesthesiology: 
Perry L. Miller, M.D., Ph.D., anesthesiology: Neil J. Risch, Ph.D.,public 
health (biostatistics) and genetics: Stanley H. Rosenbaum, M.D., anesthesiol¬ 
ogy: William H. Sledge, M.D., psychiatry, (Jan. 1); Abigail L. Smith, Ph.D., 
comparative medicine and epidemiology: Susan S. Spencer, M.D., neurology: 
John H. Warner, Ph.D., history of medicine: and Howard V. Zonana, M.D., 
psychiatry. 
Five faculty members were promoted to associate professor with tenure, 
including Susan Ferro-Novick, Ph.D., cel! biology: Arthur E. Horwich, M.D., 
genetics and pediatrics: Eric J. Nestler, M.D., Ph.D., psychiatry; Peter J. 
Novick, Ph.D., cell biology: and Fred R. Volkmar, M.D., Child Study Center. 
Yale Epidemiologist 
Co-chairs Microbe Panel 
The Institute of Medicine Committee 
on Emerging Microbial Threats to 
Health has released a new report urging 
more vigorous, comprehensive and 
systematic efforts to monitor and 
combat infectious diseases such as 
AIDS, malaria and tuberculosis. 
Without vigilance and improved 
public health measures, “we’re vulner¬ 
able to something along the lines of the 
1918-19 influenza pandemic that killed 
20 million people worldwide,” states 
Robert, E. Shope, M.D., co-chair of the 
committee and professor of epidemiol¬ 
ogy at Yale. 
Although emergence of new 
infectious diseases is inevitable, the 
report points to an era of complacency 
as one of the main reasons microbial 
threats seem to be on the rise. The 
committee recommended strengthening 
current surveillance programs to track 
disease outbreaks; bolstering vaccine, 
drug and pesticide development; and 
improving research and training 
programs. 
Tracking and responding to out¬ 
breaks of disease were emphasized as 
key to effectively confronting and 
combating emerging microbial threats. 
The report recommends greater federal 
and state efforts to develop and 
implement surveillance strategies. 
4* 41 
Vincent T. Andriole, M.D., professor 
of medicine, has been elected vice 
president of the Infectious Diseases 
Society of America, an international 
organization of physicians and scien¬ 
tists. He has been active in the society 
since 1984 and will become president 
in the fall of 1994. 
Abbott Laboratories has named an 
award in honor of Robert W. Berliner. 
M.D.. dean emeritus, professor emeri¬ 
tus of physiology and medicine. The 
Robert W. Berliner Award for Excel¬ 
lence in Renal Physiology will recog¬ 
nize a living American scientist’s 
lifetime achievement in this field. 
Pravin N. Bhatt, M.D., senior 
research virologist in comparative 
medicine, has been elected an honorary 
member of the American College of 
Laboratory Animal Medicine. 
The National Spinal Cord Injury 
Association conferred the L.W. 
Freeman Award on Michael B. 
Bracken, M.P.H., Ph.D., professor of 
epidemiology, for significant scientific 
research to benefit individuals with 
spinal cord injury or disease. 
Irwin M. Braverman, M.D., 
professor of dermatology at the School 
of Medicine and vice chairman of 
dermatology at Yale-New Haven 
Hospital, was elected president of the 
Society for Investigative Dermatology 
for 1992-93. In addition, he has been 
inducted into the Association of 
American Physicians and elected to the 
Council of the New England Dermato¬ 
logical Society from 1992 to 1995. 
Gerard N. Burrow, M.D., dean, 
School of Medicine, serves on the 
Association of American Medical 
Colleges Advisory Panel on Strategic 
Positioning for Health Care Reform, 
which held its first meeting in July. 
The National Science Foundation 
has given Michael J. Caplan, M.D., 
assistant professor of cellular and 
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molecular physiology, a Young 
Investigator Award for his research on 
epithelial cells. 
The National Institutes of Health 
selected Joseph Caprioli, M.D., 
associate professor of ophthalmology 
and visual science, to be a member of 
the Visual Sciences A-Study Section, 
Division of Research Grants. His four- 
year term began in July. 
Joshua A. Copel. M.D.. associate 
professor of obstetrics and gynecology 
and chief of the division of maternal- 
fetal medicine at Yale-New Haven 
Hospital, has been named director of 
obstetrics at the hospital. Dr. Copel, a 
graduate of Tufts University School of 
Medicine, completed a fellowship in 
maternal-fetal medicine at Yale. 
Jack A. Elias, M.D., professor of 
medicine (pulmonary) and section chief 
of pulmonary and critical care medi¬ 
cine, has been appointed to the follow¬ 
ing organizations: the American 
Society for Clinical Investigation 
(honorary), board of directors of the 
American Thoracic Society, the 
editorial boards of the American 
Journal of Physiology; Lung; Cellular 
and Molecular Physiology, and the 
Journal of Laboratory and Clinical 
Medicine. 
Rosemarie L. Fisher, M.D., 
professor of medicine, has been named 
chair of the Gastrointestinal Drugs 
Advisory Committee of the U.S. Food 
and Drug Administration. She will 
serve for four years. 
Gerhard H. Giebish, M.D., Sterling 
Professor of Cellular and Molecular 
Physiology, has been named to the 
University’s presidential search 
committee. 
The National Institutes of Health 
(NIH) has given a Fogarty Interna¬ 
tional Research Collaboration Award 
to Gabor B, Huszar, M.D., senior 
research scientist in obstetrics and 
gynecology and director of the medical 
school's sperm physiology laboratory. 
The NIH award will allow Dr. Huszar 
to initiate male infertility studies in his 
native Hungary in collaboration with 
researchers at the Albert Szent- 
Gyorgyi Medical School at the 
University of Szeged. 
Kristaps J. Keggi. M.D., clinical 
professor of orthopaedics and rehabili¬ 
tation, is founder and president of the 
Keggi Orthopaedic Foundation, which 
has hosted 36 doctors and nurses from 
Baltic countries and the nations of the 
former Soviet Union since 1988. Dr. 
Keggi, a fellow of the American 
Academy of Orthopaedic Surgeons, is 
an attending orthopaedic surgeon at 
Waterbury Hospital. 
Gov. Lowell P. Weicker Jr. has 
appointed David F. Musto. M.D.. 
professor in the Child Study Center, 
history of medicine and psychiatry, to 
the Connecticut Alcohol and Drug 
Abuse Commission. 
Ravinder Nath, Ph.D., professor of 
therapeutic radiology, was named a 
fellow of the American College of 
Radiology (ACR) by the college’s 
board of chancellors at the ACR annual 
meeting in September in Phoenix. 
Adrian M. Ostfeld, M.D., the Anna 
M.R. Lauder Professor of Epidemiol¬ 
ogy and Public Health and Medicine, 
co-chaired a World Health Organiza¬ 
tion/Institute of Medicine meeting Oct. 
27-29 in Washington. D.C., to plan 
strategies for priorities in prevention 
and control of cardiovascular disease in 
developing and industrialized coun¬ 
tries. A subsequent international 
conference will be held in 1993. 
The New Haven Bar Association 
presented its 1992 Liberty Bell Award 
for distinguished community service to 
Howard A. Pearson, M.D. Dr. 
Pearson, professor of pediatrics, is 
president of the American Academy of 
Pediatrics. 
Richard J. Robbins, M.D., 
associate professor of medicine and of 
obstetrics and gynecology, has been 
elected to a two-year term as chairman 
of the Medical School Council, a forum 
for Yale medical faculty and students. 
The New Haven Chamber of 
Commerce gave William H. 
Rosenblatt, M.D., assistant professor 
anesthesiology, a Green Ribbon Award 
for his founding and directing Recov¬ 
ered Medical Equipment for the 
Developing World (REMEDY), a 
medical recycling program that 
recovers newly obsolete operating 
room supplies for use in developing 
countries. 
Stanford University awarded David 
G. Schatz, Ph.D., assistant professor of 
immunobiology, the first annual Cheryl 
Whitlock Pathology Prize for his 
contributions to the study of blood 
disorders and leukemia. 
The American Psychiatric Associa¬ 
tion presented its 1992 Distinguished 
Service Award to Albert J. Solnit, 
M.D., Sterling Professor Emeritus of 
Pediatrics and Psychiatry, and senior 
research scientist in the Child Study 
Center. Dr. Solnit serves as commis¬ 
sioner of the Connecticut Department 
of Mental Health. 
Richard S.K. Young, M.D., 
M.P.H.. associate professor of pediat¬ 
rics and neurology at Yale and chair¬ 
man of the department of pediatrics at 
the Hospital of St. Raphael, serves as 
medical director of the School of 
Medicine’s Physician Associate 
Program. 
Barry L. Zaret, M.D., the Robert 
W. Berliner Professor of Medicine and 
Diagnostic Radiology and head of the 
division of cardiology, has been elected 
president of an organization that he 
helped found, the Association of 
Professors of Cardiology. Its members 
are cardiology division chiefs at U.S. 
medical schools. 
Dr. Howard A. Pearson 
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The Health Sciences Library of the 
California Pacific Medical Center in 
San Francisco honored Knox Finley, 
M.D. '30. by dedicating the Finley- 
Norris Historical Neurological Library. 
Giacehino S. Parrella, M.D. ’41, 
was named an outstanding Italian- 
American at a dinner dance sponsored 
by the Milford (Conn.) Columbus 500 
Committee, a community organization 
developed to celebrate Columbus's 
discovery of America. 
Edwin I). Rogers, M.D. ’41, has 
been appointed staff psychiatrist, 
associate director at Cleveland Mental 
Health Center in Shelby, N. C. 
Karel B. Absolon, M.D. ’52, was 
given an honorary doctor of medicine 
degree at Masaryk University in 
Czechoslovakia and was presented the 
university’s Gold Medal for contribu¬ 
tions to experimental and clinical 
surgery and the history of surgery. 
Eiji Yanagisawa, M.D., HS ’56- 
'59. has been appointed chairman of the 
continuing education through television 
subcommittee of the American Acad¬ 
emy of Otolaryngology-Head and Neck 
Surgery. He was presiding officer of 
the otorhinolaryngology motion picture 
session at the Clinical Congress of the 
American College of Surgeons in New 
Orleans. Dr. Yanagisawa is president 
of the New England Otolaryngological 
Society and vice president of the 
American Broncho-esophalogical 
Association. 
Jack F. Bowers, M.D. '59, has been 
appointed director of the Methuen Eye 
Satellite, a northern community branch 
of the Massachusetts Eye & Ear 
Infirmary, Harvard Medical School. 
Dr. Bowers also serves as vice presi¬ 
dent of the Massachusetts Medical 
Society. 
Francis 1). Cogliano, M.D. 60, 
appointed chief of surgical service in 
July at Brockton (Mass.) Hospital, also 
serves as associate clinical professor of 
surgery at Boston University. 
Jerry Stolzenberg, M.D., HS '68- 
'70, has been named a fellow of the 
American College of Radiology (ACR) 
by the college’s Board of Chancellors 
at the ACR annual meeting in Phoenix. 
Robert S. New bold. HS '70, has 
returned from six months of surgical 
relief duty at the Penang Adventist 
Hospital in Malaysia. He has spent 15 
years in Central Africa and 15 years in 
East Asia. 
Jane Silver, M.P.H. ’71, has been 
appointed director of public policy for 
the American Foundation for AIDS 
Research in Washington, D.C. Ms. 
Silver formerly worked with the 
National Commission on AIDS. 
Donald L. Kent. M.D. 72, HS 73- 
'76, has been elected president of the 
Long Island Society of Otolaryngology, 
Head and Neck Surgery for a two-year 
term. 
David Moyer, M.D. ’72, a Navy 
captain and chief of allergy at the Naval 
Hospital, Oakland, Calif., has been 
awarded the Meritorious Service 
Medal by the U.S. Surgeon General for 
his educational efforts regarding the 
health hazards of tobacco. 
Joseph F. Simeone, M.D. ’73, has 
been promoted to professor of radiol¬ 
ogy at Harvard Medical School. He is 
director of ultrasound in the department 
of radiology at Massachusetts General 
Hospital. 
Mary Lake Polan, M.D. ’75, HS 
’75-’78. has been named to the board of 
directors of Metra Biosystems, a 
company devoted to diagnostic 
products for diseases and degenerative 
conditions of bone and cartilage. She is 
chairman of the department of gynecol¬ 
ogy and obstetrics at Stanford Univer¬ 
sity School of Medicine. 
William Bithoney, M.D. ’76, is 
director of the Malnutrition Clinic at 
Children's Hospital in Boston. 
The American Public Health 
Association gave Barbara Gervis 
Lubran, M.P.H. '77, its Alcohol, 
Tobacco and Other Drugs Sections 
Leadership Award. 
Robert W. Buckingham, Dr.P.H. 
'78, is dean of the College of Health 
and Human Performance at Mankato 
State University in Minnesota. One of 
the four founders of the first hospice in 
the United States, he has been instru¬ 
mental in developing more than 42 
hospice programs throughout this 
country. Dr. Buckingham is a consult¬ 
ant to the Ministry of Health in Havana, 
Cuba, and president of the Russian- 
American Institute on Health Promo¬ 
tion and Disease Prevention. 
Ann L. Elderkin. P.A. ’80. has 
been named president-elect of the 
15,000-member American Academy of 
Physician Assistants. She is director of 
the health department for the city of 
Somerville, Mass. 
George B. Holmes Jr.. M.D. ’80, 
has joined the practice of University 
Orthopaedics in Chicago to serve as its 
director of the foot and ankle 
subspecialty. Dr. Holmes is assistant 
professor and on staff at Rush-Presby- 
terian-St. Luke’s Medical Center. 
Walter H. Williams, M.D. '80, was 
promoted to associate professor of 
radiology at the University of Arizona. 
Paul B. Rothman, M.D. ’84, 
assistant professor of clinical medicine 
at Columbia University College of 
Physicians and Surgeons, has been 
named a 1992 scholar in the Pfizer 
Scholars Award Program for New 
Faculty by the U.S. Pharmaceuticals 
Group of Pfizer Inc. 
Kirk William Noraian, D.D.S., HS 
'88-'89, has been appointed clinical 
associate periodontist for the University 
of Chicago and also serves as clinical 
assistant professor and coordinator of 
continuing education for the division of 
periodontics at Northwestern Univer¬ 
sity Dental School. 
Daniel J. Donofrio. P.A. ’91, 
specializes in family medicine, pediat¬ 
rics and internal medicine at the Hill 
Health Center in New Haven. A 15- 
year veteran of the Air Force Reserve 
flying aeromedical evacuation mis¬ 
sions, Mr. Donofrio has been commis¬ 
sioned as an officer and a physician’s 
associate. 
36 Yale Medicine Fall/Winter 1992-93 
Student 
News 
Minority Students Train 
In Two Summer Programs 
Two summer programs at Yale School 
of Medicine allowed 25 minority 
students to train with researchers, to 
encourage the students to pursue careers 
in the biomedical sciences. 
The first project, initiated this year, 
enrolled 13 outstanding minority 
undergraduates in a 10-week program in 
which they helped conduct research on 
such topics as the molecular biology of 
parathyroid hormone secretion, the 
vascular endothelial-white cell interac¬ 
tion, and heart function during coronary 
occlusion. 
This program is supported by a five- 
year grant from the National Heart, 
Lung and Blood Institute. The students 
receive a research stipend and travel 
expenses and are housed at Harkness 
dormitory. 
The second program selected 16 
minority high school students from New 
Haven public schools to spend part of 
their summer vacation conducting 
research with scientists at Yale as part of 
its Summer Research Apprenticeship 
Program. The program, which ran from 
June 22 to Aug. 14, was designed to 
interest African-American and Hispanic 
students in careers in medicine and the 
biomedical sciences. 
The National Institutes of Health, 
through the U.S. Public Health Service’s 
Division of Research Resources, funds a 
majority of the students’ stipends, with 
the School of Medicine offering 
additional support. 
Among the Wilbur Downs International Travel Fellows taking part in the annual 
symposium were (from left): Daniel Stolar, Henry Chun-Hung Hsia, Andrea 
Edwards, Chidinma N. Alozie, Chinaro M. Kennedy, Marjorie S. Rosenthal, Kelly 
Shine, Annie E. Van Dusen and Tigist Hailu. 
Wilbur Downs Research 
Fellows Span the Globe 
On Wednesday, Oct. 21, the 1992 
Wilbur G. Downs International Travel 
Fellows took part in the annual sympo¬ 
sium honoring the late Dr. Downs, who 
founded both the medical school’s 
committee on international health and 
the research fellowship program that 
bears his name. Presenting their 
findings were (by country): 
Costa Rica. Annie E. Van Dusen, 
M.P.H. ’93, Baseline survey of AIDS/ 
HIV knowledge, behavior and attitudes 
among women. 
Ecuador. Marjorie S. Rosenthal, M.D. 
’95, Malnutrition and neurological 
impairment in rural Ecuador; Kelly 
Shine, M.D. ’95, Transferring usable 
but wasted medical surgical supplies to 
developing countries; Daniel Stolar, 
M.D. ’95, Taenia Solium infections: 
knowledge, attitudes and practices. 
Eritrea. Tigist Hailu, M.D. ’95, 
Evaluation of morbidity and mortality 
of mothers and infants. 
Guatemala. Andrea G. Edwards, M.D. 
’95, A comparison of unequal growth 
development between severe hearing 
impaired children and their siblings. 
Kenya. Chidinma N. Alozie, M.D. 
’95, Methylating agents as new 
trypanocides in domestic animals and 
primates. 
Nepal. Dayna D. Ferguson. M.D. '93, 
Socioeconomic consequences of 
chronic onchoclermatitis. 
Pakistan. Sara H. Cody, M.D. ’93, 
Children with pneumonia: doctors, 
dispersers, holy men and home. 
People’s Republic of China. 
Raymond W. Kam, M.D. ’95, c-myc 
rearrangements and p53 tumor 
suppressor gene mutations in nasopha¬ 
ryngeal cancer. 
Senegal. Henry Chun-Hung Hsia, 
M.D. ’95, Population dynamics of 
potential Rift Valley fever vectors; D. 
Sandra Rwambuya. M.P.H. ’93. The 
epidemiology of borreliosis. 
South Africa. Michael Knapp, Ph.D. 
’95, The public health impact and 
management of industrial effluents in 
Durban, Natal. 
Thailand. Chaiyaporn Kulsakdinun, 
M.D. ’93, Dengue epitopes and 
cytotoxic lymphocytes; I. Robert 
Grossman, M.D. '93, Effect of Den- 
gue-2 virus on the function of washed 
human platelets. 










Incoming medical student Karl Haglund dons a white coat presented hv Dean 
Gerard N. Burrow; Merle Wa.xman (right) and Dr. Robert Gifford (at podium, left) 
also assisted in the white jacket ceremony. 
Medical School Debuts 
White Coat Ceremony 
A new tradition took shape this fall at 
School of Medicine orientation when 
the 100 entering medical students were 
presented white jackets. The Sept. 9 
ceremony and reception were held in 
Edward S. Harkness Hall. 
Said Nicholas Spinelli, M.D. '44. 
who donated the coats, “The white 
coat should be a reminder of the 
covenant made between physician and 
patient for the provision of compas¬ 
sionate medical service to all members 
of our society in need. The student 
Book News 
Medicine: The Art of Healing, by 
Sherwin B. Nuland, M.D. ’55, Hugh 
Lauter Levin (Norwalk, Conn.) 1992. 
Among Friends: Hospice Care for the 
Person with AIDS, by Robert W. 
Buckingham, Dr. P.H. '78, Prometheus 
Books (New York) 1992. 
Neurobiological Disorders in Children 
and Adolescents, edited by Enid 
who fulfills this promise will derive 
gratification unique to our profession. 
The coat will confer the respect which 
one’s service has earned.” 
Robert H. Gifford, M.D., associate 
dean for education and student affairs, 
spoke at the ceremony. He said, 
“Wearing this coat implies the 
beginning of a new life for you, a 
new covenant: A lifetime commit¬ 
ment to compassion and caring for all 
who will seek your help.” 
Coats were presented to the students, 
46 percent of whom are women, by 
Dean Gerard N. Burrow; Deputy Dean 
Lawrence S. Cohen and Merle 
Waxman, director of the Office for 
Women in Medicine. 
Peschel, Ph.D., assistant professor 
(adjunct) of internal medicine, and 
Richard Peschel, M.D., Ph.D., associ¬ 
ate professor of therapeutic radiology 
and in the Cancer Center, et al. Jossey- 
Bass (San Francisco) 1992. 
Emerging Infections: Microbial 
Threats to Health in the United States. 
edited by Robert E. Shope, M.D., 
professor of epidemiology, et al. 
National Academy Press (Washington, 
D.C.) 1992. 
Down from Troy: A Doctor Comes of 
Age, by Richard Selzer, M.D. '61. 
William Morrow (New York) 1992. 
Third-year student Eileen Deignan and 
second-year students Gregory Licholai 
and Timothy Peters have been named 
1992-93 Howard Hughes Medical 
Institute-National Institutes of Health 
Research Scholars. As part of the 
Cloister Program, they will perform 
research in an NIH laboratory of their 
choice for one year. 
Fern P. Finger and Avlin Barlow, 
third-year Ph.D. students at the medical 
school, were named this year’s recipi¬ 
ents of the Miles Scholar Award for 
graduate study in the biomedical 
sciences. Ms. Finger’s research centers 
on the power of yeast genetics in 
identifying genes whose products are 
used to transport proteins to the cell 
surface. Ms. Barlow’s research focuses 
on the genes that control susceptibility 
to insulin-dependent diabetes. 
The American Liver Foundation has 
awarded Saul Karpen, M.D., Ph D., a 
$7,500 Joyce Willig Postdoctoral 
Research Fellowship. In collaboration 
with Frederick J. Suchy, M.D., profes¬ 
sor of pediatrics. Dr. Karpen is doing 
research on bile acid transport. 
Laura Nilson, a fifth-year Ph.D. 
student in the department of genetics, 
was presented the Eli Lilly Student 
Award for the most significant 
papillomavirus research by a graduate 
student. She received the award in 
September at the 11 th International 
Papillomavirus Workshop in 
Edinburgh, Scotland. 
Head Start and Beyond: A National 
Plan for Extended Childhood Interven¬ 
tion, by Edward F. Zigler, Ph.D., 
Sterling Professor of Psychology and in 
the Child Study Center, Yale Univer¬ 
sity Press 1992. 
Stanford Law & Policy Review, edited 
by Mark S. Williams, M.D. ’79, et al. 
Stanford Law School and Stanford 
University (Stanford, Calif.) 1991. 
The Good Doctor Snath: The Life and 
Times of Dr. Nathan Smith, 1762- 
1829, by William W. Field, M.D., 
lecturer in medicine. Privately pub¬ 
lished (New Haven) 1992. 
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As director of alumni affairs and an 
alumnus of the School of Medicine, I 
would like to take this opportunity to 
welcome you to a new era at the Yale 
School of Medicine under the deanship 
of Gerard N. Burrow, M.D. ’58. His 
experience as clinician, medical 
scientist, teacher and health care 
i administrator assures us of his commit- 
) ment to train those in medicine, public 
health and biomedical science who will 
lead us into the 21st century. The Yale 
system will be preserved and improved 
by someone who has benefited from it 
and understands its advantages. We 
alumni welcome Gerry’s return and we 
pledge our loyalty and support. 
Yale has always produced leaders in 
the academic, scientific and clinical 
arenas. This includes medical and 
public health practitioners, health care 
administrators and teachers. They have 
earned respect from their colleagues 
and patients. We were the best, we are 
the best and will continue to be the 
best. We are what Yale has made us. 
For this reason, it is imperative that 
we give back. As a medical school or 
public health graduate, your support of 
the School of Medicine is essential if 
YSM is to continue its leadership. Class 
i! communication should be strengthened 
to enable us to publish news of your 
professional and personal accomplish¬ 
ments. You can communicate with 
your class secretary, write to us, or call 
us at the alumni affairs office. 
Your comments will help us to plan 
meaningful reunion programs for the 
school. We know that many of you are 
a long way from New Haven, but we 
want you to know that the Association 
of Yale Alumni in Medicine executive 
committee represents all of you. We 
who are close to Yale and New Haven 
can support student activities such as 
teas, second-year shows, student dances 
and phonathons. There are opportuni¬ 
ties to work with students as instructors 
and role models, helping familiarize 
them with our traditions and our 
commitment to excellence. The Office 
of Alumni Affairs assists the students to 
become aware of the role of our alumni/ 
ae as loyal supporters of Yale and help 
them organize their class members. 
You also can help by financially 
supporting Yale to the best of your 
ability. Your contributions to the 
medical and public health alumni funds 
support the student aid program and 
help to maintain our need-blind admis¬ 
sions policy. Without this assistance 
our competitive position with other 
schools would weaken. The dean must 
pay for facility acquisition and mainte¬ 
nance to provide a work place condu¬ 
cive to continuing excellence. Ad¬ 
equate office and laboratory space are 
necessary not only to serve our current 
faculty and staff but to attract new 
faculty, as well. Discretionary funds 
must be provided to meet emergencies, 
and faculty salaries must be competi¬ 
tive. Alumni gifts to the school have 
increased each year and exceeded $ 1 
million for the first time in 1991-92. I 
congratulate you. thank you, and 
encourage you to keep up the good 
work. 
In closing, may I remind you to mark 
your calendars for the annual reunion on 
June 4 and 5, 1993. Classes ending “3” 
and “8” will be returning for five-year 
reunions, but all are welcome. A 
program of events will be mailed to you 
and a complete program will be posted 
in the next issue of Yale Medicine. The 
new Children’s Hospital at Yale-New 
Haven will be completed by reunion 
time, and alumni will have the opportu¬ 
nity to tour the facility. We continue to 
grow to meet the needs of the commu¬ 
nity and to fulfill our educational and 
research mandates in medicine and 
public health. Those of you who have 
not had the opportunity to return to New 
Haven recently will be pleasantly 
impressed by the changes which have 
occurred to complement rather than to 
destroy the old structures. 
Arthur C. Crovatto, M.D. ’54 
Director of alumni affairs 
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Basil L. Truscott 
Basil L. Truscott died April 7 at Baptist 
Medical Center in North Carolina. He 
was 75. 
Dr. Truscott, a native of Nebraska, 
received his B.A. degree from Drew 
University, M.A. degree from Syracuse 
University, and M.S., Ph.D. and M.D. 
degrees from Yale. He served as 
consultant in neurology to the U.S. 
Army in Europe, attaining the rank of 
lieutenant colonel. He held faculty 
positions in the medical schools of 
Georgetown University, Yale, the 
University of North Carolina and 
Albany Medical Center. Until his 
retirement. Dr. Truscott was professor 
of neurology and associate dean for 
student admissions at Bowman Gray 
School of Medicine. 
He was a fellow of the American 
College of Physicians and of the Stroke 
Council. 
He is survived by his wife, Jane; and 
his daughter, Elizabeth. 
Siegried A. Centerwall 
Siegried A. Centerwall, M.D., died of 
cancer on July 1 at her Silverton. Ore., 
home. She was 66. 
Dr. Centerwall, a native of Cincin¬ 
nati, graduated from Mount Holyoke 
College in 1946, from the University of 
Texas in 1948, and from Yale School 
of Medicine in 1952. 
After serving for more than seven 
years as acting director of public health 
for San Bernadino County, Dr. 
Centerwall became director in the 
California Department of Health 
Services while serving simultaneously 
as head of the departments of maternal 
and child health; women, infants and 
children; family planning; crippled 
children services; genetics; and child 
health and disability prevention. The 
San Bernadino County Board of 
Supervisors established the Siegried A. 
Centerwall Fund "in honor of her 
concern and commitment to affirmative 
action in county government,” to help 
women and members of ethnic minori¬ 
ties further their education. She also 
received a “Resolution of Commenda¬ 
tion" from the California legislature. 
Throughout her career. Dr. 
Centerwall served as assistant professor 
of health administration at Loma Linda 
University; staff physician at Pacific 
State Hospital in Pomona, Calif.; 
research associate in maternal and child 
health at the University of Michigan 
School of Public Health. She and her 
husband worked as missionaries for 
five years at the Christian Medical 
College in Vellore, South India. 
Dr. Centerwall was a co-founder 
and member of the board of directors of 
Light for the Way Inc., a non-profit 
medical education organization for 
parents of children with handicaps. 
She is survived by her husband, 
Willard; two sons, Theodore and 
Brandon; four daughters, Krista, 
Alison, Jennifer and Rebecca; and 17 
grandchildren. 
Alberta Smith Jacoby 
Alberta Smith Jacoby died July 8 at 
Yale-New Haven Hospital at age 80. 
Mrs. Jacoby, born in Worthington, 
Minn., graduated Phi Beta Kappa from 
the University of Minnesota and 
received a master’s degree in public 
health from Yale in 1967. 
Mrs. Jacoby, a specialist in mental 
health education, teacher and producer 
of documentaries at the department of 
epidemiology and public health, had 
been on the faculty at Yale for 25 years 
and was a lecturer in public health at 
the time of her death. 
She was an alternate on the 1928 
Olympic diving team, featured dancer 
on the vaudeville circuit and a cham¬ 
pion golfer. In World War II she was 
program director for the Office of War 
Information. Later she was the first 
deputy director of the President’s 
Council for Physical Fitness, an 
information officer at the Public Health 
Service for the U.S. Surgeon General, 
and chief of information for the 
National Institute of Mental Health. 
In 1949 she and her director- 
husband, the late Irving A. Jacoby, 
formed the Mental Health Film Board. 
This production company produced 
more than 100 documentaries, includ¬ 
ing award winners on subjects such as 
psychiatric illnesses, drug abuse, 
juvenile delinquency and hospice care. 
She leaves six children, Clair, Sara, 
Peter, Leslie, Tamar and Oren; three 
brothers, Paul, Robert and Sidney; five 
grandchildren and five great-grand¬ 
children. 
Memorial contributions may be 
made to the Mental Health Film Board, 
1 Moose Hill Road, Guilford, CT 
06437. 
William R. Maniatis 
William R. Maniatis, M.D., died July 
19 at his home in Woodbridge, Conn., 
after a long illness. He was 68. 
Dr. Maniatis, a Steubenville, Ohio, 
native, graduated from Ohio State 
University in 1914 and Yale School of 
Medicine in 1947. He was a member 
of the American College of Physicians 
and Surgeons, a past president of the 
Connecticut Medical Society, and 
chairman of the surgical staff of the 
Hospital of St. Raphael until his 
retirement in 1991. 
He also was a member of the 
courtesy staff of Yale-New Haven 
Hospital, a fellow of the International 
College of Surgeons, a member of the 
Florida Medical Association, the 
American Medical Association and a 
clinical instructor at Yale School of 
Medicine. 
Dr. Maniatis was a Navy veteran of 
World War II and an Air Force captain 
during the Korean War. 
He leaves his wife, Julia; two 
daughters, Chalynn and Janice; three 
stepdaughters, Pamela, Denise and 
Betsy; and six grandchildren. 
Memorial contributions may be 
made to the Hospital of St. Raphael 
Foundation, 1455 Chapel St., New 
Haven, CT 06511. 
At press time, Yale Medicine received 
word that Elias E. Mamtelidis, M.D., 
professor emeritus of neuropathology 
and neurology, had died at age 74. His 
obituary will appear in the spring issue. 
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Hester B. Curtis 
Hester B. Curtis, M.D., died of cardiac 
arrest on July 25 at Manor Care 
Nursing Home in Arlington, Va. She 
was 93. 
Dr. Curtis, a native of Point Pleas¬ 
ant, N.J., was a retired medical officer 
for the office of international activities 
of the U.S. Department of Health, 
Education and Welfare’s social and 
rehabilitative service. After graduating 
from Trinity College, Dr. Curtis taught 
fifth and seventh grades in the southern 
Maryland school system. In 1932 she 
received an M.D. degree from Yale, 
and later received a M.P.H. degree 
from Harvard. 
She served as director of maternal 
health and child health in the New 
Mexico health department, as director 
of maternal and child health in West 
Virginia and also as a medical consult¬ 
ant in the children’s bureau of the 
department of labor in Kansas City, 
Mo. From 1946 to 1950, Dr. Curtis 
was medical director in the New York 
City office of the children’s bureau, and 
from 1950 to 1961, she was maternal and 
child hygiene physician in Connecticut’s 
health department. 
In 1961, Dr. Curtis was named 
medical officer in the children's bureau 
of the federal Department of Health, 
Education and Welfare division of 
international cooperation, then joined 
the international activities office. 
Dr. Curtis received Trinity College's 
Julie Billiart Award for her contribu¬ 
tions to the health of mothers and 
children. 
William Sabella 
William Sabella, M.P.H., of New 
Haven died of complications from 
AIDS on July 25. He was 47. 
Mr. Sabella, who until 1990 was 
AIDS education coordinator with Yale- 
New Haven Hospital, served as 
Connecticut’s first AIDS education 
coordinator in the Department of 
Health Services from 1983 to 1987. He 
also co-founded AIDS Project New 
Haven, served on the governor’s 
permanent AIDS task force, and on the 
archbishop of Hartford’s AIDS task 
force. In 1989, Mr. Sabella received an 
AIDS Leadership Award from the state 
commission of health services for his 
early involvement in AIDS education. 
Mr. Sabella received his B.S. degree 
from Charter Oak College in 1980 and 
his M.P.H. degree from Yale in 1983. 
Memorial donations may be made 
to the AIDS Care Program, Yale-New 
Haven Hospital, 20 York St., New 
Haven, CT 06504. 
David W. Molander 
David W. Molander, M.D., died July 31 
at his summer home in Chatham, Mass. 
He was 69. 
Dr. Molander, a native of Iron 
Junction, Minn., was a graduate of the 
University of Minnesota Medical 
School. He was an intern and resident 
in medicine at Yale and served in the 
Army in World War II. 
Dr. Molander practiced with the 
Pack Medical Group, specializing in 
cancer treatment. He served on the 
staffs of New York and Memorial 
Sloan Kettering hospitals, and was 
professor of clinical medicine at 
Cornell University. He also was a 
consultant to the Cape Cod Hospital 
board. Dr. Molander had been deco¬ 
rated by the Dominican Republic, 
Brazil and Venezuela for his work in 
international health. 
He is survived by his wife, Marian; 
his son, John; a daughter, Susan; four 
stepsons, David, Bruce, Jeffrey and 
Dean; and two grandsons. 
Memorial contributions may be sent 
to the Audubon Society of Massachu¬ 
setts, Wellfleet, MA 02667. 
John D. Thompson 
John D. Thompson of New Haven died 
of cardiopulmonary arrest on Aug. 13 
at Yale-New Haven Hospital. He 
was 75. 
Mr. Thompson joined the faculty of the 
Yale epidemiology and public health 
department in 1956 and was head of the 
division of health policy, resources and 
administration since 1974. 
In 1967, Mr. Thompson and his 
colleague, Robert B. Fetter, developed 
a system called diagnosis-related 
groups (DRGs), which divides thou¬ 
sands of illnesses and treatments into 
standard categories. These categories 
are used to calculate and compare costs, 
lengths of stay and treatments. The 
system spread across this country and 
overseas, with its wide use in 1983. 
when the federal government adopted 
DRGs for hospitalized Medicare 
patients. 
Trained as a nurse at Bellevue 
Hospital in Manhattan, Mr. Thompson 
served there as head psychiatric nurse 
after World War II. Later he was an 
assistant director at Montefiore 
Hospital in the Bronx. 
He earned a bachelor’s degree from 
City College and a master’s degree in 
hospital administration at Yale in 1950. 
He became director of the hospital 
administration program at Yale in 1966 
and was associate dean of the School of 
Medicine from 1968 to 1974. 
Born in Franklin, Penn., Mr. 
Thompson grew up in Canton, Ohio. In 
World War II he served in the Navy as 
a chief warrant officer. 
Surviving are his wife. Dr. Andriana 
Natale; six daughters, Margaret, 
Monica, Siobhan, Dierdre, Julie and 
Maire Clare; a son, Anthony; a sister, 
Martha Carrick; and a granddaughter. 
Yale Medicine Fall/Winter 1992-93 41 
Development Report 
Yale-New Haven Hospital President and CEO Joseph A. Zaccagnino, M.P.H. 
'70, offers best wishes to Dean Gerard N. Burrow at the kickoff celebration for 
the Yale campaign. 
Yale Campaign Aids 
School of Medicine 
With last May’s launch of The Yale 
Campaign...andfor Yale: A $1.5 
Billion Investment, the University 
committed itself to a fundraising 
drive which encompasses the needs 
of all of its schools. Higher 
education’s largest-ever capital 
campaign is chaired by Vernon R. 
Loucks Jr., '57, senior fellow of the 
Yale Corporation, and president and 
chief executive officer of Baxter 
International. 
The medical school’s $285 
million goal represents YSM’s 
largest capital campaign. Funds will 
be dedicated to: 
• Strengthening the school’s curricu¬ 
lum while preserving the Yale 
system of medical education. 
• Increasing the endowment. 
• Reducing the school’s reliance 
on federal funds. 
• Renovating aging facilities and 
building new ones. 
To date, School of Medicine 
commitments total nearly $100 
million, which includes more than 
$30 million from alumni. Record 
gifts by last year’s 25th and 50th 
reunion classes have given rise to a 
new reunion giving program; every 
YSM graduate will be asked to 
mark his or her five-year reunion 
with a gift in the name of the class. 
Class agents, reunion gift 
chairmen and school development 
officers will contact alumni 
personally to discuss reunion giving 
and the ways in which gifts will 
support the school and the cam¬ 
paign. Led by Dean Gerard N. 
Burrow, M.D. ’58, the campaign 
will support the Yale School of 
Medicine’s commitment to humane 
and socially responsive medicine. 
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Walter L. Johnson 
Establishes Trust 
Walter L. Johnson, M.D. '55, has 
established a trust from the proceeds of 
the sale of a home to benefit the School 
of Medicine. Dr. Johnson used a 
charitable remainder trust to support 
Yale, take advantage of federal income 
tax deduction provisions, and to receive 
an income for life. Dr. Johnson is a 
semi-retired neurologist who has spent 
his career in private practice. The 
principal of the trust will come to Yale 
to support the School of Medicine at his 
death. 
In acknowledging Dr. Johnson’s 
generosity. Acting University President 
Howard R. Lamar wrote, “Your gift is 
particularly meaningful at this time as 
the University enters a campaign that 
will be of vital importance for its 
success in meeting its most pressing 
needs in the years ahead. On behalf of 
the entire Yale family, I thank you for 
your ongoing devotion.” 
Anne P. Whistler Helps 
Physicians of Tomorrow 
Anne P. Whistler has established an 
endowed scholarship in memory of her 
father, the late Frank E. Phillips, 
M.D.’01, who prided himself as being a 
family physician of the “old school.” 
Dr. Phillips practiced in Wells, Maine, 
and in North Chelmsford, Mass. In 
creating the scholarship, Mrs. Whistler 
recalled how much her father’s patients 
loved him and how proud she was of 
him. Dr. Phillips traveled across Maine 
and Massachusetts to see many of his 
patients and, as a hobby, built handset 
radios for many of them. Mrs. Whis¬ 
tler, who will turn 87 in January, said 
her father worked his way through 
college and medical school; hence, she 
wants to help young people finance 
their medical education. 
Yale Medicine Fall/Winter 1992-93 
Reunion Reports 
Rocko Fasanella, M.D. ’43 (left), reminisces with Harry Zimmerman, M.D. ’27. 
1927 
65th Reunion 
by Dr. Harry M. Zimmerman 
In spite of heavy rain on Friday, June 
5th. the first reunion day, the program 
proceeded with a good attendance by 
returning alumni. Regrettably, I alone 
represented the Class of 1927—the 
remaining members of this class were 
physically not up to coming. 
I attempted to rectify this by 
speaking by phone with each class 
member on the following Monday, 
June 8th, and learned that Moses 
Rothberg. who now lives in Palm 
Harbor, Fla., lost his wife several years 
ago and himself suffers from some 
memory loss. Alfred Seibert is in 
Norwich, Vt., and reports that he is 
“well and happy." Ted Sills of 
Columbus, Ohio, celebrated his 90th 
birthday six months ago and stated, 
“everything’s now wrong!” Dawson 
Tyson is in White River Junction, Vt., 
and has had a coronary artery by-pass 
that permits him to play golf occasion¬ 
ally and to work part time in the local 
hospital. 
The class originally consisted of 44 
members and now there are five of us 
left. I alone am still working full time, 
as a consultant in pathology at the 
Montefiore Medical Center in the 
Bronx. New York, and as professor 
emeritus in pathology at the Albert 
Einstein College of Medicine. 
1932 
60th Reunion 
by Dr. Robert Cushing 
Unique indeed. It occasioned that I 
was the sole member of my class who 
attended this past reunion, having 
joined my classmates during every 
reunion since graduation, save for the 
period of World War II when I was on 
duty in the Pacific Theater as a naval 
flight surgeon. 
It chanced that Peter Murphy, M.D. 
’39, whom I had not known, engaged 
me in conversation. It then followed 
that Dr. and Mrs. Murphy joined my 
wife and me for the dinner celebration, 
rendering our stay exalting and 
delightful—and worthy of repetition! 
1937 
55th Reunion 
by Dr. Wilbur D. Johnston 
Saturday, June 6. at the Graduate Club 
in downtown New Haven, ended the 
55th reunion of the Class of 1937. It 
was a gala affair made possible by the 
generous invitation of the 50th reunion 
class to join them at dinner. Classes 
with a five in their reunion year were 
invited and so we qualified. 
I as class secretary was able to 
introduce Dennie Pratt and his wife. 
Marjorie, who live in Bass. Maine. 
Both of these people looked great and 
Dennie has not changed a bit. probably 
due to the genes he inherited from his 
forebear who had the audacity to write 
the “Ballad of Chambers Street." I also 
introduced A1 Spicer and his lovely 
wife. Marian. A1 went on to Harvard 
Dental School and received his dental 
degree in two years. This allowed him 
to practice with his father in 
Weekapaug, R.I. A1 is now a trustee 
for the Horace Wells Trust Fund, a 
$300,000 fund that awards scholarships 
to dental students. So although few in 
number, the quality of our returning 
classmates was quite evident. As best 
we can count, there are still 23 surviv¬ 
ing members which is not bad. consid¬ 
ering the average age of 81. 
I thought it of sufficient interest to 
recite my interview with Dr. Winternitz 
upon applying for admission. His 
interest in the “Tug Boat Annie” stories 
and my recollection of the “Alexander 
Botts Earthworm Tractor” story, which 
he had not read—gained my admission. 
Long live the Saturday Evening Post 
stories! 
Our class began with Dr. 
Winternitz’s hand-picked group of 46 
men and four women—there was no 
admission committee, just the little 
Napoleon making the decisions. Lest I 
be misunderstood, “Winter” and I 
became best friends and I admired his 
great intellect. 
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This has been a tumultuous year for 
Yale, what with Dean Rosenberg and 
President Benno Schmidt leaving. 
Fortunately, Robert Donaldson did a 
great job as acting dean and we have a 
new dean. Dr. Gerard N. Burrow, who 
took up the reins as of July 1. Living in 
the New Flaven area, I am close enough 
to observe these changes first-hand and 
I marvel at the quality that keeps 
emerging. 
On Friday, June 5th, the reports of 
the activities and accomplishments at 
the Yale School of Medicine were 
related—all outstanding. We had an 
excellent lunch and renewed old 
friendships. 1 had the pleasure of 
meeting and chatting for a few minutes 
with Dr. Harry Zimmerman, whom we 
all admired as our pathology teacher. 
And so another five years have 
slipped by us. I urge you all to stay 




by Dr. Charles F. Scholhamer 
The Yale School of Medicine Class of 
1942 had its 50th anniversary on June 
5th and 6th. 
Fifteen members of the class 
attended an enjoyable and memorable 
reunion. Dinner at Mory’s on Friday 
and the concluding dinner at the 
Graduate Club on Saturday terminated 
two eventful days. Space permits only 
a brief note about each classmate who 
attended. 
Walter Burdette received YSM’s 
Distinguished Alumnus Award this 
year and has endowed a lectureship in 
medical science at Yale. He is leaving 
his position as chief of thoracic and 
cardiovascular surgery at Park Plaza 
Hospital in Houston to return to 
research and has already started his 
11th book. He has been head of the 
department and chief of surgery at Utah 
and Missouri medical schools and 
professor of surgery and directed the 
research program at the University of 
Texas M.D. Anderson Hospital. 
Bill Bloomer was chief of thoracic 
and cardiovascular surgery at Harbor- 
UCLA Hospital after completing a 
residency in thoracic surgery at Yale 
and has also been in private practice in 
Los Angeles and more recently in Long 
Beach. He is now limiting his practice 
and may continue in Washington state 
in the future. 
Jim Bunce has been retired for 10 
years, and he and Nancy are active in 
many civic organizations in Hartford. 
He interned at the Johns Hopkins 
Hospital, saw military service in the 
European theater and was awarded the 
Bronze Star for valor. He returned to 
residency training at the Hartford 
Hospital and was in private practice in 
obstetrics and gynecology during his 
professional career. 
Bob Carroll received his training in 
surgery and orthopaedics at the 
Massachusetts General Hospital. He 
was in World War II in the Pacific 
theater and after postgraduate training 
became the chief of hand surgery at the 
New York Orthopaedic Hospital. He 
trained many hand surgeons and 
completed much investigative work on 
congenital deformities, tumors and 
muscle transplantation, for which he 
was honored in Paris recently at the 
Congress of Federated Societies for 
Surgery of the Hand. He has given an 
annuity to Yale that will support 
student aid and research and training in 
hand surgery. Currently he is professor 
emeritus at Columbia and consultant in 
hand surgery at the Columbia-Presbyte- 
rian Center. 
Gene de Hostos was intern at the 
Hartford Hospital and resident at 
Albany General when his training was 
interrupted by the war, which he spent 
in the medical corps in Central 
America. He returned to training at 
McKinney VA Hospital and was in 
private practice in San Juan until he 
retired. He was president of the Puerto 
Rican Surgical Society for seven years 
and also the Faculty Hospital in San 
Juan. Currently, he is justifiably proud 
of the impressive beginning careers of 
his daughter and two sons. 
Bill Fleeson spent a portion of his 
time in the medical coips at the 
Manhattan Project after a decade in the 
private practice of psychiatry, associate 
professor and assistant dean at the 
University of Minnesota, and then 
helped establish the University of 
Connecticut Medical School, where he 
was professor of psychiatry and 
associate dean until retirement. 
Currently, he is working three days 
weekly as chief of psychiatry at the 
Newington Veterans Affairs Hospital. 
Ken Morgan has a long career in 
the private practice of obstetrics and 
gynecology in Florida. Since retire¬ 
ment he continues to travel and enjoy 
sports. He is now living in Southport, 
Conn. 
Bill Harrison served his internship 
and residency training in pathology at 
the Hartford and Yale-New Haven 
hospitals with interruption by Army 
service in Okinawa and Korea and a 
year in Army hospitals recovering from 
tuberculosis. After serving as a 
research assistant to Dr. Liebow, he 
entered the practice of pathology in 
Kingsport, Tenn., and later became 
clinical professor of pathology when 
the medical school was established. He 
retired as director of the Holston Valley 
Hospital, but continued to work part 
time until recently. 
Leo Kellerman continued the 
private practice of ophthalmology until 
10 years ago, when he retired. After¬ 
ward he set up and administered eye 
clinics in St. Kitts and Nevis in the 
Caribbean. He is now an arborist and 
active tree planter in Dougleston, N.Y., 
where he moved after practice in the 
Fresh Meadows section of New York. 
He continues to play tennis and claims 
his weight is the same as in medical 
school. 
Sam Ritvo completed training in 
pediatrics, psychiatry and psychoanaly¬ 
sis and returned to Yale in 1950, where 
he is now clinical professor of child 
psychiatry. He participated in estab¬ 
lishing the child psychiatry clinic and 
the Yale longitudinal study in child 
development. He continues to be active 
in teaching, research, and clinical 
practice in the stimulating environment 
of the Yale Child Study Center. 
Charlie Scholhamer obtained his 
training in pediatrics and served in the 
naval service in the Pacific theater. He 
returned to New Haven and was in the 
private practice of pediatrics for many 
years following which he became a 
medical insurance executive. At 
present, he is retired and follows events 
at Yale with interest. 
Continued on Page 46 
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Distinguished Service Awards 
Walter J. Burdette 
ii You matriculated at the School of 
I', Medicine in 1938 from your native 
I Texas, bearing a master's degree in 
■ genetics and mathematics. Following 
L graduation in 1942, you did 
f postdoctoral training in surgery at Yale 
: and the Grace-New Haven Hospital. 
: The last 21 years have found you back in 
r your beloved Texas where you have been 
professor of surgery at the Medical 
| Center in Houston. Throughout a 
distinguished career in thoracic surgery, 
an interest in genetics and oncology’ has 
i been a strong influence on your 
research. 
It is for your devotion to Yale and 
' Yale activities that you are honored 
George A. Carden Jr. 
'You have served Yale and its School of 
Medicine in many capacities and have 
been both an alumni leader and a 
vigorous fund raiser. In addition, you 
have had a distinguished career in 
internal medicine as a practitioner and 
consultant in Manhattan and as a 
George A. Carden Jr., M.D. '35 
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today. Through the years you have 
been a constantly generous host to 
visiting Yale faculty’ and deans. You 
have served as president of the Houston 
Yale Club and been a vocal champion of 
the excellence of the Yale system of 
medical education to pre-med students 
in your region. Your most precious gift 
to your medical school was that of your 
daughter Susan, who received her M.D. 
degree with distinction at Yale in 1981. 
You are a paradigm as a devoted 
regional alumnus and as such a role 
model for alumni scattered across our 
country. Your University’ and alumni 
association salute you on the 50th 
anniversary of your graduation. 
clinical professor at Columbia College 
of Physicians and Surgeons. 
You came to Yale as a college 
freshman in 1927 and were admitted to 
the School of Medicine by Dean 
Winternitz in 1931. In an interview 
several years ago you recalled your years 
here at the school as “the most exciting 
moments of my life, ” and you said “the 
Yale School of Medicine gave me a 
chance to find myself and to be proud of 
myself and that is why it is so important 
to me today. ” 
In 1965 you were elected to the 
executive committee of the Association 
of Yale Alumni in Medicine. You 
became vice president of that 
organization in 1967 and served as 
president from 1969 to 1971. During 
this period you played an important role 
in the first Alumni in Medicine (AIM) 
Campaign. 
You subsequently sen>ed as a valuable 
and influential member of the University’ 
Council committee on medical affairs, an 
advisory group to the president and 
fellows of the Corporation, for three 
consecutive five year terms from 1970 to 
1985. In addition you were part of the 
National Volunteer Committee of the 
Walter J. Burdette, M.D. ’42 
Campaign for the Yale School of 
Medicine which was launched in 1985. 
It should also be noted that in 1978, 
through gifts by your friends and 
grateful patients, the Carden Scholars 
Program was established at this school 
to provide support for junior faculty’ in 
immunology> and virology’. This tribute 
to you and your pro fessional skill was of 
considerable benefit to young faculty 
members. 
Over the years you have responded 
with vigor when called upon by your 
alma mater and have served 
enthusiastically and effectively in many 
major capacities. For your long¬ 
standing commitment and personal 
generosity, your alma mater and your 





















Continued from Page 44 
Carter Stilson still lias the youthful 
appearance he had on entrance into 
medical school. He has been in private 
practice in New Haven since his 
residency training. He is fortunate to 
have his daughters nearby. One has a 
Ph.D. in psychology and the other a 
master of nursing degree. 
Mo Tulin obtained residency 
training in internal medicine and was 
associate professor of clinical medicine 
at Cornell Medical Center at the time of 
his retirement last year. Since that time 
he has returned as emeritus associate 
professor at North Shore University 
Hospital. Miriam also has retired as 
emeritus professor of drama, and they 
are enjoying a more leisurely existence. 
Irving Wolfson was chief of 
cardiology at Worcester City (Mass.) 
Hospital, chief of medicine at Fairlawn 
Hospital, and professor of medicine at 
the University of Massachusetts. After 
a myocardial infarction nine years ago, 
he retired and has been busy as a 
landscape painter during the ensuing 
years, with pictures hanging at the 
University of Massachusetts Medical 
Center, East Brookfield town hall and 
elsewhere. He plays in chess tourna¬ 
ments and is active in his local church. 
Edgar Taft became professor of 
pathology and served on the staff of 
Massachusetts General Hospital until 
his retirement nine years ago. He and 
Piri are active in civic affairs and have 
become amateur tenant farmers. He 
continues to study and practice the 
piano and is president of the board of 
trustees of the Pittsfield Community 
Music School and vice president of the 
Laurel Hill Association of Stockbridge. 
The wives of Drs. Bunce, Bloomer, 
Carroll, Fleeson, Kellerman and 
Morgan; and friends, Olga Zagraniski 




by Dr. P. H. Phi I bin 
The Class of 1947 was in good force at 
our 45th. The class has lost about one- 
fifth of our members, but nearly one- 
half of those able made an appearance, 
including Charlie Cavanagh from 
Spokane and Frank Golbranson from 
San Diego. We heard from Bill 
Rudnian, Amoz Chernoff and Owen 
Doyle beforehand. They are well, but 
all had unavoidable interference. Each 
indicated he would make it to the 50th. 
Bill Maniatis is seriously ill, as is 
Brad Colwell. We spoke with their 
wives and extended the wishes of the 
class for their recovery. Wilhelm 
Albrink, Bert Bostrom, Chuck 
Woche and Lou Young passed away 
this year, which losses, among others, 
created some sadness. 
Those in attendance were George 
Barnes, Arizona; Henry Blansfield. 
Connecticut; Roy Breg, New Haven; 
Jack Cannon, Hartford; Charlie 
Cavanagh, Washington; Bill Collins, 
New Haven; Bob Darrow, Vermont; 
Archie Dean, Georgia; Frank Epstein, 
Boston; Frank Golbranson, San Diego; 
Bob Kerin, Connecticut; Brock Lynch, 
Massachusetts; Vic Machcinski, Cape 
Cod; Bill McClelland. Massachusetts; 
Bob Newton, New Haven; Phil 
Philbin, Washington, D.C.; Hank 
Williams, New York; and Root Ziegra, 
Connecticut. 
Ellie Barnes, Margaret Breg, 
Lorraine Blansfield, Doris Cannon, 
Elizabeth Cavanagh, Given Collins, 
Sue Darrow, Ellen Dean, Claire 
Kerin, Barbara Machcinski, Betty 
McClelland, Martha Newton, Jo 
Philbin, Mary Williams, Claire 
Thompson and Marie Ziegra were 
there very handsomely, making the 
reunion the success that all of us felt it 
was. 
Bob Newton did all of the legwork 
and nothing was lacking. He had class 
sun visors, which made our gang stand 
out at the delightful Harkness Hall 
luncheon, Saturday noon. All one had 
to do to spot one of the ’47 group was 
to look for another visor. That evening 
at the New Haven Medical Society 
building, we had cocktails and a much 
admired buffet. After dinner each of 
the class present recounted his current 
status and future plans. Needless to 
say, a number have left active practice 
and are smelling the flowers. They all 
seemed happy to be taking life more 
easily—most importantly, none 
appeared disappointed. Finally Roy 
Breg presented an interesting slide tour 
of the changes taking place at the 
medical school complex and added 
several nostalgic scenes from our days 
at Yale, including several of our 
members in uniforms, Army and Navy. 
I think everyone left in high spirits 
and all appeared definitely planning a 
return in 1997. 
1952 
40th Reunion 
by Dr. M. L. Bogdonojf 
The curtain rose on an icky day, and 
then it got worse. Travel was slow, and 
the rains came. New Haven has 
enough problems, even with good 
weather. But not to worry: After 40 
years of medicine, matters of weather 
and geography look trivial. 
The cast, from far and wide: Bob 
and Janice Nolan, Leon and Lucille 
Phillips, John Wagner, Bill and 
Shirley Minturn, John and Pat Wolff, 
Mo Bogdonoff, Bill and Jean 
Klatchko, Karel Absolon, Jack 
Roberts, Bob and Maggie Gerety, 
Frank and Barbara Coughlin. Don 
Schultz, Camille Mattie, widow of 
Louis R. Mattie, Doris Wethers and 
son, Booker. 
The Centerwalls could not make it. 
Siggie is very ill, we were to learn. 
John Wagner told us about it in his 
letter (he had to leave early for his 
son’s graduation). We are all in mind 
of Siggie’s ordeal.* 
During the two days, some people 
took the opportunity to see Ray Duff, 
who has been slowed down physically. 
(Recall Ray's remarks in JW’s recent 
newsletters.) For years, Ray and Lou 
Mattie acted as on-site maitre ds for 
Harvey Young’s superb efforts in our 
behalf. We all agree that Harvey had, 
in fact, been the vis-a-tergo for our 
little cluster. What an archivist and 
binding force he was. This year John 
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Wagner and Joe Montimurro set 
things up, with good help from Art 
Crovatto and the group at the alumni 
office. 
The school program offered, among 
other things, discussion about the 
revised curriculum and the admissions 
process. The faculty and administra¬ 
tion continues to have high confidence 
in the Yale system and plan to preserve 
it. As for admissions—what a sticky 
wicket. But the process works to the 
satisfaction of the school and the 
University. They enroll people well- 
suited to Yale; people who reflect the 
social and cultural and professional 
aspirations of the University and the 
school. One of the republic’s great 
semi-orators. Yogi Berra, got it right 
again: 95 percent of the game is half¬ 
mental! We all thought that the school 
was, and is, an exceptional place to get 
the license to learn medicine. 
Friday night we had a practice run at 
the Colonial Inn. Saturday night a 
larger group met at Mory’s in upstairs 
rooms for drinks and dinner. Most 
people got what they ordered, and the 
evening was noisy and convivial. It 
turns out that most of us have retired, 
and are pretty good at it. Covering a 
range of subjects from A to about L or 
M—no time for the rest—the animated 
discussions proceeded simultaneously. 
Technology and politics were favorites. 
Then the evening was over. Maybe not 
Babette’s feast, but very good indeed. 
William Carlos Williams supplies the 
wrap: In old age the mind casts off 
rebelliously, an eagle from its crag. 
^Editor’s note: Siegried A. 
Centerwall, M.D., died on July 1. Her 
obituaiy is featured on Page 40. 
1957 
35th Reunion 
by Dr. Jack Levin 
The Class of 1957 held its 35th reunion 
activities on Saturday, June 6th. We 
had our traditional class seminar on 
Saturday afternoon following a nice 
luncheon in Harkness Hall. Vince 
Andriole (an update on Yale School of 
Medicine): Estelle Fishbein (biomedi¬ 
cal ethics and scientific fraud); and 
Howie Minners (funding of science in 
Eastern Europe) shared their knowl¬ 
edge and experience with us in an 
effective manner. As in the past, the 
presentations were informative and the 
discussions interesting. 
We also had the customary reunion 
deluge. It rained very hard starting late 
Friday afternoon and continued well 
into Saturday afternoon. However, by 
the time we assembled at the Pine 
Orchard home of Carol Hogan's 
family (our usual venue for the class 
dinner), the sun had appeared, and we 
had lovely weather for the remainder of 
the weekend. 
The following classmates partici¬ 
pated: Vince Andriole; Jack and 
Barbara Blechner; Jack and Ann 
Carey; Harold Cross; Joe Demis and 
Joan Sheeran; Jim and Colleen Dorr; 
Ed and Carol Eyerman; Ron and 
Estelle Fishbein; Tony and Mary 
Fons; Gil and Carol Hogan; Stan and 
Carol Kilty; Bill and Priscilla Kissick; 
Jack Levin, Howie and Gretchen 
Minners; Herb and Anne Newman; 
Tom and Nancy O’Brien: Ray 
Phillips and Hong Jiang; Don and 
Amy Stahl; Bill and Barbara 
Waskowitz. 
The food was good and the atmo¬ 
sphere during and after dinner wonder¬ 
ful. Once again, our class had a 
successful reunion, made possible in 
significant part by Gil and Carol Hogan 
again making their family home at Pine 
Orchard available to us. 
1962 
30th Reunion 
by Dr. Michael Alderman 
Of the many evidences available to 
confirm our good fortune, for the Class 
of ’62. none was more appreciated than 
the twin facts of Dick Pschirrer having 
been of our class, and that he and 
Peggy were such willing and gracious 
hosts for our 30th-reunion dinner. The 
rain held off. and it was a marvelous 
New Haven weekend. Auspiciously, it 
coincided with the announcement of a 
new dean for the medical school. 
It was a fine time to visit with 
friends and experience some of the 
academic program excitement that 
continues to enliven Yale and enrich its 
whole community. Of particular 
interest to many was the description of 
the new comprehensive AIDS program 
recently expanded under Gerald H. 
Friedland, M.D., newly recruited from 
Albert Einstein and Montefiore—to the 
great loss of my home institution. But 
in addition to the general pleasure of 
renewing our connections, here was the 
special joy of spending several unadul¬ 
terated hours in the company of our 
classmates in the lovely garden and 
home of Dick and Peggy. 
The company, in addition to our 
hosts, included Mickey and Betsy 
Alderman, Anita and Fred Anderson, 
Fred Cantor. Arnie and Nancy 
Eisenfeld. Joe Ferrone. Steve and 
Kate Fricker. John and Carole 
German. John and Jean Godley, Rod 
and Vicki Haff. John and Trudy 
Harrington. Glenn and Kathleen 
Kelly, Alan and Rhona Lieberson. 
Carter and Norma Marshall. Stan 
and Maureen Matyszewski. Bill and 
Ann Miller, and James and Joyce 
Spencer. Although the number was 
rather small, it was a spirited group that 
came from as far away as Colorado and 
Texas. 
The state of medicine—mixed—and 
the world—good or bad—were of less 
interest than our individual states. We 
mostly saw ourselves as a fortunate 
generation, probably to be better off 
than our successors. As individuals, we 
have learned that neither medicine nor 
life was always easy. We discovered 
that several classmates were no longer 
practicing medicine. Alan Lieberson, 
for example, had mostly passed the 
great divide from medicine to law. Rod 
Haff had left the Air Force and entered 
private practice, while Dick Collins 
had left private practice and was 
pursuing possibilities for a foreign 
assignment. Overall, it was a mellow 
time with some sentiment for an 
interim reunion, perhaps someplace 
other than New Haven. I would love to 
hear from any and all classmates with 
news, notes, suggestions for future 
meetings. 
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(From left) Drs. John Pastore, Dan Arons, Robert M. Donaldson Jr. and John 
Foster, chairman of the School of Medicine Alumni Fund. 
Class of 1967 Gift Sets Record 
The Class of 1967, led by Dan Arons, M.D., and John Pastore, M.D., com¬ 
memorated its 25th reunion by endowing a scholarship fund. Drs. Arons and 
Pastore recruited a reunion gift committee that included: Drs. Kenneth 
Crumley, James Dineen, Richard Hart Jr., Joseph Morris. Jennifer Niebyl, 
Robert Roy, Stephen Schimpff, Sidney Smith Jr., David Tilson III and Joseph 
Walter. The committee’s goal was to endow a scholarship fund in memory of 
deceased classmates to support at least three medical students per year. 
Committee members coordinated their work through the school’s alumni 
fund office, working with Monica Robinson, director, and her staff. At reunion 
weekend on June 6, Drs. Arons and Pastore presented Acting Dean Robert M. 
Donaldson Jr. with a check for $181,850. This gift represented the largest 
reunion gift ever made by a class to the school. 
When the year ended on June 30, 1992, the Class of 1967’s reunion gift had 
increased to $211,521, with 83 percent of the class participating. 
1967 
25th Reunion 
by Dr. Bob Kirkwood 
The 25th class reunion was a great 
success. Not only did we have a good 
turnout of 34 classmates, but we raised 
an unprecedented amount of money to 
be used to endow three scholarships for 
medical students. More than $200,000 
was pledged by over 80 percent of our 
classmates. This is a wonderful 
testament of the generosity of our class 
and our collective commitment to the 
ideals of medicine. Special thanks go 
to Dan Arons and John Pastore, who 
conceived of the campaign, and to each 
of you who solicited and contributed to 
attain the goal. 
As usual, our class activities 
centered around social events. We had 
dinner Friday night at Adriana’s Italian 
restaurant, once again during a heavy 
rain. The Yale golf course had to be 
closed for a day after the storm. Dinner 
and friends were enjoyed until we 
closed the place. On Saturday night, 
Jim and JoAnne Dowalibv hosted the 
class for cocktails and buffet supper at 
their home in New Haven. I have some 
wonderful pictures of the party. 
The following attended. I tried to 
record what each is doing, and where 
each is living. Dan Arons with Lisa, 
endocrinology practice, Cambridge, 
Mass.; Art Beaudet with Marge, 
pediatrics and genetic research, Baylor, 
Houston, Texas; Mary Williams 
Clark, pediatric orthopaedics, 
Hershey, Penn.; John Drews, law 
school, Newport Beach. Calif.; Mel 
Goldblat with Gail, ophthalmology 
practice, Livingston, N.J.; Dick Hart 
with Lilian, cardiology practice. Falls 
Church, Va.; Dick Heppner with 
Carol, cardiology practice, Pittsburgh, 
Penn.; Peter Herbert with Maureen, 
chairman, department of medicine, St. 
Raphael’s Hospital, New Haven; Bob 
Kirkwood with Gale, neuroradiology 
faculty, Baystate Medical Center, 
Springfield. Mass.; Tony Lovell with 
Kathy, cardiology practice. Spring- 
field, Mass.; Laura Kirchman 
Manuelidis with Emmanuel, 
neuropathology faculty, Yale; Steve 
Miller with Chris, cardiac radiology 
faculty, Massachusetts General 
Hospital, Boston; Joe Morris with 
Anne, orthopaedic practice, Easton, 
Md.; Jennifer Niebyl, chairman, 
department of OB/GYN, University of 
Iowa, Iowa City; John Pastore with 
Marilyn, cardiology practice and 
leader of Physicians Against Nuclear 
War. St. Elizabeth’s Hospital. Boston; 
Brian Rigney with Robin, OB/GYN, 
New Haven; Helen Smits with Roger 
LeCompte. University of Connecticut, 
Farmington; Martin Wand with 
Karen, ophthalmology practice, 
Hartford; Red Williams, psychiatry 
faculty, Duke University, Durham. 
N.C.; Bob Winer with Bonita, 
psychiatry practice, Washington. D.C.; 
Bob Young. U.S. Food and Drug 
Administration, Washington, D.C.; 
Ihor Zachary, ophthalmology 
practice, Cleveland. Ohio; Peter 
Zeman with Ellen, psychiatry 
practice, the Institute of Living, 
Hartford; Sid Smith with his daugh¬ 
ter, Lucy, cardiology practice. La 
Jolla, Calif.; Marian Davidson, 
emergency medicine, San Francisco; 
Dave Ingram, pediatric faculty, 
University of North Carolina, Chapel 
Hill; Jim Dowaliby with JoAnne, 
ENT practice. New Haven; Harry 
Holcomb, orthopaedic practice, 
Nassawaddox, Va.; Dick Swett, 
orthopaedic practice, Dover-Foxcroft, 
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Maine; Dennis Egnatz, corporate 
medical director. Miles, Inc., Elkhart, 
Ind.; Cindy Rapp Curry, pediatric 
practice, Fresno, Calif.; Peter Egbert, 
chairman, department of ophthalmol¬ 
ogy, Stanford University, Palo Alto, 
Calif.; Joe Walter, radiology, the Palo 
Alto Clinic, Palo Alto, Calif.; Alex 
Dora, ophthalmology practice, New¬ 
port Beach, Calif. 
Others whom I have heard from or 
about, but who could not attend: Gary 
Burget, plastic surgery (the nose), 
Chicago; Ken Crumley, psychiatry, 
Albuquerque, N.M.; Karen Harkavy 
Toker, pediatric practice, Jacksonville, 
Fla.; Vic Haughton, neuroradiology 
faculty. Medical College of Wisconsin, 
Milwaukee; Lee Strohl, dermatology, 
Chicago; Tim Dondero, Centers for 
Disease Control, Atlanta, Ga. 
I thoroughly enjoyed seeing all who 
returned to reunion. I look forward to 
the challenges of the next five years 
and to our next reunion, when I hope 




by Dr. Jerome H. Meyer 
Thirty-one survivors of the “new 
curriculum” including spouses/ 
significant others gathered in New 
Haven for the weekend of June 5 and 6. 
A warm start to Saturday evening was a 
cocktail party hosted by Jerry and Roz 
Meyer followed by dinner at the New 
Haven Lawn Club. Live entertainment 
at the dinner was provided by Larry 
Temkin and Jeff Menkes, who sang 
the complete lyrics to several of the 
“Greatest Hits of the Second-year 
Show” (available by fax from Dr. 
Temkin). Larry is practicing cardiol¬ 
ogy in Tucson and recently celebrated 
his 21st wedding anniversary with 
Barbara. Jeff is director of emergency 
medicine at Hartford Hospital. 
Classmates returned to Yale from all 
parts of the country. Tom Converse 
came from Lewiston, Maine; Bob 
DeBlasi from Fredricksburg, Va., 
where he practices orthopaedics and 
provided at least one excellent free 
consultation during the evening. Steve 
Liebhaber came in from Philadelphia, 
where he is a hematologist, spending 
much of his time doing research. 
Dave Romond and his wife Anne flew 
in from Oshkosh, Wise., where he is 
an orthopaedic surgeon. Dick 
Robbins and his wife came from 
Columbus, Ga.; he was happy to see 
everyone and remembered good times. 
Several classmates flew in from 
California for the reunion. David 
Moyer recently moved from Southern 
California to Northern California and 
continues to be a Navy physician. 
Lenny Cohen practices gastroenterol¬ 
ogy in San Pablo and remembers 
asking himself, “What happened to the 
revolution?” when we graduated in ’72. 
Lenny looks exactly the same as he did 
20 years ago. Is it skiing and swim¬ 
ming or his sense of humor that keeps 
him young? Does he tell jokes and do 
endoscopy at the same time? David 
Francis lives in La Jolla and attended 
his first YSM reunion. He brought his 
wife, Karen, and their 3-month-old 
daughter, Nina, who appeared to have 
a wonderful time. Nina seems to be 
the youngest child of those who 
attended, while Don and Ellen Kent 
now have two children at Brown; one 
is a senior. 
The evening was replete with warm 
reminiscences and humor. Gary 
Strauss told a hilarious story about 
chemotherapy (he’ll repeat it at the 
25th for those of you who could not 
attend this year) and Felix Freshwater, 
who practices plastic surgery in Miami, 
explained how he once attempted to 
specialize in the treatment of the left 
hand (and how and why an EKG 
machine once was flung down a seven- 
story stairwell at the Memorial Unit). 
Several classmates from New Haven 
attended, including Bruce Haak, who 
has a neurology practice (he didn't 
raise his hand and ask a single question 
during dinner), and Phil Rothfeld, who 
is a diagnostic radiologist. 
The most heavily represented 
specialty was again psychiatry. Ruth 
Lasell lives in Pittsburgh and practices 
psychoanalysis when she’s not too busy 
with her three children. Frank Kahr 
attended with his wife, Katherine; he’s 
a psychiatrist in Great Barrington, R.I. 
Tom Horn is a psychiatrist in Forest 
Hills, Penn., and Michael Charney 
does psychoanalysis when he’s not 
busy organizing a program to teach 
chess to prisoners. Mike attended with 
his fiancee, Liz, who is completing a 
medical residency in Boston. By latest 
count our class produced 15 psychia¬ 
trists. “What does this mean, doctor?” 
During and after dinner everyone 
reported on the whereabouts and fates 
of those classmates who did not attend 
the reunion. We were aided in this 
pursuit by a printout of everyone's last 
known address provided by David 
Moyer, and Felix Freshwater gave 
everyone a copy of our first-year mug 
shots, which immediately doubled the 
evening’s liquor consumption. We 
were able to account for almost 
everyone, and all who did not attend 
were missed. Hopefully more of us can 
get together for another pleasant 
evening at the 25th. 
1977 
15th Reunion 
by Dr. Attilio Granata 
After participating in the school-wide 
festivities, the class members joined for 
drinks and dinner at Mory’s, on 
Saturday evening, June 6. We enjoyed 
many hours of reminiscing, catching up 
on other classmates, and also honoring 
the memory of two deceased members 
of the Class of 1977, Dave Kreis and 
Lawrence Biris. 
The following members were 
present (spouse/guest name noted in 
parenthesis): 
George Bolen (Anne); Jerry Brody 
(Pat); Jim Fox (Alissa); Alan 
Penziner (Paula); Bob Hand; Marge 
McKenna; Ron Vender (Amy); Anne 
Flitcraft; Gail Sullivan (Victor); 
Attilio Granata (wife, Claudia Dinan, 
M.D. ’80, home with 8-month-old 
triplets who had chicken pox. Special 
thanks to her!) 
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1982 
10th Reunion 
by Drs. Stephanie Wolf-Rosenblum 
and Paula Bravennan 
Steve Gore (hematology/oncology, 
Johns Hopkins) wins the prize for 
attending the most official functions. 
The fun began in earnest with what 
turned out to be the highlight of the 
weekend, an informal family gathering 
at Carrie Redlich's followed by a 
tennis/pool party. The hardest part was 
prying the kids away from the sunny 
afternoon so the adults could move on 
to the class dinner held at the Chart 
House. The weather was magnificent, 
and our view of the harbor was 
spectacular. 
The prize for coming furthest goes 
to Gussie Roth (Phoenix) and Burt 
Ungricht (Utah, ophthalmology). 
Gus's trip had an ulterior motive 
however, landing her a PGY2 position 
in the Yale psychiatry program. After 
practicing family medicine at the Indian 
Health Service in Oklahoma and OB/ 
GYN in Phoenix, she plans to special¬ 
ize in crisis counseling for sexually 
abused women. Special mention to 
Rich Doan, who took a break from his 
child psychiatry practice on Prince 
Edward Island, Canada, to visit us with 
his wife. 
It appears that quite a few people 
gravitated back to Yale, including 
Carrie (occupational medicine). Lynn 
Tanoue (pulmonary), and Sandy 
Wolin (molecular biology). Also in 
New Haven are Stu Gardner (pediat¬ 
rics, Branford) and Chris Roberts 
(medicine/CHCP). It also appears that 
there is a YSM satellite in Philadelphia 
with Sylvia Beck (ophthalmology), 
Paula Bravermen (adolescent medi¬ 
cine) and Jessica Herzstein (occupa¬ 
tional medicine, Medical College of 
Pennsylvania). It was also great seeing 
Daphne Hsu (pediatric cardiology, 
Columbia) specializing in heart 
transplants. Patti Kellner, who took 
time from her solo family practice in 
Cleveland, Ohio, and Stephanie Wolf- 
Rosenhlum (pulmonary/critical care. 
New Hampshire). Duncan Wright 
(psychiatry. New York)joined us fora 
short time as well. The group also 
heard about Brian D'Angona (emer¬ 
gency medicine, Boston), Bob 
Rohrbaugh (psychiatry. West Haven 
VA), Jeff Tepler (hematology. New 
York), Mary van der Velde (pediatric 
cardiology, Boston). In Baltimore, we 
have Rise Chait Jampel (dermatol¬ 
ogy), Jim Michelson (orthopaedics, 
Johns Hopkins), Liba Goldblum 
(radiology). Michael Katz (radiology), 
Henry Stern (interventional radiology, 
Michigan). Don Stromquist 
(rheumatology. New Haven). Seattle 
contingent includes Terry Massagli, 
(pediatric rehabilitation), Fred 
Drennan (gastroenterology), and Jon 
Younger (geriatrics). Dave Fassler 
(child psychiatry, Virginia) and in 
California, Bruce Yager (pediatrics), 
Howard Jaffe (biotechnology), Juan 
Larach (medicine), Phil Sager 
(cardiology). 
Finally, the Class of 2000 continues 
to grow. While it would be impossible 
to name all the children attending the 
reunion or letting their parents have the 
weekend off, special mention goes to 
Lynn Tanoue who brought her 2-week- 
old son, Robert. 
Continued health and success. See 
you in '97! 
1987 
5th Reunion 
by Dr. Seth Rosenthal 
The YSM Class of 1987 had a reunion 
dinner on Saturday night of reunion 
weekend. Present were: Nancy Olson 
and Lauri Robertson, who have both 
finished their psychiatry residencies at 
Yale and are practicing in the New 
Haven area; Steve Gaskin, practicing 
emergency medicine in Wilmington, 
Del., Leslie Vogel Rosetti, who 
completed her psychiatric training at 
Columbia and is now working part 
time, supervising the psychiatric 
emergency room there, Linda Lewin, 
who along with husband, Jonathan 
Lewin, M.D. ’85, are living in Cleve¬ 
land with their daughter, Sarah. Linda 
is in private pediatric practice and 
Jonathan is on staff at the Cleveland 
Clinic as a neuroradiologist. Susan 
Bove Kinney and Robert Kinney, 
M.D. '86, were also present. Rob and 
Susan are living in Minneapolis (with 
their son, Sam) and both work as 
general internists in the same medical 
group there. Rebecca Kadish and her 
husband. Bob Levine (former Yale 
endocrine fellow and Primary Care 
Clinic attending) have moved to Hollis, 
N.H., with their daughter, Jessica, and 
are both in private practice; Rebecca in 
anesthesiology and Bob in endocrinol¬ 
ogy. Seth Rosenthal and his wife, Joi 
Barrett, M.D. '88, have moved to 
California. Seth is an assistant profes¬ 
sor of radiation oncology at UCSF and 
UC Davis, and Joi is working as a 
general internist in Sacramento. 
Other news from classmates not 
seen at the reunion dinner includes: 
Richard and Linda Hudak Jenkins, 
living in Palo Alto with their daughter, 
Gwen. Linda is finishing her psychiat¬ 
ric residency, and Richard is working 
as an internist. Diane Louie completed 
her pathology training and is at 
Memorial Sloan-Kettering in New 
York. Fred Long, having completed 
his radiology residency at Duke, plans 
to go to the University of Pennsylvania 
for fellowship training in pediatric 
radiology. He has two boys. Andres 
Cortes is practicing ophthalmology in 
California. Jonathan Friedes just 
completed his OB/GYN residency at 
UCSF. Michelle Smith-Jefferies just 
had her second child and is practicing 
internal medicine in the Boston area. 
Bob Malison and Jean Vining have 
moved to Philadelphia, where Bob is an 
assistant professor of psychiatry at the 
University of Pennsylvania and Jean is 
following her ENT residency with a 
fellowship in endoscopic sinus surgery, 
also at Penn. Cynthia Kapphahn 
finished her pediatric residency at 
Hopkins and is at UCSF doing fellow¬ 
ship training. Amy Justice completed 
her medicine residency at Penn and 
went on to do a Robert Wood Johnson 
fellowship there. Husband Joseph 
King is continuing with his 
neurosurgery residency at Penn. 
Subba Gollamudi completed his 
ophthalmology residency at Hopkins 
and went on to pursue a cornea 
fellowship. 
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Alumni Fund Report 
From the YSM 
Alumni Fund Chairman 
As you will see elsewhere in this issue 
of Yale Medicine, 1991-92 was 
extremely successful for the alumni 
fund. We exceeded our goal of 
$725,000 by 42 percent to reach a total 
of $1,029,968 for use by the School of 
Medicine. This is the greatest percent¬ 
age increase in a single year of any of 
the professional schools of Yale 
University and is the first year in which 
more than $1 million was raised by the 
School of Medicine Alumni Fund. 
Reaching this record total was not 
the achievement of any individual. 
Rather, it is the cumulative result of a 
variety of efforts by alumni through¬ 
out the classes. The alumni on the 
fund board of directors, through their 
committee structure, have worked to 
establish a reunion gift program in 
conjunction with the five-year reunion 
cycle. The first such effort, the Class 
of 1967 25th-reunion gift, was a 
resounding success. Co-chaired by 
Drs. Dan Arons and John Pastore, the 
25th raised a record total of $211,520, 
the highest total ever contributed to 
the alumni fund by a single class. 
Alumni from the Class of 1943 set a 
record 50th-reunion gift with a total of 
$176,411. We look forward to other 
classes following this new tradition of 
reunion giving. 
We would have never achieved our 
great success this year without the 
generosity of alumni in many other 
classes, both during reunion and non¬ 
reunion years. Alumni who serve as 
class agents are the ongoing links 
between the school, the fund and the 
alumni. They deserve our thanks for 
all of the time and effort they devote 
in addition to their personal generos¬ 
ity. The professional staff, under the 
guidance of Monica Robinson, worked 
closely with the reunion special gift 
committee and class agents. 
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Dr. John Foster 
I hope that my first message as 
chairman makes it clear that it takes all 
of us working and contributing 
together to achieve such success for the 
School of Medicine. My heartfelt 
thanks go to all the alumni whose 
names are included as contributors in 
this report. 
John Foster, M.D. ’71 
Dean’s Message 
Coming back to the School of Medicine 
as dean has been a wonderful and 
nostalgic experience. The library where 
I lived for the first two years of medical 
school is magnificent. The renovated 
Jane Ellen Hope Building and the new 
Boyer Center for Molecular Medicine 
are exciting additions. Most of all, the 
Yale system continues to attract a 
special breed of medical students who 
are bright, inquiring and enthusiastic. 
I am absolutely delighted that my 
first message to School of Medicine 
Alumni Fund contributors, both alumni 
and friends, is one of gratitude and pride 
for the records you have set in charitable 
giving for fiscal year 1991-92: 
• All-time medical alumni fund 
donations topped the seven-figure 
level for the first time. 
• The proportion of alumni who have 
contributed—fully half—also 
represents a stunning achievement. 
• Our Class of 1942 set a record for 
those who graduated a half a century 
ago, thanks in no small part to the 
leadership of class agent Walter 
Burdette, M.D. 
• Finally, the efforts of class agents 
Dan Arons, M.D., and John Pastore, 
M.D., led to a Class of 1967 25th- 
reunion gift of $211,520—the most 
generous class donation ever. 
Congratulations and deepest thanks 
go out to alumni fund chairman John 
Foster, M.D. ’71, who with the assis¬ 
tance of Monica Robinson, alumni fund 
director, has worked long hours to 
organize telethons manned by student 
volunteers and to encourage the efforts 
of our many dedicated class agents. 
Nicholas P.R. Spinelli, M.D. ’44, has 
continued to assist director of alumni 
affairs, Arthur C. Crovatto, M.D. ’54, 
in marshalling the esprit de corps of the 
newly graduating classes as never 
before, allowing us to achieve 50 
percent participation. 
Finally, I commend each of our 
graduates who has donated to their 
medical school alma mater. Under my 
deanship, your gifts, unless otherwise 
designated, will continue to support 
student financial aid as the average debt 
approaches $48,000 for the nearly 70 
percent of Yale medical students who 
receive financial aid. To every one of 
you who has shared with the Yale 
School of Medicine your time, your 
concern or your financial resources, my 
warmest regards. 
Gerard N. Burrow, M.D. ’58 
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Contributors 
The names and data included on the following pages were provided by the 
Yale School of Medicine Alumni Fund and reflect contributions made 
between July 1, 1991 and June 30, 1992. Posthumous donations are 
denoted by asterisk (*). 
YSM ALUMNI 
1858 
T. Beers Townsend* 
1887 
George Frederick Converse 
1906 
Charles R. Mitchell* 
Max R. Smimow* 
1908 
Michael A. Parlato* 
1912 
Walter Clark Tilden* 
1913 









Chester E. Hurwitz* 
Helen P. Langner 
1923 
William Cohen* 
Julius Anthony Olean* 
Hyman W. Weinstein* 
1924 
Donato Anthony D'Esopo* 
David M. Raskind 
Myron A. Sallick* 
Jacques Diamond Soifer* 
1925 
Waldo F. Desmond* 
Samuel Reback 
Eli Hyman Rubin* 
Alice A. S. Whittier 
Howard Asa Wood* 
1926 
Stanton T. Allison* 
Maxwell Bogin 
William H. Hahn* 
Joseph L. Hetzel* 
Joseph T. Matteis 
1927 
Wallace Robert Bostwick* 
Henry Irwin Fineberg* 
John Martin Freiheit* 




William C. Meredith 
Alfred F. Seibert 
Harry M. Zimmerman 
1928 
Max Alpert* 
Sheldon A. Jacobson 
Edward P.J. Kearney 
Ralph E. Knutti 
R. Harold Lockhart 
Edward W. Ludwig* 
Nathan E. Ross 
Robert I. Rubinstein* 
John M. Russell* 
Alvin A. Schaye* 
1929 
James Rae Arneill Jr.* 
John M. Bailey* 
John W. Cass Jr.* 
Robert A. Frisch 
George S. Goldman 
Alexander O. Haff* 
John A. Hangen 
Tony Liebman Rakieten* 
William Frederick Roth Jr.* 
Russell B. Scobie 
Robert Tennant 
Newell Raymond Washburn* 
Julius G. Weiner* 
Mabel Wilson 
1930 
Daniel N. Beers* 
Charles A. Breck* 
Lewis Dickar* 
Vincent A. Doroszka* 
Knox H. Finley 
J. Roswell Gallagher 
Amy H. Hunter Wilson* 
Paul Harold Lavietes* 
Moses D. Lischner* 
James Merriman Lynch* 
John W. Maroney 
John C. Mendillo 
Paul Watson* 
Charles L. Wood* 
1931 
Henry H. Briggs Jr. 
Benjamin Castleman* 
Michael D'Amico 
Paul A. Harper 
Morris Heller* 
Thomas C. Jaleski 
Nelson Newmark 
Abraham J. Schechter 
James A. Stringham 
Max Taffel 
1932 
Louis K. Alpert 
Reginald V. Berry* 
Henry Brill* 
Frank Carroll 
Clement C. Clarke 
Hester B. Curtis 
Joseph P. Donnelly 
Lee E. Farr 
Thomas E. Farthing* 
Elizabeth M. Ramsey 
Myron E. Wegman 
Roland T. Wehger* 
1933 
Myron J. Adams* 
Fred W. Buse 
Warren P. Cordes 
Franklin M. Foote 
Jack Greenberg 
Daniel Foster Harvey* 
Robert Watkinson 
Huntington Jr.* 
John G. Martin 
Raymond Everett Miller* 
Ashley Pond Ill* 
Edwin B. Seelye* 
Sidney Stringer* 




Francis P. Guida* 
Derick Algernon* 
Knowles B. Lawrence 
Herbert C. Miller 
Edward Thomas O'Donnell* 
John B. Ogilvie 
Lucien M. Pascucci 
Harry Sherman 
Wedgwood P. Webber 
George Zalkan* 
1935 
Walter E. Barney* 
George A. Carden Jr. 
Edgar S. Childs 
H. Hoffman Groskloss 
James Quintin Haralambie 
W. Howard Horner* 
Mildred Hartshorn 
Samuel D. Kushlan 
Donald P. Morris* 
Norman E. Peatfield 
John D. Preece 
Norman P. Rindge 
Milton Rose* 
Clark P. Searle 




Lester W. Burket* 
Albert W. Diddle 
Margaret C. L. Gildea 
George D. Gross 
George A. Hahn* 
Louise G. Hutchins 
Philip M. LeCompte 
Donald F. Marshall 
Stephen F. Nagyfy 




William G. Cooper Jr. 
Guido A. Deblasio 
David A. Dolowitz 
D. Crosby Greene* 
Wilbur D. Johnston 
Alfred E. King 
Dunham Kirkham 
Julia Mehlman 
James P. Morrill 
T. Dennie Pratt 
Alan A. Rozen 
Morgan Sargent 
Edward J. Shaw 
Albert D. Spicer 
John M. Thomas 
Jean Wells 
Lorande M. Woodruff 
1938 
Roy N. Barnett 
Henry L. Carideo 
S. Charles Kasdon 
Benjamin E. Lyons 
John J. McGillicuddy 
Nelson K. Ordway 
Edward W. Pinkham Jr. 
James Radcliffe Jr. 
George E. Roberge 
Lester J. Wallman 
1939 
Stephen W. Collins Jr.* 
Harold H. Coppersmith 
Norman L. Cressy 
William H. Druckemiller 
Robert Goodfellow Ernst* 
John P. Ferguson Jr. 
Joseph B. Forman 
S Jerome Greenfield 
Nathaniel Kenigsberg* 
Arthur E. Laidlaw 
Ward J. McFarland* 
James Peter Murphy 
Russell Nahigian* 
Douglas S. Riggs 
Roger N. Ryley 
Ernest L. Sarason 
Bradford Simmons 
Rebecca Z. Solomon 
John D. Tobin 
Arthur S. Tucker* 
Darrell G. Voorhees 
Douglass W. Walker 
John H. Wentworth 
Malvin F. White 
1940 
Theodore E. Allen 
Joseph V. Baldwin 
Ronald S. Beckett 
Jack S. Blaisdell 
Philip S. Brezina 
David Crocker* 
Wynant Dean 
Richard E. Dormont 
James F. Ferguson Jr. 
Eugene J. Fitzpatrick Jr. 
Henry D. Humphrey 
H. Stuart Irons* 
Donald G. Johnson 
Ira D. LeFevre Jr. 
Paul D. MacLean 
Edward Martin 
Maurice Ross* 
W. Norman Sears* 
Joseph E. Sokal* 
J. Champneys Taylor 
Patricia E. Wanning 
Helen H. Woods 
1941 
Sophia H. Alway 
Robert H. Areson* 
W. Randal Bell 
Knute E. Berger* 
William A. Carey 
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Joseph P. Carson Jr. 
Charles B. Cheney 
Herbert W. Diefendorf 
Robert F. Dine* 
Peter A. Duncan 
John E. Fenton 
Lloyd D. Flint 
Frederick P. dike 
William Edmund Kenney 
William Lee 
Bjorn Lih 
John R. McDermott* 
Willys M. Monroe 
Malcolm C. Murfitt 
Edward B. O’Connell 
Robert W. Ollayos 
Gioacchino S. Parrella 
Edwin D. Rogers 
Leslie Simmonds 
1942 
William E. Bloomer 
James M. Bunce 
Robert E. Carroll 
Donald S. Childs Jr. 
Vincent J. Collins 
Eugene M. de Hostos 





Allan V.N. Goodyer* 
William Harrison Jr. 
Wilson E. Hughes* 
Leo Kellerman 
John R. Lincoln 
Kenneth R. Morgan 
Patrick S. Mullins* 
Dean Nichols* 
Michael A. Puzak 
Samuel Ritvo 
Lois Knight Rogers 
Charles F. Scholhamer 
Richmond W. Smith Jr. 
Carter Stilson 
Edgar B. Taft 
Maurice Tulin 
Francis P. Vose* 
Irving Norman Wolfson 
1943A 
Ralph D. Alley 
John R. Brobeck 
Edward S. Brown 
Lycurgus M. Davey 
Donal L. Dunphy 
R. M. Fasanella 
Gerard Fountain 
Edward Douglas Horning* 
Stuart L. Joslin 
R. Leonard Kemler 
Joseph P. Kriss* 
Jonathan T. Lanman* 
Douglas Lindsey 
J. Philip Loge 
Henry E. Markley 
Dorothea R. Peck 
Edward F. Rabe 
Earl J. Rhoades 
Henry A. Riedel 
Bernard R. Rowen 
Marcus E. Sanford 
Robert A. Sears* 
Edward Hersey Soule 
Hilliard Spitz 
Nicholas M. Stahl 
Sophie Trent Stevens 
Oliver G. Stonington 
Robert G. Turner 
Frederick A. Waldron* 
John J. Weber* 
Morris A. Wessel 
Robert H. Wyatt 
1943B 
Richard N. Abbott 
John R. Almklov 
David G. Borden 
James L. Bradley* 
Robert F. Bradley 
S. Brownlee Brinkley 
Henry B. Bruyn Jr. 
Thomas L. Bucky 
Jane B. Cadbury 
Philip B. Chase 
Hunter H. Contly 
Norman I. Condit 
Thomas D. Cook 
Ronald W. Cooke 
Joseph I. Epstein 
Robert H. Furman 
Victor C. Hackney 
Frank R. Hurlbutt Jr. 
Henry H. Jones 
Joseph F. Kell 
Sawyer E. Medbury 
Hoyt B. Miles Jr. 
Donald W. Seldin 
Francis A. Spellman* 
W. Keasley Welch 
1944 
Carl E. Andrews 
Joseph Ciola* 
Edward J. Conway 
Robert E. Cooke 
John C. Coolidge 
George B. Corcoran Jr. 
Frank W. Countryman 
Lawrence S. Crispell 
Charles H. Crothers 
Lawrence G. Crowley 
John H. Doherty 
Robert W. Frelick 
Carol Goldenthal 
Charles A. Hall* 
Howard B. Hamilton 
Robert I. Hinkley 
W. Raymond James 
Ward S. Jenkins 
Edith M. Jurka 
Harvey W. Kausel 
Jerome J. Kaye 
John Weaver King 
Frederick F. Krauskopf 
Ronald E. Losee 
Ellen P. MacKenzie 
Elias J. Marsh 
Katharine Hawley Martin 
Joseph Massaro 
A. Reese Matteson 
Paul E. Molumphy* 
Russell R. Monroe 
Lawrence K. Pickett 
Laurence G. Roth 
Haynes W. Sheppard 
Sarah P. Sherwood 
Nicholas P.R. Spinelli 
Mrs. Gertrude Spinelli* 
Priscilla Dienes Taft 
Anthony Varjabedian 
Calvin Watts Woodruff* 
Reuben Zucker* 
1945 
George Howard Allison 
Albert S. Atwood 
Richard W. Breck 
Louise H. Bun' 
Alice Shepard Cary 
Sanford F. Cockerell 
Jay B. Cohn 
Robert S. Easton 
Alice Dershimer Friedman 
Raymond A. Gagliardi 
James D. Gardam 
Philip S. Good 
Herbert S. Harned Jr. 
Isao Hirata Jr. 
Paul W. Hoffert 
O. Roger Hollan 
Hans R. Huessy 
William L. Jenney 
Lei and W. Jones 
Michael W. Lau 
William E. Laupus 
Mark McD Lindsey 
James R. Mason 
Charles E. McLean 
George W. Naumburg Jr. 
Fitzhugh C. Pannill 
Richard M. Peters 
Charles E. Sherwood 
Kenneth C. Steele 
1946 
Margaret J. Albrink 
William G. Banfteld Jr. 
Aaron T. Beck 
Franklin C. Behrle 
Sanfurd G. Bluestein 
Linus W. Cave 
Thomas J. Coleman 
James F. Cooney* 
George C. Cusick 
Thomas A. Doe 
Edward F. Edinger 
Gregory E. Flynn 
Martin E. Gordon 
Charles Sheldon Judd Jr.* 
Harold King 
Benjamin F. Kitchen Jr. 
James A. Kleeman 
Vincent J. Longo 
Richard Hess Mann* 
Thomas J. Mathieu 
Hugh J. McLane 
Joe D. Morris 
John H. Morton 
Thomas J. Murphy 
John F. Neville Jr. 
Laura W. Neville 
Harry Dickson Patton 
Francis G. Reilly* 
David H. Riege 
Phillips E. Roth 
Julian A. Sachs 
Donald P. Shedd 
Richard G. Sisson 
Robert R. Wagner 
William P. Walsh 
William J. Wedemeyer Jr. 
Thomas J. Whelan Jr. 
Hugh R. Williams* 
1947 
George R. Barnes Jr. 
Henry N. Blansfield 
John E. Bowers 
W. Roy Breg Jr. 
Richard G. Britton* 
John L. Cannon 
M. Richard Carlin 
John C. Carpenter 
Charles R. Cavanagh Jr. 
Robert A. Chase 
Amoz I. Chernoff 
William F. Collins Jr. 
Bradford S. Colwell 
Robert P. Darrow 
Jean H. Dougherty 
Owen W. Doyle 
Franklin Harold Epstein 
Edward Foord* 
Richard K. Friedlander 
Frank L. Golbranson 
Frank H. Horton 
Robert J. Kerin 
Don F. Kimmerling 
Brock Lynch 
Victor A. Machcinski 
William K. McClelland 
Robert F. Newton 
Myron K. Nobil 
Lawrence C. Perry* 
Philip H. Philbin 
Olive E. Pitkin 
Irving Rudman 
Lawrence P. Shea* 
Alvin Somberg 
Igor Tamm 
William F. Thompson 
Patricia B. Tudbury 
Ellis J. Van Slyck 
M. Henry Williams Jr. 
Sumner Root Ziegra 
1948 
Russell J. Barrnett* 
George F. Batten 
Edith M. Beck 
Jonathan S. Bishop 
Ruth E. Cortell 
Richard H. Cote 
G. Robert Downie 
Victor A. Drill* 
Elizabeth Fuller Eisner 
Albert A. Fisk 
Boy Frame* 
Emil Frei III 
Julian Frieden 
Anne Godley 
Paul S. Goldstein 
Allan Green* 
B. Herold Griffith 
Sylvia Preston Griffiths 
Richard M. Hannah 
Ross R. Harcus 
Halsted R. Holman 
Paul B. Koehler 
Robert E. Lempke 
Patrick J. McLaughlin Jr. 
C. Arden Miller 
John P. Morris 
John B. Morrison 
David E. Morton 
James W. Needham 
Lewis P. Rowland 
Benjamin F. Rush Jr. 
Gabriel A. Saviano* 
Paul Talalay 
Wallace W. Turner 
Paul Woodbury Weld 
1949 
William G. Anlyan 
Jonathan S. Bishop 
Mary Pucci Couchman 
Phillip G. Couchman 
N. Joel Ehrenkranz 
Daniel W. Elliott 
Albert A. Fisk 
Eleanora C. Gordon 
Frederic W. Gray 
Daniel K. Halvorsen 
Jackson Harris 
Frederick R. Hine 
Gordon D. Jensen 
Benjamin A. Johnson 
Frank D. Law 
Orlando J. Millet- 
Timothy F. Nolan Jr. 
Julian I. Pichel 
Charles L. Rennell Jr. 
Murray Z. Rosenberg 
Carl M. Russell 
William H. Sewell 
Lawrence E. Shulman 
R. David Sudarsky 
Martha Vaughan 
Vernon T. Watley 
Mary-Agnes P. Wine 
1950 
Russell N. Anderson* 
Lyal D. Asay 
Sylvia L. Axelrod 
Malcolm A. Bagshaw 
John E. Borowy 
William H. Bucher 
Alvin Davis 
Claude W. Delia 
Marie C. Duncan 
Kent Ellis 
Thomas J. Ferraro Jr. 
Daniel Fine 
Lawrence R. Freedman 
David A. Frucht 
Carl A. Gagliardi 
Archie James Golden* 
Chesterfield G. Gunn Jr. 
Lucian S. Lapinski 
Sidney S. Lee 
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Janus C. Lindner 
Margaret S. Lyman 
Harold March 
Harry L. McClelland 
John H. Meyers 
Marina P. Meyers* 
Orlando J. Miller 
Charles A. Nugent Jr. 
Robert Edward Quinn* 
Robert T. Sceery 
Cynia B. Shimm 
Jane B. Shumway 
Martin E. Smith* 
John S. Strauss 
Myra D. Tyler 
Frederick E. Vultee* 
1951 
Karel Bedrich Absolon 
W. Robert Adams 
Frank R. Allen 
Thomas T. Amatruda Jr. 
Muriel H Bagshaw 
Eleanor Clay Bigley 
John J. Egan 
Sidney S. Furst 
Joseph M. Garland 
Lowell I. Goodman 
John T. Groel 
Robert N. Hamburger 
John V. Haxo 
Carrold K. Iverson 
Robert D. King 
John J. McGarry 
Francis L. Merritt 
Paul D. Millikin 
Walter S. Morgan 
Albert R. Mowlem 
Richard S. Munford 
Ismail Nik Nevin 
Gerard B. Odell 
Jose Felix Patino 
Arthur A. Pava 
Majic S. Potsaid 
William A. Taylor* 
Andrew S. Wong 
1952 
Maurice L. Bogdonoff 
Frank A. Carone 
Siegried A. Centerwall 
Willard R. Centerwall 
Frank R. Coughlin Jr. 
Barbara B. Coughlin 
Richard N. deNiord Jr. 
Richard D. Floyd 
Robert P. Gerety 
Arthur P. Hustead 
William Joseph Johnson 
Thomas S. Kelly 
William W. Klatchko 
James Kent Luce 
N. Karle Mottet 
Robert L. Nolan 
Robert F. Owen 
Sidney Nathan Paly 
Robert G. Petersdorf 
Leon A. Phillips 
John Macklin Roberts 
Leonard Rush 
Mary Wheatland Schley 
Medical students do their part during an alumni phonathoi 'l. 
Donald H. Schultz 1954 Joseph I. Boylan Jr. 
Robert B. Schultz George W. Bostwick Irwin M. Braverman 
John H. Wagner Jr. Richard J. Bouchard Edward Noel Brennan 
Doris L. Wethers George N. Bowers Jr. Padraic Burns 
John L. Wolff Ralph K. Campbell Paul Calabresi 
Harvey L. Young* John R. Cole Nicholas A. Coassin 
Robert Zeppa Alan H. Covey Edward D. Coppola* 
Arthur C. Crovatto Pasquale James Costa 
1953 Donald D. Davis Robert G. Crounse 
Jonathan Barry* Michael DeNicola Jr. John G. Daley 
Claude Bloch Walter J. Freeman Fred Wendell Doyle 
Harold D. Bornstein Jr. Orlando F. Gabriele William S. Elliott 
Remi J. Cadoret John A. Gariepy Leroy Engel 
William R. Chaffee Samuel T.J. Giammona F. Robert Fekety Jr. 
Allen Chetrick Frank L. Gruskay Edwin G. Fernand 
Rex B. Conn Nicholas A. Halasz Mahlon V.R. Freeman 
Louis R. M. Del Guercio Katherine H. Halloran James Conway Garlington 
John Leo Doppman Robert P. Hatch Paul Gonick 
James P. Dunn Walker R. Heap Jr. Ion Gresser 
Donnell Dencil Etzwiler Eva 11. Henriksen John H. Hodge 
Thomas 0. Gentsch Samuel J. Hunter D. Franklin Johnson Jr. 
Vincent Lynn Gott Herbert S. Hurwitz Harry O. Kendall 
Robert Emanuel Hamlisch Robert F. Hustead David R. Kessler 
A. Daniel Hauser Robert J. T. Joy Robert A. Kramer 
George L. Hoffmann Donald S. Kornfeld Edward A. Krull 
David Purdy Holman Richard Lamb Roger Lester 
Peter Biggs Hukill Harry C. Miller Jr. James Lum 
Richard R. Knowles III Paul N. Neufeld Alexander Maitland III 
Frederick Martin Lane James J. Nora Joseph S. McGuire Jr. 
Hildegard Mueller Leslie Lowell E. Olson James P. Nolan Jr. 
Preston Lee Leslie William J. Paule Sherwin B. Nuland 
John Dutch Lord Anthony V. Piccirillo Gloria C. Onque 
Robert N. Melnick Richard D. Pullen Edward J. Ottenheimer Jr. 
Harvey Martin Peck Jacques M. Quen John C. Pace Jr. 
Warwick Potter Jr. Earl D. Rees Robert H. Peters Jr. 
Paul G. Quie John Keilh Rose Gregory Peterson Jr. 
Jose Ramirez-Rivera Elihu M. Schimmel Robert A. Reich 
John C. Roberts Leonard M. Silverman Clement B. Sledge 
Irwin K. Rosenberg Robert L. Stein Phillip W. Smith 
Barbara F. Rosenberg John W. Vosskuhler Alan A. Stone 
Virginia C. Saft Myron P. Walzak Jr. 
Richard Andrew Sinnott Jr. 1955 
Ora K. Smith John B. Atwater 1956 
John Frazier Snyder III John C. Bailar 111 Alan E. Apfel 
Lynn Cortland Stoker George E. Becker Peter Bios Jr. 
William Junior Vandervort Jerome Bobruff Levon Z. Boyajian 
James Frederic Young Douglas G. Boyden Thomas M. Brown 
Rosalie A. Burns 
Edwin L. Child 
James C. Collias 
Donald J. Dalessio 
Chandler Dawson 
Mitchell Edson 
Gilbert M. Eisner 
Thomas F. Ferris 
John B. Fine* 
John H. Gardner 111 
Sumner Gochberg 
George E. Green 
Val Shea Greenfield 
Robert H. Groves 
Arne G. Haavik* 
Joan Marasco Hardenbergh 
John Herd Hart 
Robert L. Hill 
William H. Hindle 
Charles L. Hopper 
Marie-Louise T. 
Johnson 
George T. Kammerer 
Jerome O. Klein 
William V. Lewit 
Leo Lutwak 
Preston C. Manning 
Dwight F. Miller 
Elmer T. Mitchell Jr. 
Norman F. Moon 
Donald J. Nalebuff 
William M. Narva 
A. Frederick North Jr. 
David A. Page 
James Richard Patrick 
George W. Paulson 
Stewart E. Pursel 
Robert J Rice 
Robert Lee Scheig 
Edward C. Senay 
Benjamin A. Shaver Jr. 
Donald William Sherrick 
Daniel R. Silbert 
1957 
Donald Agostinelli 
Joseph S. Amenta 
Louis V. Avioli 
Jack Norman Blechner 
Richard I. Breuer 
Harry C. Briggs 
Car! A. Brinkman 
John P. Carey 
Albert K. Chun-Hoon 
Louis Z. Cooper 
Harold Dick Cross 
Thomas H. Danaher 
James R. Don' 
Edward Louis Eyerman Jr. 
Salvatore Falbo 
Harold J. Fallon Jr. 
Robert E. Fishbein 
James R. Fitzgerald 
Anthony L. Fons III 
Elizabeth H. Forsyth 
Gary A. Fry 
Robert H. Glass 
Anne H. Good 
Jack Peter Green 
Gilbert F. Hogan 
Warren R. Johnson 
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Richard Lee Kahler 
Stanley E. Kilty 
William L. Kissick 
Edgar H. Levin 
Jack Levin 
Bennett F. Markel 
Mark D. Marshall 
Howard A. Minners 
Robert K. Modlin 
Hugh Lamson Moffet 
George Albert Nelson Jr. 
Herbert A. Newman 
Thomas F. O’Brien Jr. 
Raymond E. Phillips 
Clifford B. Reifler 
Arnold Schoolman 
Stanley Simbonis 
Kenneth A. Simon* 
Gilbert B. Solitare 
Donald C. Stahl 
Arthur Taub 
William J. Waskowitz 
James G. Zimmer 
1958 
George K. Aghajanian 
Don P. Amren 
Joseph E. Angelo 
John P. Arnot 
Gerard N. Burrow 
Benjamin Bursten 
David A. Carlson 
John A. Carlston 
John A. Creatura 
Robert V. Diserens 
Robert J. Donohue Jr. 
Lawrence Dubin 
Donald A. Duncan 
Joel C. Eberlin 
Philip R. Fazzone 
Michael E. Fishman 
Peter A. Flynn 
Raymond A. Gaito 
John Currier Gallagher* 
Marcia Kraft Goin 
William M. Gould 
James Greenwald 
Ernest L. Hartmann 
Roger C. Herdman 
Michael Kashgarian 
Haskins K. Kashima 
Jay Ward Kislak 
Theodore W. Lieberman 
Myron Lotz 
Leo T. McCallum 
Andrew J. McGowan Jr. 
Richard Charles Miller 
Albert Muggia 
Robert S. Neuwirth 
David W. O’Keeffe 
Carol F. Phillips 
David M. Pugh 
William B. Radcliffe 
Paul A. Rudnick 
Bruce H. Sklarew 
Delbert B. Smith 
Edward Lloyd Socolow 
Arlene Sweedler 
Raymond W. Turner 
Margaret Smith Wenzel 
Joseph P. Wierzbinski III 
John Patrick Wood 
Pauline B. Wood 
1959 
Scott Ingram Allen 
Carol J. Amick 
Robert M. Amick 
Asa Barnes Jr. 
Francis A. Beer 
Jack F. Bowers 
William C. Butterfield 
Edwin M. Clayton 
Sidney M. Cohen 
Lyall S. Crary Jr. 
Ronald C. De Conti 
Gerald Fenichel 
Robert L. Fisher 
Eric Gillett 
Gerald B. Gordon 
W. Keith Hadley 
James H. Halsey Jr. 
H. Rodney Hartmann 
William H. Heydorn 
C. Richard Hinckley 
Leonard Inker 
Herbert J. Kaufmann 
David W. Kingsbury 
Myron S.S. Lee 
Kathryn Huxtable Lewis 
Raymond Mark 
John C. Marsh 
Brian J. McGrath 
Peter M. Molloy 
James A. O’Neill Jr. 
Robert H. Ostberg 
Nicholas M. Passarelli 
Charles A. Phillips 
Lincoln T. Potter 
James D. Prokop 
James R. Ralph 
David Pardee Reed 
Joseph D. Saccio 
Marc D. Schwartz 
Owen A. Shteir 
Sanford P. Solomon 
Gene W. Spector 
James J. Stagnone 
Lisa A. Steiner 
John S. Strauss 
Lois W. Tice* 
Leo H. Von Euler 
Muriel D. Wolf 
1960 
Festus O. Adebonojo 
Victor A. Altshul 
Jack D. Barchas 
Colin Mercer Bloor 
Stuart P. Bowne 
Donald P. Buebendorf 
Stanley M. K. Chung 
Gerald N. Cimmino 
Francis D. Cogliano 
Neil R. Cooper 
Malin Dollinger 
David Paul Dunn* 
March Enders 
Warren H. Fisher 
Paul Jay Friedman 
Eugene C. Gaenslen Jr. 
James I. Gilman 
Maxwell E. Gottesman 
Roland H. Ingram Jr. 
Daniel M. Jones 
William S. Kaden 
Eric P. Kindwall 
Frank J. Kleeman 
Susan T. Kleeman 
Thomas P. Kugelman 
Edward R. Lang 
Thomas L. Lincoln 
Eugene G. McCarthy Jr. 
Donald L. Miller 
Richard G. Morrill 
Allan W. Newcomb 
Buford L. Nichols Jr. 
Fred Palace 
Jerrold M. Post 
Albert Matthew Ross 
Daniel J. Rubin 
John J. Schrogie 
Fred Stargardter 
Constantine M. Voyagis 
Robert C. Wallach 
May Yung-Fun Woo Wang 
Ronald A. Yankee 
1961 
Kenneth A. Arndt 
Earl L. Baker 
Albert A. Bechtoldt Jr. 
Robert S. Briggs 
Orson R. Dee 
Paul David Deiter 
Ronald A. Dierwechter 
Jon Dudley Dorman 
T. Wayne Downey 
Christopher Francis Durham 
John E. Fenn 
Norbert Fleisig 
Charles F. Gibbs 
Edward C. Gilbert 
J. Dale Howe 
Louis D. Hunt 
Richard L. Keefe 
Marguerite Stein Lederberg 
Robert Isaac Levy 
George M. Lordi 
Hugh James Lurie 
Vincent T. Marchesi 
David B. Malloff 
John Foster, M.D. '71, chairman of the School of Medicine Alumni Fund 
(left); Monica Robinson, director of the fund; and Peter G. Fritzsche, 
managing director of the University alumni fund; celebrate the YSM fund 
breaking the $1 million mark. 
Joseph W. McDaniel 
Anoush Miridjanian 
Richard Allen Moore 
Norman I. Moss 
Roland D. Paegle 
John Curtis Parker 
John Pearce Jr. 
Elaine Pitt 
Bruce C. Robinson 
Roy E. Ronke Jr. 
Shaun J. Ruddy 
Charles R. Sachatello 
Stanley G. Schade 
John J. St. Andre 
Robert N. Taub 
Hugh C. Thompson III 
Franklin H. Top Jr. 
David E. Weaver 
Warren D. Widmann 
Murray Wittner 
John R. Woodward 
Donald A. Young 
1962 
Charles B. Anderson 
Frederic P. Anderson 
Fredric K. Cantor 
Thomas Newell Chase 
Oliver Townsend Dann 
Arnold Joel Eisenfeld 
I. Bruce Elfenbein 
Leroy A. Forstrom 
Stephen John Fricker 
Anthony V. Furano 
John N. German 
Roderick C. Haff 
John T. Harrington 
Patricia C. Hassakis 
Walter Watson Karney 
Glenn L. Kelly 
David E. Knoop 
Manuel J. Lipson 
John P. Lynch 
Malcolm A. Martin 
Stanley E. Matyszewski 
David J. McConnell 
William G. Meffert 
William A. Miller 
Malcolm S. Mitchell 
David D. Nicholas 
A. Richard Pschirrer 
Joseph Ross 
James A.E. Spencer 
Nancy Ann Staley 
Larry Lee Stewart 
Seth Thaler 
1963 
Richard J. Almond 
Miguel R. Alonso 
Charles W. Carl Jr. 
Theodore J. Chu 
Gordon S. Cohen 
Andrew Edin 
John P. Eliopoulos 
B. Allen Flaxman 
William T. Friedewald 
David H. Fulmer 
Alexander R. Gaudio 
Lee D. Goldberg 
Peter B. Gregory 
Yale Medicine Fall/Winter 1992-93 55 
Benjamin Keith Harris 
Constantine D. Kyropoulos 
Edward C. Larkin 
William B. Lehmann 
Peter B. Livingston* 
Craig H. Llewellyn 
Edward G. Lund Jr. 
Robert H. Margulis 
Herbert Meltzer 
Robert E. Mueller 
Sheldon R. Pinnell 
Jay M. Pomerantz 
Gene R. Profant 
Lee Bland Talner 
Thomas W. Tillack 
Peter V. Tishler 
Lawrence Tremonti 
Peter G. Weiner 
James G. Wepsic 
Charles S. Wilson 
Jerome Allen Winer 
1964 
William A. Alonso 
Berton W. Ashman 
Leland S. Berger* 
Philip Blume 
Robert M. Briggs 
Thomas A. Cardella 
Joseph F.J. Curi 
Anthony Ferrante 
Norman C. Fost 
Peter A. Gross 




Richard V. Lee 
Thomas L. Lentz 
James S. Levine 
Paul R. Lightfoot Jr. 
Richard Murray Linburg 
Robert W. Lyons 
Andrew E. MacMahon 
William F. Matchett 
Robert L. Mitchell 
Alan H. Morris 
James J. Murphy 
Donald A. O’Kieffe Jr. 
William B. Pratt 
Jack S. Rice Jr. 
Stanley J. Rosenberg 
Saul M. Schanberg 
Norman Scher 
Robert L. Shelton 
Donald G. Skinner 
A. Thomas Snoke 
Lyall C. Stilp II 
Sigrid L. Tishler 





Jon R. Almquist 
Susan A. Aoki 
Thomas T. Aoki 
John H.M. Austin 
John Barchilon 
Thomas B. Caldwell III 
David G. Campbell 
Grant L. Christian 
Robert M. Cohn 
Michael J. Cummings 
David S. Fedson 
Robert I. Finkel 
Michael P. Flynn 
Frank J. Grady 
Robert Andre Gryboski 
Reid R. Heffner Jr. 
David A. Hill 
Carl E. Hunt 
Virginia Burnham Johnson 
Ronald J. Karpick 
Mohandas M. Kini 
Robert H. Koehl 
Richard J. Kozera 
Sandra Chook Levine 
Mark W. Lischner 
Philip D. Manfredi 
Michael B. Mayor 
Walter W. Noll 
A. Lawrence Ossias 
John A. Parrish 
Robert L. Pickens 
Gene A. Robinson 
George B. Rowland 
John H. Seashore 
Margretta Reed Seashore 
David M. Shames 
David P. Simmons 
Robert T. Solis 
Alan William Stone 
Robert G. Weiner 
Bert Yuan-Shu Wong 
1966 
Benjamin F. Balme 
John D. Baxter 
Patricia Bazemore 
Robert P. Bazemore 
Philip Bernstein 
James Edward Brown 
Eugene Patrick Cassidy 
Thoburn A. Dadisman Jr. 
Joseph A. Donadio 
Jared M. Emery 
Peter M. Fitzer 
Robert N. Frank 
Peter D. Gibbons 
Stanley I. Greenspan 
J. McLeod Grifftss 
Robert A. Gunn 
Henry G. Hanley 
Jay G. Hayden 
Mary Alice Houghton 
Richard J. Howard 
Gordon R. Kelly 
Stuart M. Kotler 
Wilbur L. Kukes 
Lynne L. Levitsky 
Caroline O. McCagg 
John J. Mooney 
William Y. Moores 
Eli H. Newberger 
Edward J. O'Keefe 
Neil J. Peterson 
William D. Peterson 
James D. Slavin Jr. 
Parker J. Staples 
Gary L. Townsend 
Jon S. Wayland 
Joan T. Wayland 
1967 
Daniel L. Arons 
Arthur L. Beaudet 
Richard S. Bockman 
Arthur Walker Boddie Jr. 
Daniel J. Booser 
Gary C. Burget 
William T. Cave Jr. 
Mary Williams Clark 
David M. Conkle 
Kenneth F. Crumley 
Cynthia Rapp Curry 
Marian C. Davidson 
James Lucius Davis 111 
James J. Dineen 
Timothy J. Dondero Jr. 
Alexander F. Dora 
James M. Dowaliby II 
John A. Drews 
Peter R. Egbert 
Herbert W. Felsenfeld 
Melvin Victor Goldblat 
Richard J. Hart Jr. 
Richard L. Heppner 
Peter N. Herbert 
George P. Herr 
David L. Ingram 
Mary Jurbala 
J Robert Kirkwood 
Melvyn Korobkin 
Carl E. Lane 
Anthony P. Lovell 
Carl K. Marling 
Stephen W. Miller 
Joseph L. Morris 
Jennifer Robinson Niebyl 
John Northup Jr. 
John O. Pastore 
William E. Perkins 
Brian F. Rigney 
Robert 1. Roy 
Jonathan L. Saveli 
Alfred Q. Scheuer 
Stephen C. Schimpff 
Sidney C. Smith Jr. 
Helen L. Smits 
Lewis S. Solomon 
Robert S. Steinberg 
Richard B. Swett 
M. David Tilson III 
Karen H. Toker 
Robert A. Vogel 
Robert A. Vollero 
Joseph F. Walter 
Martin Wand 
Redford B. Williams Jr. 
Robert J. Winer 
Robert S.K. Young 
Ihor George Zachary 
Peter M. Zeman 
1968 
Julius H. Anderson 
Philip L. Barry 
Daniel I. Becker 
Bernard D. Beitman 
Donald R. Coustan 
Rutledge W. Currie 
Medical student literary magazine cover 
design by fourth-year student Daniel Aldana. 
Barbara Mayer Egbert 
Alan G. Finesilver 
Richard A. Getnick 
Mark Gilbert Grand 
Ralph S. Greco 
Kevin N. Hennessey 
John R. Hill II 
Thomas R. Johnson 
Peter Jokl 
William F. Keane 
Peter A. Kirkpatrick 
Jeffrey S. Lee 
Marc E. Lippman 
Frank E. Lucente 
Stephen I. Marglin 
Rodrigo Martinez 
Harmon Michelson 
Richard P. Mills 
Richard M. Morehead Jr. 
Janies B. Morris 
John A. Ogden 
Margot Onek 
Jackson B.E. Pickett III 
Ralph Jerome Rauch 
Joseph L. Renda 
Gordon H. Sasaki 
Jacob J. Schlesinger 
Bruce Stuart Schoenberg* 
Frederick C. Sherman 
Howard W. Siegel 
Gerald L. Springer 
Lee H. Strohl 
Edmund C. Tortolani Jr. 
James L. Weiss 
Per Henrik Wickstrom 
Creed W. Wood 
1969 
Charles S. Angell 
David G. Ansel 
David W. Barry 
Robert E. Belliveau 
David A. Berkowitz 
Donald H. Buchholz 
N. Roger Cooke 
Leo M. Cooney Jr. 
Richard J. Daly 
Michael W. Dennis 
Charles A. Dinarello 
Douglass T. Domoto 
Ralph J. Falkenstein 
Gary S. Farnham 
Lesley Forman Fishelman 
Steven A. Frankel 
William H. Frazier 
Royal J. Gay 
Sander G. Genser 
Robert O. Gordon 
John Frederick Hiatt 
Larry C. Horowitz 
Thomas C. Howard 
Lee M. Jampol 
Joel Mark Kaufman 
Paul H. Kelker 
Rowena Korobkin 
Stephen Krant 
Lynn G. Lagerquist Jr. 
Michael R. Liebowitz 
Elliot M. Livstone 
C.E. Long III 
Robert L. Marier 
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Paul A. Markey Geoffrey P. Kane 
Arnold F. Mazur Richard Katzman 
Ellen B. Milstone Barbara K. Kinder 
Lionel M. Nelson Stuart R. Kleeman 
Nancy Olmsted Michael E. Klein 
N. Burgess Record Jr. William L. Krinsky 
Joseph M. Rochford Sherry W. H. Loo 
Dennis J. Rudzinski William J. Mangione 
Adrian M. Schnall Wallace J. Matthews Jr. 
Gerald J. Smallberg Patrick T. Minihan 
David L. Upton Richard Albert Moggio 
Robert J. Walat Robert Park 
Stephen R. Webb John A. Patti 
Barry Bruce Perlman 
1970 Stuart B. Phillips 
Elissa B. Arons Michael C. Piercey 
Richard A. Charlat Barry S. Rand 
Henry Chessin Irving G. Raphael 
Michael J. Chusid David M. Rinzler 
C. Norman Coleman Douglas R. Schmidt 
Michael Cynamon John Smiarowski 
James E. Delano Jr. James P. Southwick 
Daniel Frizell Dedrick Jonathan W. Stewart 
Jonathan Ecker Daniel R. Synkowski 
Robert Alan Epstein Richard D. Travers 
Bruce A. Fabric Yvonne E. Vaucher 
Steven L. Fish Paul A. Vignola 
Thomas H. Gouge Robert B. Vranian 
Paul C. Hessler Albert Carl Weihl 
Jay H. Hoofnagle 
Jonathan D. Katz 
Daniel G. Wright 
Ely A. Kirschner 1972 
Mark A. Korsten Robert D. Arbeit 
Thomas L. Lewis R. Michael Buckley Jr. 
Robert B. Litman Michael A. Catalano 
Anne W. Lucky Leonard H. Cohen 
Roger A. Mason Philip L. Cohen 
Leonard M. Milstone Gloria Cummings* 
James R. Missett Robert F. DeBlasi 
William K. Mueller Norman M. Dinerman 
James J. O'Donnell William H. Druckemiller Jr. 
Bruce A. Reitz David J. Francis 
Robert M. Rosa M. Felix Freshwater 
Dennis E. Shield John P. Fulkerson 
Stuart S. Shorr Robert D. Glassman 
Ray W. Tripp III Dorothy M. Gohdes 
C. Bruce Wenger Andrew E. Hoover 
Daniel Wuensch Thomas L. Horn 
Marc O. Yoshizumi Vernon H. Humbert Jr. 
Fred Hyde 
1971 Richard J. Inwood 
Judith L. Bader Anthony H. Jackson 
Gregory W. Bartha Jesse B. Jupiter 
Michael J. Beierle Frank M. Kahr 
Bruce Block Michael A. Kaufman 
Marian H. Block Donald L. Kent 
John L. Cieply David L. Kneapler 
Frederick L. Cohn Theodore M. Levin 
Edward C. Cottle Paul A. Lucky 
Michael Cynamon Harry L. Malech 
Leonard I. Eisenfeld Jeffrey S. Menkes 
Daniel E. Feldman Jerome H. Meyer 
Harvey Fembach Jorge A. Motta 
Fred Finkelman David B. Moyer Jr. 
John W. Foster Jr. James A. Nathanson 
Jared J. Gardner John P. O’Grady 
Allan W. Graham William L. Risser 
Jerold Alan Haber Richard S. Robbins 
Kenneth L. Harkavy David H. Romond 
William W. Hay Jr. Philip M. Rothfeld 
N. Timothy Jette Michael Rothkopf 
Memorials 
Deceased medical alumni and friends may be 
memorialized by a gift at any time to the School of 
Medicine Alumni Fund endowment in the name 
and class of the person so honored. The next-of- 
kin of a deceased medical alumnus/a is advised 
about this In Memoriam Program by a mailing 
from New Haven some weeks after the School of 
Medicine receives notification of the death. The 
letter of information includes a copy of the 
Testament of Remembrance in which the names of 
all persons so memorialized are listed in the 
medical section by class, thus establishing a lasting 
memorial. Donors receive a personally penned 
note of appreciation from the In Memoriam 
program director. Your inquiries and interest are 
welcome. 
Deceased alumni and friends so honored in 
1991-92 were: 
Max R. Smirnow '06 
Vincent A. Doroszka '07 
Henry Bill '32 
Dean Lester W. Burket '36 
Phillip H. Gates '39 
Joseph E. Sokal '40 
Robert H. Areson '41 
John R. McDermott '41 
David G. Decker '42 
Francis P. Vose '42 
Charles A. Hall '44 
Frederic M. Blodgett '46 
Charles Sheldon Judd Jr. '46 
Francis G. Reilly '46 
Russell N. Anderson '50 
Harvey L. Young '52 
John Currier Gallagher '58 
James R. Blanning 
Director 
In Memoriam Program 
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Charles F. Scholhamer Jr. 
Frederick D. Stockwell 
Gary M. Strauss 
Lawrence P. Temkin 
Philip J. Weyman 
Michael W. Yogman 
Steven M. Zeldis 
1973 
David A. Adler 
David A. Baggish 
David Nelson Bailey 
Clement R. Boland 
Mary Ann Brunstetter-Shafer 
James N. Campbell 
Marvin M. Chassin 
William T. Choctaw 
F. Sessions Cole III 
Joseph M. Connors 
David L. Coulter 
Christopher M. Doran 
Jane H. Ferguson 
Richard J. Fingeroth 
Robert A. Florin 
Lee Goldman 
Gary V. Gordon 
Howard S. Honig 
Andrew G. Kadar 
Lynne M. Liptay 
George Lister Jr. 
Harold Mancusi-Ungaro Jr. 
John A. McDowell 
Jerry Nagler 
John Frederick Neil* 
Claes M. Nilsson 
David E. Peach 
David Piekar 
Robert Joseph Polackwich* 
James S. Robertson 
Thomas J. Romano 
Harry S. Romanowitz 
Jerrold F. Rosenbaum 
Joseph F. Simeone 
Robert A. Sirota 
Charles F. Stroebel 
James F. Sullivan 
Thomas F. Sweeney 
Robert J. Ursano 
Christine A. Walsh 
Marc A. Weinberg 
Richard S.K. Young 
1974 
Stephen B. Arnold 
Irving M. Asher 
Douglas A. Berv 
Bruce David Blumberg 
Neil Blumberg 
Ronald C. Brown 
Peter J. Buchin 
Bert D. Collier Jr. 
Paul David 
Vincent A. Di Maria 
Irl L. Extein 
Allan B. Friedland 
Michael A. Gerber 
Ary Louis Goldberger 
David Grant 
Robert F. Hempton 
Edward O. Janosko II 
Robert C. Jimerson 
Ancil A. Jones 
Marie T. Kelly 
Robert M. Kolodner 
Saul Lande 
Olusegun O. Lawoyin 
Bruce M. Markle 
Edward L. Marut 
James R. McMonagle 
Ronald D. Neumann 
Richard C. Pasternak 
Andrew L. Ries 
David Z. Ritvo 
Daniel I. Rosenthal 
Amy S. Schechter 
Robert J. Schechter 
Alan B. Silken 
George H. Talbot 
Maisie Tam 
Edward M. Wolin 
1975 
Ralph E. Binder 
Sharon L. Bonney 
William S. Bush 
Rodney J. Butch 
Chau V. Dang 
Robert G. Drake Jr. 
Elizabeth R. Gawron 
Paul A. Johnson 
Kevin Kane 
Bernhard H. Lisker* 
Richard J. Loewenstein 
Yvonne E. Lomax Burnett 
David A. London 
Hyman J. Milstein 
Mary Jane Minkin 
Robert G. Nankin 
Andrew B. Newman 
Edwin G. Olson 
Howard Ozer 
George J. Pardos 
Mary Lake Polan 
Vivian Reznik 
Philip J. Rich 
Salvatore V. Romano Jr. 
Robert S. Sandler 
Steven A. Schwartz 
Thomas W. Smith 
Barbara J. Stoll 
Douglas R. Zusman 
1976 
Sarah S. Auchincloss 
Alfredo L. Axtmayer 
Peter B. Bitterman 
Alan B. Bloch 
Randall D. Cebul 
Pauline Y. Chao 
Richard S. Childs Jr. 
Joseph Ciabattoni 
John D. Clemens 
Vincent C. Dicola 
Gary S. Dorfman 
Geoffrey Etherington 
Leonard Firestone 
Ira H. Gewolb 
Glenn A. Gorlitsky 
Joel Kabak 
David T. Kawanishi 
Richard D. Kayne 
Norman V. Kohn 
William J. Lederer 
William K. Levy 
Douglas G. Mann 
Jon S. Morrow 
Richard L. Neubauer 
Paul R. Ramirez 
Emanuel R. Reinitz 
Susan H.K. Ryu 
Lawrence E. Samelson 
Richard S. Schottenfeld 
Charles R. Swenson 
Peter M. Ting 
John C. Wiles 
Jerome B. Zeldis 
Carol M. Ziminski 
1977 
Michael G. Adelberg 
Phyllis August 
John J. Boronow 
Richard D. Bucholz 
Mark A. Dillingham 
Stuart Brian Dubin 
Sybil E. Duchin 
Marybeth Ezaki 
Susan Firestone 
James A. Fox 
Julia B. Frank 
Steven R. Hahn 
Robert W. Hand 
Bruce L. Innis 
Howard K. Koh 
David J. Kreis Jr.* 
Margaret S. McKenna 
Robert J. Mitchell 
Alan S. Penziner 
Richard E. Peschel 
Theodore M. Pitts 
Jordan S. Pober 
Leonard A. Rappaport 
Steven J. Scheinman 
Ricky M. Schneider 
Simeon A. Schwartz 
Mark S. Smith 
Ronald J. Vender 
Steven L. Warsof 
Sharon R. Weinstein 
John E. Whitcomb 
J. Douglas White 
Daniel Wohlgelemter 
1978 
Kathy L. Ales 
Thomas T. Amatruda 
Michael J. Anderson 
Richard J. Baron 
Duke E. Cameron 
Jesse M. Cedarbaum 
Paul M. Copeland 
Julius Dean 
James N. Dreyfus 
James T. Elder 
Emily A. Fine 
Mark L. Finklestein 
Maija G. Freimanis 
Robert A. Gelfand 
Arthur M. Gershkoff 
Linda J. Hall 
Jeffrey Neal Hausfeld 
Alexandra N. Helper 
Robert Hershfield 
Anne A. Knowlton 
Cynthia S. Kretschmar 
Sanford D. Markowitz 
Robert K. McLellan 
Michael J. Mitchell 
Yvette L. Piovanetti 
Seth M. Powsner 
Jeffrey David Roth 
Sally Rudicel 
Neal D. Ryan 
Steven M. Shoum 
Donald C. Simonson 
Thomas Joseph Smith 
Timothy J. Swartz 
Rebecca A. Taub 
Caroline R. Taylor 
Stanley J. Tillinghast 
Marcia J. Wade 
David L. Wessel 
Susan Wong 
1979 
Ronald Jay Berenson 
Nancy Berliner 
Guthrie S. Birkhead 111 
David A. Brenner 
J. Kenneth Burkus 
Paul E. Collier 
Kerry Cooper 
Jeffrey Neil Dombusch 
Norman L. Elliott 
Joel I. Franck 
David E. Golan 
Bruce Halperin 
Edward C. Halperin 
Leslie Jay Katz 
Roxanne E. Kendall 
Forrester A. Lee Jr. 
Wing-Yin Leong 
Michael K. Lindsay 
Timothy W. McKeithan 
David E. Ness 
Barbara Ann Peters 
Jean Rosenthal 
Lynn K. Rudich 
Gary L. Schaer 
Cynthia Anne Sherman 
Jill A. Silverman 
Alfred Windsor Sloan 
Edward B. Strauss 
Gary Vitale 
John T. Woo 
Jeffrey Work 
Gary R. Zeevi 
1980 
David E. Adelberg 
Eduardo Alfonso 
Seth Leo Alper 
Frederick R. Aronson 
Alan B. Astrow 
David Allen August 
Milton Frank Austin 
Jean Lynn Bolognia 
Patricia Church Brown 
Daryl F. Browne 
Stuart L. Bursten 
Michael W. Champeau 
Michael M. Chang 
Thomas F. Deering 
Forrest John Doud 
Stephen G. Emerson 
Barbara G. Fallon 
Judy E. Garber 
Todd J. Garvin 
Marc F. Glickstein 
David Jay Goldberg 
Nancy S. Goldman 
Jonathan L. Jacobs 
Barry M. Kacinski 
Theodore W. Marcy 
Suzanne M. Matsui 
Cesar R. Molina 
Neal L. Rosen* 
Steven 1. Rosenfeld 
Gerri A. Schulman 
John A. Selling 
Jeffrey N. Siegel 
Hillel D. Skoff 
Kim R. Swartz 
Marcia R. Taylor 
Howard W. Telson 
Walter H. Williams 
Mary Hill Wise 
1981 
Cynthia B. Aten 
Robert B. Bailey Jr. 
Alicia Barela 
Sherri L. Brown 
Steven M. Brown 
Patricia A. Burke 
Jeffrey Chodakewitz 
Chee C. Chow 
Marc D. Coltrera 
Paula M. Fracasso 
Steven H. Fugaro 
Ramona Q. Fung 
Robert L. Galli 
Robert S. Goldman 
Laurie J. Gordon 
Jeffrey A. Gruskay 
Jason D. Horowitz 




David Y.C. Lu 
Robert M. Milstein 
Richard L. Mogerman 
David A. Paly 
Robert B. Portney 
Barbara A. Roach 
Dovelet Shashou 
Martin H. Teicher 
Stephen Burgos Wilson 
David H.W. Wohns 
John C. Wong 
1982 
Sylvia R. Beck 
Thomas J. Brennan 
David Goldstein 
Steven D. Gore 
Jed B. Gorlin 
Daphne Hsu 
Laurie B. Komreich Katz 
Michael E. Katz 
Patricia Kellner 
Suzanne M. Lohmann 
Kathleen Anne Nolan 
Joyce A. O'Shaughnessy 
58 Yale Medicine Fall/Winter 1992-93 
Dan B. Odenheimer 
Robert Pierattini 
Carrie A. Redlich 
Steven D. Resnick 
William M. Sikov 
Henry J. Stern 
Lynn T. Tanoue 
Patrick Toth 
Albert L. Ungricht 
David A. White 
Stephanie Wolf-Rosenblum 
N. Bruce Yager 
1983 
John Taylor Adams* 
Robert E. Bookstein 








Robert M. Kotloff 
David Lindgren 
Laurie Margolies 
Frederic R. Martin 
Miguel A. Martinez 
David P. Norton 
Dan A. Oren 
Harlan A. Pinto 
Moshe Rubin 
ij Daniel Paul Sabbeth 
I Leonard B. Saltz 
ij Susan J. Seward 
Daniel M. Sosin 
I Philip M. Spiro 
Nancy K. Terrell 
Eric P. Winer 
Pamela Leslie Zeitlin 
1984 
Geoffrey Ahern 
Martha Ray Arden 
Robert W. Arnold 
David I. Astrachan 
1 Leonard Bell 
Jessica Berman 
Joseph William Chambers 
Barbara Ann Coda 
Joseph G. DeSantis 
David J. Fillmore 
David A. Frank 
Claudia A. Heath 
Emilio J. Juncosa 
Michel Kliot 
Daniel M. Kolansky 
Jay R. Kostman 
John H. Krystal 
Richard L. Leff 
James G. Linakis 
Dominic D. Pennachio 
Jill S. Ratain 
Ronnie G. Rosenberg 
Paul B. Rothman 
Ana M. Salazar 
Joshua D. Schor 
David A. Shrier 
Michael Simons 
Paul M. Snyder 
Mark Stein 
Valerie E. Stone 
Susan P. Tredwell 
Aron David Wahrman 
1985 
Barry D. Bergquist 
Alice S.Y. Chi 
Bryan DeSouza 
Carol F. Farver 
Guy Fried 
Richard Bruce Garber 
Samuel D. Goos 
Angela Grant 
Marie Hobart 
Stuart Neal Isaacs 
Ellen Rieur Kolarik 
Susan Korrick 
Shirley J. Lee 
Ted W. Love 
Jeffrey A. Lowell 
Anthony Marks 
Elizabeth G. Moy 
Mary C. Nakamura 
Leslye C. Pennypacker 
Samuel Richard Pesin 
Anne Regenstein 
Greg A. Sachs 
Fred Santoro 
Sara A. Schutzman 
Timothy Alan Shapiro 
Joshua David Sparrow 
Louis J. Tesoro 
Javier Vizoso 
1986 
Catharine Ann Arnold 
David Atkins 
W. Lee Bailey 
Eric F. Bernstein 
Samir M. Bhatt 
Ian A. Cook 
John A. Detre 
Amanda B. Dill 




Jacqueline C. Hodge 
Jeremy L. Holtzman 
Liangge Hsu 
Manuel B. Litchman 
Thomas J. Lynch Jr. 
Stacey Mandelbaum 
Matthew R. Moore 
Steven M. Peterec 
Elizabeth A. Plotkin 
D. Bradford Reich 
Lawrence N. Sampson 
Eric P. Suan 
Steven Waisbren 
Jesse G. Wardlow Jr. 
1987 
Andrew Bazos 
Charles D. Brackett 
Robert Englander 
Subba R. Gollamudi 
Laurence Adam Greenbaum 
Glenn A. Healey 
Hugh C. Hemmings Jr. 
Peter T. Ho 
Amy Caroline Justice 
Rebecca E. Kadish 
Joseph Thomas King Jr. 
Christopher King 
Elliott Levy 
Patricia M. Powell 
Lauri R. Robertson 
Seth A. Rosenthal 
Patrick A. Ruwe 
Mindy G. Schuster 
Michael H. Solon 
Lynn Street 
Richard P. Tierney 
Robert C. Urban Jr. 
Leslie Vogel 
David H. Weingold 
Barry Weinstock 
Mark D. Widmann 
1988 
Kenneth A. Andreoni 
Joi Barrett 
Susan J. Baserga 
John Pieter Belzer 
Kathleen Carney-Godley 
David P. Chelmow 
Joshua E. Freedman 
Frederick F. Lang Jr. 
Lisa Conrad Larkin 
Peggy M. Liao 
Frederick Long 
Lance Arlen Markbreiter 
Peter Alexander Merkel 
Theodore Miclau 
Michael Emetic Mockovak 
Donna Richman 
Michael A. Rothschild 
Mitchell J. Sklar 
Steven Slovic 
Susan Valley 
Terry Q.C. Yee 
Hedayatollah Zaghi 
1989 
Katherine Ann Albert 
Stephen Bharucha 
Jennifer Franklin Bock 
Maura Jo Brennan 




Virginia Jordan Greenbaum 
Joni H. Hansson 
Kraig E. Humbaugh 
Howard Kesselman 
Lawrence R. Kleinberg 
Robert L. Levin 
Lewis Lipsey 
Melissa Terry Myers 
Lisa Ragen 
Viviann Mattson Rubin 
Robert Spiera 
David M. Stier 
Andrew Thomas Walker 
John Thomas Whalen 
Roger F. Widmann 
Phillip Chung-Ming Yang 
School of Medicine 
Alumni Fund Board 
John W. Foster, M.D. ’71 
Chairman 
Members of the Board 
Daniel L. Arons, M.D. ’67 
Sharon L. Bonney, M.D. ’76 
Harry C. Briggs, M.D. ’57 
Robert J. Donohue, M.D. ’58 
James M. Dowaliby, M.D. ’67 
M. Felix Freshwater, M.D. ’72 
Alex R. Gaudio, M.D. ’63 
James Q. Flaralambie, M.D. ’35 
Sidney S. Lee, M.D. ’50 
Benjamin E. Lyons, M.D. '38 
Andrew J. McGowan Jr., M.D. ’58 
Richard A. Moggio, M.D. ’71 
John B. Ogilvie, M.D. ’34 
Mindy G. Schuster, M.D. ’87 
Helen L. Smits, M.D. ’67 
Ronald J. Vender, M.D. ’77 
Stephanie Wolf-Rosenblum, M.D. ’82 
Ex-Officio Members 
Arthur C. Crovatto, M.D. '54 
Director of Alumni Affairs 
Gerard N. Burrow, M.D. ’58 
Dean 
Will Melton 
Director of Development 
Monica C. Robinson 
Director, Yale School of 
Medicine Alumni Fund 
Muriel D. Wolf, M.D. ’59 
President, Association of 
Yale Alumni in Medicine 
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1990 
Susan G. Anderson 
Nancy R. Angoff 
Ercem S. Atillasoy 
Thomas J. Christopher 
Mark A. Dettelbach 
Jonathan Todd Foster 
Douglas Marc Freedman 
Alan Sander Hilibrand 
Betty Shin Wun Kim 
Toshiko F. Magnus 
Erika H. Newton 
Chander N. Sarny 
Julia A. Schillinger 
Susie K. Sharpe 
Neil A. Solomon 
James H. Stein 
Daniel Stryer 
Marc Jay Warman 
1991 
Jeanne B. Ackman 
William T. Andrews 
Vivek David 
Sarah A. Davidson 
Daniel J. Donofrio 
Jean L. Fraser 
Gwendolyn Grant 
Carl T. Henningson 
Lawrence J. Hirsch 
Bruce H. Horwitz 
Richard G. lhnat 
Richard G. Ingber 
Paul A. Isenbarger 
James S. Levine 
Karen Shieh Lu 
Charles Lu 
Funda Meric 
Robert Z. Orlowski 
Andrew F. Phillips 
John L. Phillips 
Eleanor S. Poliak 
Robin Smith 
Robert M. Spillane 
Margaret M. Toth 
FORMER HOUSE 
OFFICERS 
Phillip R. Aaron 
Frederick W. Ackroyd 
Arthur Ames 
Renato Armas 
William F. Arndt 
John P. Amot 
John M. Aversa 
Adel H. Ayoub 
Ronald J. Bailey 
Arnold M. Baskin 
Richard Bass 
Carl Bennett Bean 
Gregory Kent Bergey 
Michael Richard Berman 
Larry Berte 
Ralph Daniel Bien 
Richard A. Blasband 




Malcolm B. Bowers Jr. 
Hubert B. Bradburn Jr. 
Christine Brahney 
Ronald W. Braun 
Kenneth Burke 
John K. Burkus 
Peter M. Carney 
Richard S. Casden 
J. Richard Casuccio 
Richard Allen Chase 
Ryszard Chetkowski 
Chang Song Choi 
Jane R. Clark 
James C. Cobey 
Gary M. Cohen 
Howard J. Cohen 
Burton H. Cohen 
Cynthia Conrad 
Leandro Cordero 
Philip F. Corso 
Leslie H. Cronau Jr. 
Robert E. Crootof 
F. Mitchell Cummins 
Philip Sheridan Dickey 
Daniel M. Divack 
Donald S. Dock 
June F. Donnelly 
John I. Dorfman 
John W. Drake 
William R Drucker 
Edward Dunn 
Stephen A. Edelstein 
David E. Eibling 
Malcolm Mitchell Ellison 
Walter Ettinger 
Charles Farrow 
Louis B. Fierman 
Richard Webster Finner 
Stephen V. Flagg 
Alex Harris Frank 
Lawrence Z. Freedman 
George J. Friou 
Marjorie S. Gagliardi 
Phillip H. Gates* 
David M. Gershenson 
Jonathan Gertler 
V. Philip Glassman 
Neal Benjamin Goldberg 
Joel S. Golden 
John W. Goldkrand 
Isaac Goodrich 
Richard Reed Gramse 
Donald R. Greene 






Hedda Ann Litowitz Haning 
Ray V. Haning Jr. 
Michael D. Heafner 
William H. Heydorn 
Edward Higgins Jr. 
Douglas P. Hobson 
Judith Hochstadt 
Ralph I. Horwitz 
David Smith Hubbell 
Peter Hutchin 
Eric A. Hyson 
Paul J. Jakubiak 
Clifford Joseph 
Juliana Haeng-Cha Kang 
Neil B. Kappelman 
Jill P Karpel 
David M. Kessner 
Stephen King 
Samuel C. Klagsbrun 
Arthur H. Knowlton 
Barbara Koblenz 
Alexander Sandor Koleszar 
Joseph A. Kovarik 
Kenneth M. Kramer 
Eugene Kuchner 
Joel C. Labow 
Pritchard T.C. Lam 
W. Clark Lambert 
Emmanuel Landau 
Randi Leavitt 
Robert Jan Lerer 
Vincent Leung 
Douglas M. Levin 
Sidney Levitsky 
Arthur L. Levy 
John D. Lewis 
Daniel James Luthringer 
Steven Macht 
Edward J. Manwell 
Kim Margolin 
Carmi Z. Margolis 
Stephen Mariani 
James B.D. Mark 
Frank Masino 
Richard J. Maunder 
John P. McGovern 
Thalia Mesologites 
Anthony B. Minnefor 
Yasmeen A. Moody 
Patrick E. Moriarty 
Sheila M. Moriber Katz 
Lewis B. Morrow 
H. Weston Moses 
Seymour Cy Nash 
George Nichols 
James C. Niederman 





Donald C. Rankin 
Gilbert A. Ratcliff 
Robert R. Rickert 
James A. Robb 
Jeffrey P. Robbins 
Claude Roge 
Jean F. Rogier 
Fred M. Rosenbioom 
Robert L. Rowley 
James R. Sabetta* 
Michael Saruk 
A.S. Hasan Sarwar 
Mark Scharf 
Ronnie G. Schlesinger 
William M. Schreiber 
Jonathan Schreiber 
Doug Schulman 
M. Peter Scibetta 
Richard Alan Selzer 
Howard Senter 
Edwin C. Severinghaus 
Carlton C. Sexton 
Thomas E. Shaffer 
Daniel W. Shapiro 
Vernon H. Sharp 
Irving Sherman 
Gary R. Siegel 
Andrea L M Silber 
Joel Silidker 
Frederic N. Silverman 
Robert E. Silverman 
Earl J. Simburg 
Ethan A.H. Sims 
John Raymond Slavik 
Leon G. Smith 
Daniel Perry Snower 
Thomas J. Spackman 
Stephanie S. Spangler 
Meritt W. Stark 
John G. Steciw 
Sturla Stefansson 
Judit Stenn 
Elsa L. Stone 
Fred Leslie Strieker 
Craig Summers 
Saul Marcos Suster 
Herbert Tabor 
Imad F. Tabry 
James P. Taitsman 
Marc J. Taylor 
Samuel Thatcher 
Lee Lawrence Thibodeau 
Troy L. Thompson II 
James W. Thompson 
Carol Touloukian 
James S. Touloukian 
L. Newton Turk III 
Ingrid Tuxhorn 
Daniel W. VanHeeckeren 
Romulo L. Villar 
Robert S. Waldman 
Barbara Ann Ward 
Thomas A. Warthin 
Kalman Lewis Watsky 
Alan Weinberg 
Herbert Allan Wenner 
Mark D. Widmann 
Princess Williams 




Robert C. Young 
Raymond F. Zekauskas 
Marvin Paul Zimmerman 
Richard Walter Zimmerman 
PARENTS AND 
FRIENDS 




Harriet Farnsworth Brown* 
Betty P. Carlin 
Mr. Paul W. Carstens 
Mr. & Mrs. Abe Cazen 
Mr. Howard Chin 
Mr. Fred C. Colin 
Mrs. Judy Coppola 
Anthony Deluca* 
Mr. Arthur E. Dolnansky 
Mr. & Mrs. Kenneth T. Doran 
Mrs. Vincent A. Doroszka 
Dorothy Marie Ference 
Philip Arthur Fey 
Mr. Max Finkelman 
Henry M. & Judith Zachs 
Foundation 
William J. German* 
Dr. Herbert I. Goldman 
Gideon Goldstein 
Hans Graichen* 
Mrs. Harold Grant 
Maurice Raymond Greenberg 
Frederick W. Heilman 
Mrs. Gloria F. Holmes 
Guenther August Kaiser 
Kenneth P. Kinney 
Chem Hsiung Lee 
Edward G. Lund Jr. 
Natesh Magge 
Mrs. Virginia G. Mannick 
Dr. Bernard George Miklos 
Mary Elizabeth Mintum 
Mr. & Mrs. Victor M. 
Newman 
Dr. William G. O'Donnell 
Mr. & Mrs. Louis Parent 
Dr. & Mrs. Levi V. Perry 
Henri Peyre* 
R. Donald Reich 
Mr. & Mrs. Jack Saltz 
Harold & Frances Sampson 
Henry S. Sanematsu 
Maurice Hyman Shaw 
Leon G. Smith 
Argyle Stoute 
David Donaldson Strachan 
Prof. & Mr. Lubert Stryer 
Mrs. Leo Teitz 
Thomas M. Tierney* 
Jack Weingold 
James Wells* 
Quaneta Ahsanullah Zafar 
Lloyd & Margo Zbar 
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Medical School Alumni Fund Class Participation 
1990-1991 1991-1992 
CLASS AGENT TOTAL % PART. TOTAL % PART. 
1922 and prior $ 2,370 100 $ 2,464 100 
1923 William Cohen 1,546 100 623 100 
1924 David Raskind 12,214 100 12,654 100 
1925 Alice Whittier 611 75 604 67 
1926 Maxwell Bogin 841 75 654 50 
1927 Harry Zimmerman 1,710 83 1,265 43 
1928 Lewis Scheuer 2,191 100 3,455 63 
1929 Paul McAlenney 1,553 89 1.264 60 
1930 70,425 67 8,928 50 
1931 Michael D'Amico 3,256 100 2,572 89 
1932 2,514 85 78,580 53 
1933 2,303 113 2,543 60 
1934 John Ogilvie 7,028 100 51,390 80 
1935 James Haralambie 6,975 100 7,405 71 
1936 4,361 61 4,651 40 
1937 Wilbur Johnston 2,040 83 2,317 74 
1938 Nelson Ordway 1,488 92 1,115 67 
1939 Rebecca Solomon 3,869 90 3,829 78 
1940 James Ferguson 12,070 95 31,838 61 
1941 Charles Cheney 9,776 90 4,501 63 
1942 Walter Burdette 5,369 85 176,411 76 
1943 Dorothea Peck 29,174 100 5,541 84 
Brownlee Brinkley 7.092 93 4.212 68 
36,266 97 9,753 76 
1944 Nicholas Spinelli 10.297 100 9,748 85 
1945 Richard Breck 5,806 94 6.859 59 
1946 Thomas Whelan 55,973 79 12,073 69 
1947 George Barnes 5,191 93 6,213 75 
W. Roy Breg 2.444 93 3.190 75 
7,635 93 9,403 75 
1948 Anne Godley 8,644 82 6,787 60 
1949 Daniel Elliot 3,864 84 4,604 66 
1950 8,886 79 10,421 78 
1951 Lowell Goodman 15,324 69 8.586 54 
1952 John Wagner 5,634 60 8,576 67 
1953 Vincent Gott 8,737 72 10,562 69 
1954 John Rose 7,435 79 7.883 75 
1955 Robert Kramer 6.085 68 7,137 66 
1956 John Gardner 10.262 75 6,944 66 
Donald Dalessio 6.855 74 5.260 68 
17,117 75 12.204 67 
1957 Harry Briggs 7,275 73 4,475 68 
Howard Minners 5.485 67 4.525 69 
12,760 70 9,000 69 
1958 Andrew McGowan 9,746 65 8,868 76 
Paul Rudnick 4.955 66 4.610 66 
14,701 66 13,478 71 
1959 Asa Barnes 8,859 83 7,251 64 
Muriel Wolf 5.051 70 4.290 65 
13,910 77 11.541 65 
1960 Eugene Gaenslen 3,171 59 4.638 62 
Thomas Kugelman 5.375 63 5.750 60 
8,546 61 11.388 61 
1961 Robert S. Briggs 4,650 60 4,050 51 
Warren Widmann 9.425 77 6.430 74 
14,075 67 10,480 63 
1962 A.R. Pschirrer 3,101 66 3,025 51 
Frederic Cantor 3.826 50 4.380 40 
6.927 58 7,405 46 
1963 Craig Llewellyn 8.722 50 9.828 49 
1964 William J. Houghton 3,885 48 2.256 36 
Robert Lyons 10.750 79 11.605 79 
14,635 64 13.861 58 
1965 David Hill 14,243 53 24,850 55 
1966 Mary Alice Houghton 3,150 59 3,750 64 
Gary Townsend 3.495 55 2.615 45 
6,645 57 6,365 55 
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1990-1991 1991-1992 
CLASS AGENT TOTAL % PART. TOTAL % PART. 
1967 James Dowaliby 3,572 63 91,681 86 
Anthony Lovell 6.390 IX 119.840 80 
9,962 67 211,521 83 
1968 Frank Lucente 16.353 58 4,778 50 
Donald Lyman 6.188 75 3.944 58 
22,541 67 8,722 54 
1969 Adrian Schnall 11,307 65 10.380 58 
1970 James Missett 5,403 50 5,194 45 
1971 John Cieply 5,944 66 6.297 56 
Barbara Kinder 10.450 70 7.324 59 
16,394 68 13,621 58 
1972 Harry Malech 10,386 59 13,762 58 
1973 Lee Goldman 1,599 45 1.872 55 
John McQuade 2,831 48 3,607 39 
Jerrold Rosenbaum 2.029 54 2.054 50 
6,459 49 7.533 48 
1974 Amy Schechter 1,745 49 5,040 53 
Robert Schechter 3.040 50 4.475 45 
4,785 50 9,515 49 
1975 1,631 35 1,950 32 
Mary Jane Minkin 1.559 30 1.875 27 
3,190 33 3,825 30 
1976 William Levy 4,570 56 3,570 41 
Glenn Gorlitsky 2.725 40 1.200 32 
7,295 48 4,770 37 
1977 5,910 32 11.290 34 
Ronald Vender 1.570 56 2.795 50 
7,480 44 14,085 42 
1978 Duke Cameron 3,070 42 3,025 41 
Seth Powsner 350 40 655 47 
200 33 450 42 
3,620 38 4.130 43 
1979 Jeffrey Kaine 1,770 51 2,235 37 
Cynthia Sherman 3,160 37 3.575 40 
4.930 44 5,810 39 
1980 Eduardo Alfonso 1,855 40 2,195 48 
Steven Rosenfeld 1.357 46 1.482 35 
3,212 43 3,677 42 
1981 Anthony Urbano 3,703 37 3,075 32 
1982 Muriel Cyrus 948 23 695 12 
Jed Gorlin 385 50 525 52 
S. Wolf-Rosenblum 970 57 501 38 
2,303 43 1,721 34 
1983 Michael Tom 971 27 806 26 
David Schwartz 585 36 1.135 38 
1,556 32 1,941 32 
1984 Hingge Hsu 620 33 743 32 
Jay Kostman 750 32 933 39 
1,370 33 1,676 36 
1985 Greg Sachs 807 31 1,025 32 
Fred Santoro 700 31 655 31 
1,507 31 1,680 32 
1986 Eric Bernstein 958 28 875 32 
Clinton Lindo 125 20 375 22 
Eric Suan 700 15 1.450 31 
1,783 21 2,700 28 
1987 Barry Weinstock 745 39 678 24 
Subba Gollantudi 123 32 105 26 
Mindy Schuster 360 41 560 50 
Mark Widmann 725 20 1.025 10 
1,953 33 2,368 28 
1988 Michael Mockovak 237 32 111 18 
Susan Valley 168 18 235 30 
Hedi Zaghi 215 28 160 30 
620 26 506 26 
1989 Stephen Bharucha 250 28 2,158 14 
Lewis Lipsey 175 39 255 44 
Melissa Myers 76 33 130 28 
Roger Widmann 205 50 200 43 
706 38 2,743 32 
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1990-1991 1991 -1992 
CLASS AGENT TOTAL % PART. TOTAL % PART. 
1990 Chander Samy 160 36 40 17 
Daniel Stryer 75 50 75 40 
Jonathan Foster 88 36 138 60 
Roberto Soto 5 10 10 10 
Thomas Christopher 150 36 35 18 
Tracy Nelson 
Ercem Atillasoy 30 22 10 11 
Betty Shin Wun Kim 80 14 35 10 
588 29 343 21 
1991 Stephen Bell 125 24 
Carl Henningson 70 9 
Lawrence Hirsch 95 30 
Karen Sheih Lu 65 25 
Richard Ihnat 51 38 
Francis Lobo 95 33 
Funda Meric 75 29 
Andrew Phillips 45 33 
John Phillips 50 9 
Robin Smith 20 II 
691 24 


















Alumni 3,735 1.630 44 $607,960 3,836 1.913 50 $ 976,844 
Former House Staff 2,093 207 10 71.366 2,093 213 10 25,640 
Parents/Friends 432 39 9 10.761 395 45 11 12,951 
Interest/Misc. — — -— 13.285 — —- 14.533 
Total 6,182 2,287 37 $695,839 6,324 2.171 34 $1,029,968 




Robert E. Carroll ’42 
Berthold M. Comeau '28* 
J. Roswell Gallagher '30 
John B. Ogilvie ’34 
Michael A. Puzak ’42 
Elizabeth M. Ramsey '32 
Nathan E. Ross ’28 
Myron A. Sallick ’24* 
Myra D. Tyler ’50 
Robert R. Wagner '46 
Amy H. Hunter Wilson ’30* 
SPONSOR 
Joseph E. Sokal '40* 
PATRON 
Michael G. Adelberg ’77 
Daniel L. Arons ’67 
Kenneth F. Crumley ’67 
Michael J. Cummings ’65 
William Harrison Jr. '42 
Richard J. Hart Jr. ’67 
Peter N. Herbert ’67 
Anthony P. Lovell '67 
Joseph L. Morris ’67 
Jennifer Robinson Niebyl ’67 
John O. Pastore '67 
Robert I. Roy ’67 
Myron A. Sallick ’24* 
Joseph F. Walter ’67 
FELLOW 
Arthur L. Beaudet ’67 
David M. Conkle ’67 
James M. Dowaliby II '67 
M. Felix Freshwater '72 
Richard L. Heppner '67 
Amy H. Hunter Wilson ’30* 
Mohandas M. Kini ’65 
J. Robert Kirkwood '67 
Brian F. Rigney ’67 
Sidney C. Smith Jr. ’67 
Helen L. Smits '67 
Robert S. Steinberg ’67 
Richard B. Swett ’67 
Robert A. Vogel ’67 
Robert A. Vollero ’67 
ASSOCIATE 
Theodore E. Allen '40 
Ralph D. Alley '43 
Carol J. Amick ’59 
Robert M. Amick '59 
Franklin C. Behrle '46 
Sanfurd G. Bluestein '46 
Harold D. Bomstein Jr. ’53 
Gary C. Burget ’67 
Lester W. Burket ’36* 
Gerard N. Burrow ’58 
Thomas B. Caldwell III ’65 
The School of Medicine Alumni Fund's Sterling Association 







$50,000 and above 




200 - 999 
John A. Carlston ’58 
Mary Williams Clark ’67 
Sanford F. Cockerell ’45 
Jay B. Cohn ’45 
Thomas J. Coleman '46 
Arthur C. Crovatto ’54 
Lawrence G. Crowley ’44 
Cynthia Rapp Curry ’67 
Marian C. Davidson ’67 
James Lucius Davis III '67 
Robert F. DeBlasi ’72 
Claude W. Delia '50 
Amanda B. Dill '86 
James J. Dineen ’67 
Timothy J. Dondero Jr. ’67 
Robert J. Donohue Jr. '58 
Alexander F. Dora ’67 
Owen W. Doyle ’47 
Mitchell Edson '56 
Kent Ellis ’50 
Elizabeth Fuller Eisner ’48 
Ralph J. Falkenstein ’69 
Lee E. Farr '32 
Philip R. Fazzone '58 
John E. Fenton ’41 
John W. Foster Jr. '71 
Allan B. Friedland '74 
Paul Jay Friedman '60 
Robert H. Furman ’43 
J. Roswell Gallagher ’30 
Alexander R. Gaudio '63 
Margaret C. L. Gildea ’36 
Anne Godley ’48 
Melvin Victor Goldblat ’67 
Lowell I. Goodman '51 
Martin E. Gordon ’46 
Ralph S. Greco ’68 
Peter A. Gross ’64 
Jay G. Hayden ’66 
George P. Herr '67 
William H. Hindle ’56 
Sheldon A. Jacobson ’28 
Marie-Louise T. Johnson ’56 
Mary Jurbala ’67 
Alfred E. King ’37 
Ralph E. Knutti ’28 
Paul B. Koehler ’48 
Carl E. Lane ’67 
Sidney S. Lee '50 
Hildegard Mueller Leslie ’53 
Preston Lee Leslie ’53 
Richard Murray Linburg '64 
Michael K. Lindsay ’79 
Lynne M. Liptay ’73 
James Lum '55 
Brock Lynch ’47 
Harold R. Mancusi-Ungaro Jr. ' 
Philip D. Manfredi '65 
Carl K. Marling ’67 
Edward L. Marut '74 
A. Reese Matteson ’44 
Harry L. McClelland ’50 
Patrick T. Minihan ’71 
Anoush Miridjanian '61 
Robert L. Mitchell 64 
Richard Albert Moggio ’71 
Willys M. Monroe '41 
Donald P. Morris ’35* 
Robert E. Mueller ’63 
Nelson Newmark ’31 
Robert G. Petersdorf ’52 
Earl D. Rees ’54 
John Macklin Roberts ’52 
Nathan E. Ross ’28 
Paul A. Rudnick '58 
Dennis J. Rudzinski ’69 
Charles R. Sachatello '61 
Jonathan L. Saveli ’67 
Amy S. Schechter ’74 
Robert J. Schechter ’74 
Stephen C. Schimpff ’67 
Charles F. Scholhamer ’42 
John J. Schrogie ’60 
Harry Sherman ’34 
Frederick C. Sherman ’68 
Donald G. Skinner ’64 
Ora K. Smith ’53 
A. Thomas Snoke '64 
Michael H. Solon ’87 
Nicholas P.R. Spinelli '44 
Donald C. Stahl '57 
Seth Thaler ’62 
M. David Tilsons III "67 
Gary L. Townsend ’66 
Lawrence Tremonti ’63 
Raymond W. Turner ’58 
Ronald J. Vender ’77 
Constantine M. Voyagis '60 
Marcia J. Wade ’78 
Stephen Waltman ’64 
Martin Wand '67 
Peter G. Weiner ’63 
Warren D. Widmann ’61 
Redford B. Williams Jr. ’67 
Robert J. Winer ’67 
Robert S. K. Young '67 
Peter M. Zeman ’67 
Sumner Root Ziegra '47 
FORMER HOUSE 
OFFICERS 
Ronald W. Braun 
Ralph I. Horwitz 
Samuel C. Klagsbrun 
Robert L. Rowley* 
PARENTS AND 
FRIENDS 
Mrs. Vincent A. Doroszka 
Gideon Goldstein 
Maurice Raymond Greenberg 
Frederick W. Heilman 
Mr. & Mrs. Jack Saltz 
Argyle Stoute 
MEMBER 
David E. Adelberg ’80 
Donald Agostinelli ’57 
Margaret J. Albrink ’46 
Kathy L. Ales ’78 
Frank R. Allen ’51 
George Howard Allison '45 
Jon R. Almquist '65 
Miguel R. Alonso ’63 
William A. Alonso ’64 
Victor A. Altshul '60 
Thomas T. Amatruda Jr. ’51 
Charles B. Anderson '62 
Carl E. Andrews ’44 
Joseph E. Angelo ’58 
William G. Anlyan '49 
David G. Ansel ’69 
Stephen B. Arnold ’74 
Irving M. Asher ’74 
Berton W. Ashman ’64 
David Atkins ’86 
Albert S. Atwood ’45 
Alfredo L. Axtmayer '76 
Judith L. Bader ’71 
Malcolm A. Bagshaw '50 
Muriel H. Bagshaw '51 
David Nelson Bailey ’73 
Robert B. Bailey Jr. '81 
Earl L. Baker '61 
Jack D. Barchas ’60 
Alicia Barela ’81 
George R. Barnes Jr. ’47 
Asa Barnes Jr. '59 
Gregory W. Bartha ’71 
George F. Batten '48 
John D. Baxter ’66 
Albert A. Bechtoldt Jr. ’61 
Aaron T. Beck '46 
Edith M. Beck '48 
George E. Becker '55 
Daniel I. Becker ’68 
Francis A. Beer '59 
Ronald Jay Berenson ’79 
Daniel Bergsma '36 
Eleanor Clay Bigley '51 
Ralph E. Binder '75 
Jonathan S. Bishop '48 
Jonathan S. Bishop ’49 
Henry N. Blansfield ’47 
Bruce Block '71 
Marian H. Block ’71 
William E. Bloomer '42 
Colin Mercer Bloor ’60 
Peter Bios Jr. ’56 
Bruce David Blumberg ’74 
Richard S. Bockman ’67 
Arthur Walker Boddie Jr. ’67 
Maurice L. Bogdonoff ’52 
Maxwell Bogin ’26 
Sharon L. Bonney ’75 
John E. Borowy ’50 
Richard J. Bouchard ’54 
Stuart P. Bowne '60 
Levon Z. Boyajian '56 
W. Roy Breg Jr. '47 
Thomas J. Brennan ’82 
Richard I. Breuer ’57 
Henry H. Briggs Jr. ’31 
Robert S. Briggs ’61 
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Thomas M. Brown '56 
James Edward Brown '66 
Sherri L. Brown '81 
Steven M. Brown '81 
Padraic Burns '55 
William S. Bush '75 
Rodney J. Butch '75 
William C. Butterfield '59 
Duke E. Cameron '78 
John L. Cannon '47 
Fredric K. Cantor '62 
Thomas A. Cardella '64 
George A. Carden Jr. '35 
William A. Carey '41 
John P. Carey '57 
Charles W. Carl Jr. '63 
Alice Shepard Cary '45 
Eugene Patrick Cassidy '66 
Michael A. Catalano '72 
Linus W. Cave '46 
William T. Cave Jr. '67 
Siegried A. Centerwall ’52 
Willard R. Centerwall '52 
William R. Chaffee ’53 
Michael W. Champeau ’80 
Pauline Y. Chao ’76 
Robert A. Chase '47 
Thomas Newell Chase '62 
Charles B. Cheney '41 
Edgar S. Childs '35 
Theodore J. Chu '63 
Albert K. Chun-Hoon '57 
Joseph Ciabattoni '76 
John D. Clemens '76 
Sidney M. Cohen '59 
Robert M. Cohn '65 
Frederick L. Cohn '71 
James C. Collias '56 
Stephen W. Collins Jr. '39* 
Vincent J. Collins '42 
William F. Collins Jr. '47 
Marc D. Coltrera '81 
Norman I. Condit '43 
Edward J. Conway '44 
John C. Coolidge '44 
Leo M. Cooney Jr. '69 
Louis Z. Cooper '57 
Kerry Cooper ’79 
Edward D. Coppola '55* 
Ruth E. Cortell '48 
Pasquale James Costa '55 
Richard H. Cote '48 
Edward C. Cottle '71 
Alan H. Covey '54 
Rutledge W. Currie '68 
Hester B. Curtis '32 
William S. Curtis '89 
Michael D'Amico '31 
Donald J. Dalessio '56 
Richard J. Daly '69 
Oliver Townsend Dann '62 
Lycurgus M. Davey '43 
Alvin Davis ’50 
Chandler Dawson ’56 
James E. Delano Jr. ’70 
Orson R. Dee '61 
Hendrik DeKruif ’42 
Michael W. Dennis ’69 
Herbert W. Diefendorf ’41 
Ronald A. Dierwechter ’61 
Charles A. Dinarello '69 
Dorothy M. Gohdes ’72 
David E. Golan ’79 
Carol Goldenthal '44 
Lee Goldman '73 
Nancy S. Goldman "80 
Paul Gonick '55 
Anne H. Good '57 
Eleanora C. Gordon '49 
Glenn A. Gorlitsky '76 
Thomas H. Gouge ’70 
Angela Grant '85 
George E. Green ’56 
Jack Greenberg ’33 
Peter B. Gregory ’63 
J. McLeod Griffiss ’66 
B. Herold Griffith ’48 
Chesterfield G. Gunn Jr. ’50 
Victor C. Hackney ’43 
W. Keith Hadley '59 
Linda J. Hall '78 
James H. Halsey Jr. "59 
Robert N. Hamburger '51 
James Q. Haralambie ’35 
Ross R. Harcus '48 
Joan Marasco Hardenbergh '56 
Paul A. Harper ’31 
Jackson Harris ’49 
Benjamin Keith Hams ’63 
John Herd Hart ’56 
H. Rodney Hartmann ’59 
Patricia C. Hassakis '62 
A. Daniel Hauser ’53 
William W. Hay Jr. ’71 
Kevin N. Hennessey '68 
William H. Heydorn '59 
David A. Hill '65 
C. Richard Hinckley '59 
Gary Hirshfield '86 
Paul W. Hoffert '45 
Gilbert F. Hogan '57 
O. Roger Hollan '45 
Jay H. Hoofnagle ’70 
Charles L. Hopper '56 
Thomas L. Horn ’72 
Larry C. Horowitz ’69 
Thomas C. Howard ’69 
J. Dale Howe '61 
Vernon H. Humbert Jr. '12 
Henry D. Humphrey ’40 
Scott A. Hundahl '81 
Carl E. Hunt '65 
Herbert S. Hurwitz '54 
Arthur P. Hustead '52 
Fred Hyde '72 
Roland H. Ingram Jr. '60 
Leonard Inker ’59 
H. Stuart Irons ’40* 
Carrold K. Iverson '51 
Jonathan L. Jacobs '80 
Thomas C. Jaleski '31 
Benjamin A. Johnson ’49 
William Joseph Johnson '52 
Virginia Burnham Johnson ’65 
Thomas R. Johnson '68 
Paul A. Johnson '75 
Henry H. Jones '43 
Daniel M. Jones '60 
Robert J. T. Joy '54 
Charles Sheldon Judd Jr. '46* 
Emilio J. Juncosa '84 
Jesse B. Jupiter ’72 
Robert V. Diserens ’58 
John H. Doherty ’44 
Malin Dollinger '60 
Joseph A. Donadio '66 
Joseph P. Donnelly '32 
Gary S. Dorfman ’76 
Richard E. Dormont ’40 
Vincent A. Doroszka '30* 
James R. Dorr ’57 
G. Robert Downie ’48 
John A. Drews '67 
William H. Druckemiller '39 
William H. Druckemiller Jr. '72 
Stuart Brian Dubin 'll 
Peter A. Duncan '41 
James P. Dunn ’53 
Robert S. Easton '45 
Jonathan Ecker ’70 
Andrew Edin ’63 
Peter R. Egbert '67 
N. Joel Ehrenkranz '49 
I. Bruce Elfenbein '62 
John P. Eliopoulos ’63 
Daniel W. Elliott "49 
William S. Elliott '55 
Norman L. Elliott ’79 
Jared M. Emery '66 
Leroy Engel ’55 
Franklin Harold Epstein '47 
Edward L. Eyerman Jr. '57 
Harold J. Fallon Jr. ’57 
Herbert W. Felsenfeld '67 
John E. Fenn ’61 
John P. Ferguson Jr. ’39 
Jane H. Ferguson ’73 
Anthony Ferrante '64 
Thomas F. Ferris '56 
Alan G. Finesilver ’68 
Knox H. Finley ’30 
Leonard Firestone '76 
Susan Firestone 'll 
Lesley Forman Fishelman '69 
Robert L. Fisher '59 
B. Allen Flaxman '63 
William Fleeson '42 
Gregory E. Flynn '46 
Michael P. Flynn '65 
Anthony L. Fons III '57 
David J. Francis 'll 
Joel I. Franck ’79 
Robert N. Frank '66 
Steven A. Frankel "69 
William H. Frazier "69 
John Martin Freiheit ’27* 
Robert W. Frelick '44 
Richard K. Friedlander '47 
Alice Dershimer Friedman '45 
Anthony V. Furano ’62 
Sidney S. Furst ’51 
Eugene C. Gaenslen Jr. "60 
John Currier Gallagher ’58* 
James D. Gardam ’45 
Joseph M. Garland '51 
Todd J. Garvin '80 
Elizabeth R. Gawron '75 
Royal J. Gay '69 
Sander G. Genser ’69 
Richard A. Getnick '68 
Edward C. Gilbert ’61 
Robert D. Glassman ’72 
Sumner Gochberg '56 
Edith M. Jurka ’44 
Andrew G. Kadar '73 
Richard Lee Kahler '57 
George T. Kammerer ’56 
Ronald J. Kaipick '65 
Michael Kashgarian '58 
Jonathan D. Katz ’70 
Herbert J. Kaufmann ’59 
Jerome J. Kaye ’44 
Richard L. Keefe ’61 
Leo Kellerman '42 
Thomas S. Kelly '52 
R. Leonard Kentler '43 
Harry O. Kendall '55 
Roxanne E. Kendall '79 
Donald L. Kent ’72 
Robert J. Kerin '47 
David R. Kessler '55 
Don F. Kimmerling '47 
Barbara K. Kinder '71 
Ely A. Kirschner '70 
Jay Ward Kislak '58 
William L. Kissick '57 
Frank J. Kleeman '60 
Thomas Kievan '81 
David E. Knoop '62 
Richard R. Knowles III '53 
Robert H. Koehl '65 
Norman V. Kohn '76 
Robert A. Kramer '55 
Stephen Krant '69 
Frederick F. Krauskopf '44 
Edward A. Krull '55 
Thomas P. Kugelman '60 
Wilbur L. Kukes ’66 
Samuel D. Kushlan ’35 
Constantine D. Kyropoulos '63 
Saul Lande '74 
Lewis Landsberg '64 
Edward R. Lang '60 
Jonathan Trumbull Lanman '43* 
Frank D. Law ’49 
Olusegun O. Lawoyin '74 
Philip M. LeContpte '36 
Marguerite Stein Lederberg '61 
Myron S.S. Lee '59 
Jeffrey S. Lee '68 
William B. Lehmann ’63 
Edgar H. Levin ’57 
Jack Levin '57 
James S. Levine ’64 
Sandra Chook Levine '65 
Lynne L. Levitsky '66 
Robert Isaac Levy '61 
William K. Levy '76 
William V. Lewit '56 
Theodore W. Liebernran ’58 
Paul R. Lightfoot Jr. '64 
Janus C. Lindner’50 
Marc E. Lippman '68 
Mark W. Lischner ’65 
Peter B. Livingston ’63* 
J. Philip Loge ’43 
George M. Lordi '61 
Frank E. Lucente ’68 
Paul A. Lucky ’72 
Edward G. Lund Jr. ’63 
John P. Lynch ’62 
Benjamin E. Lyons '38 
Robert W. Lyons '64 
Alexander Maitland III ’55 
William J. Mangione '71 
Douglas G. Mann '76 
Preston C. Manning ’56 
Harold March ’50 
Vincent T. Marchesi '61 
Stephen I. Marglin '68 
Bruce M. Markle '74 
Elias J. Marsh ’44 
John G. Martin ’33 
Edward Martin '40 
Miguel A. Martinez '83 
William F. Matchett '64 
Thomas J. Mathieu "46 
Stanley E. Matyszewski '62 
Caroline O. McCagg '66 
Eugene G. McCarthy Jr. '60 
William K. McClelland ’47 
John J. McGillicuddy ’38 
Andrew Joseph McGowan Jr. '58 
Joseph S. McGuire Jr. ’55 
William G. Meffert ’62 
John C. Mendillo '30 
John H. Meyers '50 
Harmon Michelson '68 
Orlando J. Miller ’49 
Harry C. Miller Jr. ’54 
Richard Charles Miller '58 
Donald L. Miller '60 
William A. Miller'62 
Stephen W. Miller '67 
Mary Jane Minkin '75 
James R. Missett '70 
Charles R. Mitchell '06** 
Robert K. Modlin ’57 
Peter M. Molloy "59 
John J. Mooney "66 
Joe D. Morris ’46 
Jon S. Morrow '76 
N. Karle Mottet '52 
Albert R. Mowlent '51 
William K. Mueller '70 
Jerry Nagler "73 
Stephen F. Nagyfy '36 
Donald J. Nalebuff '56 
William M. Narva '56 
George W. Naumburg Jr. ’45 
James W. Needham '48 
Lionel M. Nelson '69 
David E. Ness '19 
Paul N. Neufeld '54 
Ronald D. Neumann '74 
Robert S. Neuwirth '58 
Allan W. Newcomb '60 
Herbert A. Newman '57 
Andrew B. Newman ’75 
Buford L. Nichols Jr. '60 
Dean Nichols ’42* 
Claes M. Nilsson ’73 
Myron K. Nobil '47 
Timothy F. Nolan Jr. '49 
Walter W. Noll ’65 
James J. Nora '54 
James J. O’Donnell '70 
Donald A. O'Kieffe Jr. '64 
James A. O'Neill Jr. ’59 
Gerard B. Odell '51 
John A. Ogden ’68 
Julius Anthony Olean ’23* 
Robert W. Ollayos ’41 
Nancy Olmsted '69 
Lowell E. Olson '54 
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Margot Onek ’68 
Gloria C. Onque '55 
A. Lawrence Ossias '65 
John C. Pace Jr. '55 
Sidney Nathan Paly '52 
George J. Pardos '75 
Robert Park '71 
John Curtis Parker '61 
Michael A. Parlato '08* 
Gioacchino S. Parrella "41 
John A. Patti '71 
George W. Paulson '56 
Arthur A. Pava ’51 
Norman E. Peatfield ’35 
Harvey Martin Peck ’53 
Alan S. Penziner ’77 
William E. Perkins ’67 
Richard E. Peschel ’77 
Robert H. Peters Jr. ’55 
Barbara Ann Peters ’79 
Leon A. Phillips ’52 
Stuart B. Phillips ’71 
Anthony V. Piccirillo ’54 
Julian 1. Pichel '49 
David Pickar ’73 
Robert L. Pickens ’65 
Michael C. Piercey ’71 
Olive E. Pitkin ’47 
Elaine Pitt ’61 
Ashley Pond 111 ’33* 
Frederick A. Post ’36* 
Majic S. Potsaid ’51 
William B. Pratt '64 
James D. Prokop ’59 
Richard D. Pullen ’54 
Stewart E. Pursel ’56 
Jacques M. Quen '54 
Tony Liebman Rakieten "29 
James R. Ralph ’59 
Jose Ramirez-Rivera ’53 
Barry S. Rand ’71 
Irving G. Raphael ’71 
David M. Raskind ’24 
D. Bradford Reich '86 
Clifford B. Reifler ’57 
Francis G. Reilly '46* 
Henry A. Riedel '43 
Samuel Ritvo ’42 
Richard S. Robbins ’72 
James S. Robertson ’73 
Gene A. Robinson ’65 
Joseph M. Rochford '69 
Lois Knight Rogers ’42 
Thomas J. Romano ’73 
Harry S. Romanowitz ’73 
Robert M. Rosa ’70 
Laurence G. Roth '44 
Alan A. Rozen ’37 
Daniel J. Rubin ’60 
Shaun J. Ruddy ’61 
Benjamin F. Rush Jr. ’48 
Carl M. Russell ’49 
Susan H.K. Ryu ’76 
Leonard B. Saltz ’83 
Gordon H. Sasaki '68 
Stanley G. Schade '61 
Gary L. Schaer '79 
Robert Lee Scheig ’56 
Alfred Q. Scheuer ’67 
Mary Wheatland Schley ’52 
Douglas R. Schmidt ’71 
Adrian M. Schnall '69 
Gerri A. Schulman ’80 
Donald H. Schultz ’52 
Marc D. Schwartz ’59 
John H. Seashore ’65 
Margretta Ann Reed 
Seashore ’65 
David M. Shames ’65 
Robert L. Shelton ’64 
Cynthia Anne Sherman ’79 
Donald William Sherrick ’56 
Charles E. Sherwood ’45 
Cynia B. Shimm ’50 
Jane B. Shumway ’50 
Leonard M. Silverman ’54 
Joseph F. Simeone ’73 
Richard Andrew Sinnott Jr. ’53 
Hillel D. Skoff’80 
Clement B. Sledge ’55 
Alfred Windsor Sloan '19 
Gerald J. Smallberg ’69 
John Smiarowski ’71 
Richmond W. Smith Jr. ’42 
Phillip W. Smith ’55 
Edward Lloyd Socolow ’58 
Robert T. Solis ’65 
Rebecca Z. Solomon ’39 
Sanford P. Solomon ’59 
Lewis S. Solomon '61 
Edward Hersey Soule ’43 
James P. Southwick ’71 
Gene W. Spector ’59 
Hilliard Spitz ’43 
James J. Stagnone ’59 
Nancy Ann Staley ’62 
Fred Stargardter ’60 
Robert L. Stein ’54 
Lisa A. Steiner ’59 
Larry Lee Stewart ’62 
Lyall C. Stilp II ’64 
John S. Strauss ’50 
Gary M. Strauss ’72 
Sidney Stringer ’33* 
Charles F. Stroebel ’73 
R. David Sudarsky ’49 
Edgar B. Taft ’42 
Priscilla Dienes Taft ’44 
Morris Tager ’36 
Paul Talalay ’48 
Lee Bland Talner ’63 
Igor Tamm ’47 
Caroline R. Taylor ’78 
Martin H. Teicher ’81 
Lawrence P. Temkin ’72 
Robert Tennant ’29 
Walter A.L. Thompson ’35 
Hugh C. Thompson III ’61 
Walter Clark Tilden ’12* 
Peter V. Tishler ’63 
Sigrid L. Tishler ’64 
Karen H. Toker ’67 
Franklin H. Top Jr. ’61 
Richard D. Travers ’71 
Ray W. Tripp III 70 
Patricia B. Tudbury ’47 
Maurice Tulin ’42 
Yvonne E. Vaucher ’71 
Martha Vaughan ’49 
Paul A. Vignola ’71 
Gary Vitale ’79 
Leo H. Von Euler ’59 
John W. Vosskuhler ’54 
Robert B. Vranian ’71 
Robert R. Wagner ’46 
John H. Wagner Jr. ’52 
Robert C. Wallach ’60 
William P. Walsh ’46 
Oscar Wand ’64 
May Yung-Fun Woo 
Wang ’60 
Steven L. Warsof 'll 
David E. Weaver ’61 
Stephen R. Webb ’69 
John J. Weber ’43* 
William J. Wedemeyer Jr. ’46 
Myron E. Wegman ’32 
Albert Carl Weihl’71 
Marc A. Weinberg ’73 
Robert G. Weiner ’65 
James L. Weiss ’68 
James G. Wepsic ’63 
Doris L. Wethers ’52 
Philip J. Weyman 'll 
Thomas J. Whelan Jr. ’46 
Malvin F. White ’39 
Alice A. S. Whittier ’25 
Per Henrik Wickstrom ’68 
Muriel D. Wolf’59 
John L. Wolff’52 
Irving Norman Wolfson ’42 
Edward M. Wolin ’74 
Howard Asa Wood ’25* 
Creed W. Wood ’68 
Jeffrey Work ’79 
Robert H. Wyatt ’43 
Ronald A. Yankee ’60 
Marc O. Yoshizumi ’70 
James Frederic Young ’53 
Ihor George Zachary '61 
Robert Zeppa ’52 
Harry M. Zimmerman ’27 




John M. Aversa 
Adel H. Ayoub 
Richard Allen Chase 
Stephen A. Edelstein 
Charles Farrow 
Louis B. Fierman 
Richard Webster Finner 
John W. Goldkrand 
Michael D. Heafner 
William H. Heydom 
Paul J. Jakubiak 
Clifford Joseph 
Eugene Kuchner 
W. Clark Lambert 
James B.D. Mark 
John P. McGovern 
H. Weston Moses 
Wilfred Raine 
Robert R. Rickert 
M. Peter Scibetta 
Daniel W. Shapiro 
Ethan A.H. Sims 
Carol Touloukian 
James S. Touloukian 
L. Newton Turk III 
PARENTS AND FRIENDS 
Chem Hsiung Lee 
Edward G. Lund Jr. 
R. Donald Reich 
Henry S. Sanematsu 
Maurice Hyman Shaw 
Leon G. Smith 
Prof. & Mr. Lubert Stryer 
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EPH Alumni Fund 
The names and data included on the following pages were provided by the 
Yale Epidemiology and Public Health Alumni Fund and reflect contributions 
made between July 1, 1991 and June 30, 1992. Posthumous donations are 
denoted by asterisk (*). 
EPH ALUMNI 
1921 




Alice S. Baldwin 
1930 




Miriam M. Campbell 
Eunice Nickerson Tyler 
1934 
Amy H. Hunter Wilson* 
Iwao M. Moriyama 
1935 
Franklin M. Foote 
Almeda King 
1936 




Willard H. Boynton 
Richard K.C. Lee 
Lucy S. Morgan 
Jean H. Nelbach* 
1939 
Carl I. Cohen* 
1940 
Meyer J. Plishner* 
1941 
Roslyn L. MacNish 
A. Helen Martikainen 




Henry F. Canby 
Leonard Parente 
Arthur B. Robins 
Charles D. Spangler 
1943 
Carolyn S. Koffler 
Eric W. Mood 
Miriam H. Rohde 
Jane L. White 
Muriel Bliss Wilbur* 
1944 
Massimo Calabresi* 
Jean F. Heston 
Jane Y. Parker 
Einar H. Raysor 
1945 
Roslyn R. Bilford 
Naomi Barer Golden 
Joe Bales Graber 
Lois M. Jund 
1946 
Dorothy B. Hamilton 
D. Patricia Nelson 
1947 
Sidney S. Chipman 
Anne E. Fulton 
Lillian L. Konick 
Jean M. Pinder 
Cecil G. Sheps 
Oscar Sussman 
1948 
John B. Dibeler 
Mary L. Ellis 
Samuel S. Herman 
Barbara L. Holman 
Richard E. Johnson 
Beatrice H. Kaasch 
Dorothea S. LaBelle 
Hiram Sibley 
1949 
Edgar L. Geibel 
Eleanor P. Kostant 
Edmund R. Mattos 
Christine R. Owre 
William B. Parsons 
Elizabeth D. Robinton 
Ernest M. Sable 
1950 
Dorothy Reese Bloomfield 
Ida M. Bucher 
Helen P. Cleary 
Austin J. Evans 
Dorothy R. Granoff 
Martha P. Jayne 
1951 
Joseph Axelrod* 
Clarissa E. Boyd 
Clarence William Bushnell 
Norton G. Chaucer 
Joanne E. Finley 
Florencia M. Herrera 
Homer P. Hopkins Jr. 
Robert L. Johnson 
Leonard F. Menczer 




Joanna Adele Henry 
Malcolm C. Hope 
Charles Holway Lawrance 
Sidney S. Lee 
Helen Kardys Loria 
Yolande F. Lyon 
Hannah Eileen MacHenry 
Richard B. Ogrean 




Laurence K. Rainsford 
Donald N. Zehl 
1954 
Calvin P. Hatcher 
Ruth M. Taber 
1955 
Amy L. Cawley 
Evelyn S. Farnsworth 
Morris London 
Mary Me C. Mogan 
Frances R. Ogasawara 
Gerald Rosenblatt 
1956 
David D. Boyd 
Lois Blatchford Fuller 
Kathleen H. Howe 
John E.Ives 
Paul I. Kaufman 
Julia R. Nole 
Mary K. Ochiai 
1957 
Anne M. Anzola 
William A. Clermont 
Edward R. DeLouise 
Sheldon Selig King 
Shirley T. Steidel 
Paul W. Stemlof 




Helen H. Davenport 
Thomas T. Flynn 
Normand E. Girard 
Patricia P. Grimaila 
Fred M. Haddad 
E. Field Horine Jr. 
Edward H. Noroian 
Joseph A. Scorpion 
Mary K. Spiker 
Robert Kenneth Wood 
1959 
William L. Kissick 
Marvin A. Lavenhar 
Lee J. Podolin 
John S. Pullman 
Ellwyn D. Spiker 
Mattie Lee D. Wade 
1960 
Bruce A. Barron 
Gyla E. Brooks 
Kathryn L. D'Amico 
Wouter Ekker 
Maxine Geeslin 
Rose A. Iannotta 
Katharine Anna Keppel 
John J. Kwasnowski 
R. John C Pearson 
Hannah Clark Russell 
1961 
Gordon R. Beem 
Martin Donabedian 
Yoh Ok Lee 
Helen M. O’Connell 
Margaret P. Parker 
Angela M. Russo 
William R. Slivka 
1962 
Thomas A. Blumenthal 
Thomas R. Mayhugh 
1963 
Hamp Coley 
Raul R. Cuadrado 
C. DuVe Florey 
Edward M. Kenney 
Jean M. Maynard 
Samuel B. Webb Jr. 
1964 
James J. Culhane 
John S.T. Gallagher 
Estelle Siker 
Monroe W. Spero 
Claudewell Sidney Thomas 
1965 
Robert M. Edwards 
Edgar W. Francisco III 
James F. Jekel 
Michael E. Kove 
Peter J. Levin 
Charlotte Miller 
Francia M. Pagano 
Norman R. Penner 
Elliot A. Segal 
Viola J. Spinelli 
Sarah L. Turner 
1966 
Allen Cohen 
Robert C. Lowrie Jr. 




Dennis J. Magid 
Patricia D. Mail 
James M. Malloy 
Charles J. Petrilio Jr. 
Nancy Ruth Phillips 
Bruce J. Steinhardt 
Irma Willner 
Robert L. Woodward 
Peter T. Wotton 
1968 
Doris Storms Brenner 
Sonia M. Colon 
Joseph L. Dorsey 
Elizabeth Schwartz Elliot 
Robert R. Everett 
L. Carol Femow 
Carl R. Fischer 
Michael J. Geaney Jr. 
Francis J. Greaney 
William D. Harkins 
R. Elizabeth Leif 
Harold C. Lovely 
Jean C. MacCorison 
Doreen P. Sharabati 
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Martha F. Steel 
Theodore H. Tulchinsky 
Elizabeth C. Wright 
1969 
Susan S. Addiss 
Janet A. Albrecht 
Victor Crown 
James M. Dawson Jr. 
Gerald R. Harpel 
Sylvia N. Holtzberg 
Charles C. Jeffrey 
Samuel P. Korper 
John N. Parker 
Marva Serotkin 
Wanda Vierthaler 
Carolyn K. Wells 
Chester W. Zamoch Jr. 
1970 
Susan W. Balter 
Katherine Benesch 
Arthur A. Berarducci 
Michael B. Bracken 
Hamilton B. Brown Jr. 
Shan Cretin 
Walter M. Gawlak 
Robert S. Gureasko 
C.P. Noel McCarthy 
Andrea W. Nevins 
Peter Orris 
Saro Palmeri 
Carol B. Phillipy 
Nancy Norton Reitz 
Stephen Skorcz 
Joseph A. Zaccagnino 
1971 
J. David Amundson 
John Bihldorff 
Evelyn J. Bromet 
Katrina H. Clark 
Karen S. Cohen 
John A. Daeley 
Harvey Fernbach 
Anne-Marie A. Foltz 
Wanda J. Hatmaker 
Mohamed Ismail Johnson 
Mark J. Magenheim 
Eugene S. Mayer 
Wan Hin Ooi 
Carol L. Paul 
Marcia Russell 
Jane Silver 
Robert E. Steele 
1972 
David P. Barone 
Michael L. Benjamin 
C. Gene Cayten 
Catherine A. Connolly 
Daphne deJ. Gemmill 
Susanne Harris 
Jean T. Harrison 
Dorothy N. Lewis 
Sergio Ruschel 
Jo Ann K. Silverstein 
Laurence A. Tanner 
Joyce R. Waksman 
From the EPH 
Alumni Fund Chairman 
As the newly appointed chairman of the EPH 
Alumni Fund, I acknowledge that I will have 
much to do to be as successful as the two prior 
chairmen, namely Kathleen H. Howe, M.P.H. 
’56, and Stephen Skorcz, M.P.H. ’70. How¬ 
ever, I pledge to do my very best to meet the 
challenges. 
In this difficult economy, the first challenge 
will be to restore alumni giving to its pre¬ 
recession level. In 1991-92, $137,953 was 
contributed, down from 1990-9l’s $140,247 
total. (Included in each of these years were 
installments on a one-time endowment gift of 
$100,000.) In 1991-92, 611 graduates made 
contributions, down from 654 graduates in the 
prior year. The participation rate in 1991-92 
was 25 percent, down from 28 percent in 1990- 
91. Despite this trend, 13 classes reached and 
surpassed their class goals. 
The overall fund goal for 1992-93 is to 
increase the contributions to $50,000, with at 
least 33 percent of graduates participating. This 
is achievable, but will require the diligence of 
class agents and cooperation of the graduates. 
In closing, I wish to thank those graduates 
who supported the Yale Epidemiology and 
Public Health Alumni Fund during 1991-92 and 
Eric W. Mood 
to invite others to join with us, your colleagues 
and classmates, in this important endeavor. 
Eric W. Mood, M.P.H. ’43 
1973 
Emily M. Barclay 
Eva Danielsson Cohen 
Bernice E. Coleman 
Ellen B. Doft 
James L. Mason 
Dennis P. May 
Dwight N. McNeill 
Marjorie E. Nelson 
Gary Dean Sax 
Janet B. Schoenberg 
Alice S. Stark 
Thomas J. Stranova 
Irene Trowell-Harris 
Larry S. Webber 
Bonnie C. Yankaskas 
1974 
Gregory Belok 
Thomas A. Benoit 
Ian B. Berger 
Beth G. Crocker 
Elizabeth M. Helming 
Roberta Lawrence 
Edward J. Mullen 
Heather Maycock Ogilvy 
Deborah Rose 
Abigail L. Smith 
Myrna M. Weissman 
Bienvenido G. Yangco 
1975 
Ralph E. Binder 
Gerald E. Bisbee Jr. 
Linda K. Broker 
Ann C. Cunningham 
Linda K. Demlo 
Jack A. Eiferman 
William J. Grego Jr. 
Donna Brown Grossman 
Anne H. Hall 
Barbara R. Unterman Jones 
Stuart L. Lefkowich 
Marsha Alex Lubick 
Hillary Demby Malafronte 
Laurence F. McMahon Jr. 
Mary W. Palshaw 
Edward V. Sargent 
Audrey Weiner Solomon 
Nancy E. Stroup 
Maura M. Tobin 
John H. Tobin 
Thomas J. Trudell 
Franziska U. Ulrich 
1976 
Elaine P. Anderson 
Rochelle Arcus-Ting 
Paul H. Etkind 
Robert H. Frazier 
Wendy Corn Friedman 
Annette B. Garofalo 
Gail lies Genvert 
Karen A. Gordon 
Robert T. Kauer 
Robert A. Knauf 
Janina Levy 
Lawrence V. Meagher Jr. 
Gino A. Nalli 
James B. Rokos 
Robert Risdon Schwarz 
Mary Jo Shepard 
Gladys A. Williams 
Thomas S. Wingardner Jr. 
1977 
Edward A. Bortnichak 
Richard B. Burford Jr. 
Patrick F. Carone 
Steven R. Cohen 
Gerard J. Foley 
Teri J. Klein 
Ronald F. LaPensee 
Robert Walter Makuch 
Polly W. Marvin 
Kristin K. O'Connor 
Veronica C. Oestreicher 
Harris Pastides 
Linda Mendelsohn Pottem 
Dorothy A. Rice 
Abby Rothschild 
Carroll Schilling 
Gail M. Sullivan 
Virginia R. Towle 
1978 
Kathleen M. Berman 
Ann T. Freedman 
Janice F. Gold 
Cynthia R. Gross 
Stephen W. Hildreth 
Nancy G. Hildreth 
Jane E. Hill 
David W. Houck 
Margaret Long Karis 
Rosalyn I. Liss 
John Mauro Jr. 
Robert K. McLellan 
Marguerite Nelligan 
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Patricia Lynn Noeker 
Peter F. O’Connor 
David W. Osborne 
Ellen J. Reifler 
Ellen D. Rothberg 
Karen C. Schneider 
Gloria Shappy-Meickle 
Marie Stoeckel 
Bernadette S. Vissani 
Lucy Ellen Weiger 
1979 
Bruce S. Anderson 
Virginia P. Bainbridge 
Gertrud S. Berkowitz 
Ralph J. Coburn 
Susan De Renzo 
Nurit Erger 
Elizabeth Feuer 
Laura Meisler Finkelstein 
Judith B. Gancher 
Shelley Helfer-Amira 
Karen G. Hellenbrand 
Joseph D. Henn-DeMayo 
Lucinda H. Hogarty 
Geoffrey P. Kane 
Phillip S. Katz 
Karen Kmetzo 
Benjamin Krevsky 
Renee S. Leary 
Mary Elisabeth Lorenzi 
Osvaldo Marrero 
Patricia J. Moore-Pastides 
Helen O’Brien 
Marcia C. Richardson 
Lisa Klar Rosenfeld 
George B. Rowland 
William E. Schweizer 
Audrey P. Silvey 




Phillip R. Aaron 
Frederick R. Aronson 
Diane Denis Aye 
Curtis S. Breslin 
Antoinette M. Brooke 
Gary L. Busack 
Barbara H. Granger- 
Russota 
Ellen B. Greif 
Samuel S. Hamilton 
James P. Harisiades 
Virginia S. Humphrey 
Helen E. Kelly 
Yee-Lean Lee 
LeRoy F. Ludwig 
Kristina Obom Maldarelli 
James S. Marks 
Jane Ungate O'Connor 
Ann L. Prestipino 
Jeri Ann Rose 
Susan L. Schwartz 
Lydia A. Selling 
Marsha L. Silverman 
Judith Stavisky 
R. Blake Whitaker Jr. 
Marie L. Zanotti 
1981 Marcia Lipkind Hirsch Marijane L. Carey 1988 
Christopher J. Bevan Sarah M. Horwitz Nancy E. Fithian Barbara Ellen Andrews 
Heidi Boerstler Mehrdad Jalali Stephen B. Gruber Robert Joseph Anthony 
Harold J. Burdo Jr. Jean G. Larson Roxanne Kapikian Ellen Sofia Bass 
Lionel K. Chadwick Cathy Nager Kenichiro Kato Elaine P. Berger 
Patricia J. Checko Grael M. O'Brien Wendy Lee Giselle Charlotte Bleecker 
Rollin C. Chew James H. Reich David C. Lowy Mark William Legnini 
Angelo J. Devita Dennis G. Shrauger Karen C.P. Milliken Carrie A. Redlich 
Judy E. Garber Robin Kupfer Spencer Bernadette M. Mosellie Shivarudrappa Satish 
Marie F. Gavula Gerald L. Springer Philip 0. Renzullo Lawrence Vincent Silvia 
Joan Urquhart Goodman Marie Ann Tobin Denise Amy Riedel Carol Ann Strycharz 
Susan E. Jennings Maria J. Schymura Howard S. Teitelbaum 
Cindy F. Kleiman 1985 Eric Triffin Lisa Wilson 
Thomas J. Krause Christine D. Berman Marie Irene Tsivitis 
Blackford Middleton Rene S. Cabral Lynn D. Wilson 1989 
Marlee D. Mooney Joan M. Cleary Linda F. Wood Christine Appel 
Barbara Gaugler Pennebaker Marjorie M. Eichler Judy Gardner Audette 
Frederick V. Peterson Jr. Jerald A. Fagliano 1987 Mary Beth Durkin 
Gerald W. Robinson Jr. Katherine Santella Hilda C. Chaski Elizabeth Harrison Hadley 
Elizabeth N. Shapiro Fitzpatrick Margaret D. Corbae Marcella Perez Jones 
Keith D. Tait Denise L. Jacobson Meg B. Domino Clifton Ping Lee 
Nancy Schlesinger Weiss Shirley J. Lee Bridgid M. Garrison Joanne Susan Mosca 
Kathleen R. Yager P. Douglas McConatha Sara A. Holdcroft Deena Beth Myers 
Rona Janis Mogil Timothy A. Jacobs Kenji S. Nakamura 
1982 Mary Ann Morreale Michael T. Koff Jr. David Dean Peete 
Jamie L. Amaral Mara Natkins Peter James Malloy Elizabeth Ann Platz 
Doris Gordon Marcia Shapiro Deirdre McDonald Robert P. Sbriglio 
Denise Heinemann James V. Soscia Barbara J. Moggio Joy Misako St. Germain 
Linda F. McCaig Heidi Roberta Sulis Maureen Brady Moran Sophie Helene Tworkowski 
William F. McKeon Anne Harmon Sweeney Joseph J. Napolitano Maureen McBride Whitehurst 
Tsuneki Mizuta Shirley J. Tirrell Elizabeth Rockwood 
David L. Mork Priscilla A. West Patterson 1990 
Carolyn Xavier Orcutt Terry Martin Zingman Lynn Pezak Malloy Sylvia Elaine Bailey 
Susan G. Rice Anita A. Roth Linda V. Bergonzi 
Michele T. Visconti 1986 Judith Natale Sabino Stanley Bernard 
Nancy K. Wander Andrea Lee Boissevain Robert J. Schwartz Andrew K. Bhak 
Sandra Michaelson Warren Lewis P. Bower Jr. Michael J. Testa Michael Anthony Carrozza 
Alvin C. White Louise M. Brenner Joel A. Wasserman Tina Chung 
Jill Okrent Zaheer Angela Colantonio 
1983 
Barbara W. Abraham 
Gail Alexander 
Lorraine DeNicola 
Robert A. Duncan 
Philippe Duprat 
Eileen McDonald Egan 
Susan Faris 
James N. Gaito 
Ellen M. Ginzler 
Margaret M. Kolb 
Allen F. Levy 
Wendy L. McGill 
Scott K. Mock 
Judith F. Nelson 
Jeannee Parker-Martin 
Barbra G. Rabson 
Nano G. Rush 
Paul M. Schur 
Russell W. Scott 
Elizabeth C.H. Stevenson 
Patricia C. Weber 
Nancy K. Wright 
1984 
Leslie A. Balch 
John R. Beecher 
Jean L. Freeman 
Laura D. Gibowski 
Carolyn H. Grantham- 
Millman 
Jennifer W. Hincks 
Cheryl Fattibene MacDonald 
Rebecca J. Mark 
Jennifer Jennings Miller 
Karyn J. Nair 
Al-Karim F. Rehemtula 
Brian Yong-Seop Shin 
Charles W. Tornatore 
1991 
Lisa A. Amerino 
Jennifer B. Bonney 
John P. Concato 
Maureen P. Corry 
Patricia J. DeFelice 
Robert B. Giallongo 
Katie B. Horton 
Timothy A. Jacobs 
Kathryn S. Katz 
Melanie Moses 
Jill M. Quinn 
Carole R. Robbins 
Louise P. Roumagoux 
Diane D. St. Pierre-Maston 
Charles W. Tornatore 
James Tsai 
Lucie L. Wilkins 
Patreece T. Williams 
FACULTY 
U. Robert Merikangas 
Arthur J. Viseltear* EPH Laboratory 
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Epidemiology and Public Health Alumni Fund Class Participation 
1990-1991 1991-1992 
CLASS AGENT TOTAL % PART. TOTAL % PART. 
1941 and prior Eric Mood $ 2,330 62 $ 3,903 44 
1942 Eric Mood 750 60 780 80 
1943 Eric Mood 176 30 271 40 
1944 Eric Mood 180 3 207 50 
1945 Stephen Skorcz 160 42 150 33 
1946 Stephen Skorcz 25 14 55 29 
1947 Stephen Skorcz 325 37 210 32 
1948 Samuel Herman 100,575 56 100.800 53 
1949 Edgar Geibel 450 35 485 35 
1950 Eric Mood 750 52 185 30 
1951 Robert Johnston 595 42 710 45 
1952 Yolande Lyon 1,100 44 1,180 37 
1953 Milton Sisselman 195 26 145 21 
1954 Eric Mood 25 7 40 14 
1955 Frances Ogasawara 340 50 280 43 
1956 David Boyd 390 42 365 37 
1957 Edward DeLouise 570 50 550 37 
1958 Philip Hallen 620 33 785 46 
1959 Dorothy Wilson 2,200 22 685 22 
1960 Gyl A. Brooks 625 48 1,400 43 
1961 Joseph Prekup 210 5 310 44 
1962 Thomas Mayhugh 150 20 
1963 David Dolins 49 32 515 33 
1964 Estelle Siker 625 23 560 23 
1965 675 34 575 38 
1966 Allen Cohen 160 12 125 12 
1967 James Malloy 1,650 34 1,045 30 
1968 Francis Greaney 960 36 1,335 40 
1969 Robert Young 2,097 38 1,300 33 
1970 Susan Balter 1,350 31 1,480 33 
1971 John Bihldorff 1,719 52 1,369 31 
1972 Dorothy Lewis 525 26 590 29 
1973 Gary Sax 1,085 27 920 27 
1974 Thomas Benoit 390 23 285 23 
26 520 26 
840 25 805 25 
1975 Linda Broker 1,568 35 1,168 28 
1976 Elaine Anderson 1,685 31 1,150 27 
1977 Dorothy Rice 1,050 25 635 21 
1978 Ann Freedman 1,145 26 1.190 26 
1979 Catherine Norton 670 34 545 26 
Ralph Tartagione 875 43 570 40 
1,545 39 1.115 33 
1980 Christina Quinn 1,320 32 1.040 24 
1981 Angelo Devita 565 25 575 20 
Barbara Pennebaker 350 43 395 44 
915 34 970 31 
1982 Constance Jarowey 255 12 125 5 
Jean Milton 560 35 490 30 
815 24 615 18 
1983 Jeffrey Hughes 315 17 515 19 
Marybeth McNerney 570 43 545 31 
885 30 1,060 25 
1984 Anthony Alberg 405 22 290 16 
Leslie Balch 330 16 230 19 
735 19 520 18 
1985 Joan Cleary 40 4 135 15 
Katherine Fitzpatrick 233 21 555 29 
273 13 690 22 
1986 Indu Ahluwalia 655 24 475 16 
Aric Wilt 430 28 595 25 
1,085 26 1,070 21 
1987 Hilda Chaski 740 29 485 18 
Elizabeth Wennar 225 IQ 295 16 
965 20 780 17 
1988 Joseph Della Puca 370 14 355 13 
1989 Joy St. Germain 455 18 405 16 
1990 Jennifer Miller 415 12 410 16 
1991 Patricia DeFelice 510 17 
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EPH Chairman’s Message 
This past academic year 
was one of many changes. 
The faculty, students and 
staff of EPH were saddened 
by the death of two long¬ 
time faculty members, John 
Thompson and Alberta 
Jacoby. As most of you 
know, John was a member 
of this faculty for more than 
35 years. During that time, 
he brought to this depart¬ 
ment outstanding scholar¬ 
ship, a sense of humor and a 
strong commitment to the 
education of students. 
Alberta Jacoby, a specialist 
in mental health education, 
a teacher and producer of 
film and video documentaries, had been on our faculty for 25 
years. She had an abundance of energy and enthusiasm that 
touched many of the faculty and students in our department. 
John and Alberta's friendship, leadership and their depth of 
experience will be greatly missed. 
In happier news, the School of Medicine’s appointment of 
Gerard N. Burrow, M.D., as its new dean is most heartening. 
In Dr. Burrow's inaugural speech to the medical school 
faculty, he indicated a strong commitment to public health at 
Yale. I look forward to a long and rewarding association with 
Dean Burrow. 
Notably, Dr. Burrow was with me on August 31 to 
welcome the new class of 85 M.P.H. students. This class is 
remarkable not only because of its large size but also because 
of its diversity. Included in its ranks are 12 physicians, two 
veterinarians, two lawyers and one Ph.D. There are 15 foreign 
students who hail from Taiwan, Canada, Switzerland, Colom¬ 
bia, Bangladesh, Singapore and Cameroon. 
Change also has marked our alumni fund leadership this 
year. I would like to extend a special thanks to departing 
alumni fund chairman, Steve Skorcz, M.P.H. ’70, who so ably 
served for the past two years. He did an outstanding job of 
keeping alumni and the class agents informed and involved. 
Taking on this mantle is Eric Mood, who has been a part of 
EPH for more than 35 years. You will be hearing from him in 
the months to come about our alumni fund effort, and I ask 
you to respond generously. Eric has set a goal of increasing 
our alumni participation to over 30 percent. These funds will 
support student financial aid and student projects. With our 
larger student body, there will be an ever increasing demand 
for these dollars. I applaud those of you who have donated to 
EPH this year, and encourage all of you to invest in our 
future—and the future of public health both in this nation and 
throughout the global village. Warmest regards. 
Burton H. Singer, Ph.D. 
Chairman and associate dean 
1991-92 EPH Distinguished Alumnus 
William L. Kissick 
M.D. ’57, M.P.H. ’59, Dr.P.H. ’61 
After studying at Yale for 12 years, you spent seven 
years in Washington, D.C., in various health policy 
positions, primarily in the U.S. Department of Health, 
Education and Welfare. You joined the faculty of the 
University of Pennsylvania in 1968 as the George Seckel 
Pepper Professor of Public Health and Preventative 
Medicine in the School of Medicine, professor of health 
care systems in the Wharton School, and chairman of 
the governing board of the university's Leonard Davis 
Institute of Health Economics. 
You have been an advisor or trustee of many national 
and international health organizations and a consultant 
to numerous corporations. Since graduation from Yale 
you have served on the Alumni Schools Committee, the 
board of directors of the Yale Club of Washington, D.C., 
as president of the Association of Yale Alumni in 
Medicine, on the development board, and as chairman 
of the alumni fund. Before being elected alumni fellow 
to the Yale Corporation in 1987, you served a six-year 
term as chairman of the University’ Council Committee 
on Medical Affairs. 
For your distinguished professional career and for 
your dedication to Yale University, its School of Medi¬ 
cine and to its department of epidemiology and public 
health, your alma mater salutes you. 
Dr. William L. Kissick 
Dr. Burton H. Singer 
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This is your invitation to take a closer look 
at the benefits of membership in The Yale 
Club of New York City. 
For close to a century, the Club has 
served generations ol Elis, their families and 
friends. 
After making eight million dollars of 
improvements over the past five years, the 
Yale Club is simply the best place in the City 
tor you to enjoy traditional club amenities at 
a most reasonable price. 
Whether you’re interested in 
comfortable overnight accommodations, 
professionally managed dining or meeting 
facilities, our wide range of athletic offerings or social events, the Yale Club offers 
you the warmth we’re famous for and the service you expect. 
Please take this opportunity to see for yourself how easy it is to join the 
Yale Club. Mail the coupon below and we’ll send you a membership application, 
our full-color brochure and our dues schedule. 
If it’s more convenient, call the Membership office at 212-661-2070 to 
request information or schedule a tour of the Club. 
Come get together with some old friends at the Yale Club. Send vour 
application by September 1st and, on admission, we’ll treat you to dinner for two 
in the Tap Room. We look forward to seeing you soon. 
D Yes, please send an application form and full 
the benefits of membership in the Yale Club. 
information about 
n 
Name (please print) Class & School 
Company 
Address Apt. or Suite 
City State Zip 
Mail to: Ms. Caral Craig, Membership Assistant of The Yale Club of New York City, 
50 Vanderbilt Avenue, New York, NY 10017 4 1 
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Child Abuse Issues and Dilemmas of the ’90s 
25th Anniversary of the DART Committee 
Director: John Leventhal, M.D. 
The DART Committee is a Yale-New Haven Hospital-based child protection team 
for detection, assessment, referral and treatment of children believed to be 
abused, neglected or at risk of maltreatment. 
Neuroimmunology for the Clinician 
Director: Timothy Vollmer, M.D. 
Sponsored by the department of neurology, Yale University School of Medicine, 
and the Connecticut Neurological Society. 
Immunocytochemistry & Cryosections: 
A Practical Course 
Director: Paul Webster, Ph.D. 
Small Incision Cataract Surgery 
Director: David Silverstone, M.D. 
Guest Speakers: Howard Fine, M.D., James Gill, M.D., Manus Krajf, M.D., and 
Sam Musket, M.D. 
Stouffer Hotel 
Westchester, New York 
The Role of Biological Response Modifers in 
Molecular and Clinical Transfusion Medicine 
Director: Edward Snyder, M.D. 
Stouffer Concourse Hotel 
Arlington, Virginia 
Second Anaesthesia & Critical Care Symposium 
Director: Sorin Brull, M.D. 
Sponsored by the department of anesthesia, Yale University School of Medicine, 
and Royal College of Surgeons in Ireland 
The Great Southern Hotel 
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YSM and the Community: Toward a Healthier Future 
The Children’s Hospital at YNHH: A Place of Their Own 
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The Mouse: From Mythology to Modern Medical Research 
In tracing the age-old relationship between man and mouse, Sara Rockwell, Ph.D.. 
explains how crucial these animals are to today’s medical research. 
Comparative Medicine at Yale 
Discover how this autonomous section at the medical school 
succeeds in both overseeing the University’s laboratory animal 
population and leading in medical and veterinary research. 
The Children’s Hospital: A Place of Their Own 
The new Children’s Hospital at Yale-New Haven — designed to embody caring 
pediatric medicine — reveals the symbiosis between YNHH and the medical school. 
YSM and the Community 
Although their efforts are not always trumpeted, medical 
school and EPH faculty and students are helping out in the 
New Haven community as never before. 
Asian-Americans Serve School, Community 
With the debut of Asian-Americans in Yale Medicine, a new 
medical student service organization, a large segment of the 
student body is discovering its voice. 
Some Ironies at the Interface of Medicine and Public Health 
Susan S. Addiss, M.P.H. '69, Connecticut's commissioner of health, reflects on the 
challenge of balancing the health of individuals and communities. 
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Emphasis on Prevention 
To the editor: 
Asa 1971 M.D. graduate, I just got my 
recent Fall/Winter issue of Yale Medicine. 
Since I also received a simultaneous 
M.P.H. from Yale and am currently work¬ 
ing at the Centers for Disease Control and 
Prevention. I was thrilled by the promi¬ 
nence that Yale Medicine gave to preven¬ 
tion-related activities. 
The article by Michael Bracken on pub¬ 
lic health challenges of the future was 
particularly timely. His analogy about 
how much more complex (socially, politi¬ 
cally, bureaucratically and even scientifi¬ 
cally) John Snow's job would have been 
if he were trying to remove the pump 
handle today is so true. The challenge to 
all of us attempting to train future health 
professionals is to provide them with the 
essential scientific and clinical skills nec¬ 
essary to assess problems and evaluate 
interventions, as well as the essential in¬ 
terpersonal skills necessary to get a "buy 
in" from whatever individual or commu¬ 
nity one is hoping to influence. 
The other areas of epidemiology and 
public health activity were also impres¬ 
sive. Whether it be Bob Shope's role in 
the most recent National Academy of 
Sciences report on the future of infec¬ 
tious diseases, the pivotal place of EPH 
in the article on laboratory medicine, or 
the different awards won by the mem¬ 
bers of the EPH department — all show 
the pioneering way in which the School 
of Medicine is incorporating the science 
base for prevention and public health 
(namely epidemiology) into training 
health care professionals of the future. 
Finally, I know the involvement of Gerry 
Burrow as an interface between the clini¬ 
cal and community aspects of the medi¬ 
cal school will lead to an even stronger 
partnership. 
Congratulations on this wonderful is¬ 
sue of Yale Medicine. I hope to see 
continued emphasis on epidemiology and 
public health in the future. 
Willard Cates Jr. 
M.D. '71 M.P.H. '71 
Atlanta 
1992-93 Association of 
Yale Alumni in Medicine 
Muriel D. Wolf. M.D. '59 
President 
Marie-Louise T. Johnson, M.D. '56 
Vice President 
Gilbert F. Hogan, M.D. '57 
Secretary 
Thomas P. Kugelman, M.D. ’60 
Past President 
Executive Committee 
Harold D. Bornstein Jr., M.D. '53 
Frederic K. Cantor, M.D. '62 
Leo M. Cooney Jr., M.D. '69 
Lycurgus M. Davey, M.D. '43 
Michael Kashgarian, M.D. '58 
R. Leonard Kemler, M.D. '43 
Michael H. Owens, M.D. '78, 
M.P.H. '78 
Gioacchino S. Parrella, M.D. '41 
Nicholas M. Passarelli, M.D. '59 
Barbara A. Ross, M.D. '8! 
Ex-officio 
Gerard N. Burrow, M.D. ’58 
Dean 
Arthur C. Crovatto, M.D. '54 
Director, Alumni Affairs 
John W. Poster Jr., M.D. '71 
Chair. YSM Alumni Fund 
Representatives to the 
Association of Yale Alumni 
John N. German, M.D. '62 
Martin E. Gordon. M.D. '46 
Benjamin E. Lyons, M.D. '38 
W. Scott Peterson. M.D. '71 
Robert M. Rosa, M.D. '70 
Andrew S. Wong, M.D. '51 
A YAM Representative 
Medical School Council 
Dorothea R. Peck, M.D. '43 
Editor’s Note: YM Readership Survey 
For more than 27 years, the staff of Yale Medicine has endeavored to produce a 
lively, informative publication for our alumni and other readers. Our goal has 
been to make each issue of the medical alumni bulletin a “visit to the School of 
Medicine,” so that you, our readers, can be kept abreast of the changes and 
accomplishments of this institution. We also hope to help graduates stay in touch 
regarding the careers of their Yale colleagues and friends. 
In recent years, Yale Medicine has grown in many ways, both in size and in the 
number of features that we offer, but our best measure of success is the response of 
our readers. So, to keep us on track and to help us plan future issues, we have 
composed a brief readership survey, found in the center of this issue. 
Won’t you please take a few minutes to fill out this questionnaire and mail it 
back to us? Your responses will help keep Yale Medicine an effective link 
between our readership and the Yale University School of Medicine. Thank you. 
Michael Kashgarian, M.D. '58 
Editor 
Yale Medicine Spring 1993 
Dr. Hirata’s Reunion 
To the editor: 
1 would like to share a personal anecdote 
that should be of interest to my fellow 
Class of 1945 graduates. It began at our 
1990 reunion, when Dr. Alice Shepard 
Cary returned from Kyoto. Japan, where 
she has been since 1947. None of us had 
seen her since she completed her post¬ 
graduate training, and it was wonderful 
to see her again. Moreover, her timely 
return coincided with my futile attempts 
to relocate my own “roots” in Japan, 
which were totally inaccessible since 
World War II in the face of the deter¬ 
mined silence of parents, embittered by 
those war years. 
On impulse, I sought Alice out and 
asked if there was any way she might 
suggest to pierce the curtain. As I knew 
she would, she eagerly picked up the 
challenge, and using her knowledge of 
Japanese, both written and oral, she 
tracked down the family name which 
had been in the medical field for some 
10 unbroken generations in the Fukuoka 
area of the island of Kyushu. Beyond 
that meager beginning, truly all that I 
could provide, she had to devise and 
improvise as best she could! 
Suffice it to say. within eight months, 
through multiple advertisements and 
written inquiries, particularly in medical 
journals, she found my relatives, an en¬ 
tire clan of Hiratas, headed by a cousin 
in general medical practice, with two 
sons in anesthesiology! 
In brief, I have just returned from a 
three-week sojourn in Japan, including 
an emotional family “reunion” with some 
40-odd relations, a visit to the family 
cemetery where 10 continuous genera¬ 
tions of physicians are interred, and an 
exhausting hike to the ruins of the clan 
castle of the late 1500s; truly an over¬ 
whelming emotional experience that has 
already begun to assume a dream-like 
quality! If it wasn't for the 100-odd 
photographs we have already filed so 
carefully in a precious album, I would 
not be able to convince myself that it 
really happened! 
And, despite the cynicism that sur¬ 
rounds the emotional content of any class 
reunion, be it high school, college, yes, 
even medical school, there is still this 
one thing, the reunion of fellow class¬ 
mates — and the true affection that such 
reunions reestablish. And. sometimes, 
just sometimes, help toward the fulfill¬ 
ment of a seemingly futile quest! 
lsao Hi rata Jr., M.D. '45 
Columbia, S.C. 
Dr. Langner Says Thanks 
To the editor: 
Regarding the alumni news article in the 
Summer 1992 Yale Medicine — Well 
done. 
1 should like to pay tribute to those 
who over the years here helped to keep 
me in touch, especially the New Haven 
chapter of the Hunter College Alumni 
Association and the Yale University 
School of Medicine Alumni Association. 
Thank you. 
Helen Parthenay Langner, M.D. '22 
Milford, Conn. 
Jack Maypole created the poster and program cover art for the Class of 1995's Second-Year Show, “Into the Wards, held on Feb. 26 
and 27 in Harkness auditorium. Cathleen J. Greenberg directed the production; Chip Skowron was producer. 
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The Mouse: From Mythology 
To Modern Medical Research 
by Sara Campbell Rockwell, Ph. D. 
Virtually everyone associates white mice with biomedical re¬ 
search. Most people do not realize, however, that laboratory mice 
are very special animals, with unique characteristics and with 
pedigrees that trace back more than 3,000 years. Some of these 
singular qualities have allowed laboratory mice to play a critical 
role in biomedical research projects spanning subjects from 
classical physiology to the treatment of cancer and diabetes, to 
the most erudite fringes of molecular biology and molecular 
medicine. 
People and mice have lived together since ancient times. Our 
English word “mouse” traces back through the Latin mus and 
Greek mys to the Sanskrit mush, derived from a Sanskrit verb 
> meaning “to steal.” This suggests that the habits of these little 
' rodents were familiar to the Indo-Europeans at least 6,000 years 
ago. Although we don’t know when people first began raising 
and studying mice, we do know that mice have been raised in both 
Europe and Asia for more than 30 centuries. 
In about 1,500 B.C. a Greek contingent from Crete was 
I victorious in battle against the Troad. According to Greek 
mythology, the army was aided in their victory by mice sent by 
the god Apollo. These mice entered the Troadian camp the night 
before the battle and chewed the leather thongs from the shields, 
rendering them useless. The victorious Greeks celebrated by 
building a temple on the island of Tenedos dedicated to Apollo 
Smintheus (Apollo, the god of mice). Similar temples were later 
built throughout Asia Minor and parts of Egypt. White mice 
raised under the altars in these temples were used in prophecy and 
for healing. 
We also know from Chinese and Japanese texts and paintings 
that mice have been bred for unusual coat colors and appearance 
in the Orient for many centuries. The Chinese character meaning 
“white mouse” is ancient, and the symbol for “spotted mouse” is 
present in the first Chinese lexicon, compiled in 1,100 B.C. 
Governmental records in China describe the discovery and col¬ 
lection of wild albino mice over 2,000 years ago. “Waltzing 
mice,” which run in circles, are also described in Chinese records 
dating back more than two millennia. The Japanese considered 
the mouse to be a wise creature which acted as the messenger to 
Daikoku, the god of wealth. The activities of mice raised in the 
temples of Daikoku were used to predict the success or failure of 
business ventures. 
Sara Campbell Rockwell, Ph.D., is a professor of therapeutic 
radiology at the School of Medicine and has an appointment in 
the Yale Comprehensive Cancer Center. 
Domesticated mice have been bred and raised in Europe and 
the Orient ever since these ancient times. Domesticated house 
mice and “fancy mice” with unusual characteristics appear in the 
art of both continents, not only as allegorical symbols, but also as 
part of the fabric of everyday life. Many literary works, including 
folk tales such as Cinderella and Beatrix Potter’s children’s 
stories, include mice as characters. The drawings and descrip¬ 
tions in these books show that the writers and artists were very 
familiar with the activities and varieties of domesticated mice. 
By the 17th and 18th centuries, the breeding of fancy mice had 
become a common hobby and a commercial enterprise. Mice 
were bred to have unusual coat colors including white, tan, 
yellow, chocolate and black, and to have patterns including spots, 
stripes and markings like those of Siamese cats. Breeders also 
raised dwarf mice, hairless mice, mice with kinked tails, and 
other unusual strains. Fanciers in Europe and the Orient ex¬ 
changed mice. Commercial mouse “farms” which raised and 
sold fancy mice of European, Japanese and mixed origins also 
appeared in America. 
The Development of Laboratory Mice 
The emergence of biology as an experimental science in 18th- 
century Europe heralded the use of the domesticated mouse as an 
experimental subject. In the mid-1600s, William Harvey’s 
fundamental studies of circulation and anatomy rested in part on 
studies of mice. Studies of respiration published by Joseph 
Priestley in 1775 and by Antoine Lavoisier in 1777 also describe 
experiments using these rodents. 
Some historians believe that one of Roman Catholicism's 
most famous monks, Gregor Johann Mendel, bred fancy mice in 
the mid-1800s, and that his laws of genetics were derived from his 
observations of the inheritance of coat colors in mice as well as 
his studies of pea plants. The existence of Mendel’s mouse 
research, however, was suppressed because of the prevailing 
view in the Church at that time, that the deliberate breeding of 
animals represented a usurpation of God’s power. 
With the rediscovery of Mendel’s laws in 1900, fancy mice 
became a primary tool for studying genetics. The animals’ short 
gestation time (21 days) and young age at sexual maturity (3 to 4 
weeks) made them admirably suited for studies of inheritance. In 
addition, mouse fanciers had already produced lines of mice with 
discernable inherited differences ranging from size, coat and eye 
color, to aggressiveness and other behavioral traits. Geneticists 
studied the inheritance of such traits and asked whether heritable 
traits could be “fixed” in mammals by inbreeding, as they were 
known to be in plants. 
Yale Medicine Spring 1993 3 
In the early 20th century, several fancy mouse breeders and 
geneticists noticed that the incidence of cancer varied dramati¬ 
cally in the different “families” of mice they were raising. Ernest 
Tyzzer also found that tumors could sometimes, but not always, 
be transplanted from one mouse to another. A number of 
geneticists and mouse breeders soon began to inbreed mice to 
produce uniform, genetically defined animals that could be used 
to study the relationship between genetics and cancer, as well as 
the genetics of tissue transplantation. The implications of these 
breeding programs have extended well beyond the field of cancer 
research, because they resulted in the development of the inbred 
strains of laboratory mice that are used throughout biomedical 
research today. 
Modern Laboratory Mice 
The unique characteristics of inbred mice have provided a price¬ 
less resource for 20th-century biomedical research. Each inbred 
mouse strain available today results from a deliberate breeding 
program spanning more than 50 mouse generations. At each 
generation, a brother-sister pair is selected for uniformity and for 
Although we don’t know when people first 
began studying mice, we do know that mice 
have been raised in both Europe and Asia for 
more than 30 centuries. 
the presence of the characteristics desired in the strain, and is bred 
to produce the strain’s next generation. The genetic composition 
of the resulting inbred mouse strain is very different from that of 
ordinary, randomly mated house mice. First, each strain of mice 
has been inbred for so long that the individual mice within a strain 
are genetically the same; in essence, they're all identical twins. 
The only major source of genetic variability among the mice is 
that between males and females, resulting from the difference in 
the information carried on the X and Y chromosomes. 
This homogeneity allows researchers to examine the effects of 
experimental environments or treatments with a precision not 
possible in a random population of genetically variable subjects. 
Inbred mouse strains also have allowed researchers from differ¬ 
ent laboratories around the world to study animals that are 
genetically identical. Using identical subjects, researchers can 
easily conduct tests to verify or build on one another’s results. 
In addition, inbred mice are uniformly homozygous; that is, at 
every gene, the copy inherited from the mother and the copy 
inherited from the father are the same. As a result, all of the 
recessive genes are expressed and the genotypes of the mice are 
thoroughly defined. 
These well-defined, genetically identical animals allow re¬ 
searchers to study phenomena that could not be discovered or 
examined in studies with more variable populations, including 
people. For example, we know from studies with inbred mice that 
X-rays can cause mutations in germ cells, which can lead to 
“Mice and Rice Bales, ” a Japanese painting of the Edo 
period attributed to Hokusai (1760-1849). 

























genetic changes and genetic disease in the offspring of the 
irradiated individuals. As a result of this knowledge, we take 
great care to minimize our exposure to ionizing radiations. 
By contrast, in human populations, the genetic variability, 
large number of deleterious recessive genes that occur naturally, 
and high background level of genetic disease prevent researchers 
from detecting or studying the genetic effects of radiation in 
people. Even very large epidemiological studies taking decades 
and costing millions of dollars — such as those performed on the 
atomic bomb survivors of Hiroshima and Nagasaki — have never 
revealed a significant increase in the incidence of mutations in the 
descendants of an irradiated human population. Everything we 
know about the genetic effects of radiation is extrapolated from 
studies with mice and with fruit flies. In these and many other 
ways, inbred mice play a critical role in studies aimed at protect¬ 
ing and improving human health. 
Laboratory mice also contribute to biomedical science through 
studies of their spontaneous mutations, which occur naturally in 
mouse breeding colonies. Mouse breeders watch carefully for 
such mutations, not only to protect the genotype of the strain, but 
also because these mutant mice ultimately may prove to be useful 
models for medical research. Careful observation of mouse 
breeding colonies has resulted in the identification of thousands 
of heritable mutations. 
Scientists have developed many inbred strains of mice carry¬ 
ing such mutations. Some of these strains have provided valuable 
models for human diseases including hypertension, diabetes, 
muscular dystrophy, immune deficiencies, auto-immune dis¬ 
eases and many biochemical defects. Research using these well- 
defined mouse model systems has been of tremendous value in 
identifying the biochemical, biological and genetic factors re¬ 
sponsible for diseases of humans and animals in finding ways to 
detect these diseases before they produce clinical symptoms, and 
in finding treatments. 
Gnotobiotic Mice 
The next chapter in the history of the laboratory mouse occurred 
not as a result of further defining the animal, but by defining its 
environment. Before the 1950s, studies using mice were plagued 
by infections. This problem was especially severe in large 
research institutions and medical schools. 
In such institutions, several factors — including the large 
numbers of mice arriving from many different outside locations, 
and the proximity of the animals to laboratory and clinical 
sources of infectious diseases — combined to produce frequent 
epidemics. Outbreaks of severe viral or bacterial diseases often 
destroyed valuable animal colonies and occasionally resulted in 
illness and even death among researchers. 
Less dangerous infections, with agents ranging from pin- 
worms to mycoplasma, had the insidious effect of perturbing the 
physiology and immune responses of the mice, thereby introduc¬ 
ing subtle variability into experimental results and errors into the 
interpretation of the data. For example, experiments in the 1970s, 
once thought to show that the transplantation of certain tissues led 
to immunosuppression, were later found to reflect infection of the 
transplanted tissues with immunosuppressive viruses. (Studies 
of these immunosuppressive retroviruses were of intellectual 
interest to molecular biologists and of practical importance to 
researchers using mice — they suddenly acquired new impact 
when the AIDS epidemic proved that analogous human 
retroviruses also existed and were hazards to human health.) 
Studies during the 1940s led to the development of techniques 
that could be used to maintain highly immunosuppressed human 
patients in isolation from a contaminated hospital environment. 
Breeders soon applied these techniques to mice. In the late 1950s 
and 1960s small colonies of “germ free” mice were derived by 
Caesarian section and hand raised in isolation in a sterile environ¬ 
ment, using sterile food and water. 
Today, most major breeding facilities use similar isolation 
techniques to maintain their mouse colonies. Because the com¬ 
plete absence of microbes produces unusual characteristics in 
tissues such as the intestine, lung and immune system, which are 
normally in direct contact with bacteria, most mouse colonies are 
deliberately inoculated with a defined set of nonpathogenic 
intestinal bacteria. 
Such mice, formally called “gnotobiotic" animals (from the 
Greek roots gnotos, meaning well-known, and biota meaning 
biological content), are colloquially known as “clean" mice. The 
use of clean mice offers many advantages to researchers. Be¬ 
cause all the animals are healthy, are uniform in their health 
histories, and are raised under relatively stress-free conditions, 
experiments using these animals are often more informative and 
precise than those previously possible using “conventional” 
mice. Researchers therefore can obtain the information they need 
using fewer experiments and fewer animals, and with less chance 
of unexpected illness to the mice. 
Immune-deficient Mice 
Another important development occurred in 1962, when mice 
bearing the “nude" mutation were first reported. While mice 
inheriting two copies of this mutant gene fail to grow hair, their 
most important feature is not baldness, but theirlack of a thymus, 
which results in severe defects in cell-mediated immunity. Nude 
mice and other immune-deficient animals can be raised only 
under scrupulously “clean” conditions, because they cannot 
defend themselves against infections. 
Other immune-deficient mice, with different or multiple im¬ 
munological defects, have been developed more recently, includ¬ 
ing the severe combined immunodeficiency (SCID) mouse, with 
multiple, severe immunologic defects. These immune-deficient 
mice have been of tremendous value in helping immunologists to 
unravel the workings of the immune system. Research with these 
animals also has been of great importance in improving the lives 
of children born with immunologic defects and in attacking the 
problem of AIDS. Nude mice are also of value because their 
immunologic defect allows them to accept transplants, not just 
from closely related mice, but also from unrelated mice or even 
from other species, including man. Scientists inoculate nude 
mice with human tumors to study the biology of human cancers 
and to identify and develop new treatments for cancer. SCID 
mice reconstituted with human immune tissues are proving to be 
of great value to research on AIDS. 
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Chimeric, Transgenic and Knockout Mice 
In the 1950s, Beatrice Mintz, a geneticist at the Institute for 
Cancer Research in Philadelphia, and her collaborators developed 
techniques for producing “chimeric” mice. Like the fire-breath¬ 
ing chimera (kai-MARE-uh) of Greek mythology, which was a 
composite of a lion, a goat and a serpent, these laboratory animals 
too are mosaics. Although modern chimeras, gratefully, are not 
incendiary, different parts of their bodies do comprise genetically 
distinct cell populations of different origins. 
Scientists produce chimeric mice by isolating two early mouse 
embryos (for example, at the 8-cell blastula stage), gently disso¬ 
ciating the embryos into individual cells, then allowing the cells 
of two embryos to reaggregate into a single, 16-cell embryo. This 
embryo is then transplanted into the uterus of a foster mother and 
allowed to develop. The resulting mouse pup will be a mosaic, 
with some areas and some tissues derived from one embryo and 
some derived from the other. A chimera between an albino mouse 
and a black mouse, for example, has black and white stripes. 
The techniques used to produce chimeric mice have been 
combined with molecular biology techniques to produce 
Sara Campbell Rockwell, Ph.D. 
Sara Campbell Rockwell, Ph.D.: 
Cancer Researcher, Educator 
Sara Campbell Rockwell, Ph.D., is a professor of therapeu¬ 
tic radiology and has an appointment in the Yale Compre¬ 
hensive Cancer Center. Her research examines the biology 
of cancer and attempts to develop better regimens for 
treating cancer. This research includes studies with labo¬ 
ratory mice as well as experiments with cell cultures and 
subcellular systems. Dr. Rockwell lectures on her area of 
research to scientific and medical groups and also speaks on 
the biomedical research process to school and community 
groups as a volunteer for CURE, Connecticut United for 
Research Excellence, Inc. 
“transgenic” mice, which carry a foreign gene. In this process, 
scientists use molecular biology techniques to insert a copy of a 
foreign gene into the DNA of undifferentiated embryonic mouse 
cells. These cells are then selected in cell culture to obtain cell 
lines that contain and express the desired gene. Researchers 
insert these “transfected” cells into mouse blastulas to form 
chimeric embryos, which are then transplanted into a foster 
mother and allowed to develop. 
Some cells and tissues of the resulting mouse pups will 
express the transfected gene. A mouse transfected with the 
human gene for hemoglobin, for example, might have some red 
blood cells producing human hemoglobin. If the transfected 
gene is present in the eggs or sperm, the mouse can be bred to 
begin a strain of mice which all express this gene. Transgenic 
mice are proving useful in studying the cellular, developmental 
and physiological effects of normal or abnormal human genes. 
Transgenic animals may eventually prove to be useful as sources 
of “human” hormones, such as human insulin or human growth 
hormone, which are needed to treat diseases. 
“Knockout” mice are the genetic opposites of transfected 
mice. These mice are produced using similar molecular biology 
methods; however, instead of adding a gene, researchers use a 
process called homologous recombination to inactivate, or knock 
out, a specific gene. This can be done without knowing either the 
function of the gene or the protein it encodes. Researchers then 
breed chimeric mice expressing the defective gene; if the altered 
gene is present in the germ cells, a strain of mice carrying the 
defective gene can be produced. 
Knockout mice have already proved to be of great value in 
studying the development of the immune system and in examin¬ 
ing the regulation of embryonic development. Researchers 
studying cystic fibrosis are optimistic that knockout mice will, 
for the first time, provide an animal model in which to study the 
biology of this disease and in which to test potential treatments 
before trying them on sick children. Although developed only in 
the mid-1980s, it is already clear that knockout mice will play a 
major role in the research of the 21st century. 
Today’s laboratory mice are very special creatures, with 
unique characteristics that are of tremendous value to modern 
biomedical research. While it is in vogue in some circles to speak 
of “animal research” as obsolete, as though the future lay entirely 
in the realm of computer modeling and molecular biology, the 
truth is that this “new biology” requires information that can only 
be obtained from studies using living animals. The modern 
laboratory mouse continues to play a central and critical role in 
molecular biology and molecular medicine, just as the fancy 
mice studied by Mendel, Lavoisier and Harvey played a critical 
role in the fundamental biological studies of the 18th and 19th 
centuries. 
What does the future hold for laboratory mice? It's impos¬ 
sible to say. Researchers 25 years ago would not have envisioned 
the scientific and medical horizons opened by the development 
of transgenic mice and knockout mice. We can only predict that 
these and other modern laboratory mice will continue to be 
essential in research aimed at improving the health and welfare 
of both people and animals. YM 
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Comparative Medicine at Yale: 
Service, Research and Teaching 
by Sandra J. Ackerman 
It’s an ordinary weekday morning, and here at Yale, as in medical 
facilities all over the country, the health-care personnel are 
making rounds. In this quiet corridor, three or four white-coated 
specialists make their way from one room to the next, monitoring 
patients with a practiced eye. They draw a small amount of blood 
for scheduled tests, compare yesterday's careful records with 
i today’s observations, and prepare to summarize the results for I consultations with colleagues later in the day. 
One aspect of these rounds, however, might strike a casual 
observer as unusual: Most of the patients are small, furry and 
four-footed, and their care givers work for the veterinary clinical 
services unit of the School of Medicine’s section of comparative 
medicine. 
Our Subjects Are Legion 
On a typical day across Yale University, some 20,000 animals 
figure in a wide range of biomedical research — from studies in 
preventive and therapeutic medicine to basic biology and behav- 
ior. While these animals comprise a veritable Noah’s Ark, from 
the fruit fly and humble sea slug to colonies of sheep and 
chimpanzees, a large majority, more than 90 percent, are rodents, 
mostly laboratory mice and rats. 
Although most research involving animals is conducted at the 
medical school, the veterinary clinical services unit sees to the 
continued care of the University's laboratory animals no matter 
where they may be housed. But the scope of comparative 
medicine extends well beyond such specialized care. The section 
also is a leader in the postgraduate training of comparative 
medicine scientists and conducts its own research. 
Robert O. Jacoby, D.V.M., Ph.D., professor and chairman of 
comparative medicine, explains how these three areas mesh: “To 
understand the service component, we look at comparative medi- Icine as a group of veterinary specialists — all of whom have 
advanced degrees and board training in their specialties — who 
protect the animals used in research at Yale, and who advise 
investigators. A second component is teaching, particularly at 
the postdoctoral level, through our National Institutes of Health- 
funded training program in comparative medicine.” 
Sandra J. Ackerman is a free-lance writer living in New Haven. 
Her book, Discovering the Brain, was published in March 1992 
by the National Academy Press; her article “Rare Disease 
Research: The Road Less Traveled” appeared in the Fall/Winter 
1992-93 issue of Yale Medicine. 
Dr. Eleanor C. Weir exanunes a breeder rabbit. 
Regarding research, the third component, “There is a signifi¬ 
cant body of work that pertains directly to human health, and 
another body that pertains to the health of laboratory animals that 
are used to study human health.” Through these studies the 
section has made important contributions to both animal and 
human health. 
With nine ful 1-time faculty and the same number of postdoctoral 
fellows, comparative medicine is the standard size for a free¬ 
standing section within the medical school. In terms of funded 
research, the section boasts a grant portfolio exceeding $2 mil¬ 
lion, primarily from the National Institutes of Health (NIH). 
Comparative medicine’s leading role in Lyme disease re¬ 
search illustrates the quality and depth of the studies that take 
place within the section. The mere thought of the tick-borne 
bacterium keeps many lovers of the outdoors on edge throughout 
the summer in the continental United States, with the disease's 



















Section of Comparative Medicine 
Offers Direct Veterinary Services 
Direct veteri nary service to the hundreds of scientists at Y ale who 
do research involving laboratory animals also comes under the 
aegis of the section of comparative medicine. Much of this 
responsibility falls on the shoulders of David G. Brownstein, 
D.V.M.. professor of comparative medicine and chief of the 
section's pathology unit. 
As Dr. Brownstein explains, “The unit offers diagnostic 
support for ongoing health management for the University's 
laboratory animals. We interface constantly with Veterinary 
Clinical Services.” 
Dr. Brownstein and Stephen W. Barthold. D.V.M.. Ph.D., 
professor of comparative medicine, provide the professional 
support to four technical-level employees who work in the 
necropsy, histology and microbiology laboratories; viral serol¬ 
ogy is a separate unit with Abigail L. Smith, Ph.D., professor of 
comparative medicine and epidemiology, serving as chief. 
The pathology and virology units monitor the health of rodent 
colonies University-wide through a sentinel program designed to 
detect the presence of infectious agents. In addition, the pathol¬ 
ogy unit attempts to determine the cause of unexplained illnesses 
or deaths of animals submitted by Veterinary Clinical Services. 
(From left) Research associates Fu-Chen Yang and Gordon 
Terwilliger receive a lesson in examining a laboratory mouse 
from Dr. David G. Brownstein. 
Infectious disease outbreaks, such as those caused by STAD 
(sialodacryoadenitis) virus in rats and Sendai virus and mouse 
hepatitis virus in mice, do occur despite stringent, ongoing 
efforts to prevent them. 
Says Dr. Brownstein, “Prompt diagnoses are essential to 
institute control measures and minimize spread.” 
well-publicized symptoms ranging from skin rash and fatigue to 
nerve or joint disorders and inflammation of the heart. 
Named for Old Lyme, Conn., where the disease was first 
identified by Yale researchers in 1975, Lyme disease has since 
been found in almost every part of the Lower48, with 8,000cases 
reported in 1990. In most cases, antibiotics prove an effective 
means of treatment; early diagnosis or, ideally, prevention con¬ 
tinue to pose a challenge for the medical community. 
The section of comparative medicine has advanced research 
on both these fronts by developing an animal model for Lyme 
disease. In such a research model, scientists develop an animal, 
through breeding or genetic manipulation, that is susceptible to 
the target disease. Because the animal is affected by the disease 
in ways similar to humans, it offers scientists a unique opportu¬ 
nity to study the natural course of the disease and pursue a 
treatment or vaccine. 
Stephen W. Barthold, D.V.M., Ph.D.. professor of compara¬ 
tive medicine, explains that the search for an animal model for 
Lyme disease involved several stages. Early work, which fo¬ 
cused on rabbits, met with limited success. Later. Drs. Jacoby and 
Barthold found a better model in a strain of laboratory rat. 
Finally, the model came to fruition, as Dr. Barthold explains: 
"I like mice. And the reason I like mice is that the genetics of the 
mouse are probably better known than those of any other animal, 
and many highly specialized strains of mice are available.” 
This allows researchers to draw their lines of inquiry quite 
speci fically, without concern, for example, that the findings on an 
infectious disease may be complicated by allergies, increased 
resistance or other distorting health factors that a non-inbred 
individual might be carrying. Moreover, inbred mice, being 
genetically identical, offer researchers a plethora of advantages 
over other animal populations as experimental subjects. [See 
"The Mouse: From Mythology to Modern Medicine,” Page 3.] 
The current Yale model for Lyme disease is a type of inbred 
mouse which, when infected with the disease-causing spirochete 
Borrelia burgdorferi, develops arthritis and heart inflammation. 
Importantly, these symptoms can be measured in mice, unlike the 
more subtle effects of Lyme disease, such as fatigue. Dr. 
Barthold and colleagues have identified two inbred strains of 
mice, one showing severe Lyme disease, the other a milder form. 
By comparing the two strains genetically, the researchers can 
explore why the two kinds of mice have different levels of 
susceptibility. 
The Yale researchers are also using the mouse model to test a 
Lyme disease vaccine. This work illustrates how well compara¬ 
tive medicine lends itself to interdisciplinary research: Fred S. 
Kantor, M.D., the Paul B. Beeson Professor of Medicine, has 
brought his expertise in immunology to the vaccine research 
team, while Howard Hughes Medical Institute investigator Rich¬ 
ard A. Flavell, Ph.D.. professor and head of immunobiology, and 
Erol Fikrig.M.D., assistant professor of medicine (rheumatology), 
added their expertise in recombinant genetics. 
Vaccine research also has opened up the door to industry 
collaboration: The Lyme disease vaccine, which uses the spiro¬ 
chete's outer surface proteins A and B as antigens, has been 
licensed to SmithKline Beecham, which has begun clinical trials. 
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Healthy Animals Yield Valid Data 
Dr. Barthold, who is a comparative pathologist, unites several 
interests in his research on infectious diseases — particularly on 
the pathogenesis of diseases that are natural to laboratory mice. 
Such diseases, he points out, introduce an intervening variable 
that can distort or even invalidate a researcher’s data, perhaps 
ruining months or years of work. 
For 18 years. Dr. Barthold has studied mouse hepatitis, a 
common ailment. “This is not like human hepatitis at all,” he 
explains. “If anything, it’s more like the common cold.” What 
merits his and other researchers’ serious attention, however, is 
that mouse hepatitis virus interferes with the immune system. 
Since the mouse is often employed as a model of the human 
immune system, researchers have a strong incentive to under¬ 
stand and, if possible, counter this highly infectious disease, 
which has an impact on immunological research. 
Working with Dr. Barthold in combating mouse hepatitis is 
Abigail L. Smith, Ph.D., professor of comparative medicine and 
epidemiology, who is chief of the virology unit in comparative 
medicine. Dr. Smith is intrigued by the population dynamics of 
this disease in laboratory colonies. Its spread, by a virus, is rapid 
— "almost explosive, when introduced into a new room,” she 
points out. Some estimates suggest that up to 85 percent of 
laboratory mice in North America and Europe may be infected. 
Dr. Robert O. Jacoby 
Some standard laboratory practices actually facilitate the 
spread of the disease. For instance, the usual age for ordering 
mice is three to four weeks, which means that the new arrivals are 
introduced to a novel environment just as the immunity they have 
received from their mothers is beginning to wane. Moreover, 
with new mice brought in weekly, the hepatitis virus continu¬ 
ously has a fresh population on which to prey, and never is in 
danger of dying out. 
What makes the mouse hepatitis virus particularly insidious is 
that it often operates on a subclinical level, producing no symp¬ 
toms, but disrupting the immune system nevertheless. Dr. Smith 
has found that the subtle virus does not kill a significant number 
of immune cells, but greatly reduces their effectiveness. 
“Among those hardest hit are the T-cells, which when primed 
can act as 'killer cells,”’ she says, to fight infections. “During the 
acute phase of mouse hepatitis infection, the function of the T- 
cells is reduced to 1 or 2 percent of normal levels. Instead of 
proliferating and producing cytokines, they just sit there." 
In other words, although the T-cells are activated as killer cells 
to respond to the virus, these immune cells are unable to go on and 
clear the body of infection. Hence, a researcher’s best bet is to be 
on guard against the infection in the first place. For this. Dr. 
Smith has developed a sensitive blood test which the animal care 
division regularly uses to screen Yale colonies. 
Such preventive measures underlie “the principle of herd 
health,” explains Eleanor C. Weir. B.V.M.S., associate professor 
of comparative medicine and chief of the section’s veterinary 
clinical services unit. “For rats and mice, the emphasis is on 
monitoring the populations’ overall health. For larger animals — 
we have some dogs, cats and non-human primates -— we take 
preventive measures, as well.” 
For the non-human primates, these measures include vaccina¬ 
tion against measles, and testing for tuberculosis three times per 
year, as well as testing and treatment for intestinal parasites. 
When a research unit at Yale receives primates from outside the 
University, the animals are quarantined for at least eight weeks 
and must clear several tests for tuberculosis, parasites and bacte¬ 
rial infections before joining the home colony. 
Much of the monitoring and the routine preventive medicine 
is the responsibility of the unit’s six veterinary technicians. With 
a degree in animal science or a related field, “most of these people 
have been here a long time,” Dr. Weir emphasizes: the two 
supervisors. Gail Cameron and Susan Morganstern. R.N., each 
have been on the job at Yale for more than 15 years. “All our 
technicians are very loyal and very dedicated to the humane 
treatment of animals,” she adds. 
The three clinical veterinarians rely on the technicians for day- 
to-day reports and oversee the care of sick animals, stepping in if 
unusual problems arise. Newest addition to the veterinary team 
is Joe Scott. D.V.M., an assistant professor who arrived from 
Harvard in July 1992 to work as assistant director of the division 
of animal care. This expert in husbandry, facilities management 
and planning also brings his experience in federal regulations 
regarding animal welfare. 
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A Bridge to Medicine 
When Dr. Weir is not troubleshooting for the animal colonies — 
which occupies about half her time — she conducts research into 
human disorders of bone metabolism, especially osteoporosis. In 
collaboration with endocrinologist Karl L. Insogna, M.D., asso¬ 
ciate professor of medicine, she is examining the role of a locally 
acting protein, macrophage colony-stimulating factor (M-CSF), 
in bone resorption. Drs. Weir and Insogna have demonstrated that 
certain bone cells produce M-CSF, and that this may contribute to 
bone loss in post-menopausal women. 
Dr. Weir also collaborates with colleagues on research into a 
disorder that causes high blood calcium in some cancer patients. 
Known as humoral hypercalcemia of malignancy (F1HM), this 
disorder can cause kidney damage, coma and even death. 
Identifying the protein, PTHrP (parathyroid-related protein), 
that is responsible for the disorder were Arthur E. Broadus, M.D., 
professor of medicine and of molecular and cellular physiology, 
along witli Andrew F. Stewart, M.D., chief of endocrinology at 
the Department of Veterans Affairs Medical Center in West 
Haven, and researchers at two other laboratories. Dr. Weir has 
joined Drs. Broadus and Insogna, initially in characterizing ani¬ 
mal models for HHM and later in studying the protein’s role in 
normal physiology. 
Since PTHrP is present in many normal tissues — in the uterus 
of the pregnant rat, for instance, as well as in the rat’s central 
nervous system — the researchers hope to identify the role of the 
protein in these locations. This work now relies mainly on tissue 
cultures in established rat cell lines, says Dr. Weir. 
Most other scientists in the department still require animal 
models for their primary research. For example, Lisa Ball- 
Goodrieh, D.V.M., a postdoctoral fellow in comparative medi¬ 
cine, studies parvoviruses, a family of small DNA viruses, each of 
which affect a different species. Parvoviruses introduce a signifi¬ 
cant health factor into any laboratory that houses animals, because 
the microbes spread easily among animal colonies. Like mouse 
hepatitis virus, parvoviruses can undermine the validity of re¬ 
search on the immune system. 
Quite apart from the threat they represent, however, 
parvoviruses interest researchers because their genome (their full 
complement of DNA) is small enough to be manipulated in 
various experiments. This makes it possible to identify the 
specific regions of DNA that are important for the pathogenesis 
of viral diseases that affect the mouse. “I’m trying to understand 
the molecular virology of these viruses and how they interact with 
host cells,” says Dr. Ball-Goodrich. 
Research into parvoviruses does not simply benefit rodents, 
however. In humans, parvovirus B 19 causes a rubella-like rash, 
sometimes called the “fifth disease” of childhood. As with the 
other four standard childhood diseases, measles, chicken pox, 
rubella and the mumps, fifth disease usually poses a far greater 
threat to adults than to children. 
Like rubella, fifth disease can harm a pregnant woman's fetus; 
in people with sickle-cell anemia, parvovirus BI9 can cause 
aplastic crisis — a dangerous drop in the level of red blood cells. 
Because B19, the human parvovirus, is difficult to grow in tissue 
Dr. Stephen W. Barthold 
culture, rodent parvoviruses may serve as an animal model in 
which to explore some aspects of B19 infections. 
Here again, the mouse is the animal of choice. Dr. Ball- 
Goodrich’s approach involves using two strains of mouse 
parvovirus; of these, one grows in tissue culture, the other does 
not. From the culture-adapted strain, she has isolated the 
parvovirus’s DNA directly. The next step, cloning and sequenc¬ 
ing the DNA, has been highly informative, she says. "Because 
I’ve determined the genetic information of the virus that will 
grow in tissue culture, we can compare it to the other rodent 
parvoviruses. This gives us an initial explanation of why the 
pathogenesis of each virus is different in the mouse.” 
Dr. Ball-Goodrich says she values the opportunity to work 
both with tissue culture systems and with animal models: “To my 
mind, one important aspect of this section is the studying of 
viruses in vivo. Tissue-culture studies give good answers in a 
simple host-virus interaction, but so many different factors are at 
work in an animal that in order to understand a disease you must, 
at some point, study it in its natural environment” — a live, whole 
biological system. 
Postdoctoral fellow Carol Nielsen, D.V.M., brings to com¬ 
parative medicine her own brand of experience with live animals, 
having worked for several years as a wildlife disease biologist for 
10 Yale Medicine Spring 1993 
Dr. Abigail L. Smith 
the Alaska Department of Fish and Game. She says that this 
background, hardly standard for a Yale biomedical researcher, 
has served her well. 
She comments with a smile, “Most veterinarians would come 
here with more of a background in dogs and cats, and not so much 
in reindeer and moose. But these types of wildlife actually have I a lot in common with lab animals.” She cites, for example, her 
own doctoral project, which involved studying parasitic stomach 
worms in laboratory rabbits as a model for such worms in 
reindeer and in commercial livestock. 
"There are common parasites that inhabit all grass-eating, 
cloven-hoofed animals, including ruminants such as sheep and 
cows,” adds Dr. Nielsen. “Because the parasites are difficult and 
expensive to eliminate, we're looking for ways simply to mitigate 
their effect on the host animal.” 
Detective Work 
Dr. Nielsen’s postdoctoral fellowship, funded by the National 
Institutes of Health, represents an NIH initiative, in her words, “to 
encourage more research training for people who want to enter 
laboratory animal medicine, and not just make them policemen 
for other people’s use of animals.” 
Thus, she and two other postdoctoral fellows in the section, 
working under the supervision of three clinicians board certified 
in laboratory animal medicine, provide medical care for the 
University’s animals. They often find themselves consulted as 
health detectives when a scientist encounters unexpected results 
in his or her research animals. 
“They'll call us when something that they consider unusual 
comes up,” says Dr. Nielsen. “Researchers have a mental 
checklist of questions: 'Is something wrong with my antigen or 
my new equipment? Is there a new technician? Maybe there's 
some problem with the research methods.' After this, they' 11 ask, 
‘Could there be a problem with the animals?”’ 
In some intriguing cases, for example, with a new or highly 
specialized strain of mice, a researcher calls to report that the 
population is not reproducing at its normal rate, although other¬ 
wise the animals seem to be healthy and behaving normally. 
"These are the more subtle problems,” says Dr. Nielsen. "It's 
not like treating a dog whose leg has been broken in a car 
accident.” 
She adds that such cases, where the challenge lies as much in 
identifying the problem as in resolving it. also have theirparallels 
in the wilds of Alaska: “Quite often when I was at Fish and Game, 
a biologist would come in and say something like, 'In this area in 
the Dry Creek drainage, lamb production is down over a period 
of several years.’ So we have, again, a sleuthing problem. You 
have to look among the animals for signs of possible problems — 
parasites, various diseases, tumors — until you arrive at the 
culprit.” 
The broad approach at comparative medicine, and the strong 
interdisciplinary network within which the section operates, 
attracted Dr. Nielsen to the program. “What I was looking for. 
and I believe I’ve found,” she says, “is a situation where experts 
can communicate and everybody benefits.” 
Dr. Brandsma ’v approach — using both cell 
cultures and an animal model — has proven 
effective in researching cervical cancer. 
Another specialist whose work benefits from such communi¬ 
cation is molecular virologist Janet Brandsma, Ph.D. An assis¬ 
tant professor in comparative medicine and epidemiology. Dr. 
Brandsma is developing an animal model to study 
papillomaviruses. These viral infections can cause many types of 
warts, but each strain affects only specific tissues of one or 
another species. In humans, various papillomaviruses cause 
common warts, plantar warts and genital warts, the last of which 
are sometimes associated with cervical cancer. 
"Cell-culture systems do not show the pathogenicity of a 
virus,” Dr. Brandsma explains, “so we are studying a 
papillomavirus in a rabbit model.” Using molecularly cloned 
DNA, she and her collaborators can make mutations in individual 
genes, then observe the results in the rabbit model. 
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Comparative Medicine Leads 
Medical School in Gender Equity 
Comparative medicine’s strength in research support and 
in its rich interdisciplinary network complement another 
area of the section’s leadership — the full participation of 
women at all levels of professional activity. Of nine full¬ 
time faculty, five are women, as are a similar number of 
postdoctoral fellows. 
In addition, as pointed out by Abigail L. Smith, Ph.D., 
chief of the virology unit in comparative medicine, “Our 
business manager is a woman, and so is our facilities 
manager.” She adds that full participation by women is 
“just not an issue in this section.” 
A member of the University’s Committee on the Status 
of Women. Dr. Smith thinks the advances at comparative 
medicine have two components. One is the great increase 
in numbers of women entering veterinary medicine. 
"Twenty years ago, if you had one or two women in an 
entire class, that was considered a lot,” she says. Now, at 
many veterinary schools, women make up 40 to 60 percent 
of a class. The second component is that “we have a very 
supportive chairman,” says Dr. Smith of Robert O. Jacoby, 
D.V.M.. Ph.D. She adds that this encouraging attitude on 
the part of Dr. Jacoby sets the tone throughout the section. 
Dr. Brandsma’s approach — which uses both cell cultures and 
an animal model — has proven effective in researching cervical 
cancer. Her cell culture studies first identified a gene called E7 
as having the ability to transform cells. Dr. Brandsma’s studies 
in rabbits then established that the E7 gene is essential in forming 
papillomas. Further in vitro studies found that the E7 protein 
binds to an acellular protein called retinoblastoma protein, or RB. 
In normal cells, RB acts as a tumor suppressor, preventing 
uncontrolled growth. But in certain cancerous cells, says Dr. 
Brandsma, the picture changes: “In cervical cancer, for the most 
part, it appears that E7 binds to the retinoblastoma gene product 
and takes it out of commission. To investigate this in rabbits, we 
made a mutation in E7 that precludes its ability to bind RB. We 
then inoculated rabbits, expecting that they would not get 
papillomas.” The rabbits did indeed develop papillomas, how¬ 
ever, and this unexpected finding led to a rethinking of how these 
infections proceed. 
The current model proposes that there are probably two 
classes of genital papilloma viruses. First is a benign class, in 
which E7 binds to RB weakly and which produces condylomas, 
or genital warts. Second is an oncogenic class, in which E7 binds 
to RB strongly, and can lead to cervical cancer. E7 contributes to 
the formation of papillomas, but the aspect of E7 that binds to RB 
is not essential for the process. Instead, this aspect of E7’s 
function is implicated in transforming papillomas from the be¬ 
nign to the malignant state. The model calls for more study, as 
does the intriguing question of why papillomavirus will replicate 
and spread only in wild (non-laboratory) rabbits — although it 
readily produces all other aspects of the disease in laboratory 
rabbits. 
A timely use of an animal model can be seen in Dr. Smith’s 
research into how respiratory infections interact in laboratory 
mice bred to have an ineffective immune system. Pneumocystis 
carinii, the most common opportunistic infection in human AIDS 
patients, also can inhabit the lungs of the SCID (severe combined 
immunodeficient) mouse. This form of pneumonia often does 
not pose an immediate threat: after infection, the SCID mouse can 
live four to five months in a pristine environment. If, however, 
this Pneumocystis carinii-infected animal also is experimentally 
infected with an unrelated agent called pneumonia virus of mice, 
or PVM, it succumbs almost exactly one month later. This does 
not suggest a simple cause-and-effect, however. “We think the 
PVM virus may be activating macrophages in the lung,” explains 
Dr. Smith, “and these macrophages may, in some as yet unknown 
way, stimulate the pneumocysts, which up to then had been 
relatively innocuous.” 
Exploring that unknown mechanism of pathology will not be 
easy, because the Pneumocystis agent does not grow in standard 
tissue cultures. The only source at present is an animal or human 
lung, and even then “it’s very difficult to get a pure preparation,” 
notes Dr. Smith. “The microorganism is very sticky and always 
carries some of the host tissue with it,” which would likely 
contaminate tests carried out in vitro. 
Paradoxically, the animal model — while more complex — 
may offer more straightforward results, at least for now. More¬ 
over, “this model may allow us to test some drugs and possible 
treatments for Pneumocystis pneumonia,” notes Dr. Smith. If so, 
the benefits to AIDS patients could be important, as underscored 
by the support for this study, a grant from the NIH special fund 
for AIDS-related research. 
In reviewing comparative medicine’s approach to veterinary 
care, postdoctoral training and biomedical research. Dr. Jacoby 
sees research as the key unifying factor. In contrast to many 
medical schools whose one or two staff veterinarians are em¬ 
ployed solely to manage regulatory business and routine animal 
care, he says, “Yale’s model is duplicated in only a handful of 
schools, where veterinarians are given full opportunity for aca¬ 
demic participation. And the school gets the benefit of a wide 
range of service expertise, because all of these people also have 
research support.” 
Dr. Weir sees widespread benefits in this combination of 
service expertise and research experience. “We're an academic 
department, and because we do research ourselves, when we 
discuss a problem with investigators we can look at it from their 
perspective; we know what’s important to them,” she says. 
For Dr. Barthold, too, such interaction with faculty in many 
areas is part of the very nature of comparative medicine. He 
explains, "Whereas the medical school has departments of radi¬ 
ology, endocrinology, infectious diseases, and so on, we have one 
or two people whose work touches on each of these fields.” In this 
way, he says, “comparative medicine is a microcosm of the 
medical school at large.” YM 
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The Children’s Hospital 
A Place ol Their Own 
by Gregory’ R. Huth, M.P.H. '84, and C.W. Vrtacek 
For Emilie and Paul Jacobs, a professional couple in their early 
30s, the weekend will be one of abrupt emotional contrasts. 
Friday afternoon will begin as a nightmare with the serious 
illness of their 3-month-old daughter, Susan; Saturday morning, 
their best hopes for their daughter's health will have been 
realized. The difference between tragedy and triumph will be 
made by the Children’s Hospital at Yale-New Haven — and the 
Yale medical faculty’ who attend there. 
Friday, 11:45 a.m. In her law office in New Haven. Emilie 
takes the emergency call about Susan. For no apparent reason, the 
little girl had collapsed semi-conscious in her crib at the daycare 
center, and was rushed to the hospital. Could Emilie come down 
to the Children’s Hospital at Yale-New Haven and meet with a 
member of the medical team as soon as possible? 
Friday, 1 p.m. In the Children’s Hospital emergency depart¬ 
ment. Emilie and her husband stand on either side of Susan's bed. 
awaiting the results of diagnostic tests. Emilie holds the hand of 
her baby, who, though a bit more alert with all the excitement, is 
still weak. The parents’ conversation turns briefly to how child- 
friendly the surroundings are. Here the walls are painted in 
pleasant pastels and adorned with pictures of cartoon characters. 
No adults occupy neighboring beds; in this emergency depart¬ 
ment, there are only children, their parents and care givers. 
Friday, 2:15 p.m. Susan has proved to have a serious 
congenital vascular defect which had gone undetected since birth 
— patent ductus arteriosus — a hole in the artery near her heart. 
Nevertheless. Susan’s parents are relieved to discover that chest 
surgery will not be required. Instead, the girl's physician. 
William E. Hellenbrand, M.D.. professor of pediatrics, has her 
scheduled to undergo treatment in the Children's Hospital 
catheterization laboratory that very afternoon. 
Friday, 3:30 p.m. Susan undergoes her catheterization under 
sedation and with her parents at her side. In the half-hour 
procedure, which was developed at Yale in the late 1980s, Dr. 
Hellenbrand threads a thin, flexible, fluoroscope-guided tube 
through the little girl's arm and into her aorta. Once the catheter 
reaches the hole that caused the fainting spell, the doctor springs 
open a tiny metal umbrella, which closes the gap. In the coming 
weeks, Susan’s body will form scar tissue over the implanted 
device, sealing the hiatus permanently. For the time being. 
Gregory R. Huth is publications editor at the Yale School of 
Medicine office of public information. C.W. Vrtacek is a staff 
writer at the Yale-New Haven Hospital office of public relations. 
however, Dr. Hellenbrand wants Susan to stay overnight at the 
Children’s Hospital for observation. 
Friday, 5:30 p.m. Susan’s much-relieved parents read her a 
story as they sit together in the cheerful, brightly lighted private 
room, which offers a beautiful view of Long Island Sound. 
Dr. William E. Hellenbrand displays the life-saving umbrella 
device which was developed at the School of Medicine. 




Friday, 8 p.m. To the delight of Susan’s parents, they have 
been invited to stay the night in their daughter’s room, designed 
to accommodate portable beds for such parental visits. 
Saturday, 9 a.m. Dr. Hellenbrand gives the “all clear” for 
Susan's relieved parents to take her home. 
While Susan and her parents may be fictional, the situation 
they illustrate is real. When the Children’s Hospital at Yale-New 
Haven opens in July, its patients will benefit from YNHH’s ties 
with a leading medical school; such ties will help the hospital to 
offer such services as the catheterization laboratory, a heart-lung 
transplant unit, a newborn intensive care unit and a fetal cardio¬ 
vascular center. At the same time, the 11 -story, 450,000-square- 
foot Children's Hospital will help the School of Medicine pursue 
its mission of research, teaching and patient care. 
Rising above the rest of the medical center at the corner of Park 
Street and Howard Avenue, the Children’s Hospital is the center- 
piece of a $ 156 mill ion facilities renewal project at YNHH, which 
includes a new main entrance of the hospital, an atrium/lobby 
linking all of the inpatient buildings, and renovations to the 
Memorial Unit, the 1982 facility and the Primary Care Center. 
(As part of this reorganization, the Memorial Unit will be re¬ 
named the East Pavilion; the 1982 facility the South Pavilion.) 
In addition to providing women’s and children’s services, one 
floor of the new building will house adult oncology. [See "The 
Children's Hospital at a Glance.”] Commenting on the Children's 
Hospital. Mania Borgstrom. senior vice president for administra¬ 
tion at YNHH, says, “The thing that makes it special is that nearly 
everything that has to do with pediatrics will be located in one 
place — from babies right on up through adolescents.” 
While the 221 beds of the Children’s Hospital will increase 
YNHH's total only from 875 to 900 beds, the additional 400,000 
square feet of space will enable Yale-New Haven to phase out 
three- and four-bed rooms; the goal is to better meet the demands 
of today’s patients and the requirements of modern medical care. 
By 1995, all non-special care Yale-New Haven patient rooms 
will be private or have two beds, an arrangement that will offer 
more space for the machinery that has become integral to high- 
technology medicine. 
The rooming-in arrangements offered to families of pediatric 
patients will extend to the obstetric service. In addition to the 
rooming-in option for both the father and the new baby, each 
obstetric patient's room will be private, with its own bath. 
Such changes go beyond making medical treatment more 
efficient; they also reflect YNHH’s attempt to make hospital care 
as humane as possible. Observes Vincent S. Conti. YNHH senior 
vice president for administration, “Over the years, medicine has 
not always been as sensitive as it should to the special emotional 
needs of kids and their families. We’ve come to see that it’s less 
than ideal to have an emergency room that treats physical 
ailments superbly but has children side-by-side with adults 
suffering from a coronary ora stab wound. Situations like that are 
traumatic to the kids and the families as well.” 
Fulfilling a Dream 
Joseph B. Warshaw, M.D., chairman of the pediatrics department 
at the medical school and chief of pediatrics at YNHH, explains 
that the Children’s Hospital was designed to embody the 
department’s philosophy of caring for children: “Our sensitivity 
The Children ’s Hospital at a Glance 
• Architect: Lloyd Acton of the Boston-based Shepley, 
Bulfinch. Richardson and Abbott. 
• The basement, floors one through five and the seventh 
floor: Connect with the South Pavilion. 
• First floor: Features a separate entrance to the Children’s 
Hospital on Howard Avenue, a lobby and a separate pediatric 
emergency department. 
• Second floor: Houses pediatric diagnostic imaging, spe¬ 
cialty clinics and pediatric rehabilitation services. 
• Third floor: Includes four pediatric operating rooms, proce¬ 
dure and recovery rooms for both inpatient and outpatient sur¬ 
gery, as well as a cardiothoracic intensive care unit. 
• Fourth floor: Offers labor and delivery rooms and the 
Newborn Special Care Unit. 
• Fifth and sixth floors: Contain the building’s mechanical 
equipment. 
• Seventh floor: Houses pediatric patient rooms, attaching 
directly to the current pediatric floor and Children's Clinical 
An exterior view of the Children's Hospital. 
Research Center; includes a new adolescent unit and pediatric 
intensive care unit. 
• Eighth and ninth floors: Offer adult services — oncology 
and gynecology. 
• 10th and 11th floors: Provide maternity services for 
mothers, newborns and a 10-bed maternal special care unit. 
14 Yale Medicine Spring 1993 
to patients must be felt by them as soon as they walk through the 
front door. The experience of coming to a hospital can be 
overwhelming for children. To overcome that, you have to create 
a special ambience in which kids are treated differently.” 
Architecturally, that atmosphere will go beyond the separate 
children’s emergency room or even the cheerful patient rooms 
and the striking views of West Rock and the Sound that they 
provide. In fact, the ambience will become apparent from the 
moment people arrive at the separate entrance of the Children's 
Hospital on Howard Avenue. The lobby there features a railroad 
motif, with light boxes on the walls that look like train windows 
offering a panorama of the Connecticut shoreline. This theme is 
echoed by a model train that will run through the lobby, courtesy 
of local model train enthusiasts. 
Pediatric patients will sense the feeling of special care in the 
Children’s Hospital’s four pediatric operating rooms and 
endoscopy suite, which will make it possible for parents to stay 
with their children until anesthesia is administered. And when 
children come out of surgery, the recovery rooms are large 
enough for families to visit — children no longer will awaken in 
the company of unfamiliar adults. 
Such arrangements, notes Dr. Warshaw, “have a calming 
effect on parents as well.” He emphasizes that the elusive quality 
of ambience goes beyond child-friendly facilities: “Everything 
has to be different. Not just the building. Not just the doctors and 
nurses. You need security officers who are willing to get down 
on their hands and knees to play with kids, technicians and 
orderlies who understand and appreciate what it’s like for chil¬ 
dren. You need menus that offer ‘kid-friendly’ food.” 
The Best Medicine Has to Offer 
Another departmental commitment. Dr. Warshaw notes, is pro¬ 
viding leading physicians who can offer a wide range of expertise 
to pediatric patients and their families. A well-designed and 
equipped children’s hospital goes a long way toward attracting 
such physicians; so does having an affiliation with the Yale 
School of Medicine. 
“We have pediatric specialists in every major discipline,” 
explains Dr. Warshaw. “They focus on childhood problems, 
understand development and appreciate the issues that make the 
pediatric patient uniquely vulnerable. It's no surprise that 80 
percent of the nation’s pediatric subspecialists practice in aca¬ 
demic medical centers such as Yale’s.” 
Yale pediatrics offers a remarkable array of subspecialties, 
including adolescent medicine, ambulatory pediatrics, cardiol¬ 
ogy, critical care, endocrine, neurology, gastroenterology, hema¬ 
tology/oncology, infectious diseases, nephrology, perinatology 












and respiratory medicine. In addition, pediatric specialists are 
available in anesthesia, dentistry, dermatology, neurosurgery, 
ophthalmology, orthopaedics, otolaryngology, orthodontics, pa¬ 
thology. psychiatry, radiology and surgery. 
Dr. Warshawsays that the new Children’s Hospital has helped 
in recruiting such leading subspecialists as Thomas Renshaw, 
M.D.. professor of orthopaedics and rehabilitation, a leading 
pediatric orthopaedist, and John Persing, M.D., professor of 
surgery at the medical school and chief of plastic surgery at 
YNHH, an expert in facial and cranial reconstruction. 
Yale pediatrics has put special emphasis on expanding its team 
of pediatric anesthesiologists. Comments Stephen Rimar, M.D., 
associate professor of anesthesiology and pediatrics, and head of 
pediatric anesthesiology at YNHH, “As a fully developed spe¬ 
cialty, pediatric anesthesiology is only available in children's 
hospitals.” Dr. Rimar notes that parents are comforted to know 
that the physicians who will administer anesthesia to their chil¬ 
dren are pediatric specialists. 
Yale's leadership in research also will contribute to the 
Children's Hospital/School of Medicine symbiosis. "Both philo¬ 
sophically and practically, research goes hand-in-hand with the 
concept of a children’s hospital,” says Dr. Warshaw. 
He points out that while the faculty members gain the oppor¬ 
tunity to combine clinical care with their research and teaching 
skills, pediatric patients benefit from having available the latest 
Dr. Joseph B. Warshaw 
clinical advances from the laboratory. Yale pediatrics has more 
than 50 active research protocols funded at $10 million in direct 
costs. This makes the relatively small department (with 55 full¬ 
time faculty) second in the nation in overall federal research 
funding, and first in terms of such funding per faculty member. 
Yale also offers only one of seven Children's Clinical Re¬ 
search Centers (CCRCs) in the United States. Funded by the 
National Institutes of Health, the five inpatient beds and two 
examining rooms of this institutional resource will remain at its 
present location on the seventh floor of the 1982 facility, but will 
be connected to — and considered part of — the Children's 
Hospital. 
Center director, William V. Tamborlane, M.D.. professor of 
pediatrics and head of pediatric endocrinology, comments, "CCRC 
serves as a resource for a wide range of studies, from clinical trials 
of pediatric AIDS medications to childhood epilepsy research 
and studies of airway obstruction in infants and children. One 10- 
year longitudinal study is looking at the effectiveness of aggres¬ 
sive treatment of insulin-dependent diabetes mellitus in the 
prevention of diabetic complications.” 
Yale’s leadership in pediatric and other research is reflected, 
in part, by the following clinical statistics: 
• More than 300 diabetic children from Connecticut, New 
York and Rhode Island are treated by medical school/YNHH 
pediatric endocrinologists. 
• Almost half the children in Connecticut with cancer see a 
pediatric oncologist affiliated with Yale. 
• Yale’s pediatric pulmonologists treat more children with 
cystic fibrosis than any other service in Connecticut. 
• Yale offers the only pediatric renal transplant program in 
Connecticut. 
A Symbol of Commitment 
In concluding his reflections on the new Children's Hospital for 
which he has advocated so strongly. Dr. Warshaw acknowledges 
the challenge of providing the best medical care in the face of 
growing social ills, both locally and nationally. "The big problem 
in America right now is not medical, it’s the problem of poverty,” 
he states. "Low birth weight, infant mortality, violence, AIDS — 
it all comes back to poverty. While in general the health of the 
overall population is better, what worries me are the areas where 
it is not better and, in fact, is worse.” 
For example. Dr. Warshaw feels that racism, poverty, drug use 
and flawed social policy have contributed to New Haven's high 
infant mortality rate. He says, “In Bulgaria, the infant mortality 
rate is less than 15 per 1.000 live births. In the Dixwell area of 
New Haven, it’s above 30 per 1,000. Two miles away in Hamden, 
it's seven per 1,000. That's a big discrepancy and it's a major 
concern to the pediatric community here.” 
Says Dr. Warshaw, “What our Children’s Hospital must 
communicate is that this institution places a high priority on 
children, within the hospital and the community.” YM 
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YSM and the Community: 
Toward a Healthier Future 
New Haven Mayor John C. Daniels is flanked by Joseph A. Zaccagnino, president and CEO of Yale-New Haven Hospital (left), and 
School of Medicine Dean Gerard N. Barrow, at the December 1992 press conference announcing a tuberculosis grant to the cits’. 
by Gregory R. Hath, M.P.H. '84 
On Dec. 2, 1992, the New Haven Register testified to the medical 
school’s increasing involvement in its host city. On the front 
page, the hometown newspaper offered two articles announcing 
new local health initiatives that are being funded jointly by the 
School of Medicine and Yale-New Haven Hospital (YNHH). 
First is a $60,000 contribution to the city of New Haven to 
enable the New Haven Coalition to Eliminate Tuberculosis to 
hire a director and establish a permanent office. In January, the 
new director, Allison Kalloo, M.P.H. '90, began working with 
the coalition, a group of 20 Yale medical faculty and other area 
health professionals, to head off a dramatic increase of TB, 
especially among the city's most vulnerable people: AIDS 
patients, the homeless and IV drug users. 
The Register's second article announced the Women's Health 
Initiative, co-directed by Florence Comite, M.D., '16, associate 
professor of medicine, obstetrics and gynecology, and pediatrics,‘ 
and Janet B. Henrich, M.D., associate professor of medicine. 
This wide-ranging program in the department of internal medi¬ 
cine is providing centralized, interdisciplinary care for women at 
YNHH's Dana Clinic, encouraging research into women’s health 
problems, and developing a core curriculum course in women's 
health at the medical school. 
A subsequent Registers ditorial said the two initiatives “would 
not only serve New Haven but enhance the already deserved high 
reputations of both the medical school and hospital.” 
Gregory R. Hath is publications editor at the Yale School of 
Medicine office of public information. 







Myron Genel, M.D., associate dean for government and 
community affairs, says to expect even more such community- 
oriented programs to debut in the coming months and years. Dr. 
Genel makes that prediction confidently, for his office sponsors 
the 40-member Focus Group on Community Health and Educa¬ 
tion Initiatives — comprising health professionals from the 
University and the community — which played an active role in 
bringing the TB program to fruition. 
"It’s all in keeping with our academic plan,” adopted in 1990, 
he emphasizes. That plan calls for Yale to become “the unques¬ 
tioned academic leader in making science-based and humane 
medicine responsive to the needs of society as a whole, not just 
the needs of the individual.” 
Adds Dr. Genel. "These are not just nice sounding words. 
We're well on our way to implementing them.” 
The Global Village Begins at the Hill 
At a time when “community” has come to encompass an ex¬ 
tremely broad range of social ties — from the medical school’s 
internal relationships to the school's service to people in devel¬ 
oping lands half a world away — the thrust of the new academic 
plan is distinctly local. 
YSM Dean Gerard N. Burrow, M.D. ’58. has eagerly em¬ 
braced the commitment to community service made by the 
medical school's previous dean, Leon E. Rosenberg, M.D., and 
advanced by former Acting Dean Robert M. Donaldson Jr., M.D. 
In fact. Dr. Burrow has made it clear from the time of his 
appointment that the School of Medicine must aggressively 
address the medical and public health problems of the surround¬ 
ing community, both the Hill neighborhood and the city of New 
Haven. 
Says Dean Burrow: "There are many wonderful examples of 
the way Yale University contributes to the well-being of the city, 
using an academic approach to help solve difficult social prob¬ 
lems. We need to do even more.” 
The city’s health challenges — inseparable from its social 
problems — are many and dramatic. To offer a brief overview, 
the New Haven health department and other sources report that: 
• New Haven is one of the poorest cities in the United States 
with a population over 100,000, with 21.2 percent of the populace 
at or below the poverty level ($10,400 annual income for a family 
of three.) 
• The infant mortality rate of 20.2 per 1,000 is one of the 
highest in the nation; for non-whites the rate is 27.3. 
• Nearly one in 60 women giving birth in New Haven is 
infected with HIV, and 47 percent of women attending prenatal 
clinics at Yale-New Haven Hospital have used cocaine during 
pregnancy. 
• More than 20 percent of New Haven AIDS cases are women, 
largely due to their intravenous drug use or having injecting drug 
users as sex partners; many of these women are infected in their 
teens and early 20s. 
• 108 cases of pediatric AIDS have been treated at the Yale- 
New Haven Hospital Pediatric AIDS Clinic since it opened in 
1987; 37 of these children have died from AIDS, and 50 babies 
are being monitored for possible HIV infection. 
• Tuberculosis incidence among New Haven’s African-Ameri¬ 
cans is 29 per 100,000, nearly three times the national average of 
the general population. 
• In 1991.35 violent deaths occurred in the city, along with 
490 aggravated assaults and 100 rapes; the police made 1.400 
dispatches responding to "shots fired.” 
A Vocation of Service 
At the department of epidemiology and public health (EPH), the 
academic plan’s commitment to community service continues a 
legacy that dates back more than four decades, when the commu- 
(From left) At a focus group meeting in the Dwight Street 
neighborhood, Steven Marans speaks about children and 
violence. Listening are Dr. Myron Genet, Dr. Stephen C. 
Updegrove of the Hill Health Center and William Quinn, New 
Haven director of health sen’ices. New Haven police chief 
Nicholas Pastore sits in the background. 
nity project requirement first became part of the EPH curriculum. 
In fact, EPH’s community projects — in which teams of students 
do research and problem-solving for area health-oriented agen¬ 
cies — represent one of the nation’s most enduring programs 
integrating experiential learning and student service. 
Although the help offered through these projects rarely makes 
the headlines, in 1990, the department did gain national recogni¬ 
tion when the Association of Schools of Public Health cited 
EPH’s community projects as a national model for addressing the 
Institute of Medicine’s recommendations for graduate education 
in public health. 
Explains Elaine Anderson, M.P.H. '76, director of EPH’s 
Center for Health Professions, “Our students come to us believ¬ 
ing, as we do, that the mission of public health is toenhance health 

















in human populations through organized community effort. 
There is no better way for a student to do this than hands-on 
experience, under close faculty supervision, with service-ori¬ 
ented organizations and government agencies.” She notes that 
the community also benefits, since community projects often 
provide agencies with a way to gather information or undertake 
! tasks for which they would otherwise not have the resources. 
Among the 12 community projects for the spring of 1993 are 
a needs assessment in conjunction with the APT Foundation, a 
local organization closely affiliated with the School of Medicine 
that specializes in substance abuse education and prevention as 
well as treatment. The study will focus on barriers to treatment 
for female substance abusers, and is being done by APT, Yale and 
the city to further the goals of the “Fighting Back” anti-drug 
initiative, a city-wide anti-drug effort funded by the Robert Wood 
Johnson Foundation of Princeton, N.J. 
Karen Guilmette {left) welcomes New Haven school teacher 
Wancla Chanclri and her class to the medical school as part of the 
Elementary Student Medical Center Tour Program. 
Other New Haven-based community projects will help 
Women's Health Services, a local clinic, to survey current and 
potential patients to determine whether expanded services are 
warranted. A community project with national policy implica¬ 
tions will help a local nursing home determine whether Medicare 
and Medicaid rules are truly cost-effective in providing disincen¬ 
tives to nursing homes for accepting chronically ill patients. 
Student volunteerism is another way the School of Medicine 
is making its mark on the neighborhood and the city. For entering 
medical students, the emphasis on community service begins at 
orientation, when two student volunteer coordinators offer pre¬ 
sentations about local outreach opportunities. Appointed for a 
one-year term by the medical school's Student Council, this 
year’s coordinators are second-year students Alice Chang and 
Sunghoon “Sung” Lee, who also lead the new student service 
group called “Asian-Americans in Yale Medicine.” [See: “Asian- 
American Students Serve School, Community,” Page 26.] 
Both at orientation and at the fall student activities fair, 
coordinators and program leaders invite their peers to volunteer 
for local health- or science-education projects or other service 
opportunities. At EPH, the Student Organization encourages 
community service through its volunteer committee, chaired this 
year by first-year student Elise Riley. 
Karen Guilmette, J.D., associate director of government and 
community affairs, serves as administrative coordinator for stu¬ 
dent volunteer programs. She notes that “the number of medical 
students making substantial commitments to community service 
has increased tremendously over the past few years. Approxi¬ 
mately 75 percent of the first- and second-year students partici¬ 
pate in some form of community outreach.” 
Sung Lee adds that 100 first-year medical students have 
signed up to serve 120 volunteer units, revealing that some 
students are working with more than one project. While many of 
the students work with 10 community outreach programs avail¬ 
able through the School of Medicine, four programs garner the 
lion’s share of volunteers. 
Most popular is ASAP, Adolescent Substance Abuse Preven¬ 
tion, which has attracted 80 volunteers. Through ASAP, begun 
in 1990 as a pilot by the American Medical Student Association, 
teams of medical and public health students go into classrooms at 
the Roberto Clemente Middle School, located in the Hill, to teach 
about the health consequences of illegal drugs, alcohol and 
tobacco. Overtime, the Yale volunteers teach seventh-graders to 
pass along what they’ve learned in classroom presentations to 
fifth-graders; last year’s project included production of a video¬ 
tape by the seventh-graders to educate the younger students. 
ASAP coordinator Dara Thomas, a second-year medical stu¬ 
dent, reports that this year the program is expanding with CATCH 
— Counseling Adolescents Towards Careers in Health. To start, 
numerous faculty and students attended a careers fair at Roberto 
Clemente in the fall. They recruited students, who, for four days 
this spring, are following a health care professional at Yale-New 
Haven Hospital to learn about the work of medicine. 
Another popular volunteer opportunity, with approximately 
40 students, is Students Teaching AIDS to Students (STATS). In 
this program, coordinated by second-year medical students Steven 
Kawut, Dorothy Novick and David Morales, the Yale students 
teach about the dangers of — and the misconceptions about — 
AIDS to ninth-graders in the public schools. 
The other two most popular student volunteer efforts include 
the Prenatal Care Program and the Elementary Student Medical 
Center Tour Program. In the former effort, medical students 
volunteer through the department of obstetrics and gynecology to 
work with pregnant patients at the Hill Health Center and the 
Women’s Center at Yale-New Haven Hospital. 
In the latter program, suggested to the school by the leadership 
of the Hill Development Corp. (HDC). medical students serve as 
hosts to fourth- and fifth-graders from the neighborhood, to show 
what goes on behind the walls of the medical school. Tours 
include four interactive laboratory projects — and such activities 
as reading X-rays and making stethoscopes — designed to give 
the children a taste of patient care and biomedical research. 
Other volunteer opportunities include the Hillhouse High 
School/Macy Science Program, in which Robert H. Gifford, 
M.D., associate dean for education and student affairs, leads a 
group of medical students and faculty to the high school every 
week to introduce seniors to the medical and biological sciences. 











To recognize the hard work of student volunteers, in 1992, the 
School of Medicine began presenting Distinguished Community 
Service Awards to medical and EPH student volunteer leaders at 
the annual observance of Martin Luther King Jr. Day. This year’s 
awards, given on Jan. 18, recognized 17 medical students and 
three students from EPH. [See "Student News,” Page 40.J 
Comments Dr. Burrow: "As these medical and public health 
students successfully combine the rigors of their educational 
programs with hours of community involvement, they establish a 
pattern of service that we hope will continue throughout their 
professional lives.” 
Martin Luther King Jr. Day itself represents one of the most 
visible signs of the medical school’s growing community aware¬ 
ness. Begun in 1988. the school's observance of Dr. King’s 
birthday replaces the regular schedule of classes with a series of 
lectures, seminars and a convocation featuring national civil 
rights and local community leaders and faculty members. They 
discuss the nation’s urban social and health crises, with an 
emphasis on New Haven. 
This year's program was entitled "Violence and Its Impact on 
the Community,” and featured such speakers as William R. 
Dyson, a local representative to the state legislature, and Mark 
Rosenberg, M.D., director, division of injury control, the Centers 
for Disease Control. [Further Martin Luther King Jr. Day cover- 
Dr. James P. Comer 
age is featured on Page 32.J Many Martin Luther King Jr. Day 
activities are organized by a committee chaired by Dr. Gifford; 
YSM's office of minority affairs arranges the convocation. 
Opened in 1989 with Maxine Whitehead as its director, the 
office of minority affairs also gets directly involved with the 
local community. For example, the office administers summer 
research fellowships for gifted minority high school students 
from New Haven, a program funded by the National Institutes of 
Health and the School of Medicine. 
Reports Ms. Whitehead. "Last year, 16 local students gained 
experience in various aspects of health-related research with 
leading medical school scientists. We hope that this exposure 
will encourage these talented young people to consider careers in 
biomedical science.” Gregory H. Tignor, D.Sc., associate pro¬ 
fessor of epidemiology, and John T. Stitt. Ph.D., associate 
professor of epidemiology and physiology, are involved with 
another aspect of this program, in which 15 high school juniors 
from New Haven worked with 13 medical school faculty precep¬ 
tors in basic research. 
Outreach to Mothers and Children 
Medical school health programs and the work of student and 
faculty volunteers also reach out to the area’s mothers, and to 
their children from the time of conception through late adoles¬ 
cence. Many of these programs involve faculty from the medical 
school’s Child Study Center. 
Comments center director, Donald J. Cohen, M.D. ’66, the 
Irving B. Harris Professor of Child Psychiatry, Pediatrics and 
Psychology: “Since the time of its founding by Dr. Arnold Gesell 
in 1911. the Child Study Center has put Yale’s expertise to work 
for the psychological and emotional well-being of New Haven 
area children. Over the decades, the faculty and staff of the center 
have been committed not only to advancing knowledge about 
child development, but also to collaborating with professionals 
and agencies in the community and throughout the University in 
applying this knowledge to improve services for children and 
families and to help meet the pressing needs of our community’s 
children.” 
One result of this commitment is the Commission on Infant 
and Child Health, which since 1986 has focused on the services 
and programs that affect the health of New Haven’s children. 
Supported by the New Haven Foundation and the city of New 
Haven, the commission has been chaired by Jean A. Adnopoz, 
M.P.H. ’81, since its founding. Among the commission’s 30 
members are nine faculty members and administrators from the 
School of Medicine, the School of Nursing and Y ale-New Haven 
Hospital. 
Ms. Adnopoz, associate clinical professor in the Child Study 
Center, explains that the commission’s purpose is “to bring the 
community together — health professionals, business leaders, 
educators, neighborhood and church leaders — to address the 
complex problems related to infant mortality and morbidity and 
to promote healthy physical, psychological and cognitive devel¬ 
opment.” For example, the commission collaborates with the 
New Haven health department and the Child Study Center in 
operating a school-based clinic at the Katherine Brennan School, 
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a primary school in the West Rock neighborhood of New Haven. 
An example of the commission’s service to mothers is the 
pregnancy hotline, an information and referral service initiated 
by the commission in New Haven and now available statewide 
through the Infoline telephone service. Using the hotline, ex¬ 
plains Ms. Adnopoz, “Women in New Haven are able to schedule 
appointments for pregnancy screening and prenatal care at YNHH 
and other health care facilities.” 
With the caller's permission, the Infoline operator will even 
make a follow-up call to make sure that the appointment went off 
without any problems. In early 1992, more than 100 calls per 
month came into the pregnancy hotline. 
Perhaps the best known Child Study Center initiative is the 
School Development Program, which has come to be known by 
the name of its founder, James P. Comer, M.D., HS ’64-'67, the 
Maurice Falk Professor in the Chi Id Study Center and Psychiatry. 
In the “Comer Process," parents, teachers and school administra¬ 
tors work together to create a school climate that promotes 
students’ social and academic learning, an approach that has 
improved both short-term academic performance and long-term 
career prospects for inner-city students. 
Begun in the 1960s in several public elementary schools in 
New Haven, over the next three decades, the Comer method 
spread to more than 165 schools throughout 12 states and Wash¬ 
ington, D.C. Then, in 1990, the Melville Corporation of Rye, 
N.Y., joined with the Rockefeller Foundation of New York City 
in a multi-million dollar effort to further expand Dr. Comer’s 
approach. Today, more than 250 urban schools in 17 states are 
using Dr. Comer’s process, a number that will grow during the 
final two years of the grant. 
Another Child Study Center program that has gained national 
attention — and Rockefeller Foundation support — is run with 
the New Haven Department of Police Service. In early 1992, the 
Rockefeller Foundation matched $50,000 in private donations to 
fund the Child Development and Community Policing (CD-CP) 
program to train the city police to deal sensitively and effectively 
with children and families who have witnessed or directly suf¬ 
fered from violence. Steven Marans. M.S.W., the Harris Assis¬ 
tant Professor of Child Psychoanalysis in the Child Study Center, 
is coordinator of the program. 
Mr. Marans points out that people affected by violence “must 
deal with the horror of feeling unsafe and terribly vulnerable.” He 
emphasizes that victims of, or witnesses to, violence may need 
help in dealing with feelings of helplessness and fear: “Long¬ 
term reactions can range from depression and anxiety to becom¬ 
ing actively involved as perpetrators rather than to assume the 
role of a helpless victim,” says Mr. Marans. A well-trained police 
force, he suggests, may be a crucial first step in minimizing the 
damaging consequences of violence. 
The CD-CP program has three components: 
• A graduate-level course in child development for all police 
recruits; 
• A system for officers in the field to receive 24-hour consul¬ 
tation about, and referrals for, clinical interventions for at-risk 
youth; 
• A fellowship for selected police officers to learn about 
available mental health services for children. 
At the end of the program’s first 16 months, CD-CP has 
trained more than 150 police officers and 10 child development 
fellows at the level of sergeant and above, including the assistant 
chief of police. More than 200children have been helped by these 
trained officers and faculty members at the Child Study Center. 
Finally, the Bush Center, an administrative component of the 
Child Study Center, is nationally recognized for its important 
work in relation to social policy and child development. Directed 
by Edward Zigler, Ph.D., Sterling Professor of Psychology and in 
the Child Study Center, the Bush Center has shaped national 
policy concerning early intervention. Head Start, child care, 
school reform and parental leave. 
Comments Dr. Cohen, “The Bush Center’s work has been 
deeply felt by New Haven’s children and families, who benefit 
from these national programs, and has been recognized by the 
naming of the New Haven Head Start as the Zigler Center.” 
Among the many other Child Study Center services that 
benefit the community are: 
• The Maternal and Child Health Outreach program, in which 
faculty consult with administrators and outreach workers of the 
New Haven Health Department who work with pregnant women; 
Drs. Ezra E.H. Griffith (left) and Robert El. Gifford 




• Outpatient clinics for children with autism, pervasive disor¬ 
ders, tic disorders, developmental disorders, fragile X syndrome 
and other neuropsychiatric conditions. Clinics serve families 
from throughout the region regardless of ability to pay; 
• Consultation programs to New Haven public schools, pro¬ 
viding psychiatric and developmental consultation to children 
and adolescents, and referring children in need to specialized 
services in the School of Medicine; 
• School-based clinics in 11 New Haven schools to deliver 
direct care to children and families. These clinics are direct 
extensions of the Child Study Center outpatient programs and 
represent an innovation in health care delivery to under-served 
children. 
A cornucopia of community programs Hows from the medical 
school's department of pediatrics, as well, chaired by Joseph B. 
Warshaw, M.D. Observes Dr. Warshaw: "More than for any 
other segment of society, New Haven’s problems are those of its 
children. Yale pediatricians are keenly aware of this and are 
doing their part to help rescue a generation of children that is 
threatened on many fronts, whether from poverty, violence, 
drugs, AIDS, sexual abuse or a combination of these ills.” 
Such dedication can be seen in the work of John M. Leventhal, 
M.D.. HS ’73-’76, professor of pediatrics and in the Child Study 
Center. Dr. Leventhal is medical director of both the YNHH 
Child Abuse Program and its Child Sexual Abuse Clinic; each 
service evaluates more than 300 children annually. The Child 
Abuse Program also educates community outreach workers, 
child care workers, police officers, nurses, teachers and others 
about how to detect possible abuse. 
Outside the clinic. Dr. Leventhal serves on the Commission on 
Infant and Child Health and its Health Care Delivery Committee. 
He also is working with local pediatricians to develop a city-wide 
computerized system to increase child immunization rates. As a 
board member of the Domestic Violence Services of Greater 
New Haven, he plays an active role in the area's battered 
women’s program. 
Another faculty member who has assumed multiple commu¬ 
nity responsibilities is Walter R. Anyan Jr., M.D., HS '66-'68, 
professor of pediatrics, who directs the Medical Program for 
Adolescents. This program is responsible for 3,000 or more visits 
per year at the medical school and at the New Haven Juvenile 
Detention Center. 
In 1982, Dr. Anyan also helped establish the "Body Shop” at 
Wilbur Cross High School. Supervision of this comprehensive 
health clinic, which has served as a model for other school-based 
clinics in Connecticut and across the nation, was fully assumed by 
the New Haven Board of Education and the Fair Haven Commu¬ 
nity Health Clinic in 1986. 
David J. Schonfeld, M.D..assistant professor of pediatrics and 
in the Child Study Center, is responsible for no less than three 
community service programs. First is an effort to combat a health 
problem related to New Haven's aging housing stock: lead 
poisoning. In 1992, more than 100 New Haven-area children 
were treated at Yale for severe poisoning from lead they had 
ingested from eating paint chips or contaminated dust; many 
required hospitalization. 
A pediatric lead clinic meets twice weekly to coordinate 
ongoing care for children with severe lead poisoning; its staff 
screens for and treats lead poisoning in the YNHH Primary Care 
Center and consults with doctors who have admitted lead-poi¬ 
soned children to the hospital. 
Dr. Schonfeld and eight colleagues in the lead program also 
work with the State Task Force on Lead Poisoning Prevention 
and community leaders in search of creative solutions to lead 
poisoning. For instance, the program is working with Edward M. 
Kennedy Jr., a recent Yale Forestry and Environmental Studies 
graduate, and the Hill Development Corp. in developing a "safe 
houses” program for New Haven. These faculty and staff also 
educate health-care providers and community members about 
lead poisoning and explain the resources available for treatment. 
Dr. Brian W.C. Forsyth exemplifies a School of Medicine faculty 
member who has dedicated much of his career to community 
service. In addition to his work with the Mother's Project and 
with support programs for families affected by AIDS, he serves as 
chairman of the board of AIDS Project New Haven, the largest 
local community-based organization providing education and 
sen'ices to people affected by AIDS. He also represents the 
medical school and New Haven on the state of Connecticut’s 
Alcohol and Drug Abuse Commission's committee on pregnant 
substance abusers. 
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Dr. Schonfeld’s second major activity arose from the Forum 
on Education and Society, organized by the Child Study Center, 
and including 40 or more community leaders, members of the 
New Haven police, the Consultation Center, and medical school 
faculty and students. Dr. Schonfeld chairs a forum committee 
that has developed a model for crisis response for New Haven and 
other area school systems. 
To illustrate the kinds of stress that are facing today’s inner- 
city teen-agers. Dr. Schonfeld notes, “In one high school, they've 
had to help children work through the violent death of four fellow 
students within a single month.” Recent workshops trained more 
than 300 teachers and administrators from area public and paro¬ 
chial schools in how to help students cope with their grief when 
the death of a friend or loved one occurs or when some other life 
crisis strikes. 
Dr. Schonfeld’s third community effort is the AIDS Education 
Project, which works with New Haven public schools to deter¬ 
mine what young children understand about AIDS. Dr. Schonfeld 
explains: “Young children may seem to understand about AIDS, 
but when asked detailed questions, they are often confused. 
Some of the younger children thought they could get AIDS from 
dirt, as a result of hearing about dirty hypodermic needles. They 
don’t understand that AIDS is caused by a virus.” 
Dr. Schonfeld hopes to show how school programs can help to 
advance children’s understanding of the disease. Funded by the 
National Institute of Mental Health, the five-year project has 
completed more than 1,000 interviews of elementary school 
students from six New Haven public schools. This information 
has been used to develop a model AIDS education curriculum. 
Fighting HIV, Helping Those with HIV Disease 
The AIDS Education Project and Students Teaching AIDS to 
Students are only two of many School of Medicine initiatives to 
educate the community about this disease, to prevent HIV infec¬ 
tion. and to seek out and provide care for seropositive people and 
their families. 
Director of the AIDS Care Program at the School of Medicine 
and Yale-New Haven Hospital is Gerald H. Friedland, M.D., 
professor of medicine and of epidemiology and public health. 
The comprehensive services he oversees include medical, nurs¬ 
ing and psychosocial care to more than 1,000 adults and 250 
children from greater New Haven. HIV counseling and testing 
are offered in YNHH inpatient units, the Women’s Center, the 
Other Medical School Services 
To New Haven and Connecticut 
Some of the many other community services offered by Yale 
medical faculty and staff include: 
• Public schools educational initiative. Sara S. Sparrow, 
Ph.D., professor in the Child Study Center, consults with 
psychologists, social workers and teachers in the New Haven 
school system about children's academic and social-emo¬ 
tional development. 
• Free vaccines. Eugene D. Shapiro, M.D., associate 
professor of pediatrics and epidemiology, has arranged for 
thousands of doses of Haemophilus influenzae type b (Hib) 
vaccine to be sent to the State Department of Health for 
distribution to Connecticut children. 
• Mobile mammography van. This Yale Comprehensive 
Cancer Center (YCCC) service provides screenings for fees 
well below the standard charge and offers free screenings 
twice a month to minority and elderly women. Overall, more 
than 40,000 women have been screened since the van made its 
debut in 1989. Another of many YCCC outreach programs 
offers the public free cancer education workshops in area 
libraries. 
• Yale Skin Cancer Detection Program. David J. Leffell, 
M.D., HS ’84-’87, assistant professor of dermatology, directs 
this statewide program in collaboration with YCCC. Since 
1988, free full-body exams to more than 1,500 people have 
detected potentially lethal melanoma in several patients at the 
earliest, most curable stage. 
• Occupational Health Clinic. MarkR. Cullen, M.D. '76, 
associate professor of medicine and epidemiology, who di¬ 
rects the Yale Occupational Medicine Program, treats more 
than 800 patients a year who suffer from job-related diseases. 
• Health and Aging Project. This long-term study follow¬ 
ing the health of 2.812 New Haven residents age 65 and over 
has yielded a wealth of data that has benefitted the community. 
For example, Joanne McGloin, M.S.. M.Div., project director, 
reports that data regarding disabilities among older minority 
residents helped the Varick Church and Hannah Gray retire¬ 
ment home to gain state funds to build the Ella B. Scantlebury 
Senior Residence, 20 units of elderly congregate housing in 
the Dixwell neighborhood. 
• Mobile Van Homeless Health Care Project. Michele 
Barry, M.D., HS ’77-’81, associate professor of medicine, 
directs a mobile medical van staffed with medical residents, 
nurses and social services. AIDS and substance abuse coun¬ 
selors. Visiting every major soup kitchen weekly, the van 
dispenses health care, medications and vaccines free of charge. 
Beginning in January, the van widened its services by making 
concurrent visits with the New Haven needle exchange van. 
• Rape crisis senhees. Merle Waxman, director of the 
Office for Women in Medicine, works with the YWCA of 
Greater New Haven Rape Crisis Services in training volun¬ 
teers for certification as rape crisis counselors. Counselors 
provide services such as individual counseling and an emer¬ 
gency hot-line to rape and incest survivors. 
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Primary Care Clinic and in an alternative test site to provide 
access to people at risk for HIV from the local community. 
In the fall of 1992, the School of Medicine won designation by 
the National Institutes of Health (NIH) as an Adult AIDS Clinical 
Trial Unit (ACTU), with Dr. Friedland serving as principal 
investigator. As a result, patients with HIV benefit by having 
promising experimental HIV/AIDS medications made available 
free of charge as they participate in clinical studies. The ACTU 
emphasizes recruiting minority and women subjects and injec¬ 
tion drug users, all of whom have been under-represented nation¬ 
ally in AIDS clinical trials. 
In addition to their duties at the medical school and hospital. 
Dr. Friedland and other faculty members such as Drs. Peter 
Selwyn, Elizabeth L. Cooney, Frederick L. Altice and postdoctoral 
fellow Helena Brett-Smith, serve on the Mayor's Task Force on 
AIDS, the Connecticut AIDS Task Force and national bodies 
involved in public health and policy related to HIV. 
Specializing in the problems of young AIDS patients is 
Warren A. Andiman, M.D., HS '76, associate professor of 
pediatrics and epidemiology, who directs the Pediatric AIDS 
Program at the School of Medicine and YNHH. which began in 
1987. Why do children need specialized care when struck by 
AIDS? Explains Dr. Andiman: “First, the clinical manifestations 
of AIDS are different in children than in adults, and it takes some 
experience to familiarize oneself with the conditions that are 
specific to infants and young children. Second, because all HIV- 
exposed children have mothers who are infected, we have to treat 
these young patients in the context of their families, paying 
special attention to the physical and emotional needs of the 
mothers and of other affected siblings.” 
In his quest to relieve the suffering caused by AIDS, Dr. 
Andiman has dedicated many hours to community volunteer 
efforts. For example, early in the AIDS epidemic, when near 
panic about the emerging disease gripped the public. Dr. Andiman 
met with members of the New Haven Board of Education and 
other school administrators and teachers in nearby cities and 
towns. He helped the educators set policies that would allow 
HIV-infected students to remain in school. Dr. Andiman did 
similar consultative work with area daycare centers. 
Comments Dr. Andiman: “Today, I get almost no calls 
regarding HIV-infected children in New Haven schools. Years 
ago we assured school administrators that infected children could 
continue their education without putting other children at risk, 
and this has proved to be the case.” In other community work. Dr. 
Andiman advised the American Civil Liberties Union in its 
successful legal fight to improve AIDS treatment and prevention 
in the Connecticut prison system. 
Brian W.C. Forsyth, M.D., associate professor of pediatrics 
and the Child Study Center, also has met with area educators to 
help develop humane policies toward HIV-infected students. 
In addition, he has helped the medical school reach out to the 
community outside the clinical setting through the Family Sup¬ 
port Service for HIV-infected Children. Explains Dr. Forsyth, 
who helped develop the program and serves as its medical 
director, “The stigma associated with this disease often prevents 
people from turning to their families or friends for support and 
from getting appropriate medical treatment for their children.” 
The service’s health workers help family members cope with 
their HIV-infected children and escort mothers and their children 
to pediatric AIDS clinics. A program with regional impact, the 
family support service is being used as a model for Bridgeport, 
another community hard hit by the AIDS epidemic. 
Complementing this work is another program that Dr. Forsyth 
helped start and for which he serves as medical director: the Yale 
Program for Uninfected Children in HIV-affected Families, a 
joint venture of the Child Study Center and the YNHH AIDS 
Care Clinic. This program offers support services for uninfected 
children and other family members in HIV-affected families. 
Health workers identify and refer children in need of mental 
health services. 
Closing an AIDS Window of Opportunity 
New Haven’s needle exchange program was initiated by the 
city’s health department following an extensive grassroots and 
legislative campaign. The program is unusual because from its 
inception, it was accompanied by a scholarly effort to evaluate its 
effectiveness. This effort involves researchers from the medical 
school, EPH, the School of Organization and Management (SOM) 
and the city health department's AIDS division. 
Results from the ongoing study, led by principal investigator 
Edward H. Kaplan, Ph.D., an associate professor both at SOM 
and in the medical school, and Robert Heimer. Ph.D., assistant 
professor of medicine, have provided the first hard evidence that 
needle exchange can directly reduce the spread of AIDS caused 
by sharing HIV-infected needles. In the New Haven program, 
more than 1,500 injected drug users have exchanged used sy¬ 
ringes on a one-to-one basis for new syringes with attached 
needles. Dr. Heimer’s laboratory tests the returned syringes 
using polymerase chain reaction — a sophisticated molecular 
technology — to determine which have been used by an HIV- 
infected individual. 
What has this testing revealed? As reported in the Dec. 24, 
1992 New England Journal of Medicine, a fall in the prevalence 
of infected syringes from 67 percent to 43 percent during the first 
14 months of the needle exchange program. Comments Dr. 
Kaplan, “Mathematical models suggest that this decrease trans¬ 
lates into a one-third reduction in the rate of new infections 
among the program’s active participants. Moreover, the data 
show that offering clean needles led to a high demand for drug 
treatment among program participants, and in no way did it create 
a new generation of drug addicts.” 
New Haven’s needle exchange effort, a kind of outreach 
program to street addicts, has been included as part of the 
Fighting Back initiative mentioned previously. On Feb. 4, the 
city announced that it will receive $2.4 million from the Robert 
Wood Johnson Foundation to continue its Fighting Back effort 
for four more years, making the city a model of community-wide 
cooperation in fighting alcohol and drug abuse; the first year of 
the Robert Wood Johnson grant was for $600,000. 
Yale’s contribution — particularly that of its medical school 
— has played a major role in the city receiving and implementing 
the Fighting Back grant. In fact, in December 1992, the 
University’s Weekly Bulletin and Calendar filled four tabloid- 
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Yale Medicine Readership Survey 
Please carefully remove this questionnaire and complete it. Then fold according to the instructions on Page 4. 
staple, affix a 29-cent stamp, and mail. Abbreviations used in survey: YSM.Yale University School of Medicine; 
EPH, Department of Epidemiology and Public Health. All answers are confidential. Please mail by 6/1/93. 
I. What I think about Yale Medicine 
A. On average, how much of Yale Medicine do you read? 
_ P) most of it 
_(3) some of it 
_ (4) none of it (Go to Part II, Page 4) 
_ Si I do not receive Yale Medicine (Go to Part II, Page 4) 
B. On average, I spend about the following amount of time reading Yale Medicine: 
_(|| up to 15 minutes 
_ P) 15 to 30 minutes 
_ (3) more than 30 minutes 
.C. The parts of the magazine I read most carefully are (check all that apply): 
_ short pieces, three pages or less 
_ photographic essays 
_ feature articles, in the front section of the magazine 
_ articles written by alumni 
_ Editor’s Message 
_ Gallery (art history from the Yale medical historical library) 
_ Scope (news about research at the school) 
_ Faculty News 
_ Alumni News (short reports on YSM or EPH graduates) 
_ Student News 
_ Obituaries 
_ Alumni Report (report of the Office of Alumni Affairs) 
_ Development Report 
_ Continuing Education 
_ Reunion Reports 
_ Alumni Fund Report 
D. In general, I prefer (check one): 
_ ih in-depth, feature articles 
_ r) shorter, 1- to 3-page features 
_ (3) the current mix of some long and some short articles 
E. In general, the level of complexity of the features is (check one): 
_ (1) about right 
_ too detailed scientifically and medically; hard to understand 
_ (3| too superficial 
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F. I enjoy articles that are (check all that apply): 
_ historical 
_ about basic research at YSM 
_ about clinical research at YSM 
_ about student research at YSM 
_ articles by or about students 
_ articles by or about alumni 
_ about social or humanitarian issues in medicine or public health 
_ about travel or international issues 
_ about financial and policy issues in medicine or public health 
_ clinical stories 
_ accounts by persons who have interests outside of their field of medicine or public health 
_ fiction/poetry 
_ educational issues 
_ other (please specify): 
G. What recent feature, if any, have you found most memorable and enjoyable? 
H. Are there any subjects about which you feel Yale Medicine should offer more coverage? (Please list) 
I. How would you rate the overall content and writing in the magazine? 
_ (1) excellent _(2)good — (3)fair — (4) Poor 
J. If 'fair” or “poor, ” please offer suggestions for improvement, if any: 
K. How would you rate the overall appearance of the magazine? (Check one) 
_ (1, excellent _(2)good _ (3) fair _(4)poor 
L. If "fair” or "poor, ” briefly state any suggestions for improvement: 
M. Do the covers invite you to read the magazine? (Check one) 
_(|i always r usually _(3) sometimes _(4) never 
N. Do you have a preference about the use of color on the cover? I prefer (check one): 
_ (|) black and white 
_ black and white and one color 
_ (3) black and white and two colors 
... full color 
- (4) 
_ .1 have no preference on the use of black and white or color 
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O. What do you like best about Yale Medicine? 
P. What do you like least about Yale Medicine? 
Q. We have begun to run limited advertising from Yale-related organizations in Yale Medicine to help subsidize 
increasing costs. How do you feel about such advertising in Yale Medicine? {Mark one): 
(|) Strongly _P) Unfavorable _(3) Neutral _(4| Favorable _ . Strongly 
Unfavorable Favorable 
R. How would you feel if Yale Medicine began to run limited non-Yale-related advertising {no tobacco or alcohol 
products) (Mark one): 
_ Strongly _(2) Unfavorable _ V) Neutral _ 4| Favorable _ . Strongly 
Unfavorable Favorable 
S. To help offset increasing costs, Yale Medicine may offer readers the chance to contribute an annual voluntary 
subscription fee for the magazine. If this were to happen, would you be willing to contribute: 
_... $0 _,,,$25 ,,$50_,.,$75 _ ,,$100 _ 8aa Other: {If "other,” please denote amount) %_ 
T. Yale Medicine is published three times a year. Would you prefer to receive it four times a year? 
_(1|Yes _(2)No _(3) No opinion 
U. We welcome additional comments or suggestions about Yale Medicine. 
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II. Personal information 
A. I am a (check all that apply): _YSM graduate 
_YSM full-time faculty _YSM clinical faculty 
B. My age is:_under 30 _30s _40s _50s 
(1) (2) (3) (4) 
C. I am: _(|male _(1| female 
D. My academic degree(s) (check all that apply): 
_ EPH graduate _Former house staff 
_Other (If “other, ” explain):_ 
_ 60s _70s _80s or older 
(5) (6) (7) 
M.P.H. _Dr. P.H._M.D. _ Ph.D. _ M.D., Ph.D. _ D.Sc. _ Other: 
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instructions still show. 
2. Fold up on the dotted line below, again, away from you, so that the panel below, which is printed upside 
down, becomes the front of the survey envelope. These instructions will become the back of the envelope. 
3. Staple the survey closed as marked on the front of the envelope. 
4. Affix 29 cents postage and mail. 
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YPI trainees pictured with the institute’s Paul Haberle are (from 
left): Ruth Hoff, Elizabeth Muniz and Dolores Pittman. 
sized pages with articles detailing the medical school’s contribu¬ 
tions to drug research, outreach, and substance abuse education 
and treatment. School of Medicine drug treatment programs and 
YSM-affiliated organizations offer valuable training to medical 
students, YNHH resident physicians and social workers, and 
provide much needed care to community patients. 
Among those substance abuse treatment efforts are: 
•APT Foundation. Under the direction of Yale medical 
faculty members, the APT Foundation is a separately incorpo¬ 
rated organization. In addition to its alcohol abuse treatment, 
prevention and education activities, APT does similar work with 
cocaine and opiate addiction. Services include methadone main¬ 
tenance for heroin addicts. Executive director: Rosalyn S. Liss, 
M.P.H. ’78, lecturer in psychiatry. 
• The Mother's Project. The APT Foundation, Child Study 
Center, the department of pediatrics, the YNHH Women’s Cen¬ 
ter and the Primary Care Center collaborate to provide drug 
treatment, in-home support and obstetrical care for women who 
are active cocaine users during pregnancy. Pediatrician Brian 
Forsyth notes that therapeutic child care is provided to the women 
and children in the program. Director: Tracy Washington. 
• West Haven VA Medical Center. School of Medicine faculty 
also play a major role in the extensive inpatient and outpatient 
substance abuse treatment offered by the Department of Veterans 
Affairs Medical Center in West Haven, which is affiliated with 
the medical school. 
Mental Health Outreach 
The School of Medicine's service to the community in drug 
treatment is part of YSM’s commitment to offer quality mental 
health care to New Haven area residents, regardless of their 
ability to pay. At the forefront of providing low-income people 
with such care is the Connecticut Mental Health Center (CMHC), 
operated jointly by Yale and the State of Connecticut. Ezra E.H. 
Griffith, M.D., professor of psychiatry, is CMHC’s director. 
CMHC’s Substance Abuse Treatment Unit (SATU) is one of 
the area’s major resources for such care. SATU itself comprises 
three units: evaluation and brief treatment; alcohol treatment; and 
outpatient services. Directed by Richard S. Schottenfeld, M.D. 
'76, associate professor of psychiatry. SATU annually treats 400 
or more individuals who are addicted to alcohol and drugs and 
those who are dually diagnosed with a mental disorder, such as 
schizophrenia, plus a substance addiction. SATU also serves as 
a centralized referral source to anyone interested in treatment. 
Offering similar treatment services is CMHC's Hispanic 
Clinic at One Fong Wharf. Directed by Carlos A. Gonzalez. 
M.D., assistant professor of psychiatry, this clinic serves ap¬ 
proximately 300 patients a year. 
A leader in substance abuse research, CMHC is in the midst of 
$3.4 million in construction to expand its basic and clinical 
research programs in this area. In addition to substance abuse 
treatment and research, CMHC offers both inpatient and outpa¬ 
tient settings to people with such disorders as schizophrenia and 
depression. As a lead agency in the state’s managed care system, 
the center coordinates mental health care in New Haven. Hamden. 
Woodbridge and Bethany. 
Among CMHC’s many community outreach efforts, its Con¬ 
sultation Center advises area mental health agencies on how best 
to organize their resources. And a CMHC conference held in 
1992, “The Police and the Black Family,” drew more than 500 
people to Albertus Magnus College. Co-sponsored with the New 
Haven police, the meeting was so well received that another 
conference, on violence against women, will occur this year. 
Fast fall, the medical school added a mental health worker 
training program to its array of services to the surrounding 
community. In October 1992, the Yale Psychiatric Institute 
(YPI), the department of psychiatry’s private psychiatric hospi¬ 
tal, and the Hill Development Corp. announced that YPI would 
provide on-the-job training to six local residents over two years. 
Each trainee rotates through both the inpatient and outpatient 
services at YPI, and receives classroom instruction, a stipend and 
individual medical benefits. 
Comments HDC President Bonaventure W. Console III: "We 
are very pleased to see another fine example of how the medical 
school is actively working with us to help revitalize the Hill 
neighborhood. The growth of Yale and the Hill are dependent on 
each other, and the future of both depends on benchmarks of 
collaboration like the YPI/HDC program.” 
Yale’s commitment to help New Haven address its pressing 
social, health and economic problems might well serve as a 
national model of town-gown cooperation as the sense of crisis 
intensifies in many of America’s cities. The magnitude of 
national urban erosion is reflected in the 1990 census figures, 
which showed that New Haven had risen from its 1980 status as 
the nation’s seventh-poorest city to become the 33rd poorest — 
not because New Haven’s wealth had increased, but because so 
many other cities had become poorer. 
Observes Dean Burrow: “During the past decade, national 
policy toward the cities has gone in the wrong direction. I have 
great hopes that the new administration will reverse this course. 
On the local level, Yale too must do its part. Although the 
University cannot make the social problems that affect New 
Haven simply vanish, we must rededicate ourselves to using our 
great academic strength to help solve those ills.” YM 
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Asian-American Students 
Serve School, Community 
by Rosalind D 'Eugenio 
In the fall of 1887, Shiukichi Shigemi, a first-year medical 
student newly arrived from Tokyo, Japan, anxiously stood before 
Yale’s Medical Hall on York Street. The small, two-story 
wooden building and brick addition served as the dispensary, 
laboratories, lecture hall and offices of the Medical Institution of 
Yale College. Four years later, after studying with such legend¬ 
ary faculty members as William H. Carmalt and James K. 
Thacher, Mr. Shigemi would receive his M.D. degree with 14 
other classmates, and thus become the first graduate of Asian 
descent from the Yale School of Medicine (YSM). It would be 
nearly two decades later, in 1909, before Fu-Chen Yen. a Chinese 
national, would become the second Asian alumnus of the school. 
Over the next seven decades, the School of Medicine experi¬ 
enced a sporadic increase in Asian and Asian-American student 
enrollment. Yale medical graduates would come to include such 
physicians as Isao Hirata Jr., M.D. ’45, a retired surgeon who as 
a Japanese-American during World War II. gratefully accepted 
the emotional support of his fellow students [see “Yale Medical 
Students March to War," Yale Medicine, Summer 1990] and 
Andrew S. Wong, M.D. '51 .clinical professor of ophthalmology 
at Yale, who serves as a medical school alumni representative to 
the Association of Yale Alumni. 
By the early 1980s, the percentage of students with an Asian 
background had risen to the low-teens. Then, in the 1987-88 
academic year, an abrupt — and unexpected —jump in applica¬ 
tions from Asian-Americans occurred, from 230 to 335, with a 
similar number of applicants continuing to the present day. 
Because of the high quality of these applications, a large number 
of Asian-Americans have been accepted, and today attend the 
medical school. In fact, at 103 in number, Asian-Americans 
make up 22 percent of the medical student population, the largest 
group of ethnic minority students at the school. 
In addition to adding to the diversity of the medical school, 
Asian-American students have taken a leadership role in service 
to the school and the surrounding community. Their presence in 
increasing numbers also has raised important questions, for 
instance: 
1. Because Asian-Americans are a minority, but are not as a 
rule economically disadvantaged, what kind of special support, if 
any, should the school offer them? 
2. Why have so few Asian-American physicians pursued 
careers in academic medicine, leaving relatively few mentors for 
students of Asian background at Yale and other medical schools? 
0% 
From left. Sung Lee, Hyun Bae and Irene Wu. 
3. What can be done to counter negative stereotypes about 
people of Asian descent that occur both in the general population 
and among disadvantaged minority groups, as tragically demon¬ 
strated during the most recent Los Angeles riots? 
AAIYM Makes its Debut 
To help Asian-American students and the medical school deal 
with such issues, during the 1991-92 academic year, a group of 
three medical students, Hyun Bae, then a second-year student, 
and Irene Wu and Sunghoon "Sung” Lee, then in their first year, 
formed Asian-Americans in Yale Medicine (AAIYM, pronounced 
‘‘aim"). AAIYM’s charter states that the group is dedicated to 
serving the School of Medicine by: 
• establishing a sense of community for Asian-Americans; 
• serving as a voice for Asian-Americans; 
• supporting multiculturalism. 
Taryn Ha, a second-year student who is active in AAIYM, 
says that forming the organization was a challenge: “We had so 
many different people and ideas. Some students thought we were 
trying to be exclusive, setting ourselves apart.” She adds that 
AAIYM’s organizers reassured those with such concerns that 
"we are trying to find out more about ourselves so that Asian- 
Americans can share with others.” 
Rosalind D‘Eugenio is media specialist at the Yale School of 
Medicine office of public information. 





Mr. Lee. who is one of AAIYM’s leaders, explains that 
AAIYM meetings attract people from a variety of Asian back¬ 
grounds. including Indians. Southeast Asians and Vietnamese, as 
well as Japanese. Chinese and other East Asians. He adds that it’s 
left up to individual students to decide whether they share an 
Asian-American identity: “I wouldn't say there is one Asian 
identity. Rather, there are many differences, geographically and 
historically, among Asians. What our group tries to do is be 
receptive to everybody.” 
Mr. Lee hastens to add that while AAIYM may be a represen¬ 
tative voice for Asian-American students, it doesn't claim to be 
the only voice. In acknowledging that some students of Asian 
background see no need for such a group, he adds that AAIYM 
members “feel that Asian-Americans share enough in common 
1 so that when we’re together we can do some good.” 
A strong supporter of AAIYM is M. Lynne Wootton. the 
medical school’s director of admissions. She recalls that when 
she assumed her present position five years ago, she was sur¬ 
prised that Asian-American students, the most numerous minor- !ity group in the first-year class, didn't have an organization 
similar to the Student National Medical Association (SNMA), 
which represents African-Americans. Hispanics and other disad¬ 
vantaged minorities. “I thought it was important for Asian- 
Americans to have their own voice,” she says. 
One of the ways that Ms. Wootton shows her support is by 
inviting AAIYM to help recruit prospective YSM students of 
Asian descent. It’s not an unprecedented effort: for years her 
office has helped Latino and African-American students send 
letters to applicants who have identified themselves as members 
of their respective groups. The correspondence welcomes the 
applicants and gives telephone numbers of Yale medical students 
who can put them up for the night before their interviews. Last 
year, with the help of Ms. Wootton and AAIYM, Asian-Ameri¬ 
can students began sending welcoming letters to accepted stu¬ 
dents of Asian descent. 
Not all such issues are as easily supported, however. Take, for 
instance, the lack of Yale medical faculty of Asian descent, a 
problem that AAIYM also is trying to address. Explains Alice 
Chang, who serves on the YSM committee on minority affairs, 
“The lack of mentors has caused difficulties, especially for Asian 
women students. I think I understand how to work within an 
American community, and in that sense I don’t feel disadvan¬ 
taged. I am concerned, however, about the lack of Asian faculty.” 
Ms. Ha agrees: “I think I met one Asian woman here at Yale 
who is a full-time faculty member. She’s the only person who 
could relate to any experiences I have as a female Asian- 
American medical student at Yale.” 
This lack of role models is related to another issue facing the 
Asian-American medical community: Why so few physicians of 
Asian descent are choosing to go into academic medicine. Ac¬ 
cording to the Association of American Medical Colleges, na¬ 
tionwide, people of Asian background make up only 7 percent of 
medical school faculty. 
While such figures were not available for the Yale medical 
faculty, Robert H. Gifford. M.D., associate dean for education 
and student affairs, agrees that Yale must improve its recruitment 
of prospective Asian-American faculty. He comments, “When 
the Asian-American students came to me and said they'd like to 
have a faculty advisor. I said fine. But when I looked through our 
faculty list. I was amazed to see how few Asian faculty are here.” 
Dr. Gifford acknowledges that he doesn't know what may be 
keeping Asians away from the faculties of medical schools, 
including Yale’s: “Maybe it will simply take more time for our 
current students to move into faculty positions. For Yale, the 
problem of having few Asian faculty members is a serious one 
and one that we are devoting attention to.” 
Dean Gerard N. Burrow, M.D. "58, agrees: “When I served as 
chair of the medical school admissions committee back in the 
1960s, we had far fewer Asian students than we do today. With 
the recent increase of Asian-American students at the school, it's 
imperative that we work toward providing more faculty mentors 
for this major segment of our student population.” 
How is AAIYM contributing to this dialogue? They're 
sponsoring a series of lectures and visits from Asian-American 
medical faculty members from Yale and other universities. The 
hope is that the example of Asian-American mentors will encour¬ 
age today’s students to move into academic medicine. 
Last year, the lecture series made its debut with Richard S. K. 
Young, M.D., associate professor of pediatrics and neurology at 
Yale and chief of pediatrics at the Hospital of St. Raphael. He 
presented slides and discussed his work on tuberculosis in Hong 
Kong as part of the Volunteer in Asia program. “We had a great 
turnout for Dr. Young,” reports Sung Lee, "and before and after 
his presentation we held receptions so that the students and 
faculty could mingle.” 
Dr. Young's lecture was followed some weeks later with a talk 
by Jung H. Kim. M.D.. a Yale associate professor of surgery. 
Other speakers are scheduled for the spring of this year. 
Into the Neighborhood 
Although historically Asian-American students have kept a low 
profile, today their community work is gaining much-deserved 
recognition. For example, Alice Chang and Sung Lee, elected by 
their fellow medical students as this year’s student volunteer 
coordinators, were among the school’s 1993 Distinguished Com¬ 
munity Service Award winners. [See "Student News," Page 40.] 
In their role as volunteer coordinators. Ms. Chang and Mr. Lee 
work with Karen Guilmette. assistant director of government and 
community affairs and administrative coordinator for student 
volunteer programs. The students and Ms. Guilmette organize 
orientation activities, prepare newsletters advising students of 
volunteer opportunities, and manage the volunteer office in 
Harkness dormitory. 
Second-year medical students Junhee Lee and Paul Lee (not 
related to each other or to Sung Lee) are two other Distinguished 
Community Service Award winners. These Asian-American 
students combine a love for children with their desire to help the 
community as co-coordinators of the medical school’s Elemen¬ 
tary Student Tour Program. The program gives local elementary 
school students the chance to view a videotaped tour of the school 
and to engage in several hands-on, interactive stations. 
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Explains Junhee Lee, “We introduce the children to different 
parts of the medical sciences. They can listen to a heart at the 
diagnostic station, look at a diseased heart at the cardiology 
station, or test each other's reflexes at the clinical diagnosis 
station." 
Mr. Lee adds that since most of the children live in the 
surrounding Hill neighborhood, it's important to let them know 
that the medical school is a friendly neighbor. Moreover, he 
hopes that the tour program may encourage children to go into the 
medical sciences when they get older: "We want to generate an 
interest in medicine and show the children that there are a lot of 
careers in the field they can choose aside from being a doctor, 
such as a nurse or technician.” 
Ms. Ha and Ms. Chang are two of the many Asian-American 
student volunteers with the Adolescent Substance Abuse Preven¬ 
tion Project (ASAP). As part of ASAP. Yale medical and public 
health students visit the classrooms of seventh graders at Roberto 
Clemente Middle School to talk about the health effects of drugs 
and alcohol and how to resist peer pressure to try harmful 
substances. Says Ms. Chang, "The kids especially enjoy it when 
we bring in body and organ models and explain what effect drugs 
and alcohol have on them.” 
In addition to drug education, Ms. Chang says that Asian- 
American students in ASAP hope to offer the Roberto Clemente 
students, who are mostly African-American and Hispanic, a 
lesson in cross-cultural friendship. She says, "At first, students 
did ask us questions about our looks and origins, but after a few 
visits they realized that we're people just like they are. All those 
stereotypes started to break down.” 
Opening Lines of Communication 
Alice Chang and her fellow AAIYM members are also trying to 
combat prejudice within the medical school. They are, for 
example, working with fourth-year medical student Bill 
Rodriguez, president of Yale’s SNMA chapter. This year, 
AAIYM and SNMA have joined forces to promote understand¬ 
ing between their members. 
Mr. Rodriguez explains, “The idea of SNMA and AAIYM 
working together stems from the 1992 conflicts between the 
black community and the Asian shopkeepers in Los Angeles. 
After those riots, we held a discussion among the medical 
students and discovered that we had no understanding of each 
other, even with the common bond of being in medical school 
together. So, we decided that, although we couldn't do anything 
to help in L.A., we could have a greater understanding of each 
other here.” 
In September 1993, both organizations hope to begin a 
multicultural education project for elementary and junior high 
school students. Yale students from both AAIYM and SNMA 
will visit classrooms and conduct discussions about Asian- 
American, African-American and Hispanic communities. "We 
hope to make kids aware of stereotypes that may or may not hold 
true, and to explain to them that a person can't be judged by his 
or her appearance,” explains Mr. Rodriguez. 
Finally. AAIYM hopes to get Asian-American students better 
acquainted with each other through extracurricular activities. For 
instance, this year AAIYM held a potluck dinner at the home of 
second-year student Roger Yang. an event attended by more than 
50 students. "This was a perfect opportunity for the first-year 
students to get to know the senior students,” says Sung Lee. 
Despite the importance of AAIYM's cross-cultural commit¬ 
ments. Sung Lee says Asian-American students must keep sight 
of their goal to support each other. As he explains, "There are 
students and faculty here who look through the medical school 
telephone directory and come across names of Asian colleagues 
they’ve never met. So, it's important that AAIYM provide the 
chance for new students, older students and faculty to meet." 
With nearly two years of accomplishments behind them, the 
students of AAIYM seem encouraged to press on toward meeting 
this and their other goals. Moreover, they’re doing so with the 
medical school administration’s blessing. Says Dean Burrow, 
"Asian-Americans make a vibrant addition to the life of our 
school, and will play a vital role in its future. I'm grateful for the 
example of hard work, leadership and community service that 
these students have brought to us, and look forward to their 
increasing contributions to the Yale School of Medicine.” YM 
Second-year medical student Junhee Lee discusses the use of 
X-rays with students from the Hill Central Elementary' School. 




Some Ironies at the Interface 
Of Medicine and Public Health 
by Susan Silliman Addiss, M.P.H. '69, M.U.S. 
Over the 20 years or more that I have been working as a public 
health professional, public health and medicine have had a poorly 
understood relationship — no less by those who make up the 
partnership. Public health and medicine are inextricably inter¬ 
twined, but each at times has tried to define itself in a way that 
excludes the other. 
A recent Institute of Medicine study. The Future of Public 
Health, establishes three basic functions of public health. The 
study committee, which included several physicians, defined 
these functions as assessment, policy development and assur¬ 
ance. Each of these functions has its parallel in medicine. 
For example, the first function, assessment, represents the 
diagnosis of a community, rather than an individual. It consists 
of the collection, analysis and study of health status indicators — 
population-based measures. 
Second, policy development might be likened to a treatment 
plan. In public health, the plan consists of goals, objectives and 
strategies to improve the people’s, not the individual's, health. 
Instead of a prescription or a procedure, it is a call for community- 
based programs to meet health needs identified during the assess¬ 
ment stage. 
Finally, the assurance function reflects the concept of “a 
governmental presence at the local level” or “the guarantor of last 
resort” to carry out the public sector responsibility to see that 
programs are in place. While assurance does not necessarily 
require that a public health agency offer the programs itself, the 
agency must provide the leadership and advocacy to see that 
health care needs are met. Assurance emphasizes both preven¬ 
tion of illness and promotion of healthy life-styles that will 
protect against or delay the onset of illness and disability. Given 
this framework of assessment, policy development and assur¬ 
ance, there are instructive ironies that occur when public health 
calls on medicine, and vice versa. 
Take the area of primary care. Assessment yields the distress¬ 
ing figures about the uninsured, about lack of access to care, about 
inappropriate utilization of hospital emergency rooms, about 
excess costs incurred through failure to treat simple conditions 
before they progress to serious illness. Policy development 
results in recommendations to create subsidized insurance pro¬ 
grams, increase the level of Medicaid eligibility, provide addi¬ 
tional funding to community health centers, establish school- 
based health centers, and support other programs to increase 
access to care. 
When we turn to assurance, however, we are brought up short. 
America’s health care system has in fact increased access to 
Susan Silliman Addiss, M.P.H. ’69: 
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Addiss serves on the editorial board of the Journal of 
Public Health Policy. 
primary care, especially for women and children, but we now 
discover that there are not enough primary care providers (phy¬ 
sicians, nurse practitioners and physicians’ assistants) to handle 
the additional visits occasioned by the increased access. The 
result is long waiting lists, closed intakes — in short, delayed care. 
Susan S. Addiss 
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or no appropriately early care. (Of course there will always be 
care provided when illness has reached emergency proportions.) 
The shortage of primary care physicians is a problem that 
public health by itself cannot do very much to alleviate. In the 
world of medicine, primary care does not have the attractive 
image that the subspecialties do. Nor does it pay as well. 
Moreover, primary care lacks glamour, and its most high-risk 
patients are sometimes difficult and non-compliant. 
The solution to this problem lies in part with the country’s 
medical schools and in part with social policies that must change 
the way primary care is regarded and rewarded. Medical students 
should have required exposure to ambulatory settings delivering 
primary care; medical school curricula need to place more 
emphasis on, and acknowledge the importance of, primary care. 
And, ultimately, the distribution of residency positions will need 
to be revised, with a potential limitation on slots available for the 
subspecialties. 
These changes would best be accomplished by medicine and 
public health in tandem. Public health, through its assessment 
function, can provide an estimate of the magnitude of the adjust¬ 
ment required, of the desired changes in the ratio of primary care 
to subspecialty physicians. (Many other countries with well- 
regarded health care systems have primary care:subspecialty 
ratios close to 50:50, for example: Canada, 52:48; the former 
West Germany, 45:55. Ours in the United States is, at best, 
30:70.) 
In Connecticut, both schools of medicine — Yale and the 
University of Connecticut — have begun to focus more on 
primary care, perhaps partly because of Gov. Lowell P. Weicker 
Jr.’s initiatives to improve access. As this renewed emphasis on 
primary care increases, it will be appropriate for public health 
agencies and primary care providers to advise medical schools 
about the dimensions of the problem, including information 
about recruitment for specific vacancies in specific institutions. 
A Two-edged Sword 
An ironic situation in which medicine is prepared and the public 
health system is not occurs in the area of childhood lead poison¬ 
ing. Recent studies have shown that lower blood lead levels than 
had been previously thought can cause mental deficits and 
behavior problems in young children. 
The medical world has received this message. More and more 
children under the age of 6 are being tested, and increasing 
numbers with unacceptably high levels of lead in their blood are 
being reported to local health departments, as required by law. 
(In Connecticut, in the first two quarters of 1990, there were 21 1 
reports of blood lead test results at or above 20 micrograms per 
deciliter, the new threshold for lead poisoning. During the first 
half of 1991, there were 666 cases.) 
The reason why public health cannot respond adequately to 
lead poisoning is because its infrastructure in Connecticut has 
been eroding as communities’ economies have come increas¬ 
ingly under siege. Many local health departments have had to 
reduce staff, as has the State Department of Health Services. This 
means there may be delays before local health departments can 
deploy sufficient personnel to assess a child's environment, take 
paint samples, determine the source of the lead, issue orders to the 
owner of the dwelling, and enforce those orders through the 
courts, if necessary. It also means there are often delays in 
receiving lead test results from the state laboratory. The physi¬ 
cian, who has anxious parents expecting immediate action, is 
likely to feel let down by the public health system. 
In this case, organized medicine will need to join with others 
in advocating for increased resources for the public health infra¬ 
structure, so that adequate follow-up and abatement of environ¬ 
mental lead can be assured. Such advocacy has in fact been 
brought to bear through the Yale School of Medicine's Focus 
Group on Community Health and Education Initiatives, which 
has drawn attention to this problem in New Haven. [See "YSM 
and the Community: Toward a Healthier Future,” Page 17.] 
A final example of irony at the interface has to do with one of 
the most important programs of public health, communicable 
disease surveillance and control. It is through surveillance that 
state and local health officers get early warning of outbreaks of 
disease in a community, and the earlier the warning, the greater 
the chance that rapid investigation and control measures can 
reduce transmission to the absolute minimum. 
Most surveillance systems are based on mandatory reporting 
of listed communicable diseases by physicians and by laborato¬ 
ries. Unfortunately, most physicians do not report diseases on the 
list with any regularity. If it were not for nearly 100 percent 
reporting by laboratories, health officials would frequently be 
faced with situations in which unnecessary transmission of 
disease has occurred, sometimes with resulting hospitalization 
and even death. 
No more than 20 percent of community physicians in Con¬ 
necticut report as mandated. I suppose this is because most 
physicians are focusing on the welfare of individual patients, and 
it is not in their usual frame of reference to think of one patient’s 
illness as it could affect the community. 
Salmonella provides a good example of the different mindsets 
of medicine and public health. Physicians think about preventing 
possible dehydration, about reducing diarrhea and coping with 
other symptoms of the individual patient. This contrasts greatly 
with the health official’s point of view. 
From the latter perspective, the sick individual becomes an 
“index patient” because of the potential impact of his or her 
illness on other people. Is the patient a food handler, a daycare 
worker or a health worker? Health officials think about excluding 
the food handler from work, about follow-up to get three con¬ 
secutive negative stool cultures and about the need to get stool 
cultures from others at the patient’s place of work. 
Despite health officials’ perpetual complaints about physi¬ 
cians’ failure to report communicable disease, reporting rates do 
not improve. The irony here is that the physician may “cure” the 
patient, but because of failure to report, further cases of disease 
transmitted by the patient are incubating and will soon break out. 
There are still other ironies at the interface of public health and 
medicine, but these three examples serve to make my point: 
Better relationships between the two professions will require 
more frequent dialogue and a better understanding by each side 
of the other. For the health of our communities, we must commit 
ourselves to making the effort. YM 
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Gallery 
The Yale Medical School Clinic and Dispensary 
(Jane Ellen Hope Building), circa 1902 
In 1902, the Yale Medical School Clinic Building opened be¬ 
tween the corner of Congress Avenue and Cedar Street and what 
was Rose Street, to better integrate medical student education 
with the dispensary care that Yale had been providing New 
Haven residents for 30 years. A $100,000 gift by Mrs. Thomas 
G. Bennett, the daughter of humanitarian Jane Ellen Hope and 
Oliver Fisher Winchester, covered complete construction and 
equipment costs of the “free Renaissance” style building. Archi¬ 
tect L.W. Robinson of New Haven had the edifice built of North 
Haven red brick and East Haven stone. 
The main entrance on Congress Avenue opened into a large, 
central hall that rose the entire three stories of the building, and 
was crowned by a massive skylight. Floors one and two offered 
clinics in internal medicine, orthopaedics, surgery, neurology, 
pediatrics, obstetrics/gynecology, laryngology and ophthalmol¬ 
ogy. An X-ray room, darkroom and patient waiting room were 
located on the second floor; a surgical amphitheater on the first 
floor featured a seating area set in steep tiers to afford each 
medical student a clear view of the art of Yale faculty surgeons. 
Student and custodian apartments occupied the third floor. 
In 1932, the medical clinics — which were serving 63,000 
patients annually — moved to New Haven Hospital's new Clinic 
Building. In time, the surgical amphitheater was abandoned to a 
ghostly network of mechanical ductwork, and only the dental 
clinic founded by Bert Anderson, M.D., an oral surgeon formerly 
with the Yale-China program, was left to provide subsidized care 
to New Haven’s low-income residents. 
By the 1970s. the dental clinic too had moved, and the limited 
laboratory and classroom space that remained, having fallen 
short of modern fire code requirements, was vacated except for 
the medical instrument shop in the basement. On June 19, 1982, 
the Yale Corporation approved $2.5 million to renovate the Hope 
Building for seminar rooms and lecture halls: this time, $100,000 
was enough to cover only the cost of furnishings and carpeting. 
Major funding came from the Pew Memorial Trust of Philadel¬ 
phia. and the Ira W. De Camp Foundation of New York. 
New Haven architects Alexander Purves and Allan Dehar 
Associates called for renovation of the old amphitheater as a 150- 
seat lecture hall, plus the creation of lecture halls with 75 and 150 
seats, nine seminar rooms and a lounge area on the third floor, 
which would retain the original skylight. This space would later 
become the Arthur Ebbert Jr.. M.D., Eounge. With its new main 
entrance on Cedar Street, the Hope Building reopened in 1983. 
and in April of that year earned a Merit Award from the New 
Haven Preservation Trust for creative use of an historic building. 
Gregory• R. Huth 
















Dr. Martin Luther King Jr. Day 
The School of Medicine marked the 25th 
anniversary’ of the death of Martin Luther King Jr. 
with seminars and a symposium on urban violence. 
Photographs feature (counterclockwise from 
upperleft): (I) Beverly Deloach of the New Haven 
YWCA Rape Crisis Center; (2) Dr. Martin Luther 
King Jr. Day poster, designed by Yale Printing 
Service; (3) Second-year student Marjorie 
Rosenthal receiving a Distinguished Community’ 
Service Award from Dean Gerard N. Burrow. 
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(4) 
Clockwise from above: (4) Curtis Patton, Ph. D., professor of 
epidemiology, and first-year student Carole Smith: (5) Curtis 
McBride, a representative of Brothers Getting Busy, a community 
support group for children; (6) Symposium speakers Anne 
Flintcraft, M.D., director of the Domestic Violence Training 
Project in New Haven, and Mark Rosenberg, M.D., director, 
division of injury control. Centers for Disease Control. 
(6) 
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Shark Research May Aid 
Human Immune Systems 
During the 22 years that John N. 
Forrest Jr., M.D.. professor of medi¬ 
cine. has conducted research on dogfish 
sharks, he has identified a new hor¬ 
mone in the shark’s heart and cloned 
the gene for the hormone. He also 
made two startling, but unpublished, 
observations. One, sharks resist 
infection. Two, these fish do not 
appear to get cancer. 
As part of this ongoing research, 
recent collaboration between Dr. 
Forrest and Michael Zasloff, M.D., 
formerly of the University of Pennsyl¬ 
vania, resulted in the discovery of a 
new steroid in dogfish shark tissue that 
exhibits powerful antibiotic action 
against a variety of bacteria, fungi and 
protozoa. In the Feb. 14, 1993, issue of 
the Proceedings of the National 
Academy of Sciences, the scientists 
named the new substance squalamine. 
Dr. Forrest states that squalamine is 
"as powerful as ampicillin and also is 
effective against the fungus Candida. 
More research is needed on the toxicity 
and effectiveness of squalamine, but 
squalamine and related compounds 
eventually could be valuable in treating 
newly emerging drug-resistant strains 
of infectious agents.” 
Pierce Lab to Study 
Skin Sensations in Aged 
The John B. Pierce Laboratory has been 
awarded a four-year, $550,000 grant 
from the National Institute on Aging 
(NIA) to conduct a study on how aging 
affects sensations of the skin. Affili¬ 
ated with the School of Medicine, the 
Pierce laboratory focuses on sensory 
research, and the impact of indoor 
environment on human health. 
P E 
Joseph C. Stevens, Ph.D., a Pierce 
Laboratory fellow and senior research 
scientist and lecturer in psychology, 
will conduct the study with Martin G. 
Cherniak, M.D., associate professor of 
environmental and occupational 
medicine, in collaboration with the 
University of Louisville Perceptual 
Alternatives Laboratory. 
Dr. Stevens says, "We're testing the 
hypothesis that aging influences some 
parts of the body more than others.” 
He added that the researchers will 
“explore and map the skin surface for 
its ability to detect faint sensations of 
warmth, cold and vibratory touch and 
for its capacity to discriminate textures 
and dot patterns similar to the dot 
elements of Braille letters.” 
Autoimmune Link Found 
Between Breast Cancer 
And Stiff-man Syndrome 
By studying one of the rarest human 
diseases, the Stiff-man syndrome, an 
international team led by researchers 
from Yale University School of 
Medicine and Howard Hughes Medical 
Institute (HHMI) has discovered a 
new, possible link between breast 
cancer and autoimmune mechanisms. 
Stiff-man syndrome, a central 
nervous disorder characterized by 
rigidity and painful spasms of the 
skeletal muscles of the trunk and 
limbs, is a rare autoimmune disease. 
It is often associated with insulin- 
dependent (type I) diabetes mellitus. 
Researchers now have identified rare 
cases of Stiff-man syndrome not 
associated with type I diabetes, but 
associated with breast cancer. 
These patients have autoantibodies 
— substances produced by immune 
cells that go awry and attack the body's 
healthy cells — in their cerebral-spinal 
fluid and serum, directed against a 
brain protein with biochemical proper¬ 
ties that have not been fully identified. 
The association of breast cancer. Stiff- 
man syndrome and autoantibodies with 
the protein in two patients led to the 
early diagnosis of breast cancer in a 
third patient affected by Stiff-man 
syndrome, who was positive for the 
same antibodies. 
The Yale paper, reported in the Feb. 
25, 1993, edition of The New England 
Journal of Medicine, is the first 
description of a close correlation 
between breast cancer. Stiff-man 
syndrome and a specific set of antibod¬ 
ies. The research team, including 
scientists from Yale, HHMI and from 
Italy and the United Kingdom, included 
Yale postdoctoral fellows Franco Foli, 
M.D., Michele Solimena, M.D., and the 
paper's senior author, Howard Hughes 
Medical Institute investigator Pietro de 
Camilli, M.D., a professor of cell 
biology at Yale. 
NIMH Gives $2.5 Million 
For Tourette’s Research 
The National Institute of Mental Health 
(NIMH) has given a $2.5 million, 
three-year grant to Yale to support 
research on Tourette’s syndrome (TS) 
and related disorders. 
James F. Leckman, M.D., the 
Neison Harris Professor of Child 
Psychiatry and Pediatrics at the Yale 
Child Study Center, directs the multi- 
departmental project. Dr. Leckman and 
colleagues will research four specific 
aspects of TS: genetic factors; non- 
genetic factors that interact with genetic 
factors; the underlying biology of the 
brain; and possible treatments. 
Usually beginning in early child¬ 
hood, TS affects one in 1,000 boys and 
one in 10,000 girls. It is thought to 
contribute to some behavioral difficul¬ 
ties young boys experience in school. 










Drs. Redmond and Spencer and other members of the fetal tissue transplant team. 
The project involves faculty 
members from several departments, 
including biology, diagnostic radiology, 
epidemiology and public health, 
genetics, obstetrics and gynecology, 
psychiatry and psychology. 
David L. Pauls, Ph.D., associate 
professor of genetics, directs the 
project's genetic unit. He and his 
colleagues are trying to isolate TS 
candidate genes by separating the genes 
that are only developed in brain regions 
where TS tissue is found. He concen¬ 
trates part of his research on the 
possible genetic link between TS and 
obsessive compulsive disorder (OCD). 
According to Wayne K. Goodman, 
M.D., associate professor of psychiatry 
and director of Yale’s OCD program, 
the complex motor tics of TS can 
resemble the compulsions of OCD. If a 
relationship is found between the two 
disorders, then the course of treatment 
will likely change for OCD. 
Non-genetic factors being studied 
include prenatal environments, includ¬ 
ing the amount of stress the mother 
undergoes during pregnancy, and the 
amount of nausea and vomiting she 
suffers during her first trimester. The 
neurobiological studies include brain 
imaging studies to determine functional 
and structural differences between affected 
and normal brains. Other researchers are 
looking for differences based on the 
response of TS patients to certain 
medications or physiological challenges. 
Medication and Therapy 
Help Problem Drinkers 
Adults undergoing treatment for 
alcohol dependence may benefit from 
the medication naltrexone administered 
along with psychotherapy, says a team 
of researchers at Yale and the Univer¬ 
sity of Connecticut. “Naltrexone, an 
opiate antagonist, appears to enhance 
abstinence rates when a clear message 
about abstinence is provided, and 
efforts made to enhance patients’ 
commitments to an abstinence goal,” 
states Stephanie S. O'Malley, Ph.D., 
associate professor of psychiatry and 
the study’s co-principal investigator. 
The researchers reported their 
findings in the Nov. 15, 1992, issue of 
the Archives of General Psychiatry,’. In 
the study, 97 alcohol-dependent 
patients were treated for 12 weeks in 
the Substance Abuse Treatment Unit at 
the Connecticut Mental Health Center, 
a collaborative program between Yale’s 
department of psychiatry and the State 
Department of Mental Health. 
Patients treated with naltrexone and 
supportive therapy showed the highest 
cumulative rate of abstinence, at 61 
percent. Patients who received 
naltrexone and coping skills therapy 
were least likely to relapse, defined as 
five or more drinks at one time for men 
and four or more for women. 
Fetal Tissue Research Aids 
Yale Parkinson’s Patients 
Successful Yale clinical research on 
Parkinson's disease employing fetal 
tissue transplantation was reported in 
the Nov. 26, 1992, issue of The New 
England Journal of Medicine. 
“Three of the four patients have 
shown significant improvements during 
18 months of evaluation on which we 
are reporting,” states D. Eugene 
Redmond Jr., M.D., professor of 
psychiatry and director of the Yale 
Neural Transplant Program. 
Dr. Dennis D. Spencer, the 
Nixdorff-German Professor of 
Neurosurgery and principal investigator 
of the study, notes that transplantation 
combined magnetic resonance imaging 
with computer-targeted stereotactic 
surgical techniques. 
While the neural transplant team 
reported only on its first four patients, 
the team has transplanted a total of 13 
patients in the clinical study. In this 
research, initiated in 1988, fetal brain 
cells replaced the dopamine-producing 
brain cells deficient in people with 
Parkinson’s disease, a degenerative 
brain disease that affects approximately 
one million Americans. 
In contrast, a control group of three 
patients who did not undergo surgery 
but were followed for one year under 
nearly identical circumstances, showed 
no objective improvement and even 
required additional quantities of 
medication, the researchers report. 
“Although still impaired by 
Parkinson’s disease, patients improved 
their ability to perform a variety of 
motor movements and to perform such 
daily activities as dressing and feeding 
themselves and moving about. These 
improvements occurred after transplan¬ 
tation surgery and while taking reduced 
doses of anti-parkinson medications,” 
Dr. Redmond explains. 
This work is based on research in 
laboratory animals. In their research 
involving human subjects, the Yale 
scientists were first to document survival 
of frozen human fetal neural tissue 
transplanted into a human brain in 1990. 
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Sense Researchers 
Discover Supertasters 
Yale research has revealed that all 
people do not have the same number of 
taste buds. In fact, some people, catego¬ 
rized as supertasters, have as many as 60 
times more taste buds than others. 
Using a solution designed to test the 
sensitivity of people’s palates, the 
researchers developed three categories 
of tasters: nontasters, who taste the 
solution as water: medium tasters, who 
taste the solution as slightly bitter; and 
supertasters, who taste the solution as 
intensely bitter. Supertasters, because 
they have more taste receptors, perceive 
the flavor of such things as saccharin, 
sugar and caffeine as more intense. 
“Microscopic examination revealed 
that not only do supertasters have more 
taste buds,” explains Linda M. 
Bartoshuk, Ph.D., head of the study and 
professor of surgery (otolaryngology) 
and of epidemiology, “but the size and 
shape of the papillae, which contain the 
taste buds, are different.” 
According to Dr. Bartoshuk, with 
each bad cold or ear infection we suffer, 
one of the taste nerves is attacked. 
Nontasters are affected more by taste 
disorders because they have less taste 
bud redundancy, making them more 
susceptible to damage. Very little can 
be done to cure problems that affect 
taste, but Dr. Bartoshuk hopes that her 
research will help change that situation. 
New Imager Designed 
For Joint Movement 
Researchers in orthopaedics and 
rehabilitation and diagnostic radiology 
at Yale have designed a new device that 
will allow physicians to accurately 
measure complex wrist joint motion. A 
cine-computed tomography (CCT) scan 
enables physicians to determine 
individual wrist-bone movement and 
may allow more accurate diagnosis of 
ligament abnormalities. 
Scott W. Wolfe, M.D., assistant 
professor of orthopaedics and rehabili¬ 
tation, explains that after the initial 
images are taken with the CCT scan, 
the data are transferred to a computer, 
permitting digital tracking of the 
motion of each bone arc. The image, 
shown from several angles and trans¬ 
lated into a motion picture graphic, 
allows the physicians to calculate the 
movements and decipher which of the 
wrist bones has the abnormal motion. 
“Injury to the wrist has become one 
of the most common joint problems 
seen in Yale-New Haven Hospital's 
emergency department,” states Lee D. 
Katz. M.D., associate professor of 
diagnostic radiology and co-designer of 
the new imaging tool. "The repairing 
of these injuries needs to be done before 
chronic instability occurs.” 
Collaborating with Drs. Wolfe and 
Katz is Joseph J. Crisco, Ph.D., 
assistant professor of orthopaedics and 
rehabilitation, who played a key role in 
the computer software design. 
Yale/VA Study Shows 
Reduction in Stroke Risk 
A Yale-led study has demonstrated that 
low doses of the anticoagulant warfarin 
can reduce the risk of stroke by 79 
percent in patients who suffer from a 
common heart irregularity known as 
atrial fibrillation (AF). The 16-site 
Department of Veterans Affairs 
Cooperative Study was published in the 
Nov. I 1, 1992. issue of The New 
England Journal of Medicine. 
Michael D. Ezekowitz, M.D., 
professor of medicine at Yale and chief 
of cardiology and the Department of 
Veterans Affairs (VA) Medical Center 
in West Haven, is the principal 
investigator for the national study. 
Although previous studies have 
sought to examine treatment methods 
to reduce AF-related stroke, the Yale/ 
VA study is the only U.S.-based, 
double-blind, placebo-controlled trial. 
"We estimate that if patients were 
routinely treated with anticoagulant 
therapy,” says Dr. Ezekowitz, “the 
nation could save $2 billion in stroke- 
associated costs, and avoid the tragic 
consequences for patients and their 
families.” 
Gerontologist Suggests 
Training in Fall Recovery 
A Yale study published in the Jan. 5, 
1993, issue of the Journal of the 
American Medical Association suggests 
that elderly persons would benefit from 
learning techniques to pull themselves 
up after a fall. 
Mary E. Tinetti. M.D.. associate 
professor of medicine, states that elderly 
persons who panic after falling use 
strategies that are less effective, such as 
attempting to get up from a supine 
position as opposed to turning to a 
prone position, crawling to a support 
surface, and pulling themselves up. 
The researchers studied 1,103 New 
Haven residents who were at least 72 
years old and able to walk unassisted. 
After an interview, the researchers 
assessed the subjects’ upper- and lower- 
extremity strength, balance and gait. 
Inability to get up without help was 
reported after 220 of 596 non-injurious 
falls. Compared with fallers who were 
able to get up, fallers who were unable 
to get up were more likely to suffer lasting 
decline in activities of daily living. 
Yale Wins Rockefeller 
Grant for Malaria Studies 
The Rockefeller Foundation has 
awarded $1.2 million to the Yale 
Institute for Biospheric Studies (YIBS) 
to support research on the increase in 
malaria and other insect-borne diseases 
in Brazil’s Amazon River Basin. 
The three-year study by the YIBS 
Center for Human Ecology. Environ¬ 
ment and Infectious Disease and seven 
Brazilian organizations, examines 
whether the outbreaks are linked to 
tropical forest destruction and an influx 
of new frontier settlements. 
Burton H. Singer, chairman of 
epidemiology and public health and 
director of the YIBS infectious disease 
center, estimates that malaria cases in 
Brazil, which had dropped to about 
50,000 annually in 1960, have increased 
in recent years more than 10-fold. The 
Yale study is the first to systematically 
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analyze the dose interrelationship 
between forest destruction, frontier 
settlements and malaria outbreaks. 
A team of researchers also will 
examine whether agriculture is the best 
economic use of forest areas that have 
( been cleared, or if harvesting tropical 
fruits and other forest products can 
provide a better economic return. 
Lucille Markey Trust 
Grants $2.1 Million 
For Research Training 
Yale School of Medicine has been 
awarded a $2.1 million Lucille P. 
Markey Charitable Trust grant to 
enhance research training of young 
physicians and scientists. 
The five-year grant enables the 
1 medical school to train I 1 students in 
basic laboratory techniques, and 
encourage them to combine research 
with patient care in their careers. 
After completing their technical 
training, participants will work on an 
individual research project for two and 
one-half years in their primary research 
mentors’ laboratories. They then will 
return to their residency training. The 
experience will count toward research 
fellowship requirements and will 
streamline time requirements for 
residency training. 
Book News 
Translating Freud, edited by Darius 
Gray Ornston Jr., M.D., D.S.M.H. ’64- 
’73, Yale University Press 1992. 
Allergy Shots, by Robert B. Litman, 
M.D. '67. Ivy League Press, Inc. (New 
York) 1993. 
Week by Week to a Strong Heart: An 
Action Plan for Preventing or Treating 
Heart Disease and Other Circulatory 
Problems, by Marvin Moser, M.D., 
clinical professor of medicine, Rodale 
Press Books (Penn.) 1992. 
Faculty 
News 
Michael B. Bracken, Ph D., professor 
and vice chairman of epidemiology and 
public health, received a “Highly 
Commended” certificate in the textbook 
category from the medical writers of the 
Society of Authors for co-editing 
Effective Care of the Newborn Infant. 
Thomas P. Duffy, M.D., professor 
of medicine and in the Yale Compre¬ 
hensive Cancer Center, delivered the 
annual Edward F. Dobihal Jr. Lecture 
on Religion and Health in October at 
the School of Medicine. 
The American Association for the 
Advancement of Science (AAAS) has 
honored Patricia Goldnian-Rakic, 
Ph.D., professor of neuroscience, for 
her distinguished career and scientific 
achievement in behavioral neuro¬ 
sciences. In February, she received the 
John P. McGovern Award in the 
Behavioral Sciences at the AAAS 
national meeting in Boston. 
At a ceremony in Brussels, the 
European Society of Anesthesiologists 
awarded Nicholas M. Greene, M.D., 
professor emeritus of anesthesiology, 
the Carl Roller Gold Medal for his 
studies in physiological responses to 
local anesthesia. 
Robert S. Higgins. M.D.. instructor 
in cardiothoracic surgery, has received 
the 1993 American Cardiology/Bristol 
Faboratories Affiliate Travel Award of 
the American College of Cardiology. 
Charles A. Janeway Jr., M.D., 
professor of immunobiology, biology 
and in the Cancer Center, has been 
elected to the Council of the American 
Association of Immunologists for a 
four-year term. He was also elected to 
the board of the Federation of Ameri¬ 
can Society of Experimental Biology. 
Dr. Janeway is chairman of the 
Friends, colleagues and family members of Dr. Leon E. Rosenberg, dean of the 
School of Medicine from 1984 to 1991. gathered March 5 at the Boyer Center for 
Molecular Medicine for a ceremony to unveil a portrait of the former dean. Dr. 
Gerard N. Burrow, who succeeded Dr. Rosenberg as dean, accepted the portrait for 
the University. The portrait, commissioned by the Portrait Committee chaired by Dr. 
Vincent T. Marchesi, director of the Boyer Center, now hangs on the second floor of 
the Sterling Hall of Medicine, near the dean's office, along with portraits of other 
previous deans. William F. Draper of New York, an internationally known portrait 
artist, painted Dr. Rosenberg’s portrait; Mr. Draper also has done portraits of Drs. 
John R. Paul, C.N.H. Long and Arthur Ebbert. 




Immunobiology Study Section of the 
Research Giants Division, National 
Institutes of Health. 
J. Cameron Kirchner, M.D., 
assistant clinical professor of surgery 
(otolaryngology), was among 23 
otolaryngologist-head and neck sur¬ 
geons nationwide to receive the 
American Academy of Otolaryngology- 
Head and Neck Surgery’s Honor 
Award, which recognizes those who 
have served the academy on a voluntary 
basis. He has served on the academy's 
committee on equilibrium, which 
reviews literature and develops ques¬ 
tions for in-training and board examina¬ 
tions. He also serves on the faculty of 
the academy’s home study course. 
Brian P. Leaderer, Ph.D., professor 
of epidemiology (environmental health) 
at the medical school and at the John B. 
Pierce Laboratory, has been appointed 
to the U.S. Environmental Protection 
Agency’s Science Advisory Board. 
David L. Olive, M.D., associate 
professor of obstetrics and gynecology, 
has been named chief of the section of 
reproductive endocrinology at Yale- 
New Haven Hospital. 
Lynne J. Regan, Ph.D., assistant 
professor of molecular biophysics and 
biochemistry, received a National 
Science Foundation Young Investigator 
Award for her research on proteins. 
Margretta R. Seashore, M.D., 
professor of genetics and pediatrics, has 
been named co-director of the New 
England Regional Genetics Group, a 
consortium of geneticists, counselors, 
parents and support groups. She is also 
chair of the Committee on Genetics for 
the American Academy of Pediatrics. 
George A. Silver, M.D., M.P.H., 
professor emeritus of public health 
(international health), is one of 29 new 
members elected to the National 
Academy of Social Insurance. The 
academy is a non-profit, non-partisan 
organization devoted to furthering 
knowledge and understanding of Social 
Security, health care financing, and 
related public and private programs. 
The American Geriatrics Society 
(AGS) and the Humana Foundation 
honored Mary E. Tinetti, M.D., 
associate professor of medicine 
(geriatrics), with their Outstanding 
Scientific Achievement Award for 
Clinical Investigation at the December 
AGS meeting in Washington. D.C. 
Edward F. Zigler, Sterling Profes¬ 
sor of Psychology and in the Child 
Study Center, was one of three educa¬ 
tors to be awarded the 1992 Harold W. 
McGraw Jr. Prize in Education for his 
contribution to the importance of early 
childhood education in the success of 
students in society. 
Alumni 
News 
J. Karl Poppe. M.D., HS '38-’41, of 
Portland. Ore., retired from his practice 
of thoracic surgery in 1978. 
The University of Vermont College 
of Medicine has named its National 
Obesity/Nutrition Research Center in 
honor of Ethan A.H. Sims. M.D., HS 
’42-’44. Dr. Sims serves on the 
college's internal medicine faculty. 
Ralph D. Alley, M.D. ’43, of 
Loudonville, N.Y., has retired from his 
practice of cardiothoracic surgery. 
Jerome H. Shapiro, M.D. ’48, 
professor of radiology at the University 
Hospital in Boston, was one of four 
recipients of the 1992 Gold Medal of 
the American College of Radiology. 
Dr. Shapiro also has been elected to 
Alpha Omega Alpha, the national 
honor medical society, by the Boston 
University chapter. 
Robert G. Petersdorf, M.D. 52, HS 
'52-’54, of Washington, D.C., has 
announced that he will retire as president 
of the Association of American Medical 
Colleges, effective June 30, 1994. 
Paul C. Kaufman, M.P.H. ’56, is a 
hospital consultant to the Memorial 
Healthcare System in Houston and 
other hospitals in southeast Texas. 
Harold J. Fallon, M.D. '57, chairman 
of the department of internal medicine at 
the Medical College of Virginia, has been 
named dean of the University of Alabama 
School of Medicine. Dr. Fallon has served 
on the Association of American Medical 
Colleges’ Council of Academic Socie¬ 
ties and the Task Force on the Generalist 
Physician. 
Former dean of the Federal Univer¬ 
sity of Rio de Janerio Dental School, 
Amilcar W. Vianna, D.M.D., HS 58- 
’59, is currently a professor of dentistry 
at the school and a member of the 
Brazilian Academy of Dentistry. 
John A. Poglinco, M.D. ’59, serves 
on the staff at Long Island College 
Hospital in the Mary Polak Oenslager 
Department of Obstetrics and Gynecol¬ 
ogy in Brooklyn, N.Y. 
Robert L. Johnson, M.D., HS '60- 
'64, clinical professor of otolaryn¬ 
gology at the University of California 
San Francisco School of Medicine, has 
returned from lecturing on sinus surgery 
in Bangalore, India, and Lvov, Ukraine. 
Darius G. Ornston Jr.. M.D., HS 
'60-'64, who practices general psychia¬ 
try in Greenville, S.C., serves as 
chairman of the department of psychia¬ 
try in the Greenville Hospital System, 
clinical professor of psychiatry at the 
Llniversity of South Carolina School of 
Medicine, and associate clinical 
professor of psychiatry at the Medical 
University of South Carolina. 
Ronald A. Dierwecher, M.D. '61, 
who spent the 1960s in Liberia, Algeria 
and Zaire with the Methodist church, 
recently returned from Somalia, where 
he helped to open a hospital in Beidoa 
with the International Medical Corps. 
He is now in private surgical practice in 
Storm Lake, Iowa. 
Leonard Gold. M.D., HS '65-'68, is 
attending physician, chief of anesthesi¬ 
ology at Campus Eye Group in 
Hamilton Square, N.J. 
Michael W. Fanger, Ph.D. '67, has 
been named chairman of the depart¬ 
ment of microbiology at Dartmouth- 
Hitchcock Medical Center (DHMC) in 
Lebanon, N.H. He heads DHMC's 
immunology section and the immunol- 
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ogy program at the Norris Cotton 
Cancer Center. 
Philip J. Rich, M.D. ’75, was 
promoted to associate clinical professor 
of radiology at the University of California 
San Francisco School of Medicine. 
Christine Brahney-Aria, D.M.D., 
HS ’75-’76, is professor of oral/ 
maxillofacial surgery (OMS) at Seton 
Hall University School of Graduate 
Medical Education; director of resi¬ 
dency education, OMS section, at the 
Jersey City Medical Center; secretary/ 
treasurer of the Garden State Surgical 
Center; and is in private practice in 
Jersey City, N.J. 
Geoffrey Etherington, M.D. ’76, 
was elected to the John B. Pierce 
Laboratory’s board of trustees and will 
serve as vice president of the corpora¬ 
tion. Dr. Etherington is president and 
owner of Etherington Industries, Inc., 
in New Haven. 
Lawrence M. Wexter, Ph D. ’79, 
M.P.H. ’76, M. Phil. ’76, is director of 
research in the department of 
orthopaedic surgery and associate 
professor of community and preventive 
medicine (epidemiology) at New York 
Medical College. 
Carlos Ceballos, M.P.H. '81, has 
been named head of the New Haven 
school-based health clinics. He will 
coordinate services between clinics at 
Jackie Robinson, Roberto Clemente 
and Fair Haven middle schools, and 
Wilbur Cross High School. 
Bernard H.P. Shen, M.D. ’81. HS 
'81-'84, M.P.H. ’81, M.Phil. '80, 
received the 1992 Society for Aca¬ 
demic Emergency Medicine/Emer¬ 
gency Medicine Foundation Innovation 
in Medical Education Award. He is 
working at Mercy Hospital in Pitts¬ 
burgh. in international emergency 
medicine and medical informatics. 
Diane Belinkie Pern, M.P.H. ’82, is 
a Connecticut nursing home adminis¬ 
trator and a student at Bridgeport 
School of Law at Quinnipiac College. 
Maria T. Andrews. M.P.H. '83, is 
working for the Westport/Weston 
Health District as a food service 
sanitarian. 
Caroline (Carrie) R. Martinek. 
M.P.H. '86, received a B.S. degree in 
nursing from the University of Pennsyl¬ 
vania School of Nursing, in December 
1992. She won the Theresa I. Lynch 
Award for consistent contributions to 
the advancement of the school. Ms. 
Martinek is working on the physical 
rehabilitation unit at Thomas Jefferson 
University Hospital in Philadelphia. 
Peter S. Marcus, M.D. ’92, is a 
resident at the University of Chicago in 
obstetrics and gynecology. 
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Student 
News 
School of Medicine 
Presents Service Awards 
The School of Medicine has presented 
its second annual Distinguished 
Community Service Awards to 20 
students, recognizing their outstanding 
contributions to the city of New Haven. 
Second-year students and their 
activities include: 
• Alice Chang and Sunghoon Lee, 
elected by their classmates to serve as 
student volunteer coordinators; 
• Oliver Bacon, Marjorie Rosenthal, 
Nicholas Schwartz. Daniel Stolar and 
Dara Thomas, the Adolescent Sub¬ 
stance Abuse Program, which annually 
reaches some 200 neighborhood middle 
school students; 
• Barbara Garcia and Walter 
Jackson, the 1992 Summer Research 
Program for Minority High School 
Students, in which 16 New Haven 
young adults worked in medical school 
laboratories; 
• Junhee Lee and Paul Lee. the 
student tour program, in which more 
than 350 fourth- and fifth-grade 
students from the Hill Central Elemen¬ 
tary School visit the medical school, 
participate in interactive lessons and 
experiments, and learn about future 
careers; 
• Alicia Jacobs. Margot Kushel. 
Dorothy Novick and Marjorie 
Rosenthal, the Prenatal Care Program, 
which assigns first- and second-year 
medical students to follow one patient 
from either the Women’s Center or the 
Hill Health Center through pregnancy. 
• Steven Kawut, David Morales and 
Dorothy Novick, Students Teaching 
AIDS to Students, which educates city 
youths about the dangers of the Human 
Immunodeficiency virus. 
Other students include: 
• Suresh Karne, a fifth-year M.D.. 
Ph.D. student, the Hillhouse High 
School Macy Program, which intro¬ 
duces students to the medical sciences; 
• Janine Cory, a second-year M.P.H. 
student who produced promotional 
materials for African-American women 
with breast cancer through an initiative 
with the Hill Health Center and the 
Yale Comprehensive Cancer Center. 
She also served on the New Haven 
Foundation Council, which is dedicated 
to improving health education for the 
city's Hispanic population; 
• Shelley Geballe, an attorney and 
second-year M.P.H. student who is 
active in several women’s health 
groups, including the Planned Parent¬ 
hood Federation of America, the 
Women’s Health Initiative at Yale, and 
the Professional Foster Care Associa¬ 
tion of Connecticut; 
• Kaveh Khoshnood, an Iranian 
student working on a Ph.D. degree in 
epidemiology and public health, who 
focused on community service work 
through the AIDS Project New Haven 
and the Hill Health Center’s street out¬ 
reach program, “AIDS Busters.” He also 
served on the city police commission's 
subcommittee on bias and hate crimes, 
working on new legislation to make hate 
crimes illegal in Connecticut. 
New Student Group 
To Foster Cooperation 
First-year epidemiology and public 
health students Kelly Buller and 
Allison Richman have formed the 
Health Care Student Council (HCSC) 
to create a link between dietetic, 
epidemiology and public health, 
medical, nursing and physician 
associate students. The council will 
foster greater awareness and under¬ 
standing of the different roles that each 
profession will play in health care in 
the future. 
The HCSC has four voting represen¬ 
tatives from each program, but meet¬ 
ings, held every two weeks, are open to 
all students to discuss interdisciplinary 
health issues and to plan social events. 
Comments Kelly Buller, "The goal 
of the HCSC is to increase interaction, 
communication and understanding 
between the different health care 
students through our bi-monthly 
newsletter and social, educational and 
community service activities. Our 
intent is not to replace each program's 
student council, but to integrate the 
students on the medical campus for a 
more rewarding experience at Yale and 
closer professional relationships.” 
At the council's suggestion, beginning 
in fall 1993, all of the schools and 
programs related to HCSC will hold one 
day of joint student orientation, featuring 
an assembly and information fair focusing 
on student organizations and community 
service opportunities. The council also has 
created an elective class dealing with the 
roles of health care professionals. 
§§§ 
The National Institute of Diabetes and 
Digestive and Kidney Diseases has 
presented William F. King Jr., a 
fourth-year medical student, with a 
1992-93 Outstanding Medical Student 
Award for academic excellence and 
community service. 
National Medical Fellowships, Inc., 
honored fourth-year medical student 
William R. Rodriguez with the 1992 
William and Charlotte Cadbury 
Award for his leadership in academ¬ 
ics and in the community. 
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In the photograph at right, second- 
year medical students (from left) 
Margot Kushel, Marjorie Rosenthal, 
Dorothy Novick and Alicia Jacobs. 
At left, ASAP volunteers, second-year students 
Marjorie Rosenthal, Oliver Bacon. Daniel 
Stolar and Dara Thomas. 



















Michael J. Moynihan 
Michael J. Moynihan. M.D.. a native of 
Worcester. Mass., and former resident 
of Plattsburgh, N.Y.. died July 12 while 
vacationing on Cape Cod. 
Dr. Moynihan, a 1960 medical 
school graduate, was an internist for 
many years before his retirement. He 
also served as chief of staff at the 
Champlain Valley Physicians Hospital 
Medical Center in Plattsburgh and as 
clinical professor emeritus of medicine 
at the University of Vermont College of 
Medicine. Dr. Moynihan was a fellow 
in the American College of Physicians, 
a member of the New York State 
Professional Medical Conduct Board, 
the American Medical Association, and 
various state and local medical societies 
and service organizations. 
He leaves his wife, Patricia; a 
daughter, Deirdre; four sons, Michael. 
Denis, Sean and Timothy; and a 
grandson. 
William B. Lattanzi 
William B. Lattanzi, M.D., of Orange, 
Conn., died at his home on Oct. 5. He 
was 66. 
Dr. Lattanzi, after a tour in the 
Army, graduated from Yale with both 
M.D. and M.P.H. degrees in 1955. He 
was a pediatric intern and resident at 
Grace-New Haven Hospital and served 
as chief resident in 1957. Following 
years of private practice in New Haven, 
in 1971 he was appointed chairman of 
the department of pediatrics at the 
Hospital of St. Raphael, a position he 
held for the remainder of his life. 
He is survived by his wife, Harriet; 
two daughters. Laura and Susan; and 
four grandchildren. 
Donal L. Dunphy 
Donal L. Dunphy. M.D., of Chapel Hill 
and Emerald Isle, N.C., died at his 
home on Sept. 12. He was 75. 
Dr. Dunphy received his M.D. 
degree in 1944 from Yale, where he 
completed his pediatric residency and 
training in cardiology. He remained at 
Yale as director of the ambulatory 
clinics and had a private pediatrics 
practice in Stratford, Conn. In 1961, he 
was named chairman of the department 
of pediatrics at the University of Iowa. 
In 1973, he served as pediatric 
liaison to the Area Health Education 
Centers (AHEC) program in associa¬ 
tion with the department of pediatrics at 
the University of North Carolina 
(UNC). In addition, he had been the 
UNC senior associate for clinical 
education, chairman of the dean’s 
committee on medical education in the 
community, and from 1979 until his 
retirement in 1989, assistant to the 
AHEC program director. 
He is survived by his wife, Sandra; 
two daughters, Karen and Tina; two 
sons, Michael and Colin; and seven 
grandchildren. 
Abraham J. Schechter 
Abraham J. Schechter, M.D., of Los 
Angeles, died Aug. 20 at U.C.L.A. 
Medical Center. 
A 1931 graduate of the School of 
Medicine, Dr. Schechter was a fellow 
of the American Academy of Radiol¬ 
ogy and practiced radiology in Brook¬ 
lyn, N.Y., for 50 years. He gained wide 
recognition as a skilled diagnostician. 
He is survived by his wife, Vivian; 
his daughter. Minda; his son. Robert; 
and five grandchildren. 
William A. Whalen Jr. 
William A. Whalen Jr., M.D., died of 
cancer on Aug. 30 at his home in 
Pinehurst, N.C. He was 67. 
Dr. Whalen, who recently retired 
from practice as a general surgeon, was 
a graduate of Duke University and a 
1953 graduate of Yale School of 
Medicine. He was an associate clinical 
professor of surgery at Yale, former 
president of the medical staff of 
Windham Community Memorial 
Hospital, of the Windham County 
Medical Association and of the 
Connecticut State Medical Society. 
The board of M.D. Enterprises of 
Connecticut and its subsidiary, M.D. 
Health Plan in North Haven, Conn., has 
established an endowed fellowship at 
the School of Medicine department of 
surgery in honor of Dr. Whalen, who 
Obituaries 
was the health plan's founding chair¬ 
man and its mentor. 
He leaves his wife, Cornelia; three 
sons, William, Christopher and Jeffrey; 
two daughters. Elizabeth and Sarah; 
and five grandchildren. 
For information regarding the 
endowed fellowship, call Joy Gillen. 
(203)785-2694. 
Evelyn B. Man 
Evelyn B. Man, Ph.D.. died of cancer 
on Sept. 3 at her West Hartford. Conn., 
home. She was 87. 
Dr. Man earned a Ph.D. degree in 
physiological chemistry from Yale in 
1932. She worked as a technician, 
researcher and professor at the school 
from 1928 until 1961. when she left to 
work at Brown University. A full-time 
researcher and educator in biochemistry 
for more than 40 years, she was one of 
the top authorities on the thyroid. In 
the 1930s she worked with John P. 
Peters and Herman Yannet to develop 
the first practical test for thyroid levels. 
Although she retired from full-time 
work in 1970, she continued her 
research; over a period of 60 years she 
published 156 scientific papers, the last 
in 1991. Her efforts won the American 
Thyroid Association’s Distinguished 
Service Award and the United Cerebral 
Palsy Award for Research. 
There are no immediate survivors. 
Alfred F. Seibert 
Alfred F. Seibert, M.D., died Oct. 5 at 
his home in Norwich, Vt. He was 90. 
Dr. Seibert, a 1927 School of 
Medicine graduate, was a retired 
medical director of the life, accident 
and group medical division for the 
Travelers Insurance Cos., where he 
worked for 36 years. From 1942 to 
1945, he was a captain in the U.S. 
Army Medical Corps in the South 
Pacific. He also worked for the 
Connecticut Department of Health 
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Services for two years. 
He is survived by his wife, Laura; a 
daughter, Joanne; and a son. Dean. 
Gerald S. Yudkin 
Gerald S. Yudkin, M.D., a retired child 
psychiatrist, died Oct. 23 at the 
Department of Veterans Affairs 
Medical Center in West Haven, Conn. 
He was 69. 
A 1946 Yale medical school 
graduate. Dr. Yudkin interned at 
Mountainside Hospital in New Jersey 
and did both his residency and fellow¬ 
ship in the Child Study Unit at the 
University of Kansas Medical Center. 
He completed his residency at Cincin¬ 
nati General Hospital and his fellow¬ 
ship at the Amherst H. Wilder Child 
Guidance Clinic in Minnesota. 
Dr. Yudkin was director, psychiatrist 
and executive director of the Clifford 
W. Beers Child Guidance Clinic in 
New Haven from 1957 to 1963 and was 
in private practice in New Haven from 
1963 until his retirement in 1977. 
Besides his wife, Elaine, he is 
survived by two daughters, Marjorie 
and Marisa; a son, David; and two 
grandchildren. 
Michael D’Amico 
Michael D'Amico, M.D.. of North 
Haven, Conn., died in the Hospital of 
St. Raphael on Nov. 3. He was 85. 
Dr. D'Amico, a retired radiologist, 
was born in New Haven. He graduated 
from Yale College in 1928 and from 
the School of Medicine in 1931. He 
served at Yale as a clinical instructor 
Dr. Saundra D. Shepherd 
Saundra D. Shepherd 
Saundra D. Shepherd, M.D., a 
nationally known pediatrician, 
professor and advocate for inner-city 
children, died Oct. 9 of chronic 
pulmonary disease at the Columbia- 
Presbyterian Medical Center in 
Manhattan. She passed away at the 
age of 47. 
Dr. Shepherd, a native New 
Yorker, graduated from Yale 
medical school in 1975 and was a 
fellow in pediatric hematology at 
both Bellevue and Columbia- 
Presbyterian hospitals. She was 
director of the social pediatrics 
residency program at Montefiore 
Medical Center and assistant 
professor of pediatrics and epidemi¬ 
ology and community medicine at 
the Albert Einstein College of 
Medicine. She consulted with the 
Legal Service Corp. and the Legal 
Aid Society of New York, and 
worked on the mayor's advisory 
council on child health. 
She leaves her husband. Dr. Peter 
Finch; her daughter, Abi; and her 
parents. 
from 1935 to 1938. In 1937, he 
founded the radiology department at 
Milford (Conn.) Hospital and headed 
the department until 1968. 
He was a roentgenologist at the Yale 
department of university health from 
1936 to 1975 and consultant to Milford 
Hospital and the Village Medical 
Center in North Haven from 1980 to 
1983. As an Army lieutenant colonel 
in World War II, he was chief of 
radiology for the Yale Medical Unit at 
General Hospital in New Zealand and 
Saipan. 
He leaves a son, Ralph; and three 
grandchildren. 
Walter E. Gustafson 
Walter E. Gustafson. M.D., died Nov. 
19 at Hartford Hospital in Connecticut 
at age 71. 
Dr. Gustafson, a 1949 graduate of 
the medical school and intern at Grace- 
New Haven Hospital, was a pediatri¬ 
cian in East Hartford for 35 years 
before his retirement in 1990. He was 
commissioned a first lieutenant in the 
U.S. Army Medical Corps and served 
as preventive medicine officer and 
chief medical officer of the dependents' 
dispensary at Fort Bliss, Texas, in the 
1950s. 
He is survived by his wife, Ethel; 
two daughters, Diane and Heidi: and a 
grandson. 
Arthur S. Reynolds 
Arthur S. Reynolds, M.D., of 
Havertown, Penn., died Dec. 13 at the 
age of 80. 
A 1938 graduate of Yale medical 
school. Dr. Reynolds was on the staff 
of Bryn Mawr, Delaware County and 
Mercy Haverford hospitals. He was 
appointed Haverford Township police 
surgeon and was an officer of the 
township board of health. As founder 
of the Delaware County Medical Dental 
Bureau, he served as its first president. 
He is survived by his wife, Virginia; 
three daughters, Nancy, Shirley and 
Sally; two sons, Arthur and William; 
six grandchildren, and two great¬ 
grandchildren. 







Dr. Elias E. Manuelidis 
Elias E. Manuelidis 
Elias E. Manuelidis, M.D., professor 
emeritus of neuropathology and of 
neurology at Yale, died of a stroke 
Nov. 1 1 in Yale-New Haven Hospital. 
He was 74. 
An internationally known expert on 
viral brain infections and brain tumors, 
Dr. Manuelidis taught at Yale from 
1951 until 1989. Dr. Manuelidis, a 
Javits Scholar, built a reputation on his 
work on Alzheimer’s disease and polio 
virus. He continued his research until 
the time of his death, particularly on 
Creutzfeldt-Jakob disease, a degenera¬ 
tive disease of the nervous system 
which often strikes in mid-life and is 
usually fatal. Among his contributions 
was to demonstrate viremia in the 
disease — the presence of viruses in the 
blood. Other contributions included the 
first long-term tissue culture of human 
brain tumors in 1959, and the demon¬ 
stration that a virus could be used 
selectively to kill a malignant tumor, in 
1964. 
Dr. Manuelidis was born in 
Constantinople and became a refugee in 
Athens at the age of 4. He enrolled in 
the University of Munich, where he 
received his medical degree in 1942. 
From 1946 to 1949, he was director of 
anatomical pathology at the Max 
Planck Institute of Psychiatry in 
Munich. 
He worked as a civilian 
neuropathologist for the U.S. Army 
immediately before joining the Yale 
medical faculty. At Yale, he was head 
of neuropathology and curator of the 
Harvey Cushing Brain Tumor Registry. 
Among his professional aetivities, he 
served as president of the American 
Association of Neuropathologists from 
1982 to 1983. 
He leaves his wife and scientific 
collaborator, Laura K. Manuelidis, 
M.D. '67; and two sons. Emmanuel and 
Laertes. 
At the December meeting of the 
medical school's Board of Permanent 
Officers, his wife, Laura, eulogized, 
“Manuel, icon, iconoclast, had great 
joie de vivre, and an unswerving belief 
that truth is irrepressible. I have 
received many letters from friends, 
students, colleagues and people that he 
helped for no reason except that it was 
right. They, in turn, have emulated his 
generosity and spirit.” 
Contributions to benefit neuro¬ 
science research can be made to: The 
Manuelidis Fund, c/o Yale University 
School of Medicine Department of 
Surgery/LH-122, 333 Cedar St., New 
Haven, CT 06510. 
Sidney S. Lee 
Sidney S. Lee, M.D., of Boston 
(Jamaica Plain), died Nov. 29 after 
suffering a heart attack. He was 70. 
Dr. Lee, one of only two graduates 
to earn four degrees from Yale, 
received an M.D. degree in 1950, as 
well as B.S., M.P.H. and D.P.H. 
degrees. In the 1960s he served as an 
adviser to the U.S. Secretary of Health, 
Education and Welfare on drafting 
Medicare and Medicaid laws. He was 
associate dean at Harvard Medical 
School and later held the same position 
at MeGill University in Montreal. 
Among his many honors, the 
government of France made him a 
chevalier of L Ordre de Sante 
Publique. Dr. Lee also was a fellow of 
the American Public Health Associa¬ 
tion, the New York Academy of 
Medicine and the Royal College of 
Physicians. 
He leaves his wife, Karen; three 
Dr. Sidney S. Lee 
daughters, Amanda, Rebecca and 
Civia; two sons. Jonathan and Michael; 
his mother; and two granddaughters. 
Memorial gifts may be sent to the 
Sidney S. Lee, M.D., Book Fund, c/o 
Yale University School of Medicine 
Office of Development, 100 Church St. 
South #211, New Haven, CT 06519- 
1714. Attention: Jay Angeletti. 
Stanley J. Weigel 
Stanley .1. Weigel. M.D., a native of 
Danielson, Conn., died Dec. 1 at his 
home. He was 78. 
Dr. Weigel graduated magna cum 
laude from the University of Notre 
Dame and from Yale medical school in 
1943. He served his internship and 
residency at Hartford Hospital. In 
1987, he retired from Day Kimball 
Hospital in Putnam, and from his 
family medicine practice in Danielson 
after 39 years. 
He is survived by his wife, Bernice; 
a daughter, Jane; and a granddaughter. 









In Memoriam Harvey A. Humphrey 
September 14, 1992 
M.D. ’44 Nelson Newmark 
June 25, 1992 
M..D. ’31 
Alan E. Apfel 
July 17, 1992 
M.D. '56 Alberta S. Jacoby 
July 8, 1992 
M.P.H. ’67 Arthur S. Reynolds 
December 13, 1992 
M.D. ’38 
Janet Beach 
December 15, 1991 
M.P.H. '57 William E. Lattanzi 
October 5, 1992 
M.D. '55 
PHSP* 
Abraham J. Schechter 
August 20, 1992 
M.D. ’31 
Frederic M. Blodgett 
March 12, 1992 
M.D. '45 Sidney S. Lee 
November 29, 1992 
M.D. '50 
Dr.P.H. ’53 
Saundra D. Shepherd 
October 9, 1992 
M.D. ’75 
Henry H. Briggs Jr. 
September 17, 1992 
M.D. ’31 Joseph R. Lusby 
July 22, 1992 
M.D. '61 James A. Stringham 
August 29, 1992 
M.D. ’31 
Littleton J. Bunch 
August 19, 1992 
M.D. ’50 William R. Maniatis 
July 9, 1992 
M.D. ’47 William A. Whalen 
August 30, 1992 
M.D. '53 
Michael D’Amico 
November 3, 1992 
M.D. ’31 David W. Molander 
July 31, 1992 
M.D. ’46 Gerald S. Yudkin 
October 23, 1992 
M.D. ’46 
Walter E. Gustafson 
November 19,1992 
M.D. '49 Michael J. Moynihan 
July 12, 1992 
M.D. '60 
* Special Public Health 
Edith Fry 
Edith Fry, a retired instructor of 
medicine at Yale, died Dec. 3 at the 
Hospital of St. Raphael in New Haven. 
She was 86. 
Miss Fry started at Yale in 1936 as a 
research assistant in the physiological 
chemistry department and later worked 
in physiology, the department of 
medicine and at the Veterans Adminis¬ 
tration Hospital in West Haven until 
her retirement in 1971. Her lifetime 
research was focused on hormone and 
carbohydrate metabolism and in 
endocrinology. 
She left no survivors. 
Charles W. Watson 
Charles W. Watson, M.D., died at his 
home in Cape Cod on Dec. 26 at the 
age of 73. 
A graduate of Yale College in 1943 
and the medical school in 1945, Dr. 
Watson was a Markle scholar and did 
research and teaching on electro¬ 
encephalography at the New England 
Medical Center in Boston. He was an 
associate professor of neurology at 
Tufts University. 
After moving to Cape Cod several 
years ago, he became attending 
neurologist at Jordan Hospital in 
Plymouth, where he maintained a 
private practice. 
He leaves his wife, Patricia Emerson 
Wanning, M.D. '42; and a son, Dennis. 
He was predeceased by his first wife, 
Barbara (Kaschenko) Watson. 
Robert B. Jamieson Jr. 
Robert B. Jamieson Jr., M.D., died Jan. 
14 at his home in Melbourne, Fla. He 
was 82. 
A native of Boston, Dr. Jamieson 
graduated from Harvard College in 
1932 and from Yale School of Medi¬ 
cine in 1937. Upon graduation from 
medical school. Dr. Jamieson joined 
the Navy and served aboard aircraft 
carriers in the South Pacific from 1942 
through 1946. He spent two years as 
chief of surgery aboard the hospital 
ship USS Consolation, stationed in 
Korea during the Korean War. 
Dr. Jamieson retired as a captain 
from the Navy in 1952 and started a 
private practice as a general surgeon in 
Cocoa, Fla. He retired in 1977. 
He leaves his wife, Talitha; two 
sons, Robert and Philip; a daughter, 
Eilen; and 11 grandchildren. 
At press time, Yale Medicine 
received word of the deaths of 
Sally A. Provence, M.D., 
professor emeritus at the Yale 
Child Study Center, and 
A. Pharo Gagge, Ph.D. '33, 
biophysicist and professor 
emeritus of epidemiology at the 
School of Medicine. Their 
obituaries will appear in the 
summer issue. 
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Alumni Report 
Our medical school alumni directory 
has been widely distributed, and the 
response of medical school and EPH 
graduates has been excellent. Due to 
changes of address that went unre¬ 
ported to the department of alumni 
records, a large number of house staff 
alumni did not respond and were 
considered “lost." As a result, this 
office is working with the alumni 
records office to update the addresses 
of former house staff and compile a list 
of graduates by specialty. This process 
also will allow each department to 
maintain contact with their former 
residents. Current lists are being 
maintained by our office and the house 
staff office at Yale-New Haven 
Hospital. Sharing information with 
other medical school alumni associa¬ 
tions has been mutually beneficial. 
Our efforts continue to strengthen 
the organization of individual classes as 
a means of increasing meaningful 
alumni involvement in reunion and 
educational affairs. This office is 
promoting the role of class secretary as 
archivist and organizer of class 
activities to increase the number of 
participants from each class. We also 
strive to maintain a close relationship 
with our class officers. 
Alumni affairs continues to work 
with medical students to establish a 
class structure w hile they are still in 
New Haven. We in the office encour¬ 
age class leaders to identify and elect 
class secretaries and class agents. The 
process of nurturing students as future 
alumni is aided by this office’s active 
participation in student activities. I or a 
staff person attend student council and 
medical school council meetings, and 1 
serve on the committee for the well¬ 
being of students. Alumni affairs also 
sponsors an annual student-faculty tea, 
assists in solicitation of alumni support 
for the second-year show and supports 
the annual Cadaver Ball. 
A phonathon to support student 
financial aid took place on March 23, 
24, 25, at the alumni fund office. The 
office of alumni affairs, with assistance 
from student council members and 
class officers, coordinated the evenings. 
The process of nurturing student 
organization for, and future participa¬ 
tion in, alumni affairs has been en¬ 
hanced by increasing alumni interaction 
with students. 
The Recovery Room (formerly the 
Harkness dormitory student lounge), 
which was renovated with the help of 
the Yale Alumni Association of 
Greenwich Initiative Prize, has ex¬ 
ceeded expectations. A television set. a 
gift to the students, serves as the 
room's focal point. Student council 
members have successfully assumed 
responsibility for maintaining the room. 
Continuing improvement in the 
condition and use of the dormitory 
remains a priority of Muriel D. Wolf, 
M.D. '59. president of the Yale Alumni 
Association in Medicine. Happy 
students (Dr. Wolf reminds us) make 
happy alumni. 
Plans for alumni reunion weekend 
are complete. A strong program will 
highlight the completion of the new 
Children's Hospital at Yale-New 
Haven, and will further emphasize the 
commitment of Dean Gerard N. 
Burrow. M.D. '58, and the faculty to 
the practice of science-based and 
humane medicine responsive to the 
needs of society. A class reunion 
planning committee headed by Harold 
Bornstein Jr., M.D. '53, is urging class 
leaders to consider planning activities 
to kick off the weekend on Friday. 
Such activities could range from a 
formal seminar or program to an 
informal gathering of friends. 
Official greetings will be offered by 
the dean and by Joseph B. Warshaw, 
M.D., chairman and chief, department 
of pediatrics, who will discuss the 
Children’s Hospital. Surgical grand 
rounds on June 5 will present cases of 
pediatric surgical diseases. Subjects of 
faculty seminars will be: 
• The Children's Hospital: A 
Symbol of Caring; 
• An Update on the Medical Cur¬ 
riculum. 
The annual meeting of the Association 
of Yale Alumni in Medicine will 
follow. A much-anticipated state of the 
school address will be offered by Dean 
Burrow. A YAM Distinguished Service 
Awards will be presented. A buffet 
luncheon will follow, and guided tours 
of the medical center and downtown 
New Haven will be available. We also 
have scheduled class dinners. 
Dean Burrow is planning visits to 
alumni in various cities in the spring. 
He will travel to Boston on May 5; 
Washington, D.C., on May 10; and Los 
Angeles and San Francisco on May 12- 
13. These visits allow the dean to 
discuss his goals for, and the needs of, 
the school. 
The office of alumni affairs again 
emphasizes the need to assist the 
alumni fund. John Foster. M.D. '71, 
alumni fund chairman, hopes to exceed 
the record contribution attained last 
year. Coordinated efforts by all alumni 
groups will assure a successful result. 
Arthur C. Crovatto, M.D. ’54 
Director of alumni affairs 
46 Yale Medicine Spring 1993 
Highlights: Alumni Weekend 
June 4 and 5 
Friday, June 4 
8:00 a.m. Registration 
1:00 p.m. Class reunion seminars (concurrent): 
1943 (March), 1953, 1958, 1968 
4:00 Special presentation: 
The Children's Hospital at Yale-New Haven 
Joseph B. Warshaw, M.D., 
Professor and chairman, department of pediatrics 
5:00 Dean’s reception 
Saturday, June 5 
8:00 a.m. Registration 
9:00 Surgical grand rounds 
Introduction: 
William F. Collins, M.D. 
The Harvey and Kate Cushing Professor 
of Neurological Surgery 
Chairman, department of surgery 
9:15 Faculty seminars 
I. The Children's Hospital: A Symbol of Caring 
II. Update on the Curriculum 
10:30 Annual meeting of the Association of the Yale Alumni 
in Medicine (AYAM) 
A YAM Distinguished Service Award presentations 
12:15 p.m. Sherry and buffet luncheon 
2:45 Guided tours: Yale Center for British Art. historic sections 
of New Haven, Children’s Hospital at Yale-New Haven, 
Cushing/Whitney Medical Library 
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Development Report 
Ex-residents Honor 
Mentor with Symposium 
The Yale Club of New York City 
was the site of a scientific sympo¬ 
sium and black-tie dinner to celebrate 
the 70th birthday and extraordinary 
career of Wayne O. Southwick. M.D., 
professor of orthopaedics and 
rehabilitation. The day-long event, 
held on Jan. 16. was organized by the 
Yale Orthopaedics Association 
(YOA), a group of former residents 
who trained under him. The fete 
attracted more than 200 people from 
around the world. 
Led by James J. Elting, HS ’70- 
’73, and Kristaps Keggi. M.D. '59, 
HS '61 -'64, the YOA set out last fall 
to establish a professorship in Dr. 
Southwick's name. To date, more 
than 60 of Dr. Southwick's 125 
trainees have given more than $600,000 
in gifts and pledges toward a $2 million 
goal. Gifts also have come from Yale 
College alumni who knew Dr. 
Southwick in his role as a master of 
Branford College. Other contributions 
have come from friends, former patients 
and colleagues, and the YOA is now 
reaching out to the corporate sector, as 
well. Dr. Southwick, who served as 
section chief of orthopaedics from 1958 
to 1979 and from 1983 to 1984, is 
responsible for establishing 
orthopaedics at Yale as a full-time 
academic program. 
Gary E. Friedlaender, M.D., took 
over as section chief in 1984 and 
became the first chairman of the 
department of orthopaedics and 
rehabilitation when it was established in 
1986. He comments, “As our relatively 
young department builds its endow¬ 
ment, it’s most fitting that a professor¬ 
ship honoring Dr. Southwick will be the 
first endowed chair in orthopaedics 
and rehabilitation.” 
Dr. Wayne O. Southwick 
Harold C. Strong Estate 
Supports Anesthesiology 
A charitable trust established through 
the estate of Harold C. Strong, a 1906 
graduate of Yale College, will benefit 
the School of Medicine's department of 
anesthesiology. The bequest is to be 
used by the department to establish an 
endowment and to support research. 
For a period after graduating from 
Yale College, Mr. Strong followed an 
adventurous career path, as he relates in 
his autobiography: “I bought some 
overalls and started on an 11-hour-a- 
day schedule with the New England 
Knitting Company in Winsted, Conn., 
to learn the business. Having had a 
technical education, I decided in 
December to see what a mining camp 
looked like before settling down, and 
went to Nevada for eight months, did 
assaying and prospecting, and, although 
having the time of my life, decided that 
mining was not steady enough.” 
Mr. Strong’s interest in finance 
eventually took him to New York City 
and the brokerage house of Hemphill, 
Noyes and Co., in which he became a 
partner. His spirit of adventure also led 
Mr. Strong to invest in the dreams that 
Nicholas Greene, M.D., had for the 
emerging discipline of anesthesiology 
at the School of Medicine. 
In 1955, Dr. Greene, now professor 
emeritus of anesthesiology, was 
appointed chairman of the section of 
anesthesiology. It was his charge to 
establish the section as a leader in 
research, teaching and clinical service, 
and eventually to develop the section 
into a department. Through years of 
careful planning, hard work and 
extensive fundraising. Dr. Greene 
achieved these goals: the section 
became a department in 1971. 
In the process, Dr. Greene devel¬ 
oped a lifelong relationship with many 
loyal and generous donors, including 
his neighbors, Mr. and Mrs. Strong. 
Annual gifts from the Strongs and 
others enabled the department to 
support a variety of teaching and 
research efforts. In recognition of this 
devotion. Dr. Greene dedicated to Mr. 
Strong the chronicle of his experiences 
at Yale, memoirs entitled Anesthesiol¬ 
ogy and the University. Dr. Greene 
further encouraged Mr. Strong to 
consider the invaluable effect an 
endowment would have for the future 
of anesthesiology at Yale. 
This shared vision between the 
Strongs and Dr. Greene has now been 
realized in the family’s memorial, 
which will benefit the department of 
anesthesiology in perpetuity. 
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EDUCATION AT YALE 
jlnesday 
i 12 
Comprehensive Care of the Pediatric Patient: Managing Trauma in the Office Practice (A) 
Director: Robert J. Touloukian, M.D. 
Park Plaza Hotel, New Haven 
i ly-Saturday 
21-22 
Emmetropic Small Incision Cataract Surgery - Defining the State of the Art <B» 
Director: DavidSilverstone, M.D. 
Stouffer Hotel, Westchester, New York 
tiesday 
16 
Sixth Annual Rheumatology Symposium - Lyme Disease (C) 
Director: Robert T. Schoen, M.D. 
Mary Harkness Auditorium 
Yale University School of Medicine 
sday-Saturday 
1-3 
International Symposium of Advanced Lapro-Endoseopic Surgery <D) 





Immunocytochemistry and Cryosections ’93: A Practical Course (E) 
Director: Paul Webster, Ph.D. 
Jane Ellen Hope Building 
Yale University School of Medicine 
iiy-Saturday 
30-31 
Recent Findings from the Neuroscience Revolution: Relevance to Autism, (F) 
Schizophrenia, ADHD and Other Neurobiological Disorders in Children and Adults 
Director: Enid Peschel, Ph.D. 




Annual Yale Sports Medicine Seminar (G) 
Director: Peter JokI, M.D. 
Jane Ellen Hope Building 
Yale Llniversity School of Medicine 
ly-Saturday 
ist 20-21 
Thrombosis, Thromboembolism and Thrombolysis (H) 
Director: Michael D. Ezekowitz, M.D., Ph.D. 
Jane Ellen Hope Building 
Yale University School of Medicine 
^E THE APPROPRIATE LETTER!S) ON THE ATTACHED POSTCARD TO OBTAIN MORE INFORMATION ON 
;ERENCES DISCUSSED IN THIS ISSUE. PLEASE BE SURE TO INCLUDE YOUR NAME AND ADDRESS. 
Yale Medicine 
P.O. Box 7612 
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Passion and Promise: 
Dr. Howard Spiro’s Commencement Address 
Why Women’s Health? 
Anesthesia at Yale: 
Continuing the Legacy 
Yale Medicine 
■ 
Alumni Bulletin of the School of Medicine Summer 1993; Volume 27, Number 3 
q Passion and Promise 
^ In his commencement address. Dr. Howard M. Spiro challenges the Class of 1993 
to remain compassionate in the face of the pressures that will soon confront them. 
Confessions of a First-year Medical Student 
Kathleen Figaro. YSM '96, begins the first of an annual series on 
the life and trials of a Yale medical student. 
Women’s Health Issues: A 21st-century Agenda 
Mary Lake Polan, M.D. ’75, Ph.D. ’70, shares her insights into how medicine and 
public health should prepare for the women's health issues of the new millennium. 
WH Why Women’s Health? Discover how a chance conversation on an airliner led to a new health 
movement, which includes the Women’s Health Initiative at Yale. 
I 
YM Interview: Kathryn E. McGoldrick, M.D. 
Kathryn E. McGoldrick, M.D.. an anesthesiologist and an advocate of women’s health, talks 
with Yale Medicine about such issues as the progress — and promise — of women in her field. 
22 
30 
Anesthesiology at Yale: Continuing the Legacy 
From setting the foundation for modern procedures to relieve pain, to pioneering 
studies in regenerating heart cells, Yale anesthesiology advances the cutting edge. 
An Overseas Teaching Program in Anesthesiology 
Learn how a former Yale chairman of anesthesiology has turned his 
formidable talents toward training his colleagues in Africa. 
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Medicine. The tri-annual magazine is produced by the Yale University School 
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Yale Medicine is distributed to members of the Association of Yale Alumni in 
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Why Does YSM Not Train 
In Family Medicine? 
To the editor: 
We would like to communicate our dis- i tress over Yale University School of 
Medicine’s continued neglect of an im¬ 
portant medical specialty, family medi¬ 
cine. Each year only a very small per¬ 
centage of Yale's class chooses to go into 
family medicine, one of the newest spe- 
1 cialties. This may be due to lack of 
exposure to specialists in this field, and 
discouragement of such a career choice 
by faculty members. As 1990 graduates 
of the School of Medicine, we chose this 
route despite these factors. 
We believe that family medicine fills 
an important training role in an environ¬ 
ment overly dedicated to medical spe¬ 
cialization. In this era of escalating medi¬ 
cal care, family medicine physicians may 
prove to be an important part of the solu¬ 
tion to our health care crisis. More and 
more policymakers, including a recently 
elected American president, are empha¬ 
sizing the need for primary care practi¬ 
tioners. Simultaneously, we become more 
and more frustrated with the School of 
Medicine’s continued insistence on ig¬ 
noring this specialty. 
When we entered the medical school 
in 1986, there was no department of fam¬ 
ily medicine, no family physicians that 
we were aware of who admitted to Yale- 
New Haven Hospital, no family medicine 
elective available in New Haven, and no 
information whatsoever made available 
to upper-level students about electives 
offered in nearby cities (Middletown, 
Hartford or Providence, R.I.) With no 
exposure to role models, no information 
distributed on available electives, and 
active discouragement upon the part of 
some faculty members, we were not sur¬ 
prised that few students chose this spe¬ 
cialty. Has anything changed in the last 
seven years? We would bet not. 
We have heard arguments against our 
specialty. That no one can possibly mas¬ 
ter such a broad range of information, that 
med-peds programs are more rigorous, 
that obstetrics training is useless since 
family doctors don’t really deliver ba¬ 
bies. People presenting such arguments 
are often misinformed, and are usually 
biased against the specialty. We believe 
that Yale would serve their students and 
the community better if it actively ex¬ 
posed students to all the major medical 
specialties. Why not allow students them¬ 
selves to decide which path seems most 
beneficial, rather than create the illusion, 
out of prejudice, that family medicine 
does not exist? 
Why not circulate a list of family 
medicine electives available in nearby 
cities? Why not establish a committee to 
investigate why New Haven is one of the 
few cities in the Northeast in which fam¬ 
ily medicine electives are not available? 
Why not establish a family medicine 
department at Yale? We fear that Yale, 
while trying to guard its “prestige,” may 
actually be proving that it is simply be¬ 
hind the times. 
This morning, we wrote out a check 
for a contribution to the YSM alumni 
fund. The next letter we opened con¬ 
tained Dean Burrow’s survey. We thought 
the alumni survey might give us an op¬ 
portunity to express some of these ideas, 
and we were right. On question 27 you 
asked us our medical specialty, but failed 
to list family medicine amongst the 20 
listed specialties. This is an offensive 
omission to us, and we suggest that you 
make the necessary adjustments both in 
the survey and in the curriculum at Yale. 
Christopher Wolf-Gould, M.D. '90 
Carolyn Wolf-Gould, M.D. '90 
Hilton, N.Y. 
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Jane Ellen Hope Building 
To the editor: 
The photo of the old Yale Dispensary 
{YaleMedicine, Spring 1993) moves me 
to write. Well do 1 remember the time 1 
spent in that building as a medical student 
in the surgical outpatient clinic. I remem¬ 
ber my very first patient and the comfort¬ 
ing reassurance that local anesthesia re¬ 
ally did work, so that I could proceed to 
work on the overgrown toenail. 
Even more clear is the recollection of 
my experience as a third-year student 
doing a psychiatric elective in the clinic. 
Since office space was not available, I 
was assigned the second floor landing of 
the rear stairwell with two folding chairs. 
It was not luxurious, but we made it work, 
with some interruptions of interviews as 
an occasional passerby would come within 
earshot. The entire psychiatric depart¬ 
ment was Lloyd Thompson who was a 
wonderful teacher and who encouraged 
me to become a psychiatrist. 
Yalf. Medicine is a delight to receive. 
It makes clear that the uniqueness and 
vitality that was characteristic of Yale 
Medical School in the 1920s has lived on 
and grown through the entire century. 
While on the subject of Yale journals, I 
must — in passing — refer to the Yale 
Journal of Biology and Medicine which 
was started by our group of medical stu¬ 
dents. I served as an editor. 
1 presume there are not many of my 
class (1929M) still about, but it was reas¬ 
suring to see a letter from Helen Langner 
of a still earlier class. 
George S. Goldman, M.D. ’29 
McLean, Va. 
To the editor: 
The fitting article ( Yale Medicine, Spring 
1993) on the Jane Ellen Hope Building 
misses one significant fact. The fourth 
floor used to house medical students in a 
warren of narrow rooms (now fused into 
fuchsia-toned conference spaces and of¬ 
fices). A somewhat separatist band in 
those days (necessarily — there were not 
many rooms), sometime residents have 
included alumni of later celebrity includ¬ 
ing Shep Nuland, M.D. ’55, and Jim 
Nolan, M.D. ’55, among others. I re¬ 
cently found myself giving a genetics 
seminar in a modern amphitheater in a 
building where I had slept nearly 40 years 
ago! Hope is better used these days 
(although it might be described more 
aptly as in an “industrial” rather than a 
“free Renaissance” style). A number of 
us are happy to see Hope live on. 
Joseph S. Pagano, M.D. '57 
Chapel Hill, N.C. 
Editor’s note: While the long and rich 
history’ of the Jane Ellen Hope Building 
made it impossible to go into much detail 
in the space alloted for our “Gallery ” 
feature, please notice that the last sen¬ 
tence of the second paragraph does pay 
homage to the fact that “Student and 
custodian apartments occupied the third 
floor.” (There are three floors to the 
building, plus the basement.) The refer¬ 
ence to "free Renaissance ” architecture 
was taken from a description provided by 
a 1902 edition of the Yale Alumni Daily. 
A 1965 Classmate Passes 
To the editor: 
I wish to notify the School of Medicine 
Class of 1965 and all readers of Yale 
MedicineWm. Phyllis Hurwitz Duvdevani, 
M.D. '65, died on May 4,1993, after a 15- 
month struggle with cancer. 
Phyllis bore her illness with remark¬ 
able equanimity, often shielding those 
around her from her discomfort. She 
was one of those unusual people who 
was able to reach beyond her own pain 
and nurture others. 
Phyllis leaves her husband, Ilan, and 
daughters, Yael and Tamar. 
Virginia Burnham Johnson, M.D. '65 
Middletown, Conn. 
Corrections 
In the Spring 1993 edition of Yale Medi¬ 
cine on Page 7, it was mistakenly reported 
that the Section of Comparative Medi¬ 
cine housed a “colony of chimpanzees.” 
There is no such colony. Also, on Page 
21, the academic degree of Steven Marans, 
Ph.D., was listed incorrectly. 
Yale Medicine Summer 1993 
Passion and Promise 
by Howard M. Spiro, M.D. 
I Let me tell you the story of a patient I saw a few weeks ago: A 
i 36-year-old woman from Guatemala had persistent abdominal 
pain and trouble swallowing. Elsewhere she had been studied by 
CT scan, ultrasound and barium X-rays. She had seen the 
gynecologist, the otolaryngologist, the psychiatrist and now the 
gastroenterologist. She spoke little English. Through the 
translator it came out that her husband drank; he had no job. One 
of two children she had gained through three pregnancies suf¬ 
fered from spina bifida, and was confined to a wheelchair and 
burdened with a urinary bag. The gastroenterologist, asked 
whether bacteria in her stomach could account for the pains, 
wondered whether her referring physician felt that every pain had 
to have a site somewhere in the body. 
No one listens now. It’s easier to look and it’s far better paid. 
! It’s hard not to endoscope everyone with dyspepsia, for after all, 
the patient expects it if you are up-to-date, third parties still pay 
, generously for the procedure, far better than for time spent talking 
—listening—to patients, the endoscopy suite fees will be shifted 
i: to other hospital debt, and no one will be sued for delayed 
diagnosis. Probabilities are ignored by the “complete workup” 
which rules out disease in every subspecialist’s field. Diagnosis 
now is almost entirely visual, but what the images display to the 
subspecialist may have little to do with the real problems that 
bring patients to doctors. 
Technology has vastly improved the world since my gradu- 
I ation in 1947, but it has made medicine more visual, focusing on 
disease — what the doctor can find, rather than on illness — what 
the patient can tell. The first ultrasounds and CT scans of the 
i! 1970s seem laughably imprecise now, like the late night weather 
maps on TV. But their views of internal anatomy completely 
changed how we physicians regard our patients or, to be more 
precise, their organs. The images — the icons really — of 
technology have let the eye dominate definitions of disease; the 
ear has subsided into silence. 
Now, despite modern medical miracles, you may have heard 
that medicine has left its Golden Age behind, that mostly medi¬ 
ocrity lies ahead. Your passion and your promise will be wasted. 
Some of your medical parents or grandparents here today have 
sighed, “I wish you hadn’t gone into medicine. You missed the 
good old days.” That is the old malarkey. From a social and a 
scientific viewpoint, the medical world is far better than at my 
graduation. From Harvard Medical School, in those “good old 
days,” no Asians, no African-Americans, no women were gradu- 
Howard M. Spiro, M.D., professor of medicine (digestive dis¬ 
eases) and director of the medical school’s Program for Humani¬ 
ties in Medicine, delivered the commencement address to the 
School of Medicine Class of 1993 on May 24. 
Dr. Howard M. Spiro 
ated; 5 percent of the class were Jews and 10 percent Catholics. 
Heart attacks were treated with six weeks of bed rest, no one dared 
operate on the lungs, penicillin was doled out in minute dosage, 
and there were few other antibiotics. There were no anti-ulcer 
agents, no flexible scopes, no CT scans, little of the technology 
so commonplace today. The Golden Age is yet to come — and 
will always be just ahead, thanks to science and technology. 
On the personal level, however, matters have worsened. 
Technology has widened the gap between patient and physician, 
has made many doctors feel like mere conduits of power, no 
longer healing agents but simply purveyors of pi Us or wielders of 
scalpels; rulers out of disease, anyway. Team medicine has 
diffused personal responsibility and lessened the importance of 
personal virtue or character in our hospitals. 
Doctors are so busy doing something that they have little time 
for contemplation. When they are not taking care of patients, they 
are filling out forms. I used to pride myself on short consultation 
notes, but now I am warned they do not demonstrate the requisite 
torment to justify our fees to Medicare, and so I dictate several 
pages to satisfy the requirements. I take a little consolation in the 
hope that maybe another secretary will get a job typing my 
bloated verbiage. Regulations, algorithms, managed care, the 
web of restrictions and financial considerations have constricted 
the spirit of physicians which should be soaring at this time of 
medical miracles. 
The civility which once characterized medical care seems 
lost, and the reciprocal duties of patient and doctor, the obliga¬ 
tions of a community, seem far away. Y ou are right to be anxious 








at your next few years of training. For you will have much to do. 
and very little time to think. You will acquire confidence in your 
skills, and sadness at the cynicism which comes with it. Our 
hospitals — your hospitals now — have become intensive care 
units, where you will wonder at the pain your treatment inflicts 
upon the old and dying, at the diseases of self-abuse and license 
running rampant, at the teachers you never see. 
But pendulums swing back and forth — “God writes straight 
with crooked lines.” It is terribly true that over the past half- 
century much that made medical practice a humane endeavor has 
vanished, thanks in part to the business of medicine. No one 
thinks of how to retrieve the joy of practice except in economic 
terms. The words “bottom line,” which once held only anatomi¬ 
cal connotations for doctors, have become a metaphor for medi¬ 
cine. Society has turned doctors into business people as patients 
have become “consumers” or “clients.” My professional organi¬ 
zation has a lobby in Washington to complain about the prices 
doctors are paid for passing tubes, but not to suggest limits on how 
many procedures a doctor should do, or whether technicians 
could do many of them just as well. 
To call physicians and nurses “health care providers” may be 
politically correct, but it makes a lie of the old adage, “I dress the 
wound, God heals it.” For the most part, even now, we physicians 
do not give health, we take care of disease. For some diseases 
cure has replaced care, yet for so many problems still, social and 
economic forces remain more important than what doctors can 
do: who needs a physician to ensure that women get prenatal care, 
that smoking cigarettes is curtailed, or that sexual excess is at 
least accompanied by condoms? On the whole, physicians 
remain medical care givers; the Creator alone gives health. 
Imperturbable, Efficient, Omniscient 
You graduates of the Class of 1993 can still recall what drew you 
into medicine — dare 1 say it without blushing? — the love of 
humanity and the hope to help the suffering. Yet your work over 
the next few years will destroy that empathy, the forms and the 
films, the techniques and the tasks, all the burdens of daily living 
in a complicated society dim that vision of youth when Heaven 
truly did lie about you. 
I want to praise your passion, 1 want to praise your emotion. 
Keep your feelings, keep your empathy. We physicians have 
grown so distant from our patients, in part thanks to the technol¬ 
ogy which has turned us into mechanics, but thanks also to our 
tradition which has long advised, “Don't get too involved.” 
Equanimity has been our model, and sadly will be yours: In 
medical school you have learned to appear so cool, not to express 
your feelings, not to say what you think. Long practiced, this 
repression will turn into denial and it will someday make you fail 
to recognize emotion in yourselves as well as in your patients. 
Rounds sometimes look like a masked ball to me, where everyone 
pretends imperturbability, efficiency and omniscience. Every¬ 
one is so calm, so detached. At a conference in a community 
hospital not so long ago, a resident burst out, “I envy those people 
who believe in God." and the discussion that followed will not 
soon be forgotten. 
Our detachment accounts for the attraction of holistic alterna¬ 
tive medicine, where the patient as a person is not yet a message 
without a meaning. We need to balance equanimity with empa¬ 
thy, the feeling that "I might be you" or “I am you.” But empathy 
is more than a technique, more than a tool to find out what the 
patient feels or what the patient knows; it must be accompanied 
by real emotion. 
Empathy gets drained out of medical students early. To call 
someone “empathic” will hardly gain the enthusiasm of the admis¬ 
sions committee where victory in grades and scientific experience 
counts for more than introspection or sensitivity. Training in 
molecular biology to the exclusion of the humanities and social 
sciences emphasizes the microscopic mechanical views of human¬ 
kind that weaken empathy; yet even today 80 percent of the 
complaints that will bring patients to you outside the hospital have 
their origin in social, economic and emotional forces. 
Who would have thought that sterilizing the stomach of that 
young Hispanic woman I told you about would have brought 
solace to her sorrows? A fine colleague driving me to the hospital 
one day told of a surgical resident with abdominal pain whose 
cause none of his endoscopies or scans could ferret out: at my 
remonstrance that the stress of her work might be a factor, he 
laughed, “Howie, that’s your field. My job is to rule out disease.” 
Soon, the algorithms of hospital care will armor you against 
feeling too much, for empathy gets in the way of the technical 
tasks so important in a hospital. The weariness and the frustration 
of hospital residencies may explain why so many of you will find 
so little joy in medical practice that you will flee to fields with 
defined technical tasks where physicians can act upon a patient as 
an object, no Thou, — as Martin Buber put it — only an It. After 
residency, so few doctors still feel called upon to enter the life of 
another person to try to help. 
Don't misunderstand. I set up no dichotomy. To be truly 
empathic, to be truly ethical, you must get all the data; that means 
understanding the scientific background of the case, as well as the 
circumstances of the person. An ignorant doctor is truly unethi¬ 
cal. For the good physician the spheres merge, the spirit and the 
mind, as well as the body of the patient; you can still find joy in 
humankind and stories in your patients. Even now, when bureau¬ 
cracy threatens to turn physicians into interchangeable modules, 
when managed competition measures up medical practice in units 
which can be weighed, delivered and paid for like any parcel, you 
new physicians, full of passion and fresh from your promise, still 
have the chance to be care givers. Sometimes — only too rarely 
— you may even be rewarded by that indefinable mystical feeling 
of being at one with your patient — and the world. But you will 
have a hard time knowing what has happened unless you read 
outside medicine, unless you talk with your colleagues, and you 
may feel too embarrassed to tell of that joy. 
Let me remind you once more that physicians can be thera¬ 
peutic, not only for the disease which your science will cure, but 
for the illnesses of the spirit, where your character and, yes, your 
virtue, still can help. Your promise — the promise of a new 
millennium now so close — is bright indeed. But do not lose your 
feelings. Keep your passions aflame. Be more than just a doctor. 
Good luck. Bless you all. YM 
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Confessions of a First-year 
Medical Student 
Iby Mary Kathleen Figaro, YSM '96 
I had been terribly clever, I thought. Why, coining here two 
months in advance of most of my first-year medical classmates I would be an absolute coup. I would learn how to navigate the 
New Haven streets in my first-ever automobile, a used Honda. I 
would learn where to walk and not to walk at night; I would 
perhaps meet some friends, go dancing on hot, overcrowded 
dance floors; in short, get an early start on a brand new life. 
As usual, though, the dream and the reality had little to do 
1 with each other. The summer turned out to be the most solitary, 
and sometimes the loneliest, of my life. Having left behind home 
and everyone in the world who loved me meant that I spent most 
of my afternoons and evenings alone, thinking about a future that 
loomed large before me. Sometimes the future seemed poten¬ 
tially as lush as the gigantic elm tree that reached beyond the 
third-story living room window outside of my new apartment on 
Whitney Avenue. At other times, its leaves, occasionally rustling 
in the summer breeze, were as restless as the agitated, uncertain 
thoughts that buzzed almost constantly in my head. To counter 
this assault on my equanimity, 1 adopted an attitude of almost 
continual prayer. 
I found a church: a small, Protestant church nestled in the 
Orange Street neighborhood. First Baptist’s services had been 
filled with families once, so said its long-time members. Pres¬ 
ently, about 45 dedicated members come together every Sunday 
in God’s presence of the Holy Spirit, relying on the promise that 
! “where two or three are gathered, there I shall be also.” I do not 
complain of the congregation’s small size. First Baptist more 
than makes up for its size by its friendly attitude towards visitors, 
including the few Yale students who regularly attend there. In 
fact, being the only student who was dedicated enough to become 
a member, I felt as if I had actually found a home. 
Still, like my apartment, the dome-like, dark wood-paneled, 
austere First Baptist Church was at first a bit too old and a bit too 
large for me. I strained to compensate and to fill both the gaps of 
age and size with my spirit, my personality and my voice. With 
the same attitude that I filled the walls of my living room with 
familiar, beloved posters, I joined the choir at church and sang an 
occasional classical solo in hopes of sharing a part of myself with 
Editor’s Note: This article is the first of a series that Kathleen 
Figaro has agreed to contribute to Yale Medicine annually for 
the next several years. The series will document her impressions 
and changing perceptions about her education and training as a 
medical student and resident physician. 
its members. While I did not find my “dream” during my first 
summer, perhaps First Baptist was the most important place of all 
that I could have begun my search, for this feeling of being at 
home stood me in good stead throughout the uncertain period of 
the first few weeks of classes. 
Finally, a Medical Student 
The highlight of my first day of classes was, in fact, a result of 
my early arrival. Friends in the second-year class had told me 
of the great bargains to be had at the student-run used bookstore 
in the basement of Sterling Hall of Medicine. So after my first 
anatomy lecture, I stationed myself outside its door, behind 
several people who had been even more enterprising than I. and 
waited for it to open. 
I was sorely disappointed, however, when a student-em¬ 
ployee finally unlocked and swung open the door; the place 
resembled a closet and was about the same size. To this small 
space was added the chaos of a dozen or more students shouting 
and snatching books all around. Thanking God that I was as little 
as I am, I squeezed my 5-foot-3, 105-pound frame into the spaces 
between the other first-years and quickly snatched half my books 
at a significant discount. 1 returned two more times to finish this 
task and even asked about and received a job at the bookstore, 
illustrating that one does not have to be first or greatest to 
succeed; tenacity still has a place in life. 
Such biblical wisdom, however, didn't help me answer the 
question that silently kept nagging at me: “What was I doing in 
this prestigious institution called the Yale School of Medicine?" 
Several days of classes passed with no insight into this 
question. Clearly the professors were knowledgeable, the stu¬ 
dents eager to be educated. But 1 had no idea how I fit into all of 
this, especially as a black woman. I was being swept along by the 
mass of new faces, students like myself, some welcoming, some 
afraid to greet me, others already twisted with contempt against 
me, even unwilling to acknowledge my presence. Was I sure that 
I could endure? I aimed to find out. even if the 183-year-old 
medical school was the third space in New Haven — along with 
my apartment and my church — that I had found to be a bit too 
old and too large. 
By the first week of school it became clear how much of my 
struggle to feel at home here had to do with me being a woman. 
Already I had read and heard the word “man" used to describe the 
human race so many times—each time with a small shock — that 
1 began to wonder if anyone else felt uncomfortable with it. 
Granted, I worshipped for many years in churches where the 
liturgy referred to "he, man, his. ..’’ and only sometimes paused 
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to recognize the woman. It was equally, if not more, frustrating 
though to have female parts of anatomy listed in parentheses next 
to the male parts in the androgynous, computer-generated draw¬ 
ings in my dissection booklet. When it came to actual dissection, 
a majority of the cadavers were female, so actually, more students 
were viewing the female parts. 
1 did not dare to discuss this with anyone, sensing that it’s best 
not to be considered "radical,” if only for the first few weeks of 
class. My greater concern was that this insensitivity could be a 
harbinger of other inequitable practices here ... or perhaps, did 
what I consider to be sexist not make any difference to most 
people? In any case, I am not parenthetical (1 don't think.) 
Neither are other women. I hope someday everyone will realize 
this, especially at a leading medical school such as Yale. 
As a result of this and other episodes in my life in which I have 
played the role of pioneer, I have sometimes been forced to think 
that it was an entirely appropriate choice for God to make me a 
black woman. Frankly, that is the only perspective I have, so I 
cannot really know if it would be better to be, say, a white man. 
After all, they have their problems too. Among them is not 
racism, I figure, nor is being parenthetical. But they must sit, as 
I sat, through the "diversity" sessions that were part of our 
orientation. 
On one sunny afternoon in the Harkness dormitory lounge, 
first-year medical and physician's associate students gathered, 
were separated into groups with about one minority student per 
table, and essentially were asked to answer Rodney King’s 
question: “Can we all get along?” Though I may be a bit too 
pessimistic, to me these sessions, while immensely important to 
continue, will not be a major component in the fight to end 
prejudice based on race or gender. 
I learn as little as some white people do from those sessions, 
because we all know where we stand; certain people don’t want 
to learn more than they already are forced to know about racism. 
Breaking up into small discussion groups further complicates 
(and simplifies) the issue. The population can be neatly divided 
into two groups: the converted and the inconvertible. This is 
reminiscent of the sermons I have heard in which those who can 
"hear" repent their sins; those who cannot are quite convinced 
they need no repentance. 
Throughout the whole session, as most of us tried on our most 
liberal and understanding selves, I tried not to get angry or 
frustrated, or worse, to become weary. After all, as a black woman 
1 was supposed to be a source for the minority opinion at my table. 
White participants in the session would tell me about the reality 
that they had picked up from the media about black people; that in 
heartless and cold cities, dangerous black men lurk on every comer 
with semi-automatics, waiting for the simple pleasure of mugging 
or raping the first white person to come along. 
I would reply with the things that remain hidden to most white 
Americans: that there are many children who rely on television 
to see most of the white people that they ever will encounter, 
children who don't know what the word "ethnic” means. But 
these two facts remained: All of us medical students had come 
here for a first-class education; I had to combat racial and gender 
issues whether or not I was tired of dealing with them. 
Perhaps that is why I have become hypersensitive. I describe 
this state of mind as having an enormous internal radar disk that 
is coated with a sticky, tar-like film. My radar can usually pick 
up the impending onslaught of racist talk and actions. Sensing 
such potential insults, I try to walk away before one thoughtless 
word or deed has been uttered or performed. If I do not make a 
swift enough exit, adrenalin pumps, my heart starts beating 
faster; I feel trapped as the film coating attracts to it all manner of 
detritus that I do not want to carry with me. Sometimes when I 
have no choice but to stay and confront the situation, I have the 
audacity to condemn. Always, I'm left a bit more wizened after 
such an event; my soul becomes hardened and scarred. 
My Eyes Opened: ASAP 
I have a feeling that some of the seventh graders at Roberto 
Clemente Middle School also come equipped with such a radar 
disk. This year, in keeping with a three-year tradition, I joined the 
majority of the first-year class that volunteers at Clemente 
through ASAP — Adolescent Substance Abuse Prevention — 
sponsored by the American Medical Student Association (AMS A). 
Most of the children there are either African-American or His¬ 
panic; all, I think, are poor. Instead of dealing as 1 do with seini- 
subtle comments from accomplished suburbanites whose words 
must be processed to be understood as insults, these children deal 
with drug dealers blatantly poised on their street corners and with 
antediluvian science books in school. 
While AMSA sponsors many volunteer programs such as 
ASAP nationwide, Yale’s ASAP chapter is one of the most active 
and accomplished. Since it began in 1990, our ASAP chapter, 
having established a curriculum and structure, has grown sub¬ 
stantially beyond the original vision of its founder, William King, 
M.D. '93. Each week, my group of eight medical students rushed 
to the school with as much preparation as our busy first semester 
permitted, and taught our version of that week’s “don't take 
drugs” lesson. 
While ASAP is a tremendous example of how one person can 
make a difference, this is not so in ways that might seem obvious. 
ASAP cannot change unwanted behavior, nor can it affect the 
environment in which the children live. ASAP’s forte is present¬ 
ing the medical students as enthusiastic, successful young people 
who care enough to spend time with the children. 
I had volunteered with kids before at home in Montclair, N.J., 
a suburban community in the northern part of the state. I’d served 
as a Sunday school and summer Bible school teacher and infor¬ 
mal church music director. These experiences, mostly with 
middle-class kids from stable homes, did little to prepare me for 
my encounter with New Haven’s low-income, urban children. 
“Katie,” for example, one of our seventh graders in ASAP, 
wrote that she wants “programs for kids in the projects or the 
ghetto that will keep them busy so they won’t have to be around 
people like that.” Her comment seems to combine the stated 
purposes of the many people attempting to help Katie and 
children like her. These children have been through so many 
“programs” that transport them out of their neighborhoods for 
a while that they believe the only way they will escape their 
curious predicament of living inside an American city is with 
the help of others. 
6 Yale Medicine Summer 1993 
In fact, no one has ever seriously suggested to Katie that she 
could change her own neighborhood; even I did not fully believe 
it, so challenging are the problems. She had coolly scanned my 
face with her pragmatic, street-wise charcoal eyes when I told her 
she could start to make a change at home. I thought that perhaps 
she wouldn’t have to leave her neighborhood to attend an ad¬ 
equately funded school or to feel safe as she walked to and from 
Roberto Clemente. After all, weren’t most of her neighbors as 
nice as all of us who came to help her? I started to imagine that 
if people in the neighborhood could gain enough self-esteem — 
and loans — to create private businesses and jobs within their 
immediate community, they could also better influence who 
moved into the neighborhood. 
However, when I mentioned to Katie that there were things 
that even kids like herself could do, she seemed mildly incredu¬ 
lous. “Was I talking about her neighborhood?’’ she seemed to ask 
with the look she gave me. With this, our brief discussion came 
to an end and the ASAP lesson continued. I talked on about 
avoiding the pressure to use and sell drugs. 
Representing the Profession 
After I had settled down somewhat to my new life, I faced the 
new problem of being recognized as a doctor-to-be. On my first 
major trip off campus, in October, I took my kitten, Gatsby, back 
to Montclair to be neutered at the local animal hospital. Having 
traveled 100 miles away from school to bring Gatsby to the 
veterinarian’s office, I felt insulated from the general confusion 
that came from my status as a first-year med student and did not 
wish to be reminded of the massive amount of work I was not 
doing this Saturday. Yet, as a new medical student, I found myself 
strangely eager to be viewed as a member of this learned group. 
My ambivalence first demonstrated itself when the hospital' s 
receptionist asked my address — a pretty simple question for 
most people — but one that I've found increasingly hard to 
answer each succeeding year of higher education, first, during my 
undergraduate days at Princeton, and now, while at Yale. My 
current address was in New Haven, but there I stood in my 
hometown of Montclair, with my parents’ address on the hospital 
voucher. “Which was it to be?” the receptionist’s eyes seemed to 
ask. I stammered, then retreated, explaining that I was in med 
school in New Haven. 
Strangely, I felt like my kitten, Gatsby, on one of the many 
occasions when I entered the apartment to discover that he had 
just chewed up one of my plants. Before I even checked to see the 
extent of the day’s damage, he would slowly crawl away into a 
closet, anticipating my anger. As for the receptionist. I knew I had 
explained more than the poor woman wanted to hear about the 
discrepancy in the addresses. Saying that I was visiting my 
parents would have been sufficient. Frankly. 1 thought, the 
receptionist does not care whether you are comfortable with 
being a medical student at Yale. 
To add insult to injury, when I took my cat into the examin¬ 
ing room, I quickly and foolishly established my limited famil¬ 
iarity with medicine by noticing the veterinarian’s stethoscope 
and exclaiming, “Oh, you have a Lippmann!” 
The veterinarian, tall, gray-haired, turned his unamused, 
blue-eyed gaze slowly toward me while still holding my squirm¬ 
ing kitten by the scruff of his neck. 
I realized immediately that commenting had been a mistake. 
“Are you a doctor?” the vet questioned. 
“No, just a first-year medical student.” 
As if to demonstrate that I had senselessly trod on his sacred 
ground, he successively assumed the postures of admissions 
officer, professor and clinical tutor. Looking at me intently, my 
mentor of the moment began to tell me of his time in Ontario at 
veterinary school when his friends who were medical students 
had undergone an unbelievable triage that left only half of the 
















Kathleen Figaro, YSM ’96 — 
Discovering Her Voice 
Mary Kathleen Figaro, who likes to be called Kathleen, 
spent most of her childhood in Montclair. N.J., as the only 
child of Jean and Rosanna Figaro. She attended college at 
Princeton University, where she majored in French litera¬ 
ture and civilization. 
During her undergraduate years, Ms. Figaro studied 
voice and became an accomplished classical singer. In 
addition to singing with the Katzenjammers, an under¬ 
graduate a cappella group, she also performed oratorio 
works with the Princeton Chapel Choir, and gave two full 
recitals her junior and senior years. During the summer 
before her senior year. Ms. Figaro received a scholarship to 
do research in Haiti, an experience that aided in the writing 
of her literature thesis on the work of Marie Chauvet, an 
acclaimed Haitian writer. 
At the medical school, Ms. Figaro has volunteered with 
ASAP. Adolescent Substance Abuse Prevention, and now 
is one of the student coordinators of the program. Also a 
member of Yale’s Student National Medical Association 
chapter, she hopes to take part in its effort to encourage 
accepted minority students to matriculate at Yale. 
Ms. Figaro, as yet unsure of her eventual professional 
path, hopes to be a primary care provider and, for some 
portion of her life, a medical missionary. 
first-year class to graduate. Professors failed them for spelling, 
Latin grammar, anything, he said. 
I tried not to take it personally that my cat’s office visit had 
abruptly transformed into my oral examination: “Now, why is 
it." the vet asked authoritatively, “that your cat needs more than 
one distemper shot?” 
I was taken aback. I delivered the obvious answer, that the cat 
perhaps did not acquire full immunity after one vaccine. But not 
having had immunology yet, I knew little more. 
After giving a minute's worth of arcane explanation during 
which I felt very nervous for not having understood, the veteri¬ 
narian finished by saying, “Now, you know how to explain to 
your patients the necessity of multiple vaccinations. . .” 
“No. 1 do not know,” I confessed. 
“Well," he responded with a tired, sardonic smirk, “You can 
tell them that it's like a teacher giving a lesson more than once so 
that a student can learn it better. The vaccine is the teacher and 
the body's immune system is the student." 
I understood that better than anything. If despite all the 
lectures I had attended and studying I had done, explanations 
could still come from my own life experiences, there was hope for 
me yet as a doctor. 
Just then, the nurse entered abruptly and bluntly asked the 
doctor, “Does raw egg white kill cats?” 
I shuddered. 
I had been talking freely in the waiting room with a woman 
1 had not seen in 10 years, since our parents had driven us 
together to piano lessons in seventh-grade. Other cat owners 
had been listening as I mentioned to my long-lost friend that in 
one biochemistry lecture a professor discussed the ill effects of 
raw egg whites, which contain a biotinase. Since I had not 
remembered precisely why this was important, I just told my 
friend something like, “If you feed raw egg whites to your cat. 
it messes up the cat's metabolism; I guess it dies.” 
No sooner had I uttered the comment than an older lady 
holding a huge tabby gasped and clutched her cat closer. Such 
hyperbole is marginally allowed during late-night discussions in 
undergraduate dormitories. In a roomful of anxious cat owners, 
it is simply inexcusable. 
The veterinarian calmly read at a glance the tension and 
embarrassment in my guilty, flushed face and replied to the nurse, 
"No, raw egg whites would have to be the cat’s entire diet to have 
that much of an effect.” 
Shot down on my first attempt to be a know-some-of-it-all, I 
slunk, Gatsby-like, into a corner of my mind and stayed there for 
the duration of my time at the veterinarian. With my thoughtless 
comments, had I just diminished the respect that all those in the 
vet’s waiting room held for medicine men and women? 
For the first time. I felt the tug to keep medicine sacred and 
“True.” Since its Truth has the power to heal, if its practitioners 
were seen as prevaricators and false prognosticators, our magic, 
our art, would cease to work. I shuddered again and thought of 
the mountain of work that awaited me back in New Haven. 
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Understanding Suffering and Grief 
More life lessons awaited me upon my return to the School of 
Medicine, under the guise of an elective course offered to first- 
year students called “Seminar on the Seriously Ill Patient,” 
taught by the medical school chaplain, Alan C. Mermann, M.D. 
For some unknown reason, I felt compelled to attend the semi¬ 
nar. Perhaps I felt that I had to discover the sort of grief that I was 
spared as a child, since no one I personally knew had died. 
It didn’t work out quite as I had expected. After all, this grief 
was “for a purpose” and was sterilized enough so that I did not 
break down or become desperate. This was sanctioned grief, to 
which I was exposed under professional circumstances. 
Besides, I never really got to know the woman, “Noel,” with 
whom I had been paired. I came to realize this at the very end of 
our encounter, as I walked into her room in intensive care at Yale- 
New Haven Hospital. I was struck by how still she lay in her bed, 
this slightly overweight, dark woman in her 30s, this woman 
whose impassive face still revealed no secrets. Suddenly, I 
became worried. When Noel didn't respond to my call or to my 
gentle touch, my heart began to race. I rushed to find a nurse or 
doctor, only to discover that no one was immediately available; 1 
myself had to examine her chart to find out her situation. 
Paging through the barely legible writing, I gathered that 
Noel had been unconscious for a week from some sort of brain 
infection. I decided to telephone later to find out her official 
condition: “unresponsive,” not expected to recover. After the 
initial shock, my mind concentrated on the irony of her situation: 
Noel, who had not yet come to terms with a grim prognosis; 
Noel, stricken suddenly unconscious; Noel, who will die alone. 
I recall that when I first met her, I was struck by how she had 
retained the lilted accent of her native Barbados. Noel had been 
diagnosed with cancer, a fact that she told me with characteris¬ 
tically masked face and somber eyes. That day, her physician 
had remarked to her, she was not wearing lipstick, and he took 
this to mean that she was not feeling well. As Noel and I talked, 
an IV by her side silently dripped chemotherapy into her fore¬ 
arm. She said that although she had a slight fever, she felt fine, 
just a bit weak. 
As the conversation progressed, we talked about Noel’s 
physicians and the care she was getting. We talked about my 
motives for being at Yale and by her side. We talked about God. 
The subject came up as she discussed how her faith was 
sustaining her. When I dared ask her more about it, I saw the first 
glint of personality showing through an otherwise impassive 
face. The way Noel saw it, her life had been a series of miracles, 
including her current condition: Her cancer had been properly 
diagnosed; her care provided by concerned, professional doc¬ 
tors; although Noel had not yet responded to chemotherapy, but 
she was hopeful that, in time, she would. Even more than death. 
Noel despised cancer patients who refused to believe good news 
from their doctors — that their condition was improving — and 
she had little sympathy for those who could not fight despair with 
faith and hope as she did. 
We talked a few times over a period of days. What a strange 
friendship to develop, when friendship was not the goal, and 
when there was a definite, appointed span, if not to our relation¬ 
ship, then to her life. True to what Dr. Mermann had taught us 
about our dying patients, Noel would talk more of life and her 
hopes and desires for the remaining time than about her death. 
And so I remain puzzled as to whether she ever imagined this 
ending to her life. 
I am equally puzzled over my reaction to her physical 
weakness during our last mutual meeting. That morning, she was 
looking completely different with her wig removed, revealing the 
fistula, the dark, bruised bump on her head, where fluid had been 
drained from her skull. Her dry. cracked lips and her nauseated 
expression, instead of inspiring me with sympathy, distanced me. 
No longer did I show sympathy for Noel as a friend; I reverted to 
seeing her simply as a patient who needed my help. Although she 
was groggy from pain and perhaps from her medication, I felt 
almost sure that she recognized her own isolation, that I was 
backing away emotionally from her and her suffering. 
While discussing this with the "Seriously Ill" class, I shared 
my amazement at my own self-protecting apathy. My white, 
medical student’s coat seems to have provided me the armor I 
needed to shield me from the patient's distress. Does this mean 
that I, in an effort to avoid depression and anxiety, will become 
a cold-hearted physician? I’m convinced that some hardening of 
heart must and will take place, but I have this deep fear that in my 
case it will be total and complete, and that 1 will lose my ability 
to empathize with my patients. 
In a sense, I have been mostly concerned with losing parts of 
myself, even as I have gained others since coming to Yale. More 
than ever in my life, I now "play a role.” Becoming a doctor 
means that I must change some things which, at first, seem to be 
irrevocably part of my nature. To start, I must dismantle the radar 
disk that attracts so much unwanted junk; I must learn to shun 
hyperbole and somehow navigate the rough waters between 
apathy and crippling sentimentality. Such intangibles are as 
much a part of my education here as learning the science to 
become a competent physician. 
So. the Yale School of Medicine has served me well. I am 
sincerely happy to be at an institution where I have had an early 
opportunity to battle with these important aspects of becoming 
a physician. Because community service is stressed in the first 
year, I have had occasion to make a small difference in the lives 
of a few children. Because we already have clinical tutors who 
allow us to see their patients, mentors who let us follow along 
as they do their work, I have good models of what it is to be a 
kind physician. 
Finally, because of courses like the "Seriously Ill" seminar, 
I have come into early contact with the physician's greatest 
enemy, suffering. All these activities make worthwhile the hard 
work required to learn the necessary basic science. In fact, I've 
come to realize that it was not until after I came to Yale that I truly 
decided to become a physician. 
Somehow, as my first year of medical school comes to a close, 
Yale no longer seems too old or too large. YM 
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Women’s Health Issues: 
A 21ST-CENTURY AGENDA 
by Mary Lake Palan, M.D. 75, Ph.D. 70 
Women visit physicians far more frequently than men. They take 
more medications. They're hospitalized more frequently. 
Women’s health care needs, however, have not commanded 
commensurate attention from either the biomedical research 
community or the clinical delivery system. Women have not 
been included in a number of large clinical trials and, therefore, 
information derived from studies on men are only questionably 
applicable to women. 
For example, the Physician’s Health Study, conducted by the 
Harvard Medical School and Brigham and Women’s Hospital, 
studied more than 22,000 men, but no women; the conclusion 
that taking an aspirin every other day may reduce the risk of heart 
disease was applied to women, even though no evi¬ 
dence exists that aspirin reduces the cardiovascular 
disease risk in women. A major study on aging begun 
in 1958, funded by the National Institute on Aging, 
did not include women until 20 years later. There¬ 
fore, long-term data on women and the aging process 
are still not available. And the rapidly growing 
population of women and children with AIDS re¬ 
ceived virtually no attention until very recently. 
Research on conditions which are unique to 
women, such as breast cancer, menopause, 
osteoporosis and ovarian cancer, often receive little 
attention or funding. Compare, for example, the 
public outrage caused by the death of 58,000 Ameri¬ 
cans during the Vietnam War between 1964 and 
1975, with the mute response regarding the approxi¬ 
mately 330.000 American women who died of breast 
cancer during those same years. 
In an even more striking contrast, since 1980, 
approximately 54,000 Americans have died from 
AIDS, while eight times as many American women 
have died from breast cancer. Despite the relative 
magnitude of morbidity and mortality between the 
two diseases, the National Institutes of Health (NIH) 
spent 44 times as much money on basic AIDS re¬ 
search in 1989 than was spent on breast cancer research. 
Recent Progress 
Although the medical research establishment historically has not 
focused on women or women’s diseases, the tide appears to be 
turning. The genesis of change came in June 1990, when the U.S. 
General Accounting Office reported that the NIH was failing to 
keep its own mandate to include women in research on the 
etiology of diseases and their possible therapies. In response to 
this oversight, the NIH created the Office of Research on Women's 
Health and named Vivian Pinn, M.D., as its first director. 
Bernadine Healy, M.D., was then named the first woman director 
of the NIH. Under Dr. Healy’s leadership, the largest study on 
women’s health took form: the Women’s Health Initiative. This 
study will follow thousands of women nationwide for at least a 
decade to document the age-related changes that occur in women, 
both with and without hormone replacement therapy. 
We are an aging population; since the turn of the century, life 
expectancy at birth, which was 48 years for American white men 
and 51 years for white women, has increased to 72 years and 79.1 
years, correspondingly. In part because women live an average 
of seven years longer than men, they acquire more disabilities and 
require more care. Other factors also come into play when 
discussing disability among older people; for instance, 
osteoporosis affects women more severely than men. For women, 
cessation of ovarian function with decreased estrogen and pro¬ 
gesterone production signals the beginning of the climacteric. 
The median age of menopause in the United States is 52, and 
at that point, the lack of estrogen, manifested immediately by hot 
flashes, heralds the long-term sequelae of increased bone resorp¬ 
tion leading to osteoporosis. Nearly 250,000 hip fractures occur 
DURA TION OF MENOPA USE 
Since the turn of the century, female life expectancy has steadily increased, but 
the mean age at onset of menopause has remained at approximately 51.4 years. 
Consequently, women now spend more years of their lives postmenopausal. 
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Dr. Mary Lake Polan 
Mary Lake Polan, 
M.D. y75, Ph.D. >70 — 
Grounded in Basic Science 
Mary Lake Polan is chairman and the Katharine Dexter 
McCormick and Stanley McCormick Memorial Professor 
at Stanford University Medical Center department of gyne¬ 
cology and obstetrics. One of only five women to chair an 
ob/gyn department in an American medical school. Dr. 
Polan was elected to the Institute of Medicine (IOM) of the 
National Academy of Sciences. Since 1992, she also has 
served on the IOM's Board of Health Sciences Policy. 
Dr. Polan received her B.A. degree cum laude from 
Connecticut College in 1965, and in 1970 was awarded her 
Ph.D. degree from Yale University in molecular biology 
and biophysics. After taking two years of postdoctoral 
training in the laboratory of Joseph Gall, Ph.D.. in the Yale 
department of biology, she entered the Yale School of 
Medicine to begin work on her M.D. degree. A 1975 YSM 
graduate. Dr. Polan was a resident at Yale in obstetrics and 
gynecology from 1975 to 1978 and had fellowships in that 
department in oncology, and endocrine and infertility, for 
the following two years. 
Dr. Polan served on the Yale School of Medicine 
faculty from 1978 until her appointment at Stanford in 
1990. Her recent research interests include differentiation 
in human granulosa cells and the effect of gonadal steroids 
on Interleukin-1 production. 
in the United States annually and roughly 25 percent of women 
with hip fractures die within six months as a direct result of that 
fracture. 
Spinal compression fractures, although not fatal, cause sig¬ 
nificant morbidity for women. Not only is pain an issue, but the 
development of the “dowager's hump” signals a loss of height. 
As you grow older, it not only seems that your mother is getting 
smaller— she is. Spinal compression fractures can result in a loss 
of two-to-four inches in height as women age. The kyphosis that 
ensues — the severe, outward arching of the spine — has a 
negative impact on both lung and gut functions because of 
displacement of the pulmonary and digestive system organs. The 
third most common fracture, a Colies wrist fracture, also occurs 
with great frequency in post-menopausal women. 
Although the mortality and morbidity of osteoporosis are 
high, perhaps an even more important post-menopausal risk is 
heart disease. Lack of estrogen almost immediately places 
women’s cardiac risk in the same category as men's. The pre¬ 
menopausal protection that estrogen provides rapidly disappears 
and women rival men in incidence and types of cardiovascular 
diseases, such as myocardial infarction and stroke. 
An ongoing question in the health care of the aging woman is 
estrogen replacement therapy. Overall, we know that women who 
take estrogen live approximately seven years longer than women 
who don't. But that observation begs a series of more specific 
questions about hormone replacement therapy. Who should be 
treated? At what age? For how long? In what treatment regimens? 
These questions are the basis for studies which could and 
should be performed so that we can better determine how to treat 
estrogen loss. In view of the fact that women spend approxi¬ 
mately 30 years of their lives in an estrogen-depleted state, we 
need to know more about the risks of hormone-replacement 
therapy for specific subgroups of women. The risks of endome¬ 
trial cancer and cancer detection are fairly well understood. We 
know that women with a uterus need to receive not just estrogen, 
but also a progestin to maintain a quiescent endometrium. 
The fact that estrogen increases clotting factors constitutes a 
risk for women who have a history of phlebitis as deep venous 
thrombosis. The major question that has arisen over the past 
several years, however, is the increased risk of breast cancer. Are 
women who have already had a breast cancer forever barred from 
receiving estrogen therapy? Equally important, what are the risks 
for women who have a family history of breast cancer? We 
believe that for the vast majority of women, there is no increased 
risk of breast cancer with hormone replacement therapy. How¬ 
ever, we need to design more specific studies of subgroups of 
women who are at higher risk for disease in order to measure any 
potential increase in risk related to hormone replacement. 
We must educate ourselves and our patients who need all the 
information that we as their physicians can provide. They need 
to be able to understand the risk versus benefit ratio of the 
possible therapies. We should not only invest more money in 
clinical trials including women and in specific women’s diseases, 
but we also must educate women and their families about these 
major health issues. The future of women's health care in the 21 st 
century rests on the tripartite base of health education, laboratory 
research studies and clinical trials. YM 
















Why Women’s Health? 
Denise Conte, R.N., medical 
nurse with the Women's Health 
Initiative, explains the electro¬ 
cardiogram procedure to a 
first-time patient. 
by Sandra K. Ackerman 
It all began innocently enough, in mid-winter 1989, on a com¬ 
mercial airliner waiting to be cleared for takeoff to Washington, 
D.C. from a Denver airport. U.S. Congressional Rep. Pat 
Schroeder. D-Colo., found herself seated next to Florence 
Haseltine, Ph.D.. M.D.. director of the Center for Population 
Research at the National Institutes of Health and a lecturer at Yale 
in obstetrics and gynecology. 
Ms. Schroeder was intrigued by the headline news of the 
now-classic “aspirin study" of 22,000 physicians aged 40-80. 
Reported in a January 1989 edition of The New England Journal 
of Medicine, the five-year study showed that taking aspirin once 
a day reduced the odds of having a heart attack. The congress- 
woman asked Dr. Haseltine whether she would recommend that 
women of perimenopausal age take an aspirin daily. 
The answer was disconcerting. "I have no idea," Dr. Haseltine 
said, "because the study was done only on men.” For the nascent 
field of women’s health, the reverberations caused by that reply 
Sandra J. Ackerman is a free-lance writer living in New Haven. 
Her book, Discovering the Brain, was published in March 1992 
by the National Academy Press; her article “Rare Disease 
Research: The Road Less Traveled ” appeared in the Fall/Winter 
1992-93 issue of Yale Medicine. 
would be like the echo that began the avalanche. 
Fast forward to the summer of 1990. The congressional 
caucus on which Rep. Schroeder serves opened hearings to 
investigate how much of federally funded medical research 
included women as subjects. The committee’s conclusion? 
“Unknown.” 
On June 18, 1990, the federal government's General Ac¬ 
counting Office reported to the committee that numerous major 
research studies funded by the National Institutes of Health 
(NIH) had never been monitored to ensure that women, as well as 
men, were included as subjects. Witness after expert witness, 
however, reported that women and their health concerns were 
severely underrepresented in NIH-sponsored medical studies. 
Many segments of the American public — including groups 
representing taxpayers, health-care professionals and health-care 
consumers — reacted indignantly to the news of this conspicuous 
void in government-sponsored research. What made this disclo¬ 
sure particularly ironic was the fact that, on paper at least, the NIH 
had been calling for the inclusion of women and minorities as 
research subjects since 1986, a policy that obviously hadn't been 
implemented. 
Thus on June 18, 1990, under the harsh, uncompromising j 
spotlight of the national press, the field of women's health was 
born. With the leadership of Reps. Schroeder and Olympia J. 
Snowe, R-Maine, the bipartisan Congressional Caucus for 
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Women’s Issues began to hold the NIH to its stated policy. 
Perhaps not coincidentally, the NIH has since created an Office 
of Research on Women's Health, while the National Institute of 
Child Health and Human Development (NICHD) is developing 
its own programs in this field. 
An Initiative of Our Own 
In keeping with this new awareness, the Yale School of Medicine 
and a handful of other medical schools are introducing courses, 
research projects and new clinical formats regarding women's 
health. The School of Medicine has named its effort the Women’s 
Health Initiative (WHI) and is developing a comprehensive 
program in partnership with Yale-New Haven Hospital (YNHH). 
WHI began to see patients in December 1992. 
In keeping with the missions of the medical school and 
YNHH, WHI not only provides clinical services but also con¬ 
ducts research and educates professionals — and patients, as 
well. The program's co-directors, Florence Comite, M.D. 76, HS 
’76-’78, associate professor of medicine, obstetrics and gynecol¬ 
ogy, and pediatrics, and Janet Henrich, M.D., associate professor 
of medicine, are also attending physicians at YNHH. 
At this early stage, WHI's clinical component is the most 
visible. Each Friday in a suite at the Charles A. Dana Clinic 
Building, a team of WHI care givers offers comprehensive 
medical evaluations that, in Dr. Comite's words, "look at the total 
woman.” For women who are conscientious about their health 
care and have long been resigned to piecing together a yearly 
regimen of visits to three, four or a half-dozen specialists, a day 
at the WHI is a welcome change. 
The initial appointment here includes a medical history and 
physical examination, laboratory tests as appropriate (lipid analy¬ 
sis), diagnostic studies (EKG, mammography, bone density), 
consultations with a physician and a dietitian, and referrals for 
general or specialized care as needed. Because patients have been 
fasting in anticipation of blood tests, services include a healthy 
breakfast. An educational lunch forum run by the dietician and 
nurses occurs while test results are retrieved by fax and phone. 
Women who undergo a WHI examination — the clinical 
center can serve up to eight patients per weekly session — tend 
to find the comprehensive medical screening considerably less 
time-consuming than the "patchwork quilt” of health care they 
may have faced previously. Moreover, practitioners from differ¬ 
ent medical disciplines work closely together at the clinical 
center, optimizing communication between the clinicians. 
Dr. Henrich sees the WHI's multidisciplinary approach as 
addressing a long-standing need: “So many women see several 
specialists and receive fragmented care. Often there’s no one 
with a broad overview of their health." Such a perspective helps 
a health-care professional to weigh a wide assortment of factors 
in prescribing care for each individual, to address specific con¬ 
cerns and to avert possible crises. 
Just as important, each WHI patient is engaged as an active 
partner in maintaining her own health. At the end of their day¬ 
long stay at WHI clinical center, new patients may be struck by 
the wealth of information that they receive — both a written 
summary and a careful, face-to-face explanation of the prelimi¬ 
nary medical evaluation. When the final test results are in, 
usually within two weeks, a formal report is sent to the patient and 
to the physician she designates. 
Dr. Comite sees such extensive patient contact as helping to 
fulfill the third part of WHI’s mission: education. Patients benefit 
from the WHI's educational mission — not only in the customized 
reports they receive, but also in the readiness of everyone at the 
clinical center to offer something not easily found in American 
health care today: the time to explain. Dr. Comite adds. “To 
optimize overall health, physicians and other health-care providers 
must work in partnership with their patients. This includes 
educating women about their bodies.” 
Comments one patient who for years had been seeing a 
variety of doctors for several medical problems, "I've finally 
found a place where people treat me like a human being, who have 
time to answer my questions.” About the WHI staff, she adds, 
“It's particularly gratifying that so many women in the medical 
profession are willing to help other women.” 
WHI also assumes an important role in teaching medical 
students and house staff, and by offering continuing education to 
established physicians and other health-care providers. With the 
aim of taking an interdisciplinary approach to teaching as well as 
patient care, WHI's curriculum draws on faculty whose expertise 
includes such diverse fields as reproductive endocrinology, car¬ 
diology, mammography, oncology and bone densitometry. 
At the Clinical Center: A Healthful Day 
On a typical Friday morning, a patient from New York City, who 
had contacted the clinical center after hearing Dr. Comite deliver 
a talk at a forum on women's health, has arrived for a day's 
appointments. 
“Now, for these tests, you need to go over to the Yale 
Physicians Building,” says WHI's nurse coordinator, Jean Vulte, 
R.N., clinical research assistant in medicine and lecturer in 
obstetrics and gynecology. “Do you know the way?” the nurse 
practitioner asks. 
The patient does not. It’s her first time at the medical center. 
So Ms. Vulte steps briskly out from behind the desk and heads 
down the hallway with the patient. 
Upon Ms. Vulte's return, she pops her head in at the door of 
a conference room to alert Dr. Comite of a patient and various 
phone messages that await. Glancing down at her watch, Dr. 
Comite silently apportions a few minutes of her schedule to talk 
about the philosophy that underlies the WHI. 
“Ever since 1985,” she begins, “when 1 joined the Yale 
faculty, I’ve been aware of the real need to concentrate health 
care for women. Not to replace gynecologists or any other 
specialists, but to bring together a specialized approach that 
utilizes the cutting edge of medical knowledge in one place. 
“Our typical patient — whatever her age — may have many 
symptoms of evolving changes in her body. She may be very 
bright, she's often well-educated, but the chances are she won't 
be well-informed about these changes because she has no place 
to look questions up, to get an integrated picture. That’s what we 
want to provide. It’s okay if we don't always have a definitive 
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answer; there are limits to medical knowledge. But often, just 
explaining a process or a recommendation takes away the fear. 
And in giving people what information you have, you empower 
them. They can make their own choices.” 
Dr. Comite sketches the case history of a recent WHI patient: 
A woman in her early 30s, whose family history includes several 
cases of colon cancer and heart disease in close relatives. Her diet 
includes high levels of fat and relatively little fiber. "This woman 
is in a position to make critical changes now, if she's given the 
information she needs,” says Dr. Comite. 
A consultation with the WHI dietitian, which is scheduled for 
each patient, can thus set the tone for emphasizing moderate 
lifestyle improvements in the setting of each individual’s medical 
and family history. This approach may impact significantly on 
the patient’s future health. Ellen Liskov, a registered dietitian and 
nutrition specialist at YNHH. makes a point of providing not just 
general information but a specific nutritional analysis that is 
based on the individual’s self-reported intake of food. Before a 
patient arrives at the clinical center, she already has filled out 
several questionnaires for Ms. Liskov, which, taken together, 
should present a full picture of the patient’s eating habits. 
"The first questionnaire is more or less a standard form — 
how many meals do you eat per day, do you take any vitamins or 
minerals, and so on,” explains Ms. Liskov. “The second form is 
a three-day food diary; 1 ask the women to write down exactly 
what they eat during a three-day period. This gives me a snapshot 
view of how they eat. The third form, which asks about “food 
frequency, lists about 60 foods, from staples to snacks, and asks 
the person to note how many times per day or per week she eats 
each one.” 
Ms. Liskov uses a computer to compile the data, factoring in 
the individual’s age, weight, activity level and other health 
factors. Lrom these she derives a set of recommended dietary 
allowances (RDAs) specific to the patient. 
Although dietary allowances vary considerably, Ms. Liskov 
has noted a few common patterns among her patients. “Women, 
even those in great shape, all seem to have deficiencies of zinc, 
copper and pantothenic acid," she says. “Since zinc is associated 
with our senses of smell and taste, and many people start to 
complain in their 60s about losing their sense of taste, the low 
levels of zinc in particular are interesting.” Ms. Liskov sees this 
as a potentially fruitful area of sensory research. In fact, such 
thinking has already resulted in a research study, designed by Dr. 
Comite and Ms. Liskov, to prospectively look at the nutritional 
deficiencies of women seen at WHI. 
Levels of physical activity, which figure among the many 
factors that Ms. Liskov analyzes, soon will receive even closer 
attention. By arrangement with Gaylord/Yale-New Haven Reha- 
bilitation Center, a physical therapist will evaluate and make 
recommendations based on each patient’s exercise profile, much 
as the nutritionist did with eating habits. 
Such consultations and analysis comprise only one facet of 
the patient’s regimen during the course of her day at WHI. 
Explains nurse-coordinator Jean Vulte, "By the time Dr. Comite 
sits down with the patient this afternoon, she will have in her 
hands a good part of today’s test results: mammogram, chest X- 
ray. bone density, preliminary printout of the electrocardiogram, 
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urinalysis, many of the blood studies and a preliminary reading 
of cholesterol levels.” 
If, for example, the patient’s cholesterol levels suggest a 
significant risk of heart disease, or if the mammogram has 
revealed some spot that needs a closer look, Ms. Vulte does her i 
best to fit into the patient’s afternoon a quick appointment with 
a cardiologist, or she will try to schedule an ultrasound. “These 
extra steps can’t always be accomplished the same day,” she 
acknowledges, “but we try at least to get the referrals in place, so 
that the patient can be evaluated within the next week.” The goal 
is to cut down on the patient’s time of uncertainty and implement 
early intervention when necessary. 
“Overall, though,” adds Ms. Liskov, “we’re not seeing a lot 
of people come in as a direct result of medical emergencies. 
Instead, we have to be on the lookout for hypertension, colon and 
breast cancer, cardiac disease, osteoporosis — these can be very 
silent problems.” 
A New Approach 
Integrated health care, taking time to treat each patient as an 
individual, encouraging wellness and prevention — these prin¬ 
ciples could equally benefit both sexes. So why is this approach 
being advanced under the banner of “women's health?” Lur- 
thermore, what specifically can a program in women’s health 
contribute that has been missing from the American medical 
landscape? 
In reply to the first question. Dr. Comite agrees that the 
WHI’s comprehensive, one-day evaluation — “one-stop shop¬ 
ping" as it is affectionately known at the clinical center — should 
be available to men. “Many of the women seen here say that men 
would benefit from this approach,” Dr. Comite says. “I agree, j 
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I think it would be ideal for everyone.” 
To answer the second question. Dr. Comite offers an example 
of where the medical establishment has not historically served 
women well: “Women are largely overlooked when it comes to 
heart disease,” she says, “and yet, as many women as men 
ultimately die of it. Yet, most of the women seen at the WHI have 
never had a baseline EKG, in contrast to men at the same age.” 
Adds Dr. Henrich, “Cardiovascular disease accounts for one- 
half of all deaths among women in the United States.” She is 
quick to note, however, that the disease presents itself differently 
in the two sexes. To begin with, the peak onset of heart disease 
usually appears about 10 years later in women than in men — 
possibly because the estrogen circulating in a woman's blood 
during her reproductive years confers some protection. 
“Now that we know more about the effects of estrogen on the 
blood vessels, I think the findings will support that theory,” says 
Dr. Henrich, noting further that approximately 90 percent of all 
heart attacks in women occur after menopause. 
She also points out that women face a greater risk of dying 
within a year of their first heart attack, as compared with men. 
While not all the contributing factors are clear, a portion of this 
elevated risk appears to be associated with the failure to detect 
heart disease in women at its earlier stages, when it can be most 
effectively treated. 
Hoping that WHI can set a better example, Dr. Comite relates, 
j “One woman who came in last week needed a stress test, based 
on our reading of the medical questionnaire we obtained prior to 
her scheduled visit at WHI. We coordinated this with a cardiolo¬ 
gist at the medical school, and she had her test during the day of 
her visit.” Dr. Comite adds that many women seen at WHI have 
had abnormalities signaled by their EKG. 
Research: Righting the Balance 
As the 1989 aspirin study painfully illustrates, women's cardio¬ 
vascular health has received less than its share of attention not 
; only clinically, but in terms of the nation’s research agenda, as 
(well. To this day, no one knows how, or whether, to apply such 
findings to women. 
Why were women barred from research studies to begin 
with? Dr. Haseltine, now director of population studies at the 
I NICHD, can recite a list of official excuses — all of which she 
finds unconvincing. One explanation, for example, was that new 
drugs should not be tested on women of reproductive age because 
of possible harm to fetuses, and because of the daunting logistics 
of arranging childcare for young mothers. 
“It was said that women's cycles are 'too complicated,’ and 
that the medications they take could interfere with research 
findings,” she adds. “But most women don't take any particular 
medication for their cycle until they reach their 50s, so excluding 
younger women on these grounds made no sense. In any case, 
when researchers did start including women in their studies, they 
found that these points of concern were not real problems.” 
To the contrary, for many medical research topics, inclusion 
of women as subjects could enrich the findings considerably. 
Take studies of the liver. This organ appears to metabolize many 
chemicals — including drugs and alcohol — differently in males 
and females. “These differences are probably pre-set during 
gestation, when the developing liver is or is not exposed to 
testosterone,” says Dr. Haseltine. The implications are great — 
especially for the treatment of substance abuse -— and largely 
unexplored. 
Endocrinology offers an especially intriguing topic for com¬ 
parative study: hot flashes. These sudden, uncomfortable 
sensations of warmth, with accompanying perspiration and flush¬ 
ing, are mostly associated with menopause. But men may suffer 
hot flashes, too, if their gonads have been removed as a result of 
cancer or other disease. 
“Hot flashes are believed to be not as bad — not as prevalent 
or severe — in men in this situation, as in most women.” says Dr. 
Haseltine. “But are they perhaps under-reported? Could there be 
a cultural pressure at work here: Men don't dare to report hot 
flashes, and when they do they’re not taken as seriously?” In both 
sexes, the problem appears to be similarly rooted: a steep drop of 
sex hormones. 
“This is an example of why we should know more about how 
disorders occur in both sexes,” says Dr. Haseltine, adding that if 
scientists find that a particular condition affects the two sexes 
differently, researchers should do studies to compare those 
differences. “We might find that hot flashes in men really are as 
bad as in women — which could lead to more effective treatment 
for men. Or maybe we would find they’re not as bad — which 
would be very interesting, and could perhaps be helpful to 
women.” If so, and if significant differences could be identi¬ 
fied, such results might suggest new approaches to therapy in 
women and men. 
Education: “A Lot of Catching Up to Do” 
As the example of “hot flashes” suggests, when medical science 
concentrates on one sex only, the result may be that neither gender 
receives optimal treatment. While on leave from Yale, at the NIH 
Dr. Henrich has been working to broaden the perspective of 
medical education in this regard. “Part of my purpose this year has 
been to develop a core curriculum in women's health for medical 
schools wishing to address the many issues of this field,” she 
explains. 
At present, few medical schools offer so much as a single 
course focusing on women’s health. When such offerings are 
available, though. Dr. Henrich offers a caveat: “It's important not 
to polarize men’s health and women’s health.” She adds that 
making a separate specialty of women’s health “would be a grave 
mistake. But I do feel that this content should be incorporated into 
every physician’s training, much as geriatrics has been.” 
On the educational front, in the spring of 1994, women’s 
health will be the topic of a new course at Yale College under the 
aegis of the Women’s Studies Program. Linda M. Bartoshuk, 
Ph.D., professor of surgery, epidemiology and psychology, will 
coordinate the new course with Dr. Henrich and a male faculty 
member, Kelly Brownell. Ph.D.. professor of psychology and of 
epidemiology and public health. 
Dr. Bartoshuk says the course will address medical and 
Continued on Page 18 
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Drs. Comite (left) caul Henrich, WHI co-directors, wearing 
the WHI pin created by Jan Leslie, N.Y. jewelry designer. 
Florence Comite, M.D. y76, HS '76- '78: 
Something New at Every Turn 
Florence Comite, M.D., did not have women's health specifically 
in mind when she entered the Yale School of Medicine in the 
early 1970s; the field would not even begin to define itself for 
another decade or so. 
As a medical student, however, she did relish new ways of 
looking at familiar fields. Dr. Comite was one of only five honor 
students to present her thesis orally at Student Research Day in 
1976; her original research examined the use of thyroid-hormone 
analogues in rats in utero to treat goiter in the developing fetus as 
a potential therapy for children with congenital hypothyroidism. 
She says she owes a debt of gratitude to her thesis advisor in 
directing her budding career: “I was fortunate to conduct this 
work under the guidance of Jerry Burrow,” comments Dr. Comite, 
referring to the current dean of the medical school, Gerard N. 
Burrow, M.D. “He was then an associate professor in the 
department of medicine, but also held a consultant post in the 
department of obstetrics and gynecology. He was known for his 
work on hyperthyroidism in pregnant women, and in the interface 
of endocrinology with medicine and gynecology. In Dr. Burrow 
I encountered a compassionate mentor and skilled clinician, and 
he helped spur my interest in a multidisciplinary approach to the 
care of women.” 
IVF Adds Donor Egg Program 
The Yale In Vitro Fertilization (IVF) Program — which has 
addressed the needs of infertile couples since 1982 — has 
recently added a donor oocyte program for women who are 
unable to produce their own eggs for bearing children. 
Several pregnancies have resulted from the donor oocyte 
program, says Ervin E. Jones, M.D., Ph.D., associate professor of 
obstetrics and gynecology and director of the Yale IVF program. 
Dr. Jones views the oocyte program, managed by David Keefe, 
M.D., assistant professor of obstetrics and gynecology, as an 
important complement to the program. 
Women may need donor eggs because they have experienced 
early menopause, surgical removal of ovaries, or failure to 
appropriately respond to ovarian stimulation. Most patients 
going through the Yale donor program are between age 40 and 45. 
“We stimulate the ovaries, just as we do in IVF; harvest the 
oocytes that then are fertilized by the recipient’s husband’s sperm 
and the embryos are placed in the recipient’s uterus,” Dr. Jones 
explains. “The recipient's cycle must be synchronized with the 
donor cycle since the developmental maturation of the embryos 
must appropriately coincide with the implantation window of the 
donor cycle.” 
Extra embryos can be cryopreserved and saved for use in 
subsequent cycles, eliminating the need for medication, ultra¬ 
sound and estrogen monitoring. 
The Yale IVF program also has opened a center for microma¬ 
nipulation, which offers yet another hopeful option to couples 
with male-factor infertility. In this process, called assisted 
fertilization, sperm cells are injected directly into the eggs and 
fertilization is allowed to occur. 
Another form of micromanipulation, known as assisted hatch¬ 
ing, is used to weaken the zona pellucida, the microscopic 
membrane around the eggs, before the embryos are placed in the 
uterus. This facilitates pre-implantation hatching and improves 
the efficiency of implantation. 
Micromanipulation also allows Yale physicians to perform 
pre-implantation assessment of embryos in order to detect and 
prevent certain X-linked disorders, such as Duchenne’s muscular 
dystrophy, Lesch-Nyhan disease and X-linked mental retarda¬ 
tion, Dr. Jones notes. 
The Yale IVF team, which traditionally has been on the 
cutting edge of reproductive technology, includes reproductive 
endocrinologists, embryologists, molecular biologists, geneti¬ 
cists, specialty nurses and social workers. They continue to refine 
methods for treating infertility. 
“A lot of high-powered technology complements the IVF 
procedure,” says Dr. Jones, who cites two sophisticated proce- 
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Dr. Comite spent several years, following her Yale residency, 
at the National Institute of Child Health and Human Develop¬ 
ment (NICHD) as a clinical investigator in reproductive endocri¬ 
nology. returning to Yale in 1985. At that time, she was studying 
the use of synthetic hormone (GnRH) analogues in humans to halt 
“precocious puberty” — a disorder in which growth spurts and 
sexual maturation begins abnormally early. 
Estimated to affect about one in 5,000 children as young as a 
year old. precocious puberty can leave girls and boys with short 
stature as adults, and psychological complications due to the 
early sexual development. Dr. Comite, together with Myron 
Genel, M.D., today, the associate dean for government and 
community affairs, and then, the director of the Children's Clini¬ 
cal Research Center, established a treatment program at Yale- 
New Haven Hospital, coordinated by the section of pediatric 
endocrinology, with the assistance of research nurses Angela 
Notarfrancesco and Mary Bronson. Recently, several analogues 
have been approved by the Food and Drug Administration as drug 
treatments for precocity. 
Further work with these analogues has led Dr. Comite into 
studies of endometriosis, a painful and sometimes debilitating 
condition in which misplaced cells from the lining of the uterus 
grow within the pelvis, on the ovaries, bladder and bowel. “This 
research serendipitously led to the finding that women with this 
condition — estimated to be 3 to 5 million in the United States — 
appear to have reduced bone density,” she says. Dr. Comite is 
now doing laboratory research with Agnes Vignery, D.D.S., 
associate professor of orthopaedics and rehabilitation, and cell 
biology to discover if immune dysfunction plays a role in 
endometriosis as well as in bone loss. 
In 1987, such research also prompted Dr. Comite to 
introduce a patent for clomiphene, a fertility drug commonly 
used for women with endometriosis or other causes of infer¬ 
tility, as an experimental treatment to increase bone in women 
prior to menopause. "This might help avert osteoporosis in 
women with reduced bone thickness, and perhaps be utilized in 
menopausal women who can’t take estrogen,” she says. 
Collaborative research with Shirley McCarthy. Ph.D., 
M.D. ’79, HS ’80-’83, associate professor of diagnostic imag¬ 
ing, and clinical director of MRI at YNHH, resulted in the use 
of magnetic resonance imaging (MRI) in endometriosis. Cur¬ 
rent studies in women suggest that MRI as a diagnostic probe 
is a cost-effective approach to avoid pelvic surgery. 
Psychiatric aspects of this disorder also have drawn Dr. 
Comite's attention. She reports that working with Dorothy Otnow 
Lewis, M.D., professor of psychiatry at New York University 
Medical Center and clinical professor in the Yale Child Study 
Center, "We found an increased risk of bipolar disorder among 
women with endometriosis.” Abnormal levels of several 
hormones, which occur in both endometriosis and several 
mood disorders, may offer clues about a possible connection. 
Dr. Comite feels strongly that the systems are linked: 
“We’re not separate parts that function independently. Medi¬ 
cine is most effective when it views the body as a system: 
integrated, connected, related.” She adds that such an outlook 
characterizes the field of women’s health. 
dures that will further enable the team to assist infertile couples: 
• Polymerase chain reaction (PCR) has opened a new fron¬ 
tier in genetic analysis, allowing the IVF team to take DNA from 
one cell and replicate the genetic materials and to produce a 
supply with which to work. Specifically, PCR permits the 
amplification of a specific DNA sequence by as much as one 
million times, and it now makes analysis of DNA from a single 
cell possible. 
The earliest uses of PCR in the reproductive technologies is 
for embryo sexing using a single cell obtained by biopsy. The 
strategy, based on chromosome specific repeat sequences on 
either the x or y, uses specific probes to determine the sex of the 
embryo. 
• Fluorescence in situ hybridization (FISH) allows direct 
visualization of DNA sequences of interest in metaphase of 
interphase nuclei. This technique is useful for detecting numeri¬ 
cal chromosomal abnormalities using specific probes. 
The application of these powerful techniques increases the 
overall clinical utility of the IVF process. Yale’s IVF success rate 
continues to be approximately 35 percent per transfer for all 
patients, which is above the national average. To date, approxi¬ 
mately 290 babies have been born at Yale-New Haven Hospital 
and other hospitals throughout the country as a result of IVF and 
embryo transfer. Dr. Ervin E. Jones 
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Continued from Page 15 
Gerontology: An Area of Women’s Health? 
While the Women’s Health Initiative (WHI) provides a focus for 
this emerging field here at Yale, WHI constitutes only a single 
part of the diverse work related to women’s health at the medical 
school. Many Yale physicians and scientists are striving to 
improve the health of women in specialties that range from 
obstetrics and gynecology to surgery and oncology. 
Some exemplary lines of research have arisen in the field of 
gerontology, among them, a series of fall injury studies, includ¬ 
ing a new study of hip fracture rehabilitation led by Mary E. 
Tinetti. M.D., associate professor of medicine. Although women 
hold no monopoly on hip fractures, this injury does take a 
disproportionate toll among elderly women. 
In fact. Dr. Tinetti. who also is director of the Older American 
Independence Center, argues that geriatrics itself can be consid¬ 
ered an area of women’s health, for two reasons: "The first is 
simply the demographics,” she explains. “Of the people who live 
to age 75 in this country, two-thirds are women. The second 
reason is that women not only live longer but also seem to develop 
more disabilities as they age than men. To oversimplify, it's as 
if frail men die and frail women live.” 
Dr. Tinetti notes that women suffer approximately 200,000 
hip fractures annually in the United States. Half of the patients 
go home to recuperate; the others go to nursing homes, either 
briefly or permanently. Her current study, conducted through 
Yale-New Haven and St. Raphael’s hospitals, and 22 home-care 
agencies, examines whether more intensive, rehabilitative fol¬ 
low-up care at home improves the rate and extent of recovery, as 
compared with usual care at home. 
Dr. Tinetti confesses a bias: She hopes that the data will 
support keeping people in their own homes. “If we find that our 
care results in improved functional level of recovery and is cost- 
effective, then perhaps Medicare will eventually fund this level 
of care more fully.” 
Examples of other School of Medicine faculty who are doing 
research projects with implications for women's health include: 
• Fitzhugh Pannill, M.D., assistant professor of medicine, 
who heads a study at the Department of Veterans Affairs Medical 
Center in West Haven on urinary incontinence — an age-related 
disorder with a significant cost to quality of life. 
• Mark S. Lachs, M.D.. assistant professor of medicine, who 
is studying the poorly understood problem of elder abuse. 
• Teresa E. Seeman, Ph.D., research scientist in epidemiol¬ 
ogy. and Lisa F. Berkman, Ph.D., professor of epidemiology. 
Their study, funded by the MacArthur Research Network on 
Successful Aging, asks whether there are gender differences in 
patterns of aging. 
Dr. Tinetti explains that while important for women's health, 
these studies will benefit both sexes: “I don't think it makes any 
sense to divide up the health issues of aging arbitrarily by gender. 
It was ridiculous when we did it for men, and it would be 
ridiculous now to do it for women.” 
scientific topics as well as “the larger cultural context of what it 
means that we are behind in women’s health.” Talks are sched¬ 
uled by eminent researchers and policy-makers both from Yale’s 
School of Medicine, the faculty of Arts and Sciences, and from 
outside the University. 
The first lecture will be given by Judith Rodin. Ph.D., the 
Philip R. Allen Professor of Psychology, professor of medicine 
and psychiatry, and University provost. She will discuss the 
status of women’s health in the United States. Ann Flitcraft, 
M.D., assistant professor of medicine at the University of Con¬ 
necticut, will speak on violence against women; Dr. Flitcraft also 
is director of the Domestic Violence Training Project in New 
Haven. Dr. Haseltine will discuss the policy implications of birth 
control. 
Yale's WHI also is developing projects that combine educa¬ 
tion and women’s health care. The initiative will also seek 
funding for researchers in women's health. Immediate plans call 
for encouraging research in women’s health, and for cross- 
disciplinary faculty research. Dr. Comite notes, "If we were to 
discover a blood or tissue test to suggest an increased risk of 
breast or colon cancer, it would be simple to test specimens from 
women who present with this positive family history. The 
application of new techniques could be rapidly implemented 
through WHI. bringing research progress to patients without the 
usual delay of months or years.” 
WHI has already gained broad respect from the community, 
and has established an advisory council, co-chaired by Jane 
Cohen, M.S.W., and Ruth Edelson, M.P.H., J.D., with Elaine 
Lawson as the executive coordinator. The volunteer council 
represents a spectrum of professions and interests. In the words 
of one member, Doris Zelinsky, vice president of operations for 
Lender's Bagels, "The WHI combines medical assessment with 
opportunities for education and research — exciting and fre¬ 
quently under-utilized components of health care.” Katharine 
Weber, writer and book critic, adds, “An absolutely essential 
function of the advisory council will be the ongoing and creative 
search for financial support to maintain WHI programs.” 
Dr. Comite says long-term plans include seminars for WHI 
patients that will offer up-to-date medical findings and interpre¬ 
tations: “We could bring in patients with cardiac illness, and 
have a cardiologist give a presentation to them. Or we could put 
together a seminar for our patients with breast cancer — and for 
their daughters, who will need to know how to lower their risk. 
“At an academic center like Yale we should be able to offer 
the cutting edge of medical expertise,” she continues. “It’s only 
by integrating the various medical specialties — cardiology 
with endocrinology; gynecology with psychiatry — that we can 
begin to clarify our understanding of the complexities of the 
human body.” 
It does not trouble Dr. Comite that this approach may blur the 
lines between traditional medical disciplines. To the contrary, 
she believes “a multidisciplinary effort that combines clinical 
care, research and education, such as we try to embody here at the 
WHI, is the key to tomorrow’s health. I think WHI's approach 
may be the future of medical care in America.” YM 
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YM Interview: 
Kathryn E. McGoldrick, m.d 
Dr. Kathryn E. McGoldrick 
On May 10, 1993, Rosalind D' Eugenio, media specialist for the 
Yale School of Medicine Office of Public Information, inter¬ 
viewed Kathryn E. McGoldrick, M.D., professor of anesthesiol¬ 
ogy at the medical school and director of ambulatory surgery at 
Yale-New Haven Hospital. Dr. McGoldrick received her M.D. 
degree from Cornell University Medical College in 1970 and 
served residencies at the New York Hospital-Cornell Medical 
Center, Peter Bent Brigham Hospital and the Children \s Hospi¬ 
tal Medical Center in Boston. She serves as editor-in-chief of the 
Journal of the American Medical Women’s Association and has 
written the books, Anesthesia for Ophthalmology, Anesthesia for 
Ophthalmic Otolaryngologic Surgery, and Women in Society. 
For five weeks during February and March of this year. Dr. 
McGoldrick taught in Tanzania as part of the Overseas Teaching 
Program in Anesthesiology, led by Nicholas M. Greene, M.D., 
professor emeritus of anesthesiology. The program is sponsored 
by the American Society’ of Anesthesiologists. (See “An Overseas 
Teaching Program in Anesthesiology, ” Page 30.) 
What attracted you to the field of anesthesiology? 
During my third year of medical school, I served an anesthesia 
rotation and was fascinated with the applied physiology and 
pharmacology of the field. I’ll never forget the time I gave half 
a cc of atropine to a patient whose heart had slowed down and the 
heart rate sped right up and I thought, "Wow, just that little bit of 
drug could make such a dramatic improvement in how the patient 
was doing.” So I think that was when I really took to the field. 1 
guess it’s the power of an excellent teacher, too, that attracted me 
to anesthesia. I was taught by Alan Vanpoznak and Joseph 
Artusio, who are two very famous anesthesiologists at Cornell. 
So, my decision was a combination of liking the subject matter, 
plus having professors who took an interest in me. 
How has the field of anesthesia changed over the past 20 years ? 
It’s advanced so much. Monitoring has become much more 
extensive. We not only have more invasive monitoring but also 
more non-invasive, which is exciting to see, because with invasive 
monitoring you're always trading risks verses benefits. We can 
glean a lot of valuable information with minimal risk, and that has 
just advanced anesthesia tremendously. With these new monitor¬ 
ing devices, we pick up on things in a matter of seconds and 
intervene appropriately, making anesthesia a lot safer in the past 
decade. 
As director of ambulatory surgery, I can say that we have such 
terrific pharmaceuticals which enable ambulatory surgery to be 
so successful, that now, over 50 percent of operations in the 
United States are on an out-patient basis. That's in no small part 
due to anesthetic drugs which have been devised to have minimal 
effects and to wear off more quickly. Patients are having certain 
types of procedures today that, 10 years ago, I wouldn’t have 
dreamed it possible for them to go home the same day. 
What other advancements have you seen? 
There are a lot of places where open-heart surgery patients are 
brought in the same day as their surgery and just stay several days 
afterward, which still amazes me. When I was doing cardiac 
anesthesia, open-heart patients would come in a few days in 
advance and have some testing and get acclimated to the hospital, 
then have their surgery and stay in for two or three weeks. Now 
the procedure is usually compressed into seven or eight days. 
When you were serving your residency in anesthesiology, were 
there other women in your group? 
There were two other women in the program, typical for the time. 
Anesthesia has always been about 17 to 20 percent women. The 
other women were from Ireland and Israel, so I was the only 
Yale Medicine Summer 1993 19 
American. That was at the Brigham Hospital in Boston. 
Do you feel the field of anesthesiology offers equal opportuni¬ 
ties to women? 
From the beginning of the specialty women were involved, and 
so. traditionally, anesthesia has been a good field for women. 
Interestingly, anesthesia was not always as prestigious as it is 
today, and now that anesthesia is more lucrative, the percentage 
of women in anesthesia hasn't gone up as dramatically as it has 
in some of the other fields. That may be due to more women going 
into surgery, but when I chose anesthesia, very few women went 
into surgery. It’s possible that if a woman had some interest in 
surgery, she felt too discouraged and overwhelmed by the lack of 
women in that field, so she turned to anesthesia instead. Now 
maybe those women are going directly into surgery. 
What are some of the major contributions that women have 
made to the field of anesthesia ? 
Virginia Apgar. who designed the Apgar score, is the major 
contributor who stands out in my mind. Dr. Apgar was an 
anesthesiologist at Columbia and played a very prominent role in 
advancing obstetrical anesthesia. She devised a scale to evaluate 
the conditions of a newborn, quantitating whether the newborn 
needed resuscitation or not. And Gertie Marx, who is still 
practicing anesthesia — she must be close to 80 — was another 
pioneer i n the field. She did a lot to advance obstetrical anesthesia 
and to make childbirth safer and more comfortable. 
Tell us about your volunteer work in Africa. What part of the 
continent did you go to and in what capacity did you serve? 
I went to a little town called Moshie in Tanzania, and I was at the 
Kilimanjaro Christian Medical Center, one of the two or three top 
hospitals in Tanzania. I taught anesthesia to a class of 22 students 
for nearly five weeks. It was a wonderful experience, because the 
students are so eager to learn. There are only eight or nine M.D. 
anesthesiologists in all of Tanzania, and most anesthesia care is 
provided by anesthesia officers, who roughly compare to a 
physician assistant here. It was very interesting to go there and 
see people who have so very little in the way of drugs and 
equipment being able to actually take very good care of patients 
with serious illnesses. 
What kind of training do the anesthesia officers have? 
Most of the students were in their 30s and 40s and had served 
several years as medical officers. They have a broad medical 
background, and now they’re specializing in anesthesia. Basi¬ 
cally, they learn all the skills that an anesthesiologist would learn 
in America. They learn to do epidural anesthetics, spinal anes¬ 
thetics, general and endotracheal anesthetics, but they don’t have 
the equipment or the drugs that we have. However, they do a good 
job of providing care to very sick patients. Patients there have 
diseases that you just don't see here, a lot of malaria, for example. 
Unfortunately, the form of malaria that is so common there, 
salciparum malaria, is the fatal kind. They also suffer from the 
AIDS virus due to promiscuous heterosexual sex. The men in 
particular just have one partner after another. 
Is AIDS highly prevalent among the children? 
Yes, AIDS and malnutrition are prevalent among the children. I 
had one patient in her early 20s who weighed 22 kilos, about 45 
pounds. It's just pathetic. There is very little in the way of protein 
for food. Half of the time we didn't have electricity, and hot water 
is a luxury. They appreciate what this program is trying to do for 
them, and I just can't say enough good things about Dr. Greene 
because he established two very dynamic programs in two parts 
of Africa that have made such a difference. 
Dr. McGoldrick with two of her students at the Kilimanjaro 
Christian Medical Center in Moshie. Tanzania. 
What's anesthesia like in Tanzania? 
It’s where we were years ago. For example, when we give an 
epidural, we tend to use catheters, because they give us a great 
deal of flexibility in terms of how long we can deliver the 
analgesia to the patient. There they don’t have catheters. As a 
matter of fact, just the needles to insert the epidural itself are hard 
to come by, so if they get epidurals at all, it’s just one injection for 
a surgical procedure. They really don’t give analgesia to women 
delivering babies, because they just don't have the equipment to 
do it. The only time that anesthesia got called in for a delivery 
over there was if there was a caesarian section; otherwise it’s all 
natural childbirth. Their predominant anesthetic is ether, which 
we haven’t used for decades. But, that’s their major agent 
because it's so cheap. 
Did you find teaching there difficult? 
It was a real intellectual challenge. The first day I was there, they 
asked me to give an hour lecture on anesthesia for the eye, which 
is my subspeciality. I wasn’t sure how I would condense 
everything to one hour. I soon realized that I wasn’t pitching the 
delivery right at all, so I started to speak more slowly or write 
terms on the blackboard; their language is Swahili, but the classes 
are all conducted in English. I had to rephrase things sometimes 
four times, and finally I could tell by the look in their eyes that 
they understood. My one-hour lecture on anesthesia for the eye 
turned into three different days of lectures on that one topic. I 
wish I could have stayed longer; my last week there, I realized 
that the students and I were finally on the same wavelength. 
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Did you meet any women in medical practice in Africa? 
I didn't see any African women physicians. I know that they do 
have African women physicians, but I just didn't happen to 
encounter them. 
Returning to American medicine, do you feel that the profes¬ 
sion is welcoming women? 
I think women are being encouraged to go into medicine, I really 
do, and it’s starting in the families too. Parents are seeing that 
because of financial necessity, raising children is one of many 
things that women do in their lives, and that it takes two incomes 
to survive and to raise a family and to give them an education. 
With the divorce rate around 50 percent, women cannot count on 
having a man to support them, nor would they necessarily want 
a man to support them or their children. 
What are some of the larger issues that are facing women in 
medicine today? 
The problem for women today isn't one of recruitment, it's more 
one of advancement. Our numbers are increasing. Women make 
up about 40 percent of freshman medical students, which is very 
impressive. When I was a student in the 1970s, there were four 
women at Cornell in a class of 84 or 86, so it was about 5 percent. 
In the late 1970s, numbers started improving for women. 
To what do you attribute this increase? 
I think one of the reasons was that the Women's Equity Action 
League filed a class action lawsuit against every medical school 
in the country claiming discrimination. With that, coupled with 
individual lawsuits, coupled with federal grants being contingent 
upon not discriminating, we started to see this tremendous 
increase of women going into medicine. 
Is there still progress to be made? 
Our numbers are increasing, but we need to get those women into 
positions of power, to have more women as chairs of depart¬ 
ments, as professors and associate professors. Even though 
women are 40 percent of entering classes, it's such a recent 
phenomenon that many of the women in medicine tend to be quite 
young. For example, only 20 percent of practicing physicians are 
women, because many are still in medical school or in house 
officerships. We've got a way to go; more than anything else, we 
have to look at how we can advance women. 
What trends or changes do you see in the next decade for 
women in medicine? 
When you compare the practice styles of female to male physi¬ 
cians, a couple of features come to mind; one of them being that 
women make less money. Most studies show that the average 
female physician makes about two-thirds of the average male 
physician’s income, and there may be several reasons for that. 
First of all, women tend to be younger. They also tend to work 
fewer hours a week, but not enough less to account for the 
monetary difference. Women often go into specialties that pay 
less, and are more heavily concentrated in primary care rather 
than surgical specialties or procedure-oriented specialties. 
What do you think are the reasons behind those decisions? 
There may be something about the lifestyle of surgical specialties 
that discourages women, or the specialties themselves may prefer 
to offer the slots to men rather than to women. Women may feel 
that their opportunities for advancement in urology, for example, 
are not as great as they are in pediatrics. I'd like to see women 
advance in a specialty that they truly want and not pick something 
just because of the hours or what they perceive to be their chances 
for being accepted. That's very important. 
Do women need to do more to help advance their own careers 
in the medical field? 
Some of the advancement problems for women are institutional 
and governmental, but I think there is a large part of personal 
responsibility that women have to bear. It’s fine for us to think 
that hospitals and residency programs have to spell out their 
maternity leave policies, but at the same time. I think personal 
responsibility needs to play a role. What I envision is women 
expecting their husbands to share parenting so that the women 
don't have to do 95 percent, which historically has been the case. 
We are seeing more fathers involved in parenting, which is to 
everybody’s advantage, especially the children’s. When I am 
asked to recommend someone for a committee. I always try to 
recommend a woman, provided she is qualified and I think she'll 
do a good job. Women also have to network, which is something 
we haven't realized until recently. We have to help one another; 
women haven’t always done a very good job of that. 
What does the immediate future hold for women in medicine? 
I think the atmosphere for women is much better. Women are 
branching out into different fields. You used to see an occasional 
woman in neurosurgery or surgery when I was training, and I 
knew one female orthopaedic surgeon up until five years ago. and 
now I know several. I know several urologists and neurosurgeons 
who are women, which was unheard of when I was training. I 
think we’re starting to see women get promoted earlier and more 
frequently. Again, when I was a medical student and house 
officer, I knew few women professors and they didn't attain that 
rank until they were well into their 50s. That's all changing now. 
How long will it take before women are taken as seriously as 
men are in the medical field? 
I think it’s going to happen within the decade. We’re starting to 
see women as chairs of departments, they're going into presti¬ 
gious specialties, and they are starting to get recognition, and 1 
think women are going to change medicine. 
Once in more prominent positions within medicine, women 
can be role models, for men as well as women. If women are 
geared into the qualitative aspects of medical care rather than the 
quantitative aspects of productivity and how many patients they 
see a day. then as more women assume prominent roles, it will 
become acceptable for men to have women as role models. I’m 
very optimistic. I think it’s an exciting time for women in 
medicine. YM 










Anesthesiology at Yale 
Continuing the Legacy 
Luke M. Kitahata, M.D., (right) in the Pain Management Center, treating a patient with the assistance of John Dombrowski, M.D., a 
postdoctoral fellow in anesthesiology. 
by John Dinolfo 
Visitors to the office of Paul G. Barash, M.D., professor, chair¬ 
man and chief of anesthesiology, are quick to encounter his wry 
sense of humor. On the wall next to Dr. Barash’s desk is displayed 
a subtle sample of his wit: a framed wall plaque on which is 
inscribed in Russian Cyrillic, “Trust But Verify." While this relic 
of the Cold War maybe sage advice to any medical school 
department chair, the proverb also reveals a serious truth regard¬ 
ing the practice of anesthesiology. 
John Dinolfo, a free-lance writer, recently won an Award of 
Excellence from the American Medical Writers Association/New 
England Chapter for his article, “Pathology at Yale: Bridging 
the Gap, ” which appeared in the Fall/Winter 1991-1992 edition 
of Yale Medicine. 
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Trust in hard-earned skills, plus precise verification of the 
factors that determine the choice of anesthesia, are essential to 
managing critical incidents in the operating room. Respiratory 
failure, a precipitous rise or drop in blood pressure and an 
endocrine crisis represent just a few of the emergencies anesthe¬ 
siologists encounter. 
Depending on the case, verification of a patient’s drug and 
medical history, so crucial to surgical success and crisis manage¬ 
ment, may occur a few hours — or just minutes — before I 
anesthesia delivery and surgery begin. In particular, the increas¬ 
ing need for “on-the-spot” anesthetic evaluation of elderly pa¬ 
tients before ambulatory surgery can lead to unforeseen chal- I 
lenges during an operation, if the drug and medical history are 
complicated — or unknown. 
Dr. Barash, who also is associate dean for clinical affairs, 
suggests that while learning how to adapt effectively to unex¬ 
pected incidents “is an intrinsic part of the specialty," the practice 
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of anesthesiology at Yale goes far beyond high drama in the 
operating room. In addition to managing anesthetic care for 
surgical and pain-management procedures at Yale-New Haven 
Hospital (YNHH), anesthesiology faculty play a vital role in 
educating medical students and in training as many as 60 resi¬ 
dents annually. 
Also of note is the department's international reputation for 
basic and clinical research. The wide range of Yale anesthesia 
studies includes: 
• the role played by key spinal neurons that receive, inte¬ 
grate and process pain signals from peripheral cells; 
• neurophysiological mechanisms of hyperalgesia — the 
heightened sensitivity to pain that appears to account for some 
cases of chronic pain; 
• use of inhaled nitric oxide to prevent life-threatening 
pulmonary hypertension in children and adults who are undergo¬ 
ing surgery; 
• regeneration of the cells that cause the heart to beat — a 
goal once thought impossible; 
• the use of advanced computer networks to ensure the most 
efficient delivery of patient care. 
Progress Against Pain 
Yale anesthesiology has gained international recognition for its 
leadership in pain research; in fact, the department is the leading 
recipient of National Institutes of Health (NIH) funds to study the 
causes and management of pain. Much of this legacy can be 
traced back through almost two decades of ground-breaking 
work led by Luke M. Kitahata, M.D., Ph.D.. professor and former 
chairman of anesthesiology. 
In the 1970s, Dr. Kitahata’s basic and clinical research set the 
foundation for modern procedures to relieve acute and chronic 
pain. Dr. Kitahata was the first, for example, to hypothesize and 
prove that processing pain signals for incisional pain and other 
trauma occurs in the spinal cord rather than the brain. 
Those findings prompted clinical experiments at the Mayo 
Clinic that led to the use of spinal narcotics in humans. Yale 
clinicians also were among the first to administer narcotics in the 
spinal space, rather than use local anesthetics such as lidocaine or 
novocaine. "That is now a foundation of modern pain relief,’" Dr. 
Barash says. 
By blocking pain without impairing motor activity or con¬ 
sciousness, spinal injections of opioids (morphine-like drugs 
derived from opium) help patients recover from surgery with a 
minimum of discomfort. 
More recently. Dr. Kitahata and his colleagues have been 
studying the neuropharmacology of spinal opioids. This research 
has led. among other developments, to the use of local narcotics 
to manage pain after arthroscopy —joint surgery using a thin, 
fiber-optic tube rather than a scalpel — and the experimental use 
of opioids in some patients with chronic pain involving the 
cranial or spinal nerves. 
Anesthesiology researcher J.G. Collins, Ph.D., in his laboratory. 












Much of Dr. Kitahata’s research has been manifest at the Yale 
Center for Pain Management. The center is a leading tertiary care 
center for the treatment of debi 1 dating chronic pai n due to cancer, 
injury to nerves, muscles, limbs, joints, the back or other parts of 
the body. 
Patients typically are referred to the clinic after unsuccess¬ 
fully seeking relief elsewhere. The center’s multidisciplinary 
team of anesthesiologists, internists, oncologists, psychiatrists, 
nurses and other health professionals treat about 500 patients a 
month. "In effect, we are the primary care physicians for the 
management of their pain,” explains Lloyd R. Saberski, M.D., 
assistant professor of anesthesiology and clinical director of the 
pain center — a position he inherited from Dr. Kitahata in 1990. 
After the center’s team diagnoses the source of pain — no 
mean accomplishment in many of its patients — epidural ste¬ 
roids, local anesthetics, bioelectrical stimulation or a wide range 
of other analgesic procedures may be employed to ease or 
eliminate the patient's discomfort. 
The Center for Pain Management is one of only two Ameri¬ 
can sites chosen to conduct early clinical trials in epidural 
endoscopy. Like an arthroscope, an endoscope consists of a 
highly flexible, fiber-optic tube; only in the latter case, the 
physician uses the device to view intraspinal spaces. Early results 
of the clinical trials are promising; Dr. Saberski reports that 
endoscopy provides unrivaled views of the intraspinal space. 
Consequently, Yale anesthesiologists are now able to pin¬ 
point pain generators once accessible only by surgery — includ¬ 
ing foreign bodies, fibrous scarring, tumors and other lesions. As 
part of the clinical trials, Drs. Saberski, Kitahata and colleagues 
are determining the efficacy and safety of spinal endoscopy in 
various surgical patients. 
To explain why he’s so optimistic about endoscopy. Dr. 
Saberski gives the example of a 30-year-old male patient. After 
being disabled by back pain caused by lifting a heavy carpet, the 
man had been unable to find adequate pain relief — or even a 
diagnosis of the cause of his pain. At other locations, the patient 
had undergone a regimen often used to counteract severe back 
pain of unknown cause: Injection of a steroid or local anesthetic 
near the affected area. Such treatment usually brings only 
temporary relief, especially if the underlying cause of pain 
remains a mystery. 
With the patient in question, though, Yale physicians used 
epidural endoscopy to identify the unexpected pain generator — 
fibrous scar tissue encasing a nerve root. A gentle injection of 
saline solution loosened the fibrous debris; subsequently, pre¬ 
cisely targeted steroid injection led to pain relief. 
Dr. Saberski suggests that without epidural endoscopy, it is 
highly unlikely that the diagnosis would have occurred. He 
foresees the day when epidural endoscopy may be used to 
pinpoint and perhaps even treat spinal nerve root compression 
and inflammation, neural tissue destruction, cysts, foreign bod¬ 
ies, tumors and other lesions. 
In addition. Dr. Saberski believes the spinal scope will guide 
the "closed surgical” removal of pain generators, in much the 
same way that arthroscopy eliminates pain-causing debris in the 
knee. "Epidural endoscopy will likely be available as an adjunct 
to the anesthesiologist's practice within one to two years,” he 
predicts. 
Paul G. Barash, M.D. 
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Acute and ambulatory pain management fall under the aegis 
of the department’s Acute Pain Service, directed by Ray Sinatra, 
M.D., Ph.D. The service provides state-of-the-art analgesic care 
to a wide range of patients, including those with acute post¬ 
operative pain and children with sickle cell disease. Specific 
therapy provided includes patient-controlled analgesia, epidural 
and spinal administration of opioids and continuous nerve blocks. 
On the educational front, this service offers residents valuable 
training in case-oriented problem solving; for example, how to 
manage acute postsurgical discomfort and chronic cancer pain 
with opioids, local anesthetics, peripheral nerve blocks and other 
therapies. 
“We have one of the largest acute pain services in the United 
States,” Dr. Barash points out. Approximately 40 YNHH pa¬ 
tients are followed daily by Dr. Sinatra’s team, which provides 
round-the-clock coverage, seven days a week. 
Up to 80 percent of the service’s patients relieve their own 
pain with patient-controlled anesthesia, or PCA — self-adminis¬ 
Center for Pain Management: 
On the Front Lines of Care 
“Anesthesiologists have expertise in putting needles in the 
right place to diagnose the cause of pain and to treat it,” 
explains Lloyd R. Saberski, M.D., assistant professor of 
anesthesiology and clinical director of the Yale Center for 
Pain Management. 
While this description is accurate in one sense, patients 
treated for chronic pain at the center also may be eligible for 
various diagnostic approaches that confirm the location of 
pain generators and improve the specificity of therapy. 
Those state-of-the-art procedures include: 
• Facet blockade. Injections to determine if facet 
articulation — abnormal friction between bones or other 
surfaces — contributes to low back pain. A positive 
finding may lead to treatment by lumbar fusion or a 
percutaneous cryorhizotomy — the freezing of peripheral 
nerve roots. 
• Discography. Contrast material and specialized X- 
rays are used to determine possible disc damage. 
• Radiculogram. Guided by a CT scan or fluoroscopy, 
a radiopaque dye is injected onto a nerve root, followed by 
a local anesthetic to pinpoint a solitary pain generator; a 
steroid injection to eliminate pain may follow. 
At Yale, some patients with chronic back pain may 
receive special radiographic tests called lumbar mapping 
to pinpoint pain generators. The tests may be given as part 
of the Center for Pain Management’s innovative “Back on 
Track” program, which helps work-disabled patients re¬ 
turn to productive employment as quickly as possible. 
tered IV opioid delivery with dosing established by a physician. 
Dr. Barash adds that the remaining 20 percent receive various 
other therapies, most often, epidural injections of opioids or 
dilute solutions of local anesthetic. 
Departmental researchers are studying ways to improve 
PCA, for example, by supplementing the opioids with non¬ 
narcotic analgesics that may lower total disc requirement while 
maintaining equivalent analgesia. Dr. Sinatra’s team also is 
investigating new and better methods of opioid administration 
and for relieving postoperative pain — including the use of 
patient-controlled epidural administration of opioids and a 
transdermal opioid patch for some patients. 
Just How Do We Feel Pain? 
Basic science studies at Yale anesthesiology seek to discover the 
biological basis of severe pain. Much of this research holds 
promise for the development of highly specific — and safe — 
anesthetics and analgesics. 
Take, for example, the research of J.G. Collins, Ph.D., asso¬ 
ciate professor of anesthesiology, and his colleagues, who are 
trying to determine just how general anesthetics work. It's been 
more than 150 years since March 30,1842, when Crawford Long, 
M.D., a Georgia surgeon, first administered ether to James 
Venable before removing a tumor from his neck. To this day, 
medical science still does not understand how anesthesia causes 
the loss of consciousness and sensation. 
In the tradition of Dr. Kitahata, several researchers in the 
department have discovered some solid clues to this riddle within 
the spinal cord. Dr. Collins, for instance, is conducting animal 
experiments to learn how general anesthetics alter the ability of 
spinal neurons to receive and process bioelectric messages, in 
particular, signals from a wound in the periphery — areas of the 
body that are connected to the spinal neurons. 
“Until recently," he explains, “the spinal cord was thought to 
be a fairly simple communication system, not unlike a telephone 
cable that simply carried messages from one part of the body to 
another. We now recognize that there is a huge amount of 
integration of information that occurs within the spinal cord.” 
Dr. Collins has uncovered new evidence that general anes¬ 
thetics disrupt this bioelectric integration within the spinal cord; 
“We have been able to demonstrate that this change occurs in the 
absence of any input from the brain itself,” he says. By 
pinpointing some or all of the biomolecular action of general 
anesthetics in the mammalian spine. Dr. Collins hopes to 
uncover clues about how such drugs may affect other parts of 
the central nervous system. 
The Collins team also is trying to determine how severe pain 
caused by trauma induces chemical changes in single spinal 
neurons. “We are now beginning to understand that some chronic 
pain states are probably the result of changes in the chemical 
balance within the spinal cord itself,” Dr. Collins explains. 
He hopes his team’s efforts to identify the neurochemistry of 
such changes will speed the development of new drugs to reduce 
the pain associated with spinal cord trauma. 
Continued on Page 27 
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Medical Informatics to Revolutionize 
Information Use at Yale, YNHH 
When Professor of Anesthesiology Perry L. Miller, M.D., 
Ph.D.. became director of the Yale Center for Medical 
Informatics in January 1991, he was charged with developing 
new. dynamic uses of the computer to improve patient care 
and biomedical research. True to that mandate. Dr. Miller and 
his staff have helped make major changes in the way medical 
information is collected and transmitted at Yale. 
“Essentially, the medical library of the future is going to 
sit on your desk or in the wards of the hospital," Dr. Miller 
explains. 
The change is coming soon. By the end of the year, about 
50 special computer workstations should be installed through¬ 
out the medical center. At first, clinicians will be able to use 
the newly designed Clinical Care Support System (CCSS) to 
enter and review all medical orders given at YNHH (in a 
context of strict patient confidentiality that has been built into 
the system.) 
By the end of 1994, users also will be able to access 
Internet, mini-Medline and other databases via the new work¬ 
stations. In time, the computers will provide digitalized 
medical images from gastrointestinal and other endoscopies; 
portable chest X-rays; thallium, CT and MRI scans and other 
images. 
When finalized, this clinical workstation will place an 
unprecedented amount of clinical information at the physician's 
fingertips. A cardiac anesthesiologist, for example, could use 
the system to compare a patient' s heart function against earlier 
data, and to access the latest medical literature for potential 
new therapies. 
With his colleagues in medical informatics. Dr. Miller 
has been creating the software for the clinical workstation. He 
believes the computer system will facilitate clinical decision¬ 
making and outcome studies in the medical center. The 
system also may be used to develop and implement practice 
guidelines for various specialties. Dr. Miller suggests. 
Yale's medical informatics team is also deeply involved 
in the international Human Genome Project to map each of the 
human chromosomes. Dr. Miller and his team are collaborat¬ 
ing with Yale researchers in biology, human genetics, and 
various medical specialties to design databases for storing 
gene-mapping information. The biomedical computer scien¬ 
tists are also creating software to analyze data on the human 
genome. 
Perry L. Miller, M.D., Ph.D. 
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Steven Rimar, M.D., HS '85- '88, explains to students the many uses of the nitric oxide analyzer, seen at his right. 
Continued from Page 25 
Robert LaMotte. Ph.D.. professor of anesthesiology, takes a 
different research approach by studying hyperalgesia, the height¬ 
ened sensitivity to painful stimulation. Dr. LaMotte explains that 
hyperalgesia can be primary — originating within a surgical 
incision or other surface wound — or secondary — radiating out 
from healthy tissue near a wound. 
“On rare occasions, and for reasons not yet understood, the 
hyperalgesia after certain tissue injuries can persist long after the 
injured tissue has healed,” says Dr. LaMotte, an expert in periph¬ 
eral and central mechanisms of pain. 
To discover more about the causes of such chronic pain, he 
has induced short-term, secondary hyperalgesia in humans by 
injecting the pain-sparking chemical capsaicin — derived from 
hot chili peppers. Such injury to the arm or back produces a 
sunburn-like effect that appears in minutes and persists for up to 
12 hours. 
Subjects report a greatly heightened sensitivity to a pinprick 
or other such stimulus. Even gentle skin stroking with a rounded 
object can cause exquisite pain. By correlating the subjects' 
perception of pain with bioelectric activity in selected cutane¬ 
ous and spinal neurons. Dr. LaMotte hopes to learn more about 
how nociceptive neurons regulate secondary hyperalgesia after 
a skin injury. 
Finally. Dr. LaMotte"s team of neuroscientists is studying 
how certain injuries cause peripheral nociceptive neurons to 
over-respond to norepinephrine, a hormone present in the body's 
sympathetic nerve endings; the result can be prolonged spinal 
sensitization — and chronic pain. Dr. LaMotte hopes these lines 
of research will reveal how the body peipetuates certain types of 
chronic pain, for example, the discomfort caused by sympathetic 
reflex dystrophy, a deep, burning sensation felt in an extremity 
that has been injured, although not burned. 
His research goal, says Dr. LaMotte, is to learn how to block 
pain at the level of the nociceptor. Such knowledge could 
produce more highly specific analgesics than are now available. 
Nitric Oxide and the Lung 
Research on another front is helping physicians to understand the 
workings of nitric oxide (NO), named the 1992 “Molecule of the 
Year” by the journal Science because of its potential to advance 
medical treatments in humans. C. Norman Gillis, Ph.D., profes¬ 
sor of anesthesiology and pharmacology, is studying how nitric 
oxide, which occurs naturally in the human body, achieves its 
potent vasodilating effects in pulmonary blood vessels. 
NO plays a key role in relaxing vascular smooth muscle 
throughout the body. By increasing the diameter of blood 
vessels, NO increases blood flow and reduces blood pressure. In 








this way. nitric oxide helps to improve the distribution of oxygen 
in the lung and body. 
The molecule’s vasodilating action, first described in the 
mid-1980s, is now recognized to be only one of several actions 
which make NO an important transmitter in many systems, 
including the central nervous system, thus increasing the scope of 
its physiologic role. As Dr. Gi I lis explains, “Nitric oxide synthe¬ 
sized by the endothelium (the innermost lining of blood vessels) 
is now recognized as a mediator of cell-to-cell communication.” 
Endothelial-produced NO appears to relay key biochemical 
messages to vascular smooth muscle and to platelets, macroph¬ 
ages and other blood cells. Dr. Gillis notes. Such biochemical 
orchestration is vital for healthy cardiovascular function. 
Conversely, disruption of NO synthesis in blood vessels is 
thought to contribute to atherosclerosis, hypertension and vari¬ 
ous vascular diseases. Dr. Gillis says. He and his colleagues are 
focusing on how NO is synthesized by the pulmonary vascular 
endothelium — the cells that line blood vessels in the lung. With 
Stephen Rimar, M.D., assistant professor of anesthesiology and 
pediatrics, Dr. Gillis has developed an experimental rabbit model 
to study how vascular damage — such as caused by atheroscle¬ 
rosis — impairs NO synthesis. 
In addition, Drs. Gillis and Rimar are collaborating with 
Harvard researchers to evaluate the potential use of inhaled NO 
in selected lung patients. The Gillis team has already shown that 
NO can dilate rabbit pulmonary vessels without affecting other 
blood vessels — a key finding that they hope to demonstrate in 
humans, too. 
Why is this observation of such import to humans? Dr. 
Rimar, who is chief of pediatric anesthesia at YNHH, explains 
that in surgical patients whose lungs are impaired, blood vessels 
in other parts of the body can divert too much blood and oxygen 
from the lungs, where it is needed most. For such patients, 
anesthesiologists seek to use drugs that dilate the lung only. 
Research into NO may shed new light on how to do this more 
safely and effectively. Dr. Rimar suggests. 
Dr. Gillis and his team hope their research will lead to new 
cardiopulmonary drugs that mimic NO's activity. Such medica¬ 
tions could help prevent a life-threatening rise in blood pressure — 
pulmonary hypertension — in patients undergoing a heart/lung 
bypass, an increasingly frequent operation at Yale and elsewhere. 
Future bioengineered drugs that mimic NO's activity may 
also help other surgical patients endangered by pulmonary hyper¬ 
tension, including children with congenital heart disease or 
patients with sepsis-induced adult respiratory distress syndrome 
(ARDS), Dr. Gillis says. Dr. Rimar adds that current research 
will help determine the potential use of inhaled NO to treat 
persistent pulmonary hypertension in neonates (PPHN), a life- 
threatening condition for some babies. 
A Fascinating Discovery 
In the late 1970s, Yale anesthesiologists led by Dr. Barash helped 
to pioneer the use of echocardiography for operating room 
monitoring — now widely used in ORs nationwide. Today's 
challenge in cardiovascular anesthesiology at Yale involves the 
molecular biology of the heart. 
At center stage is Mahboubeh Eghbali, Pharm.D., Ph.D., 
associate professor of anesthesiology and director of molecular 
cardiovascular research in anesthesiology. In 1991. Dr. Eghbali 
reported in vitro findings strongly suggesting that cardiac fibro¬ 
blasts — interstitial cells in the heart — can under certain 
conditions change into cells that resemble cardiac myocytes, the 
beating cells that pump the body’s lifeblood. 
The molecule driving this metamorphosis is transforming 
growth factor-beta, or TGF-beta, which is also responsible for 
many other types of body cell differentiation, explains Dr. 
Eghbali. A few years ago, she was the first to demonstrate that 
while 90 percent of the heart is composed of myocytes, roughly 
95 percent of all other cardiac cells are fibroblasts. Dr. Eghbali 
was also among the first to show that TGF-beta is present in the 
mammalian heart. 
REMEDY: One Hospital’s “Waste”... 
Less than 2 years old, the REMEDY program to recover 
unused, uncontaminated surgical supplies for use in develop¬ 
ing nations already has garnered worldwide attention and has 
enlisted 15 health care facilities in seven states. Organized by 
William H. Rosenblatt, M.D., assistant professor of anesthe¬ 
siology, REMEDY recovers the equipment and supplies from 
Yale-New Haven Hospital (YNHH) operating rooms and 
distributes them in Central and South America, Eastern Eu¬ 
rope, China and in other developing lands or in war-torn areas. 
During the program’s first 24 months, Yale and YNHH 
anesthesiologists, surgeons, nurses and managerial staff — 
plus medical students and community volunteers — collected 
more than 5 tons of material worth more than $690,000. 
Recovered materials included bandages, sutures, gloves, 
sponges, gowns, surgical drapes, syringes and other items. Dr. 
Rosenblatt calls the value of these materials “incalculable” to 
the institutions and people that have benefitted from them. 
REMEDY also offers a model for cost-effective conserva¬ 
tion. While the expense to YNHH to salvage the supplies was 
only $300, savings from not incinerating the unused materials 
as surgical “waste” were in excess of $2,500, Dr. Rosenblatt 
says. To help other hospitals implement REMEDY’S ap¬ 
proach, his team provides a training packet that includes a 
slide presentation, computer databasing software, and written 
instructions — plus a list of more than 200 U.S. charities 
seeking salvaged supplies for shipment abroad. 
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Mahboubeh Eghbali, Pharm.D., Ph.D. 
Dr. Eghbali cautions that she and her colleagues have not yet 
demonstrated “terminal differentiation” — the complete trans¬ 
formation of a cardiac fibroblast into a beating cardiac myocyte. 
“However, we have shown many lines of evidence that suggest 
that these cells are heading toward terminal differentiation,” she 
notes. 
For example. Dr. Eghbali has shown that fibroblasts affected 
by TGF-beta change their shape to resemble that of myocytes. In 
addition, the transformed cells adopt key molecular features of 
beating cells. If Dr. Eghbali’s team can learn all the mechanisms 
that lead mammalian cardiac fibroblasts to change into beating 
cells, solutions may be closer for one of medicine’s more urgent 
tasks: to learn how to regenerate beating cells that die after a heart 
attack or other form of cardiac disease. 
Last year. Dr. Eghbali made major progress in providing 
evidence of in vivo fibroblast transformation in rat hearts. “The 
next step would be to see if these findings also happen in the 
human heart,” she explains. Toward this end, she intends to 
conduct experiments on discarded but still functional cardiac 
tissue obtained after heart transplantation. 
Dr. Eghbali and her team at Yale are also studying the 
deposition and degradation of cardiac extracellular matrix — the 
proteinous material that resides between cardiac muscle cells. 
The matrix, which maintains the heart's functional integrity, is 
comprised mostly of collagen, the most prevalent protein in the 
body. Dr. Eghbali hopes to learn how the matrix is affected by 
various diseases and injuries of the heart. 
Dr. Barash sees such imaginative research as continuing a 
legacy that dates back to the specialty’s earliest days. He reflects, 
"The discovery and application of anesthesia has been the single 
most important contribution of American medicine to human¬ 
kind. The major achievements of modern surgery would not have 
taken place without the accompanying vision of the pioneers of 
anesthesiology. 
“Today,” he continues, “the boundaries of anesthesiology 
extend far beyond the operating room. Advances in the anes¬ 
thetic management of patients depend on the progress that is 
made in the laboratory. The future of anesthesiology is linked to 
choosing drugs and techniques that specifically target the areas of 
the brain and central nervous system so that noxious side effects 
are avoided. Therefore, there will be an increasing reliance on 
molecular medicine to help solve these problems. The clinical 
and basic research programs of the department of anesthesiology 
are focused on these areas and use the strengths of the medical 
school to help physicians better manage patients throughout the 
perioperative period.” YM 
— > 
William H. Rosenblatt, M.D. 
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An Overseas Teaching Program 
In Anesthesiology 
by Nicholas M. Greene, M.D. 
My introduction to teaching anesthesiology in Africa came in the 
1970s, when 1 taught at the newly opened University of Tunis in 
North Africa. It was not my medical, but my ornithologic 
interests that subsequently led me to East Africa. It soon became 
apparent to me, however, that the opportunity to view birds, 
though delightful, was overshadowed by the overwhelming chal¬ 
lenges in all fields of medicine, especially anesthesiology. This 
led me to become increasingly involved in medical care in East 
Africa, and within a few years I became acquainted with and 
worked as a teacher in already established anesthesia teaching 
programs in Ethiopia, the Sudan, Uganda, Kenya, Tanzania and 
Zimbabwe. 
My exposure to the realities of medicine in this area of the 
world led me to two conclusions. One was that numbing personal, 
institutional and national poverty was so overwhelming that it 
was totally irrelevant to teach anesthesia or anything else in 
medicine in East Africa in terms that might be relevant in the 
Western world — the national budget for medical care in most 
East African countries comes to about $1 per person per year. 
Conclusion number two was that only a minority, about 15 
percent, of the surgery that should and could otherwise be 
performed was actually being done because of the bottleneck 
created by the shortage of anesthesiologists. This problem was 
created when the East African nations, upon achieving indepen¬ 
dence. accepted without question the prevailing attitude of Euro¬ 
pean colonial powers and international health organizations that 
anesthesia played no role in the delivery of health care. The result 
was an over-production of surgeons, who, ironically, were inca¬ 
pable of operating because of a lack of safe anesthesia. 
By the late 1980s, 1 had worked with and had come to know 
the leaders of anesthesia training programs, such as there were, in 
East Africa. It was clear that something could and must be done 
to improve the quality and the availability of anesthesia. So I 
suggested to my African associates that instead of continuing to 
serve as a single, intermittent teacher of anesthesia in East Africa, 
I should develop a large, continuous teaching program designed 
along lines that the African leaders in anesthesia thought would 
be best. My colleagues accepted the idea, which came to be 
embodied in the Overseas Teaching Program (OTP) in anesthe¬ 
sia, sponsored by the American Society of Anesthesiologists 
(ASA) and the non-profit Foundation for Anesthesia Education 
and Research (FAER). 
OTP is unique among medical teaching programs in develop¬ 
ing countries for several reasons: 
Dr. Nicholas M. Greene in East A frica 
Nicholas M. Greene, M.D. — 
World Ambassador of Anesthesiology 
The teaching career of Nicholas M. Greene, M.D., profes¬ 
sor emeritus of anesthesiology, has taken him from the 
University of Rochester to Harvard Medical School and 
universities around the world. He began Yale’s section of 
anesthesiology in 1955 within the department of surgery 
and served as its chairman through 1973, three years after 
the section became a department. Dr. Greene has been 
editor-in-chief of both major journals in the field. Anes¬ 
thesia and Analgesia, and Anesthesiology, and has been a 
member of the surgical and pharmacology study sections 
at the National Institutes of Health. 
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• First, and very importantly, the program was designed by 
Africans, not by Americans or Europeans. The difference is 
considerable—especially the emphasis on clinical practice in the 
host country, as opposed to a Western clinical experience. 
• Second, OTP concentrates on teaching, both clinical and 
didactic. OTP prohibits instructors from taking over the admin¬ 
istration of anesthesia, that is, providing an ongoing service. 
• Third, OTP is affiliated with only two anesthesia training 
programs — already established and complete with teachers and 
formal curricula. 
• Fourth, the program recruits experienced American and 
Canadian anesthesiologists to serve, one at a time, as volunteer 
teachers, providing teaching assistance year-round at both sites. 
The objective is to concentrate a consistent supply of these 
teachers for a relatively long period in pre-existing, structured 
settings, rather than to spread teachers of anesthesia erratically 
throughout East Africa for short periods of time. 
• Fifth and finally, teaching involves not only students, but 
also persons at policy-making and decision-making levels na¬ 
tionally and locally. Unless these leaders are educated about the 
role and importance of modern anesthesia, nothing will change. 
For that reason, I have worked closely with the ministries of 
health. 
As for its anesthesiologist volunteers, OTP provides them 
with round-trip tourist class airfare between their homes and East 
Africa. They are also given $10 per diem while teaching. The 
minimum volunteer tour of duty is one month; the maximum, 
three months. Volunteers are provided adequate, if spartan, 
living accommodations at the institution they are serving. They 
handle their own cooking, food shopping and other daily chores 
as part of OTP’s emphasis on having volunteers function inde¬ 
pendently of the anesthesia department in which they are work¬ 
ing. This also requires that each volunteer arrive four days before 
taking over as the OTP anesthesiologist. During this transition 
time, the incoming volunteer is oriented by the outgoing OTP 
anesthesiologist, thereby sparing the host department this other¬ 
wise burdensome chore. 
A Conservative Beginning 
OTP is operating as a five-year trial program under the direction 
of an OTP committee of six anesthesiologists who were ap¬ 
pointed by the American Society of Anesthesiologists; I serve as 
chairman. The $400,000 cost of the program over the span of five 
years includes $275,000 for volunteers’ expenses and $125,000 
for administrative costs, the former through FAER, the latter 
through the ASA. 
On January 1, 1990, OTP started on its five-year course. 
Because it was necessary to have OTP located in countries in 
which the students spoke English, and because of my own 
experience and knowledge of East Africa, the OTP committee 
decided to start the training program there. The first year of the 
program, 1990, was devoted to visiting the sites of all anesthesia 
training programs in East Africa, to establishing an administra¬ 
tive structure and to recruiting volunteers to start in 1991. 
On February 1, 1991, OTP made its debut at the University of 
Zambia’s Teaching Hospital (UTH) in Lusaka, and a year later, 
opened at the non-sectarian Kilimanjaro Christian Medical Cen¬ 
ter (KCMC) in Moshi, Tanzania. UTH and KCMC were selected 
in part because they represent two somewhat different approaches 
to addressing the paucity of anesthetic personnel throughout the 
region. 
UTH is a 1,500-bed institution affiliated with a medical 
school. OTP volunteers here teach medical students as well as 
physicians entering anesthesiology and paramedical anesthetic 
officers. KCMC, by contrast, is a 420-bed teaching hospital not 
affiliated with a medical school or university. Nevertheless, this 
tertiary-care referral hospital is deeply involved in teaching in 
many medical fields. There are also substantial differences 
between Kilimanjaro and the University Teaching Hospital in 
their settings, the former being semi-rural, the latter, semi-urban, 
and in the types of anesthetic equipment each has available. 
The ratio of physicians to population in much of East Africa 
is approaching one per 100,000 in rural areas. Medical care thus 
depends to a considerable degree on non-physicians. Typically 
there are two levels of paramedical personnel: medical assistants 
and medical officers. Medical assistants, upon completion of the 
standard, basic educational process, enter what is usually a two- 
year program for training in first-aid and very basic medicine. 
Upon completion of these courses, they are assigned to rural 
dispensaries or to hospitals. In these locations, the medical 
assistants are involved in every aspect of medicine, whether it be 
pediatrics, orthopaedics, obstetrics or whatever circumstances 
require. After four to eight years of such practice, medical 
assistants become eligible for further, two-year training to ad¬ 
vance to the rank of general or anesthetic medical officer. 
By the end of 1993, 37 OTP volunteers will have provided 
teaching assistance at UTH and KCMC. Eleven (30 percent) of 
the 37 volunteers have been women; 26 have been men. Ages of 
volunteers have been equally distributed throughout the decades 
of 30-39, 40-49, 50-59 and 60-69, with two volunteers in their 
early 70s. Twenty-five volunteers have served for one month, 
seven for two months and six for three months. Twenty-two (60 
percent) came from private practice of anesthesiology; 15 from 
staffs of residency training programs in the United States or 
Canada. 
As of May 15, 1993, 21 of the 24 months that need to be 
covered by OTP at Kilimanjaro and University Teaching Hospi¬ 
tal during 1994 have already been spoken for. Towards the end 
of this, the fourth year of the program, an ad hoc committee of 
four anesthesiologists experienced in overseas teaching will 
forward to the ASA its recommendation for the future of OTP 
beyond its scheduled termination at the end of December 1994. 
Mutual Benefits 
The OTP experience has been unanimously rated by volunteers 
as outstanding in broadening their professional and personal 
horizons. OTP also has been enthusiastically received by anes¬ 
thetists and other physicians at both Kilimanjaro and University 
Teaching Hospital. What is more, hospital administrators and the 
ministries of health are strong supporters of the program. 
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A produce vendor at a local market in Lusaka, Zambia, where volunteers shop for their food. 
Nevertheless, quantifying OTP’s success, or lack thereof, is 
difficult. At the University Teaching Hospital, evidence of 
success may be found in the enrollment of three Zambian physi¬ 
cians in an anesthesia training program there simultaneously with 
the start of OTP at UTH in February 1991. These were the first 
Zambian doctors to start training in their home country as a 
prelude to becoming full-time anesthesiologists. Not all three 
completed their training at UTH, however, because of the pre¬ 
vailing attitude in Africa and Europe that graduate training of 
African physicians in a medical specialty is incomplete if it does 
not include two or more years of training in Britain or Western 
Europe. 
The concept that Africans can and should be able to train 
African doctors to practice anesthesiology in Africa is, neverthe¬ 
less, gradually gaining acceptance. There also is a nascent 
realization that training Africans in Europe is often counterpro¬ 
ductive because too many African physicians simply stay in 
Europe after completion of their training there. It is also becom¬ 
ing more widely appreciated that the education in advanced. 
Western-based sophisticated anesthetic methods and techniques 
that African physicians are exposed to in Europe is irrelevant, 
unnecessary and frustrating in Africa. 
OTP has also been instrumental in furthering the develop¬ 
ment of anesthesia in Zambia by helping the Ministry of Health 
and the University of Zambia to approve a course of training in 
anesthesiology, leading to accreditation as a specialist with a 
postdoctoral M.Med (anesthesiology) degree. The M.Med de¬ 
gree is a widely used form of accreditation in medical specialties 
throughout much of Africa and the Indian subcontinent. Similar 
evidence of OTP success at Kilimanjaro cannot be seen because 
OTP has been there for a shorter time and because OTP volun¬ 
teers teach only paramedical personnel, whose numbers and 
qualifications are determined in the Ministry of Health. 
The success of OTP to date justifies it as a prototype of a new 
and unique approach for industrialized nations to use in helping 
to improve the quality and availability of medical care in eco¬ 
nomically deprived nations by emphasizing medical education, 
not service. The program has already received widespread 
favorable attention in Britain and the Continent, especially Ger¬ 
many. YM 
OTP volunteer Vincent Vilasi, M.D., from Massachusetts General 
Hospital, with colleagues in the operating room at University 
Teaching Hospital in Lusaka, Zambia. 
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Ephraim McDowell, uFather of the Ovariotomy” 
Jane Todd Crawford had been pregnant with twins for more than 
11 months, or so she was led to believe, until Dr. Ephraim 
McDowell met and properly diagnosed the suffering woman with 
an ovarian tumor. He explained to her that such a tumor was fatal 
because “to open the abdominal cavity of a living person is 
beyond the realm of man,” and broke the sad news that Mrs. 
Crawford would have to bear her extreme pain until her death, 
which could be months or years away. Mrs. Crawford pleaded 
with the doctor to allow her to be the first patient of such tumor 
surgery. Against the prevailing wisdom of the medical profes¬ 
sion — as well as the public opinion of his day — Dr. McDowell 
agreed to do the operation. 
It was December 1809 when Mrs. Crawford ventured on a 
three-day journey by horseback to the home of Dr. McDowell in 
Danville, Ky. It was the year that gas lamps were invented, 
Abraham Lincoln was born, and gunshots were the most com¬ 
monly treated wounds by frontier doctors. Upon her arrival at Dr. 
McDowell’s home, Mrs. Crawford was welcomed by protestors, 
led by a local minister, accusing the doctor of being a murderer 
for performing a surely fatal operation. 
The demonstration deterred neither the patient nor the sur¬ 
geon. Strapped to the kitchen table and with no anesthesia, Mrs. 
Crawford successfully underwent the historic operation with her 
servant by her side, with whom she recited the Psalms. In his 
notes. Dr. McDowell wrote that he and his nephew-assistant, 
James McDowell, removed a 22-pound tumor, completing the 
operation in 25 minutes. Dr. McDowell made a nine-inch 
incision, drained the gelatinous substance inside the tumor by 
turning Mrs. Crawford on her side, then removed the solid portion 
of the growth. Within five days, Mrs. Crawford was walking. On 
the 26th day after her operation, she made the trip back home. 
Dr. McDowell, cognizant of the experimental nature of his 
ovariotomy procedure, waited seven years until he performed 
three more such operations, all successful, before he published 
his results. His notes on Mrs. Crawford were received by the 
medical profession with such skepticism that in 1824, after his 
nephew had passed away. Dr. McDowell was forced to locate 
Mrs. Crawford and have her sign an affidavit affirming the facts 
about her operation. 
Although having studied at the University of Edinburgh in 
Scotland, Dr. McDowell received no formal degree until 1825, 
when he was bestowed an honorary degree by the University of 
Maryland. Dr. McDowell died in 1830 at age 59, almost 40 years 
before the invention of anesthesia. 
Rosalind D 'Eugenio 
Media specialist 
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Student Research Day 
Fourth-year student Christopher Fey (left) explains his poster on “Political Information and the Brunonian System of Medicine 
of the Late 18th Century” to classmate Bonnie Gould and John S. Hughes, M.D., associate clinical professor of medicine. 
Opening Remarks 
Student research and the required thesis have been a part of Yale 
Medical School since 1839, when graduating students presented 
their thesis work to the Connecticut Board of Medical Examiners. 
The quality and diversity of original student research, displayed 
on the scientific posters presented here today (May 10), are an 
affirmation of this tradition at Yale. 
The students presenting and listening today may be interested 
to know a bit of history of the research done by medical students. 
Vesalius published his anatomy text on the day after graduation 
(a remarkable feat in the days before the word processor). The 
discovery of insulin by Charles Best, and the discovery of heparin 
by Jay MacLean, were accomplished as students. In the current 
era, when thousands of scientists worldwide are studying the 
biology of AIDS, a medical student from an institution to the 
north of us recently made a breakthrough discovery regarding 
combination therapy against the AIDS virus. 
The format of the scholarship is not just published papers. 
Here are two highly acclaimed, recently published books based 
on Yale medical students theses: Just Doctoring-Medical Ethics 
in the Liberal State by Troy Brennan, M.D. '84, based on work 
carried out with Dr. Robert Levine in the department of medicine; 
and The Surgical Solution: A History of Involuntary Sterilization 
in the United States by Philip Reilly, M.D. ’81. 
The papers to be presented today from the platform are five 
of 14 outstanding theses that will receive awards at graduation. 
These were selected by members of the thesis subcommittee. We 
thank them for their efforts on behalf of student research. 
I want to acknowledge three people who do an immense 
amount of work for this day. 1 would ask them to stand so that we 
might recognize them. They are: Linda Seigneur and Gail 
Beamon in the office of biomedical communications, who made 
practically all of those posters; and Laura Jean McDonald, who 
coordinates not only Student Research Day, but all of the many 
activities of the office of student research. All of us join in 
thanking you. 
All of this is secondary to the essential unit of student 
research, which is the individual medical student working with a 
devoted faculty mentor who puts the student’s interests first. It 
is this mentorship and this partnership that makes this day and 
much more possible. 
John N. Forrest Jr., M.D. 
Director, Office of Student Research 
Professor of medicine 
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Abstracts 
Counter-regulation of Ileal Motility 
in Rabbit Small Intestine 
by Stephen J. Ferzoco 
Faculty advisor: Garth H. Ballantyne, M.D. 
Associate professor of surgery 
Faculty discussant: James R. Goldenring, M.D. 
Assistant professor of surgery 
Disorders of intestinal motility continue to plague surgeons of the 
20th century. Unfortunately, the regulation of intestinal motility 
remains incompletely understood. Utilizing the isolated whole 
organ perfusion system, segments of rabbit terminal ileum were 
infused with a variety of known gastrointestinal hormones, 
peptides and neurotransmitters. 
In the first series of experiments, prokinetic agents such as 
carbachol (an acetylcholine analogue), cholecystokinin, and 
motilin were tested. All three agents caused a concentration- 
dependent increase in measured motor activity. 
In the second series of experiments, agents which increase 
intracellular levels of c AMP, vasoactive intestinal peptides (VIP), 
forskolin and norepinephrine, were tested against prokinetic- 
stimulated segments of ileum. All three agents caused a concen¬ 
tration-dependent inhibition of motility. 
In the third series of experiments, neuropeptide Y (NPY) and 
peptide YY (PYY), agents which block intracellular cAMP, 
reversed the inhibitory action of VIP. 
In the final series of experiments, various NPY/PYY ana¬ 
logues with specific Y receptor affinity were tested. The Y, 
receptor analogue [Leu31, Pro34]NPY demonstrated similar abil¬ 
ity to reverse VIP's effect. 
In conclusion, peristalsis can be divided into two distinct 
phases. Ascending contraction caused by prokinetic agents is 
orad to a food bolus. In addition, VIP is responsible for the 
descending inhibitory reflex distally. NPY released within 
neurons within the gut wall causes reversal of the VIP-mediated 
inhibition, leading to a wave of ascending contraction. This 
reversal is mediated via a Y, receptor mechanism. 
Synaptic and Pathway Remodeling of the Human 
Hippocampus in Temporal Lobe Epilepsy 
by Matthew Frank Philips 
Faculty advisor: Nihal de Lanerolle, D.Phil. 
Associate professor of surgery (neurosurgery and neurobiology) 
Faculty discussant: Michael Brines, M.D. 
Assistant professor of medicine (neuroendocrinology) 
Light microscopic studies of immunostained gyrus of hippocampi 
surgically removed from two groups of patients with medically 
intractable temporal lobe epilepsy revealed organizational differ- 
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Poster presenters and faculty members (from left: Stephen J. 
Ferzoco, 1. Robert Grossman, Robert H. Gifford, M.D., associate 
dean of education and student affairs, Dean Gerard N. Burrow, 
M.D., Anthony M. Powell, Matthew F. Philips, John N. Forrest 
Jr., M.D., and Shridar Ganesan. 
ences with respect to the somatostatin, neuropeptide Y. and 
substance P like-immunoreactive (SOMLI, NPYLI. and SPL1 
respectively) systems. One group with extrahippocampal tempo¬ 
ral lobe tumors (TTLE) revealed no specific pathology, while the 
other group, or cryptogenic group (CTLE), with no gross lesions, 
revealed a loss of SOMLI. NPYLI, and SPLI hilar interneurons 
and changes in the fiber staining patterns in the dentate gyrus. 
The ultrastructural changes between the groups were compared. 
SOMLI dendrites were found ramifying from the TTLE hilus 
up through the inner molecular layer. The CTLE dentate gyrus 
showed a significant loss of SOMLI dendrites in the hilus and the 
inner molecular layer. SOMLI terminals, restricted to the outer 
molecular layer in the TTLE group, occupied the entire CTLE 
molecular layer. 
In the TTLE group, NPYLI terminals were most concen¬ 
trated in the outer molecular layer, but were found throughout all 
layers of the dentate. Few NPYLI dendrites were found in the 
molecular layer. Large axon-terminal complexes traversed the 
outer and inner molecular layer and often contacted several 
dendrites at once. The CTLE dentate gyrus had more of these 
terminals in the inner molecular layer. 
In the TTLE group, the SPLI fibers in the molecular layer are 
terminal in nature. The terminals synapse on small dendrites in 
the outer molecular region and are concentrated in a band-like 
distribution on either side of the granule cell layer. They synapse 
on proximal dendrites of granule cells in the inner molecular 
layer. In the CTLE hilus, the band of SPLI fibers disappears and 
new large SPLI terminals stud the apical proximal dendrites of 
granule cells. Large SPLI terminals were also found synapsing 
on granule cell somata. The synaptic reorganization of these 
peptide-immunoreactive systems may provide a neural substrate 




Peter S. Aronson, M.D. 
Emile L. Boulpaep, M.D. 
Dennis L. Cooper, M.D. 
Anne Curtis, M.D. 
John N. Forrest Jr., M.D. (Chairman) 
Robert H. Gifford, M.D. 
James R. Goldenring, M.D. 
James D. Jamieson, M.D., Ph.D. 
Barry Kacinski, M.D.. Ph.D. 
M. Stephen Meyn. M.D.. Ph.D. 
Irvin M. Modlin, M.D. 
Coralie Shaw, M.D. 
Frederick J. Suchy, M.D. 
The Role of Protein Kinase C in Glucose-Induced Insulin 
Secretion from Pancreatic B-cells 
by Shridar Ganesan 
Faculty advisor: Howard Rasmussen, M.D. 
Professor of medicine (endocrinology) and cell biology 
Faculty’ discussant: Gerald I. Shulman, M.D. 
Associate professor of medicine (endocrinology) 
The aim of this dissertation was to investigate the role of protein 
kinase C (PKC) in mediating glucose-induced insulin secretion 
from pancreatic B-cells. Peptide-derived affinity-purified 
polyclonal antibodies specific for the a, 6, and y isoforms of PKC 
were generated and characterized. These antibodies were used to 
determine that a-PKC was the predominant form of PKC present 
in isolated rat pancreatic islets. Western blotting studies revealed 
that glucose-stimulation of freshly isolated, perifused rat islets is 
associated with a translocation of a-PKC immunoreacti vity from 
a cytosol to a membrane fraction. 
Glucose-stimulation of rat islets was also shown to induce 
catalytic activation of PKC, as demonstrated by phosphorylation 
of a specific PKC-substrate. Inhibition of PKC-activity with 
staurosporine greatly inhibited the second phase of glucose- 
induced insulin secretion in perifused islets. Immuno-fluores- 
cence confocal microscopy using an a-PKC-specific mono¬ 
clonal antibody revealed that high glucose-concentrations can 
induce the redistribution of a-PKC from the cytosol to the cell 
periphery of B-cells in both isolated rat islets and in intact rats. 
The intracellular redistribution and catalytic activation of a-PKC 
can be inhibited by blocking intracellular glucose metabolism 
with mannoheptulose. These demonstrate that the intracellular 
metabolism of glucose in B-cells induces the translocation and 
activation of a-PKC, and suggest that this glucose-induced 
activation of PKC plays an important role in mediating glucose- 
induced insulin secretion. 
The Effect of Dengue-2 Virus on the Function 
of Normal Human Platelets Separated from Plasma 
by I. Robert Grossman 
Faculty1 advisor: Robert E. Shope, M.D. 
Professor of epidemiology, director of medical studies, EPH 
Faculty’ discussant: Diana S. Beardsley, M.D. 
Associate professor of pediatrics (hematology/oncology) 
Platelet dysfunction and thrombocytopenia are characteristic 
abnormalities in dengue hemorrhagic fever (DHF) that may 
contribute to the pathogenesis of the disease. A previous study 
showed that dengue-2 (Den-2) virus could affect the function of 
platelets in plasma; plasma proteins, however, may have influ¬ 
enced the viral effect. This project examined the effect of Den- 
2 virus on the function of normal human platelets separated from 
plasma. 
Whole blood was obtained from healthy blood bank donors, 
and platelets were isolated from plasma by centrifugation on an 
albumin density gradient followed by gel filtration. Platelets were 
incubated with Den-2 virus, Japanese encephalitis (JE) virus, and 
a mock-infected control. Adenosine diphosphate (ADP)-induced 
aggregation and secretion were assayed in an aggregometer. 
Three types of response were observed: aggregation and 
secretion were either enhanced by Den-2 (“Den-2 responders”), 
enhanced by JE, or not enhanced compared with the mock 
control. After 15 minutes of incubation, 5 of 17 samples were 
Den-2 responders, one a JE responder, and 11 nonresponders. 
After 90 minutes of incubation, 3 of 8 samples were Den-2 
responders and 5 nonresponders. Platelets were also counted and 
no difference observed between treatments at 15 or 90 minutes. 
This study, in conjunction with previous work, identifies a 
distinctive Den-2 (and possibly a JE) responsive platelet popula¬ 
tion and implicates the virus itself as cause of the functional 
enhancement. This direct interaction of virus with platelets may 
represent the in vivo mechanism by which DHF platelets become 
dysfunctional and, in turn, targets of immune-mediated 
thrombocytopenia. 
uiatea (luring Magnetic Resonance Imaging orhetal \nntoim: hxltero 
P I \iarsh.i D. Robert-. Robert C. Tango. Ph D.. Shirks M MoCarthcy. M.D.. Ph.D. 
Marsha D. Roberts' poster was entitled: “Magnetic Resonance 
Imaging of Fetal Anatomy: Ex Utero. ” 
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Impaired Hormonal Responses to Hypoglycemia 
in Spontaneously Diabetic and Recurrently Hypoglycemic 
Rats: Reversibility and Stimulus Specificity of the Deficits 
by Anthony M. Powell 
Faculty advisor: Robert S. Sherwin. M.D. 
Professor of medicine (endocrinology) 
Faculty discussant: William V. Tamborlane, M.D. 
Professor and section chief of pediatrics (endocrinology) 
Deficient glucagon and epinephrine responses to hypoglycemia 
are thought to underlie the high incidence of hypoglycemia in 
patients with insulin dependent diabetes mellitus (IDDM). We 
hypothesize that recurrent iatrogenic hypoglycemia plays a role 
independent of the pathologic process of diabetes in further 
diminishing hormonal counterregulation. 
To evaluate the roles of iatrogenic hypoglycemic and diabe¬ 
tes per se in the pathogenesis of defective hormonal 
counterregulation, non-diabetic and spontaneously diabetic BB/ 
Wor rats were studied using a euglycemic/hypoglycemic clamp, 
with continuous insulin and variable glucose infusions to clamp 
glucose at 110 mg/dl for 90 minutes, and then at 50 mg/dl for 90 
minutes. To evaluate the stimulus-specificity of the secretory 
defects during a euglycemic clamp, the glucagon and epinephrine 
responses to arginine infusion and hypovolemic stress stimuli, 
respectively, were evaluated. 
As shown in the table below, in non-diabetic rats, recurrent 
(four weeks), insulin-induced hypoglycemia (mean daily glu¬ 
cose (MDG) 59 mg/dl) dramatically reduced glucagon and epi¬ 
nephrine responses (peak - baseline) to hypoglycemia by 84 
percent and 94 percent, respectively. These deficits persisted for 
at least four days after restoring normoglycemia, and were 
specific for hypoglycemia, with normal glucagon and epineph¬ 
rine responses to arginine infusion and hypovolemic stress, 
respectively. After four weeks of normoglycemia, epinephrine, 
but not glucagon, counterregulation fully recovered. 
In diabetic BB rats (MDG 245 mg/dl with intermittent 
hypoglycemia, “intermediate control”), glucagon and epineph¬ 
rine counterregulation were reduced by 86 percent and 90 per¬ 
cent. respectively. Chronic iatrogenic hypoglycemia (MDG 52 
mg/dl) further suppressed counterregulation. In contrast, pro¬ 
spective elimination of hypoglycemia (MDG 432 mg/dl. “poor 
control”) improved, but did not normalize hormonal 
counterregulation. In diabetic rats, the glucagon defect appeared 
to be specific for hypoglycemia, whereas deficient epinephrine 
secretion also occurred during hypovolemia. 
Conclusions: Both recurrent hypoglycemia and the diabetic 
state independently lead to defective hormonal counterregulation. 
In IDDM. iatrogenic hypoglycemia magnifies pre-existing 
counterregulatory defects, thereby increasing the risk of severe 
hypoglycemia. 
^^^Stimulus Glucagon (pg/ml) Epinephrine (pg/ml) 
Group Hypoglycemia Arginine Hypoglycemia Hypovolemia 
Non-diabetic: untreated 748+91 4931139 866011560 2114012740 
Immed. post treatment 117+33* — 4801170* — 
4 d. post treatment 184163* 404160 7001280* 2118013280 
4 wk. post treatment 328+69** — 6670+1120* — 
Diabetic: Int. control 105±21 * — 9001370* — 
Chronic hypoglycemia 45110*f — 260190* — 
Poor control 188±36*¥ 282+22 40301880*+¥ 484011250* 
*p<0.05 vs. untreated non-diabetics; xp<0.05 vs. non-diabetics immediately post 3-4 wk. 
hypoglycemic treatment; :p<0.05 vs. diabetics under intermediate (Int.) control;¥p<0.05 
vs. diabetics under chronic hypoglycemia. 
















Clockwise, from above: (1) Racing to make the class photo; 
(2) Gregory Heinen receives congratulations from classmate 
Jonathan Harwin as Dana Ferguson and Stephanie Falcone 
study their programs; (3) M.D./Ph.D. graduates (from left) 
Shridar Ganesan, Jody L. Baron, David Utzschneider, 
Chimveike Ukomadu, Gualberto Ruano; (4) Aba Bar don, 
center, celebrates with family members from Ghana. 
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Clockwise, from above: (5) The 1993 Charles W. Bohmfalk 
Prizes for Teaching went to Walter F. Boron, M.D., Ph.D., 
professor and chairman of cellular and molecular physiology 
(basic science teaching); and to (6) Peter P. Stein, M.D., 
assistant professor of medicine (clinical teaching), who is 
pictured receiving congratulations from Dean Gerard N. 
Burrow: (7) Aparna Tipirneni, M.P.H., joins family and 
friends after the EPH graduation: (8) M.P.H. graduate 
Marissa Cortes awaits the beginning of EPH commencement 
ceremonies with her husband and son. 
(6) 
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Residency Placements 1993 
ARIZONA 
Mayo Graduate School of Medicine, Scottsdale 
Linda Wilmarth, transitional 
CALIFORNIA 
California Pacific Medical Center, San Francisco 
Michael Lee, medicine 
Thomas Lee. medicine 
LAC-USC Medical Center, Los Angeles 
Gregory Heinen, orthopaedics 
Loma Linda University Medical Center 
Daniel Aldana, pediatrics 
Mercy Hospital, San Diego 
Mark Halsted, transitional 
Santa Clara Valley Medical Center, San Jose 
Harriet Roeder, transitional 
Stanford University Hospital 
Jody Baron, interned medicine 
Michael A. Brown, internal medicine 
James Chang, plastic surgery 
Sara Cody, internal medicine 
Anthony Powell, internal medicine 
Harriet Roeder, psychiatry 
Linda Wilmarth. radiation oncology 
University of California, San Francisco 
Tracy Contant, obstetrics and gynecology 
David Greene, surgery, otolaryngology 
Joanna Rosen, internal medicine 
Toyooki Sonoda, surgery 
University of California, Irvine Medical Center 
John Yang, medicine, anesthesiology 
University of California, Los Angeles Medical Center 
Eileen Chen, obstetrics and gynecology 
Marc Weinstein, neurosurgery 
University of California, San Diego Medical Center 
Mark Halsted, diagnostic radiology 
Barbara Ramlo-Halsted. internal medicine 
CONNECTICUT 
Greenwich Hospital 
Christopher Fey. medicine 
Suresh Mandava, medicine 
Hospital of St. Raphael, New Haven 
Nina Abramson, medicine 
Stephanie Goodman, medicine 
Errol Grannum, medicine 
Yale-New Haven Hospital 
C. Bruce Baker, psychiatry 
Y. Aba Barden, internal medicine 
Matthew Bigham, medicine, anesthesiology 
May Chen, interned medicine 
Dayna Ferguson, medicine 
Errol Grannum, ophthalmology 
Lisa Grohskopf, internal medicine 
Jonathan Harwin, pediatrics 
Deborah Jotkowitz, medicine 
Chai Kulsakdinun, orthopaedics 
Dai-Trang Le, internal medicine 
Michael Lee, ophthalmology 
York Moy. general surgery 
Stephen Solomon, medicine 
Edward Weaver, surgery, otolaryngology 
ILLINOIS 
University of Chicago Hospitals 
Charles Winans, general surgery 
MARYLAND 
Johns Hopkins Hospital, Baltimore 
Silvia Abularach, obstetrics and gynecology 
William Dockery, diagnostic radiology 
Lawrence Gardner, internal medicine 
Samer Najjar, internal medicine 
Victor Perry, surgery’, neurosurgery 
Stephen Solomon, diagnostic radiology 
University of Maryland Medical Center, Baltimore 
David Utzschneider, medicine 
MASSACHUSETTS 
Beth Israel Hospital, Boston 
Nan-Ning Chang, internal medicine 
Adina Chelouche, obstetrics and gynecology 
Matthew Cohen, obstetrics and gynecology 
Christopher Fey, diagnostic radiology 
Lisa Nelson, psychiatry 
David Tendler, internal medicine 
Valerie Ward, medicine 
Boston University School of Medicine 
Michael Locker, transitional 
Brigham & Women’s Hospital, Boston 
Nina Abramson, diagnostic radiology 
Joseph Choo, internal medicine 
Stephen Ferzoco, general surgery 
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Shridar Ganesan, internal medicine 
David Lee. obstetrics and gynecology 
Subu Magge, surgery, neurosurgery 
Julie Miner, obstetrics and gynecology 
William Rodriguez, internal medicine 
Chinweike Ukomadu, internal medicine 
Valerie Ward, diagnostic radiology 
Cambridge Hospital, Boston 
Lisa Nelson, transitional 
Children’s Hospital, Boston 
Phaenarete Osako, pediatrics 
Massachusetts Eye & Ear, Boston 
Albert Assad, otolaiyngology 
Antonio Vinals, ophthalmology 
Massachusetts General Hospital, Boston 
Anthony Adrignolo, orthopaedics 
Thomas Davenport, surgery, urology 
Paul Desan, psychiatry 
Blair Fosburgh, medicine/primary 
David Marby, pediatrics 
Valerie Vanhoutte, internal medicine 
McLean Hospital, Belmont 
Craig Boyajian, psychiatry 
New England Deaconess, Boston 
Albert Assad, surgery 
MICHIGAN 
University of Michigan Hospitals, Ann Arbor 
Joseph Fodero, plastic surgery 
Kris VanDeKerkhove, obstetrics and gynecology 
MISSOURI 
St. Louis Children’s Hospital 
Kevin Blanton, pediatrics 
NEW YORK 
Lenox Hill Hospital, New York 
Antonio Vinals, medicine 
Manhattan Eye & Ear, New York 
Suresh Mandava, ophthalmology 
Mt. Sinai Hospital, New York 
Lisa Kotler, psychiatiy 
Presbyterian Hospital, New York 
Ann Dolinsky, psychiatry’ 
Stephanie Goodman, anesthesiology 
I. Robert Grossman, internal medicine 
Elizabeth Haase, psychiatry 
St. Luke’s-Roosevelt Hospital Center, New York 
Ying Wang, diagnostic radiology 
St. Vincent’s Hospital, New York 
Stephanie Falcone, general surgery 
Ying Wang, transitional 
Strong Memorial Hospital, New York 
Lynn Hallarman, internal medicine 
SUNY/HSC Brooklyn Affiliate Hospitals 
Tae Shin, orthopaedics 
The New York Hospital 
Nanette Bracero, diagnostic radiology 
Matthew Lemer. surgery, urology 
Michael Locker, anesthesiology 
Michael Oppenheim. internal medicine 
Waichi Wong, obstetrics and gynecology 
Winthrop-University Hospital, Mineola 
Nanette Bracero. medicine 
NORTH CAROLINA 
University of North Carolina, Chapel Hill 
Evelyn Levi, surgery, neurosurgery 
OHIO 
University Hospital of Cleveland 
Denver Sallee, pediatrics 
OKLAHOMA 
University of Oklahoma College of Medicine, Oklahoma City 
Lincoln Davis, diagnostic radiology 
PENNSYLVANIA 
Children’s Hospital, Philadelphia 
William King, pediatrics 
University Health Center, Pittsburgh 
Myles Greenberg, emergency medicine 
Richard Kang, orthopaedics 
University of Pennsylvania Hospital, Philadelphia 
Sonia Friedman, internal medicine 
Edward Gunther, internal medicine 
Matthew Philips, neurosurgery 
TEXAS 
Baylor College of Medicine, Houston 
Elizabeth Elguera, obstetrics and gynecology 
John Houston, surgery, urology 
WASHINGTON 
University of Washington Affiliated Hospitals, Seattle 
Michael C. Brown, internal medicine 
Elizabeth Gold, internal medicine 
Residency placement information is provided courtesy of the 
Yale University School of Medicine Office of Education and 
Student Affairs. 
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Researchers Use MRI to 
Image Thinking Process 
Using magnetic resonance imaging 
(MRI) techniques, researchers at the 
School of Medicine have taken “snap¬ 
shots" of the human brain which enable 
them to localize portions of the brain 
that are activated when a person thinks. 
Robert G. Shulman, Ph.D., profes¬ 
sor of molecular biophysics and 
biochemistry (MB&B), leads the 
research team that he believes is the 
first to use MRI to measure brain 
regions stimulated during cognitive 
function. The team reported its 
findings in the June 1 issue of the 
Proceedings of the National Academy 
of Sciences. 
Gregory McCarthy, Ph.D.. associate 
professor of surgery (neurosurgery), 
says that these MRI techniques offer 
the potential to obtain more sophisti¬ 
cated measurements on patients before 
brain operations or after trauma. “For 
instance, when removing a brain tumor, 
we need to know where the brain’s 
speech and motor areas are located. 
With MR imaging, we can identify 
critical brain areas that may be spared 
in a surgical operation. Now such 
information is gathered using 
intercranial electrodes,” Dr. McCarthy 
explains. “It may be possible to use 
these MRI techniques to track func¬ 
tional reorganization in the brain after 
surgery.” 
Until now, there have been limited 
methods to study brain functions, 
especially higher brain functions, such 
as speech and thought. 
The MRI techniques used by the 
Yale researchers offer several advan¬ 
tages in this regard. MRI is a non- 
invasive procedure where the images 
are more accurate and offer higher 
anatomic specificity than previous 
Yale biomedical researchers used magnetic resonance imaging techniques to 
measure regions of the human brain stimulated during cognition. At left, the subject 
was asked to generate a verb after hearing a noun: hearing “volcano, ” and saying 
"erupt. ” At right, the image shows the brain during the cognitive process, or the 
difference in brain activity between generating the verb and simply repeating the 
noun. More activity occurs when generating rather than repeating. 
methods. Moreover, images of higher 
brain function may be generated from a 
single individual, rather than a compos¬ 
ite of individuals. 
In the months ahead, the Yale team 
intends to further refine the spatial 
localization of the active brain regions 
and investigate the association of each 
with the different components of this 
cognitive task. 
In addition to Drs. McCarthy and 
Shulman, co-authors include Andrew 
M. Blamire, Ph.D.. a physicist and 
postdoctoral fellow in MB&B; Douglas 
L. Rothman, Ph.D., a biophysicist who 
is assistant professor of medicine 
(endocrinology); and Rolf Gruetter, 
Ph.D., an MB&B postdoctoral fellow. 
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New Center to Advance 
Diabetes Studies at Yale 
A new Diabetes Endocrinology 
Research Center (DERC) has brought 
together 80 Yale University faculty 
members in four schools to promote 
research in diabetes and related 
metabolic and endocrine disorders. 
Robert S. Sherwin, M.D., professor 
of medicine, directs the new center, 
supported by a $5 million grant from 
the National Institute of Diabetes and 
Digestive and Kidney Diseases. Dr. 
Sherwin explains that the DERC will 
develop an infrastructure within Yale to 
enhance existing programs in diabetes- 
related research and to encourage 
established investigators not presently 
working in diabetes-related areas to 
bring their expertise to diabetes-related 
problems. 
Principal investigators, professional 
supporting staff, young investigators 
and research trainees from the follow¬ 
ing departments are involved in the 
DERC: internal medicine, pediatrics, 
immunobiology, cell biology, molecu¬ 
lar biophysics and biochemistry, 
genetics, pharmacology, pathology, 
surgery, obstetrics and gynecology, 
biology, neurology, neurosurgery and 
psychology. In addition, faculty 
members in the School of Nursing, 
Graduate School of Arts and Sciences, 
and the department of epidemiology 
and public health, also accredited as a 
school of public health, are associated 
with the center. 
Diabetics Must Take 
Care When Eating Pizza 
People with insulin-dependent diabetes 
may need to take extra care when they 
eat pizza, according to a School of 
Medicine and Yale-New Haven 
Hospital (YNHH) study. 
In reviewing the glucose records of 
eight New Haven-area young adults 
with insulin-dependent diabetes, 
physicians observed that patients under 
intensive diabetes management 
experienced high glucose levels on the 
morning after they had pizza for dinner. 
On separate evenings, each patient 
consumed a 1,300-calorie meal, similar 
in nutritional content. The experimen¬ 
tal meal was a pizzeria-style pizza 
prepared in the metabolic kitchen at the 
Clinical Research Center; the control 
meal contained the same calories and 
nutritional content but included varied 
foods, such as turkey, cheese, fresh 
tomatoes, white bread, potatoes, 
mayonnaise, raisins and apple juice. 
The study revealed that when the 
insulin-dependent patients had the non¬ 
pizza meal, their blood sugar went up 
initially, but fell to normal levels by the 
next morning. With pizza, the blood- 
sugar levels did not return to normal as 
quickly. The findings were published 
in the April issue of the American 
Diabetes Association’s Diabetes Care. 
Researchers included William V. 
Tamborlane, M.D., head of pediatric 
endocrinology and director of the 
Children’s Clinical Research Center, 
and Jo Ann Ahern. R.N., a YNHH 
diabetes nurse specialist. 
Depression Linked to 
Problem Pregnancies 
Women who have had a problem 
pregnancy are more likely to suffer 
postpartum depression, according to a 
study published in the March issue of 
Pediatrics. 
JoAnne Burger, M.D.. clinical 
instructor of pediatrics at the School of 
Medicine, with colleagues at Yale and 
Johns Hopkins University, discovered 
that women with severe pregnancy 
complications are nearly three times 
more likely to suffer postpartum 
depression even if their babies are born 
healthy. Additionally, women who 
experience both pregnancy complica¬ 
tions and postpartum depression are 
almost two times more likely to 
persistently worry about their 
children’s health. 
The study surveyed New Haven- 
area mothers of children aged 4 to 8 
about pregnancy complications. 
postpartum depression and perceptions 
of their children’s health. Out of a 
sample of 1,886 mothers, 212 women 
reported a severe pregnancy complica¬ 
tion; 227 reported postpartum depres¬ 
sion. The majority of mothers were 
white, high-school educated and 
married, with an average age of 33. 
Based on their findings, the authors 
suggest that pediatricians encourage 
mothers to discuss their pregnancies to 
help alleviate unwarranted anxieties 
that may result from complicated 
pregnancies. 
Study Debunks Dopamine 
Receptor/Aleoholism Link 
A literature review study published in 
the April 6 Journal of the American 
Medical Association found no evidence 
linking the D2 dopamine receptor gene 
and alcoholism, in contrast to the 
conclusion of the studies reviewed. 
A research team led by Joel 
Gelernter, M.D., assistant professor of 
psychiatry at the School of Medicine 
and chief of the laboratory of psychiat¬ 
ric genetics at the Department of 
Veterans Affairs Medical Center in 
West Haven, reviewed 11 studies that 
had reported a possible association 
between a marker for the dopamine 
receptor gene and alcoholism. Dr. 
Gelernter concluded that the data did 
not support a link between the gene and 
alcoholism. 
Dr. Gelernter says the studies that 
show a genetic association to alcohol¬ 
ism can best be explained by sampling 
error and ethnic variation within the 
groups studied. Reported differences 
between groups which had been 
attributed to alcoholism could have 
occurred because the ethnic composi¬ 
tion of the comparison groups differed. 
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Dean Gerard N. Burrow delivered the Lee E. Farr, M.D., Lecture on Student 
Research Day after students presented their outstanding theses. (See Page 34.) 
Dean Testifies Before 
House Regarding VA 
When medical school Dean Gerard N. 
Burrow, M.D., testified April 28 before 
a U.S. House of Representatives 
subcommittee on the role of the 
Department of Veterans Affairs (VA) 
in the national health care delivery 
system, he outlined how the VA and 
the national health care system intersect 
in a critical, but subtle, way. They are 
brought together primarily through 
academic affiliations. 
“The VA plays a critical role in the 
education and training of future U.S. 
health care professionals,” stated the 
dean, who himself was in the first 
group of medical interns at Yale who 
rotated through the West Haven VA; 
Dr. Burrow now chairs its Dean's 
Committee. "The VA also contributes 
significantly to advances in medicine 
through a research program which has 
an impressive history of success and 
innovation. 
“Whereas training and research 
issues are of primary interest to 
academic medical centers, manpower 
and staffing issues are central to the 
VA's success in meeting its primary 
mission of delivering health care to 
veterans,” Dr. Burrow stated before the 
Committee on Veterans Affairs’ Sub¬ 
committee on Hospitals and Health Care. 
“The intersection of these two goals 
brought medical schools and the VA 
together officially in 1946 and contin¬ 
ues to bring mutual benefit to both 
partners and to the nation. Changes 
instituted as part of health care reform 
need to consider the VA's special 
strengths and training responsibilities.” 
The VA simultaneously delivers 
quality health care to a unique and 
complicated population and conducts 
research on rehabilitation and mental 
health services, areas specific to 
veterans’ health. Dr. Burrow com¬ 
mented. Research in these areas and 
others, such as geriatric medicine and 
long-term care, may benefit the general 
population, as well. 
In his testimony, presented on 
behalf of the Association of American 
Medical Colleges, Dr. Burrow pointed 
out the importance of defining VA 
services to be provided and the popula¬ 
tion to whom the services would be 
offered. Options include “adjusting the 
size of the VA system as the eligible 
veteran population declines” and 
“revising eligibility for entering the VA 
system. Each option has costs and 
benefits in health policy, financial and 
political terms. 
"The VA system, the largest global 
budget for health care in the United 
States, could provide useful informa¬ 
tion to help shape a national health care 
delivery system,” Dr. Burrow contends. 
For example, issues include: central¬ 
ized management of resource alloca¬ 
tion, incentives and disincentives to 
control costs locally, means of intro¬ 
ducing new technology, conversion of 
outdated facilities and replacement of 
equipment, data collection for planning 
efforts, quality assurance activities and 
measures, and the role of health services 
and outcomes research. 
Adler Geriatric Center 
Developing Database 
Researchers at the Dorothy Adler 
Geriatric Assessment Center have 
received a $150,000 grant from Digital 
Equipment Corp. to purchase computer 
software and equipment that will help 
them build a database to enhance 
patient care. A major focus of the 
database will be research into the cause 
and treatment of Alzheimer's disease. 
The Adler center, a joint project of 
the School of Medicine and Yale-New 
Haven Hospital, is a family-centered 
assessment program serving greater 
New Haven. Ronald L. Miller, M.D., 
medical director of the center and 
associate clinical professor of medicine, 
explains that the new Geriatric Infor¬ 
mation System (GIS) will electronically 
link the Adler center and the School of 
Medicine’s clinical epidemiology unit, 
making research data readily available 
to physicians and clinicians. 
When the GIS is fully in operation, 
Adler center physicians expect to 
expand their knowledge both of 
Alzheimer's disease and related 
dementias, and problems such as 
delirium, depression, falls and urinary 
incontinence. 
44 Yale Medicine Summer 1993 
Study Shows Optic Nerve 
Reveals Early Glaucoma 
Research by School of Medicine 
ophthalmologists indicates that the most 
accurate measure of early glaucoma is 
optic nerve examination and not 
measurement of peripheral vision. The 
study’s prinicipal investigator. Joseph 
Caprioli, M.D., associate professor of 
ophthalmology and visual science, states 
that by monitoring changes to the optic 
nerve, ophthalmologists can detect 
whether a person will be prone to 
peripheral vision loss and progressive 
glaucoma at an earlier stage. 
Dr. Caprioli and his colleagues 
assessed the relationship between visual 
field loss and optic nerve deterioration 
in 15 patients who suffered glaucoma 
damage in one eye and had normal 
vision in the other, putting them at high 
risk for glaucoma in the healthy eye. 
During a six-year period, the physicians 
measured the rates of visual loss and of 
nerve change in the unaffected eye and 
concluded that loss of vision can be 
detected through sequential photo¬ 
graphs of the optic nerve. 
“We now know that detectable 
optic disc damage usually occurs before 
measurable visual field loss occurs in 
glaucoma,” states Dr. Caprioli, who 
reported these findings in the Archives 
of Ophthalmology. “The rate of disc 
change to peripheral visual field change 
is higher in the early stages of glau¬ 
coma, but is lower at more advanced 
stages of the disease. Therefore, early 
evaluation of the optic disc is manda¬ 
tory in the management and treatment 
of early glaucoma.” 
Yale Software Wins Top 
International Award 
Interactive teaching software from the 
Yale Center for Advanced Instructional 
Media recently won honors — includ¬ 
ing a gold medal — from the New 
Media INVISION 1993 Multimedia 
Awards, an international software 
design competition in San Jose, Cal. 
The Yale software, “Atlas,” was 
selected from several hundred multime¬ 
dia software applications submitted. 
The “Atlas of Myocardial Perfusion 
Imaging,” which won the gold medal in 
the Health Care and Medical Training 
category, will be published on CD- 
ROM and videodisc this summer by 
Yale University Press. 
Book News 
Manual of Ornithology: Avian Struc¬ 
ture and Function, by Noble S. Proctor 
and Patrick J. Lynch, director of 
biomedical communications, Yale 
University Press. 1993. 
When Illness Strikes the Leader: The 
Dilemma of the Captive King, by 
Jerrold M. Post. M.D. '60. and Robert 
S. Robins, Yale University Press, 1993. 
Nuclear Cardiology: State of the Art 
and Future Directions, by Barry L. 
Zaret. M.D.. Robert W. Berliner 
Professor of Medicine, and George A. 
Beller, M.D., Mosby. 1993. 
The Merck Manual of Diagnosis and 
Therapy, sections on nutrition and 
endocrine/metabolic diseases edited by 
Philip K. Bondy. M.D.. professor 
emeritus of medicine, Merck Publish¬ 
ing Group, 1993. 
The Merck Manual of Diagnosis and 
Therapy, section on Lyme disease 
edited by Stephen E. Malawista, M.D.. 
HS ’58-’63, professor of medicine, 
Merck Publishing Group. 1993. 
The Merck Manual of Diagnosis and 
Therapy, section on hyperbaric 
medicine by Eric P. Kindwall, M.D. 
'60. Merck Publishing Group. 1993. 
Principles of Anesthesiology, by 
Vincent J. Collins. M.D. '42, D.Sc., 
Lea & Febiger (Philadelphia) Third 
Edition. 1993. 
In Memoriam 
Lawrence S. Crispell 
March 2, 1993 
M.D. ’44 John McLean Morris 
April 8, 1993 
M.A.H. ’62 
Joseph P. Donnelly 
February 9, 1993 
M.D. ’32 Sally A. Provence 
February 6, 1993 
M.A.H. ’67 
Donal L. Dunphy 
September 12, 1992 
M.D. ’44 Earl Douglas Rees 
March 14, 1993 
M.D. ’54 
Mary M. Fitzgerald 
January 23, 1992 
PHSP*’48 Alfred F. Seibert 
October 8. 1992 
M.D. ’27 
John Paul Gens 
February 12, 1993 
M.D. ’37 C. Wesley Watson 
December 26, 1992 
M.D. '43 
Lewis P. James 
March 23, 1993 
M.D. '21 Wedgwood P. Webber 
January 9, 1993 
M.D. ’34 
Robert B. Jamieson Jr. 
January 14, 1993 
M.D. ’37 Stanley J. Weigel 
December 1, 1992 
M.D. ’43 
Elias E. Manuelidis 
November 11, 1992 
M.A.H. ’64 
*Special, Public Health 
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Faculty 
News 
Dr. Vincent T. DeVita Jr. 
Dr. DeVita to Lead 
Yale Cancer Center 
Vincent T. DeVita Jr., M.D., HS ’66, 
director of the National Cancer Institute 
(NCI) during the Carter and Reagan 
administrations, has been named 
director of the Yale Comprehensive 
Cancer Center (YCCC), a joint pro¬ 
gram of the School of Medicine and 
Yale-New Haven Hospital (YNHH). 
His appointment is effective July 1. 
He succeeds Alan C. Sartorelli, 
Ph.D., the Alfred Gilman Professor of 
Pharmacology. Dr. Sartorelli will 
retain an appointment in the cancer 
center and will return to full-time 
research and teaching. 
Dr. DeVita comes to Yale from 
Memorial Sloan-Kettering Cancer 
Center in New York, where he holds 
the Benno C. Schmidt Chair in Clinical 
Oncology. He was successively 
Physician-in-Chief and, since July 
1991, attending physician and member 
of the program of molecular pharma¬ 
cology and therapeutics. He also serves 
as professor of medicine at Cornell 
University Medical College and as a 
visiting professor at Rockefeller 
University. 
Comments Dean Gerard N. Burrow: 
“In 1965, Vince DeVita and I were 
medical residents together here at Yale 
under Dr. Paul Beeson, and during the 
intervening years he has made many 
contributions to his nation, his profes¬ 
sion and to his patients' lives. His 
accomplishments are legion. We are 
delighted that he will bring his vast 
experience, clinical wisdom and 
management talents to our strong 
comprehensive cancer program, 
thereby enhancing our basic scientific 
research and rapidly transferring that 
information to the bedside.” 
At the NCI, Dr. DeVita was 
instrumental in developing combination 
chemotherapy programs that ultimately 
led to curative chemotherapy for 
Hodgkin’s disease and diffuse large cell 
lymphoma, another type of tumor of the 
lymph glands. He and colleagues at the 
National Institutes of Health (NIH) 
developed the four-drug combination, 
known as MOPP, that increased the 
cure rate for patients with advanced 
Hodgkin’s disease and diffuse lympho¬ 
cytic lymphoma from nearly zero to 
more than 50 percent. 
Dr. DeVita also reorganized the 
NCI’s program for drug development 
and clinical trials, and implemented a 
consistent, rigorous process of review 
by non-NCI scientists of the intramural 
research program. While director of 
NCI, Dr. DeVita established the 
institute’s prevention programs and 
invented the Protocol Data Query 
system — the only completely comput¬ 
erized treatment data base encompass¬ 
ing an entire field. 
Recognized internationally for his 
accomplishments, in 1972, Dr. DeVita 
received the Albert and Mary Lasker 
Medical Research Award for his 
contributions to the cure of Hodgkin's 
disease. Eight years later, the Associa¬ 
tion for the Development of Research 
on Cancer presented him the Griffuel 
Prize for his contributions to cancer 
chemotherapy. Among his other 
honors. Dr. DeVita was elected to the 
Institute of Medicine in 1985. 
A native of the Bronx, N.Y., Dr. 
DeVita was awarded a B.S. degree in 
1957 from the College of William and 
Mary in Williamsburg, Va. He 
received an M.D. degree with distinc¬ 
tion in 1961 from the George Washing¬ 
ton University School of Medicine, 
where he served on the faculty from 
1971 to 1988. 
The YCCC is one of 28 federally 
designated centers in the United States. 
More than 230 Yale faculty members in 
some 24 departments are associated 
with the YCCC. Yale’s cancer center 
is the New England Regional Center 
for CIS, the Cancer Information 
Service, and is one of 14 such sites in 
the United States. In addition, the NIH 
has designated Yale University to have 
one of the six Cancer Prevention 
Research Units in the nation. 
Merle Waxman Named 
YSM Associate Dean 
Merle Waxman, director of the Office 
for Women in Medicine and of the 
Office of the Ombuds, has been 
promoted to the newly established 
position of associate dean for academic 
development, effective July 1. 
In announcing her appointment, 
Gerard N. Burrow, M.D., dean, states: 
"The issue of mentoring is extremely 
important in medicine and science, and 
to enhance professional development at 
all levels, we are creating an Office for 
Academic Development and naming 
Merle Waxman associate dean. 
“She is well known throughout the 
country for her work on mentoring and 
role modeling in academic medical 
settings. She has developed effective 
programs for conflict resolution which 
have had a positive effect on our 
institution. Her diverse experiences 
well equip her to develop programs that 
will promote the professional develop¬ 
ment of our trainees and faculty,” Dr. 
Burrow states. 
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Comments Ms. Waxman: “One of 
my top priorities will focus on fostering 
the professional development of all 
members of our community, especially 
students, fellows and junior faculty. I 
am particularly interested in developing 
new programs to enhance role model¬ 
ing and mentoring.” 
In her new post, Ms. Waxman also 
will continue to direct both ombuds and 
women in medicine offices. 
Ms. Waxman, who came to Yale in 
1986 from Stanford University Medical 
School, is a fellow of Branford College, 
a member of the Hillel Foundation 
executive board of trustees, and of the 
University’s staff affirmative action 
advisory committee. She is a trustee of 
the Associates of the Cushing/Whitney 
Medical Library. 
§§§ 
John C. Baldwin, M.D., professor and 
chief of cardiothoracic surgery, has 
been appointed to the National Advi¬ 
sory Council on Graduate Education in 
cardiothoracic surgery and has been 
named chairman of the Curriculum 
Committee for Thoracic Surgical 
Residency Education. Dr. Baldwin 
represented the Thoracic Surgery 
Program directors with a talk on 
“Thoracic Surgery in the Year 2010” at 
the national meeting of the Society of 
Thoracic Surgeons in San Antonio. He 
also spoke at the National Heart and 
Lung Institute Cardiac Surgery Annual 
Meeting in London in May and at the 
International Symposium on Coronary 
Artery Surgery in Buenos Aires, 
Argentina. Dr. Baldwin served as a 
visiting professor at the John Radcliffe 
Infirmary at Oxford University in 
England in March and at the University 
of New Mexico in May. 
Michele Barry, M.D., HS ’77-’81, 
associate professor of medicine, 
received of one of 13 Elm-Ivy Awards 
for contributing to increased under¬ 
standing and cooperation between the 
Elm City (New Haven) and Yale 
University. She received an Ivy Award 
for her work as coordinator of the 
Homeless Health Care Project, a 
medical van that provides free care to 
the city’s homeless population. 
Gerard N. Burrow, M.D. ’58, 
dean, has been elected to the board of 
directors of the National Medical 
Fellowships, Inc., a non-profit organi¬ 
zation that provides assistance to 
underrepresented minority students in 
medicine. The New York-based group 
was founded in 1946. Dr. Burrow will 
serve on the awards and planning and 
development committees. 
James P. Comer, M.D., HS ’64- 
’67, associate dean for students, the 
Maurice Falk Professor of Child 
Psychiatry and director of the school 
development program in the Child 
Study Center, was awarded an honorary 
doctor of laws degree from Lawrence 
University in Wisconsin. 
Deborah Dwork. associate clinical 
professor in the Yale Child Study 
Center and a historian of children of the 
Holocaust, has been awarded a 
Guggenheim Fellowship for her 
project, “Flight from the Reich," a 
history of Jewish refugee children. 
Thomas K.P. Egglin, M.D., HS 
'86, assistant professor in diagnostic 
radiology, has been awarded a 1993 
GE-AUR Radiology Research Aca¬ 
demic Fellowship. This award is co¬ 
sponsored by GE Medical Systems and 
the Association of University Radiolo¬ 
gists. Dr. Egglin's research project is 
entitled “Magnetic Resonance 
Angiography in Patients with Limb- 
Threatening Ischemia.” 
Michael D. Ezekowitz, M.D., 
Ph.D., professor of medicine, presented 
a clinical trials symposium, “Risk 
Factors for Stroke in AFIB - Collabora¬ 
tive Analysis of Five Randomized 
Trials,” at the 42nd Annual Scientific 
Session American College of Cardiol¬ 
ogy meeting in California. He also was 
the guest speaker on “Cardiac Sources 
of Systemic Embolization,” at the 23rd 
Annual Congress Republic of China 
Society of Cardiology meeting in 
Taipei. 
Alvan R. Feinstein, M.D., HS '52- 
’54, Sterling Professor of Medicine and 
Epidemiology, has been named one of 
five 1993 Gairdner Foundation Interna¬ 
tional Award recipients. The awards 
will be presented at the University of 
Toronto in October. He was recog¬ 
nized for establishing modern clinical 
epidemiology as an investigative 
discipline for studying the causes, 
diagnosis, prognosis and therapy of 
disease. He also was honored for 
improving the classification of disease 
and the quantitative use of clinical 
signs and symptoms in the study of 
disease. 
Gerhard H. Giebisch, M.D., 
Sterling Professor of Physiology, gave 
the Walter B. Cannon Memorial 
Lecture at the Experimental Biology 
'93 Meeting in New Orleans in March. 
Dr. Giebisch, whose research is 
concerned with cellular mechanisms of 
solute and solvent transport in the 
kidney, presented a lecture entitled 
“Potassium Homeostasis: Regulation 
Through Pumps and Channels.” 
Fredrick S. Gorelick, M.D.. 
associate professor of medicine 
(gastroenterology) and of cell biology, 
was presented one of two Outstanding 
Young Physician Awards by the 
University of Missouri-Columbia 
Medical Alumni Organization in April. 
Dr. Gorelick was honored for his 
ground-breaking discoveries in the 
study of pancreatitis and cystic fibrosis. 
He is also staff physician and director 
Alvan R. Feinstein, M.D. 
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of the gastrointestinal research and 
electron microscopy laboratories at the 
Department of Veterans Affairs 
Medical Center in West Haven. 
Robert J. Groszmann, M.D., 
professor of medicine, has been 
awarded $357,464 annually from the 
National Institutes of Diabetes and 
Digestive and Kidney Diseases for a 
five-year study on “Prevention of Portal 
Hypertensive Complications by Beta- 
Adrenergic Blockers.” A co-investiga- 
tor, also from Yale, is Guadalupe 
Garcia-Tsao, M.D.. assistant professor 
of medicine. 
Gary E. Horblitt. D.D.S., clinical 
instructor in surgery, was one of 35 
dentists chosen worldwide to present 
original material on dental implant 
technology. He is one of only a few 
Connecticut dentists certified in the 
specialty of prosthodontics. restoring 
and replacing teeth with dentures, 
bridges, crowns and dental implants. 
Jeannette R. Iekovics, Ph.D., 
assistant professor of medicine and 
associate research scientist in psychol¬ 
ogy, was selected as a scholar of the 
American Foundation for AIDS 
Research. Her research examines 
factors that influence recruitment and 
retention of people traditionally under¬ 
represented in AIDS clinical trials: 
women, minorities and IV drug-users. 
James D. Jamieson. M.D.. Ph.D., 
director of the M.D./Ph.D. physician 
scientist training program and past 
chairman of the department of cell 
biology, received the American 
Gastroenterological Association’s 
Distinguished Achievement Award for 
his research, which provided a founda¬ 
tion for exploring fundamental pro¬ 
cesses in cell function. 
Charles A. Janeway Jr., M.D., 
professor of immunobiology and 
biology and an Howard Hughes 
Medical Institute investigator, was the 
first Australasian Society of Immunol¬ 
ogy Visiting Lecturer in March. Dr. 
Janeway spoke in seven capital cities 
during a two-week trip. He also was 
honored this spring as the Robert Kroc 
Lecturer in Diabetes at the University 
of Washington at Seattle, the H.R. and 
J.S. Blumenthal Lecturer in Allergy at 
the University of Minnesota, and the 
Herman Beerman Lecturer of the 
Society for Investigative Dermatology’s 
annual meeting in Washington, D.C. 
Irwin M. Braverman. M.D. '55, HS 
’55-’56, professor of dermatology at 
Yale, presided at the meeting. 
James F. Leckman, M.D., the 
Neison Harris Professor of Child 
Psychiatry and professor of pediatrics, 
was honored with one of nine Estab¬ 
lished Investigator Awards by the 
National Alliance for Research on 
Schizophrenia and Depression in May. 
Dr. Leckman works closely with the 
three other Yale recipients on research 
involving the genes responsible for the 
development of the forebrain in 
animals and humans. 
Young Investigator Awards were 
given to Paul J. Lombroso, M.D., 
assistant professor in the Child Study 
Center; Flora M. Vaccarino. M.D., 
associate research scientist; and 
Laurence Robel. M.D., post-doctoral 
fellow in child psychiatry. All award 
recipients are part of the molecular 
biology group at the Child Study 
Center. 
Steven Marans, Ph.D.. the Harris 
Assistant Professor of Child Psycho¬ 
analysis in the Child Study Center, has 
been named the B’nai B’rith Women 
(BBW) National Scholar for 1993- 
1994. The program was created in 
1990 to exchange information about the 
treatment of emotionally disturbed 
children between the United States and 
the BBW Residential Treatment Center 
in Jerusalem. Dr. Marans is coordina¬ 
tor of a program between the New 
Haven Department of Police Service 
and the Child Study Center to reduce 
the impact of violence on children. 
Vincent T. Marchesi, M.D. '63, 
Ph.D., director of the Boyer Center for 
Molecular Medicine and Anthony N. 
Brady Professor of Pathology, Cell 
Biology and Biology, received the 
Award for Advancement of Basic and 
Applied Science from the Yale Science 
and Engineering Association in April. 
He was honored for his research on 
how the cell membrane is supported by 
a protein scaffold of spectrin and actin. 
He also won the award for being the 
first to establish the molecular structure 
of transmembrane protein. 
William H. Marks, M.D.. Ph.D., 
associate professor of surgery (general/ 
transplantation), was appointed a 
member of the U.S. Medical Licensing 
Examination Step 2 Test Material 
Development Committee for Surgery. 
He also was named to the National 
Board’s Surgery Test Committee by the 
Federation of State Medical Boards of 
the United States and the National 
Board of Medical Examiners in March. 
Alan M. Reznik, M.D., clinical 
instructor of orthopaedics and rehabili¬ 
tation, was inducted as a fellow of the 
American Academy of Orthopaedic 
Surgeons at its 60th annual meeting in 
February in San Francisco. 
Joseph C. Stevens, Ph.D.. fellow 
of the John B. Pierce Laboratory and 
senior research scientist and lecturer in 
psychology, and Martin G. 
Cherniack, M.D., associate professor 
of environmental and occupational 
medicine, will conduct a study on how 
aging affects sensations of the skin. He 
won a four-year grant awarded to the 
John B. Pierce Laboratory from the 
National Institute on Aging. 
Norman J. Siegel. M.D., HS ’68- 
’70, professor and vice chairman of 
pediatrics, was named a member of the 
U.S. Medical Licensing Examination 
Step 2 Committee for Pediatrics and the 
National Board's Pediatrics Test 
Committee. He was appointed by the 
Federation of State Medical Boards of 
the United States and the National 
Board of Medical Examiners. 
The National Institute of Neurologi¬ 
cal Disorders and Stroke has presented 
a Javits Neuroscience Investigator 
Award to Frederick J. Sigworth, 
Ph.D., professor of cellular and 
molecular physiology, in recognition of 
his outstanding contributions to the 
neurological sciences. Dr. Sigworth 
conducts research on ion channels, 
which are protein molecules found in 
cell membranes. 
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Alumni 
News 
John A. Parrish, M.D. ’65, (second from left) receives an award from the Society for 
Investigative Dermatology. 
Knox H. Finley, M.D. ’30, a retired 
neuropsychiatrist, resides in San 
Francisco, Calif. 
Samuel D. Kushlan. M.D. ’35, HS 
'35-’37, internal medicine gastroenter¬ 
ologist, was associate physician-in¬ 
chief at Yale-New Haven Hospital 
(YNHH) from 1967 to 1982 and is 
active in the following positions: 
Consultant to chief of staff at YNHH 
since 1982; consultant to alumni affairs 
office at Yale medical school since 
1987; co-chair for bequest and endow¬ 
ment program. School of Medicine 
Alumni Fund, since 1980; and chair of 
the former house staff program. School 
of Medicine Alumni Fund, since 1982. 
Edwin D. Rogers, M.D. ’41, is 
staff psychiatrist at Cleveland County 
Mental Health Center in Shelby, N.C. 
Vincent J. Collins, M.D. ’42, 
professor emeritus of anesthesiology at 
the University of Illinois and North¬ 
western University medical schools, 
received an honorary Doctor of Science 
degree from Marietta College in 
Marietta, Ohio, in May, where he 
serves on the Advisory Board on 
Science and Engineering. A resident of 
Winnetka, Ill., he founded the Midwest 
Anesthesiology Conference (MAC) in 
1964 and received the “Father of 
MAC” Award in 1983. 
William Kaufman, M.D. ’42, 
Ph.D., of Winston-Salem, N.C., 
presented his clinical findings, “Niaci¬ 
namide and Osteoarthritis,” to the 
internal medicine/gerontology section of 
the Bowman Gray School of Medicine 
in North Carolina in February. 
Maurice Tulin, M.D. '42, HS ’42- 
’45, is in the department of internal 
medicine at North Shore University 
Hospital in Manhasset, N.Y. 
John P. McGovern. M.D.. HS ’45- 
'46, of Houston. Texas, was presented 
the first Houston Academy of Medicine 
John P. McGovern Compleat Physician 
Award from the Harris County Medical 
Society/ Houston Academy of Medi¬ 
cine in March. The annual award 
recognizes a physician whose career 
has been founded on Sir William 
Osier’s ideals of "medical excellence, 
humane and ethical care, commitment 
to medical humanities and writing, 
research, and harmony between the 
academician and the medical practitio¬ 
ner.” Dr. McGovern is a professor at 
every teaching institution in the Texas 
Medical Center, and is a fellow of 
Green College at Oxford University. 
David E. Morton, M.D. ’48, HS 
’49-’55, of Pueblo, Colo., has retired 
from the practice of internal medicine. 
This fall, his daughter, Sarah M. 
Morton, will enter Yale College, Class 
of 1997. 
Benjamin F. Rush, M.D. ’48, a 
surgeon and chairman of the depart¬ 
ment of surgery at the UMDNJ-New 
Jersey Medical School, has been 
presented the 1993 Edward J. Ill Award 
for outstanding service as a health care 
specialist by the Academy of Medicine 
of New Jersey. Dr. Rush resides in 
Summit, N.J. 
Virginia M. Scholl, M.D.. HS 51- 
'52, has retired from her plastic surgery 
practice in Seattle, Wash., and is now a 
full-time medical officer for the 
regional office of the Department of 
Veterans Affairs. 
Ruth Kerr Jakoby, M.D.. HS ’53- 
'54, of Chevy Chase, Md., has retired 
from the practice of neurosurgery and 
is active in the law and the formation of 
the Antioch Inns of Court. 
Roger C. Herdman. M.D. 58, HS 
’58-’63, was selected by the U.S. 
Technology Assessment Board as 
director of the Office of Technology 
Assessment (OTA), U.S. Congress. Dr. 
Herdman has directed OTA’s Health 
and Life Sciences Division since 1983. 
He was vice president of the Memorial 
Sloan-Kettering Cancer Center in New 
York City for four years. 
Eric P. Kindwall, M.D. ’60, 
associate professor of hyperbaric 
medicine in the department of plastic 
and reconstructive surgery and of 
pharmacology and toxicology at the 
Medical College of Wisconsin, chairs 
the Commission on Underwater 
Physiology and Medicine for the 
International Union of Physiological 
Sciences. 
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O'dell M. Owens, M.D. ’76 
Jonathan E. Fine, M.D. ’62, has 
been awarded an honorary Doctor of 
Science degree from Swarthmore 
College in Pennsylvania. In 1986, Dr. 
Fine founded Physicians for Human 
Rights, an organization that reports 
human rights violations, and served as 
its executive director until 1992. He 
now works as a consultant to the 
organization. Recently, he has helped 
to initiate a new international organiza¬ 
tion to monitor conflicts and to support 
the Geneva Convention's humanitarian 
principles in situations of conflict. 
Lee B. Talner, M.D. '63, HS '63- 
'68, professor of radiology and chief of 
diagnostic radiology at the University 
of California at San Diego, has been 
named director of radiology at the 
University of Washington, Seattle, 
Harborview Medical Center. 
Norman C. Fost, M.D. '64, of 
Middleton, Wise., whose specialities 
are pediatrics and bioethics, served on 
the Ethics Working Group, one of four 
groups advising Hillary Rodham 
Clinton’s Health Care Task Force. 
Richard P. Salk, M.D. '64, has 
been appointed chief of breast surgery 
at the Scripps Clinic in La Jolla, Calif. 
A. Thomas Snoke, M.D. '64, 
retired in 1990 from family practice 
with the Phoenix Health Service Indian 
Hospital, and is now a volunteer at a 
local nursing home. 
Denis A. Baylor, M.D. 65, 
professor and chair of neurobiology at 
Stanford University, was elected to the 
National Academy of Sciences in April, 
recognizing distinguished and continu¬ 
ing achievement in original research. 
John A. Parrish, M.D. ’65, 
chairman and professor of dermatology 
at Harvard Medical School, received 
the National Psoriasis Foundation 
Research Recognition Award for his 
role in developing an effective drug- 
and-light therapy involving the drug 
psoralen and ultravioIet-A light 
(PUVA). Dr. Parrish, along with the 
co-developer of PUVA, Thomas J. 
Fitzpatrick, M.D., Ph.D., received the 
award in April at the 1992 Society for 
Investigative Dermatology meeting in 
Washington, D.C. 
Sheila Moriber Katz, M.D. 66, HS 
'66-'67, professor of pathology, has 
been appointed interim dean of the 
School of Medicine, Hahnemann 
University in Philadelphia. She has 
served Hahnemann as associate dean for 
academic coordination and for continu¬ 
ing medical education. Her clinical and 
research activities involve organ 
transplantation and renal disorders. 
Gregory Belok, D.D.S., M.P.H. 
'74, of Teaneck, N.J., established the 
Nihon Shika Management Coip. to 
administer the national and interna¬ 
tional sites of the Nihon Shika Group, a 
multi-specialty group dental practice. 
Stephen C. Vlay, M.D. '75, 
director of the Stony Brook Arrhythmia 
Study and Sudden Death Prevention 
Center, and director of the coronary 
care unit at University Hospital at the 
State University of New York at Stony 
Brook, was promoted to professor of 
medicine in July 1992. 
Alicia E. Beicos, M.D. '76, is 
practicing internal medicine at OTA 
Sanda, Calle Amazonas, in Venezuela. 
O’dell M. Owens, M.D. '76, 
M.P.H. '76, has been elected chairman 
of the University of Cincinnati (UC) 
board of trustees. He is the first 
African-American to serve in that 
capacity during the university’s 173- 
year history. Dr. Owens joined the UC 
faculty in 1982 to establish and serve as 
director of the division of reproductive 
endocrinology. 
Michael H. Owens. M.D. '78, 
M.P.H. '78, vice president of Govern¬ 
ment Health Care Programs for the 
California State CIGNA Health Plan, 
presented an evening seminar on "The 
New Health Environment — Managed 
Competition and the Minority Health 
Professional” in February at Yale 
School of Medicine. 
Ilene Wach, M.P.H.’79, is 
president of CompScope, a Spring 
Valley, N.Y., consulting firm that 
handles worker's compensation issues. 
Robert V. Levine, M.P.H. '80, has 
been appointed vice president of 
operations at Lenox Hill Hospital in 
New'York City. He formerly was 
senior vice president for administration 
at Flushing Hospital Medical Center in 
New York City. 
Susan L. Schwartz, M.P.H. ’80, 
has been named associate producer of 
medicine and health issues for the ABC 
television network's news magazine, 
"A Moment of Crisis,” scheduled to 
debut this fall. 
John P. McGovern, M.D., HS ’45-'46 
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Thomas S. Kupper, M.D. ’81, of 
Weston, Mass., associate professor and 
the Thomas B. Fitzpatrick endowed 
chair in dermatology at Harvard, is also 
director of dermatology research at the 
Brigham and Women's Hospital. He 
started his residency in 1986 at Yale, 
became assistant professor in 1987, and 
in 1989 moved to St. Louis as associate 
professor of medicine and pathology at 
Washington University. 
John Artis Yopp, M.P.H. ’81, 
chairman of the New Haven Water 
Pollution Control Authority board of com¬ 
missioners, has announced his candidacy 
in the Democratic Party mayoral primary 
for the city of New Haven. 
Deborah J. Lighter, M.D., HS ’82- 
’86, has joined the department of urology 
at Group Health, Inc., Riverside Medical 
Center in Minneapolis, Minn., a not-for- 
profit, member-governed, multispecialty 
group practice and managed health care 
delivery system. Prior to joining Group 
Health, she had practiced at Twin City 
Urology since 1989. 
Tina Young Poussaint, M.D. '83, 
staff radiologist at Children’s Hospital 
in Boston, was one of five alumnae 
recipients of the Mary Lyon Award 
given by Mount Holyoke College. 
Award winners have graduated within 
the last 15 years and distinguished 
themselves by demonstrating promise 
or sustained professional achievement. 
Dr. Poussaint has served as staff 
radiologist for Massachusetts General 
Hospital, consultant in MRI interpreta¬ 
tion of head and spine at McLean 
Hospital, and has taught at Harvard 
Medical School as an instructor and 
clinical fellow in radiology. 
Caroline (Carrie) Rohr Martinek, 
’86 M.P.H., of Springfield, Pa., has 
accepted a nursing position with the 
Public Health Service/Alaskan Area 
Native Health Service, beginning in 
July. She will intern for five months at 
the Alaska Native Medical Center in 
Anchorage and then spend two years at 
the Maniilao Medical Center in 
Kotzebue, a 24-bed hospital serving 12 
villages within 36,000 square miles. 
Stephen J. Roth, M.D. ’86, joined 
the attending staff in the department of 
cardiology at Children’s Hospital in 
Boston and was promoted to instructor 
in medicine at Harvard Medical School. 
He also was awarded a Clinical 
Investigator Development Award from 
the National Institutes of Health. 
Paul E. Savoca, M.D., HS ’86-’91, 
has joined the staff of Fairfax Colon 
and Rectal Surgeons in McLean, Va., 
and is affiliated with Georgetown 
University School of Medicine. 
Virginia A. Pittman-Waller, 
M.P.H. '88, is a producer for CBS 
News in New York. One of her 
programs is called “Health Talk.” 
M. Joseph Chusid, M.D. ’70, 
professor and vice chairman of pediat¬ 
rics at the Medical College of Wiscon¬ 
sin, has been elected to a second term 
as chief-of-staff at Children’s Hospital 
of Wisconsin and is soon to be pub¬ 
lished with classmate, C. Norman 
Coleman, M.D. ’70, in the Yale 
Journal of Biology and Medicine 
regarding publication rates by their 
class in the medical literature between 
1970 and 1990. 
Karl O. Wustrack, M.D. ’70, and 
W. Romney Burke, M.D. '70, are both 
members of the board of directors of 
Willamette Falls Community Hospital 
in Oregon City, Ore. 
Francis S. Collins, M.D., Ph.D., a 
postdoctoral fellow at the School of 
Medicine from 1981 to 1984, and 
director of the Human Genome Center 
and a Howard Hughes Medical Institute 
investigator at the University of 
Michigan, has succeeded James Watson 
as director of the National Center for 
Human Genome Research. Dr. Collins 
began his position half-time in April 
and will assume full-time responsibili¬ 
ties in September at the National 
Institutes of Health in Bethesda, Md. 
In April, he was one of 60 new mem¬ 
bers elected into the National Academy 
of Sciences. 
Steven C. Herber, M.D., HS ’90- 
’92, professor of plastic surgery at 
Loma Linda University in California, 
recently traveled to Romania to teach 




Med Students Volunteer 
To Ease Children’s Fears 
Two new programs organized by Yale 
medical students aim to improve care 
for children with chronic illnesses and 
make hospitalization less frightening. 
With more than 50 students enrolled. 
Medical Buddies and Just for Kids 
match first- or second-year students 
with children who have a chronic 
illness or are in the hospital for an 
extended stay. Medical students in the 
programs attend lectures and confer¬ 
ences with faculty members to better 
understand the emotional and physical 
treatment of ill children. 
In Medical Buddies, a program for 
outpatients, a medical student accompa¬ 
nies a child to his or her Yale or Yale- 
New Haven clinic visit and later 
reviews the meaning of the child’s test 
results, the purpose of medications, and 
answers any questions children or 
parents may have. Children, aged 6 
through 16, and their parents, are 
invited into the program during a clinic 
appointment. 
“We started the Medical Buddies 
program to help students appreciate 
how children, as patients, feel and 
think, so we can make the children's 
illnesses seem less scary,” says Farzad 
Mostashari, a second-year medical 
student and founder of Medical 
Buddies. The students also try to meet 
with their young companions between 
clinic visits, preferably at the child’s 
home, to better understand the child’s 
cultural and family settings. 
According to Brian Forsyth, M.D., 
associate professor of pediatrics and in 
the Child Study Center, the students 
serve in both professional and big 
brother/big sister roles. They are a 
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support to the children’s medical teams 
by helping the children understand the 
decisions that the teams have made. 
"The students act as liaisons between 
the physicians and the children. Many 
times children feel more comfortable 
confiding in or asking questions of their 
matched student then their formal 
caregivers,” adds Dr. Forsyth, faculty 
advisor for Medical Buddies. 
Just For Kids, which began last 
November, helps pediatric patients at 
Yale-New Haven Hospital cope with an 
environment away from their home, 
family and friends. Medical and 
nursing students are paired with 
hospitalized children to help support 
the children and their families during 
hospitalization. Students meet with the 
children several times during their 
hospital stay to play games, read, and 
answer questions children or parents 
might have about the illness or hospi¬ 
talization. 
“I wanted to start a program that 
would allow medical students to help 
meet social, emotional and psychologi¬ 
cal needs of children in the hospital,” 
explains Tina Harris, a fourth-year 
student and founder of Just For Kids. 
With the students committing to at 
least one year with their matched child, 
the student/patient relationship contin¬ 
ues after the child has been released 
from the hospital. Children in the 
program continue to share visits, phone 
calls and recreational outings with other 
children who were hospitalized for the 
same or similar illnesses. 
Sally E. Shaywitz, M.D., professor 
of pediatrics and in the Child Study 
Center, says she became the faculty 
advisor for Just for Kids because “it’s a 
rare opportunity for students to 
appreciate the important interactions 
between the purely biological and the 
more personal aspects of illness. Just 
For Kids brings together the science 
and art of medicine.” 
§§§ 
Two first-year medical students, 
Katherine Day and Monica 
Escarzaga, received the McGraw Hill 
Award in recognition of their dedica¬ 
tion and hard work in medical school. 
Tail Taylor traveled to Japan for his M.D. thesis research. 
Alice Chang, second-year medical 
student, received the CIBA-GEIGY 
award for outstanding community 
service. For the past two years, she has 
been involved in the Adolescent 
Substance Abuse Prevention, Medical 
School Tours Program and is co¬ 
coordinator of student volunteers. She 
also is a member of Asian-Americans 
in Yale Medicine. 
Lin Huang, M.D., immunobiology 
graduate student, and postdoctoral 
fellow Hideo Imaseki, M.D., Ph.D., 
have been awarded 1993-1994 Richard 
K. Gershon fellowships to encourage 
biomedical research careers. Dr. 
Huang studies immune responses 
controlled by T lymphocytes that attack 
infections. Dr. Imaseki studies insulin- 
dependent diabetes mellitus. 
Lauren Hyman, a third-year 
medical student, was a presenter at the 
University of Texas 34th Annual 
National Student Research Forum. Her 
topic, "The Effect of Obesity and 
Abdominal Fat Distribution on Insulin 
Secretion and Insulin Action in 
Adolescent Females,” won her the 
Department of Pediatrics Award and 
second place in the Roche Laboratories 
Award for Excellence in Clinical 
Research, Medical Student Division. 
Her faculty advisors were Dr. Sonia 
Caprio, research scientist in pediatrics. 
and William V. Tamborlane, M.D., 
professor of pediatrics. 
Nancy I. Rennert, M.D., postdoc¬ 
toral fellow in medicine (endocrinol¬ 
ogy), has been awarded an Endocrine 
Fellows Foundation grant to evaluate 
the effect of insulin-like growth factor I 
on glucose homeostasis independent of 
changes in other glucoregulatory 
hormones. 
Daniel B. Stolar, a second-year 
medical student, has won the 1993 
Marguerite Rush Lerner Award for 
creative writing. His entry was a short 
story entitled “Daytime TV.” 
Second-year medical student Dara 
Thomas received one of 13 Elm-Ivy 
Awards presented to individuals who 
have contributed to increased under¬ 
standing and cooperation between the 
New Haven and Yale University. She 
received a Graduate/Professional 
Award for her work to infuse public 
school children with an enthusiasm for 
learning, and for establishing a program 
at Roberto Clemente Middle School 
that encourages 7th- and 8th-graders to 
pursue careers in science and health. 
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Obituaries 
Hans W. Loewald 
Hans W. Loewald, M.D., died Jan. 9 at 
Whitney Manor in Hamden, Conn. He 
was 86. 
Born in Colmar, France, he studied 
at the Marburg and Freiburg universi¬ 
ties in Germany. In 1932, he set up a 
private psychiatry practice in Padua, 
Italy, and came to the United States in 
1939. He practiced in Baltimore, was 
on the faculty of Johns Hopkins 
University and the University of 
Maryland, and trained and supervised 
psychoanalysts at the Washington- 
Baltimore Psychoanalytic Institute. 
In 1955, Dr. Loewald moved to 
New Haven and joined the Western 
New England Psychoanalytic Institute 
as a supervising and training analyst, 
and taught at Yale in the department of 
psychiatry and the Child Study Center. 
He received the Mary S. Sigourney 
Award in 1991 and the Laughlin Award 
in 1992 from the American College of 
Psychoanalysis. 
Survivors include his wife, Eliza¬ 
beth L. Loewald, M.D., HS ’75-’79; a 
son, Francis; two daughters, Katherin 
and Caroline; and three grandsons. 
Farzad Gerogan 
Farzad Gerogan, M.D., a second-year 
resident in the Yale psychiatry training 
program, died in a plane crash in his 
native Iran in February. He was born 
in 1965. 
Sally A. Provence 
Sally A. Provence, M.D., born in Wills 
Point, Texas, died Feb. 6 at Connecticut 
Hospice in Branford. 
Dr. Provence graduated from Mary 
Hardin College of Baylor University 
and Baylor University College of 
Medicine, where she was chief resident 
in pediatrics. For two years she 
maintained a private pediatric practice 
in Dallas. Her interests include the 
more complex aspects of clinical child 
development and psychoanalysis. In 
1949, she joined the Yale Child Study 
Center and two years later founded its 
Child Development Unit, which she 
directed for the next 30 years. 
Dr. Provence was appointed 
professor of pediatrics at the Child 
Study Center in 1967, and in 1978 
founded and later served as president of 
the National Center for Clinical Infant 
Programs. Her publications have 
improved standards of care for children 
in institutions, children and families in 
day care, and shaped clinical interven¬ 
tion with multiply handicapped young 
children. She received many honors, 
including the American Academy of 
Pediatrics’ C. Anderson Aldrich 
Award. Before her death, the National 
Center for Clinical Infant Programs 
established the Sally Provence Award 
for Clinical Excellence. 
John Paul Gens 
John Paul Gens, M.D.. died Feb. 12. 
Dr. Gens, a 1937 graduate of the 
medical school, served on the house 
staff from 1938 to 1939. After retiring 
from the field of urology, he lived in 
Hilton Head, S.C. 
A. Pharo Gagge 
A. Pharo Gagge, Ph.D., born in 
Columbus, Ohio, died Feb. 13, at his 
home in Branford, Conn. He was 85 
years old. 
Dr. Gagge received a Ph.D. degree 
in physics from Yale in 1933 and 
joined the John B. Pierce Laboratory. 
His career at the Pierce Laboratory and 
Yale University was interrupted in 
1941, when he began 22 years of 
military service in the Air Force 
(USAF) at the Aero Medical Labora¬ 
tory at Wright-Patterson Air Force Base 
in Ohio (1941-1950). He then became 
chief of the Human Factors Division 
Directorate, Research and Development 
Headquarters, USAF (1950-1955), 
served as commander of the USAF 
Office of Scientific Research (1955- 
1960) and was a program manager in 
cloud physics weather modification in 
the Advanced Research Projects 
Agency of the Office of Secretary of 
Defense (1960-1963). He last served at 
the rank of colonel. 
In 1963, Dr. Gagge returned to Yale 
as an associate professor of epidemiol¬ 
ogy (environmental health) and fellow 
at the Pierce Laboratory. He became 
professor of epidemiology in 1969. and 
also served as deputy director of the 
Pierce Laboratory from 1970 to 1978. 
Though he retired in 1978, he remained 
active as a consultant at the Pierce 
Laboratory. 
Dr. Gagge made significant 
contributions to the understanding of 
human thermoregulation and comfort. 
He introduced many of the concepts, 
terms and units for the characterization 
of human responses to the environment 
including “operative temperature,” 
which combines air and radiant 
temperatures into a single equivalent 
temperature index, the “clo unit” for 
quantifying clothing insulation, the 
“met unit” for quantifying metabolic 
activity, and “effective temperature” for 
quantifying the effect of temperature 
and humidity on human thermoregula¬ 
tion and comfort. 
Dr. Gagge’s wife, Edwina Mead 
Gagge, died on May 21. Their survi¬ 
vors include two daughters, Eleanor 
and Ann; two sons, Peter and John; and 
nine grandchildren. 
A. L. Chandler 
A. L. Chandler, M.D., HS ’42, who 
served his residency in psychiatry at 
Grace-New Haven Hospital and the 
Yale School of Medicine, died April 
23. He was 79. 
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Lottie Maury Newman 
Lottie Maury Newman of Woodbridge, 
Conn., died on Feb. 25 at the age of 73. 
Mrs. Newman, born in Vienna, 
Austria, trained as a speech therapist at 
the University of Vienna and was a 
lecturer at the Yale Child Study Center. 
Having worked closely with Anna 
Freud, she became her literary executor 
and was founding member of the 
Sigmund Freud Archives. She was a 
longtime member of the editorial board 
and associate editor of the journal, The 
Psychoanalytic Study of the Child. 
In 1984 she received the Distin¬ 
guished Contributor Award of the 
American Psychoanalytic Association. 
Mrs. Newman was predeceased by 
her husband, Richard Newman, a 
distinguished psychoanalyst. She is 
survived by her stepdaughter. Ellen, 
and her stepson, Nicholas. 
Lawrence S. Crispell 
Lawrence S. Crispell, M.D., died 
March 2 at the Sarasota Memorial 
Hospital in Florida. He was 74. 
Dr. Crispell received a bachelor’s 
degree from Yale College in 1941, was 
a 1944 School of Medicine graduate 
and served on the Grace-New Haven 
Hospital staff from 1945 to 1949. He 
was a captain in the U.S. Army Medical 
Corps, and from 1949 to 1953 worked 
at the Mary Hitchcock Clinic in 
Hanover, N.H. In 1986, he retired from 
private practice in Joplin, Mo. 
Dr. Crispell was a member of the 
American Society of Otorhinolaryn¬ 
gology, the Jasper County Medical 
Society, the (New York) Holland Society, 
the U.S. Professional Tennis Association 
and the Field Club in Sarasota. 
Survivors include his wife, Jane; 
three daughters, Judith, Amelia and 
Pamela; six grandchildren, and six 
great-grandchildren. 
William W. Field 
William W. Field, M.D., of New 
Haven, died March 7 at Connecticut 
Hospice in Branford. 
Dr. Field, a 1940 graduate of Yale 
College, received his medical degree 
from the Columbia University College 
of Physicians and Surgeons. He served 
as a captain in the Medical Corps 
during World War II, then practiced 
internal medicine in New York City 
from 1949 to 1971 and taught at 
Roosevelt and Bellevue hospitals. 
In 1971, Dr. Field joined the 
department of internal medicine at Yale 
and served as assistant clinical profes¬ 
sor until 1981. From 1981 to 1986 he 
was associate clinical professor, and in 
1986 was named lecturer in medicine. 
Dr. Field was a charter member of the 
staff of the Yale University Health 
Services Center and served there for 15 
years as a full-time physician. He wrote 
four books on the history of medicine. 
Survivors include his wife, Frances 
Kilpatrick Field; two sons, William and 
Kenneth; three daughters, Jessica, 
Catherine and Frances; and six grand¬ 
children. 
Memorial contributions may be 
made to the Yale Class of 1940, P.O. 
Box 1980, New Haven, CT 06520 or 
Connecticut Hospice, 61 Burban Drive, 
Branford, CT 06405. 
John McLean Morris 
John McLean Morris, M.D., born in 
Kuling, China, died at his home in 
Woodbridge, Conn., on April 8 at the 
age of 78. 
A member of the Yale faculty since 
1952, Dr. Morris was the John Slade 
Ely Professor Emeritus and chief of 
gynecology at the School of Medicine 
and Yale-New Haven Hospital, and 
twice was the school’s acting chairman 
of obstetrics and gynecology. While at 
Yale he was instrumental in establish¬ 
ing the Hunter Radiation Center. 
Dr. Morris, a leading gynecologic 
researcher who invented the “morning 
after” birth-control pill, established his 
scientific reputation in his late 1930s by 
identifying a rare sexual disorder, 
testicular feminization. The condition, 
known as Morris’ syndrome, causes 
people born with normal male chromo¬ 
somes to develop as females because of 
an insensitivity to testosterone. He also 
designed new versions of the intrauter¬ 
ine contraceptive device, new tech¬ 
niques in pelvic surgery, and was an 
early advocate in the United States of 
radiation therapy for cancer. 
He served as president of the 
Society of Pelvic Surgeons, vice 
president of the American Gynecologi¬ 
cal and Obstetrical Society, a medical 
adviser to Planned Parenthood and the 
World Health Organization, president 
of the New Haven chapter of the 
American Cancer Society and chairman 
of the Yale-China Medical Committee. 
He is survived by his wife, Marjorie 
Austin Morris; four daughters, 
Marjorie, Christina, Constance and 
Virginia; a son, Robert; and nine 
grandchildren. 
Phyllis Hurwitz Duvdevani 
Phyllis Hurwitz Duvdevani, M.D., a 
resident of Leonia, N.J.. died May 4. 
Dr. Hurwitz, a 1965 graduate of the 
School of Medicine, served on the 
house staff from 1961 to 1965. She 
interned at Bronx Lebanon Hospital, 
served a residency at the Manhattan 
Veterans Administration Hospital, and 
had a one-year hematology fellowship 
at Mount Sinai Hospital in Manhattan. 
She had a private practice of 
internal medicine in Hoboken, N.J.. and 
was an attending physician in medicine 
at St. Mary's Hospital in Hoboken. Dr. 
Hurwitz served on the quality assurance 
committee for St. Mary’s and at St. 
Francis Hospital in Jersey City. 
She is survived by her husband, Ilan 
Duvdevani; and two daughters, Yael 
and Tamar. 
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Alumni Report 
"Medicine in the 21st Century” was the 
topic of talks presented by Dean Gerard 
N. Burrow. M.D. ’58, in early May to 
Yale alumni/ae in Boston. Washington. 
D.C., San Francisco and Los Angeles. 
Medical school and University alumni/ae 
turned out in large numbers for the dean, 
and I had the pleasure of accompanying 
him and interacting with the alumni/ae at 
the receptions. 
YSM is alive and well, and being 
supported by her alumni/ae and friends. 
While we expect much from our dean — 
especially as a returning alumnus — he 
also needs our uncompromising support 
if he is to succeed. Building the Center 
for the Study of Human Diseases is high 
on his priority list. The School of Medi¬ 
cine must provide the laboratory space 
needed to continue meaningful research 
and to retain old faculty and attract new 
faculty. There also is a need to raise 
unrestricted funds to be used at the dean's 
discretion: funds to support promising 
new faculty must be available to Dr. Bur¬ 
row on an ad hoc basis. 
Finally, research grants are not as 
easily obtained as in the past, and our 
support of the dean's programs are essen¬ 
tial if Yale is to maintain its role of 
providing the leaders in medicine and 
public health in the 21 st century. We as 
alumni/ae continue to benefit from Yale's 
past and present excellence, and we must 
help our alma mater to strengthen her 
position in the future. 
Phonathons held on March 23 and 24 
again highlighted alumni/ae/student/staff 
interaction. Twenty-six students from all 
classes volunteered to join alumni/ae and 
alumni fund staff to solicit pledges for the 
annual campaign. The wonderful inter¬ 
change between students and alumni/ae 
helps to join the generations. Significant 
pledges exceeding $20,000 and an antici¬ 
pated $20,000 of promised contributions 
of non-specific amounts resulted from 
the two-day event. Alumni/ae and fac¬ 
ulty members continue to be concerned 
about our financially handed students, 
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who are the principal beneficiaries of 
fund contributions. 
In alumni/ae weekend news, four 
classes—1943,1953.1958 and 1968 — 
presented individual class reunion pro¬ 
grams on June 4. The presentations were 
informative and provocative. Reunion 
chairs included Drs. Dorothea Peck and 
Lycurgus Davey from the Class of 1943; 
Harold Bornstein. M.D. ’53. Drs. Paul 
Rudnick and Michael Kashgarian. Class 
of 1958: and Donald Lyman. M.D. '68. 
Alumni/ae were greeted by Muriel Wolf. 
M.D. "59: Dean Burrow also welcomed 
those assembled. Dr. Joseph Warshaw. 
professor, chief and chairman of pediat¬ 
rics, presented "The Children's Hospital 
at Yale New Haven.” 
Nicholas Passarelli. M.D. "59. chaired 
this year’s Association of Yale Alumni in 
Medicine (AYAM) nominating commit¬ 
tee and presented the slate at the 
association's annual meeting on June 5. 
Marie-Louise Johnson. M.D. ‘56. was 
elected president: Lycurgus Davey. M.D. 
’43. was elected vice president: Gilbert 
Hogan. M.D. ’57, w ill continue as secre¬ 
tary. The 1993 slate elected to replace 
retiring members of the executive com¬ 
mittee are: Jean Bolognia, M.D. "80. Lee 
Goldman. M.D. ’73. M.P.H. ’73; Ellen 
Milstone. M.D. ’69, Arne Youngberg. 
M.D. "66. Charles Scholhamer Jr., M.D. 
’72, will serve out Dr. Davey's unexpired 
term on the executive committee. 
Elected as representatives to the As¬ 
sociation of Yale Alumni are Robert 
Fisher. M.D. '59. and Donald Schultz. 
M.D. '52. Dr. Wolf received a certificate 
of appreciation as president of the asso¬ 
ciation from Dean Burrow. We con¬ 
gratulate her for her conscientious lead¬ 
ership and for her wise credo, “Happy 
students make happy alumni/ae." I also 
would like to thank retiring members of 
the executive committee and AY A repre¬ 
sentatives for a job well done. 
Distinguished Alumni Service 
Awards were presented to Michael 
Kashgarian, M.D. ’58, and R. Leonard 
Kemler. M.D. ’43. at the AYAM annual 
meeting. 
The annual "Friends of the 50th" din¬ 
ner w'as held at the Graduate Club on June 
5. Guests of honor were the classes of 
1943 March and 1943 December: and the 
Class of 1988. returning for its first five- 
year reunion. Guests included alumni/ae 
who were senior even to the 50-year 
celebrants. 
I want to take this opportunity to 
thank all of you who helped make Re¬ 
union ’93 such a success. Plans already 
are beginning to take shape for Reunion 
'94. Classes ending in "4” or "9” will 
celebrate their graduation anniversary — 
a committee comprising reunion class 
officers and designated co-chairs will con¬ 
vene sometime in late summer or early 
fall to discuss their plans. Also, the YSM 
program committee is in motion. 
In closing, the AYAM leadership 
w'ould like to know if you are interested in 
serving on the association’s executive 
committee. We meet three times a year, 
in October. April and June, in New Ha¬ 
ven. Members usually live within driv¬ 
ing distance, but we solicit the interest of 
anyone who can attend meetings. AY AM 
also invites suggestions about programs, 
projects, and the means and methods of 
maintaining our momentum in improv¬ 
ing your alumni/ae association. 
Remember, the Office of Alumni 
Affairs encourages your participation and 
welcomes your continued support. Keep 
in touch. I hope to see as many of you as 
possible in June 1994. 
Arthur C. Crovatto, M.D. '54 
Director of alumni affairs 
Development Report 
The Culpeper Foundation, 
Dr. Ogilvie Create a New 
YSM Exhibition Gallery 
The Charles E. Culpeper Foundation of 
Stamford, Conn., and John B. Ogilvie, 
M.D. ’34, have made it possible for the 
School of Medicine to renovate the exhi¬ 
bition area outside the entrance to the 
Harvey Cushing/John Hay Whitney Medi¬ 
cal Library in the Sterling Hall of Medi¬ 
cine. The Streeter Collection of Weights 
and Measures, which formerly occupied 
the space, has been moved to the entrance 
of the medical library’s Morse Periodical 
Room. 
The suggestion that the school im¬ 
prove its exhibition space came from 
William W.L. Glenn, M.D., the Charles 
W. Ohse Professor Emeritus of Surgery 
(cardiothoracic). Dr. Glenn has prepared 
the gallery’s first exhibit — currently on 
display — on the history of cardiothoracic 
surgery. 
Former Acting Dean Robert M. 
Donaldson, M.D., described this as an 
“exhibit on cardiovascular surgery [that ] 
neatly combines the history of the evolv¬ 
ing surgical procedures that have saved 
thousands of lives over the years with the 
people whose desire to push the limits of 
biomedical knowledge created break¬ 
throughs and [the] procedures on dis¬ 
play.” The exhibit is designed for those 
who are interested in this surgical spe¬ 
cialty or who have a general interest in the 
history of medicine. 
Once Dr. Glenn articulated his dream 
for creating this new exhibition gallery, 
the Culpeper foundation responded with 
the initial gift, in recognition of the long 
and devoted service Dr. Glenn gave to the 
foundation as one of its chief advisors. 
Dr. Ogilvie, in keeping with his interest 
in the medical library, his own back¬ 
ground as a surgeon and his devotion to 
his alma mater, donated the balance 
needed to fund construction. The refur¬ 
bished gallery was designed by Allan 
Dehar Associates of New Haven, the firm 
that renovated the Cushing/Whitney 
Medical Library; architect Alexander 
Purves acted as the chief designer on both 
projects. 
The entrance area has been repainted 
a soft gray/blue. New, subdued indirect 
lighting has been installed, and the exhib¬ 
its are housed in handsome, modem cherry 
wood cases. The school invites its guests, 
alumni/ae and members of the Yale com¬ 
munity to view the new exhibition gallery 
that the Culpeper foundation and Dr. 
Ogilvie have so generously provided. 
A view of the refurbished exhibition area as one leaves the Whitney/Cushing Medical Library. 
















































































































































The Role of Biological Response Modifiers in Molecular and Clinical ( a> 
Transfusion Medicine 
Director: Edward L. Snyder, M.D. 
Stouffer Concourse Hotel, Arlington, Va. 
Topics in the Management of Glaucoma (B) 
Director: DavidE. Silverstone, M.D. 
Yale Eye Center 
The Second Anaesthesia & Critical Care Symposium (C) 
Director: Sorin Bmll, M.D. 
Great Southern Hotel, Killarney. Ireland 
Advances in Corneal & Refractive Surgery (D) 
Director: David E. Silverstone, M.D. 
Yale Eye Center 
Semi-Annual Comprehensive Review of Psychiatry and Neurology (E) 
Director: Harvey L. Ruben, M.D., M.P.H. 
Stamford Sheraton Hotel, Stamford, Conn. 
Fifth Annual Cardiology Update (F) 
Director: Lawrence S. Cohen, M.D. 
Yale University School of Medicine 
Harkness Auditorium 
11th Annual Ella Grasso Conference (G) 
Director: Peter E. Schwartz, M.D. 
Park Plaza Hotel, New Haven, Conn. 
The New England Hand Society 
21st Annual Meeting & Scientific Program 
Director: Zeno Chicarilli, M.D. 
Sheraton Sturbridge. Sturbridge. Mass. 
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Health-Care Reform: One Dean’s Perspective 
As the national debate on the future shape of health care becomes 
increasingly prominent in the public consciousness, eminent health-care 
professionals are asked to speak out. Gerard N. Burrow, M.D. '58, a 
member of several national medical organizations addressing health¬ 
care reform, considers this significant issue. 
Reflections on Health-Care Reform 
Yale medical and public health alumni and faculty provide insights about health-care reform and the proposed 
legislation that will change the face of health care in America. Sharing their views are Angela R. Holder, LL.M., 
William L. Kissick, M.D. '57, Dr.P.H. '61, Pilar N. Ossorio, Ph.D., M. Henderson Owens, M.D. ’78. M.P.H. 
'78, Raymond W. Turner, M.D. '58, M.P.H. and Joseph B. Warshaw, M.D. 
Computers: Updating the World of Medicine 
The culture of the information superhighway, modems and 
CD-ROMs is upon us. With more than 4,000 computers in 
use at the medical center, access to information, for 
clinical, research and administrative purposes, has entered 
the high-tech age. 
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To the editor: 
As a 1989 medical school graduate, I spe¬ 
cialized in family medicine. I am the only 
graduate of my class to pursue this spe¬ 
cialty, and currently am a physician at a 
community and migrant health center in 
rural Florida. 
My work as a family doctor in this 
primary care setting has turned out to be 
the most exciting, challenging and reward¬ 
ing experience of my professional life. 
I chose to attend Yale despite its lack of 
a family medicine department and training. 
However, I believe that a medical school 
that lacks training in family medicine is 
missing one of the most central aspects of 
the healing art: the viewpoint which sees 
people as part of families, communities 
and society. It is along this axis of continu¬ 
ity that the family physician specializes. 
In my practice, I care for whole fami¬ 
lies. My patients are of all ages and present 
with the full spectrum of physical, psycho¬ 
logical and social problems. Because of 
my training as a family physician, I am able 
to help them. 
As Drs. Christopher and Carolyn Wolf- 
Gould eloquently discussed in their letter 
published in the Summer 1993 issue of 
Yale Medicine, family medicine, with its 
primary care emphasis, is part of the solu¬ 
tion to the current crisis in health care. I 
find myself somewhat embarrassed that 
my alma mater, Yale University School of 
Medicine, is not more actively choosing to 
be part of this solution. 
Howard W. Momingstar, M.D. '89 
Dade City, Fla. 
Editor’s reply: 
Dr. Momingstar should feel embarrassed 
no longer. Yale University School of Medi¬ 
cine is paying attention to the country's 
need for primary care physicians. The 
dean addresses this issue in his interview 
on health-care reform. In addition, the 
spring issue of YALE MEDICINE will fea¬ 
ture how we are introducing primary’ care 
into the medical students ’ curriculum and 
to residency training. An important part of 
our clinical curriculum reform has been 
aimed at introducing students to medicine 
that primary care physicians practice in 
their offices. Yale, indeed, is choosing to be 
part of the solution. 
Correction 
In the Summer 1993 edition of Yale Medi¬ 
cine on page 33, it should have read that Dr. 
Ephraim McDowell died in 1830, almost 
16 years before the invention of anesthesia, 
not 40 years earlier as it was incorrectly 
reported. 
The owl and the torch, symbols of wisdom and knowledge, adorn the 
entrance to Sterling Hall of Medicine and are familiar to cdl alumni/ae. 
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Health-care Reform: 
One Dean’s Perspective 
by Helaine Patterson 
Editor's note: Medical School Dean Gerard N. Burrow, M.D. 
'58, has been involved with a task force on health-care reform 
with the Association of American Medical Colleges (AAMC) and 
a similar taskforce with the Association of Academic Health 
Centers. He also sits on a joint taskforce of the Association of 
American Universities, the AAMC and the Association of 
Academic Health Centers. He is the incoming chair of the 
American Medical Association's (AMA) medical school section, 
and serves on the AMA's taskforce on the physician workforce, 
which has a great deal to do with shaping the debate on health¬ 
care reform. In a Yale MEDICINE interview, Dr. Burrow shares 
some of his thoughts on this significant national issue. 
Health-care reform lias dominated the national scene. 
How did you and your colleagues participate in the 
debate? 
None of the groups that were formed by Ira Magaziner initially 
were looking at either education or research. Because of that 
concern, virtually every organization associated with academic 
medicine, as well as the American Medical Association, became 
very interested in what they thought was going to happen and what 
their position should be. 
Have the organizations in which you participate 
spoken with common themes or goals? Do they have 
a consensus? 
Yes, more or less. One major concern focuses on graduate medical 
education. Clear interest centers on the issue that all residency 
programs would produce 50 percent primary care physicians. 
Some schools are producing a lot of primary care residents, others 
are producing less. To just make it a straight 50 percent fails to 
account for various programs that have been built up. A number of 
organizations have considered putting together a consortium so 
graduate medical education and the need to produce primary care 
physicians would be spread among several hospitals. That was 
really a common theme. 
In general, all of the organizations agreed that problems of 
Helaine Patterson is director of the office of public 
information for Yale University School of Medicine. 
access exist with the American health-care system. For example, 
37 million Americans have no health insurance, and half of the 
children in inner cities have not been immunized. These issues and 
others need to be addressed in a systems approach. 
There’s concern also that the heavy emphasis on cost contain¬ 
ment in managed competition would put academic health centers at 
an enormous disadvantage. Academic health centers are a bit like 
Noah's ark — they need two of everything whether they are cost- 
effective or not. If the special nature of university health centers 
were not taken into account, these centers would be put at a terrible 
disadvantage in a system where essentially people were bidding and 
the person who would give the lowest cost would get the patients. 
As I and the various groups look at this situation from the point 
of view of medical schools, we need patients in order to teach. 
However, taking care of massive numbers of patients is not some¬ 
thing that universities are particularly well suited to do, so our 
concern is that we insure that we have a variety of patients in order 
to teach. We simply cannot be cut out of the system because we 
cannot match the cost of the other parts of the hospital system. 
These themes have resonated through all of the organizations. 
Everybody was pleased that the reform proposal ultimately 
included a section on education and research. If that remains intact, 
then academic medical centers will be able to continue to teach 
students and take pride in the way that they have prepared them in 
the past. 
One of the real difficulties for all medical schools, but particu¬ 
larly for schools like Yale, is that a great deal of the teaching effort 
is based on cross-subsidization from revenues generated by our 
clinicians. If a massive change occurs in the way physicians are 
compensated, then we could reach a point where we simply won't 
have enough people to teach because no extra revenues would be 
available to pay for the teachers. So, there clearly are major 
concerns. We must watch very carefully what happens in Congress. 
Almost irrespective of what exactly happens, we are going to 
change dramatically. 
Who do you mean by we? 
We, specifically Yale, and we, specifically the academic health 
centers. A great number of schools see the need to set up health-care 
networks to ensure a supply of patients for themselves or access to 
patients and are talking about ways to do this. At Yale, we see the 
use of mid-level practitioners as one of the ways to provide primary 
care. We are blessed in having a School of Nursing and having a 
program within the medical school for physician associates, as well 
as a public health program that is part of the medical school. We are 
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interested in developing primary-care health teams comprising 
nurse practitioners, physician associates, public health workers and 
medical students. 
What effect, if any, will the administration’s emphasis 
on primary care have on the curriculum at Yale where 
family practice is not emphasized? 
Yale University School of Medicine is interested in educating 
leaders, but whether they are leaders in specialty training or leaders 
in primary care has really not been determined by the faculty. It is 
true that Yale, like many other schools, has been educating more 
and more individuals who have pursued specialty training for 
various reasons. Medical schools can’t force people to become 
primary care physicians. Our students need the independence of 
choice, but we can show them that primary care medicine can offer 
an attractive life and way to practice medicine. 
With the Robert Wood Johnson Foundation initiative, we have 
set up a program whereby students are practicing in physicians’ 
offices. The students are beginning to understand what it really 
means to be primary care physicians — something that is very hard 
to show on a medical ward. We are attempting to make available 
as many examples of good primary care as possible and to have role 
models with whom students can identify. 
Furthermore, if primary-care health teams are going to work, 
then nurse practitioners and physician associates can do many 
things as well as the physicians can do them. On those teams, the 
physicians needed are not simply general family physicians but, 
in a sense, specialists in general medicine — individuals who can 
handle the problems that the other groups are untrained to handle. 
Would this approach redirect the specialties that 
the students select? 
Well, we hope so. Although the government can't force people to 
become primary care physicians, it can prevent them from becoming 
specialists. Currently, the Clinton plan for reform recommends or 
demands within the next five years that primary care physician residen¬ 
cies be increased by seven percent per year and that specialty residen¬ 
cies decrease by ten percent per year. At the end of that period, there 
will be fewer total residencies and fewer specialty residencies. 
Do you see any correlation between the training 
that the medical students here receive and an 
overall plan to do more networking? 
I think so. As we form these networks and talk about managed 
competition, we are going to have more and more health-mainte- 
At a Sept. 2 reception marking the School of Medicine’s second annual White Jacket Ceremony, Dean Gerard N. Burrow, M.D. 58, 
talks with first-year medical student Sarah Nikiforow. She and her classmates, Amy Taylor, Dana Meinke and Barbara McGee, (left 
to right) are entering the medical profession during intensive debates on the complex issue of national health-care reform. 








nance organizations (HMOs). In HMOs, there is less need for 
specialists and more need for primary care physicians. In places 
where mid-level practitioners are used, this health-team concept 
w ill fit in very well with plans for managed competition or HMOs. 
Specifically at Yale, we see the use of 
mid-level practitioners as one of the ways to 
provide primary care. ...We are interested 
in developing primary-care health teams 
comprising nurse practitioners, physician 
associates, public health workers and 
medical students. 
President Clinton has said that the risks of staying 
with the present course of action are greater than the 
uncertain risks of any change. Would you comment on 
that statement? 
Change is frightening and does not occur easily within a university 
setting. Nevertheless, there is enormous unhappiness with the 
present system of health care in the United States even though we 
spend 14 percent of the gross national product. Nothing is inher¬ 
ently wrong with spending 14 percent of the GNP for health if 
people are happy, but we have a situation where the doctors are 
unhappy, the patients are unhappy, and the businesses are unhappy. 
Something has to change. Whether change occurs in this global 
manner or whether Congress does this incrementally is uncertain. 
I predict that managed competition is really coming but that we 
will be in a transition period. Ultimately, I believe we will go from 
a patchwork quilt to a system of universal care, although one not 
necessarily modeled on the Canadian system. 
Would you comment briefly about the Canadian system 
with which you are familiar? 
The Canadian system is a single-payer system administered 
through each province. Under a Clinton plan proposal, each state 
would administer the health plan. 
One of the Canadian system’s great strengths is macro-man¬ 
agement rather than micro-management. There’s a certain amount 
of money available to pay physicians, and they decide how to divide 
it up among themselves. This approach makes for a very interesting 
discussion; but there’s not the spread of salaries among specialties. 
It also is much fairer than to say that physicians can charge anything 
they want. In the U.S., insurance workers call daily wondering why 
physicians have admitted that patient to the hospital or why they are 
charging for this procedure. 
In Canada, hospitals receive a global budget and have to live 
within that global budget or cap. On the other hand, the process 
does bring physicians and hospital executives together in a very 
close relationship. The way to control funds then is to decrease or 
close beds. If beds are closed, then doctors cannot admit patients, 
so it really behooves them to work together rather than to compete 
as is happening in the United States. 
Major problems with the Canadian system now exist with 
funding. But overall its basis is the single payer, with federal 
contributions making the system applicable and level across the 
provinces. Through macro-managing the money available, one 
decides in broad strokes, rather than individually, as to what care is 
to be given. 
Would a health security card for all Americans be 
effective in the United States? 
1' m not sure that the card is the way to go, but access to care is. One 
of the issues that the United States — probably the physicians 
rather than the politicians — will have to decide is what it means to 
have that card and what a person with the card is entitled to have. 
At the moment though, 30 million Americans are without insur¬ 
ance, but they do receive care. When they get too sick to leave an 
emergency room, they are admitted to the hospital. That kind of 
system or non-system may be more expensive than giving every¬ 
body certain benefits. If you are so sick that you can’t leave an 
emergency room, then we will pay for your care by shifting your cost. 
The questions come at the other end: Should everybody have 
braces on their teeth or is that not a health benefit? What about 
receiving a liver transplant, etc., etc.? So there needs to be a 
discussion about the exact benefits which somebody receives with 
this card. 
Would benefits received with the proposed card change 
with a person’s age? 
My sense is that people will all have the same benefits. We are 
constantly bringing in new technology, and it is very helpful. 
However, decisions have to be made on how much technology is to 
be used and in what cases. 
The President frequently has mentioned violence as the 
country’s number one problem. Yale medical school has 
done a lot to address the pressures and stresses which 
violence puts on the health-care system. 
We have several programs, including the program in the Child 
Study Center for children who witness urban violence. One of the 
difficulties in deciding what the issues in health-care reform exactly 
are revolves around issues of violence. The social ills of this 
country cannot be solved by taking a medical approach. It is 
certainly clear, though, that violence as a social ill results in major 
medical problems. Many individuals end up in hospitals, and 
enormous amounts of money are spent. To the degree that we can 
approach these as academic medical problems, as has been done so 
well in the Child Study Center, then I think we can be helpful. 
However, we basically are not a social agency, we are a university. 
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President Clinton talks about eliminating the bureau¬ 
cracy and paper work, but hasn’t the federal government 
created a lot of this paper work? 
Yes. As you know, the vice president has a plan to eliminate paper 
work, and that would be absolutely wonderful. But again, on 
whether the administration can, in fact, implement this reform, I 
have concerns about capping health-care costs to a certain amount 
of money. If there were a major epidemic or an outbreak of a new 
complicated disease, then it would take more money. Those 
potential scenarios illustrate a difficulty in the reform proposal, so, 
it is probably impossible to contain costs unless capacity is limited 
in some way. 
Somebody once said that you could have your health care good, 
cheap or fast. You can have any two of the three, but not all three. 
Connecticut Gov. Lowell P. Weicker Jr. and Dr. Burrow share 
a light moment before the governor addressed representatives 
and guests at the third annual meeting of CURE. Connecticut 
United for Research Excellence, Inc., on Oct. 7 at Miles Inc. in 
West Haven. The governor called for more discussion on 
patient care and biomedical research rather than on costs and 
finances in the health-care reform debate. 
What proposals for health-care reform are the most 
needed and the most realistic? 
Access to care is certainly important to the patients, and this access 
needs to be portable so people can change jobs without losing their 
health benefits. Also, the fact that small business can't afford to 
give health benefits because the rates are so high needs to be changed. 
Other changes can be made without causing major upheavals in 
the system and can be done immediately to help health care. The 
changes would include tort reform in terms of medical malpractice 
and liability, and standardization of insurance forms to reduce 
administrative costs, which have been estimated to be as much as 
25 percent of what now is a trillion dollar business. 
What aspect of the reform will be the most difficult to 
accomplish? 
Since we are going to have health purchase alliances, health plans, 
regional committees and caps, reform itself will be extremely 
complex. There’s a danger that a massive bureaucracy will be put 
into place and then become mired. If the government attempts to 
micro-manage this giant system, then it will be difficult. 
What questions are you most frequently asked about 
health-care reform? 
The most common question is ‘What’s it all about?’ It is complex 
almost to the point of being un-understandable. There are many 
concerns: Concerns by patients that they will lose their ability to 
choose their own physicians, which is a risk in HMOs. Concerns 
by physicians that they are going to be regulated and unable to be 
free to practice as they have in the past. And. concerns by medical 
students that they are not going to be able to choose the area of 
medicine in which they want to practice. 
As dean of the Yale University School of Medicine, how 
do you feel about health-care reform? 
Everybody talks about health-care reform in terms of concerns. It 
also is a time of enormous opportunity. It is a chance to put together 
a whole new system of care. 
At the medical school, we need to be sure that the system 
guarantees enough patients so that we can teach and that the 
hospitals are financially successful enough so that we can build 
important new academic clinical programs. We at Yale believe that 
we have all of the pieces needed to be successful, provided we can 
put them together in the right order. YM 
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Reflections on 
Health-care Reform 
Editor's note: With healtli-care reform dominating national 
discussions for many months, Yale MEDICINE aslced several 
alumni, faculty and task force participants to share some of their 
ideas on this important topic. We are pleased to present their 
thoughts and experiences in this issue. 
The Health-care task force: 
A Committee Member s perspective 
by Angela R. Holder, LL.M. 
Clinical professor of pediatrics {law') 
Yale University School of Medicine 
As a member of the Health Care Task Force’s Lawyers’ Review 
Group, I and about a dozen lawyers, from law and medical school 
faculties, along with hospital counsel, and counsel for state or city 
health departments reviewed the plan as it had been put together by 
early summer of 1993. 
We were asked to answer specific legal questions, such as what 
anti-trust implications the proposals might have, how best to reform 
the legal system as it deals with medical malpractice claims, and 
how to build in adequate protection for patient choices about therapies. 
Although I do have some concerns about the program that the 
President has proposed, it is certainly preferable to the current non¬ 
system, in which people can lose insurance (if they have it in the first 
place) because they get sick. I would prefer, as Dr. Arnold Reiman 
suggested some months ago in an article in the New England 
Journal of Medicine, that fixed budgets, based on capitated 
prepayments, be created for autonomous, not-for-profit groups 
that physicians and patients would agree to operate. 
I hope that health-insurance companies, now the source of 
much of the problem, are truly unable to exercise the same controls 
and unable to continue to make the same exorbitant profits as they 
do today when they become involved in providing the new types of 
coverage. As Empire Blue Cross has recently demonstrated, many 
plans are seriously mismanaged, and some executives are paid far 
more for administering health-insurance plans than physicians would 
dream of making for caring for the patients those insurers cover. 
I was, of course, particularly interested in how the new plans 
would affect Yale and similar research institutions. I also went to 
some effort to investigate three specific problems in the current 
system. In the first place, health-insurance companies increasingly 
are refusing to pay for any services if a patient is part of a clinical 
trial, on grounds that the treatment is “experimental.” 
For example, if a cancer patient is involved with a trial of an 
investigational drug, many companies will not only refuse payment 
for the drug, they will refuse to pay the hospital bill, as well, even 
if the patient would also be in the hospital to receive what the insurer 
admits is “standard” therapy. 
Under the Clinton plan, if the clinical trial is approved by the 
NIH, the FDA. the VA, Department of Defense, or a "qualified 
non-governmental research entity as identified in NIH guidelines,” 
coverage is automatically available. 
Also, because research institutions such as this one see many 
very sick patients who have been cared for, often for protracted 
periods, before they are referred here, many of our currently insured 
Angela R. Holder, LL.M. 
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patients exhaust their life-time coverage long before their therapy 
is completed. There are no life-time limits on coverage under the 
Clinton plan. 
Thirdly, I am especially interested in the rights of adolescents 
to confidential treatment in our health-care system. I was delighted 
to see provision made for school-based and other clinics for teen¬ 
agers to receive care outside the same organization (and in many 
cases from the same physician) providing care for their parents. 
All of the people who served part-time as members of the 
original Task Force Committees and all of the people who served 
on the review committees of lawyers, physicians, economists and 
administrators did so without payment. Almost all of us were not 
even reimbursed by the White House for our expenses. 
The most important part of the experience for me. well beyond 
sitting in a room with 11 other lawyers talking about the anti-trust 
implications of hospitals getting together to buy MRIs, was seeing 
the hundreds (literally) of professionals in this country who are so 
concerned and so committed to fixing what is wrong with the 
health-care system that they were willing to put in so much time and 
so much effort, week after week and, for many, month after month, 
for no pay at all, and usually at their own expense, because they care 
about their fellow citizens. 
Angela Holder, a graduate of Yale Law School, has been a 
member of the Yale medical faculty’ since 1975. She sen’es on 
several committees at Yale, including the Human Investigation 
Committee, the Chairman's Ethics Advisory Committee in the 
department of pediatrics, the Executive Progress Committee for 
the Office of the Associate Dean for Education and Student Affairs, 
and the Admissions Committee for the Physician's Associate 
Program. She also served as counsel for medicolegal a ffairs for 
the School of Medicine and Yale-New Haven Hospital. 
Health policy: 
Ten percent Legislation, 
90 Percent implementation 
by William L. Kissick, M.D. '57, Dr.P.H. '61 
George Seckel Pepper Professor of Public Health and 
Preventive Medicine, University of Pennsylvania 
Midway through the first 100 days of the Clinton administration, 
Louis Harris testified to the House Select Committee on Aging 
concerning a nationwide health-care poll of 1,250 adults he had 
conducted shortly before the inauguration. He concluded: 
“First, they (Americans) want quality health care, 
which will cover a wide range of services. Second, they 
want everyone in the nation, without exception, covered 
for proper health care. Third, they want what they feel are 
the widely spiraling costs of health care brought under 
control. And fourth, they want those physicians and 
hospitals to be mainly controlled by the private sector.” 
The results of this poll lay out a very ambitious agenda for the 
reform of health care in our society. The Health Care Task Force 
of 500 chaired by the First Lady. Hillary Rodham Clinton, took up 
the challenge. The President presented the task force’s proposal for 
health-care reform to a joint session of Congress on Wednesday 
evening. Sept. 22, 1993. 
As the President began his remarks, no doubt a majority of those 
assembled in the House chamber, as well as tens of millions 
watching on television, agreed with the diagnosis that the American 
health-care system was badly in need of fixing. The prescription 
offered by the President and the First Lady for health-care reform 
was expressed in six principles: (1) security, (2) simplicity, (3) 
savings, (4) choice, (5) quality and (6) responsibility. Thus would 
our society seek to guarantee health care as a right. 
The 284-page President's Health Security Plan, distributed to 
key Congressional committees during the weeks preceding the 
address and available in bookstores shortly thereafter, presents a 
detailed and comprehensive theoretical strategy for restructuring 
the American health-care enterprise that is equivalent to the world’s 
seventh largest economy. This will be a Herculean task requiring 
economic, organizational, social, political, techno-scientific, if not 
all-pervasive cultural change. 
Health-care reform, like any supraordinate goal of such signifi¬ 
cance, requires a reach that exceeds our grasp. To sustain commit¬ 
ment and momentum, however, we must build on incremental 
developments with interim achievements. 
The trajectory of incrementalism in our society’s health policy 
spans more than a half-century. The rate and scope of initiatives 
have varied significantly over time. Arthur M. Schlesinger Jr., the 
noted historian and special assistant to President John F. Kennedy, 
has identified The Cycles of American History occurring every 
three decades. Social Security in 1935. Medicare in 1965. Will it 
be health-care reform in 1995? 
Social Security adopted a concept of social insurance that had 
been implemented in other societies for decades. Medicare repli¬ 
cated the three-decade-old concept of Blue Cross and Blue Shield. 
Health-care reform calls for the nationwide implementation of an 
elegant yet untested theory — managed competition. Unfortu¬ 
nately. the implementation of untested theory in health care in our 
society has enjoyed but marginal success. 
Can the behemoth of the American health-care enteiprise be 
subject to the all-encompassing embrace of a national health board, 
a global budget, health alliances and certified health plans? Can 
managed competition master the Iron Triangle of Health Care with 
the inevitable tradeoffs among access, quality and cost-contain¬ 
ment for 260 million Americans? Will the American people accept 
tradeoffs of relative access, increased waiting times or limitations 
on cutting-edge technology? The alternative is continued diversion 
of resources from other sectors of our economy to finance health¬ 
care consumption. 
What of implementation? Wilbur Cohen, the principal archi¬ 
tect of Medicare, taught me, “Health policy is ten percent legisla¬ 
tion and 90 percent implementation.” Effective implementation 
will require a blending of top-down and bottom-up initiatives. The 
proposed National Health Board will focus on the guaranteed 
benefits package, state requirements, quality management and 
health budgets. Health alliances are proposed as vehicles for 
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financing. The actual provision of services will depend on commu¬ 
nities, subscribers, providers, institutions, and health-care systems 
organized as health plans. The states are in the middle and that 
seems to be an appropriate place to concentrate opportunity. 
Florida, Hawaii, Minnesota, Oregon, Vermont and Washington 
have demonstrated initiative. Implementation requires incremen¬ 
talism that appreciates precedent, pragmatism and above all, the 
recognition of our society’s cultural pluralism. Having worked in 
southern West Virginia, eastern Kentucky, rural New Mexico and 
northern California, as well as the Bronx, Philadelphia and Detroit, 
I have a keen appreciation for diversity. 
Having followed the implementation of Medicare since 1965 
and sensing a momentum for some form of health-care reform in 
1995, I wonder what the next cycle of American history has in 
store for 2025? My medical students are quite interested, for they 
will be at my stage of their careers in the 21st century. 
As health-care reform moves down Pennsylvania Avenue from 
the White House to the Congress, The Dance of Legislation begins. 
To paraphrase Vince Lombardi, timing isn't everything, it’s the 
only thing. Sen. Harris Wofford, D-Penn., galvanized his elector¬ 
ate on the issue of access to health care in a special election in 1991. 
Congressional elections face members of the 103rd Congress in 
November 1994. What will they take home to their constituents? 
8 
Incrementalism or the unified field theory of health-care reform? 
Whether the 103rd Congress enacts or not, health-care reform will 
be with us decades into the 21st century. 
William Kissick is chairman of the governing board of the 
Leonard Davis Institute of Health Economics at the University 
of Pennsylvania. He also is professor of health-care systems at 
the Wharton School, professor of health policy and administration 
at the School of Nursing, and professor of research medicine at 
the School of Medicine. From 1962 to 1969, Dr. Kissick ser\’ed 
in the U.S. Department of Health, Education and Welfare where 
he was one of two physicians who assisted in drafting Medicare. 
His book, Medicine’s Dilemmas: Infinite Need vs. Finite 
Resources, will be published this year by Yale University Press. 
ETHICS WORKING GROUP 
Experiences Inspiring, Humbling 
by Pilar N. Ossorio, Ph.D. 
Postdoctoral associate in cell biology 
Yale University School of Medicine 
After several months of intensive work, the Clinton Health Policy 
Task Force disbanded on May 1, 1993. Associated with the task 
force were 34 working groups, and I was one of 30 members of the 
Ethics Working Group. Our primary task was to articulate the 
values and ethical principles underlying health-care reform. Since 
politicians, including Presidents Clinton and Bush, are often criti¬ 
cized for not conveying a “vision,” our job was to distill such a 
vision and present it in the form of a legislative preamble. We also | 
provided guidance on privacy protection, benefit design, health- 
plan governance, fairness in supplemental policies, and outreach to 
underserved populations. 
Members of the Ethics Working Group, which was more than 
twice as large as other groups, came from diverse backgrounds, 
including basic science, education, hospital administration, law, 
medicine, philosophy, public health and theology. Other working 
groups included economists, business executives and Congres¬ 
sional staffers. 
Individuals represented academic medical centers, community 
hospitals, and primary care clinics in low-income neighborhoods; ( 
racial diversity had obviously been considered. As a Chicana, I 
noted that those of us from Mexican-American, Cuban-American 
and Puerto Rican backgrounds were still scarce. However, the 
proportion of women was greater than I have seen in other facets of 
my professional life. 
The Ethics Working Group began deliberations in early March. 
On any given morning, we joined several hundred task force 
members at the White House’s Old Executive Office Building. 
Hosting everyone for an extended period definitely put a strain on 
the “Old Exec’s” resources. People met in anterooms, closets, the 
press room, and any other space unoccupied for more than two or 
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three minutes. Furious health-policy discussions were conducted 
in stairwells and formerly tranquil hallways. Work days were long 
and exhausting. 
Initially, each working group was charged with identifying 
important topics within their purview and laying out options, which 
then were examined in detail. Later, the number of options was 
narrowed, and matrices combining options were prepared to exam¬ 
ine possible outcomes for different sequences of choices. It often 
was impossible for "the experts" to agree on a single best option; on 
occasion, groups strongly split along ideological lines and those 
with opposing views prepared separate documents. 
During the final days, we made specific policy and legislative 
recommendations. The most contentious issues included funding 
for long-term care and mental health care, whether or how to limit 
the range of prices that plans could charge for the benefits package, 
how to measure quality, and the speed with which various aspects 
of the plan should be implemented. Not surprisingly, these same 
issues have now become the focus of Congressional debate. 
With hundreds working on their chunk of health policy, the 
process could easily have become unproductive. Ira Magaziner 
and Judy Felsteiner maintained coherence by conducting approxi¬ 
mately 10 Toll Gate meetings, the primary forums for groups to 
exchange information and discuss central issues. Our group and 
others prepared written documents, maintained at a central location 
for other task force members to read. 
Although our working papers were intended to be confidential, 
I saw news accounts which contained verbatim quotes from Toll 
Gate documents. It was strange to participate in a process so 
intensively scrutinized by the media. I was disturbed by the fact 
that, even when parts of Toll Gate documents were published, the 
picture presented was incomplete or misleading. Media accounts 
often didn't reflect our experiences. Occasionally, the task force 
was scheduled to tackle a particular issue, but the media would 
report that it had already been decided. Ira Magaziner then 
announced to the entire task force that no secret back room existed 
and that no decisions were made without us! 
One of the most interesting aspects was the opportunity to work 
closely with other groups. It was quite educational to sit in on 
discussions of the internal workings of health-care facilities with 
which I had no personal experience or to hear intense debates 
among top economists on the merits of options for funding health¬ 
care reform. 
In many discussions, a shaip dichotomy existed between the 
economists’ analytical approaches and other working group mem¬ 
bers' perspectives. Economists tend to view people as consumers 
only, whereas others of us view people, either healthy or ill. in the 
context of their ongoing relationships with the health-care system. 
Thus, the economists focused on what would make people buy a 
particular health-care plan. Others of us were equally concerned 
with making health care responsive to the needs of people who had 
already purchased a health-care plan. We were concerned with fair 
and non-discriminatory policies, grievance procedures and health- 
plan governance. 
Reforming the health-care system will affect approximately 
one-seventh of the nation’s economy. The enormity of this under¬ 
taking was graphically impressed on me by the size of the task force 
and the scope of its investigations. Many unpredictable factors can 
affect the reform's outcome, and the potential for disaster is real. 
The task force's job was not simply to envision a new health plan but 
also to imagine potential problems and devise methods of avoiding 
them. For example, one could imagine chaos during the transition 
from the old health-care system to the new. Thus, the sequence of 
events must be carefully orchestrated to avoid loss of services. 
Another potential problem, of particular concern to those of us 
from academia, is that academic medical centers, which have 
obligations and expenses beyond those of other hospitals, will find 
it difficult to compete under the new system unless provisions are 
made for additional funding. 
Toward the end of our deliberations, a special ad hoc working 
group was formed to "play war games,” imagining ways that people 
could cheat or inappropriately manipulate the new system, and to 
propose possible safeguards. 
I was particularly concerned, as were my colleagues, with the 
possibility that health care could deteriorate into a two-tiered 
system in which poor and low-income people would be "dumped" 
into an inadequate and inhumane “public" medical system, while 
middle- and upper-income people went into a private system. One 
could envision our health-care system having problems similar to 
those our public schools now face. 
Overall, my experiences on the Ethics Working Group were 
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both inspiring and humbling. My colleagues and I were participat¬ 
ing in a historic process; yet, each of us had such a small part. 
1 remember those pre-task force days, when I sat at home 
reading the New York Times and grousing that I could surely do a 
better job of making policy than "those people in Washington.” For 
a brief time. 1 was one of "those people in Washington,” helping to 
shape national policy, and during particularly contentious discus¬ 
sions, I felt as though I were living the proverb, "Be careful of what 
you wish for, because you might get it!” 
Pilar N. Ossorio, who served on the Ethics Working Group 
for the White House Health Care Reform Task Force, currently 
concentrates her research on identifying molecules involved in 
intracellular signaling pathways in cells of the human immune 
system. She received her B.S. and Ph.D. degrees from Stanford 
University. She also served as a consultant for the U.S. Depart¬ 
ment of Energy program on the Ethical, Legal and Social 
Implications of the Human Genome Project. 
THE PHYSICIAN S ROLE IN REFORM: 
Health Delivery And professional 
Advancement 
by M. Henderson Owens, M.D. 78, M.P.H. 78 
Vice President, Governmental Health Care Programs, 
CIGNA HealthCare of California 
The great health care “Gold Rush” of the 1990s has been officially 
declared with the Clinton administration’s promulgation of its 
health-care reform plan. During no other time in history have we 
chosen to subject 15 percent of our gross national product to direct 
government regulation and control. Consequently, the cast of 
players with a significant economic stake is numerous, and the 
dollars involved are not readily comprehensible by most of us. The 
expectation that the pie will be redistributed and its size limited will 
result in aggressive, if not overtly self-directed and self-centered, 
positioning of various groups. 
The plan’s cornerstone is touted to be "managed-competition/ 
managed-care" or some similar combination. It most likely will be 
a cryptic, Frankensteinian creation of unique genotype. Given the 
number of principal investigators of this emerging prototype, the 
phenotype probably will be ill-defined for a decade, regardless of 
how crafty the genetic engineering. 
The underlying “managed competition” tenet for this program 
will have substantial impact upon patient choice, provider choice 
and employer choice; and it will force a greater scrutiny of health¬ 
care decision-making and accounting for the expenditure of our 
health-care dollars than we have ever witnessed. 
The promised outcome that will motivate opting into such a 
system is increased cost-effectiveness and decreased cost inflation, 
evidenced by single-digit increases in "managed-care” premium 
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rates versus rates based on indemnity. Moving along the spectrum 
toward less choice, concerns about overutilization, iatrogeny and 
inappropriate intervention give way to fears about quality, 
underutilization and inadequate intervention. 
The most fundamental caveat of a free enterprise system is: 
"He who pays the piper calls the tune.” Let there be no mistake 
whatsoever, the principal factor driving the health-care reform 
movement is economic. 
The fact that we will provide improved access to health care and 
preventative services for 37 million Americans presents an oppor¬ 
tunity for the well-positioned physician community to partake of 
the cornucopia being prepared by the payers. And universal access 
and a guaranteed national benefit package are purported as the non- 
negotiable components of reform. 
The most basic consideration of this access to health care 
focuses on payment. Millions of Americans have no health-care 
coverage; and millions of other Americans have a benefit package 
more considerable than that which is in the President’s proposal. 
Therefore, resource redistribution either via taxes, payroll or out- 
of-pocket fees is inevitable. 
The proposed program can be effectively managed by estab¬ 
lished health-care/managed-care companies. I expect that the large 
regional and multi-site national organizations which have been 
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positioning themselves for managed competition in response to 
employer demands will become the substantial players. This leads 
to the conclusion that health-care reform will convert a fee-for- 
service system to a “managed-competition” system, whether the 
federal government’s program succeeds or not. 
One of the principal prerequisites for a government-driven 
program to succeed is for us to demonstrate a national collectivism 
indicative of a society which appreciates that the benefit to the 
whole is more important than the parochialism of our current 
system. But this approach is difficult to sell in a society predicated 
upon the concept of rugged individualism and personal autonomy 
as markers of success. 
During the past 100 years (my tender 40+ years notwithstand¬ 
ing), other than at times of war, I am unaware that this country has 
had the common sense of focus, puipose and mission that this 
health-care reform program will need to become law and achieve 
the optimal result. 
The ways we spend our health-care dollars are among the most 
personal and private considerations that individuals have. The 
reality that we may have to surrender some of these prerogatives in 
order to benefit those individuals who are not as protected or 
fortunate as ourselves is contrary to the values of a society that has 
just come through a decade of egocentricism and personal greed. 
The question is not whether we have the ability to put ourselves in 
the other person’s shoes, but whether we have the resolve to do so. 
We don’t have the juice to control the large-scale economic 
issues. But the survival and prosperity of the physician community 
resides in its ability to be an organized quality-enhancing and cost- 
efficient participant in the debate and implementation of the new 
system. The continuing development of cost-sensitive clinical 
protocols and outcome expectations, technological innovations, 
quality assurance standards and peer review represent excellent 
opportunities for us to champion the health of the populace and, 
simultaneously, to advance our professional interest and image. 
We should focus on this concept and the value that only 
physicians can bring to the health of the populace. We might, 
therefore, continue to maintain a position of privilege in our society, 
not because we have earned it, but because society will not perceive 
us as self-centered as the other interests imply. Unless we place the 
interest of the society above ours, we wil I not differentiate ourselves 
favorably, except possibly by becoming hard-boiled. 
M. Henderson Owens oversees CIGNA Healthcare's 
Medicare and Medi-Cal health insurance product lilies for the 
state and oversees the performance of CIGNA's HMO network 
of 30 health-care centers in Los Angeles and Orange counties. 
He also is developing a statewide Medi-Cal HMO product line 
and implementing a statewide Medicare risk contract. Previ¬ 
ously, Dr. Owens served as medical director of CIGNA Private 
Practice Plan, an HMO serving Central and Southern California. 
Health-care reform And 
The Resurgence Of Primary Care 
by Raymond W. Turner, M.D. '58, M.P.H. 
Vice President of Clinical A ffairs 
Health Plus, Baltimore, Md. 
Acceleration toward long overdue reform of the American health¬ 
care system shifted to high gear shortly after President Clinton’s 
inauguration. The President appointed the First Lady to chair his 
Task Force on National Health Reform; experts who were bor¬ 
rowed from academic medical centers, governmental health agen¬ 
cies and foundations presented and heard testimony almost non¬ 
stop from February through May. The draft legislation's final 
outline was presented for debate in late September. The eagerly 
awaited blueprint, as anticipated, includes phased-in guaranteed 
coverage, a required set of health benefits and an array of mecha¬ 
nisms to control costs. 
Although proponents of a single-payer plan (like Canada’s) 
have been vocal and persuasive, the President is on record for 
favoring “managed competition,” a strategy conceived by health 
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economists and policy analysts several years ago. 
This system includes a requirement for employer contribution 
to payment of premiums, an extension of the current predominant 
system. In addition, it establishes regional purchasing cooperatives 
which will pool the bargaining power of businesses and individuals 
and will set performance standards for and monitor competing 
health plans. In this arrangement, health plans, which will be quite 
similar to present-day health maintenance organizations (HMOs), 
are expected to become the dominant providers. 
Whether reform proceeds in this direction or another, a struc¬ 
ture which adds on a package of services for 37 million consumers, 
who have not had access before now, will require a re-orientation 
of our medical manpower. 
With managed competition, we can expect significant growth 
in the demand for primary care services and an increase in the 
influence of primary care doctors in day-to-day medical practice. 
This trend has already been observed in the HMO/managed-care 
industry where general internists, pediatricians and family practi¬ 
tioners are responsible, not only for basic patient care but also for 
decisions regarding the need for specialist services. In HMO 
companies, the scope of primary care physicians’ work has become 
broader than has been the rule in present-day “traditional” Ameri¬ 
can medicine, and except for the most technical services, less 
specialty and subspecialty involvement is required. Hospital care, 
both in patient and out patient, is replaced, where possible, by 
service in less costly ambulatory settings. 
Growth in the size and distribution of HMO organizations in the 
last five to 10 years has drawn attention to a relative shortage of 
generalists in the United States, in comparison with other devel¬ 
oped countries. Primary care doctors are ardently courted by 
HMOs, and demand for primary care will climb steeply as this style 
of practice expands in a managed competition environment. A 
parallel growth in opportunities and demands for specialists is not 
anticipated. 
How will our physician training programs accommodate the 
evolving marketplace? The administration’s reform package in¬ 
cludes a requirement that Graduate Medical Education policies be 
developed to influence the design and distribution of residency 
training programs and future physician supply. Currently, training 
program size and mix reflect the priorities of individual teaching 
hospitals and academic medical centers, rather than any determina¬ 
tion of the community’s requirements. 
A federal medical manpower authority will probably be estab¬ 
lished to assess nationwide trends and needs and will create 
incentives for teaching institutions to alter their training pro¬ 
grams, as necessary, to meet these needs. Powerful incentives for 
change, in the form of allocation of federal and other sources of fin¬ 
ancing for residency positions, can and very likely will be applied. 
Are the state university hospitals to continue as the principal 
training sites for generalists? As opportunities for specialists 
decline and financing of post-graduate training becomes more 
restricted, Yale and other first-tier teaching institutions must de¬ 
velop primary care training programs that are as appealing to the 
brightest students as fellowships in the more esoteric fields of 
medicine have been. In preparation for making career choices, 
students must learn more than they now do about preventive 
medicine and the socio-economic aspects of health care and should 
be able to observe it in practice. 
For these reasons, it is particularly important for the attractive¬ 
ness of primary care departments and the quality of the teaching j 
offered in out-patient settings to be at a high level. Our university 
centers need to recognize excellence in teaching and patient care 
with appropriate academic rewards for faculty in these areas. 
Support for scholarly work that is important and is of interest to 
generalists, such as outcomes research and other population-based 
investigation, must be provided. 
When primary care departments are as prominently featured 
and are as highly regarded as the other specialties within academic 
medical centers, belittling references to "the Local Medical Doc¬ 
tor” will become a rarity, and our students will begin to regard 
careers in the primary care specialties as excellent applications for 
their talents. 
Raymond W. Turner is former vice president for medical 
affairs at Greater Southeast Community Hospital in Washington, 
D C., and former medical director of internal medicine at the 
Johns Hopkins Hospital and School of Medicine in Baltimore. A 
graduate of Johns Hopkins School of Hygiene and Public 
Health, Dr. Turner also worked as medical director of a health 
maintenance organization in Baltimore. He is active in Healthy 
Babies Inc., the federally funded D.C. Healthy Start Program 
and the Mayor's Advisory Board on Maternal and Child Health. 
NEONATOLOGY AND HEALTH-CARE 
REFORM: CLINICAL CARE AND 
RESEARCH RAMIFICATIONS 
by Joseph B. Warshaw, M.D. 
Chairman of the department of pediatrics, 
Yale University School of Medicine, and 
Chief of pediatrics, Yale-New Haven Hospital 
We are in a new era of medical care in which we must validate and 
justify new clinical interventions on the basis of both cost and 
utility. Many bemoan the increasing presence of controls as 
diminishing to physicians’ autonomy and as potentially harmful to 
optimal therapies that we can bring to patients; taking a hard look 
at how we use expensive resources in this changing climate will 
result in a critical appraisal of potential benefits as well as costs, thus 
providing a greater rationale for our clinical and research initia¬ 
tives. This can benefit both clinical care and research. 
The cost of medical care demands attention and will require j 
some level of regulation if we are to incorporate uninsured patients I 
into the system and expand public health initiatives such as immu- I 
nization and school health programs — structures that should be 
taken for granted in a country such as ours. We also need the 
resources to sustain our education and research programs. 
Because of the increasing focus on medical costs and other 
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issues such as health-care rationing, it may be useful to consider the 
application of new and expensive technology within the field of 
neonatology; these applications sometimes have marginal clinical 
outcomes and can act as illustrations of many of the problems with 
which society is grappling. 
Neonatology as a discrete discipline scarcely existed 30 years 
ago. It started at Yale-New Haven Hospital in the unit that recently 
moved into new quarters at the Children’s Hospital. Neonatology 
has contributed to a technological explosion in broad areas of 
physiology and developmental biology. These developments have 
translated directly to clinical applications that increase patient 
survival, but, along the way, have spawned ethical debates and have 
raised serious societal questions about the costs and limits of our 
interventions. At the same time, we have demanded more research 
and training funds to provide the solutions that will help reduce the 
economic and social burdens that result from an increasing number 
of babies in intensive care units. While I use neonatology as the 
example, the same issues pertain to virtually all fields of medicine. 
Neonatology has become a large medical area, claiming the 
greatest number of pediatric subspecialists. In 1986, there were 
3,700 pediatric subspecialists, of whom 1,600 were neonatologists. 
By 1995, there are expected to be more than 5,500 pediatric 
specialists, of whom more than 2,200 will be neonatologists. If we 
assume that one newborn intensive care unit should serve 12,000 to 
15,000 births, then we need about 300 units in the country. With 
four neonatologists per unit, that situation would require far fewer 
neonatologists than the numbers projected. We are training too 
many people. This only adds to the tremendous cost of newborn 
care. In 1984, the average cost generated by a very low birth-weight 
baby ranged from $27,000 in level-three hospitals in Maryland to 
$60,000 in San Francisco. In 1993 dollars, the numbers are more 
than twice those amounts. Can we say that we have appropriately 
utilized our resources in newborn intensive care units? 
We must also refine our arguments that more research is 
necessary. There should be no question that medical research, as 
defined in the broadest sense, has contributed to the stunning 
decline in neonatal mortality in the United States during the last 25 
years, but we have to make the case that research will not only lower 
mortality and morbidity, but will save money as well. Not that 
fundamental investigations are not desirable in their own right or 
that we have sufficient wisdom to know what specific research will 
get us to the next level of understanding of developmental disease, 
but we must make our case more convincingly, emphasizing that 
research is cost effective — as is most of the care that we provide. 
I suggest three broad, perhaps controversial premises for the 
new era in medical care. First, we should carry out more outcomes 
research. We need to develop arguments for costly clinical inter¬ 
ventions in terms that include cost effectiveness as well as the 
conventional biological and clinical outcomes with which we feel 
more comfortable. Such analyses should become an important part 
of clinical research. 
Secondly, we should make choices in the clinical arena and be 
prepared to accept thresholds for non-intervention for certain 
problems, except at the few medical centers conducting research 
into those problems. 
And lastly, in the arena of research, we must frame our 
arguments for increased research funding in terms that recognize 
Joseph B. Wars haw, M.D. 
societal cost-benefit as well as improvements in health status of 
individual patients. Such an examination of problems in our 
intensive care units, for example, will provide compelling ammu¬ 
nition for support of research in developmental biology, develop¬ 
mental neuroscience and developmental nutrition. We should have 
sufficient data so that the ethical debate on quality of care, cost 
effectiveness and the allocation of health resources will be in¬ 
formed. The development of such data and arguments will become 
important and necessary as we see increasing rationing of clinical 
care and research in the newly emerging health-care system. 
Children will always give the biggest bang for the buck — if we can 
show the data and deliver the message. YM 
Joseph B. Warshccw, a leading proponent for the development of 
the new Children's Hospital at Yale-New Haven Hospital, is the 
program director for the Child Health Research Center at Yale. 
A Duke University Medical School graduate, Dr. Warshaw’s 
research has led to a better understanding of the adaptation 
problems that face newborns after birth and in intensive care units. 
He served a four-year term on the National Advisory Child Health 
and Human Development Council of the National Institutes of 
Health, and in 1990 was elected to the Institute of Medicine. 








The World of Medicine 
by Steve Courtney 
Soni Clubb, M.D., a Yale-New Haven Hospital internal medicine 
resident, was in a hurry. On rotation in the hospital's dermatology 
consult service, she had a patient about to arrive at the clinic — a 
7-year-old boy with demiatomyositis. 
But she wasn't in the clinic. She was in the Harvey Cushing/ 
John Hay Whitney Medical Library staring at a computer screen. 
Demiatomyositis is a progressive condition involving muscu¬ 
lar weakness and a skin rash. The boy had been treated for some 
time, and a decision had to be made whether to resume treatment 
with steroids. The attending physician had asked for the patient’s 
level of neopterin, and Dr. Clubb needed to know why, fast. She 
tapped into the library’s new CDP MEDLINE database, a huge 
collection of articles from more than 3,400 medical journals 
compiled by the National Library of Medicine in Bethesda, Md. 
Dr. Clubb typed in the words “demiatomyositis” and “neopterin,” 
causing the computer to search for any article in which both words 
appeared. Nothing showed on the screen. Next, she began scrolling 
through the 376 articles on the drug. "I'm just trying to find a 
disease that’s similar,” says Dr. Clubb as citations scrolled up her 
screen. "This is used for everything from schizophrenia to AIDS. 
It’s a million times better than anything we've had before. We are 
constantly using MEDLINE," Dr. Clubb says, looking aside from 
her search for a second. She looked back at the screen. "Well, if 
the child comes in, and I haven’t returned to the clinic it won't do 
anybody any good.” She got up, and, her white coat flapping, 
rushed out of the library. 
When John A. Paton. Ph.D., director of academic computing, 
describes the extraordinary information system that is changing the 
way Dr. Clubb and thousands of others at Yale-New Haven 
Hospital and the School of Medicine operate, he talks in terms of the 
Japanese manufacturing system called “Just In Time.” 
In a factory using this system, parts are made and moved to an 
assembly location only when they are needed, eliminating expen¬ 
sive, large-scale warehousing and waste. “We are also trying to get 
things where they are needed, when they are needed,” says Dr. 
Paton. “Instead of auto parts, we're talking about medical and 
scientific information.” 
Faculty, students and staff access much of this information 
through the 4,000 personal computers in use at the medical center. 
Many of the computers are used for research, and the findings are 
then published in national and international journals. Dr. Paton 
picks up a copy of Science, pointing out how many of the articles 
Steve Courtney, a staff writer at the Hartford Courant, also 
writes free-lance articles on scientific topics. 
printed in the weekly journal depend in some way on computer 
technology and its power to speed and strengthen scientific and 
biomedical investigation. 
Then there’s the day-to-day needs of the medical center, with 
its mix of medical and nursing schools and hospital, of education, 
research and clinical work. Dr. Paton divides these needs into two 
broad areas: 
• The use of computers for clinical information. This means 
working with a patient’s records, placing orders for medication, or 
even getting computer-selected information relevant to interpret¬ 
ing a hepatitis test. 
Medical library director Nancy K. Roderer, M.L.S., says, "The 
paper-based chart can only be in one location at a time, and this 
location may be unknown to a potential user.” 
• Second, the need for medical knowledge of the kind Dr. Clubb 
sought. This includes not only CDP MEDLINE and other biblio¬ 
graphic databases, Dr. Paton says, but also databases on drug 
information, used in prescribing drugs, on laboratory information 
and surgical information. The list is growing rapidly. 
“Another trend is that a lot of the information that folks need at 
Yale they get not from Yale, but rather from the larger community 
connected to networks,” says Dr. Paton. “One example of a clinical 
database concentrates on cancer and is known as Physician’s Desk 
Query or PDQ.... Once it was only available by dialing up, having 
accounts and all that commotion. PDQ — now called CancerNet — 
was the brainchild of the new director of Yale's Comprehensive 
Cancer Center, Vincent T. DeVita Jr., M.D., when he was director 
of the National Cancer Institute. Now PDQ is freely available over 
Internet, a worldwide network connecting computers by high¬ 
speed transmission lines. Internet, originally used for scholarly 
communications, is a fast-growing communications system that 
provides everything from access to major databases to catalog 
buying to the transmission of maps and charts. 
There is particularly rapid growth on the Internet in freely 
available, authoritative information such as that from the National 
Institutes of Health and the National Science Foundation, and these 
resources are increasingly used by Yale faculty and students. 
Computer Tools: Databases and E-mail 
In the library, a computer screen glows brightly; a rectangle on the 
screen is headed "Medical Center Information Services.” The 
rectangle provides five choices: Library, Search Assistance, Bul¬ 
letin Boards, Education, Clinical Assistance. 
This is the network menu, or, as Perry L. Miller, M.D., Ph.D., 
calls it with the computer expert’s penchant for dropping syllables 
and spaces between words, the “NetMenu.” Dr. Miller, professor 
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of anesthesiology, is the director of the Yale Center for Medical 
Informatics, the medical center's research arm for information 
systems. (See “Medical Informatics to Revolutionize Information 
Use at Yale, YNHH,” Yale Medicine, Summer 1993.) 
A resident, physician, student or faculty member makes a 
choice with one hand on the palm-size computer “mouse," one 
finger on its button. Click the button when “Library” is highlighted, 
and the door opens to a vast array of information. Click to “connect” 
to the Yale library catalog and the equivalent of a room-size card 
catalog appears on the screen, providing access to hundreds of 
volumes of references. Other buttons lead to sources of medical 
journal articles, or many years’ worth of abstracts or the articles 
themselves. 
Databases are available through NetMenu bearing names such 
as NEXIS, PsycINFO and Scientific American Medicine. NEXIS 
is a comprehensive library of business, company, financial and 
news information. Its information is constantly updated: com¬ 
puters dip into it as a bucket dips into a stream. PsycINFO is a 
database related to psychology; other databases exist for other 
specialties. Scientific American Medicine makes it possible to 
pull medicine-related articles and charts from the magazine onto 
the computer screen. 
The medical school’s move toward one-stop information shop¬ 
ping is not being done in isolation. It’s part of the Integrated 
Academic Information Management Systems (IAIMS), a 15-year 
nationwide effort which “has placed health science institutions in 
the forefront of information systems integration and communica¬ 
tions networking,” comments Donald A.B. Lindberg, M.D., direc¬ 
tor of the National Library of Medicine. Yale is one of 18 IAIMS 
sites throughout the country. 
“The goal is to integrate the information that we need,” says 
library director Roderer, who came to Yale in 1992 after working 
with IAIMS at Columbia-Presbyterian Medical Center's library. In 
an article in the Bulletin of the American Library Association, she 
puts the value of IAIMS succinctly: “convenient access to informa¬ 
tion that would otherwise be unavailable or would require substan¬ 
tial effort to obtain.” 
At Yale, she says, “We want to provide access from a single 
workstation to bibliographic databases, full-text and factual data¬ 
bases and clinical assistance." NetMenu also provides access to 
more personally oriented information: grant and research tiles and 
electronic mail, news and networks. 
Ms. Roderer points out that E-mail — electronic mail, or 
communication by computer — had been the most-used part of the 
medical school's information system. But now MEDLINE has 
taken over that first-place spot. 
Between June and July 1993, use of MEDLINE increased from 
2,678 “connections” per month to 3,411. Use of its predecessor, 
mini-MEDLINE, which included only about 6 percent of the full 
database, declined from 1,857 to 1,577 as people jumped ship to the 
more powerful MEDLINE. 
During the same two months. E-mail — "the students like to 
use it to talk to their friends in California or connect to Internet 
bulletins,” Ms. Roderer says — was used 1,915 times and 2,454 
times — now the second-largest use. 
And E-mail is not just the new way for students to chat on the 
phone, says Dr. Paton. “An increasing amount of E-mail passes 
from one side of the street to the other here,” from the medical 
school to the hospital and vice versa. “It has improved communi¬ 
cation and cut down on telephone tag. E-mail has been a step 
forward for the administration of the school." 
NetMenu, with its wide array of resources, is available both in 
the medical library and from other computer workstations through¬ 
out the medical center. To reach a large group of users, the first 
installations were in the library. But the future, Ms. Roderer 
believes, is in workplace access — faculty, students and staff using 
computers in offices, classrooms and the hospital as information 
needs arise. "We are not far from the day,” she notes, “that Dr. 
Clubb will do her searches from the clinic.” 
Striving for Clinical Uses 
The mass of medical information now available to the School of 
Medicine is sometimes daunting, and users, especially busy clini¬ 
cians, don’t always have the time to dig through it. In addition to 
developing ways to help users navigate these information seas, 
there are also systems that focus directly on assisting physicians 
with diagnosis and treatment plans. 
One goal of the Yale Center for Medical Informatics is to 
develop systems that get advice into clinical areas so physicians can 
use them as they practice. “Most of what we do has a strong clinical 
theme,” says director Miller. 
The center was set up in 1991 as a cross-departmental academic 
unit. It brings together faculty with expertise in medical decision¬ 
making, computer systems and library science to improve both 
research and patient care. 












The center’s staff designed into the NetMenu a more powerful 
tool called the Information Sources Directory. Its members have 
also been working on new databases for Yale to store the immense 
amount of information being generated by the Human Genome 
Project. Members have been studying parallel computing — the 
linking of smaller computers to provide the power of a large one — 
with the aid of Yale’s computer sciences department. They have 
contributed to the installation of a major hospital information 
system, the Clinical Care Support System (CCSS), for Yale-New 
Haven Hospital to enter and review medical orders. 
Basically, CCSS is the equivalent of the old-time hospital fever 
chart and of the file folders on physicians’ orders and patient 
progress that traditionally were moved around the medical center 
units. Now. admissions data is typed into the CCSS on a keyboard; 
subsequently, it follows a patient's progress and provides a record 
of all a physician's order entries until the time of discharge. 
By spring 1994, this clinical support system and all the NetMenu 
databases offered through the medical library will be available at 
approximately 50 workstations located throughout the medical 
center. Dr. Miller sees a lot more work ahead: providing access to 
information “published" on compact discs; providing clinical hand¬ 
books online; and adding visual information in the form of clinical 
images such as magnetic resonance brain, bone and lung scans. 
Currently, some images, such as portable chest X-ray im¬ 
ages, are available on medical center computers, says John E. 
Fenn, M.D. ’61, HS ’61-’67, chief of staff at Yale-New Haven 
Hospital and clinical professor of surgery at Yale before his 
retirement in December. “In the future, these images might be 
transmitted to individual practitioners at their practices or even 
at their homes,” he says. 
Nancy K. Roderer, M.L.S. 
To compile the kind of information the center hopes to provide 
by traditional, paper-chasing methods, Dr. Miller says, “would take 
a lot of walking around the medical center.” The history of 
information-gathering at the medical center has evolved from 
“looking through big books in the library" to asking a librarian to 
do a complex and often-expensive database search; to looking at a 
computer screen in a library, to hooking an office computer up to 
the network. “What we’ re anticipating is that you click on MEDLINE 
and you’re connected,” he adds. 
User-friendliness 
Ultimately, Dr. Miller recognizes, the users of any computer are 
human beings, and if the clinical workstations are to succeed, these 
human beings have to feel comfortable using them. Typically, it's 
too much, irrelevant, unwanted information that can boggle the 
mind of the user impatient with computers. 
In one case he cites, a physician calling up a system for making 
orders can end up with far more information than he or she needs 
for reviewing past orders. There seemed to be no way to block out 
the unwanted information and provide only what was needed — 
until one member of the center. Dr. Jeffrey I. Clyman, assistant 
professor of anesthesiology, had an idea. 
Because a computer has the capability of printing in several 
colors. Dr. Clyman instructed the machine to print the information 
a user didn't want in black, against a black background. The 
unwanted information, for all intents and purposes, vanished. It 
offered users a much cleaner screen. 
“A number of roadblocks have been overcome by the staff in 
creative ways,” says Dr. Fenn. He cites CCSS, which has been used 
for about a year, as the “most important process-oriented informa¬ 
tion system for admission and discharge data, results reporting and 
order entry.” 
Installation has not been an easy process, and Dr. Fenn says, 
"We're nearing the end of the most difficult period. It’s not 
something to be learned in the blink of an eye. We underestimated 
how long it would take for people to become comfortable with the 
system — now we know it will take about six months before people 
have some comfort level with it.” 
Though he acknowledges that many staff members felt more 
comfortable with the paper medical record and order sheet. Dr. 
Fenn envisions moving ahead ultimately to more sophisticated 
imaging systems. He looks ahead to the establishment of an 
archival database that records groups of patients and their experi¬ 
ences. Such a database will help physicians gain performance 
feedback that the process-oriented system now lacks. 
Archives of patient cases, patients’ chest X-rays being “piped” 
to physicians' homes — what happens to patient privacy in all this? 
“Actually, these systems give us a better handle on privacy than 
we previously had,” says Dr. Fenn. “Each individual has a sign-on 
code that is changed periodically. If someone else signs on, it can 
be tracked. But we need to remain ever-vigilant about confidenti¬ 
ality. When material is printed out, we need to be very cautious and 
careful that it is not left lying around. 
“On that rare occasion, we have dealt harshly with individuals 
who ‘borrow’ others’ codes — we consider that tantamount to 
forging a prescription.” 
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Aiding Education 
Back in the library, a row of desks house SuperMacs which offer 
students use of software to further their education — much of the 
software is designed in the medical school’s Center for Advanced 
Instructional Media, headed by C. Carl Jaffe, M.D., professor of 
diagnostic radiology and medicine. 
The center has won numerous awards for its software; last year, its 
Atlas of Myocardial Perfusion Imaging was selected from several 
hundred multimedia software applications for a Gold Medal and 
Award for Excellence from the NewMedia IN VISION 1993 Mul¬ 
timedia Awards in San Jose, Calif., the heart of “Silicon Valley.” 
With Anatomic Explorer, a dramatic program available in the 
NetMenu, students may call up sections of a human torso that 
correspond to the sections of the body depicted by magnetic 
resonance imaging (MRI) and CT scans. 
In the past, taking a look at a thin slice of a human was exactly 
that: inspecting a section of a cadaver stored in a tray. William B. 
Stewart, Ph.D., associate professor of surgery (gross anatomy), 
worked with the instructional media center to create pictures of each 
section and incorporate them into the Anatomic Explorer software. 
What is seen on the screen is a color drawing of the torso with 
internal organs exposed. A click on a particular part of the torso will 
provide the oval image of that area in cross-section, with the various 
organ segments colored for clarity. 
Another popular software application. Lazy Eye, displays faces 
with varieties of this ophthalmological condition; the user can conduct 
an examination, call up the anatomical structure behind the eye, and 
even administer drugs and see the dilation or constriction of the pupil. 
MacBaby takes the user step by step through the development 
of an embryo — complete with simple animation of cell division, 
as well as the rotation of the embryo for inspection, with accompa¬ 
nying sound effects. At any point, a user may review or skip a section. 
However, MacBaby is no longer the exclusive source of this 
information. Dr. Stewart has designed a new software program on the 
embryo and central nervous system called The Animated Embryo. 
Breath Sounds is just that — the computer’s sound system 
simulating the sounds of normal breath and those of breath with 
various aberrant conditions. Other educational software focus on 
cardiothoracic imaging and pathology testing. Students use the 
library computers to access both this wide array of educational 
software and all of the other NetMenu resources. 
Database Future 
The computer scene at the medical school is constantly evolving. 
Of one method of getting into a database, Ms. Roderer says, “Two 
years ago we thought it was very sophisticated. Now we think of 
it as clunky.” And attitudes are evolving. 
“Some faculty have taken to technological advancement very 
well. Some have taken longer. But when they realize that these 
systems provide more information more quickly and can be used 
from their office or home, they realize their value,” she points out. 
Dr. Paton sees additional “ways to add value:” Modify data¬ 
bases to solve problems. Make computer systems easier to use. 
And find new applications, for instance, clinical summary reports 
that provide concise summaries of patients’ status. Like Dr. Fenn, 
John E. Fenn, M.D. ’61, chief of staff at Yale-New Haven 
Hospital and Edward Weaver, M.D., a first-year resident in 
surgery, utilize the CCSS system in CICU at YNHH. 
he looks forward to the development of an archival database — 
information about groups of patients — to aid in quality assurance, 
clinical research and the formulation of public health policy. 
Michael S. Blum, M.D., a cardiology fellow who saw the 
patient-care system at Yale-New Haven Hospital initiated during 
his residency, has found the workstations in the hospital very useful 
— and their limitations frustrating. “You can get to the databases 
at any hour of the day or night. When something unusual comes in, 
you can quickly do a literature search. It raises the level of medicine 
you can practice.” But Dr. Blum expressed fmstration with the 
time-consuming aspects of the CCSS order entry system and 
impatience with delays in the development of workstations and 
other programs that will provide immediate access to this technol¬ 
ogy and the information available through it. 
In a larger perspective, one of the elements of health-care 
reform often discussed is the fact that information management is 
required to produce the best possible care. Dr. Paton says. “And the 
key to all of that is what is called the on-line patient record or the 
computer-based patient record. 
“Yale-New Haven Hospital now has the foundation to move 
toward that goal. The School of Medicine’s contribution is to 
provide medical knowledge through a very strong medical library 
and the research conducted by the Yale Center for Medical 
Informatics,” he adds. In the months ahead, leaders in the Cushing/ 
Whitney Medical Library, academic computing and medical 
informatics will continue to develop ways to provide access to the 
multitude of information systems and to the scholarly and patient 
care information available at the Yale School of Medicine. YM 









"The sovereign must look after the health of his subjects and see to 
it that there are sufficient supplies of medicaments, and appropriate 
numbers of skilled doctors and surgeons. ...Nowadays, we under¬ 
stand the word 'hospital' to mean a building in which the poor and 
those unable to work are 
taken care of free of 
charge. Formerly, one 
meant a building in which 
strangers or travelers were 
housed and fed in ex¬ 
change for payment, and 
sometimes free of charge. 
Both the hospitality 
customary of the ancient 
peoples and the love of 
one’s neighbor intensified 
by Christianity may origi¬ 
nally have been equally 
responsible for the found¬ 
ing and erecting of the an¬ 
cient ‘hospitals’ or places 
where one could obtain 
food and rest for the night. 
German forefathers 
were able and obligated to 
provide the few travelers 
with lodging and food and 
drink without cost in their 
own homes. Since travel¬ 
ers did not receive the same 
treatment in every coun¬ 
try, this was perceived to 
be unusual and an example 
of exceptional generosity 
and hospitality; the Ger¬ 
mans eventually became 
known far and wide for 
their hospitality. ...The 
church began to found hos- 
pitals, poorhouses and 
sickhouses, where strang¬ 
ers and travelers could be 
taken care of. 
Concerning the actual so-called sickhouses or hospitals: they 
are preferable to setting up a sick-bed in the patient's living 
quarters. If the person is prosperous and wealthy; if his home has 
sufficient room and is situated such that it can be aired; if he 
possesses the necessary supplies and utensils, especially enough 
white linens; if he is married and has adult children who can care for 
him with more love and affection than a hired nurse: if these 
conditions are met. he w ill be taken care of better in his own home 
than in a hospital. More¬ 
over. a sick person pos¬ 
sesses greater peace of 
mind in his own home than 
in a strange place where he 
will be unhappy and dis¬ 
quieted, separated from his 
loved ones — this has a 
detrimental effect on many 
people’s health. 
However, if the sick 
person’s living quarters are 
cramped, low. damp, and 
if he lacks wood, light, a 
bed. linens, proper food 
and drink, and medicines 
and care — then it is with¬ 
out question better for him 
to be taken to a hospital. 
...Cleanliness, care and 
assistance are so much 
easier and more depend¬ 
able in hospitals, which 
possess qualified nurses, 
and have an established or¬ 
der of practice — and such 
institutions already exist. 
When someone is ill 
for a very long time, eating 
properly is half of the cure, 
as is getting therapeutic re¬ 
freshments for one suffer¬ 
ing from an illness accom¬ 
panied by a fever. This is 
true for royalty as well as 
for the man who rests on 
feathers.” 
This description, translatedfrom the German by David Blocher, 
accompanies this 18th-century Austrian etching in the Yale Medi¬ 
cal Historical Library. Mr. Blocher is a Yale graduate student 
pursuing a Pli.D. degree in German Language and Literature. 
The Hospital 
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Trials Begin for Cosmetic 
Surgery Alternative 
Yale is the first of three centers in the 
world to test the calcium phosphate 
material. Hydroxyapatite Cement (HAC), 
in tissue engineering to reconstruct and 
build facial bones. The substance has 
been approved by the U.S. Food and 
Drug Administration for use in clinical 
trials. Craig D. Friedman, M.D., assistant 
professor of surgery (otolaryngology), 
heads the research and surgical teams 
using HAC. 
Tissue engineering, a combination of 
surgery and biomaterial, allows surgeons 
to repair abnormalities within the body 
by mimicking the body’s own natural 
: process. 
"We hope to use HAC as an alterna¬ 
tive to silicone implants and bone grafts 
for facial surgery,” explains Dr. 
Friedman. “This material is a more 
natural substance to replace bone mass or 
to rebuild facial structures.” In previous 
studies at Yale, the synthetic bone 
substitute has successfully repaired and 
replaced craniofacial bone structures. 
Surgeons primarily will use the HAC 
for congenital cosmetic deformities, 
injuries sustained in accidents, and severe 
bone fractures or loss. 
NIH Awards $1.1 Million 
For Vision Research 
The National Eye Institute has awarded 
$1.1 million to Yale for research that 
Susan Hockfield, Ph.D., associate 
professor of neurobiology, will conduct 
on the maturation of the visual system in 
mammals. 
Dr. Hockfield’s research is designed 
to understand the molecular mechanisms 
that stabilize connections between nerve 
cells. This work could lead to improved 
methods to manipulate these mechanisms 
to help people recover from neurological 
diseases or injury. 
In ongoing studies. Dr. Hockfield has 
demonstrated that major developmental 
alterations in brain function are accompa¬ 
nied by changes in the molecular 
composition of brain cells. 
DCCT Shows Intensive 
Therapy to Help Diabetics 
At the annual meeting of the American 
Diabetes Association held in May in Las 
Vegas, the National Institutes of Health 
announced the results of the ten-year, 
$165 million Diabetes Control and 
Complications Trials. Yale was one of 
29 medical centers in the U.S. and 
Canada to enroll the 1,441 volunteers for 
the trials. 
The study’s findings showed that the 
most effective treatment for Type I 
diabetes mellitus is an intensive treatment 
program to monitor blood glucose levels 
as closely as possible. In diabetes Type I, 
which primarily affects children, patients 
lose the ability to make any insulin. The 
standard treatment for this type of 
diabetes includes daily self-administered 
insulin shots. With the intensive therapy 
program, diabetics test sugar levels at 
least four times a day, take three or more 
insulin shots and maintain a special diet. 
“In these trials, we’ve been able to 
lower blood glucose levels by nearly two 
percent, reaching the range just above the 
upper limit of normal,” explains William 
V. Tamborlane, M.D., professor of 
pediatrics. “And we can keep the level at 
that point for more than eight years, so 
we realize that controlling diabetes can 
be done.” 
Patients in the intensive therapy 
program experienced a 60 percent 
reduction in the risk of complications. 
which include kidney and liver disease, 
and nerve damage that can lead to loss of 
sensation in the feet, legs and fingertips. 
Cell Biology Awarded 
Five-Year NCI Grant 
Yale’s department of cell biology has 
been awarded a $4.8 million, five-year 
program project grant from the National 
Cancer Institute to support research on 
organelle trafficking within cells. The 
grant supports the projects of seven 
principal investigators, with Peter J. 
Novick, Ph.D., associate professor of cell 
biology, serving as program director. 
Six of the projects focus on the 
cellular roles of rab proteins that are 
structurally related to ras oncogenes, 
transforming genes which are altered in 
many tumors. Alteration of ras 
oncogenes leads to the increased spread 
of disease. Rab proteins control mem¬ 
brane traffic between different organelles 
in the cell and the formation of structures 
within the cell. Together, these projects 
will help scientists to understand how the 
cell surface is altered during oncogenic 
transformation and may lead to improved 
cancer prevention and therapy. 
In 1987, Dr. Novick’s work revealed 
that Sec4, a protein important in regulat¬ 
ing membrane traffic, is structured like 
ras. Since the discovery of Sec4, more 
than 30 related proteins, termed rabs, 
have been identified. 
Co-principal investigators include: 
Pietro DeCamilli, M.D., professor of 
cell biology; Susan S. Ferro-Novick, 
Ph.D., associate professor of cell 
biology; Ari H. Helenius, Ph.D., 
professor and chairman of cell biology; 
Reinhard Jahn, Ph.D., associate 
professor of pharmacology; James D. 
Jamieson, M.D., Ph.D., professor of 
cell biology; and Ira S. Mellman, Ph.D., 
professor of cell biology. 
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Mental Health Center 
Starts Major Addition 
The Connecticut Mental Health Center 
(CMHC) broke ground Sept. 10 for a $3.3 
million addition that will consolidate and 
expand substance abuse research. Federal 
and state mental health officials, state 
legislators and medical leaders under¬ 
scored the partnership to address the 
issue of substance abuse. 
This is the first major addition to the 
CMHC, established 27 years ago as a 
joint program of the state of Connecticut 
and Yale University. The center provides 
clinical care, engages in training and 
education, conducts research, and serves 
as a resource to help solve certain 
community problems. 
“Substance abuse is a major psychiat¬ 
ric. medical and public health problem in 
New Haven, the state and this country. 
In this center, people will carry out the 
CMHC mission focused on this problem 
that has major implications for the health 
of our citizens, the structure and function 
of our families, the performance of our 
children at their educational tasks, and 
the general safety of our community,” 
stated Ezra E.H. Griffith, M.D., CMHC 
director and professor of psychiatry and 
of African and African-American studies 
at Yale. 
The project represents an innovative 
collaboration. Support comes from a 
$2.3 million grant awarded to Yale by the 
National Institute on Drug Abuse (NIDA). 
The grant — one of two competitive 
grants presented nationwide in 1991 to 
construct and renovate research facili¬ 
ties — recognizes 15 years of scientific 
and clinical leadership in substance abuse 
by psychiatry faculty members. In 
addition, the university and the state 
have each contributed $500,000. 
The addition will house basic 
research laboratories, treatment research, 
clinical services and training. More 
young men and women can be prepared 
for careers in basic and clinical research. 
Physicians, psychologists, nurses and 
social workers also participate in CMHC 
training programs. 
Thomas R. Kosten, M.D.. associate 
professor of psychiatry and principal 
investigator of the NIDA grant, noted 
that a clinical day-treatment program will 
be added for the increasing number of 
substance abuse patients who are 
psychiatrically impaired. 
The 16,350 square foot addition, 
which adjoins the building's southwest 
side, is to be completed in September. 
Robert Wendler and Paul Pizzo, New 
Haven architects, designed the space; 
Fusco Coip. of New Haven serves as 
general contractor. Thirty percent of 
project has been awarded to minority 
female-owned businesses. 
Breast Cancer Study 
Funded by NCI 
When the National Cancer Institute pro¬ 
posed that it would fund five new studies 
emphasizing environmental links to 
breast cancer, researchers in the department 
of epidemiology and public health seized 
the opportunity. As a result, Yale has 
been awarded a four-year, $821,589 grant 
to support research examining pesticide 
exposure as a risk factor for breast cancer. 
All five northeastern university teams 
are studying possible connections 
between breast cancer and organochlo- 
rine compounds, which include pesticides 
such as DDT. BHC and industrial 
compounds called PCBs. 
“Some small studies have found a link 
between PCBs and pesticides and female 
breast cancer,” says Tongzhang Zheng, 
M.D.. Sc.D., assistant professor of epidem¬ 
iology and public health and principal 
investigator of the Yale study. “But there 
is an urgent need for more rigorous, large- 
scale research on organochlorine compounds 
to assist in making any definite links.” 
Susan T. Mayne, Ph.D., assistant 
professor of epidemiology and co¬ 
investigator explains, that even though 
use of some pesticides, such as DDT, has 
been virtually banned in the United 
States for nearly 25 years, they still exist 
in our environment. “People may be 
exposed to PCBs through the air, through 
skin contact with plastic objects, or by 
handling toxic waste. Mostly, though, 
they are exposed to pesticides through the 
food they eat.” 
Four hundred women who undergo 
breast surgery at Yale-New Haven 
Hospital will be asked to enroll in the study. 
Fatty tissue from biopsies will be sent to 
Colorado State University colleagues 
who will determine pesticide and PCB 
levels. The study will also explore the 
potential association between breast 
cancer risk, pesticides and dietary intake. 
Co-investigators include: Theodore R. 
Holford, Ph.D., professor, EPH; Robert 
Dubrow, M.D., Ph.D., associate profes¬ 
sor, EPH; Darryl Carter, M.D., professor 
of pathology, all at Yale; and John Tessari, 
Ph.D., assistant professor of environmen¬ 
tal health at Colorado State University. 
This architect's rendering shows the two-storv, elevated addition now being 
constructed to the Connecticut Mental Health Center. 
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Faculty 
News 
Dr. Ronald Merrell leads 
Surgery at School, Hospital 
Ronald C. Merrell, M.D., vice dean and 
professor of surgery at the University of 
Texas Medical School in Houston, 
became chairman of the department of 
surgery at the School of Medicine and 
\ chief of surgery at Yale-New Haven 
Hospital (YNHH) on July 1. 
A specialist in endocrinologic 
surgery. Dr. Merrell succeeds William F. 
Collins Jr., M.D., the Harvey and Kate 
Cushing Professor of Neurological 
Surgery, who served as chairman and 
chief since 1986. Dr. Collins continues 
to teach and conduct research. 
“Ron Merrell is a superb teacher of 
surgery who will advance the school’s 
comprehensive surgery programs,” states 
i, Medical School Dean Gerard N. Burrow, 
M.D. “We are fortunate in recruiting 
ji him; he has the vision to lead the depart- 
j' ment in this era of changing health policy.” 
Comments YNHH President and 
I Chief Executive Officer Joseph A. 
Zaccagnino: “Dr. Merrell’s track record 
as an outstanding surgeon, educator and 
leader will be of enormous benefit to 
Yale-New Haven and the fulfillment of 
our broad mission.” 
Dr. Merrell brings extensive experi¬ 
ence in graduate education, faculty 
development, hospital relations and 
health-care delivery. As vice dean. Dr. 
Merrell added four departments to the 
school and provided oversight for expanding 
graduate education and the clinical faculty. 
He also developed and administered a 
plan for the hospital and medical school 
to jointly administer ambulatory clinics. 
Dr. Merrell was an active clinician at 
Herman Hospital, the primary affiliate of 
the University of Texas; a consultant and 
professor of surgery at the M.D. Anderson 
Cancer Center, and a staff member of the 
Lyndon B. Johnson General Hospital. 
Dr. Merrell has focused his surgical 
research on pancreatic transplantation 
and written more than 60 scientific 
articles and 18 book chapters. 
The recipient of numerous honors 
and awards. Dr. Merrell has been pre¬ 
sented the annual Outstanding Clinical 
Teaching Award in the department of 
surgery on seven occasions. 
Among his activities. Dr. Menell 
serves on the National Aeronautics and 
Space Administration’s (NASA) 
Aerospace Medicine Advisory Commit¬ 
tee. In 1989, NASA presented him its 
Dr. Ronald C. Merrell 
Headquarters Certificate of Appreciation 
for dedicated service as a member of the 
NASA/USSR Telemedicine Spacebridge 
Team, which provided medical care to 
Armenia and Ufa disaster victims. 
Dr. Men'ell received a B.S. degree in 
1967 from the University of Alabama in 
Tuscaloosa and an M.D. degree in 1970 
from its School of Medicine in Birming¬ 
ham. Between 1970 and 1977, he was an 
intern, resident and fellow at Washington 
University School of Medicine/Bames 
Hospital. Prior to joining the University of 
Texas, he was an attending surgeon at 
Stanford University Medical Center. 
Two Faculty Awarded 
Endowed Professorships 
Two School of Medicine faculty mem¬ 
bers have been named to endowed 
professorships, recognizing their out¬ 
standing scholarship. Richard A. 
Matthay, M.D., an internationally known 
specialist in pulmonary medicine, was 
named the newly established Boehringer 
Ingelheim Professor of Medicine, and a 
new faculty member, Robert W. Ryder, 
M.D., was appointed the John Rodman 
Paul Professor of Epidemiology. 
The endowed chair was established 
with Boehringer Ingelheim Pharmaceuti¬ 
cals, Inc.’s gift to Yale’s $1.5 billion 
capital campaign. The Ridgefield, 
Conn.-based company requested that the 
professorship “support Yale’s ongoing 
clinical research efforts to discover and 
develop new and beneficial therapies and 
diagnostic tools for the treatment of 
human disease.” 
Medical School Dean Gerard N. 
Burrow, M.D., stated, “Establishing a 
new endowed chair does more than 
lighten our financial burdens and open 
new scientific opportunities. Equally 
important is the continuum it sets in 
motion — an unbroken line of talent for 
teaching and acquiring new knowledge. 
For our two organizations, the 
Boehringer Ingelheim Professor of 
Medicine symbolizes a growing sense of 
trust and shared purpose.” 
During his 18-year career at Yale, Dr. 
Matthay has served as associate director 
of the pulmonary and critical care section 
in the School of Medicine and as 
associate director of the Winchester 
Chest Clinic at Yale-New Haven 
Hospital. He is an associate chairman of 
the department of internal medicine. 
Dr. Matthay’s major research 
interests encompass cardiovascular 
performance and lung disease, lung 
cancer and the immune system, the 
pulmonary aspects of connective tissue 
diseases, and chronic pulmonary dis¬ 
eases. He has written more than 300 
scientific articles and serves on editorial 
boards of 10 journals. He is past 
president of the Connecticut Thoracic 
Society and Connecticut Society of 
Respiratory Care. 
Dr. Ryder, an internationally re¬ 
nowned scholar in the epidemiology of 
infectious diseases, joined the Yale 
faculty in July, after serving as professor 
and director of Mount Sinai School of 
Medicine’s division of epidemiology in 
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the community medicine department. 
Dr. Ryder has made major contribu¬ 
tions to the literature on HIV/AIDS and 
hepatitis B/liver cancer prevention in 
Africa. He directed an international AIDS 
research project. Projet SIDA 1986-1990. 
He and his colleagues are undertaking a 
25-year controlled trial of hepatitis B 
virus vaccine to determine if use of the 
vaccine will prevent liver cancer. 
A consultant to the World Health 
Organization and United Nations, Dr. 
Ryder has received several awards, 
including the Milbank Scholar Award in 
Clinical Epidemiology and the LIFE award 
for the most outstanding scientific article 
on HIV/AIDS prevention, published in 1991. 
Yale Surgeon Tests 
His Hands at Sculpture 
At 70, while most physicians are 
planning a relaxing retirement, Wayne O. 
Southwick, M.D.. professor emeritus of 
orthopaedics and rehabilitation, is 
considering turning his hobby of sculp¬ 
ture into a full-time career. To an extent. 
Dr. Southwick’s medical background 
intensified his interest in sculpture. He 
credits his courses in anatomy, married 
with his love of art, for his fascination 
with sculptures of the human form. 
Dr. Southwick and his wife, Ann, 
recently donated two bronze sculptures 
by Bruno Lucchesi to Yale-New Haven 
Hospital and one of Dr. Southwick’s own 
statues to the Yale Sports Medicine 
Center to help diminish the “somewhat 
static, boring statues that usually sur¬ 
round universities and hospitals.” 
“An American Dream,” Dr. 
Southwick's proudest artistic accom¬ 
plishment, is temporarily located near the 
Jane Ellen Hope Building entrance on 
Cedar Street. The life-size portrait of a man 
and woman playing basketball expresses 
the coed and interracial relations preva¬ 
lent in the sport's world. "I wanted to do 
a piece to represent equality of minorities 
and subtly show that sports are non- 
racially oriented,” explains Dr. Southwick. 
After making a 20-inch model of “An 
American Dream,” Dr. Southwick was 
given the go-ahead by his Sports 
Wayne O. Southwick, M.D., with his 
“American Dream ” 
Medicine Center colleagues to make a 
life-size replica. The statue, which stands 
10 feet tall and weighs more than 800 
pounds, is the physician’s first attempt at 
a sculpture of that proportion. 
Dr. Southwick spent nearly two 
months at a Pietrasanta. Italy foundry 
working on the sculpture before it was 
cast in bronze and air-lifted to Connecticut. 
Dr. Southwick says he is absolutely 
“overwhelmed and thrilled” by the 
attention his sculpture has garnered, and 
he hopes to include more artwork in his 
future. “Maybe when I completely retire 
from medicine. I’ll enter my work in art 
shows, but I’m still recuperating from 
‘An American Dream.’” 
Medical School Announces 
Appointments, Promotions 
The Office of the Dean at the School of 
Medicine has announced the following 
appointments or promotions to senior 
ranks. All were effective July 1. In 
recognition of their excellence in 
teaching, research and patient care, these 
faculty serve on the Board of Permanent 
Officers (BPO), the school's governing 
board, which is responsible for all major 
academic decisions. 
Nine faculty members were ap¬ 
pointed or promoted to senior rank with 
tenure. They include: Colin J. 
Barnstable, D. Phil., ophthalmology and 
visual science; Kim Bottomly, Ph.D., 
immunobiology; Axel T. Brunger, Ph.D., 
molecular biophysics and biochemistry; 
Joseph Caprioli, M.D., ophthalmology 
and visual science; Vincent T. DeVita Jr., 
M.D., medicine and in the Cancer Center; 
Bruce J. Rounsaville, M.D., psychiatry; 
Robert W. Ryder, M.D., M.Sc., epidemi¬ 
ology and public health; Andrew F. 
Stewart. M.D., medicine; and Peter J. 
Tattersall, Ph.D., laboratory medicine. 
Fourteen additional faculty members 
were promoted to professor. They are: 
Warren A. Andiman, M.D., pediatrics 
and epidemiology; Frank J. Bia, M.D., 
M.P.H., medicine and laboratory 
medicine; Joshua A. Copel, M.D., 
obstetrics and gynecology; Mark R. 
Cullen, M.D., medicine; John A. 
Elefteriades, M.D., surgery; Marc S. 
Keller, M.D., diagnostic radiology and 
pediatrics; Marc I. Lorber, M.D., surgery; 
Ronald C. Merrell, M.D., surgery; 
Leonard M. Milstone, M.D., dermatol¬ 
ogy; Terrence D. Rafferty, M.D., 
anesthesiology; Eugene D. Shapiro, 
M.D., pediatrics and epidemiology; 
Coralie Shaw, M.D., diagnostic radiol¬ 
ogy; David G. Silverman, M.D., anesthe¬ 
siology; and Eleanor C. Weir, B.V.M.S., 
M.R.C.V.S., comparative medicine. 
Ten faculty members promoted to 
associate professor with tenure include: 
Charles J. Bruce, Ph.D., neurobiology; 
James S. Duncan, Ph.D., diagnostic 
radiology; Chares A. Greer, Ph.D., 
surgery and neurobiology; Thomas R. 
Kosten, M.D., psychiatry; Michael R. 
Lemer, M.D., Ph.D., medicine; Edward 
G. Moczydlowski, Ph.D., pharmacology; 
David L. Pauls, Ph.D., in the Child Study 
Center; Gerald I. Shulman, M.D.. Ph.D., 
medicine; Brian R. Smith, M.D., 
laboratory medicine; and Bauer E. 
Sumpio, M.D., Ph.D., surgery. 
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Peter S. Aronson, M.D., professor of 
medicine and of cellular and molecular 
physiology, has been selected as a member 
of the National Institutes of Health General 
Medicine B Study Section, Division of 
Research Grants, for a three-year term. 
John C. Baldwin, M.D., professor 
and chief of cardiothoracic surgery, has 
been selected by the Council of the 
American Association for Thoracic 
Surgery to serve on the Evarts A. Graham 
Memorial Traveling Fellowship Committee 
for a four-year period, assuming the com¬ 
mittee chairmanship during the fourth year. 
The Brain Tumor Society has 
awarded funding to Allen E. Bale, M.D., 
assistant professor of genetics and of 
medicine, for his study of Gorlin syndrome, 
a rare genetic disorder that increases the 
risk of medulloblastoma, the most common 
type of brain tumor found in children. 
Sonja Levanent, M.D., post-doctoral 
fellow, will collaborate on this study. 
Paul G. Barash, M.D., associate 
dean for clinical affairs, was elected to 
the Steering Committee of the Association 
of American Medical Colleges’ Group on 
Faculty Practice (GFP). This group 
represents 125 medical schools with 
practice plans across the country and serves 
as the GFP’s planning and advisory body. 
Benjamin S. Bunney, M.D., 
professor and chairman of the department 
of psychiatry; James P. Comer, M.D., 
M.P.H., the Maurice Falk Professor in 
the Child Study Center; and Florence P. 
Haseltine, M.D., Ph.D., lecturer in 
obstetrics and gynecology, were elected 
to the Institute of Medicine, part of the 
National Academy of Sciences. Dr. 
Comer also was awarded an honorary 
doctor of laws degree from Lawrence 
University in Wisconsin. 
The American Thyroid Association 
has presented Gerard N. Burrow, M.D., 
dean, its Distinguished Service Award. 
At the organization’s 67th annual 
meeting on Nov. 13 in Tampa, Fla., Dr. 
Burrow was recognized for his important 
and continuing contributions to the 
association. A member since 1968, he 
served as its president in 1986. 
Charles B. Cuono, M.D., Ph.D., 
professor of surgery and director of the 
Yale Burn Center and Skin Bank, was 
honored at the annual meeting of the 
American Association of Tissue Banks 
(AATB) for his work as president. 
During the annual meeting Aug. 21-25 in 
Boston, he also was appointed to the 
AATB board of governors. 
In June, the University of Chicago 
honored alumnus Alvan R. Feinstein, 
M.D., Sterling Professor of Medicine and 
of Epidemiology, with a Professional 
Achievement Citation, recognizing his 
pioneering work in clinical medicine. 
Erol Fikrig, M.D., assistant profes¬ 
sor of medicine (rheumatology), and 
Trevor J. Williams, Ph.D., assistant 
professor of biology, were among 20 of 
America’s most promising biomedical 
researchers named 1993 Pew Scholars in 
the Biomedical Sciences by the Pew 
Charitable Trusts of Philadelphia. 
Scholars receive total awards of $200,000 
to help support research over four years 
as they establish their laboratories. 
Gerhard H. Giebish, M.D., Sterling 
Professor of Cellular and Molecular 
Physiology, was presented the A.N. 
Richards Award by the executive 
committee of the Society of Nephrology 
at the Xllth International Congress of 
Nephrology in Jerusalem. He was 
recognized for his important research 
contributions to the field of ion transport 
and regulation of renal function. 
The Robert Wood Johnson Founda¬ 
tion has awarded a three-year grant to 
Yale to fund a new post-doctoral 
program in health policy research. 
Bradford H. Gray, Ph.D., professor of 
research in public health and sociology, 
and Mark Schlesinger, Ph.D., associate 
professor of public health, will serve as the 
program’s associate directors. Sarah M. 
Horwitz, Ph.D., associate professor of 
public health, also is associated with the 
program. Professor Gray also was 
reappointed to a three-year term as 
director of the Institution for Social and 
Policy Studies. 
Dorothy M. Horstmann, M.D., the 
John R. Paul Professor emeritus of 
epidemiology and pediatrics, received a 
special citation from the Infectious 
Disease Society of America for her 
numerous contributions in the field of 
infectious diseases. The award was given 
in October at the society’s annual meeting 
in New Orleans. To honor her for her 
professional contributions, colleagues 
and friends have established the Dorothy 
M. Horstmann Lectureship at Yale. This 
award will be jointly sponsored by the 
department of epidemiology and public 
health and the department of pediatrics. 
Diane McMahon-Pratt, Ph.D., 
assistant professor of epidemiology, was 
awarded the 1992 Bailey K. Ashford 
Medal by the American Society of 
Tropical Medicine and Hygiene for her 
distinguished work in tropical medicine. 
Diane M. Komp, M.D., professor of 
pediatrics, received an honorary Doctor of 
Humane Letters degree from her alma mater. 
Houghton College in New York, during 
its Founders' Day convocation in October. 
Howard A. Pearson. M.D.. profes¬ 
sor of pediatrics and former chairman of 
pediatrics, was honored by the Southern 
Regional Sickle Cell Association with a 
new annual award, named the “Howard 
Pearson Award,’’ that will be presented to 
the individual who has made major 
contributions to the organization for many 
years. Dr. Pearson has worked with the 
association since it formed in 1985. 
Pasko Rakic, M.D., Sc.D., chair of 
the section of neurobiology, was pre¬ 
sented the 1993 International Neuro¬ 
science Prize by the Fyssen Fondation in 
Paris. He was given the $37,000 prize 
for his distinguished basic research in the 
development and evolution of the brain. 
Sally L. Satel, M.D., assistant 
professor of psychiatry, has been named 
one of six Robert Wood Johnson Health 
Policy Fellows for 1993-1994. She is the 
fourth medical faculty member to receive a 
fellowship since the program was estab¬ 
lished in 1973 at the Institute of Medicine. 
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Steven S. Segal. Ph.D., associate 
professor of cellular and molecular 
physiology and associate fellow at the 
John B. Pierce Laboratory, received an 
Established Investigatorship Award from 
the American Haul Association, National 
Office. The three-year, grant-in-aid 
award, entitled “Microvascular Hemody¬ 
namics: Effects of Muscle Mechanics,” 
provides funds for project support. 
Robert S. Shervvin. M.D., professor 
of medicine and director of the Diabetes 
Endocrine Research Center, was presented 
the David Rumbough Award for Scien¬ 
tific Excellence in May at the 22nd 
annual conference of the Juvenile Diabetes 
Foundation International held in Texas. 
Robert E. Shope. M.D., professor of 
epidemiology and director. WHOA'ale 
Arbovirus Research Unit, and Mark L. 
Wilson, Sc.D., assistant professor of 
epidemiology, were invited speakers and 
consultants to the NIAID Conference on 
Environmental Change and Infectious 
Diseases in the Middle East which took 
place in September in Cairo, Egypt. 
Jody L. Sindelar. Ph.D., associate 
professor of public health and the 
Institution for Social and Policy Studies, 
has been awarded a five-year Research 
Scientist Career Development Award by 
the National Institute on Alcohol Abuse 
and Alcoholism. Dr. Sindelar will 
conduct research on the economics of 
alcoholism, incorporating knowledge 
from the psychiatric field. She also was 
appointed a National Bureau of Eco¬ 
nomic Research associate. 
Barry Zaret, M.D.. the Robert W. 
Berliner Professor of Medicine and chief 
of cardiovascular medicine, presented the 
plenary address, “Future Concepts in 
Non-invasive Imaging: From Surrogant 
Clinical Markers to Modern Biology," on 
Oct. 12 at the 4th International Confer¬ 
ence on Non-invasive Cardiology in 
Limassol, Cyprus. He was given a 
special award recognizing his outstand¬ 
ing contributions and continuing leader¬ 
ship in the field of non-invasive cardiology. 
He also was named editor-in-chief of the 
monthly Journal of Nuclear Cardiology, 
which will debut in February 1994. 
Student 
News 
Class of 1997: Diligent, 
Diverse and Determined 
This year, 2,695 students applied to Yale 
School of Medicine. Among the 100 
who matriculated, 55 were men and 45 
were women; of these, 36 were minority 
students. The average age is 24, and they 
have a mean grade-point average of 3.65. 
At the first Medical School Council 
meeting, M. Lynne Wootton. director of 
admissions, highlighted the students' 
scholastic, community and secular lives. 
Excerpts from her remarks follow: 
“Our students or their families began 
their journey to Yale from such far away 
and exotic places as: Egypt, Belgium, 
Korea, El Salvador, Taiwan, Iran, the 
Philippines, England. Israel. Jamaica. 
Pakistan. South Africa, the Dominican 
Republic, Haiti, Japan and India. 
"There are more than 40 colleges re¬ 
presented, and our students have majored 
in at least 30 areas of study. ...They have 
written more than 130 honors theses, 
independent project papers or publications. 
One student conducted research in a rain 
forest in Brazil. Another studied with a 
Tibetan medicine man in western Nepal. 
“Our first-year students have 
volunteered in half-way houses for the 
mentally ill and mentally retarded, in soup 
kitchens, in children’s, veterans’ and 
psychiatric hospitals and in women's 
health clinics. ...They have worked for 
AIDS programs, for the Special Olympics, 
Adopt-A-Grandparent programs and the 
Make A Wish Foundation. They have 
painted low-income housing units and 
worked for Habitat for Humanity. One 
student led a 15-member international 
construction crew — they built a single¬ 
family dwelling for a family in Tiajuana. 
...They have tutored prison inmates, dis¬ 
advantaged children aid high school students. 
...One student taught English to Vietnam¬ 
ese refugee students, and another student 
organized a math and literacy program at a 
high security youth detention center. 
“They have worked as singers, 
dancers, reporters, landscapers and 
bartenders. ... One student worked for a 
Russian resettlement program, while 
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Moscow for a journal published by the 
Russian Academy of Sciences. One 
student worked for the Hawaiian Seal 
Recovery Program. ...One student was the 
author of a science fiction series which 
consisted of five complete volumes. 
Another drove a taxi cab in London. And 
another was responsible for raising all of 
the flags on the U.S. Capitol. 
And they have other interests — one 
student won the U.S. Fencing Associa¬ 
tion National Foil Championships in the 
under 20 age group. One organized 
foozeball tournaments, while another 
was the broadcaster for our rival school’s 
varsity football and hockey games.” 
§§§ 
Three third-year medical students, 
Hyun Bae, Daniel Martin and Paul 
Santiago, have accepted positions in the 
1993-1994 Class of the Howard Hughes 
Medical Institute (HHMI 1-National 
Institutes of Health (NIH) Research 
Program (Cloister Program). Chosen 
from 45 students representing 27 medical 
schools, the students, as HHMI-NIH 
research scholars, will perform research 
in a NIH laboratory for one year. HHMI 
provides salaries and benefits. 
The board of directors of the Nicho¬ 
las J. Pisacano, M.D. Memorial Founda¬ 
tion, Inc. has selected third-year medical 
student Cheng-Chieh Chuang as one of 
the first 10 Pisacano scholarship recipients. 
Each $50,000 scholarship is awarded to 
an outstanding medical student who has 
made a commitment to the field of family 
practice and is attending a U.S. medical 
school. The foundation was created in 
1990 by the American Board of Family 
Practice, Inc. in tribute to the organization’s 
founder and first executive director. 
Victoria Holloway, fourth-year 
medical student, has been awarded one of 
the 12 James Comer Minority Research 
Fellowships for medical students. This 
award, funded through the National 
Institute of Mental Health and adminis¬ 
tered by the American Academy of Child 
and Adolescent Psychiatry, offers 
outstanding minority medical students 
early exposure to state-of-the-art research 
in child and adolescent psychiatry and 
personal contacts with active researchers. 
Joshua R, Korzenik, M.D., post¬ 
doctoral fellow in medicine, was one of 
23 scientific researchers and physician- 
scientists to receive one-year grants from 
the Glaxo Institute for Digestive Health 
for his proposed study of Heparin in the 
treatment of ulcerative colitis. 
The Radiological Society of North 
America (RSNA) Research and Educa¬ 
tion Fund has named fourth-year medical 
Raising Black Children, by James P. 
Comer, M.D., Maurice Falk Professor in 
the Child Study Center. Penguin U.S.A. 
(New York) 1992. 
Coming to America: The Kids’ Book 
About Immigration, by David Fassler, 
M.D. ’82, et al. Waterfront Books 
(Vermont) 1993. 
A Child Shall Lead Them: Lessons In 
Hope From Children With Cancer, by 
Diane M. Komp, M.D., professor of 
student Constantino S. Pena a 1993 
Gendex Corporation/RSNA Medical 
Student Scholar Assistant in academic 
radiology. He was nominated by and 
will assist 1992 RSNA Scholar Thomas 
McCauley, M.D., assistant professor of 
diagnostic radiology. This new program 
is designed to make radiology research 
opportunities possible for medical 




Rapids, Mich.) and HarperSanFrancisco 
(San Francisco) 1993. 
Rehabilitation of Late-Deafened Adults: 
Modular Program, by Steven B. Leder, 
Ph.D., associate professor of surgery 
(otolaryngology), and Jaclyn B. Spitzer, 
Ph.D.. associate clinical professor of 
surgery (otolaryngology). Mosby 
(St. Louis) 1993. 
Yale University’s new president, Richard C. Levin, visited the School of Medicine 
on Nov. 21 to address members and guests of the Medical School Council. He 
spoke about several major issues facing Yale. During the question and answer 
session, one student commented on the condition of Harkness dormitory and 
invited President Levin on a tour. So, before returning to the central campus, 
he toured several floors, with Dean Burrow, Associate Dean Robert H. Gifford 
and several students. 
Book News 
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The Mystery of Goodness: Positive 
Moral Consequences of Psychotherapy, 
by Mary W. Nicholas, Ph.D.. clinical 
instructor in psychiatry. Norton Profes¬ 
sional Books (Virginia) 1994. 
Human Longevity, by David W.E. Smith, 
M.D. '60. Oxford University Press, Inc. 
(New York) 1993. 
Clinical Gastroenterology, by Howard 
M. Spiro, M.D.. professor of medicine 
(digestive diseases), et al. McGraw-Hill. 
Inc. (New York) Fourth Edition, 1993. 
Empathy and the Practice of Medicine: 
Beyond Pills and the Scalpel, edited by 
Howard M. Spiro. M.D., professor of 
medicine (digestive diseases); Mary G. 
McCrea Cumen, M.D., D.P.H., clinical 
professor of epidemiology and pediatrics; 
and Enid Peschel, Ph.D., assistant 
professor (adjunct) of medicine. Yale 
University Press, 1994. 
Alumni 
News 
Robert E. Carroll. M.D. '42, professor 
emeritus and consultant in hand surgery 
at Columbia-Presbyterian Medical Center 
in New York, was keynote speaker at the 
annual meeting of the Japanese Society 
of the Hand held in Sapporo in May. 
Morris A. Wessel, M.D. 43, HS 
'48-’51, who recently retired after 42 
years of practice in the New Haven area, 
received the 1993 Practitioner Research 
Award by the American Academy of 
Pediatrics in November at its annual 
meeting in Washington, D.C. 
Martin E. Gordon, M.D. '46, 
clinical professor of medicine at Yale, 
co-chaired a session at the Third Interna¬ 
tional Congress on Travel Medicine, held 
in Paris. At Yale, he is a trustee of the 
CushingAVhitney Medical Library and a 
member of the Wilbur Downs International 
Travel Fellows selection committee. 
Eugene Sillman. HS '49-’51, is a 
medical examiner for the New York State 
Worker's Compensation Board in Buffalo. 
Robert G. Petersdorf, M.D. '52, 
received the Abraham Flexner Award for 
Distinguished Service to Medical 
Education in November in Washington, 
D.C., at the 104th annual meeting of the 
Association of American Medical 
Colleges. At the April convocation of 
the American College of Physicians 
(ACP), he received the ACP’s Distin¬ 
guished Teacher award. Tufts University 
School of Medicine awarded him a 
Revised Guide Helps Physicians Diagnosis and Treat Global Diseases 
The Global Disease Guide, an aid in disease prevention and post-travel diagnosis that includes arboviral information 
on diseases from more than 170 countries, has been updated and released in a second edition. Martin E. Gordon, M.D. 
'46, clinical professor of medicine at Yale, 
researched, designed and authored the guide to 
help physicians and health-care workers world¬ 
wide become more aware of parasitic, bacterial 
and arboviral diseases and how to prevent them. 
“Many of these travel illnesses share the 
same deceptive symptoms while masquerading as 
other, more common diseases,” explains Dr. 
Gordon. “By having the Global Disease Guide at 
hand, physicians can easily check sicknesses 
indigenous to an area in which their patients may 
have recently traveled. The guide helps eliminate 
guesswork and may lead to faster, more accurate 
diagnosis and treatment.” Through a simple 
color-coded method, users can correlate these 
parasitic viral and bacterial symptoms with risk 
rates specific to geographic locations. On the 
reverse side. Dr. Gordon has devised a Pre-Travel 
Immunization Guide to identify what medical 
precautions need to be taken before international 
travel. In April, the Global Disease Guide 
received a Health Sciences Communications 
Association Award at the HeSCA National Media 
Festival in Texas. 
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Edward J. Mullen, M.P.H. 
Doctor of Science, Honoris Causa degree 
at graduation in April. 
Last year, Kristaps J. Keggi, M.D. 
’59, HS ’61-'64, clinical professor of 
orthopaedics and rehabilitation at Yale, 
was elected to the Russian Academy of 
Science (Medicine). He is one of only two 
American members. In 1988, Dr. Keggi 
established a foundation to bring ortho¬ 
paedic surgeons from the former Soviet 
Union and the Baltic states for training 
and to send U.S. surgeons to these areas. 
John J. Schrogie, M.D. '60, has been 
appointed assistant director of health 
policy and special assistant to the vice 
president for special programs at Jefferson 
Medical College of Thomas Jefferson 
University Hospital in Philadelphia. 
David W. E. Smith, M.D. ’60, is a 
professor in the pathology department and 
at the Center on Aging at Northwestern 
University Medical School in Chicago. 
After 42 years of service at Yale-New 
Haven Hospital, John E. Fenn. M.D. 
'61, HS ’61-’67, retired as chief of staff 
in December. As a Dartmouth under¬ 
graduate working summers in Yale labs, 
a medical student at Yale, a practicing 
vascular surgeon, associate chief of 
surgery and, for 11 years, chief of staff. 
Dr. Fenn made innumerable contribu¬ 
tions to YNHH. During his time at the 
hospital, he witnessed the construction or 
renovation of the Dana Building, the 
Primary Care Center, the South Pavillion, 
the Children's Hospital and the atrium. 
Among the medical center employ¬ 
ees and medical staff he was known as 
a compassionate, conscientious, 
hardworking and tough administrator 
who treated his fellow employees with 
consideration. His medical colleagues 
were impressed with the high level of 
esteem and affection his patients had 
for him. 
With his free time. Dr. Fenn intends 
to spend more time with his family, do 
some consulting and pursue personal 
interests, including boating. 
Stephen C. Joseph, M.D. ’63, dean 
of the University of Minnesota School of 
Public Health, has been nominated by 
President Bill Clinton to become assistant 
secretary for health affairs at the U.S. 
Department of Defense. As of Dec. 16, 
his nomination was still pending. 
Philip J. DiSaia, HS '67, director of 
gynecologic oncology at the University 
of California, Irvine, has been elected 
1993-1994 president of the American 
Cancer Society, Orange County unit. 
J. Robert Kirkwood, M.D. ’67, vice 
president of radiology at Baystate 
Medical Center, Springfield, Mass., was 
named a fellow of the American College 
of Radiology (ACR) by the college’s 
board of chancellors at the ACR annual 
meeting in Orlando, Fla. 
Helen L. Smits, M.D. '67, has joined 
the Association of American Medical 
Colleges as scholar-in-residence for four 
months, working with the Division of 
Clinical Services and exploring the 
effects of health-care reform on medical 
education. 
Charles A. Dinarello, M.D. '69, 
professor of medicine and pediatrics at 
Tufts University School of Medicine, 
was awarded the Ernest Jung Prize in 
Medicine for 1993, given by the Ernest 
Jung Foundation of Hamburg, Germany, 
for his research on interleukin-1 and 
related cytokines. Prize money was used 
to set up the Sheldon M. Wolff Profes¬ 
sorship in Medicine at Tufts, as well as to 
support other medical institutions. 
Robert B. Diasio, M.D. '71, profes¬ 
sor of pharmacology and medicine at the 
University of Alabama School of 
Medicine, was named the first recipient 
of the Newman H. Waters Chair of 
Clinical Pharmacology at the university. 
Carol C. Teitz. M.D. ’74, was 
selected for a sports medicine/ 
orthopaedic fellowship by the American 
Orthopaedic Society for Sports Medicine 
and the Western Pacific Orthopaedic 
Association. In August and September, 
she traveled to Japan, the Philippines, 
Indonesia, Australia and New Zealand. 
Edward J. Mullen. M.P.H. '74, 
president and chief executive officer of 
VertiHealth in Los Angeles, has been 
elected to the board of directors of the 
Alliance for Children’s Rights, a public 
interest law office providing pro bono 
services for children. 
John A. Elefteriades. M.D. ’76, HS 
'76-'83, recently promoted to professor 
of surgery at Yale, continues as director 
of adult cardiothoracic surgery. 
Arthur M. Gershkoff. M.D. 78, has 
been appointed clinical director of stroke 
rehabilitation at MossRehab Hospital in 
Philadelphia and has been named to the 
Arthur M. Gershkoff, M.D. 
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staff of Einstein Medical Center in 
Philadelphia and the Philadelphia 
Geriatric Center. 
Barton A. Kamen, M.D. "78. has 
been named the first recipient of the Carl 
B. and Florence E. King Foundation 
Distinguished Chair in Pediatric Oncology 
Research at the University of Texas 
Southwestern Medical Center in Dallas. 
Elston Seal Jr.. M.D.. HS ’78-’80, 
has been promoted to the rank of medical 
director in the U.S. Public Health 
Service. He works for the Environmental 
Protection Agency's Human Studies 
Laboratory where he had been nominated 
as special assistant to the director of the 
Human Studies Division. 
Edward C. Halperin. M.D. '79. has 
been promoted to professor of radiation 
oncology and associate professor of 
pediatrics at Duke University Medical 
Center in Durham. N.C. 
Michael K. Lindsay. M.D. 79, has 
been promoted to associate professor of 
obstetrics and gynecology at Emory 
University School of Medicine in Atlanta. 
Steven M. Brown. M.D. '81, is 
chairman of the department of pulmonary 
and critical care medicine at Columbia 
Hospital in Milwaukee and assistant 
professor of medicine at the Medical 
College of Wisconsin. 
Eugenia M. Vining, M.D. 
Colleen M. Brophy, M.D. Brian G. Rubin, M.D. 
Society of Vascular Surgery Grants 
Colleen M. Brophy, M.D., HS '83-’90, and Brian G. Rubin, M.D., HS 84- 
'89, have been awarded grants by the Lifetime Foundation of the Society of 
Vascular Surgery. Dr. Brophy, assistant professor of vascular surgery at the 
Medical College of Georgia in Augusta, Ga. and chief of vascular surgery at the 
Augusta Veterans Affairs Medical Center, will conduct research on vasospasm 
and its role in circulatory disease. Dr. Rubin, assistant professor of vascular 
surgery at Washington University School of Medicine in St. Louis and director of 
the vascular laboratory at Jewish Hospital of St. Louis, will study the formation 
of blood clots after vascular surgery and subsequent arterial reinjury. Both 
physicians are associate fellows of the American College of Surgeons. 
Bruce D. Perry, M.D., HS '84-'87, 
associate professor of psychiatry and 
behavioral sciences at Baylor College of 
Medicine in Houston, has been named 
the first Thomas S. Trammell Research 
Professor of Child Psychiatry. 
Robert S. Higgins, M.D. '85, 
instructor in cardiothoracic surgery at 
Yale, has been selected by the American 
College of Cardiology as a recipient of the 
American Cardiology/Bristol Laborato¬ 
ries Affiliate Travel Award for 1993. 
Paul E, Savoca, M.D., HS '86-'91, 
has joined the staff of Fairfax Colon and 
Rectal Surgeons of McLean, Va., which 
is affiliated with Georgetown University 
School of Medicine. 
Kristin J. Kruger, M.P.H. '85, has 
been appointed vice president for 
planning and regulatory affairs of the 
Western New York Hospital Association. 
Eugenia M. Vining. M.D. 87, has 
joined the otolaryngology practice of 
John R. Loeffler, M.D., HS '80-'84, and 
Paul W. Alberti. M.D. '83, HS '83-’88, 
of New Haven and Branford, Conn. 
Luoluo Hong, M.P.H. '92, has been 
appointed wellness education coordinator at 
Louisiana State University in Baton Rouge. 
Nai-Wen Kuo, M.P.H. '92, is a 
Ph.D. candidate in health, finance and 
management at the Johns Hopkins 
University School of Hygiene and Public 
Health in Baltimore. 
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O BITUARIES 
Joseph P. Donnelly 
Joseph P. Donnelly, M.D., died Feb. 9 at 
Christ Flospital in Jersey City. Fie was 86. 
Dr. Donnelly was former medical 
director of the Margaret Haue Maternity 
Hospital in Jersey City and past president 
of New Jersey Blue Shield. He served on 
the consulting staff of several hospitals and 
taught at Seton Hall University Medical 
School, the College of Physicians and 
Surgeons, and Columbia University. 
He was a past trustee of the Medical 
Society of New Jersey and president of 
the Hudson County Medical Society. He 
was a founder of the James F. Norton 
Scholarship Fund that provides tuition 
aid for Hudson County students. 
A native of Jersey City. Dr. Donnelly 
graduated from Catholic University of 
America and, in 1932, from Yale School 
of Medicine. 
He is survived by his wife, Monica; 
three sons, Peter, Paul and James; five 
daughters, Ann. Pat, Mary, Monica and 
Kate; and 13 grandchildren. 
Lewis P. James 
Lewis P. James, M.D., died March 25 at 
his home in Rocky Hill, Conn. He was 89. 
Dr. James founded the obstetrics and 
gynecology resident training program at 
St. Francis Hospital in Hartford. Conn., 
and was a member of the department’s 
staff for 47 years. During the 1950s, he 
served as director of the surgical staff. 
After his retirement. Dr. James became a 
medical consultant for the Salvation 
Army Rehabilitation Center. 
A native of Hartford, Dr. James 
graduated from Trinity College and 
received his M.D. degree in 1927 from 
Yale School of Medicine. He was former 
president of the Hartford Medical 
Society, the New England Obstetrical- 
Gynecological Society and the Connecti¬ 
cut Board of Obstetrics and Gynecology. 
He was a diplomate of the American 
Board of Obstetrics and Gynecology 
and a fellow of the American College 
of Surgeons. 
He leaves his wife, Nancy; a son, Lewis 
P. James Jr.; three daughters, Mary, 
Nancy and Dianne; and 11 grandchildren. 
Memorial donations may be made to 
the Salvation Army Rehabilitation 
Center, 333 Homestead Ave., Hartford. 
CT 06112. 
William H. Sewell 
William H. Sewell, M.D., died May 9 at 
the Robert Packer Hospital in Sayre, 
Penn. He was 66. 
A native of Tampa, Fla.. Dr. Sewell 
was a graduate of Princeton University 
and in 1949 graduated from Yale School 
of Medicine. He served an internship at 
Grace-New Haven Hospital and took 
residency training at Albany Medical 
College and Bethesda Naval Hospital. 
Dr. Sewell specialized in cardiac 
surgery, starting the heart surgery program 
in 1966 at the Robert Packer Hospital. 
Dr. Sewell retired in 1985 after perform¬ 
ing 2,256 open-heart surgery procedures. 
He was a member of the American 
College of Surgeons, the American 
College of Cardiology, the Association 
for Thoracic Surgery and the American 
College of Angiology. 
He is survived by his wife. Karlene; 
two sons, Douglas and Jimmy; two 
daughters. Sharon and Susan; and four 
grandchildren. 
Memorials may be directed to the 
Guthrie Foundation, in care of develop¬ 
ment, Guthrie Clinic, Sayre, PA 18840 or 
to the American Heart Association. P.O. 
Box 428. Sayre, PA 18840. 
Bradford S. Colwell 
Bradford S. Colwell. M.D., died May 16 
at his North Haven, Conn., home after a 
long illness. He was 69. 
Dr. Colwell, a native of New Haven, 
graduated from Colgate University in 
1945 and was a 1948 graduate of the 
Yale School of Medicine. 
An army veteran in World War II. he 
also served as a medical officer during 
the Korean conflict. From 1954 to 1987, 
he was in private practice with his father. 
Dr. Howard S. Colwell. An internist, he 
served as medical director of the 
Clintonville Manor and Intermediate 
Care Facility. In addition, he was a staff 
physician at the Montowese Health Care 
Center. Both facilities are located in the 
New Haven area. 
He held professional memberships in 
the American Medical Association, the 
Connecticut Medical Society and the 
New Haven County Medical Association. 
He is survived by his wife. Mary; 
three daughters, Jane. Mary and Barbara; 
and three grandchildren. 
Robert S. Rosnagle 
Robert S. Rosnagle. M.D.. died June 11 
of skin cancer at his home in Albuquer¬ 
que, N.M. He was 61. 
Dr. Rosnagle practiced otolaryngology 
in New Haven for 21 years before 
moving to New Mexico in 1984 where he 
served as associate medical director at the 
Lovelace Medical Center. From 1963 to 
1966, Dr. Rosnagle was an assistant 
professor of surgery and an assistant 
clinical professor of otolaryngology at 
Yale School of Medicine. 
A native of London. Ohio, Dr. Rosnagle 
graduated from the College of Wooster in 
Ohio and from the Case Western Reserve 
University School of Medicine. 
For many years, he serv ed as a 
surveyor for the Accreditation Associa¬ 
tion for Ambulatory Health Care. 
He leaves his wife, Barbara; three 
daughters, Diane, Elizabeth and Susan; 
and two grandchildren. 
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Daniel X. Freedman 
Daniel X. Freedman, M.D., died June 2 
in his Los Angeles home. He was 71. 
Dr. Freedman pioneered research on 
physical and chemical abnormalities of 
the brain that cause mental illness and on 
the effects of addictive and hallucinatory 
drugs. In the early 1960s, Dr. Freedman 
discovered the first link between halluci¬ 
nogens and neurotransmitters. 
He chaired the psychiatry department at 
the University of Chicago from 1966 to 
1983. He later became executive vice 
chairman of psychiatry at UCLA’s 
Neuropsychiatric Institute and the Judson 
Braun Professor of Psychiatry and Pharma¬ 
cology at the UCLA School of Medicine. 
Bom in Lafayette. Ind., Dr. Freedman 
graduated from Harvard in 1947 and 
from Yale School of Medicine in 1951. 
From 1958 through 1966 he taught at 
Yale, where he won the Keese Prize for 
his work on the effects of antihistamines 
on the central nervous system. This 
research eventually led to chemical 
treatments for schizophrenia. 
He wrote more than 200 articles and 
15 books and was the chief editor of the 
American Medical Association’s 
Archives of General Psychiatry. He was 
past president of the American Psychi¬ 
atric Association, a member of the 
National Academy of Sciences Institute 
of Medicine and founder of the American 
College of Neuropsyhcopharmacology. 
Dr. Freedman is survived by his 
wife. Mary. 
Walter J.J. Nero 
Walter J.J. Nero, M.D., died June 16 at 
Bay State Medical Hospital in Spring- 
field, Mass., at age 75. 
A native of New Haven, Dr. Nero 
was a 1939 graduate of Yale University 
and a 1943 graduate of Yale School of 
Medicine. He served his internship and 
residency at Yale-New Haven Hospital, 
and then was an instructor in surgery, 
receiving the Ferris Award in surgery. 
For his service as a major and chief 
of surgery in the Army, Dr. Nero was 
awarded a certificate of commendation 
and achievement. He was chief of 
surgery at Wesson Memorial Hospital 
and maintained a private practice in 
Springfield. In 1980, Dr. Nero was 
named medical officer at the Military 
Entrance Physical Station in Springfield. 
He was a member of the American 
College of Surgeons, a fellow of the 
International College of Surgeons and a 
member of Alpha Omega Alpha. 
He leaves his wife, Annette; a son, 
Walter; and one granddaughter. 
Memorial contributions may be made 
to the Bishop Weldon Rehabilitation 
Center, Mercy Hospital, Springfield, MA. 
Elizabeth M. Ramsey 
Elizabeth M. Ramsey, M.D., died July 2 
at age 87 of a stroke at Georgetown 
University Hospital in Washington, D.C. 
Dr. Ramsey began her research on 
the structure and function of the human 
embryo with the discovery of a two- 
week-old embryo, the Yale Embryo, 
during an autopsy. She served 36 years 
in the Carnegie Institution of Washington 
embryology department on the Johns 
Hopkins University campus in Baltimore. 
Dr. Ramsey was the principal 
collector of a series of more than 600 
microscopic slides, prepared from 600 
human embryos, displayed at the National 
Museum of Health and Medicine at the 
Armed Forces Institute of Pathology. 
A native of New York, Dr. Ramsey 
graduated from Mills College and, in 
1932, received her medical degree from 
Yale School of Medicine. After interning 
at New Haven Hospital, she returned to 
Yale as an associate in pathology. 
Before her retirement in 1971. Dr. 
Ramsey had authored more than 125 
journal articles and two books. She was 
a visiting professor at the University of 
Virginia, and she lectured at Georgetown, 
George Washington and Johns Hopkins 
universities. 
In 1987, Dr. Ramsey was named 
distinguished scientist of the year by the 
Society for Gynecological Investigation. 
She also received the Distinguished 
Service Award of the American College 
of Obstetricians and Gynecologists. 
She is predeceased by her husband, 
Hans Klagsbrunn. 
William W. Klatchko 
William W. Klatchko, M.D., died Aug. 21 
at his home in Annville, Penn. He was 69. 
A native of Connecticut, Dr. 
Klatchko served with Gen. George Patton 
in Europe during World War II. He was 
awarded the combat infantryman's badge, 
two bronze star medals, a purple heart 
and four battle stars from northern France, 
Germany and the Battle of the Bulge. 
A 1952 graduate of Yale University 
School of Medicine, Dr. Klatchko was a 
fellow of the American College of 
Surgeons and the American Thoracic 
Society. He was a member of the Ameri¬ 
can Occupational Medicine Association, 
the Southeastern Surgical Congress, the 
American Medical Association and the 
Pennsylvania Medical Society. 
Dr. Klatchko was an attending 
surgeon for 30 years in Lebanon, Penn., 
and was chief of surgery at the former 
Lebanon Valley General Hospital for 25 
years. He also was an attending physi¬ 
cian at the Good Samaritan Hospital and 
the VA Medical Center and was plant 
physician at Alcoa for 25 years. 
He leaves his wife, Helen, and a 
daughter, Barbara. He is predeceased by 
his daughter, Patricia. 
Memorial contributions may be sent to 
the Class of 1952, do the Yale Alumni Fund, 
P.O. Box 1890, New Haven, CT 06508. 
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Michael Hume 
Michael Hume, M.D., died July 10 of 
leukemia at age 68. Dr. Hume was chair¬ 
man emeritus of the department of 
surgery at New England Baptist Hospital 
in Boston. 
A native of New Milford, Conn., Dr. 
Hume was a 1945 graduate of Yale 
University and a 1950 graduate of the 
College of Physicians and Surgeons. He 
was an associate professor at Yale from 
1964 to 1969. 
Dr. Hume was a lieutenant in the 
Navy during World War II. He was a 
charter member and president of the New 
England Society for Vascular Surgery 
and founding member and president of 
the American Venous Forum. He was 
co-author of several books on cardiovas¬ 
cular surgery and author of numerous 
articles for professional medical and 
scientific journals. 
He leaves his wife, Constance; a 
daughter, Nancy; and a son. Nelson. He 
was predeceased by a daughter, Claire. 
Memorial contributions may be sent 
to New England Baptist Hospital, 125 
Parker Ave., Boston, MA 02120. 
Robert Zeppa 
Robert Zeppa, M.D., died Sept. 2 of 
pulmonary embolism at Jackson Memo¬ 
rial Hospital in Florida. He was 68. 
Dr. Zeppa, a renown liver surgeon 
and expert in portal hypertension and 
cirrhosis, co-developed the Distal 
Splenorenal Shunt in the late 1960s 
which has become standard therapy for 
patients with bleeding esophageal varices. 
Dr. Zeppa started his career at the 
University of Miami/Jackson Memorial 
Medical Center in 1965 as a professor of 
surgery and pharmacology, and chief of 
surgery at the Miami VA Medical Center. 
He was named co-chair of the UM 
department of surgery the next year, and 
in 1971, was named departmental 
chairman and Jackson’s chief surgeon. 
In 1988, Dr. Zeppa was named the 
Lucille and DeWitt Daughtry Professor 
of Surgery. 
Prior to his arrival in Miami, Dr. 
Zeppa was on the department of surgery 
Robert Zeppa, M.D. '52 
faculty at the University of North 
Carolina. 
Dr. Zeppa earned his B.A. degree 
from Columbia College and his M.D. 
degree in 1952 from Yale School of 
Medicine. 
He is survived by his wife. Cicely; a 
daughter, Melissa; and a son, Scott. Contri¬ 
butions may be made to the University of 
Miami School of Medicine, P.O. Box 
016960 (R-699), Miami, FL 33101. 
Edgar B. Taft 
Edgar B. Taft, M.D., died on Oct. 4, in 
Pittsfield, Mass. He was 77. 
Dr. Taft was bom in New Haven and 
received a B.S. degree from M.I.T. He 
was a 1942 graduate of Yale University 
School of Medicine. 
He did his postgraduate training at 
Boston City Hospital, the University of 
Kansas Medical Center and the 
Karolinska Institute in Stockholm, 
Sweden. 
From 1950 until his retirement. Dr. 
Taft’s professional career in pathology 
was centered at Massachusetts General 
Hospital and the Harvard School of 
Medicine. His research focused on the 
pathology and histochemistry of liver 
disease. 
He is survived by his wife, Priscilla 
Dienes Taft, a 1944 graduate of Yale 
University School of Medicine. 
In Memoriam 
Irvin J. Beebe 
October 27, 1992 
M.D. ’32 
Bradford S. Colwell 
May 16, 1993 
M.D. ’48 
Thomas T. Flynn 
May 11, 1993 
M.P.H. ’58 
Robert A. Frisch 
June 27, 1992 
M.D. ’29 
Morris Glazer 
June 22, 1993 
Med. ’22 
Gene I. Higashi 
January 11, 1991 
M.D. '64 
Maitha P. Jayne 
October 27, 1993 
M.P.H. ’50 
William Oliver Minturn 
May 3, 1993 
M.D. ’52 
Bernard J. Naab 
November 7, 1990 
M.D. ’48 
Walter J.J. Nero 
June 16, 1993 
M.D. '43 
Elizabeth M. Ramsey 
July 2, 1993 
M.D. ’32 
William H. Sewell 
May 9, 1993 
M.D. ’49 
Robert Walker 
May 11, 1993 
Med. ’36 
Leroy S. Wolfe 
May 11, 1992 
M.D. ’45 
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Alumni Report 
As director of alumni affairs, I was again 
afforded the opportunity to address the 
entering first-year class during orienta¬ 
tion. I was again allowed to introduce 
myself and welcome the students as 
future members of the Association of 
Yale Alumni in Medicine. Alumni/ae 
support of their activities and concerns 
was briefly addressed and the stage set 
for continuing interaction between the 
students and alumni/ae. 
The Class of 1997 was the second to 
participate in our impressive annual 
White Jacket Ceremony in which each 
member of the class individually is 
presented a white jacket by Dean Gerard 
N. Burrow, M.D. '58. This year, he was 
joined by Deputy Dean Lawrence S. 
Cohen, M.D., and M. Lynne Wootton, 
director of medical admissions. 
The credentials of the 100 entering 
students were impressive, and the new 
Reminder 
Medical and Public Health 
Alumni Reunion Weekend 
Friday and Saturday 
June 3 and 4,1994 
Association of 
Yale Alumni in Medicine 
P.O. Box 3333 
New Haven, CT 06510-8055 
(203) 785-4674 
Association of Yale Alumni 
in Public Health 
60 College Street 
New Haven, CT 06511 
(203) 785-2827 
students represent the final decision of the 
admissions committee. From a total of 
2,695 applications, 45 women and 55 
men matriculated; 18 had advanced degrees 
(6 Ph.D. degrees), and 36 were minorities. 
All medical school alumni/ae children 
were interviewed, and four of the 12 
applicants were accepted and matriculated. 
It is apparent that the quality of 
students improves each year and that the 
Yale School of Medicine will train those 
who will be the leaders of medicine in 
the 21st century. The Yale system has 
been preserved and improved with 
pertinent curriculum changes. The thesis 
requirement remains. 
Our office actively encourages the 
students to establish class identity by 
forming into effective class groups that 
will function after graduation. Alumni/ae 
can participate in this process by attend¬ 
ing student affairs, both social and 
academic. We enhance the sense of family 
within the association by nurturing our 
students and continuing our interest in 
them after their graduation. The alumni 
office can provide interested alumni/ae 
with the dates of student events which 
they can attend. Call us for details. 
The Office of Alumni Affairs 
functions effectively only when alumni/ae 
are actively involved with their alma mater 
and alumni association. Our president, 
Marie-Louise T. Johnson, M.D., Ph.D. ’56, 
also invites your participation in the 
affairs of the association. Such involve¬ 
ment helps us to thank our school for the 
training and education it has given us. 
Opportunities to serve include the 
various boards and committees that are 
open to our alumni/ae. The executive 
committee of the Association of Yale 
Alumni in Medicine needs a working, 
representative board. Class agents and 
secretaries play crucial roles in maintaining 
class identity and in helping to organize 
reunions. John W. Foster Jr., M.D. ’71 is 
actively seeking volunteers to serve on the 
Alumni Fund Board. If you are inter¬ 
ested in a committee assignment, please 
notify me at the Office of Alumni Affairs. 
Congratulations to our alumni/ae who 
contributed $1,335,580 to the 1993 Yale 
Alumni in Medicine Fund Campaign, 
exceeding the $1 million goal for the 
second consecutive year. Your contribu¬ 
tions to the medical and public health 
alumni funds are essential for the dean to 
fund student aid, facility acquisition and 
maintenance, and to support and acquire 
new faculty. Our continuing financial 
support will demonstrate our loyalty to 
our school and support of our dean. 
Dean Burrow spoke to the medical 
and general Yale alumni/ae in Philadel¬ 
phia at the Top of the Bellevue on Nov. 
16 and in Chicago at the Intercontinental 
Hotel on Dec. 14. I hope that you were 
able to hear Jerry talk about Yale School 
of Medicine and its role in medicine in 
the 21st century. 
Plans for the 1994 annual spring 
reunion on June 3 and 4 are nearly 
completed. All alumni/ae are invited to 
attend, especially the quinquennial (fifth 
year) reunion classes, those ending with 
the number 4 and 9. The Class of 1944 
will be honored at the Friends of the 50th 
festivities; the Class of 1989, returning 
for its first five-year reunion, will be 
invited to join the celebration. A record 
attendance is anticipated. 
Reunion classes are encouraged to 
consider a presentation featuring class 
members who offer short papers about 
their practice, research or other profes¬ 
sional activities. Connie Tolliver, 
assistant to the director, is available and 
eager to advise reunion classes about 
their programs. Connie and our adminis¬ 
trative assistant, Patty DiNatale, will 
assist you with your reunion weekend 
class activities. Do not hesitate to contact 
us: Office of Alumni Affairs, Yale 
University School of Medicine, P.O. Box 
7613, New Haven, CT 06519, (203) 
785-4674; Fax (203) 785-4327. 
Arthur C. Crovatto, M.D. '54 
Director of alumni affairs 
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Distinguished Service Awards 
(At right) The Alumni Association and your 35th reunion class 
should be proud to acknowledge your many contributions to our 
medical school as an outstanding teacher of pathology, as a 
molecular biologist in the forefront of renal research, as editor 
of Yale Medicine, to mention only one of the many journals you 
have served in that capacity, and as a concerned friend of our 
medical students, who will be all the better alumnae and alumni 
because of your interest. Beyond the walls of academia, you 
have bridged successfully the perceived gap between town and 
gown through your quiet and unassuming sendee to many 
hospitals, especially the Yale-New Haven Medical Center, to 
various organizations in town, like the New Haven Symphony, 
the North Haven Board of Education, and, on the lighter side, 
the local International Wine and Food Society. But above all 
that, your involvement in medical society activities at both the 
state level and county level, where your chairmanship of the 
membership committee has helped the countv association to 
grow and to feel closer to our medical school. The sense of 
sendee characteristic of your endeavors, your wise counsel to 
colleagues and associates, and your promotion of all things 
good for the School of Medicine make us all proud to honor you 
with the Distinguished Alumni Sendee Award. 
Michael Kashgarian, M.D. ’58, (above) and R. Leonard Kemler, 
M.D. ’43, (at left) received Distinguished Service Awards from the 
Association of Yale Alumni in Medicine at the annual meeting held on 
June 5 in Room 110 of the Jane Ellen Hope Building. 
(At left) For the 50 years since you graduated, you have 
remained a loyal and devoted volunteer worker for your school, 
strengthening communications between the Hartford-area 
alumni and the Association of Yale Alumni in Medicine. 
Because of your recognized leadership, you were elected to two 
tours of duty on its executive committee. From 1986 to 1991, you 
sen>ed as chairman of the Yale School of Medicine Alumni Fund, 
personally communicating with volunteer fund agents of all 
classes. In 1991, under your chairmanship, the Yale School of 
Medicine Alumni Fund met the $1 million Kresge Challenge and 
achieved a record 56 percent participation by the alumni. Your 
medical school and the students who are beneficiaries of student 
aid are grateful to you. Because of your continuing loyalty and 
continuous sendee to the association, we are proud to designate 
you a Distinguished Alumni Sendee Award recipient. 

















by Dr. Charles J. Petrillo 
The Class of 1938 returned for its 55th 
reunion to a greatly changed medical 
center. Of the 48 students who matricu¬ 
lated in September 1934, 39 graduated in 
1938 and 15 are still living. Five 
returned for the reunion, for a 33 percent 
attendance rate — not bad, considering 
age-related infirmities. 
An excellent program of lectures, 
seminars, receptions, luncheons and tours 
had been arranged by the alumni office. 
Friday evening, cocktails and dinner 
at the Race Brook Country Club were 
attended by Ben Lyons (Blanche), Jim 
Radcliffe (Elizabeth), Jack McGillicuddy 
and Charles Petrillo (Mary Sullivan). 
Ben Lyons, who, with considerable 
effort and after much correspondence and 
innumerable telephone calls, had 
contacted all of our classmates whose 
whereabouts were known. He gave us 
up-to-the-minute information of their 
present status. On the sick list were Roy 
Barnett, who has had a stroke and is now 
at home. Joe Criseuolo also had a stroke 
and is now in Minnesota. Nelson Ordway 
had planned to attend but due to a disk 
problem had to cancel out. Ed Nichols 
reportedly is on the disability list also. 
Since our 50th reunion, deceased class¬ 
mates include Agnes Bartlett, Joe Bliss, 
S. Charles Kasdon and Joe Reynolds. 
Saturday activities included surgical 
grand rounds, faculty seminars, the 
annual meeting of the Association of 
Yale Alumni in Medicine (AYAM), a 
luncheon, and a tour of the Children’s 
Hospital — a truly impressive building 
(if only Dr. Powers could have seen it). 
The grand finale Saturday evening 
was the “Friends of the 50th" dinner 
honoring the Class of 1938, of 1943 and 
of 1988 and hosted by the School of 
Medicine and the AYAM. Present at this 
occasion were the Lyons, the Radcliffes, 
Charles Petrillo with Mary Sullivan, Ed 
Roberge with Genevieve, and Bill Kober’s 
son, W. Mike Kober, Mike’s wife, Ann, 
and Bill Kober’s grandson. Dr. W.H. 
Kober, and Muriel Kasdon, Sol’s widow. 
I again wish to thank Ben for his 
invaluable help in planning this reunion. 
I hope to see you all at next year’s reunion. 
1943, March 
50th Reunion 
by Dr. Dorothea R. Peck 
The 50th reunion of the Class of 1943, 
March, was a great success. It was most 
enjoyable, as well as being educational. 
Of 30 surviving class members. 19 
returned (16 men and 3 women). 
Fourteen wives attended. 
We started Friday afternoon with a 
series of “seminars” in the Historical 
Library where our graduation ceremony 
had been held 50 years earlier. (We were 
the first class to have been “accelerated” 
by the war so could not graduate with the 
University in June.) 
Bill Davey was a superb master of 
ceremonies. He began the afternoon with 
a memorial tribute to the 18 classmates 
who are no longer living: Carmen 
Bonanzino, Jack Kaye, Walter Rowson 
Jr., William F. Hillier Jr.. John V. 
Munro Jr.. Edwin D. Murphy, Robert 
Lee Taylor, Robert A. Sears, Jonathan 
T. Lanman, Joseph P. Kriss, Frederick 
A. Waldron, C. Thomas Flynn, John J. 
Weber, Donal L. Dunphy, Jean P. 
Davis. Roland N. Tessier, Russell A. 
Morisette Sr. and Stanley J. Weigel. 
(Walter J.J. Nero was not named — he 
died 11 days after the reunion.) Bill then 
asked for a moment of silence in memory 
of and in affection for these cherished 
friends and respected physicians. 
Bill then presented the first seminar 
with a discussion of the contributions of two 
of his mentors, Drs. Cushing and German, 
to neurosurgery and to Yale. He also 
described Dr. Cushing’s interest in health 
care and in national health insurance. 
Dee Peck followed, tracing the 
careers of some favorite faculty members 
after March ’43. Drs. Lindskog and 
Last June. Helen Langner, M.D. ’22, at age 101, attended reunion weekend, just as 
she has done for many years. 
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Dr. Edith M. Beck '48 (center) joins Drs. Henry E. Markley '43 and Jonathan (Jock) 
S. Bishop ’49 in the evening's conviviality. 
Zimmerman are our only professors who 
are still living. 
John Brobeck described some of his 
experiences at the University of Pennsyl¬ 
vania since he retired from teaching and 
research. As judicial administrator, he 
was involved in a racial incident among 
students which received much publicity. 
He also showed an interesting slide of a 
building at the University of Pennsylva¬ 
nia which was designed by Louis Kahn, 
who did the addition to the Yale Art 
Gallery and the British art center. 
Rocko Fasanella eulogized our 
distinguished classmate, Jonathan 
Lanman. Of his many contributions to 
medical science, outstanding was his proof, 
in 1954. that oxygen lack is the most 
significant etiological factor in retrolental 
fibroplasia of premature newborns. 
Len Kemler reported on a recent 
meeting in Washington, D.C., sponsored 
by the American Medical Association 
(AMA) and attended by 1,000 physi¬ 
cians. Many members of Congress and 
government leaders met with them, but 
Mrs. Clinton did not. Len noted that the 
AMA only wishes to be heard and to 
present its program of coverage for all 
and for health reform. 
Ed Rabe spoke on his experience in 
Saudi Arabia, where he went in 1986 to 
start a pediatric neurology service in 
Riyadh. The high number of marriages 
between close relatives provided a unique 
opportunity to study genetic effects. 
However, the traditions of the country 
made it difficult to work there. 
Sophie Trent followed with an 
account of her trip to Saudi Arabia in the 
late '40s. Things were much more 
primitive then, and she did not stay long, 
as she felt it would be impossible for her 
to practice there. 
“42 Years of Primary Practice” was 
the final talk, presented by Morris 
Wessel. He emphasized the importance 
of knowing the patient and family well, 
and of developing a mutual trusting 
relationship. His final advice was “cure, 
relieve and comfort always.” 
Our class dinner at Mory's (as guests 
of the Association of Yale Alumni in 
Medicine) was relaxed and highly 
enjoyable. Bill Davey proposed the 
establishment of a Memorial Medical 
Scholarship at Yale medical school in 
memory of our dead classmates. The 
proposal passed unanimously. Ralph 
Alley, from his wheelchair, presented his 
slides of "Omaha Beach, June 1944,” 
vividly depicting the horrors of what was 
happening in France 49 years ago. The 
rest of the evening was devoted to 
renewing old friendships. 
Saturday morning many of us heard 
Dean Burrow make an impressive 
speech, which made us feel most 
optimistic about the future of the medical 
school under his leadership. One of the 
two recipients of the Annual Award of 
the Association of Yale Alumni in 
Medicine was our classmate Leonard 
Kemler. Dr. Samuel Kushlan, whom we 
remember as an outstanding teacher of 
clinical gastroenterology, introduced Len 
and spoke with great appreciation of 
Len's contributions to the medical school. 
Among the Saturday tours for alumni 
was an unusual one organized by Bill 
Davey. He took four people on a tour of 
Dr. Fulton's beautiful house in Hamden. 
Saturday evening we were guests of 
the Alumni Association at the annual 
"Friends of the 50th" dinner at the 
Graduates Club. After dinner each 
member of our class presented a brief (!) 
summary of his/her career. A similar 
summary was given by each member of 
the Class of '43, December, and. in 
contrast, by each of the "Friends” 
attending their fifth reunion and those 
attending their 55th. We adjourned after 
a memorable weekend of camaraderie, 
admiration for classmates' professional 
achievements, and sincerest affection for 
the Yale School of Medicine. 
The eight classmates who spoke on 
Friday have been listed. Their wives 
who were present are: Artemis Davey, 
Dorothy Brobeck, Joan Kemler. Emily 
Rabe and Irmgard Wessel. The other 
classmates present at the reunion were: 
Ralph Alley (Jane and daughter. Kim), 
Gerard Fountain (Polly), Jessamine 
Goerner. Douglas Lindsey (Wally), 
Henry Markley (Nikki). Earl Rhoades 
(Nancy), Henry Riedel (Dorothea). Bob 
Rowen, Marcus Sanford (Mildred), 




by Dr. Ronald Cooke 
As guests of the university, we were feted 
Friday night at Mory's and Saturday 
night at the Graduates Club. Attending 
were Tom Cooke (Irma), Brownie 
Brinkley (Margot), Tom Bucky (Doris), 
Phil Chase (Katie), Joe Epstein 
(Estelle). Freddie Haddad (Maisie) and 
I with Fran. 














Tom and Irma came from Florida, 
accompanied by their eight-year-old 
granddaughter, who was a charmer. 
Time has been kind to Tom. His laconic 
views on medicine and politics have not 
changed. After finishing surgical training 
at Chanty Hospital in New Orleans he 
practiced in Smyrna Beach. Fla. 
Brownie was only slightly subdued 
from the old days. He no longer plays 
touch football after smashing his hip in a 
bicycle accident. He has retired from the 
Washington, D.C., scene and is now 
biking over the country with Margot. 
Tom Bucky has changed very little, 
still practicing internal medicine in 
Weston, Conn. With much modesty he 
mentioned that he might be in a televi¬ 
sion documentary about Albert Einstein, 
a close family friend. Tom, in 1963, 
wrote an article in Harper's, titled 
“Einstein as Seen Through the Eyes of 
an Adolescent.” 
Phil Chase still does family practice 
at a slower pace in Farmington, Maine. 
He talked about the years at Tufts when 
he assisted in setting up the student health 
department and then traveled to England 
and Europe to organize similar programs. 
Joe Epstein long ago retired from an 
active allergy practice. He talked about 
his much-traveled consultation to Africa 
to diagnose and treat a patient with a 
Harold D. Bomstein Jr., M.D. '53, HS 
'53-'56 attends the 40-year reunion with 
his wife, Maureen. 
penicillin reaction while doing a resi¬ 
dency with Dr. Cooke, the allergist in 
New York. He leaves Connecticut in the 
winter for Arizona. No longer does he 
play tennis. 
Freddie Haddad is well, and all these 
years he has defied Dr. Lindskog’s dire 
prognosis if he did not have a lobectomy. 
I wish some of us could look as well. 
Fran and I spend summers on the Maine 
coast and winters in Florida — fishing 
and playing golf, with an occasional 
attempt at photography and painting. 
Don Seldin regretted that he could 
not be with us but was a visiting profes¬ 
sor in Europe. 
Sawyer Medbury wrote from 
Florida that he wanted to come but had 
medical problems. 
Bob Furman urged our reunion to 
take place in Scottsdale, Ariz. This 
would have been a great party but not a 
medical school reunion. 
To those of you west of the Missis¬ 
sippi, 1 hope Bob's plans for a December 
reunion materialize. I send you all best 
wishes and good health. 
1948 
45th Reunion 
by Dr. Paul B. Koehler 
Reunion weekend at the Yale University 
School of Medicine, June 4 and 5, was 
enjoyable, informative and memorable. 
It provided the opportunity to hear and 
meet our new dean, Gerard N. Burrow, 
M.D., and to participate in surgical grand 
rounds, seminars and tours, particularly, 
the tours of the soon-to-be open 
Children’s Hospital at Yale-New Haven. 
The seminar outlining the current 
medical school curriculum was exciting, 
emphasizing “so much to learn in so little 
time.” New scientific and medical 
advances must be included with the old 
basics! The dean's reception late Friday 
afternoon and Saturday’s luncheon, 
undiminished by rain, were elegant. 
Our class dinner on Saturday, June 5, 
was held at Mory’s, with the following in 
attendance: Edith Beck, Greenwich, 
Conn.; “Jack” Bishop, Minneapolis, 
Minn.; A1 Bridge and wife. Charline, 
Moreno Valley, Calif.; Dick Cote and 
daughter, Jean, Santa Rosa, Calif.; Betty 
Fuller Eisner, Ester, Ark.; Nan Godley 
St. Goar and husband. Dr. Walter St. 
Goar, Brookline. Mass.; Paul Goldstein 
and wife, Betty, Branford. Conn.; Sylvia 
Preston Griffiths and husband. Dr. 
Raymond Griffiths, New York City; Ray 
Johnson and wife, Sydney, Berryville, 
Va.; Jim Needham and friend, Sally 
Deas-Miller, and two of Jim's children, 
Michele and Patrick, and their friend, 
Luna. Van Nuys, Calif.; Ben Rush and 
wife, Norah, Summit, N.J.: Jerry 
Shapiro and fiancee, Meredith Pearlstein, 
Wellesley Hills, Mass.; Paul Koehler 
and wife, Margaret, Bradford, N.H. 
Following dinner, the program, 
conducted by class agent Nan Godley St. 
Goar, began with an acknowledgement of 
10 deceased classmates: Bob Maurer. 
Gabe Saviano. Jim Leslie. Bob 
Lawson, A1 Green, Boy Frame, Vic 
Drill. Russ Barrnett. Bernie Naab and 
Brad Colwell. Walt Gustafson, who 
began with our class but graduated in 
1949, was also included. 
Formal letters from six classmates 
who could not attend the reunion were 
summarized: 
“Bud” Rowland, New York City — 
after 20 years, still professor and 
chairman, department of neurology and 
director, neurological service, Columbia- 
Presbyterian Medical Center. 
“Dave” Morton, Pueblo, Colo. — 
semi-retired. Two of four daughters 
presently attending college, one will 
attend Yale in the fall of 1993, and the 
youngest is presently graduating from 
high school. 
“Dick” Hannah. Walnut Creek, 
Calif. — retired five years ago from the 
Permanente Medical Group. Recovered 
from an aortic aneurysm repair and 
coronary bypass surgery. Attending 
concerts and recitals and building 
furniture. Active as a watercolorist. 
“Al” Fisk, Sonoma, Calif. — retired, 
growing grapes for wine making, playing 
bridge, hiking and remaining “left of the 
center.” 
“Bob” Downie, Greenville, S.C. — 
retired, battling childhood asthma and 
recovering from rupture of an abdominal 
aortic aneurysm and hypoxic myelopathy. 
Paul Weld. Honeoye Falls, N.Y. — 
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(From left) Drs. Andrew J. McGowan Jr., Robert J. Donohue Jr., Gerard N. 
Burrow, Raymond W. Turner and Paul Rudnick celebrate the largest reunion gift 
ever made by a class to the medical school. 
Class of 1958 Gift Sets Record 
Reunion gift chairman Dr. Raymond W. Turner recruited a reunion gift committee 
that included Drs. John A. Carlson, Robert J. Donohue Jr., Philip R. Fazzone, 
Michael Kashgarian, Haskins K. Kashima, Andrew J. McGowan Jr., Paul A. 
Rudnick, John P. Wood and Pauline Bucknell Wood. The committee’s goal was to 
endow a Dean’s Discretionary Fund to honor the return of classmate Gerard N. 
Burrow as dean of the School of Medicine. Dean Burrow and future deans will 
administer the fund to support meritorious, but otherwise unfunded, student and 
faculty initiatives. In this manner, the dean will further enhance the quality of the 
educational experience at Yale. 
Committee members coordinated their efforts through the school's Alumni Fund 
office, working with Monica Robinson, director, and her staff. At reunion weekend 
on June 5, Drs. Turner and Rudnick presented Dean and classmate Gerard Burrow 
with a check for $230,650. The gift represented the largest reunion gift ever made 
by a class to the school and helped boost the School of Medicine Alumni Fund to a 
second million dollar year. When the fiscal year ended on June 30, 1993, the Class of 
1958 reunion gift had increased to $252,816, with 76 percent of the class participat¬ 
ing. Since then, committee member Andrew McGowan was instrumental in 
bringing in an additional $100,000 gift for the school. The Gladys Brooks Founda¬ 
tion of New York will establish The Gladys Brooks Geriatric Assessment Replica¬ 
tion Endowment Fund to further support faculty initiatives involving the elderly. 
retired after 33 years at the Rochester 
General Hospital. His final position was 
chief of physical medicine and director of 
the diagnostic ultrasound division. Has 
started a catalog book business specializ¬ 
ing in ornithology and medicine and 
enjoying a cabin in the Adirondacks and 
a home on the Bay of Funday. 
“Hal” Griffith and his wife, Jeanne, 
Chicago, HI., had planned to attend the 
reunion but illness (Jeanne's brother) abruptly 
changed their plans at the last moment. 
The dinner program concluded with 
each classmate describing his/her hospital 
training, military experience, practices, 
marriages, children and grandchildren, 
travel, retirement activities, hobbies and 
major accomplishments in 45 years. 
The two days passed very quickly and 
many happy memories remain! We look 
forward to being together again in 1998. 
1953 
40th Reunion 
by Dr. Harold D. Bomstein 
Our 40th reunion was the biggest and 
best yet for our 1953 class. Friday 
afternoon we had a class symposium with 
three fascinating presentations: Rhoda 
Powsner on the interface between 
medicine and law; Irv Goldberg on his 
DNA research; and Betty and Tom 
Gentsch did a super slide show of their 
experiences as medical missionaries in 
the bush of three African nations. 
Friday dinner was at our home, as is 
customary with our reunions. Due to the 
size of the gathering, we ate Maureen’s 
delicious dinner seated outdoors, 
followed by coffee and desserts inside. 
There were 33 people in attendance: 
Claude Bloch from Manhattan: Jeanne 
and Remi Cadoret from Iowa; Emily 
and Bill Chaffee drove down from 
Auburn, N.Y.: Jack Doppman arrived 
from Bethesda. Md.; Doe and Jim Dunn 
always come up from New Jersey; Betty 
and Tom Gentsch are now from North 
Carolina; from Cambridge, Mass., Peggy 
and Irv Goldberg: Iveagh and Vince 
Gott, now from the Maryland shore; 
Ithacans Robin and Bob Hamlisch; Hyla 
and Bob Melnick of Larchmont, N.Y.; 
Bob Nolan, all the way from California; 
Betty Thompson and Harvey Peck from 
New Jersey; Joanne and Wick Potter of 
Wellesley, Mass.; Rhoda and Ed 
Powsner of Ann Arbor: our delightful 
Puerto Ricans, Leila and Jose Ramirez- 
Rivera: Barbara and Irv Rosenberg 
from their new Maine retirement home; 
and Mary Lou and Fred Young from 
Lancaster, Pa. Vicky and Rex Conn had 
to cancel at the last minute due to 
Vicky’s sudden illness, from which she is 
recovering. And Carol and Fred Lane 
had to cancel due to the imminent birth 
of twin grandchildren. Both food and 
conversation flowed freely, and we all 
had a wonderful evening. 
Saturday dinner was held once again 
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at the elegant Quinnipiack Club, with 
cocktails in the library and a delicious 
meal in the adjacent Board of Governors 
Room. While Claude Bloch and the 
Gotts had to leave, we added Andrea and 
Seth Abramson from New York and 
locals Joan and A1 Chetrick. After 
dinner each in attendance shared com¬ 
ments on personal and professional 
activities with the group assembled. We 
had communications of varied length 
from Don Etzwiler (who had planned on 
coming), George Hoffmann, Dave 
Holman (who had hoped to come), A1 
Keroaek, Dick Knowles, John Lord, 
John Roberts and Matt Tandysh. We 
look forward to an even larger and better 
class gathering in 1998. 
1958 
35th Reunion 
by Dr. Paul Rudnick 
Thirty-five years and going strong! The 
Class of 1958 celebrated with great style 
by presenting a reunion gift heretofore 
unsuipassed in the history of Yale 
Medical School. The $236,900 check 
was proudly accepted by our classmate 
and Dean Jerry Burrow and will 
establish a Dean’s Discretionary Fund in 
Jerry’s honor. Special thanks are due to 
Ray Turner, chairman of the Class 
Reunion Gift Committee, and his tireless, 
unrelenting and avaricious crew. 
Most of us arrived Friday afternoon 
and met in the Beaumont Room for an 
informal discussion of the changes in 
health care which are soon to be upon us: 
John Arnot, Mike Lotz. Lee Phillips, 
Tom and Karen Mauro, Don and Helen 
Duncan. Bob and Ellie Donohue, Andy 
(I’m retired) and Lois McGowan, Ray 
and Maria Turner, Ann and Jerry 
Burrow, Bob and Margaret Wroblewski, 
John and Jean Carlston. Pauli and Jack 
Wood, yours truly "PR” (Paul 
Rudnick), Sandra Rudnick, and of 
course, our tenured professor of reunion 
planning, Mike Kashgarian and Jeannie. 
As we wandered through Sterling 
Hall of Medicine, we had an unscheduled 
visit to Jerry’s new offices, the entrance 
to which was near the imposing portrait 
of Dean Vernon Lippard, who will 
forever keep a watchful eye on Jerry. 
Saturday, the Alumni Association 
meeting was at 9 a.m., and our class was 
heartily congratulated when the an¬ 
nouncement of the reunion gift was 
made. Mike Kashgarian, along with two 
other alums from other classes, received 
a Distinguished Alumni Service Award. 
Once again the highlight of the 
weekend was the reunion dinner which 
Mike Kashgarian had arranged at the 
Quinnipiack Club. In spite of a torrential 
downpour, we all arrived on time and had 
a fabulous evening. Mike’s culinary and 
oenological skills were once again in 
evidence. 
It was wonderful to see A1 Phillips, 
’59, at the party. A1 is recuperating 
nicely from his recent fetal tissue 
transplant surgery for long-standing 
Fathers and Sons 
Yale tradition was truly evident at reunion weekend. While M. Gilbert Grand, 
M.D. '68 (bottom right), and Leonard Grauer, M.D. '68 (bottom left), celebrated 
their 25th reunion, their sons Aaron (top right) and Jonathan (top left) carry the 
Yale torch through the generations as second-year students. "Our fathers were 
best friends cdl through their years at Yale, " explains Aaron Grand. "After 
medical school, my father moved to St. Louis and Dr. Grauer stayed in New Haven, 
so our families became a bit distant. Before / came to Yale, we called the Grauers, 
and that's when we found out that Jonathon was going to be my classmate. ” Not 
only have the second-generation Yalies grown to be best friends, they even sit in 
the same seats (next to each other alphabetically) in the same labs with some of the 
same professors as did their fathers a c/uarter of a century ago. 
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(Right to left) Muriel D. Wolf M.D. '59, HS ’59- '60, Mcirie-Louise T. Johnson, 
Ph.D. '54, M.D. '56, HS '56-'59, and her husband, Dr. Kenneth Johnson, M.D., HS 
'50- '54 and Nicholas Passarelli, M.D. '59, HS '59- '65. 
Parkinson’s disease. 
More classmates enjoying the high 
calorie revelry were Ted and Dora 
Lieberman. Bill and Dorothy Radeliffe, 
Ray and Shirley Gaito (whose son is 
now in practice with Ray), George and 
Anne Aghajanian, Jay and Barbara 
Kislak, Dave and Helen Carlson, and 
Stan and Debbie Harris. There were lots 
of impromptu toasts and warm thoughts 
shared by all. Ray Turner presented 
Andy McGowan with a gift of books as 
an award (or reward) for being the gift 
committee volunteer who raised the most 
money from his long-suffering classmates. 
And so it went. All of us had a 
marvelous time and look forward to the 
40th with more classmates attending. It 
was a particular pleasure to celebrate 
with and congratulate Jerry as he 
completes his first year as dean. 
1963 
30th Reunion 
by Dr. Jon M. Fessel 
The reunion started slowly and grew in 
numbers and scope. Five of us had lunch 
together at Mory’s on Friday. We spent 
much of the afternoon in an animated 
discussion that ranged from survival 
experiences in Central America to the 
wonder of a weapon named 600 Nitro 
Express, which will stop an elephant in 
its tracks or blow a three-inch hole in a 
telephone pole. The dean's welcome was 
tame after this. 
Dinner at the New Haven Lawn Club 
on Saturday was the social focus of the 
weekend. Attending were: Wayne 
Brenckman, John Conte, Andy Edin 
(Becky), Mike Fessel (Kathy), Bill 
Friedewald, Peter Gregory, George 
Holsten (Libby), Hal Kaplan (Barbara), 
John Mahoney (Patricia Chaves), Jay 
Pomerantz (Larida) and Jim Wepsic 
(Susan). 
A number of topics were discussed 
after dinner. The late Gary Van Galder 
was warmly remembered. Peter Gregory 
presented a report on the remarkably 
productive activities of his Class Gift 
Committee. The group has pledges and 
verbal commitments in excess of 
$130,000 toward two scholarships in the 
class name. Jay Pomerantz orchestrated 
a lively discussion of our views of the 
effectiveness of "The Yale System" from 
a 30-year perspective and the appraisal 
was generally glowing. Finally, the 
recurrent notion of organizing a West 
Coast gathering filled out the evening. 
Ben Harris has written about this, and 
several Californians expressed enthusi¬ 
asm and willingness to pitch in. We will 
appraise the enthusiasm of the West 
Coast contingent and see if this can be 
arranged next year. 
1968 
25th Reunion 
by Dr. Donald Lyman 
Fifteen classmates enjoyed an informal 
time together in drizzly New Haven. 
Grace Jordison Boxer came with 
husband. Larry Boxer. They live in Ann 
Arbor, Mich., where Gracie is in training 
to be a radiation oncologist. Rutledge 
Currie practices in North Adams, Mass., 
with Dan Becker as a radiologist where 
he lives the rural life with sheep in his 
yard. Barbara Mayer Egbert is a skin 
pathologist in the San Francisco Bay area 
and currently suffers tom ligaments in 
her left knee from a tennis mishap. She 
attended with cratches and lots of 
solicitous attention from others. Alan 
Finesilver. a rheumatologist in Wiscon¬ 
sin, showed us slides of fly-fishing in 
Montana and other exotic places. Gil 
Grand and Len Grauer attended with 
their sons, who are both freshmen at the 
Yale medical school (another dynamic- 
duo?). Bill Keane seems surprised he is 
now chief of medicine at Hennepin 
County Hospital (University of Minne¬ 
sota) but enjoys the international travel 
and other new experiences the position 
brings. Don Lyman oversees chronic 
disease and injury control for the 
California State Health Department — 
his Hollywood-produced anti-tobacco 
ads have gotten rave reviews. Richard 
Morehead. an accomplished radiologist 
in Sonoma County, Calif., is now into 
music (singing with choral groups) and 
restoration of 19th-century buildings in 
Lampasas, Texas. Chuck Post was 
“captured" by private practice after his 
time with the Public Health Service and 
now enjoys his practice of ophthalmol¬ 
ogy, along with sports and trips with his 
family. Jerry Springer has sold his 
house and is ready for a change in 
careers; only trouble is, he doesn’t know 
what the new career is yet. Bruce Wenger 
was also present as was Creed Wood, who 
is practicing orthopedics and advising 
Barbara Mayer Egbert on her knee. 
















by Dr. Thomas F. Sweeney 
A small but enthusiastic group gathered 
in New Haven on June 5 for our 20th 
reunion. Our plans for an unusual class 
dinner were dashed somewhat by 
inclement weather. A cocktail party and 
a concert by the New Haven Symphony 
Orchestra under the stars at Edgeiton 
Park has become an annual event. It is 
great when the weather cooperates. 
Instead we attended an indoor cocktail 
party, followed by picnic dinners on our 
kitchen floor. 
Class discussions lasted into the wee 
hours. By far and away the leader of our 
group was Chris Kull Walsh. She and 
her husband, Sean, have attended all of 
our reunions. For that incredible feat, 
Sean was made an honorary member of 
the class. Rick and Harriet Fingeroth 
came down from Springfield. Mass., 
where Rick is in a large orthopedic 
group. Jim and Rita Sullivan made the 
trip from the Essex/New London area 
where Jim practices rheumatology. 
The long-distance award went to Sue 
and Harold Mancusi-Ungaro, who 
came all the way from Beaumont, Texas. 
Harold has a private practice in plastic 
surgery there. Rich and Dorothy Young 
tied us for the short-distance award. Rich is 
a pediatric neurologist and chief of pediatrics 
at the Hospital of St. Raphael. Anne and 
I live in North Haven, and I practice 
vascular surgery in a private group. 
We heard from a few folks who could 
not make the trip. Jay and Carol Popp 
are doing well in Columbia, S.C. Jay is a 
gastroenterologist, but their greatest 
achievement so far is four sons, with the 
oldest attending Yale in the fall. Jim 
Campbell is professor of neurosurgery at 
Johns Hopkins and has a special interest 
in peripheral nerve surgery. Jane 
Ferguson is a member of a large 
pediatric group in Kingston, N.Y., and is 
the mother of two teen-agers. Rob and 
Karen Sirota are well and ask that we 
say hello to all. Harry Romanowitz 
came to town for Friday’s talk but could 
not make it to Saturday’s dinner. Harry 
practices pediatrics in Stamford. 
As unbelievable as it may seem, the 
25th will be here in no time. We hope 
that a large contingent will make the trip. 
It is the only way to find out what 
everyone else is up to and what we really 
say about you! 
1978 
15th Reunion 
by Dr. Seth M. Powsner 
The Class of 1978 celebrated its 15th 
reunion in New Haven on June 5 and 6. 
Classmates and significant others who 
attended: Dave Cawthon and his family, 
Eric Einstein and Claudia Gross, Stu 
Forman. Linda Gardiner and Brian 
Schwartz, Bob Gelfand and Susan 
Boulw'are, Jett Hausfeld and his family, 
Ken Marek and Deborah Dwork, and 
of course Seth Powsner and Elizabeth 
Yen. Bruxelles Brasserie and Bar agreed 
to host this year's reunion dinner. We 
assume they agree with our assessment 
that neither our prior reunion seminar at 
the Old Heidelberg nor our prior dinner 
at Peter Cheng’s five years ago had 
anything to do with the demise of both 
establishments. As for the effect our 
class had on Humphrey’s ... 
If there is anyone who started with 
our class, or who joined our class, or who 
simply prefers our class, who did not 
receive an invitation, please write. The 
staff of the Alumni Office and I made a 
concerted effort to correct the class 
affiliation lists. We would like to get the 
list right in preparation for our upcoming 




by Dr. Judy Melin 
Could it be that we really all look just 
exactly the same? And is it really 10 
years? It seems like just yesterday. 
The 10th reunion for the Yale School 
of Medicine Class of 1983 began with 
check in at the Park Plaza Hotel, then 
convocation at the medical school, a 
reception at Harkness, including Dean 
Levitin and Dr. Gifford, more conversa¬ 
tion at the hotel, breakfast in the Beau¬ 
mont Room, lunch in Harkness, a wander 
through the medical school to look at the 
familiar corridors and rooms of our past, 
reception and dinner at the Chart House 
with a waterfront view, brunch at Claire’s 
Comer Copia, and suddenly time to leave 
again, perhaps for another five years. 
In many ways, nothing has changed 
at all in New Haven; even the cracks in 
the sidewalks are the same. The student 
bulletin boards still advertise for room- 
Class of 1983 graduates pause in their conversation (from left): Drs. Nancy K. 
Terrell, Harlan A. Pinto and Judith A. Melin. 
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mates and research assistants, the 
students’ secondhand bookstore (started 
by our class) is right where we left it; the 
rotunda at 333 Cedar St. welcomes all 
visitors. But there have been impressive 
renovations to the library which provide 
additional places to study and an online 
catalog. There is a new Children’s 
Hospital, among many other improvements. 
York Square Cinema, Yorkside Pizza 
and Cutler’s records remain; Gentree’s 
marquee is dark now, and Macy’s is 
closed. There is a Yale Co-op next to 
Harkness. The White Shop and the bank 
are no longer permanent fixtures next to 
the medical school. Ashley’s Ice Cream 
is right where it always was, and Louis’ 
Lunch still serves hamburgers, now even 
on Saturdays! 
Reunion attendees included: Alan 
Bloom and Sharon, Michael Choti and 
Carole, Elena Citkowitz, David 
Helfgott and Anita Cela, Rob Homer, 
Laurie Margolies and Jason Horowitz, 
Judy Melin, Lois Morton, David 
Norton and Claire, John Neal and Dora, 
Harlan Pinto, Alan Reznik and Liz, 
Moshe Rubin and Esther, Danny 
Sabbeth, Lenny Saltz and Gail, Laurie 
Schafer, Susan Seward and Dave, 
Michael Silverberg and Barbara 
Montana, Steven Sockin and Susie, 
Nancy Terrell, Michael Tom and Linda. 
Special thanks to David Helfgott, 
reunion co-chair for YSM '83, who 
provided the initiative, when June '93 
still seemed so far in the future, to begin 
planning and writing and organizing and 
calling. And, as always, our gratitude to 
Connie Tolliver and Patty for making our 
reunion so special. 
1988 
5th Reunion 
by Dr. Susan Valley 
The Class of 1988 held its 5th reunion. 
Although not as many came as we had 
hoped, those who did had an enjoyable 
weekend. In addition to participating in 
the scheduled activities, we joined the 
50th reunion class for dinner and topped 
off the weekend with an informal brunch 
which gave us a good chance to catch up 
with what everyone has been doing for 
the past 5 years. 
Those who participated included: 
Joi Barrett Rosenthal. Joi and Seth 
(YSM ’87) were married in 1988. Joi 
completed an internal medicine residency 
at Temple, while Seth was at University 
of Pennsylvania in radiation oncology. 
They currently live in Fair Oaks, Calif., 
outside Sacramento where they both are 
in private practice. Ruth joined the 
family in January. 
Martha Brochin finished her pediatric 
residency at Yale and is now in private 
practice in Hamden, Conn. She and Joe 
are planning to be married this fall. 
Kathleen Carney-Godley is 
practicing dermatology in Rhode Island. 
Her husband, Rick '85, completed his 
residency in ENT at Yale and is also in 
private practice. Fred Augustus Godley 
IV is 2, and Kathleen is expecting 
number two in November. 
Nicole Davis and Alex Vukasin 89 
are married and living in N.Y. Nicole is an 
attending in ob-gyn at New York Hospital, 
where she did her residency. Alex is in 
the middle of his urology residency at the 
same hospital. Their daughter, Gabriel, 
was 1-year-old in May. 
Rhonda Karol is practicing derma¬ 
tology in New York. Rhonda is recently 
married and decided to break with the 
class trend and marry someone outside of 
medicine. Her husband is a banker. 
Mike Rothschild and his wife, 
Jenny, and 3-year-old son are anticipat¬ 
ing a one-year move to Cincinnati, where 
Mike will do a fellowship in pediatric 
ENT. They then will return to New York 
where Mike will accept an attending 
position at Mt. Sinai Hospital. 
Susan Valley and Terry Chen 
(YSM ’84) were married in 1989. Susan 
was in the anesthesiology program at 
Yale while Terry completed his 
neurosurgical training. They are now in 
Alamo, Calif., Bay Area, where Terry is 
in private practice and Susan is at the 
University of California at Davis. They 
have two children. Julia is 2 years old 
and Christopher, 6 months. 
Leslie Weinstein completed her ENT 
training at Yale and has accepted a 
position in private practice in Daly City, 
Calif., Bay Area. 
Through the grapevine, we have 
heard about other classmates: 
Amy Bloch completed her residency 
in pediatric psychiatry and lives in White 
Plains, N.Y. 
Laura Dember followed her internal 
medicine residency at the University of 
Pennsylvannia with a fellowship in renal. 
Charisse Deutch married Mike 
Litchman (rheumatology fellow at Yale) 
after her internship. She completed 
neurology at Cornell and is now in 
private practice in the Greenwich area. 
Joe Dizon married in 1992 and com¬ 
pleted a cardiology residency at Columbia. 
Steve Dobscha is an attending at U.C. 
San Francisco VA in psychiatry. He lives 
in Berkeley, Calif., with his wife and two 
daughters, ages 2 years and 6 months. 
Chieh-Min Fan did internal medi¬ 
cine at Yale after her 5th year. 
Dave Galbraith and Janice Janas 
were manned. They have two children. 
Heidi, 2 , and Dave Jr. was bom in 1992. 
Robin Kornegay completed pediat¬ 
rics at the University of Chicago. 
Fred Lang is still a neurosurgical 
resident at New York University. 
Mike Mockovak is doing a pediatric 
ophthalmology fellowship in Chicago. 
Vivian Orey completed pediatrics at 
Mt. Sinai in New York and will be going 
to St. Paul for a pediatric primary care 
fellowship. 
Peggy Liao and Terry Yee were 
married in 1989. Peggy completed 
ophthalmology at Yale and a fellowship 
at Manhattan Eye and Ear, while Terry 
was finishing urology at Yale. They are 
headed for Hawaii. 
Peter Merkel did internal medicine 
at U. Penn and a rheumatology fellow¬ 
ship at M.G.H. He is an attending at 
Temple in Philadelphia. 
Mike Rigsby completed an infec¬ 
tious disease fellowship at Yale and is an 
attending at the West Haven VA. 
Linda Washington did internal 
medicine at Columbia and was pursuing 
a pulmonary fellowship. 
Steve Slovic completed a surgical 
residency at Columbia. 
If anyone has updates or wants to let 
us know what you are up to, drop us a 
note and we will write another newslet¬ 
ter. Sue Valley, 20 Inverrary Lane, 
Alamo, Calif. 94507 or Joi Barrett, 5004 
Runway Drive, Fair Oaks, Calif. 95628. 

























At the deem 's reception (right to left): R. Leonard Render, M.D. '43, 
and his wife, Joan, and Harold J. Bornstein Jr., M.D. '53 
Former Deputy Dean Arthur Ebhert, M.D. (right) takes 
time off from sailing to attend reunion weekend. 
Nan Godley, M.D. '48 (center) and her 
husband, Walter T. St. Goar, M.D. catch 
up with a reunion guest. 
Russell Scobie, M.D. '29 (center) was one 
of the pre-1943 graduates recognized at 
the A YAM annual meeting. 
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Development Report 
Alumni Survey Draws 
Overwhelming Response 
Until recently, the School of Medicine’s 
knowledge about its alumni/ae has been 
limited to basic information, such as class 
year, current residence, specialty, the 
year of the last reunion attended and 
similar facts. However, the Office of 
Development has long desired to 
supplement this with the perspectives and 
opinions of the alumni/ae — information 
that could assist the school in guiding 
alumni programming and development 
planning. 
To fill some of these gaps. Medical 
School Dean Gerard N. Burrow, M.D. 
’58, in cooperation with the Office of 
Development, last February mailed a six- 
page questionnaire to each of the more 
than 4,000 YSM alumni/ae. The 
questionnaire asked about attitudes about 
the school, participation in Association of 
Yale Alumni activities, preferences for 
reunion programs and publications, 
charitable interests and other topics. 
The response was overwhelming: 
More than 1,500 alumni/ae returned the 
questionnaire. The profile of respondents 
closely matches information which the 
school has about the alumni/ae, lending 
credence to the data generated through 
this survey. Approximately 4 in 5 alumni 
are men and, although the medical school 
has awarded degrees since 1814, nearly 
half of the living alumni/ae have gradu¬ 
ated since 1970. One-quarter still reside 
in Connecticut, half in the Northeast, and 
the remainder are scattered throughout 
the United States and world. 
Interestingly, only about half of the 
alumni/ae report their primary employ¬ 
ment as clinical practice; of the remain¬ 
der, 1 in 4 serves on a university faculty, 
1 in 6 is retired, and the balance hold 
administrative, research or other posi¬ 
tions. The alumni/ae represent all of 
YSM's medical specialties, but most 
common (19 percent) is internal medi¬ 
cine, with surgery, psychiatry and 
pediatrics the only other specialties 
accounting for more than 10 percent. 
The majority of respondents exhibit 
great affinity for the school. Most report 
feeling close to many former YSM 
classmates. About 1 in 6 has volunteered 
for the school, and one-quarter have 
referred a patient to Yale faculty physi¬ 
cians within the past five years. 
More than half (52 percent) have 
attended at least one class reunion, 
although fewer of the more recent 
graduates have yet to do so. Those who 
have been unable to attend most often 
report that there is no time or that 
returning to New Haven is inconvenient. 
In general, alumni/ae prefer a reunion 
with some educational programs, but 
those graduating within the past 20 years, 
in particular, desire more free time and 
social events. And 1 in 4 would attend a 
reunion were it to be held during the 
winter at a vacation resort. 
Through the school’s publications, 
alumni/ae keep abreast of events. Most read 
is Yale Medicine, published three times 
a year by the Office of Public Informa¬ 
tion; more than half read all of it, and 
nearly all report reading at least some of it. 
Nearly all alumni/ae have made a 
charitable contribution to the School of 
Medicine, and most report doing so in 
1992-1993. Of those who did not, most 
say other causes had greater priority. 
Recent graduates, however, simply 
cannot afford to contribute. Indeed, 2 in 
3 of those who graduated since 1980 
report outstanding education loans, 
averaging $25,000. 
Fortunately, alumni/ae recognize the 
need: The single purpose which alumni/ 
ae would like their donations to support 
is financial aid for current students. 
Nearly half (43 percent) give for unre¬ 
stricted purposes, permitting the school to 
decide how the funds should be applied. 
Both the dean and the Office of 
Development appreciate the time which 
all of the alumni/ae devoted to complet¬ 
ing this questionnaire. In the months 
ahead, the school will strive to respond to 
suggestions and comments. 







30% 30% 30% 
r\F\n 8 I 
m l 11V 4 _ 












S' S S 
vA 
A0 .6o° 
Y ale Medicine Fall/Winter 1993-1994 43 
National Campaign 
Committee Convenes 
As Yale strives to reach its $1.5 billion 
campaign goal “to ensure the enduring of 
a Yale education,” the School of Medi¬ 
cine is pursuing $285 million of the goal. 
The involvement and support of 
alumni/ae and friends are more critical 
than ever before, and the School of 
Medicine is forever thankful to all 
volunteers for their leadership. 
The National Campaign Committee 
brings together the school's most active 
volunteers. Led by John E. Avery Jr. 
'52, company group chairman of Johnson 
& Johnson, the committee is reaching out 
to individuals, foundations, coiporations 
and other grant-making agencies 
interested in Yale and medical research. 
Working with Mr. Avery are these 
National Campaign Committee members: 
Joseph J. Angeletti 
William G. Anlyan. M.D. '49 
Daniel L. Arons, M.D. ’67 
John E. Avery Jr. '52 
Harvey J. Berger, M.D. 'll 
Sharon L. Bonney, M.D. '16 
Walter J. Burdette. Ph.D., M.D. '42 
Gerard N. Burrow. M.D. '58 
Donald J. Cohen, M.D. ’66 
Lawrence G. Crowley. M.D. '44 
Michael J. Cummings, M.D. '65 
Lycurgus M. Davey, M.D. ’43 
Philip R. Fazzone, M.D. '58 
Robert L. Fisher, M.D. ’59 
John W. Foster, M.D. ’71 
M. Felix Freshwater, M.D. ’72 
Carol Goldenthal, M.D. '44 
Avi J. Hettena, M.D. ’76 
Kristaps J. Keggi, M.D. ’59 
Leonard Kemler, M.D. ’43 
Mohandas M. Kini, M.D. ’65 
Andrew J. McGowan, M.D. ’58 
Sreedhar Nair, M.D. 
John B. Oglivie, M.D. ’34 
Robert G. Petersdorf, M.D. '52 
David Anthony Rosow 
Paul A. Rudnick, M.D. ’58 
Nicholas P.R. Spinelli, M.D. '44 
Richard W. Trepeta, M.D. ’78 
Raymond W. Turner, M.D. ’58 
G. Virginia Upton, Ph.D. '64 
A. Lynn Williams Jr. 
Linda Starikov Singer 
Fund Supports Cancer 
Research at Yale 
More than 40 people gathered at the Yale 
Physicians Building to mark the estab¬ 
lishment of the Linda Starikov Singer 
Fund for Ovarian Cancer Research. The 
fund honors Mrs. Singer as a woman of 
extraordinary strength and talent, whose 
life was cut short by ovarian cancer in 
June 1988. The late Mrs. Singer, of West 
Hartford, was host of two television 
shows, a successful actress and theater 
director, as well as a teacher of dra¬ 
matic arts to young people and adults. 
She is especially remembered for her 
enthusiasm in helping teen-agers 
discover the arts. 
Mrs. Singer's widower, Bruce Singer, 
president of Puritan Furniture, estab¬ 
lished the fund, along with family and 
friends. The Singer fund will support the 
Spring Gathering: Pictured with representatives of the Paralyzed Veterans of 
America (PVA) and the Eastern Paralyzed Veterans Association (EPVA), depart¬ 
ment of neurology chairman and center director, Stephen G. Waxman, M.D., 
Ph.D., displays the most recent joint gift from the organizations. Since 1986, 
PVA and EPVA have given Yale more than $2.5 million to build the center at the 
Department of Veterans Affairs Medical Center in West Haven and support 
research on spinal cord injury and diseases of the central nervous system. 
research of Peter E. Schwartz, M.D., the 
John Slade Ely Professor and vice 
chairman of the department of obstetrics 
and gynecology, and chief of the section 
of gynecologic oncology. 
Bruce Singer (center) with his brother, 
Allan, (left) and Peter E. Schwartz, M.D. 
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Alumni Fund Report 
From the YSM Alumni Fund Chairman 
For the second consecutive year, the Yale 
School of Medicine Alumni Fund has 
raised more than $1 million for use by 
the school. The final 1992-1993 total 
was $1,335,581, which exceeds the 
annual goal by 30 percent. This amount 
is the greatest ever raised by the school's 
Alumni Fund during an annual campaign. 
It is notable that more than $900,000 of 
this year’s total was contributed by classes 
celebrating their reunions. Under the 
Reunion Gift Program, ably chaired by 
Board member Andrew J. McGowan Jr., 
M.D. ’58, several reunion classes and 
individuals set new records. Highlights 
include: 
• Single largest gift by an alumnus was 
made by Fred W. Buse, M.D. ’33, who 
was celebrating his 60th reunion. His 
$100,000 life-income gift eventually will 
revert to the school to support research 
on AIDS and other viral diseases. 
• The Class of 1958 — Dean Gerard N. 
Burrow’s class — set a new reunion 
record by raising $352,816, with 76 
percent participation. This money will be 
used to endow a Dean's Discretionary 
Fund for supporting selected projects. 
Raymond W. Turner, M.D. ’58 was the 
reunion gift chairman behind this 
remarkable effort. 
• The 50th Reunion Class of 1943, 
March, had the highest level of participa¬ 
tion among reunion classes, with 78 
percent of its members contributing. 
Reunion Gift Chairmen Lycurgus M. 
Davey, M.D. '43 and R. Leonard 
Kemler, M.D. ’43 with Class Agent 
Dorothea R. Peck, M.D. '43 led their 
class, which gave $155,678. 
The Reunion Gift Program, now in 
its third year, is designed to encourage 
alumni/ae to make a special gift of support 
to the School of Medicine during their 
reunion years, in addition to their regular 
Annual Fund contribution. I am very 
pleased that, to date, alumni during their 
reunion years have made both kinds of gifts. 
However, I would like to take this 
opportunity to encourage alumni/ae from 
both classes which recently celebrated 
their reunions to continue to make their 
annual gifts, as they pay off their reunion 
John W. Foster, M.D. '71 
pledges. The school also depends on 
these annual contributions to provide 
student financial aid and to maintain its 
day-to-day academic life. Class agents, 
during reunion years, will participate in 
the Reunion Gift Program, working even 
more closely this year with the reunion 
gift chairmen and their committees. 
Our board of directors, the reunion 
gift chairmen and their committees, and 
our class agents have demonstrated their 
leadership in setting the fund’s direction 
and pace, in working to organize the solici¬ 
tations, and in displaying the personal 
generosity that has enabled the fund to 
accomplish so much. However, these 
individuals alone cannot accomplish the 
important work of the Alumni Fund. 
To achieve our important and 
ambitious goals, we must have the 
participation of all our alumni/ae, in both 
reunion and non-reunion classes. For 
1993-1994, we have set a fund goal of 50 
percent alumni participation, with a total 
gift of at least $1.2 million. 
On behalf of the Yale School of 
Medicine, I would sincerely like to thank 
those who worked on the campaign this 
year and those who contributed. 
John W. Foster, M.D. '71 
Chairman 
YSM Alumni Fund 
Dean’s Message 
During this incredibly exciting and 
constantly evolving period in health care 
change and management, the Yale 
University School of Medicine greatly 
values the contribution, both professional 
and financial of its alumni/ae. Your 
support provides strength, breadth and 
depth to this school and University. 
This is my second message to the 
School of Medicine Alumni Fund 
contributors and 1 am extremely pleased 
with the continuing rise in the amount of 
charitable giving during the fiscal year. 
Medical alumni/ae fund donations sur¬ 
passed the seven-figure level for the 
second consecutive year. The percentage of 
alumni/ae who contribute is stable because 
of the dedication and hard work of 
alumni/ae volunteers and staff members. 
Their support is gratefully acknowledged. 
I would like especially to thank my 
own class, the Class of 1958, for estab¬ 
lishing a dean's discretionary fund. Ray 
Turner and his ambitious committee, 
solicitated a record-breaking 25th- 
reunion gift of $352,816 for me and my 
successors to support special needs 
identified at the school. I am very 
honored by your thoughtfulness and 
generosity. 
In this new year, I express my heart¬ 
felt thanks and send my warmest regards. 
Gerard N. Burrow, M.D. '58 
Dean 
Yale Medicine Fall/Winter 1993-1994 45 
Medical Alumni Fund 
The names and data included on the following pages were provided by the Yale School of Medicine Alumni Fund and reflect contributions 
made between July 1, 1992 and June 30, 1992. Posthumous donations are denoted by asterisk (*). 






Chester E. Hurwitz* 
Helen P. Langner 
Charles R. Mitchell* 
Willys M. Monroe* 
Michael A. Parlato* 
Ernest Russell* 
Max R. Smirnow* 
Ralph Emerson Taylor* 
Walter Clark Tilden* 
T. Beers Townsend* 





Julius Anthony Olean* 
Hyman W. Weinstein* 




David M. Raskind 
Donato Anthony 
D'Esopo* 
David M. Raskind 
Myron A. Sallick* 
Jacques Diamond Soifer* 




Alice A.S. Whittier 
Waldo F. Desmond* 
Samuel Reback 
Eli Hyman Rubin* 
Alice A.S. Whittier 
Howard Asa Wood* 





Stanton T. Allison* 
Maxwell Bogin 
William H. Hahn* 
Joseph L. Hetzel* 




Harry' M. Zimmerman 
Wallace Robert Bostwick* 
Henry Irwin Fineberg* 
John Martin Freiheit* 




William C. Meredith 
Harry M. Zimmerman 






Sheldon A. Jacobson 
Edward P.J. Kearney 
Ralph E. Knutti 
Edward W. Ludwig* 
Nathan E. Ross 
Robert I. Rubinstein* 
John M. Russell* 
Alvin A. Schaye* 





James Rae Ameill Jr.* 
John M. Bailey* 
John W. Cass Jr.* 
Olive Gates 
Alexander O. Haff* 
John A. Hangen 
Tony Liebman Rakieten 
William Frederick Roth Jr.* 




Julius G. Weiner* 
Mabel Wilson 




Daniel N. Beers* 
Charles A. Breck* 
Lewis Dickar* 
Vincent A. Doroszka* 
Knox H. Finley 
J. Roswell Gallagher 
Amy H. Hunter Wilson* 
Paul Harold Lavietes* 
Moses D. Lischner* 
James Merriman Lynch* 
John C. Mendillo 
Paul Watson* 
Charles L. Wood* 




Henry H. Briggs Jr.* 
Benjamin Castleman* 
Michael D'Amico* 
Paul A. Harper 
Morris Heller* 
Thomas C. Jaleski 
Rhoda M. Mickey 
Max Taffel 




Reginald V. Berry* 
Henry Brill* 
Frank Carroll 
Clement C. Clarke 
Joseph P. Donnelly* 
Thomas E. Farthing* 
Elizabeth M. Ramsey 
Myron E. Wegman 
Roland T. Wehger* 




Myron J. Adams* 
Fred W. Buse 
Warren P. Cordes 
Franklin M. Foote 
Jack Greenberg 
Daniel Foster Harvey* 
Robert Watkinson 
Huntington Jr.* 
Raymond Everett Miller* 
Ashley Pond III* 
Paul L. Saffo 
Edwin B. Seelye* 
Sidney Stringer* 




John B. Ogilvie 
Joseph Budnitz 
Francis P. Guida* 
Derick Algernon January* 
Knowles B. Lawrence 
Herbert C. Miller 
Edward Thomas 
O'Donnell* 
John B. Ogilvie 
Lucien M. Pascucci 
Harry Sherman 
George Zalkan* 






Walter E. Barney* 
George A. Carden Jr. 
H. Hoffman Groskloss 
James Quintin 
Haralambie 
W. Howard Horner* 
Mildred Hartshorn 
January 
Samuel D. Kushlan 
Donald P. Morris* 
Norman E. Peatfield 
John D. Preece 
Norman P. Rindge 
Milton Rose* 
Clark P. Searle 
Walter A.L. Thompson 




Lester W. Burket* 
Albert W. Diddle 
Margaret C.L. Gildea 
George A. Hahn* 
Louise G. Hutchins 
Philip M. LeCompte 
Donald F. Marshall 
Stephen F. Nagyfy 
Frederick A. Post* 
Hugh Allan Smith 
Margaret Sommers 
Morris Tager 




Wilbur D. Johnston 
Edmund R. Blower 
William G. Cooper Jr. 
Guido A. Deblasio 
David A. Dolowitz 
Wilbur D. Johnston 
Alfred E. King 
Dunham Kirkham 
Julia Mehlman 
James P. Morrill 
Morgan Sargent 
Edward J. Shaw 
Albert D. Spicer 
John M. Thomas 
Jean Wells 
Lorande M. Woodruff 
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Nelson K. Ordway 
Roy N. Barnett 
Benjamin E. Lyons 
John J. McGillicuddy 
Nelson K. Ordway 
Edward W. Pinkham Jr. 
James Radcliffe Jr. 
George E. Roberge 
Theodore W. Steege 
Lester J. Wallman 




Rebecca Z. Solomon 
Stephen W. Collins Jr.* 
Harold H. Coppersmith 
Norman L. Cressy 
William H. Druckemiller 
Robert Goodfellow Ernst* 
John P. Ferguson Jr. 
Joseph B. Forman 
S. Jerome Greenfield 
Nathaniel Kenigsberg* 
Arthur E. Laidlaw 
Margaret A. Lennox 
Ward J. McFarland* 
James Peter Murphy 
Russell Nahigian* 
Ernest L. Sarason 
Bradford Simmons 
Rebecca Z. Solomon 
John D. Tobin 
Arthur S. Tucker* 
Darrell G. Voorhees 
Douglass W. Walker 
John H. Wentworth 
Malvin F. White 




James F. Ferguson Jr. 
Theodore E. Allen 
Joseph V. Baldwin 
Ronald S. Beckett 
Jack S. Blaisdell 
Philip S. Brezina 
David Crocker* 
Wynant Dean 
Richard E. Donnont 
James F. Ferguson Jr. 
Eugene J. Fitzpatrick Jr. 
Henry D. Humphrey 
H. Stuart Irons* 
Donald G. Johnson 
Ira D. LeFevre Jr. 
John D. MacAllister 
Paul D. MacLean 
Edward Martin 
Maurice Ross* 
W. Norman Sears* 
Joseph E. Sokal* 
J. Champneys Taylor 
Patricia E. Wanning 
Helen H. Woods 




Charles B. Cheney 
Sophia H. Alway 
Robert H. Areson* 
W. Randal Bell 
Knute E. Berger* 
William A. Carey 
Charles B. Cheney 
Herbert W. Diefendorf 
Robert F. Dine* 
Peter A. Duncan 
John E. Fenton 
Lloyd D. Flint 
Frederick P. Glike 
William Edmund Kenney 
William Lee 
John R. McDermott* 
Willys M. Monroe 
Malcolm C. Murfitt 
Edward B. O’Connell 
Robert W. Ollayos 
Gioacchino S. Parrella 
Edwin D. Rogers 
Leslie Simmonds 




Walter J. Burdette 
James M. Bunce 
Walter J. Burdette 
Robert E. Carroll 
Donald S. Childs Jr. 
Vincent J. Collins 
Eugene M. de Hostos 




Allan V.N. Goodyer* 
William Harrison Jr. 
Wilson E. Hughes* 
Leo Kellerman 
John R. Lincoln 
Patrick S. Mullins* 
Dean Nichols* 
Samuel Ritvo 
Lois Knight Rogers 
Charles F. Scholhamer 
Richmond W. Smith Jr. 
Edgar B. Taft 
Maurice Tulin 
Francis P. Vose* 
Irving Norman Wolfson 




Lycurgus M. Davey 
R. Leonard Kemler 
Dorothea R. Peck 
Ralph D. Alley 
John R. Brobeck 
Edward S. Brown 
Lycurgus M. Davey 
R.M. Fasanella 
Gerard Fountain 
Jessamine R. Goemer 
Edward Douglas Homing* 
R. Leonard Kemler 




J. Philip Loge 
Henry E. Markley 
Dorothea R. Peck 
Edward F. Rabe 
Earl J. Rhoades 
Henry A. Riedel 
Bernard R. Rowen 
Marcus E. Sanford 
Robert A. Sears* 
Reginald H. Shephard 
Edward Hersey Soule 
Hilliard Spitz 
Sophie Trent Stevens 
Oliver G. Stonington 
Robert G. Turner 
Frederick A. Waldron* 
Morris A. Wessel 
Robert H. Wyatt 




S. Brownlee Brinkley 
Richard N. Abbott 
John R. Almklov 
Ray C. Bitterlich 
David G. Borden 
James L. Bradley* 
Robert F. Bradley 
S. Brownlee Brinkley 
Henry B. Bruyn Jr. 
Thomas L. Bucky 
Jane B. Cadbury 
Philip B. Chase 
Hunter H. Comly 
Norman I. Condit 
Thomas D. Cook 
Ronald W. Cooke 
Joseph I. Epstein 
Robert H. Furman 
Victor C. Hackney 
Frank R. Hurlbutt Jr. 
Henry H. Jones 
Joseph F. Kell 
Sawyer E. Medbury 
Hoyt B. Miles Jr. 
B. Allen Richardson* 
Benjamin R. Robinson Jr. 
Donald W. Seldin 
Francis A. Spellman* 
Stanley J. Weigel* 
W. Keasley Welch 




Nicholas P.R. Spinelli 
Carl E. Andrews 
Joseph Ciola* 
Edward J. Conway 
Robert E. Cooke 
John C. Coolidge 
George B. Corcoran Jr. 
Frank W. Countryman 
Lawrence S. Crispell* 
Charles H. Crothers 
Lawrence G. Crowley 
John H. Doherty 
Robert W. Frelick 
Carol Goldenthal 
Charles A. Hall* 
Howard B. Hamilton 
Robert I. Hinkley 
Ward S. Jenkins 
Edith M. Jurka 
Jerome J. Kaye 
John Weaver King 
Frederick F. Krauskopf 
Ronald E. Losee 
Ellen P. MacKenzie 
Elias J. Marsh 
Katharine Hawley Martin 
Joseph Massaro 
A. Reese Matteson 
Paul E. Molumphy* 
Russell R. Monroe 
Lawrence K. Pickett 
Laurence G. Roth 
Haynes W. Sheppard 
Sarah P. Sherwood 
Eugene Smith 
Nicholas P.R. Spinelli 
Mrs. Gertrude Spinelli* 
Priscilla Dienes Taft 
Anthony Varjabedian 
Calvin Watts Woodruff* 
Reuben Zucker* 




Richard W. Breck 
George Howard Allison 
Albert S. Atwood 
Frederic M. Blodgett* 
Richard W. Breck 
Louise H. Burr 
Alice Shepard Cary 
Richard R. Dyer 
Robert S. Easton 
Alice Dershimer Friedman 
Raymond A. Gagliardi 
James D. Gardam 
Philip S. Good 
Herbert S. Harned Jr. 
Isao Hirata Jr. 
Paul W. Hoffert 
O. Roger Hollan 
Hans R. Huessy 
William L. Jenney 
Michael W. Lau 
William E. Laupus 
Mark McD Lindsey 
James R. Mason 
Charles E. McLean 
George W. Naumburg Jr. 
Charles E. Sherwood 
Joseph R. Stanton 




Margaret J. Albrink 
William G. Banfield Jr. 
Aaron T. Beck 
Franklin C. Behrle 
Sanfurd G. Bluestein 
Linus W. Cave 
Thomas J. Coleman 
James F. Cooney* 
George C. Cusick 
Thomas A. Doe 
Edward F. Edinger 
H. Lambert Filer Jr. 
Gregory E. Flynn 
Martin E. Gordon 
Charles Sheldon Judd Jr.* 
Harold King 
Benjamin F. Kitchen Jr. 
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James A. Kleeman 
Vincent J. Longo 
Richard Hess Mann* 
Thomas J. Mathieu 
Hugh J. McLane 
Joe D. Morris 
John H. Morton 
John F. Neville Jr. 
Laura W. Neville 
Harry Dickson Patton 
Vincent Pepe 
Francis G. Reilly* 
David H. Riege 
Phillips E. Roth 
Donald P. Shedd 
Richard G. Sisson 
R. Bruce Thayer 
Robert R. Wagner 
William J. Wedemeyer Jr. 
Thomas J. Whelan Jr. 
Hugh R. Williams* 




George R. Barnes Jr. 
W. Roy Breg Jr. 
George R. Barnes Jr. 
John E. Bowers 
W. Roy Breg Jr. 
Richard G. Britton* 
Rocco A. Calandruccio 
John L. Cannon 
M. Richard Carlin 
John C. Carpenter 
Charles R. Cavanagh Jr. 
Amoz I. Chemoff 
William F. Collins Jr. 
Bradford S. Colwell 
Robert P. Darrow 
Archie L. Dean Jr. 
Jean H. Dougherty 
Owen W. Doyle 
Edward Foord* 
Richard K. Friedlander 
Frank L. Golbranson 
Robert J. Kerin 
Don F. Kimmerling 
Brock Lynch 
Victor A. Machcinski 
Charles L. Mache Jr.* 
William K. McClelland 
Robert F. Newton 
Myron K. Nobil 
Lawrence C. Perry* 
Philip H. Philbin 
Olive E. Pitkin 
Irving Rudman 
Lawrence P. Shea* 
Alvin Somberg 
Igor Tamm 
Patricia B. Tudbury 
Ellis J. Van Slyck 





Jerome H. Shapiro 
Russell J. Barmett* 
George F. Batten 
Edith M. Beck 
Jonathan S. Bishop 
Allyn G. Bridge 
Richard H. Cote 
G. Robert Downie 
Victor A. Drill* 
Elizabeth Fuller Eisner 
Boy Frame* 
Emil Frei III 
Julian Frieden 
Anne Godley 
Paul S. Goldstein 
Allan Green* 
B. Herold Griffith 
Sylvia Preston Griffiths 
Richard M. Hannah 
W. Rayner Johnson 
Paul B. Koehler 
C. Arden Miller 
John P. Morris 
John B. Morrison 
David E. Morton 
James W. Needham 
George P. Rostel 
Lewis P. Rowland 
Benjamin F. Rush Jr. 
Gabriel A. Saviano* 
Jerome H. Shapiro 
Jessie Parkinson Spear 
Paul Talalay 
Wallace W. Turner 
Paul Woodbury Weld 




Daniel W. Elliott 
William G. Anlyan 
DeWitt C. Baldwin Jr. 
Jonathan S. Bishop 
Mary Pucci Couchman 
Phillip G. Couchman 
N. Joel Ehrenkranz 
Daniel W. Elliott 
Albert A. Fisk 
Eleanora C. Gordon 
Frederic W. Gray 
Daniel K. Halvorsen 
Jackson Harris 
Frederick R. Hine 
Halsted R. Holman 
Benjamin A. Johnson 
Frank D. Law 
Orval I. McKay 
Orlando J. Miller 
Timothy F. Nolan Jr. 
Julian I. Pichel 
Charles L. Rennell Jr. 
Murray Z. Rosenberg 
Daniel Rudman 
Carl M. Russell 
Lawrence E. Shulman 
R. David Sudarsky 
Martha Vaughan 
Vernon T. Watley 
Mary-Agnes P. Wine 




Russell N. Anderson* 
Lyal D. Asay 
Sylvia L. Axelrod 
Malcolm A. Bagshaw 
John E. Borowy 
William H. Bucher 
Alvin Davis 
Claude W. Delia 
Marie C. Duncan 
Kent Ellis 
Thomas J. Ferraro. Jr. 
Daniel Fine 
Yvette F. Francis 
Lawrence R. Freedman 
David A. Frucht 
Carl A. Gagliardi 
Archie James Golden* 
Melvin H. Kaplan 
Lucian S. Lapinski 
Sidney S. Lee* 
Janus C. Lindner 
Margaret S. Lyman 
Harold March 
Harry L. McClelland 
Marina P. Meyers* 
John H. Meyers 
Orlando J. Miller 
Charles A. Nugent. Jr. 
Robert Edward Quinn* 
Robert T. Sceery 
Cynia B. Shimm 
Jane B. Shumway 
Martin E. Smith* 
John S. Strauss 
B. Lionel Truscott* 
Myra D. Tyler 
Frederick Edward Vultee* 





Karel Bedrich Absolon 
W. Robert Adams 
Frank R. Allen 
Thomas T. Amatruda Jr. 
Stanley D. Ardell 
Eleanor Clay Bigley 
John J. Egan 
Ferdinand H. Flick 
Sidney S. Furst 
Joseph M. Garland 
Lowell 1. Goodman 
John T. Groel 
Robert N. Hamburger 
John V. Haxo 
Carrold K. Iverson 
Jocelyn S. Malkin 
Francis L. Merritt 
Paul D. Millikin 
Walter S. Morgan 
Albert R. Mowlem 
Richard S. Munford 
Ismail Nik Nevin 
Gerard B. Odell 
Jose Felix Patino 
Arthur A. Pava 
Majic S. Potsaid 
William F. Stephenson 
William A. Taylor* 
Andrew S. Wong 






Siegried A. Centerwall* 
Frank R. Coughlin. Jr. 
Richard N. deNiord, Jr. 
Richard D. Floyd 
Thomas S. Kelly 
William W. Klatchko 
James Kent Luce 
N. Karle Mottet 
Sidney Nathan Paly 
Robert G. Petersdorf 
Leon A. Phillips 
John Macklin Roberts 
Leonard Rush 
Mary Wheatland Schley 
Donald H. Schultz 
Robert B. Schultz 
John H. Wagner Jr. 
Doris L. Wethers 
John L. Wolff 
Harvey L. Young* 
Robert Zeppa* 








Harold D. Bomstein Jr. 
Remi J. Cadoret 
William R. Chaffee 
Allen Chetrick 
Rex B. Conn 
Louis R.M. Del Guercio 
John Leo Doppman 
James P. Dunn 
Donnell Dencil Etzwiler 
Thomas O. Gentsch 
Vincent Lynn Gott 
Robert Emanuel Hamlisch 
George L. Hoffmann 
David Purdy Holman 
Peter Biggs Hukill 
Robert Francis Kiley Jr. 
Richard Robert Knowles III 
Frederick Martin Lane 
Hildegard Mueller Leslie 
Preston Lee Leslie 
John Dutch Lord 
Robert N. Melnick 
Harvey Martin Peck 
Warwick Potter Jr. 
Paul G. Quie 
Jose Ramirez-Rivera 
Irwin K. Rosenberg 
Barbara F. Rosenberg 
Virginia C. Saft 
Richard Andrew Sinnott Jr. 
Howard Willis Smith 
Ora K. Smith 
John Frazier Snyder III 
Lynn Cortland Stoker 
William Junior Vandervort 
William August Wilson 
James Frederic Young 




John Keith Rose 
Frank P. Berg 
George W. Bostwick 
Richard J. Bouchard 
George N. Bowers Jr. 
Ralph K. Campbell 
John R. Cole 
Alan H. Covey 
Arthur C. Crovatto 
Donald D. Davis 
Walter J. Freeman 
John A. Gariepy 
Edward J. Gerety 
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Memorials 
Deceased medical alumni/ae and friends may be memorial¬ 
ized by a gift at any time to the School of Medicine Alumni 
Fund endowment in the name and class of the person so 
honored. The next-of-kin of a deceased medical alumnus/a 
is advised about this In Memoriam Program by a mailing 
from New Haven some weeks after the School of Medicine 
receives notification of the death. The letter of information 
includes a copy of the Testament of Remembrance in which 
the names of all persons so memorialized are listed in the 
medical section by class, thus establishing a lasting memo¬ 
rial. Donors receive a personally penned note of apprecia¬ 
tion from the In Memoriam program director. Your 
inquiries and interest are welcome. 
Yale University 
Office of the Alumni Fund-Memorials 
P.O. Box 1890 
New Haven, CT 06508-1890 
(203) 432-5853 
Deceased alumni and friends so honored in 1992-1993 were: 
Max R. Smimow '06 
Jacques Diamond Soifer ’24 
Vincent A. Doroszka ’30 
Henry H, Briggs Jr. ’31 
Robert B. Jamieson Jr. ’37 
Edmund R. Blower ’37 
Robert H. Are son ’41 
C. Wesley Watson ’43 
B. Allen Richardson ’43 
Stanley J. Weigel ’43 
William G. Banfield Jr. ’46 
Charles Sheldon Judd Jr. '46 
Charles L. Mache Jr. '47 
Lawrence C. Perry ’47 
B. Lionel Truscott ’50 
Siegried A. Centerwall '52 
Earl D. Rees '54 
William E. Lattanzi ’55 
John Currier Gallagher ’58 
Gary Van Galder ’63 
David J. Kreis Jr. ’77 
Laura Kuckes ’88 
Edward H. Diamond (fiend) 
In Memoriam Program 
the Rev. James R. Blanning 
Director 
the Rev. William E. Bliss 
Director 
the Rev. Richard G. Jordan 
Director Emeritus 
Samuel T.J. Giammona 
Frank L. Gruskay 
Nicholas A. Halasz 
Katherine H. Halloran 
Robert P. Hatch 
Walker R. Heap Jr. 
Eva H. Henriksen 
Samuel J. Hunter 
Herbert S. Hurwitz 
Robert F. Hustead 
Robert J.T. Joy 
Donald S. Komfeld 
Lowell A. Kristensen 
Richard Lamb 
Harry C. Miller Jr. 
Paul N. Neufeld 
James J. Nora 
Lowell E. Olson 
William J. Paule 
Anthony V. Piccirillo 
Richard D. Pullen 
Jacques M. Quen 
Earl D. Rees* 
John Keith Rose 
Elihu M. Schimmel 
Leonard M. Silvemian 
Robert L. Stein 
Martin B. Vita 
John W. Vosskuhler 




Robert A. Kramer 
John C. Bailar III 
George E. Becker 
E. Edward Bittar 
Jerome Bobruff 
Douglas G. Boy den 
Joseph I. Boylan Jr. 
Irwin M. Braverman 
Edward Noel Brennan 
Padraic Bums 
Paul Calabresi 
Leo R. Cardillo 
Nicholas A. Coassin 
Edward D. Coppola* 
Pasquale James Costa 
Robert G. Crounse 
John G. Daley 
Charles Daukas 
Fred Wendell Doyle 
Leroy Engel 
F. Robert Fekety Jr. 
Edwin G. Fernand 
Mahlon V.R. Freeman 
James Conway Garlington 
Paul Gonick 
Ion Gresser 
John H. Hodge 
D. Franklin Johnson Jr. 
Harry O. Kendall 
David R. Kessler 
Robert A. Kramer 
Edward A. Krull 
William E. Lattanzi* 
Roger Lester 
Alexander Maitland III 
Joseph S. McGuire Jr. 
James P. Nolan Jr. 
Sherwin B. Nuland 
Gloria C. Onque 
Edward J. Ottenheimer Jr. 
Robert H. Peters Jr. 
Robert A. Reich 
Clement B. Sledge 
Phillip W. Smith 
Alan A. Stone 




John H. Gardner III 
Donald J. Dalessio 
Levon Z. Boyajian 
Thomas M. Brown 
Rosalie A. Bums 
Edwin L. Child 
James C. Collias 
Donald J. Dalessio 
Chandler Dawson 
Mitchell Edson 
Gilbert M. Eisner 
Thomas F. Ferris 
John B. Fine* 
John H. Gardner III 
Sumner Gochberg 
George E. Green 
Val Shea Greenfield 
Robert H. Groves 
Ame G. Haavik* 
Joan Marasco Hardenbergh 
John Herd Hart 
Robert L. Hill 
William H. Hindle 
Marie-Louise T. Johnson 
George T. Kammerer 
Jerome O. Klein 
William V. Lewit 
Preston C. Manning 
Dwight F. Miller 
Elmer T. Mitchell Jr. 
Norman F. Moon 
Donald J. Nalebuff 
A. Frederick North Jr. 
David A. Page 
George W. Paulson 
Stewart E. Pursel 
Robert J. Rice 
Robert Lee Scheig 
Edward C. Senay 
Benjamin A. Shaver Jr. 
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Donald William Sherrick 
Daniel R. Silbert 
Theodore K.L. Tseu 




Harry C. Briggs 
Howard A. Minners 
Donald Agostinelli 
Jack Norman Blechner 
Richard I. Breuer 
Harry C. Briggs 
John P. Carey 
Albert K. Chun-Hoon 
Louis Z. Cooper 
Harold Dick Cross 
James R. Doit 
Salvatore Falbo 
Harold J. Fallon Jr. 
Robert E. Fishbein 
James R. Fitzgerald 
Elizabeth H. Forsyth 
Gary A. Fry 
Robert H. Glass 
Anne H. Good 
Jack Peter Green 
Gilbert F. Hogan 
Warren R. Johnson 
Richard Lee Kahler 
Stanley E. Kilty 
William L. Kissick 
Jack Levin 
Bennett F. Markel 
Howard A. Minners 
Robert K. Modlin 
Hugh Lamson Moffet 
George Albert Nelson Jr. 
Herbert A. Newman 
Thomas Francis 
O'Brien Jr. 
Joseph S. Pagano 
Raymond E. Phillips 
Clifford B. Reifler 
Arnold Schoolman 
Stanley Simbonis 
Gilbert B. Solitare 
Donald C. Stahl 
William J. Waskowitz 
James G. Zimmer 






Paul A. Rudnick 
Raymond IV. Turner 
George K. Aghajanian 
Don P. Amren 
Joseph E. Angelo 
John P. Arnot 
Frederick Baekeland 
Peter Alfred Benson 
William C. Branscome 
A. Russell Brenneman 
Gerard N. Burrow 
David A. Carlson 
John A. Carlston 
John A. Creatura 
Robert V. Diserens 
Donald A. Duncan 
Joel C. Eberlin 
Philip R. Fazzone 
Michael E. Fishman 
Raymond A. Gaito 
John Currier Gallagher* 
Marcia Kraft Goin 
William M. Gould 
James Greenwald 
Charles A. Hall Jr. 
Stanley Harris 
Ernest L. Hartmann 
Roger C. Herdman 
Michael Kashgarian 
Haskins K. Kashima 
Jay Ward Kislak 
Theodore W. Lieberman 
Myron Lotz 
Jack Wayne Love 
Thomas J. Mauro Jr. 
Michael J. McCabe 
Leo T. McCallum 
Andrew Joseph 
McGowan Jr. 
John A. Merritt Jr. 
Richard Charles Miller 
Albert Muggia 
Robert S. Neuwirth 
Carol F. Phillips 
David M. Pugh 
William B. Radcliffe 
Paul A. Rudnick 
Bruce H. Sklarew 
Edward lJoyd Socolow 
Arlene Sweedler 
Raymond W. Turner 
Joseph P. Wierzbinski HI 
John Patrick Wood 
Pauline B. Wood 
Robert W. Wroblewski 
Gladys Brooks Foundation 




Asa Bames Jr. 
Muriel D. Wolf 
Scott Ingram Allen 
Carol J. Amick 
Robert M. Amick 
Asa Barnes Jr. 
Francis A. Beer 
Jack F. Bowers 
Edwin M. Clayton 
Martin Colodzin 
Lyall S. Crary Jr. 
Ronald C. De Conti 
William L. Donegan 
Gerald Fenichel 
Robert L. Fisher 
Paul Jay Friedman 
Eric Gilletl 
Gerald B. Gordon 
David Gowing 
H. Rodney Hartmann 
William H. Heydom 
C. Richard Hinckley 
Leonard Inker 
Edvardas Kaminskas 
Herbert J. Kaufmann 
David W. Kingsbury 
Parry B. Larsen 
Myron S.S. Lee 
Kathryn Huxtable Lewis 
John C. Marsh 
Peter M. Molloy 
James A. O’Neill Jr. 
Nicholas M. Passarelli 
Charles A. Phillips 
James D. Prokop 
James R. Ralph 
David Pardee Reed 
Joseph D. Saccio 
Constantine J. Sakles 
Marc D. Schwartz 
Owen A. Shteir 
Sanford P. Solomon 
Gene W. Spector 
James J. Stagnone 
John S. Strauss 
Lois W. Tice* 
Muriel D. Wolf 




Eugene C. Gaenslen Jr. 
Thomas P. Kugelman 
Victor A. Altshul 
Alan W. Ames 
Stuart P. Bowne 
Donald P. Buebendorf 
Stanley M.K. Chung 
Gerald N. Cimmino 
Francis D. Cogliano 
Neil R. Cooper 
Jon E. Courtney 
Malin Dollinger 
David Paul Dunn* 
Warren H. Fisher 
Eugene C. Gaenslen Jr. 
James I. Gilman 
Sylvia D. Grant 
Roland H. Ingram Jr. 
Daniel M. Jones 
William S. Kaden 
Eric P. Kindwall 
Frank J. Kleeman 
Susan T. Kleeman 
Thomas P. Kugelman 
Edward R. Lang 
Thomas L. Lincoln 
Eugene G. McCarthy Jr. 
Donald L. Miller 
Richard G. Morrill 
Allan W. Newcomb 
Buford L. Nichols Jr. 
Fred Palace 
Jerrold M. Post 
Daniel J. Rubin 
John J. Schrogie 
Fred Stargardter 
Robert C. Wallach 
May Yung-Fun Woo 
Wang 
Ronald A. Yankee 
Class of 1960 Medical 




Robert S. Briggs 
Warren D. Widmann 
Kenneth A. Arndt 
Earl L. Baker 
Frank H. Baker 
Albert A. Bechtoldt Jr. 
Robert S. Briggs 
Orson R. Dee 
Paul David Deiter 
Ronald A. Dierwechter 
Jon Dudley Dorman 
T. Wayne Downey 
John E. Fenn 
Louis D. Hunt 
Richard L. Keefe 
Paul M. Leand 
Robert Isaac Levy 
George M. Lordi 
Hugh James Lurie 
Sally Lockwood Marchesi 
Vincent T. Marchesi 
David B. Matloff 
Anoush Miridjanian 
Richard Allen Moore 
Norman I. Moss 
Roland D. Paegle 
John Curtis Parker 
Elaine Pitt 
Bruce C. Robinson 
William M. Rogoway 
Roy E. Ronke Jr. 
Shaun J. Ruddy 
Charles R. Sachatello 
Thomas H. Sakoda 
Stanley G. Schade 
Robert R. Springer 
John J. St. Andre 
Robert N. Taub 
Hugh C. Thompson III 
Franklin H. Top Jr. 
David E. Weaver 
Warren D. Widmann 
Murray Wittner 
John R. Woodward 
Donald A. Young 




A. Richard Pschirrer 
Fredric K. Cantor 
Michael H. Alderman 
Charles B. Anderson 
Frederic P. Anderson 
Spencer J. Brody 
Fredric K. Cantor 
Oliver Townsend Dann 
Arnold Joel Eisenfeld 
I. Bruce Elfenbein 
John W. Foreman 
Stephen John Fricker 
Anthony V. Furano 
John N. German 
John H. Hageman 
John T. Harrington 
Patricia C. Hassakis 
Walter Watson Kamey 
Glenn L. Kelly 
David E. Knoop 
Manuel J. Lipson 
John P. Lynch 
Carter L. Marshall 
Allan L. Mattem 
Stanley E. Matyszewski 
David J. McConnell 
William G. Meffert 
William A. Miller 
Malcolm S. Mitchell 
David D. Nicholas 
A. Richard Pschirrer 
Joseph Ross 
Edward L. Spencer Jr. 
James A.E. Spencer 
Nancy Ann Staley 
Larry Lee Stewart 
Seth Thaler 
Sherwood Waldron Jr. 
William Farnsworth Weber 
Stewart R. Wright 
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Craig H. Llewellyn 
Peter B. Gregory> 
Barbara Rosenthal Almond 
Miguel R. Alonso 
V. Richard Back 
Wayne D. Brenckman Jr. 
Charles W. Carl Jr. 
Theodore J. Chu 
David F. Cross 
James S. Dalsimer 
Dudley Seth Danoff 
Andrew Edin 
John P. Eliopoulos 
Jon Michael Fessel 
B. Allen Flaxman 
David H. Fram 
William T. Friedewald 
David FI. Fulmer 
Vincent F. Geremia Jr. 
Lee D. Goldberg 
Peter B. Gregory 
Benjamin Keith Harris 
Stephen Joseph 
i Edward C. Larkin 
William B. Lehmann 
Peter B. Livingston* 
Craig H. Llewellyn 
Edward G. Lund Jr. 
John L. Mahoney 
Herbert Meltzer 
Robert E. Mueller 
Sheldon R. Pinnell 
Jay M. Pomerantz 
William F. Porter Jr. 
Thomas A. Savignano 
Alan E. Shapiro 
Marvin R. Skolnick 
Lee Bland Talner 
Richard M. Thompson 
Thomas W. Tillack 
Peter V. Tishler 
Lawrence Tremonti 
Peter G. Weiner 
Seth M. Weingarten 
James G. Wepsic 
Charles S. Wilson 
Edward F. Wilson 
Jerome Allen Winer 
Alfred J. Wise 




William J. Houghton 
Robert W. Lyons 
William A. Alonso 
Berton W. Ashman 
Leland S. Berger* 
Philip Blume 
Robert M. Briggs 
Thomas A. Cardella 
Joseph F.J. Curi 
Alfonso Esguerra 
Anthony Ferrante 
Norman C. Fost 
Peter A. Gross 
John F.B. Haney 
Richard Hockman 
Lawrence Horwitz 
William J. Houghton 
Lewis Landsberg 
Richard V. Lee 
Thomas L. Lentz 
James S. Levine 
Paul R. Lightfoot Jr. 
Richard Murray Linburg 
Robert W. Lyons 
William F. Matched 
Robert L. Mitchell 
James J. Murphy 
Donald A. O’Kieffe Jr. 
William B. Pratt 
Jack S. Rice Jr. 
Stanley J. Rosenberg 
Jonathan J. Russ 
Richard P. Saik 
Norman Scher 
Robert L. Shelton 
Donald G. Skinner 
A. Thomas Snoke 
Sigrid L. Tishler 








David A. Hill 
Jon R. Almquist 
Susan A. Aoki 
Thomas T. Aoki 
John H.M. Austin 
Paul Balter 
Victor J. Burner 
Thomas B. Caldwell III 
David G. Campbell 
Grant L. Christian 
Robert M. Cohn 
John M. Coyle 
Michael J. Cummings 
David S. Fedson 
Robert I. Finkel 
Michael P. Flynn 
Richard I. Frankel 
Frank J. Grady 
James K. Glide 
Reid R. Heffner Jr. 
David A. Hill 
Carl E. Hunt 
Virginia Burnham Johnson 
Ronald J. Karpick 
Mohandas M. Kini 
Richard J. Kozera 
Sandra Chook Levine 
Mark W. Lischner 
Philip D. Manfredi 
Walter W. Noll 
A. Lawrence Ossias 
John A. Parrish 
Robert L. Pickens 
Alan N. Rachleff 
William A. Renert 
Gene A. Robinson 
George B. Rowland 
John F. Schilke 
John H. Seashore 
Margretta Ann Reed 
Seashore 
David M. Shames 
David P. Simmons 
Harlan Spitz 
E. James Stanley 
Alan William Stone 
Robert G. Weiner 
Bert Yuan-Shu Wong 




Mary Alice Houghton 
Gary L. Townsend 
Benjamin F. Balme 
John D. Baxter 
Patricia Bazemore 
Robert P. Bazemore 
Philip Bernstein 
James Edward Brown 
Eugene Patrick Cassidy 
Thoburn Aaron 
Dadisman Jr. 
Joseph A. Donadio 
Robert E. Dragon 
Jared M. Emery 
Anthony P. Fappiano 
Robert N. Frank 
Peter D. Gibbons 
Jeffrey B. Gluckman 
Stanley I. Greenspan 
J. McLeod Griffiss 
Robert A. Gunn 
Henry G. Hanley 
Jay G. Hayden 
Mary Alice Houghton 
Richard J. Howard 
Gordon R. Kelly 
Stuart M. Kotler 
David C. Law 
Lynne L. Levitsky 
Edward J. O’Keefe 
William D. Peterson 
Joel Singer 
James D. Slavin Jr. 
Parker J. Staples 
Lawrence J. Toder 
Gary L. Townsend 
Jon S. Wayland 
Joan T. Wayland 
John W. Wickenden 
Ame S. Youngberg 




Daniel L. Arons 
Arthur L. Beaudet 
Richard S. Bockman 
Arthur Walker Boddie Jr. 
Daniel J. Booser 
Gary C. Burget 
William T. Cave Jr. 
Kenneth F. Crumley 
Cynthia Rapp Curry 
Marian C. Davidson 
James Lucius Davis III 
James J. Dineen 
Timothy J. Dondero Jr. 
Alexander F. Dora 
James M. Dowaliby II 
John A. Drews 
Peter R. Egbert 
Dennis Grant Egnatz 
Herbert W. Felsenfeld 
Richard J. Hart Jr. 
Richard L. Heppner 
Peter N. Herbert 
George P. Herr 
David L. Ingram 
Mary Jurbala 
Melvyn Korobkin 
Carl E. Lane 
Anthony P. Lovell 
Carl K. Marling 
Stephen W. Miller 
Joseph L. Morris 
John Northup Jr. 
John O. Pastore 
William E. Perkins 
Brian F. Rigney 
Robert I. Roy 
Jonathan L. Saveli 
Alfred Q. Scheuer 
Stephen C. Schimpff 
Sidney C. Smith Jr. 
Helen L. Smits 
Lewis S. Solomon 
Robert S. Steinberg 
Richard B. Swett 
Karen H. Toker 
Robert A. Vogel 
Robert A. Vollero 
Joseph F. Walter 
Martin Wand 
Robert J. Winer 
Robert S.K. Young 
Ihor George Zachary 
Peter M. Zeman 




Donald O. Lyman 
Philip L. Barry 
Grace Jordison Boxer 
Donald R. Coustan 
Rutledge W. Currie 
Robert G. Dillard 
Edward M. Druy 
Barbara Mayer Egbert 
Alan G. Finesilver 
Richard A. Getnick 
Leonard Grauer 
Ralph S. Greco 
John R. Hill II 
Harry S. Holcomb III 
Peter Jokl 
Daniel E. Keim 
Jeffrey S. Lee 
Ellen Marks Lippman 
Marc E. Lippman 
Peter A. Livingston 
Frank E. Lucente 
Donald O. Lyman 
Stephen I. Marglin 
Rodrigo Martinez 
John Allen McCutchan 
Harmon Michelson 
David P. Millett 
Richard P. Mills 
Richard M. Morehead Jr. 
James B. Morris 
John A. Ogden 
Margot Onek 
Jackson B.E. Pickett III 
Charles T. Post Jr. 
Ralph Jerome Rauch 
Joseph L. Renda 
Gordon H. Sasaki 
Peter W. Scherer 
Bmce Stuart Schoenberg* 
Frederick C. Sherman 
Elizabeth M. Short 
Howard W. Siegel 
Gerald L. Springer 
Lee H. Strohl 
Edmund C. Tortolani Jr. 
Per Henrik Wickstrom 
Creed W. Wood 
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Adrian M. Schnall 
Charles S. Angell 
David G. Ansel 
David W. Barry 
Robert E. Belliveau 
David A. Berkowitz 
N. Roger Cooke 
Leo M. Cooney Jr. 
Richard J. Daly 
Charles A. Dinarello 
Douglass T. Domoto 
Ralph J. Falkenstein 
Gary S. Farnham 
B. Graeme Fincke 
Steven A. Frankel 
Anna S. Gail 
Royal J. Gay 
David A. Geer 
Sander G. Genser 
Robert O. Gordon 
Larry C. Horowitz 
Thomas C. Howard 
Lee M. Jampol 
Joel Mark Kaufman 
Paul H. Kelker 
Lynn G. Lagerquist Jr. 
Michael R. Liebowitz 
Elliot M. Livstone 
C. E. Long Ill 
Robert L. Marier 
Paul A. Markey 
Arnold F. Mazur 
Ellen B. Milstone 
Bruce K. Nagle 
Lionel M. Nelson 
Nancy Olmsted 
Deborah A. Putnam 
N. Burgess Record Jr. 
Joseph D. Robinson 
Joseph M. Rochford 
Dennis J. Rudzinski 
Adrian M. Schnall 
David J. Schulak 
Gerald J. Smallberg 
David L. Upton 
Robert J. Walat 
Stephen R. Webb 
Steven C. White 




James R. Missett 
Elissa B. Arons 
Richard A. Charlat 
Michael J. Chusid 
C. Norman Coleman 
Anne McB Curtis 
Michael Cynamon 
James E. Delano Jr. 
Daniel Frizell Dedrick 
Jonathan Ecker 
Richard L. Edelson 
Robert Alan Epstein 
Bruce A. Fabric 
Thomas H. Gouge 
Paul C. Hessler 
Jay H. Hoofnagle 
Jonathan D. Katz 
Ely A. Kirschner 
Mark A. Korsten 
Thomas L. Lewis 
Anne W. Lucky 
Roger A. Mason 
Leonard M. Milstone 
James R. Missett 
William K. Mueller 
Lynn Whisnant Reiser 
Bruce A. Reitz 
Robert M. Rosa 
Dennis E. Shield 
Stuart S. Shorr 
Robert S. Stern 
Ray W. Tripp III 
C. Bruce Wenger 
Joellen Werne 
Daniel Wuensch 
Karl O. Wustrack 
Marc O. Yoshizumi 




John L. Cieply 
Barbara K. Kinder 
Judith L. Bader 
Gregory W. Bartha 
Michael J. Beierle 
Bruce Block 
John L. Cieply 
Frederick L. Cohn 
Edward C. Cottle 
Leonard I. Eisenfeld 
Daniel E. Feldman 
Harvey Fembach 
Fred Finkelman 
John W. Foster Jr. 
Jared J. Gardner 
Richard Gloor 
Jerold Alan Haber 
Kenneth L. Harkavy 
Michael J. Hart 
William W. Hay Jr. 
Geoffrey P. Kane 
Richard Katzman 
Robert M. Kessler 
Barbara K. Kinder 
Michael E. Klein 
William L. Krinsky 
Gary M. Lande 
David H. Lippman 
William J. Mangione 
Samuel S. Masters 
Patrick T. Minihan 
Steven H. Mottle 
Richard Albert Moggio 
John A. Patti 
Barry Bruce Perlman 
Stuart B. Phillips 
Michael C. Piercey 
Anthony V. Proto 
Irving G. Raphael 
Douglas R. Schmidt 
John Smiarowski 
James P. Southwick 
Jonathan W. Stewart 
Charles J. Sutherland 
Daniel R. Synkowski 
Richard D. Travers 
Yvonne E. Vaucher 
Paul A. Vignola 
Robert B. Vranian 
Albert Carl Weihl 
Bums Woodward 




Harry L. Malech 
Robert D. Arbeit 
Michael A. Catalano 
Leonard H. Cohen 
Philip L. Cohen 
Gloria Cummings* 
Robert F. DeBlasi 
Norman M. Dinerman 
William H. 
Druckemiller Jr. 
John P. Fulkerson 
Dorothy M. Gohdes 
Bruce B. Haak 
Thomas L. Horn 
Vernon H. Humbert Jr. 
Fred Hyde 
Anthony H. Jackson 
Michael A. Kaufman 
Donald L. Kent 
David L. Kneapler 
Theodore M. Levin 
Paul A. Lucky 
Hairy L. Malech 
Jeffrey S. Menkes 
Stewart A. Metz 
David B. Moyer Jr. 
James A. Nathanson 
John P. O’Grady 
Louis Reik Jr. 
William L. Risser 
David H. Rontond 
Philip M. Rothfeld 
Frederick D. Stockwell 
Lawrence P. Temkin 
Philip J. Weyman 
Brooke M. Wolf 
Michael W. Yogman 
Steven M. Zeldis 









David A. Adler 
Mary Ann Brunstetter- 
Shafer 
James N. Campbell 
Marvin M. Chassin 
Joseph M. Connors 
David L. Coulter 
Carolyn G. Dedrick 
Christopher M. Doran 
Jane H. Ferguson 
Robert A. Florin 
Lee Goldman 
Jorge L. Hernandez 
Howard S. Honig 
Harold R. Mancusi- 
Ungaro Jr. 
Jerry Nagler 
John Frederick Neil* 
Claes M. Nilsson 




John W. Popp Jr. 
Charles F. Reynolds III 
Thomas J. Romano 
Harry S. Romanowitz 
Jerrold F. Rosenbaum 
John P. Sherck 
Joseph F. Simeone 
Robert A. Sirota 
Carole H. Stashwick 
John R. Stratton 
Charles F. Stroebel 
James F. Sullivan 
Thomas F. Sweeney 
Robert J. Ursano 
Christine A. Walsh 
Richard S.K. Young 
Randall M. Zusman 





Amy S. Schecliter 
Robert J. Schechter 
Irving M. Asher 
Leonard I. Banco 
Douglas A. Berv 
Bruce David Blumberg 
Neil Blumberg 
Ronald C. Brown 
Peter J. Buchin 
Robert A. Caine 
Bert D. Collier Jr. 
Paul David 
Vincent A. Di Maria 
Cheryl F. Edmonds 
Roger H. Emerson Jr. 
Irl L. Extein 
Allan B. Friedland 
Michael A. Gerber 
Ary Louis Goldberger 
Robert F. Hempton 
Edward O. Janosko II 
Robert C. Jimerson 
Ancil A. Jones 
Marie T. Kelly 
Robert M. Kolodner 
Saul Lande 
Olusegun O. Lawoyin 
Edward L. Marut 
James R. McMonagle 
Richard C. Pasternak 
Andrew L. Ries 
David Z. Ritvo 
Daniel 1. Rosenthal 
Amy S. Schechter 
Robert J. Schechter 
John D. Schrumpf 
Alan B. Silken 
Barry S. Solof 
James A. Strom 
George H. Talbot 
Maisie Tam 
Carol C. Teitz 




Maty Jane Minkin 
J. Edwin Atwood 
Sharon L. Bonney 
Chau V. Dang 
Carol L. Kandall 
Kevin Kane 
Bernhard H. Lisker* 
Richard J. Loewenstein 
Yvonne E. Lomax Burnett 
David A. London 
Bruce B. McLucas 
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Hyman J. Milstein 
Mary Jane Minkin 
Andrew B. Newman 
Edwin G. Olson 
George J. Pardos 
Daniel J. Passed 
Mary Lake Polan 
Vivian Reznik 
Philip J. Rich 
James F. Robertson III 
Salvatore V. Romano Jr. 
Fred P. Rosenfelt 
Robert S. Sandler 
Steven A. Schwartz 
Thomas W. Smith 
Barbara J. Stoll 
David J. Taylor 
Henry S. Willner 
David W. Wiltse 
David M. Zwerdling 




William K. Levy 
Sarah S. Auchincloss 
Alfredo L. Axtmayer 
John C. Bartlett 
Peter B. Bitterman 
Alan B. Bloch 
Roger A. Boshes 
William D. Carlson 
Pauline Y. Chao 
Richard S. Childs Jr. 
Ellen C. Cooper 
Mark R. Cullen 
Kenneth J. Dobuler 
Geoffrey Etherington 
Leonard Firestone 
Ira H. Gewolb 
Glenn A. Gorlitsky 
Joel Kabak 
David T. Kawanishi 
William K. Levy 
Douglas G. Mann 
Jon S. Morrow 
Richard L. Neubauer 
Daniel W. Rahn 
Paul R. Ramirez 
Susan H.K. Ryu 
Lawrence E. Samelson 
Richard S. Schottenfeld 
John T. Sladky 
Charles R. Swenson 
Peter M. Ting 
John C. Wiles 
Jerome B. Zeldis 
Carol M. Ziminski 





Ronald J. Vender 
Michael G. Adelberg 
Harvey J. Berger 
Stuart Brian Dubin 
Sybil E. Duchin 
Marybeth Ezaki 
Susan J. Fiester 
Susan Firestone 
Anne H. Flitcraft 
James A. Fox 
Julia B. Frank 
Barbara K. Gehrett 
Robert W. Hand 
Bruce L. Innis 
Howard K. Koh 
David J. Kreis Jr.* 
Margaret S. McKenna 
Robert J. Mitchell 
R. Andrew Packard 
Alan S. Penziner 
Richard E. Peschel 
Theodore M. Pitts 
Jordan S. Pober 
Rachel Z. Ritvo 
Steven J. Scheinman 
Ricky M. Schneider 
Simeon A. Schwartz 
Mark S. Smith 
Ronald J. Vender 
Steven L. Warsof 
Sharon R. Weinstein 
John E. Whitcomb 
J. Douglas White 
Daniel Wohlgelemter 




Duke E. Cameron 
Seth M. Powsner 
Michael J. Anderson 
Richard J. Baron 
Duke E. Cameron 
David F. Cawthon 
Jesse M. Cedarbaum 
Emily A. Fine 
Robert A. Gelfand 
Linda J. Hall 
Robert Hershfield 
Elizabeth S. Hodgson 
Anne A. Knowlton 
Robert L. Kraft 
Cynthia S. Kretschmar 
Gertrude Wilkins 
Manchester 
Jose Luis Martinez 
Barbara H. Pober 
Seth M. Powsner 
Sally Rudicel 
Neal D. Ryan 
Donald C. Simonson 
Rebecca A. Taub 
Caroline R. Taylor 
Marcia J. Wade 
Jonathan D. Weinberg 
Susan Wong 
Class of 1979 
Gif : $5,240 
Participation: 31% 
Agent: 
Cynthia Anne Sherman 
Ronald Jay Berenson 
J. Kenneth Burkus 
Roy D. Carlson 
Kerry Cooper 
Norman L. Elliott 
John A. Fox 
David E. Golan 
Bruce Halperin 
Marc Hellerstein 
Jeffrey L. Kaine 
Leslie Jay Katz 
Roxanne E. Kendall 
Michael K. Lindsay 
Timothy W. McKeithan 
David E. Ness 
S. Kwame Ofori-Kwakye 
Barbara Ann Peters 
Jean Rosenthal 
Lynn K. Rudich 
Gary L. Schaer 
Cynthia Anne Sherman 
Laurie Smaldone 
Pamela E. Smith 
John T. Woo 
Jeffrey Work 
Gary R. Zeevi 





Steven 1. Rosenfeld 
David E. Adelberg 
Eduardo Alfonso 
Seth Leo Alper 
Frederick R. Aronson 
Alan B. Astrow 
David Allen August 
Jay M. Baraban 
Patricia Church Brown 
Daryl F. Browne 
Michael W. Champeau 
Thomas F. Deering 
Gary Vincent Desir 
Deborah Dyett Desir 
Claudia Dinan 
Forrest John Doud 
Stephen G. Emerson 
Judy E. Garber 
Todd J. Garvin 
Marc F. Glickstein 
David Jay Goldberg 
Nancy S. Goldman 
Gary I. Greenwald 
Maria White Greenwald 
Jonathan L. Jacobs 
David Kass 
Mary C. Komei 
Ethan A. Lerner 
Mary Polly McKinstry 
Eric J. Nestler 
Mark J. Ratain 
Neal L. Rosen* 
Steven I. Rosenfeld 
Alan E. Schlesinger 
Gerri A. Schulman 
John A. Selling 
Hillel D. Skoff 
Leslie W. Sojka 
Kim R. Swartz 
Joseph L. Tate 
Marcia R. Taylor 
Nancy T. Taylor 
Howard W. Telson 
Mary Hill Wise 
Lawrence H. Young 
Raphael Zahler 





Adaora A. Adimora 
Peter R. Arvan 
Alicia Barela 
Sherri L. Brown 
Steven M. Brown 
Chee C. Chow 
Paula M. Fracasso 
Ramona Q. Fung 
Laurie J. Gordon 
Jeffrey A. Gruskay 




David E. Lebwohl 
David Y.C. Lu 
Barton N. Milestone 
Robert M. Milstein 
Richard L. Mogerman 
David A. Paly 
Robert B. Portney 
Susan Burdette Radoux 
Barbara A. Roach 
Bernard H.P. Shen 
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Stephen Burgos Wilson 
John C. Wong 





Jed B. Gorlin 
Stephanie Wolf- 
Rosenblum 
Katherine Ann Albert 
Sylvia R. Beck 
Paula K. Braverman 
Muriel Cyrus 
Fred Miller Drennan 
Jed B. Gorlin 
Jessica Herzstein 
Daphne Hsu 
Risa Maura Jampel 
Henry Jampel 
Laurie B. Kornreich Katz 
Michael E. Katz 
Patricia Kellner 
Teresa L. Massagli 
Kathleen Anne Nolan 
Joyce A. O'Shaughnessy 
Dan B. Odenheimer 
Christopher N. Otis 
Carrie A. Redlich 
Robert J. Rizzo 
Christopher W. Roberts 
Paula C. Schlesinger 
Cary S. Sennett 
William M. Sikov 
Henry J. Stern 
Lynn T. Tanoue 
Patrick Toth 
Albert L. Ungricht 
David A. White 
Stephanie Wolf- 
Rosenblum 
N. Bruce Yager 




Michael B. Tom 
David E. Schwartz 
John Taylor Adams* 
Robert E. Bookstein 




Tammy C. Harris 




Frederic R. Martin 
Miguel A. Martinez 
Lois A. Moiton 
Dan A. Oren 
Harlan A. Pinto 
David E. Schwartz 
Michael Silverberg 
Daniel M. Sosin 
Philip M. Spiro 
Michael B. Tom 





Jay R. Kostnian 
Martha Ray Arden 
Robert W. Arnold 
David I. Astrachan 
Barbara Ann Coda 
David A. Frank 
Donald Ingber 
Emilio J. Juncosa 
Jeffrey N. Katz 
Jay R. Kostman 
John H. Krystal 
Richard L. Leff 
Dominic D. Pennachio 
Jill S. Ratain 
Ronnie G. Rosenberg 
Paul B. Rothman 
Joshua D. Schor 
David A. Shner 
Michael Simons 
Paul M. Snyder 
Mark Stein 
Valerie E. Stone 





J. Alexander Bodkin 
Alice S.Y. Chi 
Bryan DeSouza 
Guy Fried 
Richard Bruce Garber 
Samuel D. Goos 
Stuart Neal Isaacs 
Ellen Rieur Kolarik 
Susan Korrick 
Shirley J. Lee 
Jeffrey A. Lowell 
Gail Mattson-Gates 
Elizabeth G. Moy 
Robert D. Needlman 
Leslye C. Pennypacker 
Samuel Richard Pesin 
Eric Murname Poeschla 
Anne Regenstein 
Fred Santoro 
Gary L. Shapira 
Timothy Alan Shapiro 
Louis J. Tesoro 
Javier Vizoso 




Eric F. Bernstein 
Clinton Undo 
Eric P. Suan 
Catharine Ann Arnold 
W. Lee Bailey 
Eric F. Bernstein 
Suzanne D. Conzen 
Raymund S. Cuevo 
John A. Detre 




Manuel B. Litchman 
Stacey Mandelbaum 
Michael D. Miller 
Steven M. Peterec 
Paula Judi Rackoff 
Lawrence N. Sampson 
Andrew W. Steele 
Eric P. Suan 
Steven Waisbren 





Subba R. Gollannidi 




Mark I. Block 
Robert Englander 
Steve M. Gaskin 
John Michael Gaziano 
Subba R. Gollamudi 
Laurence Adam 
Greenbaum 
Hugh C. Hemmings Jr. 
Peter T. Ho 
Amy Caroline Justice 
Rebecca E. Kadish 
Joseph Thomas King Jr. 
Elliott Levy 
Kenneth E. Newhouse 
Lauri R. Robertson 
Seth A. Rosenthal 
Mindy G. Schuster 
Michael H. Solon 
Lynn Street 
Richard P. Tierney 
Robert C. Urban Jr. 
Leslie Vogel 
Barry Weinstock 














Rhonda L. Karol 
Robert Kim 
Laura Kuckes* 
Lance Arlen Markbreiter 
Peter Alexander Merkel 
Theodore Miclau 
Michael Emeric Mockovak 
Kelle Harbert Moley 
Vivian Orey 
Donna Richman 
Michael A. Rothschild 
Jonathan A.S. Sherman 
Mitchell J. Sklar 
Philip Adam Stull 
Susan Valley 
Hedayatollah Zaghi 






Melissa Terry Myers 
Roger F. Widmann 
Stephen Bharucha 
Jennifer Franklin Bock 
Ira Cheifetz 







Adam L. Greene 
Joni H. Hansson 
Kraig E. Humbaugh 
Amy Lewis 
Melissa Terry Myers 
Lisa Ragen 
Viviann Mattson Rubin 
Stephen M. Smith 
David M. Stier 
Amy A. Tyson 
Andrew Thomas Walker 
Dora-Linda Wang 
Roger F. Widmann 
Christopher Wolf-Gould 
Phillip Chung-Ming Yang 




Chander N. Sarny 
Daniel Stiyer 
Jonathan Todd Foster 
Roberto Soto 
Thomas J. Christopher 
Tracy Nelson 
Ercem S. Atillasoy 
Betty Kim 
Susan G. Anderson 
Nancy R. Angoff 
Ercem S. Atillasoy 
Thomas J. Christopher 
Mark A. Dettelbach 
Jonathan Todd Foster 
Douglas Marc Freedman 


















Alumni 3,836 1,913 50 976,844 3,868 1,810 47 1,275,527 
Former House Staff 2,093 213 10 25,640 2.093 188 9 26,958 
Parents/Friends 395 45 11 12,951 395 39 10 11,587 
Interest/Misc. — — — 14,533 — .... — 21,511 
Total 6,324 2,171 34 1,029,968 6,346 2,097 33 1,335,581 
* Alumni total for 1992-1993 includes both annual giving and reunion giving. 
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Alan Sander Hilibrand 
Randi Hutter-Epstein 
Kathleen Alexia Kline 
Ira Meisels 
Erika H. Newton 
Jack Parent 
Chander N. Samy 
Susie K. Sharpe 
Daniel Stryer 
Robert Wu 
Class of 1991 





Lawrence J. Hirsch 
Karen Shieh Lit 
Richard G. Ihnat 





Jeanne B. Ackman 
William T. Andrews 
Sarah A. Davidson 
Jean L. Fraser 
Lawrence J. Hirsch 
Bruce H. Horwitz 
Richard G. Ihnat 
Richard G. Ingber 
Paul A. Isenbarger 
James S. Levine 
Francis Lobo 
Karen Shieh Lu 
Charles Lu 
Funda Meric 
Robert Z. Orlowski 
Eleanor S. Poliak 
Robert M. Spillane 
James E. Stanislaw 
Margaret M. Toth 
Ellis L. Webster 









Mary Beth Christensen 
Former House 
Officers 
Phillip R, Aaron 
Robert A. Achtel 
Ronald Angoff 
Renato Annas 
William F. Arndt 
Floyd L. Atkins 
Ronald J. Bailey 
Arnold M. Baskin 
Richard Bass 
Carl Bennett Bean 
Gregory Kent Bergey 
Grace E. Bergner 
Michael Richard Berman 
Larry Berte 
Ralph Daniel Bien 




Ronald W. Braun 
David Braun 
Charles R. Brinkman III 
Kenneth Burke 
John K. Burkus 
Dennis J. Card 




David L. Copen 
Leandro Cordero 
Sidney L. Cramer 
Robert E. Crootof 
F. Mitchell Cummins 
Michael Martin Deren 
Daniel M. Divack 
Donald S. Dock 
Steven G. Dorfman 
John I. Dorfman 
John W. Drake 
William R. Drucker 
Nancy Ann Drucker 
C. Gibson Dunn II 
Edward Dunn 
Dana Wasson Dunne 
Michael William Dunne 
Stephen A. Edelstein 
David E. Eibling 
Walter Ettinger 
Thomas Faust 
Robert A. Feldman 
Louis B. Fierman 
Richard Webster Finner 
Stephen V. Flagg 
Morris A. Flaum 
Alex Harris Frank 
Josephine Fuhrmann 
Phillip H. Gates* 
George O. Gelinas Jr. 
David M. Gershenson 
V. Philip Glassman 
Nelson H. Goldberg 
Joel S. Golden 
John W. Goldkrand 
Isaac Goodrich 
Anita Goodrich 
James Mullett Grant 
Willard F. Greenwald 
John A. Grimaldi 
Joseph Guaraldo 
Hedda Ann Litowitz 
Haning 
Ray V. Haning Jr. 
Joni H. Hansson 
Samuel Heilman 
Mary M. Herman 
Stanley Hersh 
Judith Hochstadt 
George L. Hoffman 
Eric A. Hyson 
Clifford Joseph 
Juliana Haeng-Cha Kang 
Jemo Kang 
Moreson H. Kaplan 
Rhonda L. Karol 
Jill P. Karpel 
Sheila Moriber Katz 
David M. Kessner 
Stephen King 
Samuel C. Klagsbrun 
Lawrence E. Klein 
Thomas J. Koontz 
Boonsri Kosarussavadi 
Kenneth M. Kramer 
Eugene Kuchner 
Joel C. Labow 
C. Grant LaFarge 
Sheri J. Lagin 
W. Clark Lambert 
Muriel A. Lambert 
Emmanuel Landau 
Randi Leavitt 
Robert Jan Lerer 
Vincent Leung 
Stanley B. Levine 
Arthur L. Levy 
Luke K. Licalzi 





Richard J. Maunder 
John P. McGovern 
Thalia Mesologites 
Lawrence I. Michel 
Phyllis R. Monroe 
Yasmeen A. Moody 
Patrick E. Moriarty 
Lewis B. Morrow 
H. Weston Moses 
Michael A. Moskowitz 
Maureen T. Muiphy 
Seymour Cy Nash 
Gwendolyn B. Nichols 
James C. Niederman 
Michael Patrick Noonan 
Charles O. Ogunro 
Joseph Manuel Ortiz 
Gary R. Pasternack 
Robert Princenthal 
Donald C. Rankin 
Robert R. Rickert 
James A. Robb 
Jeffrey P. Robbins 
Jean F. Rogier 
Robert L. Rowley 
David R. Rubinow 
James R. Sabetta 
Arthur W. Samuelson 
Michael Saruk 
Robert P. Sbriglio 
Mark Scharf 
Anton Schittek 




M. Peter Scibetta 
James Thomas Sehn 
Franklin D. Seney Jr. 
Howard Senter 
Edwin C. Severinghaus 
Thomas E. Shaffer 
Vernon H. Sharp 
Gary R. Siegel 
Joel Silidker 
Frederic N. Silverman 
Robert E. Silverman 
Boyd J. Slomoff 
Thomas J. Spackman 
Stephanie S. Spangler 
Richard I. Staiman 
John G. Steciw 
Mark W. Steele 
Judit Stenn 
Marjorie R. Stewart 
Barry S. Strauch 
Fred Leslie Strieker 
Herbert Tabor 
Imad F. Tabry 
Victor Nabil Takla 
Marc J. Taylor 
Troy L. Thompson II 
James S. Touloukian 
Romulo L. Villar 
Thomas A. Warthin 
Kalman Lewis Watsky 
James E. Watson 
Alan Weinberg 
Herbert Allan Wenner 
George Wharton 
Princess Williams 
Robert J. Williamson 
Philip Witorsch 
Suna E. Woods 
Eiji Yanagisawa 
Robert C. Young 
Steven M. Zamore 
Marvin Paul Zimmerman 
Richard Walter 
Zimmerman 





Yvonne and Badri 
Aghassi 
Michael Mark Babat 
Mr. Edwin Beall 
Mrs. Bieggi 
Harriet Farnsworth Brown 
Betty P. Carlin 
Mr. Paul W. Carstens 
Mr. Howard Chin 
Mrs. Judy Coppola 
Anthony Deluca 
Edward H. Diamond 
Mr. and Mrs. Kenneth T. 
Doran 
Dorothy Marie Ference 
Philip Arthur Fey 
Mr. Max Finkelman 






Frederick W. Heilman 
Mrs. Gloria F. Holmes 
Andrew S. Kim 
Bum Kim 
Kenneth P. Kinney 
March Enders Komack 
Haralyn D. Kuckes 
Edward G. Lund Jr. 
Natesh Magge 
Mrs. Virginia G. Mannick 
Bernard George Miklos 
Mary Elizabeth Mintum 
Mr. and Mrs. Victor M. 
Newman 
Dr. and Mi's. Levi V. Perry 
Henri Peyre 
Ann D'Esopo Phillips 
R. Donald Reich 
Mr. and Mrs. Jack Saltz 
Harold and Frances 
Sampson 
Henry S. Sanematsu 
Ellen Louise Schwalb 
Maurice Hyman Shaw 
Naomi Goldfarb Solomon 
Argyle Stoute 
David Donaldson Strachan 
Prof, and Mr. Lubert Stryer 
Mrs. Leo Teitz 
Thomas M. Tierney 
James Wells 
Lloyd and Margo Zbar 
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Sterling Association 
Benefactor 
Fred W. Buse '33 
Robert E. Carroll '42 
Lycurgus M. Davey '43 
Robert S. Donohue Jr. '58 
J. Roswell Gallagher '30 
John B. Ogilvie "34 
Michael A. Puzak '42 
Henry A. Riedel '43 
Nathan E. Ross '28 
Myra D. Tyler '50 
Robert R. Wagner '46 
Sponsor 
Thomas L. Bucky '43 
Gerard N. Burrow '58 
Philip R. Fazzone '58 
Andrew Joseph 




Harold D. Bomstein Jr. '53 
Edward H. Diamond * 
J. Roswell Gallagher '30 
Peter B. Gregory '63 
Michael Kashgarian '58 
R. Leonard Kentler '43 
Theodore W. 
Lieberman '58 
Jack Wayne Love '58 
Herbert Meltzer '63 
Robert E. Mueller '63 
Carol F. '58 and 
Charles A. Phillips '59 
Paul A. Rudnick '58 
Myron A. Sallick '24* 
Sophie Trent Stevens '43 
Lawrence Trentonti '63 
Richard W. Trepeta '78 
Raymond W. Turner '58 
James G. Wepsic '63 
Fellow 
Ralph D. Alley '43 
Joseph E. Angelo '58 
John A. Carlston '58 
The School of Medicine Alumni Fund's Sterling Association 
recognizes donors vt ho have made gifts at the following levels: 
Benefacto r $50,000 and above 
Sponsor 25,000 - 49,999 
Patron 10,000 - 24,999 
Fellow 5,000- 9,999 
Associate 1,000 - 4,999 
Member 200 - 999 
Dudley Seth Danoff '63 
Andrew Edin '63 
Elizabeth Fuller Eisner '48 
Alan G. Finesilver '68 
David H. Frant '63 
Lowell I. Goodman '51 
Stanley Harris '58 
William Harrison Jr. '42 
Amy H. Hunter 
Wilson '30* 
Thomas R. Johnson '68 
Peter Jokl '68 
Jay Ward Kislak '58 
Thomas J. Mauro Jr. '58 
Dorothea R. Peck '43 
Charles T. Post Jr. '68 
Jose Ramirez-Rivera '53 
Bernard R. Rowen '43 
Benjamin F. Rush Jr. '48 
Howard Willis Smith '53 
Arlene Sweedler '58 
Peter G. Weiner '63 
Seth M. Weingarten '63 
Per Henrik Wickstrom '68 
Former House 
Officers 
Ronald W. Braun 
Associate 
Michael G. Adelberg '77 
George K. Aghajanian '58 
Theodore E. Allen '40 
Miguel R. Alonso '63 
Carol J. Amick '59 
Robert M. Amick '59 
Philip L. Barry '68 
Edith M. Beck '48 
Franklin C. Behrle '46 
Jonathan S. Bishop '48 
Sanfurd G. Bluestein '46 
William C. Branscome '58 
Wayne D. 
Brenckntan Jr. ’63 
Allyn G. Bridge '48 
Henry H. Briggs Jr. '31* 
Rosalie A. Bums '56 
George A. Carden Jr. '35 
Charles W. Carl Jr. '63 
David A. Carlson '58 
Alice Shepard Cary "45 
William R. Chaffee '53 
Allen Chetrick '53 
Thomas J. Coleman '46 
Rex B. Conn '53 
Richard H. Cote '48 
Donald R. Coustan '68 
David F. Cross '63 
Arthur C. Crovatto '54 
Lawrence G. Crowley '44 
Kenneth F. Crumley '67 
Michael J. Cummings '65 
Robert F. DeBlasi '72 
Claude W. Delia '50 
Robert V. Diserens '58 
John Leo Doppman '53 
Christopher M. Doran '73 
Vincent A. Doroszka '30* 
Owen W. Doyle '47 
Donald A. Duncan '58 
James P. Dunn '53 
Mitchell Edson '56 
John P. Eliopoulos '63 
Donnell Dencil 
Etzwiler "53 
Ralph J. Falkenstein '69 
R. M. Fasanella '43 
John E. Fenn '61 
Jane H. Ferguson '73 
Jon Michael Fessel '63 
Michael P. Flynn '65 
John W. Foster Jr. ’71 
Gerard Fountain '43 
Robert W. Frelick '44 
Julian Frieden '48 
William T. Friedewald '63 
Paul Jay Friedman '59 
David H. Fulmer '63 
Robert H. Furman '43 
Raymond A. Gaito '58 
James Conway 
Garlington '55 
David A. Geer '69 
Thomas O. Gentsch '53 
Vincent F. Geremia Jr. '63 
John N. German '62 
Richard A. Getnick '68 
Anne Godley '48 
Carol Goldenthal ’44 
Martin E. Gordon '46 
Vincent Lynn Gott '53 
William M. Gould '58 
Leonard Grauer ’68 
Ralph S. Greco ’68 
B. Herold Griffith '48 
Peter A. Gross '64 
Robert Emanuel 
Hamlisch '53 
Benjamin Keith Harris '63 
Jay G. Hayden '66 
Roger C. Herdman ’58 
William H. Hindle ’56 
Howard S. Honig ’73 
Marie-Louise T. 
Johnson ’56 
Stephen Joseph ’63 
Haskins K. Kashima '58 
Daniel E. Keim '68 
Robert Francis Kiley Jr. '53 
Alfred E. King '37 
Richard Robert 
Knowles. 3d '53 
Ralph E. Knutti '28 
Paul B. Koehler '48 
Frederick F. Krauskopf '44 
Edward C. Larkin '63 
Jeffrey S. Lee '68 
William B. Lehmann '63 
Hildegard Mueller 
Leslie '53 
Preston Lee Leslie "53 
Richard Murray 
Linburg '64 
Douglas Lindsey '43 
Michael K. Lindsay '79 
Craig H. Llewellyn '63 
J. Philip Loge ’43 
Frank E. Lucente ’68 
Edward G. Lund Jr. '63 
Margaret S. Lyman '50 
Robert W. Lyons '64 
John L. Mahoney '63 
Philip D. Manfredi '65 
Preston C. Manning '56 
Rodrigo Martinez '68 
Edward L. Marut '74 
A. Reese Matteson '44 
Harry L. McClelland '50 
John Allen McCutchan ’68 
Robert N. Melnick '53 
Hannon Michelson '68 
Richard P. Mills ’68 
Anoush Miridjanian '61 
Robert L. Mitchell '64 
Richard Albert Moggio '71 
Richard M. 
Morehead Jr. '68 
Donald P. Morris '35* 
James W. Needham '48 
Robert S. Neuwirth ’58 
James A. O’Neill Jr. ’59 
John B. Ogilvie ’34 
Margot Onek ’68 
Harvey Martin Peck '53 
Robert G. Petersdorf '52 
William F. Porter Jr. ’63 
Warwick Potter Jr. ’53 
David M. Pugh '58 
Paul G. Quie ’53 
Edward F. Rabe ’43 
Earl D. Rees '54* 
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Berkeley L. Rich ’63 
B. Allen Richardson ’43* 
Harry S. Romanowitz ’73 
Irwin K. Rosenberg ’53 
Nathan E. Ross ’28 
Lewis P. Rowland ’48 
, Robert I. Roy ’67 
Dennis J. Rudzinski '69 
j Paul L. Saffo ’33 
i Virginia C. Saft ’53 
Marcus E. Sanford ’43 
Gordon H. Sasaki ’68 
Tliomas A. Savignano ’63 
Amy S. Schechter ’74 
Robert J. Schechter ’74 
Jerome H. Shapiro ’48 
Alan E. Shapiro ’63 
Reginald H. Shephard ’43 
Harry Sherman ’34 
Frederick C. Sherman ’68 
| Elizabeth M. Short ’68 
Richard Andrew 
Sinnott Jr. ’53 
Donald G. Skinner ’64 
Ora K. Smith ’53 
A. Thomas Snoke ’64 
Michael H. Solon ’87 
Nicholas P.R. Spinelli ’44 
j Hilliard Spitz ’43 
Donald C. Stahl ’57 
Lee Bland Talner ’63 
Seth Thaler ’62 
Thomas W. Tillack ’63 
Peter V. Tishler ’63 
Gary L. Townsend ’66 
Theodore K.L. Tseu ’56 
Ronald J. Vender ’77 
John W. Vosskuhler ’54 
Marcia J. Wade ’78 
W. Keasley Welch ’43 
Warren D. Widmann ’61 
Edward F. Wilson ’63 
Pauline B. Wood ’58 
Creed W. Wood ’68 
Robert W. Wroblewski ’58 
Robert H. Wyatt ’43 
James Frederic Young ’53 




Samuel C. Klagsbrun 






Frederick W. Heilman 
Mr. and Mrs. Jack Saltz 
Argyle Stoute 
Member 
David E. Adelberg ’80 
Donald Agostinelli ’57 
Margaret J. Albrink ’46 
George Howard 
Allison ’45 
William A. Alonso ’64 
Victor A. Altshul ’60 
Thomas T. 
Amatruda Jr. ’51 
Don P. Amren ’58 
Charles B. Anderson ’62 
Carl E. Andrews ’44 
William G. Anlyan ’49 
Stanley D. Ardell ’51 
Robert H. Areson ’41* 
John P. Arnot ’58 
Irving M. Asher ’74 
Albert S. Atwood ’45 
John H.M. Austin ’65 
Alfredo L. Axtmayer ’76 
V. Richard Back ’63 
John C. Bailar III ’55 
Earl L. Baker ’61 
Paul Balter ’65 
William G. Banfield Jr. ’46 
Alicia Barela ’81 
George R. Barnes Jr. ’47 
Asa Barnes Jr. ’59 
Richard J. Baron ’78 
Gregory W. Bartha ’71 
John C. Bartlett ’76 
Albert A. Bechtoldt Jr. ’61 
Aaron T. Beck ’46 
George E. Becker ’55 
Ronald S. Beckett ’40 
Francis A. Beer ’59 
Peter Alfred Benson ’58 
Ronald Jay Berenson ’79 
Reginald V. Berry ’32* 
Eleanor Clay Bigley ’51 
Jonathan S. Bishop ’49 
Ray C. Bitterlich ’43 
Claude Bloch ’53 
Bruce Block ’71 
Bruce David Blumberg ’74 
Richard S. Bockman ’67 
J. Alexander Bodkin ’85 
Maxwell Bogin ’26 
Sharon L. Bonney ’75 
Daniel J. Booser ’67 
David G. Borden ’43 
John E. Borowy ’50 
Richard J. Bouchard ’54 
Stuart P. Bowne ’60 
Grace Jordison Boxer ’68 
Levon Z. Boyajian ’56 
Joseph I. Boylan Jr. ’55 
W. Roy Breg Jr. ’47 
A. Russell Brenneman "58 
Richard I. Breuer ’57 
Robert S. Briggs ’61 
John R. Brobeck ’43 
Spencer J. Brody ’62 
Thomas M. Brown ’56 
James Edward Brown ’66 
Steven M. Brown ’81 
Mary Ann Brunstetter- 
Shafer ’73 
William H. Bucher ’50 
J. Kenneth Burkus ’79 
Padraic Bums ’55 
Paul Calabresi ’55 
Rocco A. Calandruccio ’47 
John L. Cannon ’47 
Fredric K. Cantor ’62 
Thomas A. Cardella ’64 
John P. Carey ’57 
Eugene Patrick Cassidy ’66 
Michael A. Catalano '12 
Charles R. 
Cavanagh Jr. ’47 
Linus W. Cave ’46 
Michael W. Champeau ’80 
Theodore J. Chu ’63 
Albert K. Chun-Hoon ’57 
John L. Cieply ’71 
Elena Citkowitz ’83 
Robert M. Cohn ’65 
Frederick L. Cohn ’71 
C. Norman Coleman ’70 
James C. Collias ’56 
Stephen W. Collins Jr. ’39* 
William F. Collins Jr. ’47 
Hunter H. Comly ’43 
Norman I. Condit ’43 
Edward J. Conway ’44 
Ronald W. Cooke ’43 
John C. Coolidge ’44 
Leo M. Cooney Jr. ’69 
Louis Z. Cooper ’57 
Kerry Cooper ’79 
Edward D. Coppola ’55* 
Pasquale James Costa ’55 
Edward C. Cottle ’71 
David L. Coulter ’73 
Alan H. Covey ’54 
Harold Dick Cross ’57 
Joseph F.J. Curi ’64 
Rutledge W. Currie ’68 
William S. Curtis ’89 
James S. Dalsimer ’63 
Richard J. Daly ’69 
Chau V. Dang ’75 
Oliver Townsend Dann ’62 
Robert P. Darrow ’47 
Alvin Davis ’50 
Chandler Dawson ’56 
James E. De Lano Jr. ’70 
Orson R. Dee "61 
Paul David Deiter ’61 
Herbert W. Diefendorf ’41 
Ronald A. Dierwechter ’61 
Amanda B. Dill ’86 
Malin Dollinger ’60 
Joseph A. Donadio ’66 
Joseph P. Donnelly ’32* 
Richard E. Dormont ’40 
James R. Doit ’57 
T. Wayne Downey ’61 
G. Robert Downie ’48 




Druckemiller Jr. '12 
Stuart Brian Dubin 'll 
Peter A. Duncan ’41 
Richard R. Dyer ’45 
Robert S. Easton ’45 
Jonathan Ecker ’70 
Richard L. Edelson ’70 
Barbara Mayer Egbert ’68 
N. Joel Ehrenkranz ’49 
I. Bruce Elfenbein ’62 
Daniel W. Elliott ’49 
Norman L. Elliott ’79 
Kent Ellis ’50 
Roger H. Emerson Jr. ’74 
Leroy Engel ’55 
Alfonso Esguerra ’64 
Bruce A. Fabric ’70 
F. Robert Fekety Jr. ’55 
Davitt Felder ’42 
Herbert W. Felsenfeld ’67 
Gerald Fenichel ’59 
John E. Fenton ’41 
John P. Ferguson Jr. ’39 
Anthony Ferrante ’64 
Thomas F. Ferris ’56 
Robert I. Finkel "65 
Fred Finkelman ’71 
Knox H. Finley ’30 
Leonard Firestone ’76 
Susan Firestone 'll 
Robert L. Fisher ’59 
Michael E. Fishman ’58 
B. Allen Flaxman ’63 
Gregory E. Flynn ’46 
John W. Foreman ’62 
Yvette F. Francis ’50 
Robert N. Frank ’66 
John Martin Freiheit ’27* 
Guy Fried ’85 
Allan B. Friedland ’74 
Richard K. Friedlander "47 
Alice Dershimer 
Friedman ’45 
Anthony V. Furano ’62 
Sidney S. Furst ’51 
Eugene C. Gaenslen Jr. ’60 
Anna S. Gail ’69 
John Currier 
Gallagher ’58* 
James D. Gardam ’45 
Jared J. Gardner ’71 
John A. Gariepy ’54 
Joseph M. Garland "51 
Todd J. Garvin ’80 
Steve M. Gaskin ’87 
Royal J. Gay ’69 
Sander G. Genser ’69 
Michael A. Gerber ’74 
Margaret C.L. Gildea ’36 
Richard Gloor ’71 
Jessamine R. Goemer ’43 
Marcia Kraft Goin ’58 
David E. Golan ’79 
David Jay Goldberg ’80 
Lee Goldman ’73 
Nancy S. Goldman ’80 
Paul S. Goldstein ’48 
Paul Gonick ’55 
Anne H. Good ’57 
Glenn A. Gorlitsky '16 
Thomas H. Gouge ’70 
Jack Greenberg ’33 
James Greenwald ’58 
J. McLeod Griffiss ’66 
Sylvia Preston Griffiths ’48 
James K. Glide ’65 
Bruce B. Haak ’72 
Victor C. Hackney ’43 
John H. Hageman ’62 
Linda J. Hall ’78 
Robert N. Hamburger ’51 
Howard B. Hamilton ’44 
Robert W. Hand 'll 





Paul A. Haiper ’31 
Jackson Harris ’49 
Stephen R. Harrison ’81 
John Herd Hart ’56 
H. Rodney Hartmann ’59 
William W. Hay Jr. ’71 
Robert F. Hempton ’74 
Peter N. Herbert '61 
George P. Herr ’67 
William H. Heydom ’59 
David A. Hill ’65 
C. Richard Hinckley ’59 
Gary Hirshfield ’86 
Paul W. Hoffert ’45 
Gilbert F. Hogan '51 
O. Roger Hollan ’45 
David Purdy Holman ’53 
Jay H. Hoofnagle ’70 
W. Howard Homer ’35* 
Larry C. Horowitz ’69 
William J. Houghton ’64 
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Thomas C. Howard '69 
Daphne Hsu '82 
Hans R. Huessy '45 
Peter Biggs Hukill '53 
Vernon H. Humbert Jr. '72 
Henry D. Humphrey '40 
Carl E. Hunt '65 
Robert F. Hustead '54 
Randi Hutter-Epstein '90 
Fred Hyde '72 
Roland H. Ingram Jr. '60 
Leonard Inker '59 
H. Stuart Irons '40* 
Camold K. Iverson '51 
Jonathan L. Jacobs '80 
Benjamin A. Johnson '49 
Virginia Burnham 
Johnson '65 
Henry H. Jones '43 
Daniel M. Jones '60 
Ancil A. Jones '74 
Robert J.T. Joy '54 
Charles Sheldon 
Judd Jr. '46* 
Emilio J. Juncosa '84 
Edith M. Jurka '44 
Ronald J. Karpick '65 
David Kass '80 
Jonathan D. Katz '70 
Herbert J. Kaufmann '59 
Richard L. Keefe '61 
Leo Kellerman '42 
Harry O. Kendall ’55 
Donald L. Kent '72 
Robert J. Kerin '47 
David R. Kessler '55 
Barbara K. Kinder ’71 
Ely A. Kirschner '70 
William L. Kissick '57 
Benjamin F. 
Kitchen Jr. ’46 
Jerome O. Klein '56 
Thomas Kievan '81 
David E. Knoop '62 
Ellen Rieur Kolarik '85 
Melvyn Korobkin '67 
Stuart M. Kotler '66 
Robert A. Kramer '55 
Cynthia S. Kretschmar '78 
Edward A. Krull '55 
Thomas P. Kugelman '60 
Samuel D. Kushlan '35 
Saul Lande '74 
Lewis Landsberg ’64 
Frederick Martin Lane ’53 
Edward R. Lang '60 
Jonathan Trumbull 
Lanman ’43* 
Frank D. Law '49 
Olusegun O. Lawoyin '74 
Paul M. Leand '61 
Philip M. LeCompte '36 
William Lee '41 
Sidney S. Lee '50* 
Jack Levin '57 
James S. Levine '64 
Sandra Chook Levine ’65 
Lynne L. Levitsky ’66 
Robert Isaac Levy ’61 
William K. Levy '76 
William V. Lewit '56 
Paul R. Lightfoot Jr. '64 
David Lindgren '83 
Janus C. Lindner '50 
Ellen Marks Lippman '68 
Marc E. Lippman '68 
Mark W. Lischner '65 
Peter B. Livingston ’63* 
Peter A. Livingston ’68 
Vincent J. Longo ’46 
John Dutch Lord ’53 
George M. Lordi "61 
Donald O. Lyman '68 
Brock Lynch '47 
John P. Lynch '62 
Benjamin E. Lyons '38 
Alexander Maitland III '55 
Jocelyn S. Malkin '51 
William J. Mangione '71 
Douglas G. Mann '76 
Harold March '50 
Bennett F. Markel '57 
Paul A. Markey '69 
Henry E. Markley ’43 
Elias J. Marsh '44 
Edward Martin '40 
Miguel A. Martinez ’83 
William F. Matchett "64 
Thomas J. Mathieu ’46 
Allan L. Mattern '62 
Stanley E. 
Matyszewski '62 
Michael J. McCabe '58 
Leo T. McCallum '58 
Eugene G. 
McCarthy Jr. '60 
William K. McClelland '47 
John J. McGillicuddy '38 
Joseph S. McGuire Jr. '55 
William G. Meffert '62 
John C. Mendillo '30 
Hoyt B. Miles Jr. '43 
Orlando J. Miller '49 
Harry C. Miller Jr. '54 
Dwight F. Miller '56 
Richard Charles Miller '58 
Donald L. Miller '60 
William A. Miller '62 
David P. Millett '68 
Patrick T. Minihan ’71 
Mary Jane Minkin '75 
James R. Missett ’70 
Charles R. Mitchell '06* 
Robert K. Modlin '57 
Peter M. Molloy '59 
Russell R. Monroe '44 
Joe D. Morris '46 
James B. Morris ’68 
Jon S. Morrow '76 
David E. Morton "48 
Albert R. Mowlern '51 
Albert Muggia '58 
Jerry Nagler '73 
Russell Nahigian '39* 
Donald J. Nalebuff '56 
George W. 
Naumburg Jr. '45 
Robert D. Needlman '85 
Lionel M. Nelson '69 
David E. Ness ’79 
Paul N. Neufeld '54 
Ismail Nik Nevin '51 
Allan W. Newcomb '60 
Andrew B. Newman '75 
Buford L. Nichols Jr. '60 
Dean Nichols '42* 
Myron K. Nobil '47 
Timothy F. Nolan Jr. '49 
James P. Nolan Jr. '55 
Walter W. Noll '65 
Edward J. O’Keefe '66 
Donald A. O'Kieffe Jr. '64 
Gerard B. Odell ’51 
S. Kwame Ofori- 
Kwakye ’79 
John A. Ogden "68 
Julius Anthony Olean '23* 
Robert W. Ollayos '41 
Nancy Olmsted '69 
Lowell E. Olson '54 
Gloria C. Onque '55 
Nelson K. Ordway '38 
A. Lawrence Ossias ’65 
Sidney Nathan Paly '52 
George J. Pardos '75 
John Curtis Parker '61 
Michael A. Parlato '08* 
Gioacchino S. Parrella '41 
John O. Pastore '67 
John A. Patti '71 
Harry Dickson Patton '46 
George W. Paulson '56 
Arthur A. Pava '51 
Norman E. Peatfield '35 
Alan S. Penziner 'll 
Richard E. Peschel 'll 
Robert H. Peters Jr. '55 
Barbara Ann Peters ’79 
Julian I. Pichel "49 
David Pickar '73 
Robert L. Pickens '65 
Michael C. Piercey '71 
Olive E. Pitkin '47 
Jay M. Pomerantz ’63 
Ashley Pond III ’33* 
Frederick A. Post ’36* 
Jerrold M. Post '60 
Majic S. Potsaid '51 
William B. Pratt '64 
James D. Prokop "59 
Richard D. Pullen '54 
Stewart E. Pursel '56 
Deborah A. Putnam '69 
William B. Radcliffe '58 
Tony Liebman 
Rakieten '29* 
James R. Ralph ’59 
Elizabeth M. Ramsey '32 
David M. Raskind '24 
Clifford B. Reifler '57 
Bruce A. Reitz '70 
Joseph L. Renda '68 
Charles F. Reynolds III '73 
Samuel Ritvo '42 
John Macklin Roberts '52 
James F. Robertson III ’75 
Gene A. Robinson '65 
Joseph D. Robinson '69 
Joseph M. Rochford '69 
Lois Knight Rogers "42 
Thomas J. Romano '73 
Robert M. Rosa ’70 
John Keith Rose '54 
Barbara F. Rosenberg '53 
George P. Rostel '48 
Laurence G. Roth '44 
Daniel J. Rubin '60 
Shaun J. Ruddy '61 
Carl M. Russell '49 
Susan H.K. Ryu '76 
Thomas H. Sakoda '61 
Morgan Sargent '37 
Stanley G. Schade '61 
Robert Lee Scheig '56 
Peter W. Scherer '68 
Stephen C. Schimpff '67 
Mary Wheatland 
Schley '52 
Ricky M. Schneider 'll 
Richard S. Schottenfeld '76 
John J. Schrogie '60 
Gerri A. Schulman '80 
Donald H. Schultz '52 
Marc D. Schwartz '59 
John H. Seashore '65 
Margretta Ann Reed 
Seashore '65 
Donald W. Seldin ’43 
David M. Shames '65 
Robert L. Shelton '64 
John P. Sherck '73 
Cynthia Anne Sherman '79 
Charles E. Sherwood '45 
Dennis E. Shield '70 
Jane B. Shumway '50 
Howard W. Siegel ’68 
Leonard M. Silvemian '54 
Joseph F. Simeone '73 
Donald C. Simonson '78 
Robert A. Sirota '73 
Hillel D. Skoff '80 
Marvin R. Skolnick '63 
Clement B. Sledge '55 
Laurie Smaldone ’79 
Gerald J. Smallberg '69 
John Smiarowski '71 
Hugh Allan Smith '36 
Phillip W. Smith '55 
Edward Lloyd 
Socolow '58 
Joseph E. Sokal '40* 
Rebecca Z. Solomon '39 
Sanford P. Solomon '59 
Edward Hersey Soule '43 
James P. Southwick '71 
James A.E. Spencer '62 
Gerald L. Springer "68 
Nancy Ann Staley '62 
Fred Stargardter '60 
Carole H. Stashwick '73 
Robert L. Stein '54 
Larry Lee Stewart '62 
John S. Strauss '50 
Sidney Stringer '33* 
Lee H. Strohl '68 
James A. Strom '74 
R. David Sudarsky ’49 
Charles J. Sutherland "71 
Thomas F. Sweeney ’73 
Richard B. Swett ’67 
Edgar B. Taft ’42 
Priscilla Dienes Taft ’44 
Morris Tager ’36 
Paul Talalay ’48 
Igor Tamm '47 
Caroline R. Taylor '78 
Carol C. Teitz '74 
Lawrence P. Temkin '72 
Robert Tennant ’29 
Hugh C. Thompson III '61 
Richard M. Thompson '63 
Walter Clark Tilden '12* 
Sigrid L. Tishler '64 
Franklin H. Top Jr. '61 
Patrick Toth '82 
Richard D. Travers ’71 
Patricia B. Tudbury '47 
Maurice Tulin "42 
Robert J. Ursano ’73 
Yvonne E. Vaucher '71 
Martha Vaughan '49 
Paul A. Vignola '71 
Darrell G. Voorhees ’39 
Robert B. Vranian '71 
Robert R. Wagner ’46 
John H. Wagner Jr. '52 
Joseph F. Walter '61 
Stephen Waltman '64 
Oscar Wand '64 
Martin Wand '67 
May Yung-Fun Woo 
Wang '60 
Patricia E. Wanning '40 
Steven L. Warsof 'll 
Stephen R. Webb '69 
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William J. 
Wedemeyer Jr. '46 
Myron E. Wegman '32 
Albert Carl Weihl ’71 
Robert G. Weiner '65 
C. Bruce Wenger ’70 
Doris L. Wethers '52 
Thomas J. Whelan Jr. '46 
Malvin F. White '39 
Steven C. White '69 
Alice A.S. Whittier '25 
Henry S. Willner '75 
William August 
Wilson '53 
Charles S. Wilson '63 
Jerome Allen Winer '63 
Alfred J. Wise '63 
Daniel Wohlgelemter ’77 
Muriel D. Wolf '59 
Irving Norman Wolfson'42 
Howard Asa Wood '25* 
John Patrick Wood "58 
Helen H. Woods '40 
Jeffrey Work '79 
Stewart R. Wright '62 
Daniel Wuensch "70 
Karl O. Wustrack '70 
Ronald A. Yankee '60 
Marc O. Yoshizumi '70 
Richard S.K. Young '73 
Robert Zeppa '52* 
Former House 
Officers 
Arnold H. Bierman 
Christine Brahney 
Dennis J. Card 
Richard Allen Chase 
Ryszard Chetkowski 
C. Gibson Dunn II 
Stephen A. Edelstein 
Richard Webster Finner 
John W. Goldkrand 




C. Grant LaFarge 
Steven Macht 
John P. McGovern 
Yasmeen A. Moody 
Gwendolyn B. Nichols 
Charles O. Ogunro 
Gan! R. Pasternack 
Ronnie G. Schlesinger 
James Schmidgall 
M. Peter Scibetta 
Fred Feslie Strieker 
James S. Touloukian 
Steven M. Zamore 
Parents 
and Friends 
Andrew S. Kim 
Edward G. Fund Jr. 
R. Donald Reich 
Henry S. Sanematsu 
Naomi Goldfarb Solomon 
Prof, and Mrs. Fubert 
Stryer 
* Deceased 









EPH Alumni Fund 
The names and data included on the following pages were provided by the Yale Epidemiology and Public Health Alumni Fund and reflect 
contributions made between July 1, 1992 and June 30, 1993. Posthumous donations are denoted by asterisk (*). 





Eric W. Mood 
Alice S. Baldwin 
Leona Baumgartner* 
Willard H. Boynton 
Miriam M. Campbell 
Henry F. Canby 
Richard F. Clapp 
George Feldman 
Franklin M. Foote 
Leonard Greenburg* 
Ruth E. Grout 
Ira V. Hiscock* 
Almeda King 
Carolyn S. Koffler 
Roslyn L. MacNish 
Eric W. Mood 
Margaret Hyde Moore 
Iwao M. Moriyama 
Henry Packer 
Leonard Parente 
Meyer J. Plishner* 
M. Allen Pond 
Arthur B. Robins 
Amelia F. Roe 
Miriam H. Rohde 
Adele P. Schlosser 
Charles D. Spangler 
Howard West 
Jane L. White 
Muriel Bliss Wilbur* 
Amy H. Hunter Wilson 
Alexander Witkow* 




Eric W. Mood 
Massimo Calabresi* 
Jean F. Heston 
Gloria C. Lempke 
Jane Y. Parker 
Einar H. Raysor 




Eric W. Mood 
Roslyn R. Bilford 
Naomi Barer Golden 
Joe Bales Graber 
Lois M. Jund 
Naomi Helen Kalajan 
Lawrence E. Shulman 




Eric W. Mood 
Nicholas W. Fenney 
Dorothy B. Hamilton 
D. Patricia Nelson 




Eric W. Mood 
Sidney S. Chipman 
Edna Miller Finberg 
Anne E. Fulton 
Gladys Jacoby Goldmann 
Lillian L. Konick 
Leah Lehrer 
Jean M. Pinder 
Cecil G. Sheps 




Samuel S. Hennan 
John B. Dibeler 
Mary L. Ellis 
Samuel S. Herman 
Richard E. Johnson 
Beatrice H. Kaasch 
Dorothea S. LaBelle 
Hiram Sibley 




Edgar L. Geibel 
Edgar L. Geibel 
Eleanor P. Kostant 
Christine R. Owre 
William B. Parsons 
Elizabeth D. Robinton 
Matilda Rudnick 




Eric W. Mood 
Dorothy Reese Bloomfield 
Henry G. Brickman* 
Ida M. Bucher 
Helen P. Cleary 
Austin J. Evans 
Jerome M. Glassman 
Dorothy R. Granoff 
Eugene K. Harris 
Martha P. Jayne 
Frances K. Reynolds 
Nathan M. Simon 




Robert L. Johnson 
Joseph Axelrod* 
Clarissa E. Boyd 
Clarence William Bushnell 
Norton G. Chaucer 
Joanne E. Finley 
Robert L. Johnson 
Leonard F. Menczer 
Virginia E. Torres 
Walter Wenkert 




Yolande F. Lyon 
Joanna Adele Henry 
Malcolm C. Hope 
Charles Holway Lawrance 
Sidney S. Lee* 
Helen Kardys Loria 
Yolande F. Lyon 
Hannah Eileen MacHenry 
Richard B. Ogrean 
Brena B. Wolff 





Cecilia Frances Di Cicco 
Laurence K. Rainsford 
Milton H. Sisselman 
Constance B. Thomas 




Eric W. Mood 
Ranoo W. Dissamam 
Alvin Hamburg 
Calvin P. Hatcher 
William A. Markey 
Ruth M. Taber 




Frances R. Ogasawara 
Amy L. Cawley 
Evelyn S. Farnsworth 
Morris London 
Mary Me C. Mogan 
Frances R. Ogasawara 
Gerald Rosenblatt 
Daniel E. Ross 




David D. Boyd 
David D. Boyd 
Kathleen H. Howe 
John E. Ives 
Paul I. Kaufman 
John F. Mullett 
Julia R. Nole 
Mary K. Ochiai 




Edward R. DeLouise 
Anne M. Anzola 
Lee De Cady Jr. 
William A. Clermont 
Edward R. DeLouise 
Sheldon Selig King 
Shirley T. Steidel 
Paul W. Stemlof 
Patricia A. Viscosi 




Joseph A. Scorpion 
Eduardo Anzola 
Josephine Blanchett 
Helen H. Davenport 
Thomas T. Flynn 
Normand E. Girard 
Patricia P. Grimaila 
Philip B. Hallen 
E. Field Horine Jr. 
Chun-Lin Lai 
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Edward H. Noroian 
Joseph A. Scorpion 




Dorothy M. Wilson 
! Rita Dingman 
Bennett I. Enowitch 
I John T. Foster 
William L. Kissick 
, Marvin A. Lavenhar 
Hugh J. Maher 
Feme G. Moore 
Lee J. Podolin 
John S. Pullman 
Ellwyn D. Spiker 
Mattie Lee D. Wade 




Gyla E. Brooks 
Kathryn L. D’Amico 
Wouter Ekker 
Maxine Geeslin 
Rose A. lannotta 
Katharine Anna Keppel 
John J. Kwasnowski 
Lowell Stem Levin 
R. John C. Pearson 
Hannah Clark Russell 




Joseph T. Prekup 
Gordon R. Beem 
Martin Donabedian 
Yoh Ok Lee 
Helen M. O’Connell 
Margaret P. Parker 
Angela M. Russo 
| William R. Slivka 




Thomas R. Mayhugh 
Thomas A. Blumenthal 
Thomas R. Mayhugh 





Raul R. Cuadrado 
David Dolins 
C. DuVe Florey 
Edward M. Kenney 
Jean M. Maynard 
Rosemary W. Stevens 
Samuel B. Webb Jr. 




James J. Culhane 
Katherine Maria Detre 
Neal L. Maslan 
Estelle Siker 
Monroe W. Spero 
Claudewell Sidney 
Thomas 




Joel M. Cohen 
Robert M. Edwards 
Edgar W. Francisco III 
Monte Nelson Frazier 
James F. Jekel 
Michael E. Kove 
Peter J. Levin 
Charlotte Miller 
Mary D. Murphy 
Francia M. Pagano 
Elliot A. Segal 
Karl A. Smith 
Viola J. Spinelli 
Alice J. Turek 
Sarah L. Turner 
David S. Weiner 





Barbara L. Brody 
Allen Cohen 
Anne B. Collart 
Richard H. Ferraro 
Diana B. Fischer 
Robert C. Lowrie Jr. 




James M. Malloy 
Joel Kavet 
Patricia D. Mail 
James M. Malloy 
Charles J. Petrillo Jr. 
Nancy Ruth Phillips 
Bruce J. Steinhardt 
Irma Willner 
Robert L. Woodward 




Francis J. Greaney 
Doris Storms Brenner 
Joseph L. Dorsey 
Elizabeth Schwartz Elliot 
Robert R. Everett 
L. Carol Femow 
Carl R. Fischer 
Michael J. Geaney Jr. 
Francis J. Greaney 
Chester H. Johnson 
R. Elizabeth Leif 
Jean C. MacCorison 
Robert F. Morisse 
John M. Patton 
Doreen P. Sharabati 
Martha F. Steel 
Sheila W. Wellington 




Susan S. Addiss 
Janet A. Albrecht 
Victor Crown 
James M. Dawson Jr. 
Gerald R. Harpel 
Sylvia N. Holtzberg 
Charles C. Jeffrey 
Samuel P. Korper 




Carolyn K. Wells 
Robert L. Young 
Chester W. Zarnoch Jr. 




Susan W. Balter 
Frederick G. Adams 
Robert G. Alexander 
Susan W. Balter 
Arthur A. Berarducci 
Hamilton B. Brown Jr. 
Shan Cretin 
Ruth C. Edelson 
Walter M. Gawlak 
Robert S. Gureasko 
Shirley O. Labrum 
Scott W. Lite 
C.P. Noel McCarthy 
Anthony M. Orlando 
Carol B. Phillipy 
Penny Prior 
Nancy Norton Reitz 
Charlotte F. Schwartz 
Joseph A. Zaccagnino 





J. David Amundson 
Evarists Berzins 
John Bihldorff 
Evelyn J. Bromet 
Katrina H. Clark 
Karen S. Cohen 
Dale A. Culp 
John A. Daeley 
Harvey Fembach 
Wanda J. Hatmaker 
Mohamed Ismail Johnson 
Mark J. Magenheim 
Joan L. Martinez 
Eugene S. Mayer 
Nancy P. Mogielnicki 
Wan Hin Ooi 
Carol L. Paul 
Marcia Russell 
John M. Ryan 
Jane Silver 
Robert E. Steele 
Claudia J. Svara 




Dorothy N. Lewis 
David P. Barone 
Catherine A. Connolly 
John A. Drew 
Daphne deJ. Gemmill 
Susanne Harris 
Dorothy N. Lewis 
Steven M. Lipsius 
Jo Ann K. Silverstein 
Raymond L. Sphar Jr. 
Laurence A. Tanner 
Joyce R. Waksman 




Gary Dean Sax 
Emily M. Barclay 
Eva Danielsson Cohen 
Bernice E. Coleman 
Ellen B. Doft 
Bruce Goldman 
Marilyn S. Halper 
Helen B. Hubert 
James L. Mason 
Dennis P. May 
Stanley D. Miller 
Gary Dean Sax 
Janet B. Schoenberg 
Alice S. Stark 
Thomas J. Stranova 
Irene Trowell-Harris 
Larry S. Webber 
Bonnie C. Yankaskas 
Carl J. Zack 




Thomas A. Benoit 
Thomas A. Benoit 
Ian B. Berger 
Olga Brown-Vanderpool 
Beth G. Crocker 
J. Breckenridge Eagle 
Elizabeth M. Helming 
Roberta Lawrence 
Edward J. Mullen 
Nils R. Richardson 
Abigail L. Smith 
Myma M. Weissman 
Bienvenido G. Yangco 




Linda K. Broker 
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Edith N. Baum 
Linda K. Broker 
Ann C. Cunningham 
Linda K. Denrlo 
Jack A. Eiferman 
William J. Grego Jr. 
Donna Brown Grossman 
Anne H. Hall 
Barbara R. Unterman Jones 
Philip D. Kennedy 
James E. Knoben 
Marion Lee 
Stuart L. Lefkowich 
Marsha Alex Lubick 
Laurence F. McMahon Jr. 
Dennis W. Mesenhimer 
Lois S. Michaels 
Mary W. Palshaw 
Dale P. Sandler 
Edward V. Sargent 
Audrey Weiner Solomon 
Nancy E. Stroup 
Raymond Chiu-Ping Tang 
Maura M. Tobin 
Paul H. Etkind 
Robert H. Frazier 
Wendy Corn Friedman 
Annette B. Garofalo 
Linda J. Goodhart 
Janina Levy 
Lawrence V. Meagher Jr. 
Gino A. Nalli 
James B. Rokos 
Robert Risdon Schwarz 
Mary Jo Shepard 
Henry E. Sprance 
Gladys A. Williams 
Thomas S. Wingardner Jr. 




Jerry L. Ainsworth 
Richard B. Burford Jr. 
Patrick F. Carone 
Abby Rothschild 
Carroll Schilling 
Gail M. Sullivan 
Virginia R. Towle 
Leon F. Vinci 
John Stephen Zil 




Ann T. Freedman 
Vijaya V. Bapat 
Kathleen M. Berman 
Alan B. Bloch 
Robert J. Fensterheim 
Ann T. Freedman 
Janice F. Gold 
Jane E. Hill 
David W. Houck 
Jean Crum Jones 
Margaret Long Karis 
R. Bradford Walker 
Lucy Ellen Weiger 





Ralph Tartaglione Jr. 
Bruce S. Anderson 
Virginia P. Bainbridge 
Marianne Berwick 
Ralph J. Coburn 





Judith B. Gancher 
Joseph D. Henn-DeMayo 
Lucinda H. Hogarty 
Geoffrey P. Kane 
Karen Kmetzo 
Benjamin Krevsky 
Bennett Myles Locke 
Osvaldo Marrero 
Patricia J. Moore-Pastides 
Helen O'Brien 
Nancy Rayburn 
Lisa Klar Rosenfeld 
George B. Rowland 
William E. Schweizer 
Audrey P. Silvey 
Ralph Tartaglione Jr. 
Elizabeth Tedder 
Jane P. Watkins 
Jonas Zucker 




Christina P. Quinn 
John H. Tobin 
Thomas J. Trudell 




Elaine P. Anderson 
Elaine P. Anderson 
William F. Appicelli 
Rochelle Arcus-Ting 
Cheryl F. Austein 
Steven R. Cohen 
Bruce D. Cummings 
Marsha E. Dunn 
Gerard J. Foley 
Paula Yaney Gambill 
Teri J. Klein 
Ronald F. LaPensee 
Wendy K. Lefkowich 
Robert Walter Makuch 
Polly W. Marvin 
Kristin K. O'Connor 
James M. O’Connor 
Harris Pastides 
Linda Mendelsohn Pottem 
Rosalyn I. Liss 
Christopher M. Maylahn 
Barbara J. Mieras 
Marguerite Nelligan 
Patricia Lynn Noeker 
Peter F. O'Connor 
David W. Osborne 
Ellen D. Rothberg 
Karen C. Schneider 
Robert E. Schwartz 
Roberta Jo Shapiro 
Karen Wolchuck Sher 
Alan J. Siniscalchi 
Marie Stoeckel 
Phillip R. Aaron 
Gary J. Aboff 
Frederick R. Aronson 
Richard L. Buck 
Gary L. Busack 
Anne Morrison Danaher 
Alfred E. Fasulo Jr. 
Ellen B. Greif 
John Halleran 
Irwin J. Halperin 
Samuel S. Hamilton 
James P. Harisiades 
Virginia S. Humphrey 
Helen E. Kelly 
Yee-Lean Lee 
Robert V. Levine 
Paul A. Locke 
LeRoy F. Ludwig 
Kristina Obom Maldarelli 
James S. Marks 
Linda L. Moraga 
Jane Ungate O'Connor 
Ann L. Prestipino 
Christie Michele Reed 
Norman M. Schlossberger 
Kathleen M. Scribner 
Lydia A. Selling 
Marsha L. Silverman 
R. Blake Whitaker Jr. 
Marie L. Zanotti 




Angelo J. Devita 
Barbara Gaugler 
Pennebaker 
Nancy R. Angoff 
Christopher J. Bevan 
Harold J. Burdo Jr. 
Patricia J. Checko 
Rollin C. Chew 
Angelo J. Devita 
Robert Fox 
Peggy A. Gallup 
Judy E. Garber 
Marie F. Gavula 
Joan Urquhart Goodman 
Thomas J. Krause 
Katherine M. McCormack 
William J. McLaughlin 
Blackford Middleton 
Marlee D. Mooney 
Mary E. Papke 
Barbara Gaugler 
Pennebaker 
Elizabeth N. Shapiro 
Keith D. Tait 
Nancy Schlesinger Weiss 
Kathleen R. Yager 




Jean L. Milton 
Jamie L. Amaral 
Martha Livingston Bruce 
Denise Heinemann 
Constance M. Jarowey 
David P. Klarberg 
Susan Eberle Levy 
Linda F. McCaig 
William F. McKeon 
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Jean L. Milton 
Tsuneki Mizuta 
David L. Mork 
Mercedes H. Primer 
Susan G. Rice 
Sally R. Rinaldi 
Michele T. Visconti 
Sandra Michaelson Warren 
Alvin C. White 
Theodore J. Witek Jr. 
Jill Okrent Zaheer 




Jeffrey B. Hughes 
Marybeth McNerney 
Barbara W. Abraham 
Gail Alexander 
Dalia Castillo-Aguilar 
Peter A. Chaipentier 
Linda K. Contreras 
Lorraine DeNicola 
Eileen McDonald Egan 
Susan Faris 
James N. Gaito 
Ellen M. Ginzler 
James D. Gonzales 
Daniel A. Graybill 
Virginia C. Hiland 
Jeffrey B. Hughes 
Allen F. Levy 
Peter W. Lyden 
Judith F. Nelson 
Suzanne Nutt 
Barbra G. Rabson 
Nano G. Rush 
William Sabella* 
PaulM. Schur 
Russell W. Scott 




Anthony John Alberg 
Leslie A. Balch 
Rudy Glen Davis 
Jean L. Freeman 
Carolyn H. Grantham- 
Millman 
Penny H. Hausser 
Suzanne S. Horn 
Sarah M. Horwitz 
Georgia Jennings 




James H. Reich 
Jessica L. Richer 
Julie A. Russem 
Stephen Marc Schwartz 
Robin Kupfer Spencer 
Gerald L. Springer 
Pamela Parise Suan 
Marie Ann Tobin 




Joan M. Cleary 
Katherine Santella 
Fitzpatrick 
Christine D. Berman 
Joan M. Cleary 
Grace P. Erickson 
Jerald A. Fagliano 
Katherine Santella 
Fitzpatrick 
Peter J. Kowalski 
Emily M. McClure 
P. Douglas McConatha 
Mary Ann Morreale 
Mara Natkins 
Donna Therese Perla 
Adrian J. Pinsince 
Nathan D. Wong 




Aric T. Wilt 
Indu B. Ahluwalia 
Andrea Lee Boissevain 
Lewis P. Bower Jr. 
Marijane L. Carey 
Katherine H. Ciacco 
A. Richard Dooley Jr. 
Joe Tom Easley 
Nancy E. Fithian 
Stephen B. Gruber 




David C. Lowy 
Adrienne Marks 
Bernadette M. Mosellie 
Tracey M. Orloff 
Elizabeth G. Pelz 
Philip O. Renzullo 
Denise Amy Riedel 
Eric Triffin 
Marie Irene Tsivitis 
Aric T. Wilt 
Linda F. Wood 




Hilda C. Chaski 
Elizabeth A. Weimar 
Caryl A. Beison 
Hilda C. Chaski 
Margaret D. Corbae 
Robin N. Eastman 
Bridgid M. Garrison 
Carol Guardiano 
Sara A. Holdcroft 
Kastytis V. Kaleda 
Michael T. Koff Jr. 
Mary Ann Lillie 
Deirdre McDonald 
Barbara J. Moggio 




Mark J. Pereira 
Anita A. Roth 
Judith Natale Sabino 
Robert A. Scholle 
Michael J. Testa 
Joel A. Wasserman 
Elizabeth A. White 




Joseph Della Puca 
Barbara Ellen Andrews 
Robert Joseph Anthony 
Ellen Sofia Bass 
Elaine P. Berger 
Giselle Charlotte Bleecker 
Sylvia Blackburn Farrell 
Mark William Legnini 
Paul Alan Lindia 
Saifuddin Taiyeb Mama 
Carrie A. Redlich 
Sarah Hudson Scholle 
Mi-Sook Song 








Joy Misako St. Germain 
Lisa N. Akam 
Christine Appel 
Judy Gardner Audette 
Michael Joseph Gillespie 
Elizabeth Harrison Hadley 
Wen Hsiao 
Marcella Perez Jones 
Chia-Jean Lee 
Clifton Ping Lee 
Christine Anne Lucas 
Joanne Susan Mosca 
Deena Beth Myers 
David Dean Peete 
Rock Gerard Positano 
Nipon Sermpanich 
Joy Misako St. Germain 
Sophie Helene 
Tworkowski 




Jennifer Jennings Miller 
Sylvia Elaine Bailey 
Linda V. Bergonzi 
Stanley Bernard 
Andrew K. Bhak 
Michael Anthony Cairozza 
Cynthia Elaine Carver 
Tina Chung 
Angela Colantonio 




Angela B. Miller 
Jennifer Jennings Miller 
Karyn J. Nair 
Al-Karim F. Rehemtula 
Vicki E. Stack 
Julie Ann Utroska 




Patricia J. DeFelice 
Benjamin O. Adetola 
Lisa A. Amerino 
Jennifer B. Bonney 
Sandra S. Childress 
Maureen P. Corry 
Patricia J. DeFelice 
Katrien Derycke-Chapman 
Beth S. Finkelstein 
Robert B. Giallongo 
Elaine E. Grant 
Katie B. Horton 
Timothy A. Jacobs 
Kathryn S. Katz 
Jill M. Quinn 
Ellen C. Rankin 
Carole R. Robbins 
Louise P. Roumagoux 
Mitchell S. Tepper 
Charles W. Tomatore 
James Tsai 
Patreece T. Williams 




Donald G. Cofrancesco 
Rodney M. Dourron 
William Robert White 
Friends 
Marjorie L Aubry 
Lucille Brown 
Mr. and Mrs. Robert E. 
Buckholz 
Gerald A Capizzi 
Martha M. Garrick 
J.M. and Dorothy Carrick 









Mr. and Mrs. Don Diets 
Alice L Golden 
Elizabeth Elliott 
Dorothy M. Horstmann 
Rose Kelly 
Joseph A Kelly 
Mr. and Mrs. T. Dale Lowe 
U. Robert Merikangas 
Thelma and Jean Morris 
Mr. and Mrs. James 
Nichols 
Joan and A1 Schuckie 
Strong Hill Language 
Institute 
Vera Ellen Swanger 
Mr. and Mrs. Paul Tangas 
Dulce R Villabona 
Arthur J. Viseltear* 
Robert K Watson 
Colin White 
Mr. and Mrs. Virgil Wolff 
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1993 EPH Distinguished 
Alumna Rosemary A. 
Stevens, M.P.H. ’63, Ph.D. ’68 
The board of directors of the Association 
of Yale Alumni in Public Health 
(AYAPH) presented its 1993 Distin¬ 
guished Alumni Award to Rosemary A. 
Stevens, M.P.H. '63, Ph.D. '68 on June 4 
at the Alumni Weekend awards lun¬ 
cheon. Dr. Stevens, who has spent most 
of her career in teaching and research, is 
dean and Thomas S. Gates Professor in 
the School of Arts and Sciences at the 
University of Pennsylvania. 
Before accepting her current position in 
1991, Dr. Stevens was chairman of the 
department of history and sociology of 
science and UPS Foundation Professor of 
Social Science. She also is a senior fellow 
of the Leonard Davis Institute for Health 
Economics. 
Dr. Stevens came to Yale in 1962 
after receiving B.A. and M.A. degrees 
from Oxford University in England. She 
completed her Yale M.P.H. degree in 
hospital administration and medical care 
and a Ph.D. degree in epidemiology. 
Many alumni who studied at EPH during 
the 1970s remember Dr. Stevens as one 
of the department's most inspiring 
teachers, a respected scholar and an 
international expert on health manpower 
issues. In 1974, she was the first woman 
to become master of a residential college 
at Yale (Jonathan Edwards). 
Between her “Yale years” and her 
cunent Penn posts. Dr. Stevens served as 
professor and chairman of the department 
of health systems management at Tulane 
University. 
Dr. Stevens’ professional activities, 
honors and awards span three decades. 
They include: board member. Dartmouth 
Medical School; member, numerous 
committees and councils of the Institute 
of Medicine of the National Academy of 
Sciences; member, American Hospital 
Association and American College of 
Health Administrators Historical 
Collections Advisory Committee; 
consultant. Subcommittee on Health, 
Committee on Ways and Means, U.S. 
House of Representatives; consultant. 
Office of the President, Bureau of the 
Budget; board of directors, Robert Wood 
Johnson Foundation, Clinical Scholars 
Program; member, consultant/advisory 
and publications boards, U.S. Department 
of Health and Human Services; fellow, 
American Academy of Arts and Sci¬ 
ences; scholar, Bellagio Study Center; 
and recipient. Rockefeller Humanities 
Fellowship and Guggenheim Fellowship. 
Dr. Stevens was honored by the 
American Public Health Association with 
the Arthur J. Viseltear Award. In 1990, 
she won the Baxter Foundation Prize for 
distinction in health services research and 
From the EPH Alumni 
Fund Chairman 
While the giving by graduates to the 
Yale Public Health Alumni Fund for 
the 1992-1993 academic year 
increased over the prior year, a great 
need remains for increased giving to 
the fund during the 1993-1994 
academic year. This increased need 
has been generated by the students 
currently enrolled in the department 
of epidemiology and public health. 
Many require substantial financial 
support. All of the funds donated to 
the Yale Public Health Alumni Fund 
are used to award scholarships to 
these students. 
During the 1992-1993 academic 
year, gifts to the Yale Public Health 
Alumni Fund amounted to 
$47,314.11, more than $10,000 
greater than in the previous year. 
However, this amount fell short of the 
$50,000 goal. The percent of 
graduates participating in 1992-1993 
increased to 28 percent, compared to 
25 percent for the prior year. 
We are asking graduates who 
have regularly given to the fund to 
increase their gifts by at least 10 
percent. Also, we are asking gradu¬ 
ates who have not been regular 
contributors to make a modest gift 
of$25. 
For the current giving year, we 
are hopeful that gifts to the fund will 
the Welsh Medal for distinction in the 
history of medicine. Her most recent 
book, In Sickness and in Wealth: 
American Hospitals in the Twentieth 
Century, won the James A. Hamilton 
Book Award for best book of 1990. 
One of the most inspiring aspects of 
Dr. Stevens’ distinguished career is her 
enduring commitment to community 
service. She has served on numerous 
hospital boards and has been involved 
with many community agencies, includ¬ 
ing Dixwell Community House in New 
Haven. She is a trustee of the Presbyte¬ 
rian Medical Center. 
Eric W. Mood, M.P.H. '43 
total at least $55,000, and that at least 
one-third of the graduates will 
participate. 
These are exciting times for the 
Yale department of epidemiology and 
public health. This excitement, 
hopefully, will be reflected by 
increased contributions to the Yale 
Public Health Alumni Fund from the 
graduates. 
Eric W. Mood, M.P.H. '43 
Chairman 
Yale Public Health Alumni Fund 
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EDUCATION AT YALE 
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Uveitis for the Practitioner (A) 
Director: I. Willard Abrahams, M.D. 
Yale Eye Center 
Dental Treatment: Considerations for Medically Compromised Patients (B) 
Director: Donald W. Kohn, D.D.S. 
Guest Speaker: Barbara Steinberg, D.D.S. 
Yale University School of Medicine 
Mary S. Harkness Auditorium 
Image Enhancement through Esthetic Dentistry (C) 
Director: Donald W. Kohn, D.D.S. 
Guest Speaker: Jacqueline Dzierzak, D.M.D. 
Yale University School of Medicine 
Mary S. Harkness Auditorium 
Controversies in Thoracic Trauma (D) 
Director: Stephen M. Cohn, M.D. 
Yale University School of Medicine 
Mary S. Harkness Auditorium 
Update on Retinal Diseases for the Anterior Segment Surgeon 
Director: Peter E. Liggett, M.D. 
Newport Islander Doubletree Hotel, Newport, R.I. 
Yale Alumni in Psychiatry (F) 
Director: David J. Yarington, M.Ed. 
Connecticut Mental Health Center 
34 Park St., New Haven, Conn. 
Treatment Options for the Failing Left Ventricle (G) 
Director: John Elefteriacles, M.D. 
Yale University School of Medicine 
Mary S. Harkness Auditorium 
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CONFERENCES DISCUSSED IN THIS ISSUE. PLEASE BE SURE TO INCLUDE YOUR NAME AND ADDRESS. 
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POLITICS & POLICY 
In Health-Reform Battle, Insurers Are Resistin 
Weeded 
,aceSfc& 
White HouseEfforts to Fit Them With a Black H 
By Rick Wartzman 
Staff Reporter of The Wall Street Journal 
WASHTV' Bill Gradison, presi- 
of 
nesses, labor unions and others is demand¬ 
ing that the insurers’ commercial be pulled 
from the air. 
White Ho us' ' are irritated thaf 
V insure*- 
through regional alliances, the r 
tion that prompted its TV ad about 
The White House, for its part, argu 





Linking of Universal Health Coverage 
To Cost Containment Endures Scrutiny 
°rM 
e^che, s 
Page R8 New Haven Register. Saturday. November 13, 1993 
Clinton health-care reform aide hears concerns about managed c 
By Stephen Higgins 
agister StaH 
NEW HAVEN — Doctors are 
Tied about how much power 
ailed “managed care” compa- 
will wield if President Gin- 
olan to reform the nation’s 
-»re system is 
gress last week and will be debated 
in the coming months. 
Feder, the chief health policy 
analyst for the Department of 
Health and Human <^™ices, was 
invite'4 1T-S- 
R- 
“I already spend too much time 
with these companies that want to 
hassle me to death." 
Managed care companies, 
which run various types of health 
maintenance organizations, keep a 
eye — * '*oc 
Kraus, director of health for the That’s because one of the cen- 
city of Milford. “When I worked tral goals of the plan is to turn 
for an HMO. I was restricted in the insurance companies into health- 
kind of care I could give my care providers, Feder said: “They 
patients.” will have to compete on th° basis 
Feder responded by saying the of efficiency of delivery. ac- 
Ginton plan is designed to keep cording to how much r~ 
-“d care comrwni#^ in 1 So the manage 
then- :,1 need ♦ 
providers on their lists 
for use by enrollees, Fe 
That was good news 
in the audience, includir 
practitioner and a chi I 
v both of whom expresses! 
they would be left out o | 
n’ system. 
Question remains: 
Who will pay for 
health-care plan? 
COVER STOR^ 
Reforms Proposed by Itm 
•rforieal ®*|or,c** ®^ic^'gtdoncal 
Qfcncdicai' ^‘o^catewicdka 
Cushing-Whitney Medical Library 
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The Yale System Moves beyond Cedar Street 
Revisions to the medical school curriculum emphasize learning in 
ambulatory health-care settings. 
On Managed Care and Medical Education 
Comments by Medical School Dean Gerard N. Burrow, M.D. ’58. 
---- | 
t 
Traveling the Road to Family Practice ^ 
Leadership and service to one's profession are hallmarks of Yale medical graduates. Morris B. Mellion, M.D., shares 
his recent experiences with the American Academy of Family Practice. 
Pioneer of Primary Care: William R. Willard, M.D. 
With his Yale training, the late William R. Willard, M.D. ’34, had focused his career on the development of primary 
care and training programs at three medical schools. 
Unsung Heroes One physician’s opinion on medical practice. 
Humans and the Environment: 
60 Years at Pierce Laboratory 
Founded by industrialist John B. Pierce, the research laboratory 
that bears his name observes its 60th anniversary. 
Environmental Health Surrounds Us 
Research in environmental health sciences at Yale is multi-disciplinary and multifaceted. Yale Medicine highlights 
programs and projects that are important to the public’s health. 
YM Interview: Rebeca Rico-Hesse, Ph.D. 
In her pursuit of emerging viruses, a young scientist frequently travels to South America and back to New Haven to 
continue basic research on vaccine development. Her work concentrates on equine encephalitis. 
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37 Gallery 42 Book News 54 In Memoriam 
38 Scope 46 Alumni News 55 Development Report 
40 Faculty News 49 Alumni Report 57 Continuing Education 
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Profiles Former Dean 
To the editor: 
I have recently learned that a biogra¬ 
phy of Dr. Stanhope Bayne-Jones has 
been published. “B.J.,” as he was 
known, was a distinguished microbi¬ 
ologist who was appointed dean of 
the Yale School of Medicine in 1935. 
He left the deanship in 1940 to serve 
in the Army as war clouds were 
gathering. Many readers of Yale 
Medicine would be interested to know 
of this biography, since B.J. is fondly 
remembered by many of our graduates. 
Stanhope Bayne-Jones, M.D. 
Albert E. Cowdrey wrote the 
biography, entitled War and Healing: 
Stanhope Bayne-Jones and the 
Maturing of American Medicine, 
published by the Louisiana State 
University Press. 
In a review in the September 
1993 issue of Academic Medicine, 
Margaret Humphreys, M.D. Ph.D., an 
internist and historian at Duke 
University, writes: “Bayne-Jones 
faced challenges unknown to 19th- 
century physicians as he struggled to 
manage the conflicting agendas of 
research medicine, medical education, 
and medical practice. He became 
skilled in the art of directing research 
money, of preventing donors and 
federal bureaucrats from limiting 
medical research through unrealistic 
specifications, and of helping local 
community physicians adjust to the 
reality of academic medicine’s growth.” 
Arthur Ebbert Jr., M.D. 
Professor Emeritus of Medicine 




For Patient Advocacy 
To the editor: 
It is presumed that Dr. Howard M. 
Spiro did not have opportunity to read 
the letter to the editor concerning 
family medicine prior to delivering 
his excellent commencement address 
to the Class of '93 published in the 
summer 1993 issue of Yale Medicine. 
Dr. Spiro eloquently identifies major 
problems contributing to dehumaniza¬ 
tion of health care but I suspect, being 
cloistered in one of the citadels of 
super-specialization, the private 
medical school, does not address 
realistic solutions to the problems. 
Primary-care physicians with 
assistants, as patient advocates, who 
command understanding of the 
spectrum of the potentials of all 
specialties, must help guide the 
patient through the maze of other 
providers, the exploding technologies 
and continually expanding bureau¬ 
cracy. Primary-care physicians must 
be compensated for the time to listen 
and counsel patients, be rewarded for 
thoughtful prudence in management, 
and paid to knowledgeably participate 
in the assimilation and communica¬ 
tion of the indicated data. 
Private medical schools, like 
Yale, should be exerting leadership in 
promoting this badly needed service, 
and they are not. The schools should 
be developing curricula and integrat¬ 
ing programs, especially those 
dealing with humanities, so that the 
service responsibilities by default do 
not fall to the unprepared and least 
qualified. 
The public is demanding humani¬ 
tarian, coordinated and better commu¬ 
nicated service; the politicians and 
bureaucrats are listening; private 
medical schools are not. 
Robert P. Gibb, M.D., HS ’48- ’50 
Bellingham, Wash. 
Educational Apology 
To the editor: 
I feel terrible! After 26 years as one 
of the senior physicians at the 
Southbury Training School, where 
each year I took Yale medical stu¬ 
dents on tour and lectured to them on 











the problems of mental retardation, I 
now find that I made a huge error and 
I hope Yale Medicine will help pass 
the truth on to those students. I told 
them repeatedly that retrolental 
fibroplasia in prematures was due to 
too much oxygen in the incubators. 
Now I hear it was due to “oxygen 
lack" ( Yale Medicine Fall/Winter 
1993-1994) and from "Rocky” 
Fasanella no less! To all those 
students, I send my sincere apology. 
Paul R. Bruch, M.D. 
Southbury, Conn. 
Editor’s reply: 
Dr. Bruch does not need to apologize. 
The theory current to the '50s and 
'60s suggested that the retrolental 
fibroplasia was due to the elevated 
oxygen tension in which premature 
infants were maintained in their 
incubators, and Dr. Bruch merely 
espoused theory current to that 
period. That things have changed 
only emphasizes the need to continue 
one’s education even after one has left 
the hallowed halls. 
Announcement 
With this issue of Yale Medicine, we 
introduce a new three-column format, 
with slightly larger text type. These 
changes are made in response to your 
comments on the Yale Medicine 
survey. The revisions begin design 
improvements that we plan to intro¬ 
duce in future issues. 
The magazine has always been 
100% recyclable and now is printed 
on recycled paper. 
Authors’ Seek 
Winternitz Material 
For a study of the life and accom¬ 
plishments of Milton W. Winternitz, 
M.D., former dean of the Yale 
University School of Medicine, 
Priscilla Waters Norton, the widow 
of the distinguished Yale pathology 
professor. Levin Waters, and 1 are 
interested in comments, anecdotes or 
other experiences that anyone may 
care to relate. This writing project is 
undertaken with the permission of 
Dr. Winternitz’s son. Bill. 
Please write to me at The Program 
for Humanities in Medicine, 333 
Cedar St., Box 208019, New Haven. 
CT 06520-8019. All contributions 
will be acknowledged by letter and in 
any publication which may result. 
Howard M. Spiro, M.D. 
Director, Program for Humanities 
in Medicine, Yale School of Medicine 
333 Cedar Street, New Haven, Connecticut 
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The Yale System 
Moves beyond Cedar Street 
! By Carolyn Battista 
Karen Broder, a fourth-year student at 
the Yale School of Medicine (YSM), 
was describing her recent four-week 
clerkship in primary care at Milford 
Pediatrics in Milford, Conn. 
“It was my first real experience 
i with primary care. I felt I was making 
a little bit of difference in someone’s 
life,” she says, as she recalls examining 
youngsters and — often — educating 
their parents on such subjects as 
accident prevention. 
Clerkships like Ms. Broder’s are 
an important part of the recently 
revised curriculum at YSM. “Fourth- 
year students now have a required 
primary care experience,” says 
Robert H. Gifford, M.D., associate 
dean for education and student 
affairs. “They get out into the com¬ 
munity and see what it’s like to 
practice primary care.” 
The new curriculum emphasizes 
clinical training in ambulatory 
settings, the integration of material in 
basic science courses, and the coordi¬ 
nation of the basic and clinical 
sciences. It also includes Medicine, 
Society and Public Health, a series of 
coordinated courses that address 
many issues related to health and to 
medical care. 
Carolyn Battista is a free-lance 
writer who lives in Waterford, Conn. 
The changes to the curriculum 
reflect what’s happening in medicine 
and in society. They also fit the Yale 
System of medical education, which 
for decades has emphasized indi¬ 
vidual responsibility, rigorous think¬ 
ing and comprehensive knowledge, 
and required a thesis based on 
original research. 
"The curriculum revision allows 
us to modify our educational process 
while still retaining the strengths of 
the Yale System. Having our students 
experience more of their clinical 
education away from a hospital 
setting is in accord with the increased 
national emphasis on primary care,” 
said Gerard N. Burrow, M.D. ’58, 
dean of the School of Medicine. The 
revision process is supported by a 
four-and-a-half-year, $2.4 million 
grant from the Robert Wood Johnson 
Foundation of Princeton, N.J. 
Stephen C. Edberg, Ph.D., 
professor of laboratory medicine who 
chairs the YSM Educational Policy 
and Curriculum Committee, calls the 
school’s 1988 Benz Report the 
starting point for the development of 
a “vibrant, flexible and progressive 
curriculum." Students and faculty 
have worked together on that devel¬ 
opment. “We view our medical school 
as a partnership between faculty and 
students,” he says. 
Faculty-student committees are 
still working on the curriculum, and 
they’ll continue to do so. “We’ve 
developed a process that is ongoing 
and continuous. That’s important — 
to have a process that’s continuous,” 
Dr. Edberg says. 
The revised curriculum went into 
effect at the start of the 1992-1993 
school year. Current first- and 
second-year students will experience 
it throughout their years in medical 
school, while third- and fourth-year 
students are fulfilling its new clinical 
requirements at such locations as 
community health care centers, health 
maintenance organizations and 
private practices. 
Spotlight on Primary Care 
It’s not just President Clinton’s 
health-care plan that’s put a spotlight 
on primary care. “The Clinton plan, 
which I support, is simply picking up 
on the direction medicine is already 
going,” explains Dr. Gifford, citing 
widespread concern that high costs 
and other problems in health-care 
delivery are due in part to an over¬ 
abundance of specialty care, and not 
enough primary care. “It’s become 
clear that in this country we have to 
do a better job of providing primary 
care to patients,” he says. 
YSM is “looking at the realities 
of medicine,” says Mary Anne 
Johnston, Ph.D., director of educa¬ 
tional development. She calls experi¬ 
ence in primary care important even 
for the many YSM graduates who 
become specialists rather than 
























Stephen C. Edberg, Ph.D., with Andrea Toulson, a third-year medical student. 
generalists. “It’s critical that our stu¬ 
dents who go into the specialties know 
about primary care — that they see the 
patient as a whole person,” she adds. 
Over the years, YSM students 
interested in primary care have taken 
action. Approximately 15 years ago 
students organized the Wednesday 
Evening Clinic at the Primary Care 
Center of Yale-New Haven Hospital, 
and interested students have contin¬ 
ued to provide longitudinal care to 
patients there ever since, under the 
direction of G. Morris Dillard, M.D., 
Ph.D., associate clinical professor of 
medicine (general). “That’s a true 
primary care experience, and it is a 
very effective one,” Dr. Gifford says. 
Some have sought more exposure 
to family medicine, which empha¬ 
sizes primary care. Cheng-Chieh 
Chuang, a third-year student, notes 
that he and other interested students 
meet regularly to share ideas on 
family medicine and to hear speakers 
like Morris Mellion, M.D. '70, a past 
president of the American Academy 
of Family Physicians (See Traveling 
the Road to Family Practice, Page 
14). “This year. I’m on the curriculum 
committee,” says Mr. Chuang, who 
would like to see YSM give even 
more attention to primary care. He 
recently received one of the 10 
$50,000 scholarships awarded by the 
Nicholas J. Pisacano, M.D. Memorial 
Foundation to outstanding medical 
students committed to family practice. 
Dr. Gifford notes why it’s so 
important to offer clinical experience 
— in many fields — in ambulatory 
settings, rather than only in hospitals. 
“We are very concerned with the 
clinical education of our students, and 
we particularly try to ensure that they 
are exposed to a broad base of each 
specialty. Hospitals have become 
places for very, very sick people. If 
you restricted students’ education to 
experience in hospitals, they would 
miss large numbers of disease entities 
that no longer, or seldom, get to 
hospitals, like various forms of 
arthritis, or endocrine diseases, or 
gastroenteritis,” he says. 
Hospitals are also places for 
“people who often go in for some 
procedure like coronary 
catheterization, and leave within a 
day or so. There’s not really an 
opportunity for students to develop a 
significant doctor-patient relationship 
with such patients,” Dr. Gifford notes. 
Will increased attention to 
primary care and ambulatory settings 
detract from students' scholarship and 
research? “It need not,” says John N. 
Forrest Jr., M.D., the professor of 
medicine who directs the Office of 
Student Research, as long as empha¬ 
sis remains on “the scientific method, 
careful assessment of data and 
thorough analysis of literature.” He 
adds that some settings might not be 
“conducive to rigorous analysis of the 
biology of disease,” but that students 
would have other opportunities in 
medical school for such analysis. 
Always, he adds, YSM will prepare 
students “to educate themselves 
throughout their medical careers.” 
Students enrolled in the primary 
care clerkship may select a practice 
site in either internal medicine, 
pediatrics — as in the case of Ms. 
Broder — or family practice. The 
third-year clerkship in internal 
medicine now includes a four-week 
ambulatory component, and other 
third-year clerkships — including 
pediatrics and obstetrics/gynecology 
— also include more ambulatory 
experience than previously. The aim 
is to eventually include ambulatory 
experience “in virtually every clinical 
department,” states Dr. Gifford. 
“We simply have to get the 
students out where the action is now,” 
he says. These new ambulatory 
experiences in physicians’ offices, 
primary care centers, community 
centers and health maintenance 
organizations augment medical 
students’ practice-based education. 
4 Yale Medicine Spring 1994 
The students report that their clerk¬ 
ships provide plenty of action, along 
with valuable insights into both the ail 
and the science of practicing medicine. 
“I learned that you can't make 
assumptions about people, about what 
they know or don't know. You can't 
patronize — or talk above their 
heads. That’s as much of an education 
as anything else,” relates Lynn 
Sullivan, a third-year student who did 
the ambulatory part of her internal 
medicine clerkship at the Yale Health 
Plan, the University's prepaid, multi¬ 
specialty group practice. 
Ann Hoff recalls her primary care 
clerkship in a family practice program 
at Middlesex Hospital. “I saw a lot of 
patients, including kids and old 
people. I did some gynecology, some 
dermatology, some orthopaedics,” she 
says. Ms. Hoff calls the experience 
much more illustrative of true primary 
care than any rotation in a hospital 
emergency room. She adds, ‘‘Not until 
this rotation was I the first person to 
see the patient, to diagnose the patient 
on my own. I even had some people 
come back. It’s very satisfying to see 
that you cured the patient.” 
“It was busier than I thought it 
would be.” Ms. Broder says of her 
clerkship with four pediatricians in 
their suburban office. She said it was 
especially helpful to work with 
several practitioners who each had 
different strengths and were of 
different generations. 
She also recalls an eye-opening 
experience. One young patient had a 
headache for days; sinus medication 
brought no improvement. The physi¬ 
cian ordered a CAT scan, which 
revealed inflammatory lesions of the 
brain — lesions which could have 
grown larger. The patient is now 
doing well, after two months of 
treatment with steroids. But, Ms. 
Broder notes, “This could have been 
catastrophic if it was missed.” She 
says the incident brought home to her 
how important it is for primary care 
physicians to know about the spe¬ 
cialty areas — to recognize some¬ 
thing out of the ordinary and “know 
when to go for that extra test.” 
Such experiences are just what 
the clerkship was designed to pro¬ 
vide. “We're trying to provide a good 
exposure to primary care, to create 
situations where students really get 
involved in patient care,” says Rick 
Haeseler. M.D., associate clinical 
professor of medicine and director of 
the primary care clerkship. “Longitu¬ 
dinal care and generalism are key 
components of primary care.” he 
points out. The clerkship puts stu¬ 
dents with patients who return over 
time and who present all kinds of 
problems — from minor to serious, 
medical and otherwise. 
In a hospital, students would miss 
a lot of that. “In a hospital setting, 
more emphasis is placed on the acute 
medical problems and patients tend to 
be in and out in a short time,” says 
Nancy R. Angoff. M.D. '90. HS '90- 
'93, M.RH. '81, assistant director of 
the primary care clerkship. 
"I think Dr. Haeseler sees the 
clerkship as the beginning of a 
lifetime’s education,” says Scott 
Dessain. an eighth-year Ph.D./M.D. 
student, who was supervised by Drs. 
Angoff and Haeseler and their 
partner, Catharine A. Arnold. M.D. 
'86, HS '86-'89 at the Guilford 
Internal Medicine Group. 
The clerkship is scheduled so that 
students give patient care at their 
assigned sites on Mondays, Wednes¬ 
days and Fridays. On Tuesdays and 
Thursdays, they attend didactic 
sessions on primary care. 
"These sessions are not lectures; 
they're very interactive,” states Dr. 
Johnston. Some sessions provide 
practice in skills like interviewing 
patients. Others feature talks by faculty 
members on such topics as dermatol¬ 
ogy. trauma, cardiology or terminal 
illness, in primary care settings. “They 
tended to be interesting topics, and it 
was good to have enough time to sit 
back and learn,” Ms. Broder says. 
Dr. Haeseler notes that students 
are guided in the clerkship by precep¬ 
tors who are “seasoned practitioners” 
— physicians with a wealth of 
medical and practical knowledge. But 
until recently, it was difficult to 
incorporate their experience into the 
training of YSM students. 
"Previously, there was little 
involvement with community physi¬ 
cians,” Dean Gifford says, pointing 
out that such physicians tend to have 
high overhead and to work long 
hours. In addition, many fine physi¬ 
cians have little teaching experience. 
However, the Robert Wood Johnson 
Foundation grant supports faculty 
development workshops for the pre¬ 
ceptors. with stipends to compensate 
them for taking time from busy 
schedules to attend the faculty develop¬ 
ment course and to teach students. 
"The physicians come to the 
course to learn how to teach students 
in an ambulatory setting — their 
practice,” explains Dr. Gifford.” Says 
Dr. Angoff, “Students are placed in 
offices where the physicians have 
also been given some direction and 
support in precepting students.” 
Three sessions attracted 50 to 60 
physicians apiece. The last. Develop¬ 
ing Advanced Skills for Precepting 
Medical Students, created a highly 
interactive forum for discussing 
Frederick Haeseler, M.D. 
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educational strategies that promote 
learning. Dr. Johnston presented the 
opening session, which focused on 
principles of the learning process. Dr. 
Haeseler then showed a video of a 
physician precepting a student caring 
for a standardized patient, portrayed 
by an actor, in an office setting. This 
led to a group discussion on issues 
that commonly arise in ambulatory 
teaching. Walter N. Kernan, M.D., 
assistant professor of medicine who 
developed and directs the month-long 
ambulatory component of the three- 
month internal medicine clerkship 
taken by all third-year students, con¬ 
cluded the session, using case studies 
to focus on particular challenges 
presented in some encounters between 
physicians, students and patients. 
In May, a fourth session of the 
faculty development course for 
preceptors focused on giving and 
receiving feedback. 
Preceptors like the clerkship- 
workshop combination. “When 
medical schools look to community 
doctors to provide some training, they 
need to give proper support so that 
the doctors incoiporate students into 
their practice in a way that’s mean¬ 
ingful to the students,” says Jewel 
Mullen, M.D., who is director of 
ambulatory teaching services in the 
department of medicine at the Hospi¬ 
tal of Saint Raphael in New Haven. 
She recalls attending the work¬ 
shop on challenging situations, where 
many participants worried especially 
about what should follow after “a 
very capable medical student did a 
very good evaluation of a patient,” 
and it came time for closure. The 
student would fear having the physi¬ 
cian take over, "minimize what she 
did.” Meanwhile the physician, “who 
had a continuing relationship with 
this patient, would feel responsible 
for doing his job.” Says Dr. Mullen, 
"it was very affirming for people to 
know they shared these concerns.” 
E. Maurice Wakeman, M.D., HS 
'60-'63, of Guilford Pediatrics says that 
the workshops helped preceptors to 
understand their roles. “Preceptor 
training is valuable,” Dr. Wakeman 
says, and so is the stipend for educa¬ 
tional purposes. “That’s not the reason 
any of us do this, but one has to re¬ 
cognize that there is a cost,” he adds. 
The support for these stipends comes 
to the medical school from the Robert 
Wood Johnson Foundation grant. 
A faculty-student group led by 
Dr. Haeseler has studied the primary 
care clerkship from the start. “We 
follow the program, evaluate it, and 
make changes while it’s rolling,” 
notes Ms. Sullivan, a student in the 
group who has also served on faculty- 
student curriculum committees. 
Ms. Sullivan and Lawrence 
Solomon, a third-year student who is 
now on several such committees, 
agree that students are active partici¬ 
pants in developing and evaluating 
the curriculum. “We function pretty 
much as equal members of the 
committees,” says Mr. Solomon, 
noting that students often presented 
their fellow students’ evaluations of 
courses. He calls the curriculum 
revision “a concrete example” of 
YSM’s commitment to prepare 
students for careers in a changing 
health-care environment. 
“You really feel that it’s a mutual 
thing between students and faculty,” 
Ms. Sullivan says. What faculty 
members regularly say to the stu¬ 
dents, she says, is “Tell me — what 
would make this better?” 
Margretta R. Seashore, M.D. ’65, 
HS '65-’68, who chairs the curricu¬ 
lum subcommittee on basic science, 
put it this way: “Students know how 
they learn, what supports that learn¬ 
ing, and what doesn’t. Their opinions 
have been valued.” 
Dr. Seashore cites the goal of all 
involved in the curriculum revision. 
"There’s more information out there 
than ever before, but students do not 
have more time in which to learn. Our 
goal was to develop a curriculum that 
addresses that,” she says. 
Dr. Seashore says her committee 
aimed for changes that would foster 
problem-solving, lessen memorization 
and avoid needless overlap, without 
sacrificing necessary content. Other 
medical schools, addressing the same 
problems, are making similar 
changes. Dr. Seashore adds that the 
curriculum committees greatly respect 
the Yale System and its emphasis on 
independent learning. They took care 
to maintain periods without formal 
activity, to allow time for students to 
read, study, do community service 
and pursue their research. 
Dr. Gifford calls especially 
successful “the tremendous integra¬ 
tion of all the courses” in the second- 
year curriculum. In the first part of 
the second year, the course Mecha¬ 
nisms of Disease: Basic Principles 
includes material from the formerly 
separate courses of immunobiology, 
microbiology, pathobiology, and 
pathophysiology, with material from 
pharmacology included where 
appropriate. In the second part of the 
year, the Mechanisms of Disease: 
Systems/Organs course includes such 
units as heart/vascular and lung/ 
respiratory, with each incorporating 
material usually taught in separate 
courses like pathology and laboratory 
medicine. In this new arrangement, 
says Dr. Seashore, “students are 
thinking about these things from more 
than one perspective at the same time.” 
“It’s a major change, and I think 
much for the better. Students seem very 
happy in that course,” Dr. Gifford says. 
Dr. Gifford also cites the series 
Medicine, Society and Public Health 
as a “key part” of the new curriculum. 
Many courses in the series are not 
themselves new, but they have 
become part of a coordinated effort 
that will eventually run through all 
four years. 
The series deals with issues that are 
“not necessarily biomedical, but that 
have a real impact on health,” says Dr. 
Johnston. At present, the first two years 
of the series include biostatistics, epi¬ 
demiology and public health, the family, 
health policy and health financing, 
history of medicine, preventive medi- 
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cine and professional responsibility. 
What do all these curriculum 
changes mean for the future? Mainly, 
they mean that the Yale School of 
Medicine will continue to produce 
leaders. The new emphasis on primary 
care does not mean that large num¬ 
bers of YSM graduates will pursue 
generalist careers, but it does mean 
that all students will be better pre¬ 
pared for a changing climate in health 
care. Dr. Gifford notes that both the 
United States government and the 
Association of American Medical 
Colleges are aiming for much greater 
numbers of medical school graduates 
to enter generalist careers. “The 
government is clearly going to reduce 
the funding for specialty residencies 
and increase the funding for general¬ 
ist residencies,” he says, and hospitals 
will be reducing the numbers of 
specialty residencies that they offer. 
“We hope that YSM will defi¬ 
nitely graduate more people in 
generalist careers, but that is not our 
main goal. We want people to leave 
here with an M.D. degree that 
prepares them to go in many different 
directions,” says Dr. Gifford. 
Says Dr. Edberg, “We want our 
students to have the foundation to be 
leaders.” 
Meanwhile, the curriculum 
continues to evolve. “It’s an ongoing 
process,” points out Dr. Seashore. For 
instance, members of her committee are 
now taking a “formal look” at exactly 
what students must learn in the first 
two years. "The fields are expanding 
so rapidly, yet students must be 
exposed to really critical informa¬ 
tion,” she says, so her committee 
wants to define “a core of knowledge 
without which no one can escape.” 
Dr. Gifford cites continuing 
efforts to provide ambulatory experi¬ 
ence in fields like psychiatry and 
surgery, which do not easily lend 
themselves to that, and to establish 
more true primary care sites in and 
around New Haven — sites that are 
not difficult for students to reach. 
Additional primary care clerkships in 
other areas, from Indian reservations 
in the Southwest to rural areas in 
northern New England, are also being 
established. Plans are underway to 
weave “Medicine, Society and Public 
Health” courses into the clinical years, 
when they will be particularly relevant. 
“A curriculum,” Dr. Johnston 
says, “is not a dead organism.” YM 
Rajendran Naidoo, a fourth-year medical student, with a patient and Nancy Angoff, M.D., at Dr. Angojf's Guilford office. 

























Fourth-year medical student John Landed, right, practices his patient interviewing 
techniques on patient/player Jerry Silverstein. 
Jerry Silverstein is one of several area 
actors who has been trained as a 
standarized patient, complete with medical 
and non-medical problems. 
The elderly patient was paying her 
first visit to the physician’s office. 
She looked pert, in her red jacket and 
cap, but she was worried. “My 
husband died last year, after spending 
the last two weeks of his life on a 
machine,” she tells the physician. “I 
don’t want to end that way. I want a 
little pill — something I can take if I 
need it. Understand what I’m saying?” 
Now the physician was worried. 
“Time out!” he calls. 
Time out? With the patient sitting 
there? 
Yes indeed. For the “patient” was 
a trained actor, Lynnabeth Mays, 
portraying a woman with arthritis, 
cataracts, and some deep concerns 
about her future. The “physician” was 
a fourth-year Yale School of Medi¬ 
cine student, Douglas Goldstein, 
practicing his office interviewing 
skills. Mr. Goldstein calls “Time out!” 
so he could stop and discuss — with 
two physicians and five students 
seated nearby —just how to proceed. 
“I’d want to discuss living wills with 
her, but first, I feel obligated to take a 
medical history,” he says. 
“So there’s tension,” points out 
Rick Haeseler, M.D. “Remember, an 
interview has at least three functions 
— information gathering, relationship 
building and education. Maybe here 
you can identify the most important 
goal and work on that.” 
Dr. Haeseler, director of the 
newly required primary care clerk¬ 
ship, has developed a number of 
“standardized patients,” portrayed by 
actors, to help students master clinical 
skills needed for office practice. He 
recruited actors and actresses and 
trained them to portray a variety of 
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scenarios which depict common 
issues and medical disorders that 
occur in primary care practice. He 
and Nancy Angoff, M.D. ’90, HS ’90- 
’93, M.P.H. ’81, assistant director, lead 
small groups of students who interview 
standardized patients and then discuss 
clinical encounters as they unfold. 
Many medical schools employ 
standardized patients, often to help 
students learn various skills, like 
carefully feeling a patient’s aching 
joints. However, Drs. Haeseler and 
Angoff, both of Guilford Internal 
Medicine, have created a standard- 
ized-patient program that helps 
students learn about primary care. 
The actors involved are provided with 
scripts that let them play complete 
characters. They don’t just present 
joint pains; they come with whole 
lives. They have personalities, jobs, 
families, belief systems, medical 
histories and — sometimes — a mix 
of medical and non-medical problems. 
“This goes along with what we 
see in the office all the time,” says Dr. 
Angoff, who said the program helps 
students to learn patient-centered 
interviewing techniques. 
With the actors. Dr. Haeseler 
says, “students can practice inter¬ 
viewing skills in a variety of sce¬ 
narios. For instance, we have one in 
which the physician must give the 
patient bad news.” With “time outs” 
for discussion, he adds, “we can 
explore the issues, talk about what’s 
happening and experiment with 
different approaches.” 
Dr. Haeseler has also used 
videotapes of interviews with the 
standardized patients in workshops 
for clerkship preceptors. Students and 
preceptors alike have found sessions 
with the actors helpful. 
“The standardized patients were 
good because as a group we were 
able to consider different ways of 
approaching difficult patient-student 
interactions,” notes Scott Dessain, an 
8th-year M.D./Ph.D. student. 
E. Maurice Wakeman, M.D., HS 
’60-’63, a clerkship preceptor, recalls 
attending a workshop that included a 
videotape of a standardized-patient 
interview. He says that viewing and 
discussing the videotapes pinpointed 
“the critical role of the preceptor in 
helping students understand their own 
feelings in an interview,” when they 
might encounter a patient in tears, or 
one “mad as hell.” 
The half-dozen actors in the 
program call themselves The Patient 
Players, all Shoreline area residents 
who have performed in regional 
theater. “They get very involved in 
their roles,” says Dr. Angoff. She notes 
that the actors bring in their characters’ 
financial and social problems, and they 
often discuss with students just why 
they think a character would accept 
or reject a particular intervention. 
As Mr. Goldstein interviews 
“Eloise Bloom,” played by Mrs. 
Mays, his fellow students express 
their concerns and make suggestions. 
Was this woman suicidal? “Maybe 
you could get a sense of her daily 
routine. We know she lives alone,” 
one student says. “She wants control 
of her life; she seems to be losing it in 
some areas,” another notes. 
Mr. Goldstein asks his patient 
about her arthritis and about her 
hobbies. He speaks briefly of living 
wills, and he notes that cataracts 
could be treated very successfully, on 
an out-patient basis. 
When the patient left, she did not, 
of course, have a little pill. But she 
did have a plan: to see an ophthal¬ 
mologist. “You clearly made strides 
with her,” Dr. Angoff tells Mr. 
Goldstein. “You got her to do some¬ 
thing medically. She’s trusting you.” 
— Carolyn Battista 
After an interview session, actor Jerry Silverstein talks informally with fourth-year medical 
students, from left to right, David Aghassi, Susan Liu and John Lundell. 
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Induced Dementia 
Of oil of the jobs we are apt to demean 
It’s the one that is known as associate dean. 
‘'What is it?” you ask, “That makes it so bad, 
And drives the incumbent stark raving mad?” 
Is it student demand to fix up the dorm? 
Or faculty ire with curriculum reform? 
As bad as those are, exposing our flaws. 
The dean’s mental state has some other cause. 
There are always complaints about the meal plan, 
And the heat in the weight room that lacks a good fan. 
But those aren’t the reasons our friend went insane. 
There's something more grave that has troubled his brain. 
“The practice piano is way out of tune!” 
“And the pool room’s too small, it’s like a cocoon.” 
But although these are problems the dean should not shirk. 
They do not explain what drove him berserk. 
“No parking for us!” the students complain. 
“And the food at the school is laced with ptomaine! ” 
Now all of us know that schools aren't Nirvanas, 
But we'd still like to know why the dean went bananas. 
“By biochem lectures we all are dismayed, ” 
“And tuition’s too high and there’s not enough aid!” 
But even those glitches he’s trying to fix, 
They’re not valid reasons for the dean’s nervous tics. 
And what are the clinical clerks demanding? 
That grades in all clerkships be only “Outstanding?” 
This supplication the dean easily conquers, 
But gives us no clue as to why he went bonkers. 
“There’s little to do here in old New Haven!” 
“It’s social life and dates we are cravin’!” 
But although these complaints are far from puny, 
They fail to address why the dean’s a bit loony. 
10 Yale Medicine Spring 1994 
For it's none of these crises that's been the last straw. 
It’s something more serious that sticks in his craw. 
To give you the facts will really take guts. 
To explain the real reason the dean has gone nuts. 
In the last second year, there are dissonant chords 
As the students stay home to prepare for the boards. 
Departments deplore this outrageous distraction, 
With its clinical signs of a nervous reaction. 
Despite the best efforts of all the top brass. 
Each year at that time, the students cut class. 
The faculty says that we ought to dismiss them, 
But the dean replies that this is the Yale System. 
But deep in his heart, the dean is sad too, 
For this is the issue that makes him feel blue. 
He knows for a fact that students aren't lazy, 
It's those miserable boards that drive everyone crazy! 
If performance on boards is not up to scratch. 
The students believe that they surely won't match. 
The meaning of scores has become a distortion. 
Inflating anxiety all out of proportion. 
So that is the story, it’s easy to glean 
What eats at the soul of our associate dean. 
It's the scoring on boards that we must curtail. 
And lobby for change to make them “Pass-Fail.” 
— Robert H. Gifford, M.D. 
Associate dean for education and student affairs 
Robert H. Gifford, M.D., HS '66- 
'61, has served as associate dean 
since 1985. His poem was originally 
published in the February 1994 
newsletter of the Office of Educa¬ 
tion at the Yale School of Medicine. 
Associate Dean Robert H. Gifford, 
second from left, with first-year medical 
students at the 1993 white jacket 
ceremony in September. The students, 
from left to right, are: Stephen Kavic, 
Avik Roy, Alan Cheng and Samir Shah. 
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On Managed Care 
And Medical Education 
Editor’s note: During the 104th 
annual meeting of the Association of 
American Medical Colleges (AAMC) 
in Washington, D.C., Dean Gerard N. 
Burrow spoke to the AAMC/Group on 
Educational Affairs. His topic: 
Managed Care and its Effect on 
Graduate and Undergraduate Medical 
Education. To complement the article 
on curriculum, Yale Medicine 
publishes excerpts from his AAMC 
address, delivered on Nov. 8, 1994. 
How the health-care system, and 
not incidentally medical education, 
will be funded, depends on the final 
shape of the Health Security Act. But 
the move out of the hospital setting 
and into an ambulatory care, man¬ 
aged-care environment is inexorable, 
if not, ineluctable. 
The institutional goal of provid¬ 
ing the best clinical care to every sick 
patient and preserving physicians’ 
individual autonomy has resulted in a 
system which emphasizes private 
institutions, local autonomy, hospital 
services and specialized technical 
care, with pass-through insurance to 
pay the bills. Medical schools and 
their teaching hospitals stand in the 
middle, fueling the system with 
breakthroughs in education or 
training the next generation of 
physicians on the esoteric problems 
of a highly selected patient popula¬ 
tion. We should be proud of ourselves 
in that we do that very well. The 
measure of success of a division 
director was, and I believe still is, the 
number of postdoctoral fellows who 
surround him or her as he or she 
attend a national specialty meeting. 
Perhaps, more than in any other 
country, the organization and financ¬ 
ing of medical services in the United 
States have developed from the 
leaders of academic medicine rather 
than from, as in many other countries, 
political considerations. 
Currently, clinical medical 
education is being heavily cross- 
subsidized by clinical earnings, 
significantly above 15 percent. These 
changes, this paradigm shift or re¬ 
engineering, interestingly, were 
outlined in the Journal of Health and 
Social Behavior in 1988. Now, a few 
years later, no major changes have 
occurred, and we must ask: “Can we 
stick our head in the sand, hunker 
down, and let the winds of change 
blow over?” 
In order to thrive, academic 
health centers have to have prominent 
clinical programs, need to build a net¬ 
work and have to control costs. But one 
of the problems with hospitals associ¬ 
ated with medical schools is that they 
are like Noah’s ark — they need two 
of everything, which is very expensive. 
Since medical schools are educa¬ 
tional, they also need to have two of 
everything, and some things aren’t 
profitable. Somehow we need to find 
the solution for cross-subsidization. 
As the dean of a private univer¬ 
sity research-intensive medical 
school, I have a president and a 
corporation who are concerned that 
we are going to get so involved in 
health care that we will lose our 
academic focus. But unless we have a 
strong clinical program, we are not 
going to have the resources to support 
our academic mission either at Yale or 
at medical schools across the country. 
In the societal framework in 
which managed care is occurring and 
with the structural changes that I 
think will occur in academic health 
centers, major issues and problems 
clearly exist as to how we educate our 
medical students in the context of 
managed care and health maintenance 
organizations (HMOs). 
As you know, the Rockefeller and 
Pew foundations have listed the 
educational needs of future physicians: 
• to increase clinical prevention, 
knowledge and skills building; 
• to instruct in the use of techno¬ 
logically appropriate services; 
• to better understand cost-effec¬ 
tive care; 
• to increase ambulatory-care 
teaching; and 
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• to integrate multidisciplinary 
service for education. 
These objectives are part of the 
fabric of managed care, as well as 
areas of education in which we, the 
medical schools, have not particularly 
excelled. Our challenge as educators 
is to learn how to work with this 
managed care system, which brings 
up another interesting question: Can 
physicians graduate from medical 
schools today, having learned the 
practice of medicine in a predomi¬ 
nantly ambulatory-care system? 
Academic health centers must 
affiliate to gain access to 500,000 
lives or more necessary to educate 
specialists. If there is a requirement 
of one physician for every 400 
patients, or more for geriatric pa¬ 
tients, we would unbalance medical 
school faculty. If we really expect the 
HMOs to undertake teaching in its 
traditional form in medical schools, 
problems will exist. From HMOs’ 
standpoint, there are issues of mana¬ 
gerial control; they are on capitated 
programs which they must run. In 
order to be cost-effective, HMOs 
must be productive, and HMO leaders 
are concerned about bringing in 
medical students and having their 
patients go somewhere else. ... 
On the other hand, academic 
health centers see problems of 
academic control. Can they send any 
medical problems to the managed- 
care network? How will they pay for 
this treatment? And how will they 
teach if students, day after day, see 
relatively minor medical problems? 
So, both groups are concerned 
whether they can deliver the necessary 
quality of teaching and also address 
the issue of ambulatory teaching. ... 
The academic collaborations that 
do occur have carefully maintained 
distance between the medical school 
and the managed-care organization — 
much different than the organization 
that we have or the relationship that 
we have with our primary teaching 
hospital. ... 
There are opportunities for 
research which can result in lower 
costs within HMOs, and hopefully, 
there is reliable HMO funding, which is 
not at all assured with medical schools. 
One real question: How do we 
pay for medical education in managed 
care, if reimbursement revenues de¬ 
crease as they almost certainly will? 
What does the Health Security 
Act mandate about post-graduate 
education? A decrease in specialty 
training and an increase in primary 
care. ... And how would we structure 
medical education if we had a five- 
year or six-year program? The 
health-care reform could very well do 
this. What drives the system now is 
the money which goes to hospitals or 
the hospitals have put funds in. 
Currently, the funds will go to 
program directors or chairmen, and 
hospital directors will then make 
these educational decisions. In a 
Macy Foundation seminar, David 
Rogers recommended that residency 
programs be the responsibility of 
medical schools. He thought that the 
separation had produced an artificial 
dichotomy between the undergraduate 
and graduate medical experience, and 
as a consequence, specialty training 
has been overemphasized and training 
in ambulatory-care settings has been 
underemphasized. Moving the 
residency to a medical school respon¬ 
sibility would make a clear statement 
that medical education is paramount. 
I personally believe that we are 
going to have primary-care health 
teams, including nurse practitioners 
and physician's associates. Physicians 
on those teams will be quarterbacks, 
rather than directors, who will deal 
with the medical areas in which the 
other health-care providers do not 
have competency. If this is the 
structure, then physicians really need 
to be specialists/generalists, rather 
than just family physicians. 
Finally, if I look into a crystal 
ball, I believe that managed competi¬ 
tion is in a transitional state. Ulti¬ 
mately, we will have a single-payer 
system. YM 
Gerard N. Burrow, M.D. ’58, dean 









Traveling the Road 
to Family Practice 
by Morris B. Mellion, M.D. ’70 
I didn't plan to be a doctor, much less 
a family physician. But I've experi¬ 
enced some unexpected changes in 
direction, which have allowed me to 
be part of family practice almost from 
its rebirth out of general practice to 
its incipient maturity today. 
“How easy it would be to kill 
them!” I, one of the world’s great 
sleepers, lay awake in my stateroom 
aboard the U.S.S. Intrepid with this 
thought echoing in my mind. I was a 
regular Navy line officer and a 
platoon leader in the ship’s combined 
Navy/Marine Corps landing party 
during the waning days of the Cuban 
missile crisis. We were anchored in 
Guantanamo Bay. That afternoon I 
had accompanied the landing party's 
Marine commanding officer into the 
pre-dug trenches that we would 
occupy in the naval station’s defense 
perimeter if hostilities were to break 
out. There, an easy rifle shot away, 
were Cuban sentries at the fence 
encircling the base, and, I realized: 
“How easy it would be to kill them!” 
Lying in bed, focusing on this 
single image, I felt a profound need to 
serve others rather than to hurt or 
destroy. Months and many long-night 
sea watches later, I decided to 
become a physician, to emulate the 
general practitioner who had deliv¬ 
ered me and treated me as a child. 
Although I had little background in 
science and had never thought 
seriously about the helping profes¬ 
sions, I started premed courses in 
order to qualify for medical school 
while I was in the Navy and contin¬ 
ued them after discharge. 
When I entered Yale medical 
school in the fall of 1966, I soon 
began to wonder if I were studying 
medicine at the wrong time. For more 
than 300 years, the paradigm of 
medical care in our country had been 
the general practitioner. The old G.P. 
had few scientifically proven, effec¬ 
tive tools for treating illness and injury. 
Often the general practitioner had 
treated serious conditions by nurtur¬ 
ing and supporting patients emotion¬ 
ally during difficult times. 
By the mid-20th century, a 
medical scientific revolution was 
taking place. New, increasingly 
effective tools and treatments were 
developed. In the 1950s, medical 
schools hired full-time teaching 
faculties and trained physicians to use 
these new tools and medications. By 
the mid-1960s, medical schools were 
becoming increasingly organized 
around the clusters of tools and treat¬ 
ments used for various organ systems. 
Little attention was devoted to 
nurturing. The general practitioner, 
unable to solve many of the problems 
posed by illness and injury, was 
supplanted by specialists and 
subspecialists of the medical scien¬ 
tific revolution. My personal sadness 
over this loss was short-lived, since I 
was immersed in the self-directed 
education of “The Yale System.” 
Four years later, after spurning 
advice to study in Boston, New York or 
Baltimore in favor of a more rural set¬ 
ting, I began a surgical rotating intern¬ 
ship at the Medical Center Hospital of 
Vermont, the first step toward a 
planned career in orthopaedic sur¬ 
gery. But three important experiences 
at Vermont helped change my future. 
First, at the beginning of my 
internship, I made rounds with 
Charlie Rust, a crusty old Vermont 
orthopaedist. I watched him put his 
hand on the shoulder of a middle- 
aged patient, look her in the eye, and 
say, “This is a tough problem, 
Mildred, but we’ll lick it together.” 
Immediately, I realized that some¬ 
thing had been missing from my 
education. Here was a surgeon — 
effortless and sincere — nurturing a 
patient at a difficult time. Charlie 
Rust was known for his rough surface 
... and for how his patients loved him. 
I felt comfortable in my decision to 
study at Vermont. 
The second experience came 
while I was working with Larry Weed 
and the problem-oriented medical 
record system. To be honest, interns 
didn’t work with Dr. Weed, we 
responded to him! Some years 
earlier, while on the faculty at Yale, 
Dr. Weed had developed this new 
approach to medical record-keeping. 
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Now, at Vermont, he was struggling to 
computerize it. The interns were 
struggling with it as well. Secretly 
known to us as “The Phantom Chart 
Checker,” he would come around to 
the nursing stations at 2 or 3 in the 
morning and leave us “instructive” 
notes. Like many paradigm-changing 
discoveries, the problem-oriented 
system was overly complex in its 
early computerized model. It paral¬ 
leled Dr. Weed’s unbridled compul¬ 
siveness. The interns resented the 
burden it entailed. 
My own view of the problem- 
oriented medical record was different 
in two ways. First, I didn't perceive it 
as a new idea. As a teen-ager, I had 
worked in a wholesale auto parts busi¬ 
ness which used a perpetual inventory. 
To me. Dr. Weed’s system was a 
perpetual inventory of the patient’s 
health, a transfer of methodology 
from the business world to medicine. 
Secondly, I admired the simplicity of 
its logic, in spite of the complexity of 
the experimental computerized 
version. 
Early in his training, Morris B. Mellion, M.D., learned about nurturing his patients. 
(Years later, I would realize that 
Dr. Weed’s work with the problem- 
oriented system was critical for the 
development of family practice. It is 
the information management tool 
which allows the generalist to evalu¬ 
ate and treat the multi-problem 
patient without having encyclopedic 
knowledge in each subspecialty.) 
My third important experience 
occurred later in the internship year 
when I learned that Vermont was 
starting a family practice residency. I 
didn't know exactly what family 
practice was, but the name sounded 
intriguing. I set up an appointment 
with Dr. Alan Tisdale, chairman of 
internal medicine and acting chair¬ 
man of this new program, to find out 
what it was all about. Alan Tisdale 
was the ultimate recruiter. Imagine 
my disbelief when I walked into his 
office and his first words were, “I've 
already talked to Dr. Davis [chief of 
surgery], and I have a place for you in 
the family practice residency. If you 
decide not to take it, please let me 
know in time to recruit someone 
else.” Incredulous, I asked him to 
repeat what he had just said. He did 
and then explained what the family 
practice residency would be about. 
I had a wonderful time at Vermont. 
I was the third resident in the pro¬ 
gram. The first resident. Jack Rodnick, 
was a Yale College graduate. He went 
on to become president of the Society 
of Teachers of Family Medicine and 
currently chairs family practice at the 
University of California at San 
Francisco. The second resident. Dean 
Bresnihan, is a family physician in a 
small southern Vermont town. 
While in residency I became the 
first resident member of the Vermont 
Academy of Family Physicians. I 
went on to practice in Jackson, Wyo., 
a resort town of 4,000 — 93 miles and 
three mountain passes away from a 
larger city. Later, I moved to Omaha, 
Neb., to teach at the University of 
Nebraska Medical Center’s Family 
Practice Department. My Nebraskan 
colleagues nominated me for national 
office in the American Academy of 
Family Physicians, and I have just 
completed nine years as a national 
officer, including a year as president. 
While I was studying in Vermont, 
the specialty of family practice was in 
its infancy. Vermont was about the 
50th family practice residency started 
in the country. (Nobody counted back 
then.) In 1969, the American Board of 
Family Practice was officially recog¬ 
nized by the American Board of 
Medical Specialists as the 20th 
medical specialty board. The follow¬ 
ing year, the American Academy of 
General Practice redefined itself as the 
American Academy of Family Physi¬ 
cians (AAFP). This was an attempt to 
combine the personal approach of the 
old G.P. with the scientific advances 
being developed by specialist and 
subspecialist colleagues. It was not a 
simple renaming, but a statement of 
commitment to comprehensive continu¬ 
ous care for patients in the context of 
their families and to thorough, 
rigorous and continuing education for 
family physicians themselves. 
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The road ahead was difficult for 
family practice. The challenge: to build 
both clinical and academic credibility; 
the initial task: to develop an adequate 
number of high-quality training 
programs throughout the country. 
Starting with 290 training posi¬ 
tions in 46 residencies in 1970. the 
educational capacity expanded to 
6,735 positions in 382 residencies, 
with 93.2 percent of the first-year 
increasing percentage of practicing 
family physicians with family prac¬ 
tice residency training. Academic 
credibility, however, has been slower. 
Although 91.4 percent of accredited 
family practice residencies have ties 
with medical schools, 81.4 percent of 
accredited residencies are housed in 
community hospitals. (Figure 3) In 
the early years of family practice 
education, many medical schools 






Source: AMERICAN ACADEMY OF FAMILY PHYSICIANS RESIDENCY CENSUS 
positions filled in 1980. During the 
early 1980s, the growth and consoli¬ 
dation were slower. Critical needs 
included an innovative curriculum to 
teach a biopsychosocial approach to 
patient care, additional funding to 
expand the number of residency 
positions, and more well-trained 
faculty. By 1987, medical school 
applications were down and with 
them interest in family practice, 
general internal medicine and general 
pediatrics. From 1984 to 1991, the 
first-year family practice residency 
fill rate fell from 98.7 to 88.3 percent. 
Graduates of the early family 
practice programs were bright, 
articulate young physicians. The 
growth of clinical credibility for 
family practice has paralleled the 
viewed the discipline as a community 
hospital, rather than an academic 
medical school issue. 
Although residency growth 
plateaued in the '80s, curriculum and 
faculty quality improved. Early inter¬ 
est in research and writing attained 
maturity in some academic centers. 
The family practice quest for academic 
credibility was underway. Gradually, 
more medical schools established full 
departments of family practice. 
My year as president of the Ameri¬ 
can Academy of Family Physicians 
began in October 1991, a pivotal time 
for the academy. In 1989, the acad¬ 
emy had made access to health care 
for all Americans the cornerstone of 
its national policy. We had developed 
our first access plan in the summer of 
1989 and had taken it to the AMA 
House of Delegates that December. It 
was adopted in slightly modified form 
as the AMA's “Health Access 
America.” But what had been good 
policy in 1989 was no longer adequate 
in 1991. At the annual meeting where I 
was installed, our Congress of Del¬ 
egates instructed the board of directors 
to transform the academy’s original 
access proposal into a comprehensive 
plan, capable of revitalizing and 
reforming the way health care in 
America is delivered and financed. 
Rx for Health: The Family 
Physicians’ Access Plan was the 
academy's response. We presented it 
publicly at the National Press Club in 
Washington on April 8. 1992. Not 
only did Rx for Health identify the 
academy as the first medical specialty 
society to call for major revisions in 
American health care, including 
serious cost containment provisions, it 
also was a focal point for the message 
of family practice. 
In spite of the fact that 13 percent 
of the family physicians in the United 
States provide more than 30 percent 
of the outpatient visit care, prior to Rx 
for Health our specialty was poorly 
understood on Capitol Hill. The plan 
was introduced when other societal 
and economic forces were making a 
return to the generalist approach in 
medicine more attractive, and the 
members of Congress and their staffs 
finally were interested in learning 
more about us. 
Now that I am “retired” from 
medical politics, it is satisfying to 
observe changes taking place. A total 
of 117 American medical school 
campuses have departments of family 
practice, seven have divisions or other 
administrative entities, and only 14 
have no known plans for family 
practice. Last year, officers of the 
AAFP had cordial visits with deans at 
nine of those 14 schools. Student 
membership in the American Acad¬ 
emy of Family Physicians has risen to 
17,892. The family practice residency 
fill rate has climbed to 94.8 percent. 
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At Yale, a decision has been 
made to require that the fourth-year 
primary care preceptorship be 
performed in a true primary setting. 
The Connecticut Academy of Family 
Physicians is identifying private 
practice sites, and the University has 
negotiated with the Middlesex and 
Stamford Family Practice Residencies 
to accept preceptees. The Hospital of 
St. Raphael is considering establish¬ 
ing a family practice residency which 
might fall under the Yale umbrella. 
Nationally, health-care reform 
activities are putting tremendous 
pressure on medical schools to 
establish or expand generalist training 
programs, including family practice. 
Ivy League and other heavily re- 
search-oriented medical schools are 
rightfully concerned about this 
pressure. How can they develop the 
physical resources to establish a 
family practice department or expand 
other generalist training programs 
without diminishing their eminence in 
research and technology? 
When I was recently asked this 
question by one of my Yale class¬ 
mates, I suggested that Yale’s role in 
family practice might be no different 
from its role in the other specialties. 
Yale’s greatest success has been 
training future leaders of American 
medicine — leaders in research, 
education and health-care delivery. 
Family practice also needs more 
talented researchers, educators and 
health-care innovators. If even more 
care is going to be delivered in 
outpatient settings where family 
physicians already provide care for 
30 percent of the patient visits, Yale 
might develop initiatives in this area. 
Yale can prepare medical students 
and residents to become faculty and 
leaders in family practice just as it has 
done for years in virtually all other 
disciplines of medicine. 
Has it all been worth it? As I 
look back on nine years of meetings 
and travel (60 to 180 days away from 
home each year) as an AAFP officer. 
I’ve been sustained by a strong belief: 
People need a personal physician who 
can provide continuous, comprehen¬ 
sive care in the context of their 
families. I believe that a physician 
can combine the care and nurturing of 
the old G.P with the scientific 
acumen of the late 20th century. I 
consider myself fortunate to have 
served my profession at a time when 
the American public has begun to 
share this same belief. YM 
Morris B. “Moe” Mellion, M.D.: Family Practitioner; Medical Politician 
Dr. Morris B. “Moe” Mellion is 
past president of the American 
Academy of Family Physicians 
(AAFP). He previously served as 
speaker of the AAFP’s Congress of 
Delegates and chaired the academy’s 
Committee on Health Education and 
its Task Force on Sports Medicine. 
Reporters' questions came with the AAFP presidency. 
A graduate of Cornell Univer¬ 
sity, Dr. Mellion received his 
M.D. degree in 1970 at Yale. He 
then completed a surgical rotating 
internship and a family practice 
residency at the University of 
Vermont and now is in a private 
multi-specialty practice in Omaha, 
Neb. He also is clinical associate 
professor of family medicine and 
orthopaedic surgery (sports 
medicine) at the University of 
Nebraska Medical Center in 
Omaha. He serves as team physi¬ 
cian for men’s and women’s sports 
and as adjunct associate professor 
in the School of Health, Physical 
Education and Recreation at the 
University of Nebraska at Omaha. 
Dr. Mellion has just published 
Sports Medicine Secrets. He pre¬ 
viously edited two books. Office 
Management of Sports Injuries 
and Athletic Problems, and The 
Team Physician’s Handbook. 
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Ptonf.hr of Primary Care: 
William R. Willard, md. 
by William W. Winternitz, M.D., 
A.R. Gibbons and M.M. Hill 
Today’s family practice specialty was 
pioneered by a triple-blue Yale 
graduate: William R. Willard, A.B. 
’31, M.D. '34 and M.P.H. ’37, who 
died in 1991 at the age of 83. 
Dr. Willard’s concept of family 
practice was rooted in his eclectic 
early-career experiences. After 
completing undergraduate and 
medical school at Yale, Dr. Willard 
interned in pediatrics at Johns 
Hopkins, followed by a year of 
residency at Strong Memorial Hospi¬ 
tal in Rochester, N.Y. Feeling unchal¬ 
lenged by pediatrics, he returned to 
Yale for a degree in public health. 
Dr. Willard then served as deputy 
state health officer in Maryland until 
he volunteered for military service in 
1944. Back to the states in 1946, Dr. 
Willard returned to Yale to teach 
public health and soon became 
assistant dean for post-graduate 
medical education. Continuing to 
teach, he rose rapidly in academic 
rank — from assistant to full profes¬ 
sor in five years — but found admin¬ 
istration a greater interest. 
When offered the deanship at the 
upstate Medical Center of the State 
University of New York (SUNY), Dr. 
Willard accepted, seeing an opportu¬ 
nity to explore some of his ideas. 
Committed to community health 
and a broad-based relationship 
between doctors and patients, he 
initiated an innovative curriculum that 
was a forerunner of family practice. 
The unique emphasis was on the patient 
as member of a broad community. 
During this time, medical special¬ 
ization was mushrooming and the 
traditional “G.P.” was dying out. A 
growing shortage of primary-care 
physicians was becoming apparent. 
The chance to effect his ideas came 
when the University of Kentucky re¬ 
cruited Dr. Willard to create a medi¬ 
cal school, quite literally from the 
ground up. With his customary energy 
and contagious enthusiasm, he arrived 
at Kentucky’s 39-acre cornfield in 
1956 with staff from his Syracuse 
s 
William R. Willard, M.D., M.P.H., builder of three medical schools. 
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faculty: a biostatistician, a behavioral 
scientist and a sociologist-economist. 
Within five years, the first class had 
entered. A year later, the new hospital 
was accepting patients, and colleges of 
Nursing and of Dentistry were estab¬ 
lished. Dr. Willard initiated the first 
School of Allied Health, and success¬ 
fully lobbied for a veterans’ hospital 
adjacent to the new medical school. 
At Kentucky, courses and depart¬ 
ments new to medical education were 
added to academic training. Dr. Willard 
established the first department of 
behavioral science and incorporated it 
into the basic science curriculum. 
Equally new was the world's first 
department of community medicine 
which closely integrated public health 
with clinical medicine. Community 
medicine mirrored Dr. Willard’s long- 
held view that medical education 
should serve as a tool to improve 
individual patient care and to 
strengthen community health re¬ 
sources. The concept was an imagina¬ 
tive approach to rural health care for 
the mountains of eastern Kentucky 
and was replicated nationwide. 
Dr. Willard has realized his dream 
of a health science center integrated into 
the life of the surrounding community. 
During his 16-year tenure at the 
University of Kentucky, Dr. Willard 
served 10 years on the Joint Commis¬ 
sion on Accreditation, three years as 
chair. In 1964, the American Medical 
Association’s Council on Medical Edu¬ 
cation charged an ad hoc committee, 
which Dr. Willard chaired, to examine 
family practice in the United States. 
The resulting report, Meeting the 
Challenge of Family Practice in 1966, 
known simply as the Willard Report, 
was an agent for rapid and remarkable 
change. To replenish the national 
supply of primary-care physicians, 
the committee recommended estab¬ 
lishing family medicine as a new 
specialty, an independent academic 
discipline with full faculty status and 
a three-year residency training. 
Programs began to develop 
almost immediately. Today, these 
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University of Alabama has one of the South's strongest family medicine residency programs. 
programs attract more than 20 percent 
of all medical graduates. 
In 1972, national recognition was 
accorded Dr. Willard. That year he 
received both the Abraham Flexner 
Award from the Association of 
American Medical Colleges and the 
Distinguished Service Award from the 
American Medical Association. 
Approaching the University of 
Kentucky’s mandatory retirement age. 
Dr. Willard moved to Tuscaloosa, 
Ala., to take up catfish farming and to 
establish a legislatively mandated 
clinical campus for the University of 
Alabama School of Medicine. There 
he developed a family medicine 
residency program, using Willard 
Report guidelines, and a clinical 
campus for third- and fourth-year 
medical students from the University 
of Alabama at Birmingham. 
Both projects thrived, and today the 
Tuscaloosa residency program is one 
of the strongest in the South. Many of 
its hundreds of former medical 
students and residents provide primary 
care in Alabama and nearby states. 
Creator of inclusive medical 
models and builder of three medical 
schools. Dr. William R. Willard re¬ 
defined and established the well- 
trained family doctor, the ultimate 
primary care physician. YM 
William W. Wintemitz, M.D.. profes¬ 
sor of medicine at the University of 
Alabama School of Medicine in 
Tuscaloosa, Ala., completed a two- 
year USPHS fellowship at Yale in 
1952. He remained as assistant 
professor of physiology and medicine 
until 1959 when he was recruited by 
Dr. Willard to a faculty position in the 
new University of Kentucky medical 
school. In 1977, Dr. Willard recruited 
Dr. Wintemitz to be chief of internal 
medicine at the Tuscaloosa clinical 
campus. 
Dr. Wintemitz is the youngest son 
of Milton C. Wintemitz, M.D., who 
served as dean of the Yale School of 
Medicine from 1920 to 1935. A.R. 
Gibbons is a free-lance writer and 
M.M. Hill is a social worker and 
community developer, who both live 
in Tuscaloosa. 
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Unsung Heroes 
by George S. Bascom, M.D., HS '57 
We practicing physicians have a 
perspective different in degree from 
the research scientist or academic 
physician that needs to be articulated. 
The practicing alumni are the 
faces you cannot see. We sit in 
darkness before the beautiful and 
impressive transparencies when you 
lecture to us. We are not stupid, 
though we often feel that way in the 
presence of academic physicians. We 
are the ones through whom the 
marvelous gifts of science are made 
available to our patients. 
A Lifetime of Surgery — 
George S. Bascom, M.D. 
Dr. George S. Bascom received his 
medical degree from Har\>ard 
Medical School in 1952, and com¬ 
pleted a five-year surgical residency 
at New Haven Hospital and the Yale 
School of Medicine in 1957. He then 
returned to his home of Manhattan, 
Kan., where he retired after 45 years 
of private surgical practice. 
For several years, Dr. Bascom 
served on the Harvard Medical School 
Alumni Council. At the end of his term, 
in spring 1992, he wrote a letter, 
printed in the Spring 1992 edition of 
Harvard Medical alumni magazine, 
to the alumni council president. 
His letter is reprinted here, in 
edited form, with permission of the 
author and Harvard Medical. Before 
his death on Aug. 7, 1993, Dr. 
Bascom had expressed his apprecia¬ 
tion to Yale Medicine for publish¬ 
ing this letter. 
Although we don’t discover much 
in the way of scientific knowledge, we 
do try to understand the individual 
patient and help him in his or her 
misery. Our discoveries are the small, 
local ones of diagnosis; our advances, 
the simple ones of recovery by sick 
people to better health. Our lectures, to 
patients and their families, are elemen¬ 
tary, poorly illustrated and largely 
forgotten; our rewards, the gratitude 
of people we help, the fees we collect 
and the satisfactions of competence. 
We find ourselves busy answering 
the phone at home, often about patient 
crises, running to the emergency room 
to suture lacerations, operating and 
making rounds on our patients, and 
living with their problems and compli¬ 
cations until they either get well or die. 
When they die, we go to the hospital 
or home or nursing home to lay our 
stethoscopes on them for the final 
time. We talk to the family and then 
drive home wondering if we could 
have done better. And we think about 
our own brief lives. After patients die, 
many of us write notes of condolence 
or go to the funeral. If these patients 
happen to be old acquaintances, we 
mourn them. We feel guilty. 
Our patients sometimes bore us, 
and we know boredom is dangerous, 
a good way to miss a colon cancer or 
a breast lump. We get very tired 
sometimes, but this cannot keep us 
from the office full of patients we 
must see. Sometimes when we tackle 
something at the limit of our capabili¬ 
ties, we get scared. 
We are frequently called to task 
by retrospective reviewers who have 
the advantage of hindsight and neither 
responsibility for care nor often expert 
knowledge in our field. If a patient 
dies, we have to explain it to our peers. 
We fear lawsuits and detest 
lawyers because they are often so 
pitiless and deliberately malicious. 
We suspect each patient a little and 
feel wretched about doing so. 
We have offices to run, people to 
hire and sometimes fire, taxes to pay, 
regulations to meet, accountants and 
lawyers to consult. In part because of 
the pace and the stress, many of us 
are faced with family problems: 
marital discord, alcoholism, suicide, 
disappointing kids. 
We practicing doctors are not 
whining about our lot, whether we 
chose it or were forced into it by lack 
of academic qualifications. Still, in 
our immense respect for those of you 
in academic medicine, we would like 
to see more mutual recognition of our 
vital contributions to medical care. 
A good start would be to address 
issues of great importance to the 
practicing doctor — stress, failure, 
marital and family life, money manage¬ 
ment, peer relations and peer review, 
legal hazards and human mortality — 
in the medical school curriculum. 
We practicing doctors do not 
demand that our alma mater sing our 
praises. All we ask is your acknowl¬ 
edgement that we, like you, our 
academic colleagues, play an impor¬ 
tant role in the field of medicine and 
delivery of health care. After all is said 
and done, we are on the front lines 
when it comes to our profession’s 
sacred call to improve patients’ lives. 
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Humans and the Environment: 
60 Years at Pierce Laboratory 
by Kristin White 
Defying the extremes of New 
Haven’s weather and air quality, the 
John B. Pierce who stands at the 
corner of Congress Avenue and 
Liberty Street never needs to don the 
Homburg, overcoat and gloves he 
carries in his left hand. His statue 
remains steadfast beside the labora¬ 
tory that bears his name; assaults 
from the environment only enhance 
the patina of its bronze surface. 
But living human beings respond 
biologically to the environment 
around them, and inside the brick, 
Georgian-style John B. Pierce 
Laboratory, a cadre of scientists have, 
for 60 years, been laboring to define 
just what damage pollutants and 
contaminants can do, and how the 
harm can be lessened or prevented. 
Inside the laboratory’s entrance, a 
fine portrait reveals more of the 
character of the institution’s founder. 
A confident capitalist. Pierce invented 
the cast-iron radiator and founded the 
great American Radiator and Stan¬ 
dard Sanitary Co., now known as 
American-Standard, Inc. 
Having made his fortune from 
making buildings comfortable and 
Kristin White, a former science 
writer for the Albert and Mary 
Lasker Foundation, frequently 
writes on environmental topics. 
manufacturing plumbing products 
which improved sanitation and helped 
reduce the menace of infectious 
disease, the childless Pierce arranged, 
in the year before his death in 1917, 
to dedicate his wealth “to promote 
research for the increase of knowl¬ 
edge to the end that human health and 
comfort are advanced.” 
His broad statement of puipose 
anticipated that the frontiers of 
“human health and comfort” would 
move into areas unimaginable at the 
beginning of the First World War, 
when public health efforts concen¬ 
trated on infectious diseases like 
influenza, typhoid and tuberculosis. 
His vision has allowed Pierce investi¬ 
gators to make major contributions to 
basic research in areas as diverse as 
the effects of electromagnetic force, 
the impact of indoor air quality on the 
health of children from the Connecti¬ 
cut River valley to the highlands of 
Guatemala, and the phenomenon 
known as “sick building syndrome.” 
The Pierce laboratory’s work 
began in earnest in 1932, when the 
trustees turned to the man regarded as 
the father of modern public health, 
Charles-E. A. Winslow. The first 
chairman of the department of public 
health at the Yale School of Medicine, 
Winslow agreed to direct the Pierce 
laboratory, if it would relocate to New 
Haven so he could give it his direct 
attention. 
The original building, some 8,000 
square feet, was erected in 1932 in 
the heart of what was to be Yale’s 
medical campus. Additions in 1963 
and 1974, along with the most recent 
renovation, brought the building up to 
36,000 square feet. Although the 
laboratory remained financially and 
administratively independent of the 
University, unique ties were estab¬ 
lished. Yale acquired a complement 
of world-class scholars whose salaries 
are paid by the Pierce laboratory. 
These scientists took on full faculty 
rank and responsibilities, including 
teaching and work on University 
committees. In return, the Pierce 
laboratory enjoys luxuries a small, 
freestanding institution could not 
hope for — access to the resources of 
a major university and rich prospects 
for multidisciplinary collaborations. 
There are continuing opportunities for 
research related to the patients at 
Yale-New Haven Hospital; Yale 
social scientists help structure field 
studies in different cultures. 
Under Winslow, the laboratory 
began its unbroken tradition of 
research on the interface between 
humans and their environment, 
seeking to define precisely the body’s 
normal state in the absence of envi¬ 
ronmental stressors, and to measure 
the effects of chemical, physical and 
biological factors on the body’s 
regulatory systems in varying degrees 
and combinations. 
Up to this time, studies of humans 










in different environments had been, 
for the most part, descriptive. Under 
Winslow’s guidance, environmental 
health research evolved into a 
science, where new technologies have 
improved measurements and investi¬ 
gators delineate the physiological 
mechanisms that operate when human 
tissues encounter environmental 
contaminants and pollutants. 
Pierce laboratory research in the 
1930s concentrated on the rates of 
energy exchange between organisms 
and their environments. Physiologists 
explored the effects of heat and 
humidity on humans, especially 
during intense physical activity. Data 
on the body’s needs for fuel and 
oxygen while performing hard 
physical work in hot, dry surroundings 
were used to set the range of tempera¬ 
tures allowable for steel mill workers. 
Half a century later, the present 
director of the Pierce laboratory, 
Ethan R. Nadel. Ph.D., extended this 
line of inquiry in the renowned 
Daedalus Project. With the assistance 
of United Technologies, Pierce 
physiologists and M.I.T. engineers 
collaborated to devise a 68 lb. 
aircraft, carrying a single pilot- 
passenger, who also served as its 
engine. Dike any machine, the 
Daedalus aircraft was designed 
around the power available to make it 
work — in this case, a superbly 
conditioned young athlete, pedalling a 
bicycle-like mechanism. 
Resembling a huge, fanciful 
dragonfly, the Daedalus in 1988 set 
the world record for human-powered 
flight, covering in four hours the 74 
miles between the Mediterranean 
islands of Crete and Santorini. The 
feat would have been impossible 
without Dr. Nadel’s years of research 
on the human systems that convert 
food to energy, meet all-out physical 
demands, and resist dehydration and 
heat prostration. These studies were 
founded upon earlier research like 
that of Winslow and his colleagues. 
Research Concentrations 
In the intervening years. Pierce 
researchers came to concentrate on 
three broad areas, subtly interrelated. 
• The description and assessment 
of environmental stimuli affecting 
humans — such as nicotine, ozone 
and other air contaminants. In close 
collaboration with physician-scien¬ 
tists at the School of Medicine, Pierce 
scientists have examined indoor air 
quality and have helped establish 
Ethan Nadel, Ph.D.. current Pierce director, far right, and his predecessor, Arthur B. DuBois, Ph.D., stand in the laboratory’s lobby by a 
portrait of industrialist Pierce, the institution’s founder. 
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national standards for building 
ventilation and occupational safety. 
Having found that poor indoor air 
quality severely affects the health of 
unborn children and infants, they’re 
investigating the mechanisms and 
looking for practical solutions. 
• The role of the senses in shaping 
our perception of the environment. 
Special attention is paid to the chemi¬ 
cal senses — smell, taste and what 
Pierce scientists term “pungency,” 
(the sensation, neither smell nor taste, 
elicited by substances like ammonia or 
spices.) They’re drawing crucial 
distinctions between perceiving odors, 
sensing irritation, and experiencing 
potentially damaging inflammation 
due to inhaling contaminants. 
• The effects of physical and 
chemical stimuli from the environ¬ 
ment on basic biological processes. 
Much of this work has centered on 
asthma, resulting in improved treat¬ 
ment for thousands. New studies in 
pulmonary physiology point to an 
eventual early-warning test that will 
help patients adjust their medication to 
avert or reduce asthma attacks. 
These areas of concentration 
defined themselves during the direc¬ 
torships of James D. Hardy between 
1961 and 1974, and Arthur B. DuBois, 
from 1974 to 1989. Under both men, 
Pierce scientists, working indepen¬ 
dently on their own lines of research, 
converged on these areas. “It was 
partly due to the interactions among 
the scientists, and partly because new 
technology became available to do the 
experiments,” Dr. Nadel explains, 
praising the light administrative touch 
of his predecessors. “If you put a 
well-chosen group of excellent 
people together, give them what they 
need and let them work, quality 
research comes naturally. The 
scientists take their cues from the 
science they’re doing.” 
Dr. Nadel, who joined the Pierce 
laboratory and Yale in 1969, recently 
was reappointed director for a second 
five-year term, beginning July 1, 
according to Jack B. Chaddock, Ph.D., 
president of the Pierce laboratory 
board of directors and associate dean 
emeritus of engineering at Duke 
University. 
Of the reappointment, Gerard N. 
Burrow, M.D. '58 dean, Yale School 
of Medicine, comments, “Issues 
related to health and the environment 
are becoming increasingly important. 
Having a close relationship with the 
Pierce laboratory has been an enor¬ 
mous boon for the medical school, 
both because of its interest in health 
and the environment and the quality 
of its scientific staff. Dr. Nadel has 
played a key role in fostering this 
relationship, and I am delighted that 
he has been reappointed.” 
As research institutions go, the 
Pierce laboratory is small, with an 
annual budget of just over $4 million 
this year. With 17 scientists, two 
visiting scientists, 14 pre- and post¬ 
doctoral fellows, a dozen research 
assistants, it’s small enough for 
people to know each other and the 
work they’re doing. Creative collabo¬ 
rations develop almost spontaneously. 
The laboratory’s momentum 
comes from the scientists themselves, 
who have the security to follow 
where their research leads. While 86 
percent of the budget comes from 
grants from such sources as the 
National Institutes of Health, the U.S. 
Environmental Protection Agency and 
other federal agencies, as well as 
occasional contracts from private 
industry. Pierce investigators know 
that their own careers do not depend 
on the vagaries of funding. 
The Pierce laboratory is a rich 
resource for School of Medicine 
investigators, especially the depart¬ 
ment of epidemiology and public 
health. Environmental health re¬ 
search is well known for its 
multidisciplinary demands, and Yale’s 
clinical and epidemiological research¬ 
ers often turn to Pierce scientists to 
perform the basic science needed to 
explain findings in patients and 
populations. 
“Because we’re interested in how 
humans are affected by environmen¬ 
tal factors, we’ve become interested 
in the way the environment is per¬ 
ceived,” Dr. Nadel explains. “For 
years, our researchers have been 
working on the mechanisms of the 
chemical senses; for example, Dr. 
Larry Marks, a psychophysicist, is 
among the world’s experts in uncov¬ 
ering how the brain processes sensory 
information, and how the different 
senses interact with each other.” 
New Focus on Aging 
Much environmental research has 
dealt with healthy young adults. In 
early life and among older people, 
reactions to environmental stressors 
can be quite different. It could be 
said that time, or the aging process, is 
a factor in the complex human- 
environment equation. 
In recent years, many Pierce 
scientists have been doing fundamen¬ 
tal work on this underresearched 
problem. Dr. James S. Douglas, for 
example, is concerned with changes 
in the tissues of the airway during 
development. This ties in with field 
studies Brian P. Leaderer, Ph.D., is 
doing on the impact of indoor air 
quality on newborn infants and young 
children. 
Dr. Nadel, Loretta DiPietro, 
Ph.D., M.P.H. ’85, and other col¬ 
leagues at the medical school have set 
up a research center at Heritage 
Village, a private retirement commu¬ 
nity, for a five-year, $1.5 million 
series of studies of older adults, 
sponsored by the National Institute on 
Aging. This year. Dr. DiPietro, an 
environmental epidemiologist, and 
John R. Stofan, M.S., have conducted 
a study where, for six months, two 
matched groups (average age 71 
years) exercised three days a week. 
One group followed a protocol 
designed to increase their maximum 
aerobic capacity, using a treadmill; 
the other group engaged in a program 
of low-intensity resistance, stretching 
and yoga to enhance strength, flex- 
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ibility and balance. In both groups, 
maximal aerobic capacity, blood 
volume, blood pressure regulation, 
body composition/fat distribution, and 
lipid levels were assessed at the 
beginning of the study, at the 12-week 
halfway point, and final follow-up 
data were collected in February. With 
the study's first wave completed, 
additional subjects will be enrolled in 
research on other changes in older 
adults and the effectiveness of various 
interventions. 
In 1991-1992. the Pierce labora¬ 
tory underwent a massive renovation, 
adding needed space for cell biology, 
physiology, sensory psychology and 
air-quality laboratories. The facade 
was largely unchanged. But. because 
new regulations required a fireproof 
exterior stairway, the laboratory ac¬ 
quired its own architectural treasure. 
The bright, airy, three-story 
stairwell, with its soaring windows, 
elegant geometric railings, and soft- 
colored tiled floors, contrasts with the 
panelled public spaces and the 
crowded, no-nonsense laboratories, a 
humanizing break from the intensity 
and sheer labor of research. Chance 
encounters on the stairs often turn 
into prolonged discussions and 
exchanges of ideas. The stairway 
feels like a blend of a public meeting 
place and a symbol of the interrelat¬ 
edness of the work going on in the 
laboratory, linking the third floor (cell 
biology), the second floor (physiol¬ 
ogy), the first floor (sensory psychol¬ 
ogy) and the labyrinthine basement 
with its high-technology air quality 
research equipment. 
Physically and symbolically, the 
light-filled space embodies the 
interconnectedness of the work going 
on within the Pierce laboratory, as 
well as the collegiality of the men and 
women who daily add to the knowl¬ 
edge that John B. Pierce considered 
essential to the advancement of 
human health and comfort. YM 
New architectural feature links the research floors at the John B. Pierce Laboratory. 
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Environmental Health 
Surrounds Us 
by Kristin White 
If the proper study of mankind is 
man, then the best way to learn about 
the effects of the environment on 
human beings is to study the reactions 
of human beings to the thousands of 
factors to which they’re exposed. The 
inquiry may involve populations of 
thousands; it may pass through room¬ 
sized chambers where every condi¬ 
tion people encounter can be dupli¬ 
cated under controlled conditions and 
extend to field studies in the Third 
World and computer journeys into 
many scientific journals. But the 
inquiry begins, and ends, at the point 
where human tissues meet chemical, 
physical and biological entities from 
outside. What happens there, how 
does it affect the individual, and, if 
the results are harmful, how can they 
be corrected or prevented? 
At Yale, the environmental health 
research program brings together 
scientists from many disciplines in 
collaborations that transcend tradi¬ 
tional academic definitions. The 
program is coordinated by the 
division of environmental health 
sciences (EHS), part of the department 
of epidemiology and public health 
(EPH) within the School of Medicine. 
“In conventional structures, we’d 
be a department of environmental 
sciences within a school of public 
health,” says Brian P. Leaderer, M.P.H. 
’71, Ph.D. ’75, professor and head of 
the division of environmental health 
sciences, who notes that Yale’s 
idiosyncratic set-up is explained anew 
each time the program comes up for 
reaccreditation. 
“The philosophy here has always 
been that both medicine and public 
health are best served by an interdis¬ 
ciplinary relationship which makes 
public health an important part of 
medicine, and the close ties with 
clinical departments that this relation¬ 
ship fosters,” says Dr. Leaderer. 
“Nowadays, that’s especially true. A 
lot of the work environmental health 
scientists do is tied up with other 
departments in the School of Medicine, 
as well as with colleagues in epidemi¬ 
ology, biostatistics and health services. 
“We carefully nurture this unity 
between medicine, epidemiology, 
public health and environmental 
health sciences,” adds Dr. Leaderer. 
“Being part of the medical school 
strengthens our research and teaching 
base.” It also emphasizes public 
health within the medical school’s 
teaching and research programs. In a 
1991 survey, more than half of the EPH 
faculty reported that they participate in 
research with members of the medical 
school faculty in other departments. 
In the past few years, the empha¬ 
sis has shifted from providing special¬ 
ized training in specific areas, such as 
air quality and radiation exposure, to 
teaching basic principles of environ¬ 
mental health sciences — epidemiol¬ 
ogy, toxicology, environmental 
physiology, exposure assessment and 
risk assessment. 
Yale graduates with a Master of 
Public Health degree are prepared to 
become assessors of environmental 
health risk, capable of assessing the 
potential hazards of a given factor in 
the environment, establish the dose 
response profile, determine the distri¬ 
bution of exposures, gauge the risk 
level for the population and, increas¬ 
ingly, to suggest practical solutions to 
environmental health problems. 
The EHS doctoral program, 
however, is directed toward produc¬ 
ing graduates who will contribute 
new knowledge in understanding the 
impact of environmental stressors on 
human health and comfort. Both the 
master’s and doctoral programs build 
upon the strong research base within 
the EHS division. 
As prevention increases in 
importance in the new health-care 
climate, the environmental, occupa¬ 
tional and psychosocial aspects of a 
patient’s life are also becoming more 
important in clinical medicine. 
Yale offers a joint M.D./M.P.H. 
degree program and, unlike medical 
schools which are institutionally 
separate from schools of public 
health, maintains a built-in bridge to 
the real world where patients live and 
work. According to Dr. Leaderer, 
EPH believes that the purposes and 
philosophy of public health, as well 










as its fundamental scientific method, 
epidemiology, enlighten the teaching 
and practice of medicine. 
Medical students are taught the 
principles of public health in a special 
course team-taught by, among others, 
William Beckett, M.D., associate 
professor of medicine and epidemiol¬ 
ogy, and James F. Jekel, M.D., C.- 
E.A. Winslow Professor of Epidemi¬ 
ology and Public Health. One course 
focuses on important aspects of 
public health, including epidemiol¬ 
ogy, long-term care, maternal and 
child health, and occupational health. 
The department of epidemiology and 
public health also oversees the theses 
of medical students who have chosen 
topics within the academic fields of 
epidemiology and public health. 
Dr. Leaderer's division has its 
own special ties to the renowned John 
B. Pierce Laboratory, an independent 
research institution affiliated with 
Yale. "Pierce is an integral and 
important part of the research and 
teaching effort within the division,” 
says Dr. Leaderer, himself a fellow at 
the Pierce laboratory. In like manner, 
affiliation with Yale has benefited 
Pierce laboratory scientists by 
providing access to the intellectual 
and professional resources of a major 
university, including access to clinical 
settings and population-based re¬ 
search in public health. 
As at any major institution, Yale 
scientists work with computer models, 
the tools of biotechnology, specially 
built facilities, a variety of laboratory 
animals and devices unimaginable a 
decade ago. 
At Yale, however, there are 
extraordinary resources, such as the 
Yale Cancer Center with its affiliation 
with the Connecticut Tumor Registry 
whose records go back to the 1930s; 
the patients who come from around 
the world to Yale-New Haven Hospital; 
the Pierce laboratory which celebrates 
its 60th anniversary this year; the Yale 
Perinatal Epidemiology Unit; two 
WHO collaborating centers (one in 
arbovirus research, the other in health 
promotion, policy and research); and 
the Yale Occupational Health Clinic. 
EHS faculty are engaged in more 
than 30 research projects funded by a 
variety of sources, including the 
National Institutes of Health, the 
Environmental Protection Agency and 
the National Science Foundation. 
These projects are both laboratory- 
and population-based, encompassing 
a wide range of scientific disciplines 
and are truly interdisciplinary in nature. 
Some of the current major 
research projects focus on such topics 
as taste and smell; sites of respiratory 
muscle fatigue; chemical senses and 
aging; commonalities in touch, 
hearing, vision and taste; control of 
lung surfactant secretion in newborns; 
environmental tobacco smoke and 
pregnancy outcome; respirator effects 
on infants from indoor air contami¬ 
nants; field studies of symptoms 
experienced by occupants of public 
buildings; and the relationship bet¬ 
ween electromagnetic fields, electric 
blanket use and perinatal outcomes. 
A colleague, Eleanor R. Adair, 
Ph.D., lecturer in epidemiology 
(environmental health) at Yale and 
fellow at the Pierce laboratory, can 
switch on a $130,000 electronic 
device, called a klystron, to provide a 
microwave pulse of a particular 
intensity and duration called for in an 
experiment, precisely and on demand 
in the Pierce laboratory basement. 
While her official title is senior 
research scientist and lecturer in 
psychology and epidemiology, Dr. 
Adair co-chairs the subcommittee of 
the Institute of Electrical and Elec¬ 
tronic Engineers’ safety standards 
board, which is working on guidelines 
for exposure to electromagnetic fields 
in the radio frequency range. She is 
conducting psychophysical and 
physiological studies to determine 
how accurately heat sensitivity 
mechanisms respond to radio frequ¬ 
ency and microwave fields. 
In his office down the hall, 
Enrique Cometto-Muniz, Ph.D., 
assistant fellow at the Pierce labora- 
Brian P. Leaderer, Ph.D., serves as director of the medical school's division of 
environmental health sciences. 
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Eleanor R. Adair, Ph.D. 
tory and associate research scientist at 
Yale, is trying to sort out the effects of 
airborne substances on the human 
chemical senses. These include the 
sense of smell, which accounts for 
much of what we perceive as flavor, 
and the sense of chemical irritation, 
which produces sensations that Dr. 
Cometto-Muniz calls “pungency” — 
the extra tang of spices, vinegar or 
ammonia. At relatively high levels, 
almost all substances produce pun¬ 
gency — the itchy, tingling, or 
burning sensation sometimes accompa¬ 
nied by tears, and the most intense 
exposures can cause the cellular 
response of inflammation, which can 
lead to cell damage. 
“Normally, it’s very difficult to 
separate accurately the sense of smell 
from the more general chemical 
sensations (i.e., irritation), so we 
study patients who are anosmic,” he 
says. “They’ve lost the olfactory 
sense that differentiates between the 
aroma of coffee and that of chocolate, 
but their other chemical sense still 
remains, handled by the trigeminal 
nerve. Anosmics can sense the 
pungency or irritation of a high 
concentration of vinegar, for ex¬ 
ample.” Both the olfactory and the 
trigeminal systems can interact to 
signal a life-saving warning of 
harmful airborne substances in a 
person’s immediate environment. 
Health in the Workplace 
A few blocks away, Mark R. 
Cullen, M.D. ’76, HS ’76-’80, 
professor of medicine and epidemiol¬ 
ogy, and seven other clinically trained 
faculty members staff the Yale 
Occupational and Environmental 
Medicine Clinic, the first in Connecti¬ 
cut and now one of 30 in the state. 
Since he set up the clinic 15 years 
ago, Dr. Cullen and his team have 
seen everything from cancers caused 
by asbestos to self-limiting toxic 
pneumonias, from heavy metal 
poisoning to physical damage due to 
years of operating a pneumatic drill. 
“Half of our patients are referred 
by their internist or pulmonologist, 
but many patients are non-medically 
referred, by unions, plant inspectors, 
or, increasingly, by their employers,” 
says Dr. Cullen. “We don’t use fancy 
procedures, no tubes, no toys,” says 
Dr. Cullen. Simple spirometers are 
perhaps the most elaborate devices on 
the premises. The clinic's raison d'etre 
is service to the public, the training of 
graduate fellows, and its clinical 
contributions to environmental health 
research. “Three quarters of our 
research comes out of clinical problems 
our patients bring to us,” he says. 
There was the patient who had 
suffered for five years from sarcoid 
lung disease. Too sick to work, he 
discovered in the public library that 
this fairly common disorder, a 
progressive scarring of the lungs, 
could be attributable to exposure to 
the exotic metal beryllium. “He’d 
worked in a metal refinery, but the 
textbooks said beryllium disease no 
longer occurred, and I wasn’t con¬ 
vinced his case was work-related,” 
Dr. Cullen remembers. But when he 
learned the patient’s biopsy tissue con¬ 
tained beryllium. Dr. Cullen changed 
his mind and wanted to inspect the 
refinery and find whether other 
workers had been affected. At his 
next appointment the patient surprised 
the physician by bringing along four 
other workers from the same plant, all 
with beryllium-related sarcoid. 
“The company refused to let us 
look at their premises,” Dr. Cullen says, 
“and ultimately, the federal govern¬ 
ment had to rule that reasonable 
grounds existed to do a proper study. 
Our findings formed the modern 
understanding of how beryllium 
disease occurs, and, since then, many 
other cases have been described.” 
An alert emergency room physi¬ 
cian associate phoned Carrie Redlich, 
M.D. ’82, M.P.H. '88, HS ’82-’86, 
assistant professor of medicine, then a 
fellow at the clinic, after two young 
Hispanic men with the same derange¬ 
ment of liver functions appeared 
within days of each other. They had 
been co-workers at a fabric-coating 
factory for about three weeks. 
“Everybody in the plant gets sick in 
about a month, but the wages are 
good. You work as long as you can 
and then take your money home to 
Puerto Rico,” the men told Dr. Redlich. 
Another patient came in a few days 
later with an identical story. The 
diligent Dr. Redlich found the plant 
and spoke to the owner, who blamed 
his workers’ illness on their lifestyle 
and social problems. But when she 
obtained a list of the chemicals used 
in the plant she found dimethyl 
formamide (DMF), a potent hepato- 
toxin easily absorbed through the skin. 
“To be fair, this small-scale 
employer spent little time on the floor 
of his plant. Otherwise he’d have 
noticed something wrong when 300 
people were hired annually to fill 50 
jobs,” says Dr. Cullen, noting that 
occupational health problems are 
less frequent in larger operations 
where management is attentive. Dr. 
Redlich got the owner’s permission 
to interview workers through an 
interpreter and draw their blood as 
they left the plant. Seventy-five 
percent of the exposed workers 
were affected by DMF. 
“When we uncover something 
like this, the employer has two 
options,” says Dr. Cullen. “The 
employer can work quickly with us to 
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At EPH, Dr Jan A.J. Stolwijk’s seminar comments may touch on his research interests — 
radon and sick-building syndrome. 
solve the problem, or. if he or she 
won't cooperate, then we are forced 
to turn the matter over to the State 
Department of Health and the federal 
Occupational Safety and Health 
Administration.” These authorities 
can close plants and impose substan¬ 
tial fines, without telling the employer 
how to rectify the problems. 
On occasion, recalcitrant employ¬ 
ers, opportunistic labor unions and 
resentful employees have confronted 
each other, but, with experience. Dr. 
Cullen says, the industrial community 
has learned that prudent regard for 
employees’ health and safety rewards 
them with more efficient workers, 
less absenteeism, lower costs and 
better labor relations. Nowadays, 
most employers don't stonewall us,” 
Dr. Cullen says. 
Today, the Yale clinicians have a 
contract to provide full-time medical 
service to many area employers, 
including the fabric-coating company, 
whose business situation — bleak 10 
years ago — is now robust. Lately, Dr. 
Cullen’s team has been working with 
a manufacturer of lead shielding for 
X-ray equipment. 
“A patient walked in with 
symptoms of lead poisoning,” says 
Dr. Cullen. "We told his employer, 
'there’s a problem in your plant.' His 
response was very different from 
what it would have been 10 years 
ago. He said 'Come on in.'” 
Vivid as some of these experi¬ 
ences have been, it's not possible to 
develop public policy by extrapolat¬ 
ing from what happened to one 
patient or group of patients, in one 
time and place. But with the data 
from thousands of human beings, 
organized systematically, the eye of an 
epidemiologist can spot patterns that 
simplify the clinician’s job, provide 
provocative leads for basic scientists, 
and can even guide legislators. 
Jan A.J. Stolwijk, Ph.D., the 
Susan Dwight Bliss Professor of 
Epidemiology and director of the 
Cancer Prevention Research Unit in 
the department of epidemiology and 
public health at Yale, has demon¬ 
strated that human insight can 
squeeze extra value from initially 
good data. As a member of a Con- 
gressionally commissioned National 
Research Council committee looking 
into the possible effects of electro¬ 
magnetic fields (EMF) on the incidence 
of cancer. Dr. Stolwijk stumbled on a 
curious statistical pattern in childhood 
acute lymphoblastic leukemia (ALL), 
which, while unrelated to the EMF 
controversy, may hold clues to the 
etiology of this disease. 
Dr. Stolwijk asked the Connecti¬ 
cut Tumor Registry for information 
on ALL during a 10-year period; of 
the 250 cases reported, most were 
diagnosed between the ages of 2 
and 4. "That’s the age when ALL 
tended to appear among the off¬ 
spring of women exposed to atomic 
radiation while pregnant,” Dr. 
Stolwijk notes, wondering whether 
some prenatal event — not involv¬ 
ing atomic radiation — figured in 
the risk of ALL in the Connecticut 
cases. Looking more closely, he 
found up to twice as many cases 
occurred in some years as in others. 
"That pattern of peaks doesn’t 
resemble cancer incidence, which 
remains quite constant. Had the 
pattern been related to EMF expo¬ 
sure, it would have been constant 
from year to year. No, Connecticut’s 
ALL pattern resembles the ups-and- 
downs of an infectious disease!” says 
Dr. Stolwijk. If it’s reflected in other 
registries. Dr. Stolwijk’s preliminary 
sleuthing on EMF may have led him 
to learning something completely new 
about the etiology of childhood 
leukemia — a mild infection during 
the mother’s pregnancy might be a 
contributing factor. 
Radon Researched 
Dr. Stolwijk is also principal 
investigator of a $5 million study of 
the relationship between lung cancer 
and radon, now in its ninth year. 
Because the Connecticut Tumor 
Registry accrues from reports by local 
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authorities, this system was too slow 
for the study, funded by the National 
Institute of Environmental Health 
Sciences. The study required inter¬ 
viewing just-diagnosed patients. His 
team developed an active Rapid Case 
Ascertainment system, where trained 
personnel visit hospitals biweekly, to 
collect information about new cases 
of cancer. 
“Not only do they help us find the 
cases, they obtain slides and speci¬ 
mens of tissues — which are becom¬ 
ing vitally important as we join forces 
with molecular biologists,” says Dr. 
Stolwijk. 
Dr. Stolwijk and collaborators at 
the University of Utah hope to 
determine how much risk exposure to 
radon adds to smokers’ risk of lung 
cancer. Yale researchers identified 
1,800 lung cancer patients needed 
(only five or six percent of whom had 
never smoked) and, by making 
77,000 telephone calls, found a group 
of 2,000 control subjects, matched in 
distribution for age, sex and smoking 
history. All were asked where they 
had lived during their lifetime. 
Painstakingly, investigators found 
these 10,000 houses and carefully 
measured the amounts of radon in 
each. The data are being analyzed, 
and should reveal how much more 
likely a smoker is to develop lung 
cancer if he or she has lived in high- 
radon houses. 
The Cancer Prevention Research 
Unit, also part of the Yale Cancer 
Center, would like to use this infor¬ 
mation to find a practical means of 
locating houses affected by radon, the 
radioactive gas, a byproduct of the 
degeneration of rock-bound uranium 
which, because of local geology, 
poses a greater problem in some areas 
than in others. The U.S. Environmen¬ 
tal Protection Agency wants the states 
to check every house in the country, 
at a cost of $50 each, contingent that 
no house, anywhere, can be presumed 
radon-free. Furthermore, he says it’s 
more cost-effective to concentrate on 
areas where geologists consider the 
radon risk high. 
In Guatemala, World Health Organization {WHO) representatives and Yale 
environmental health scientists are collaborating to improve indoor air quality in the 
single-room dwellings of the Mam tribe. The young boys above pose near the open 
cooking fire in their home. The woman below prepares the family meal, using a new 
plancha. or little stove, provided by the WHO and locally built. In studying the impact 
of the stoves, researchers look at both cultural and environmental health issues. So far, 
the stoves appear to be accepted and reasonably efficient, Dr. Leaderer notes. 
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The measurements obtained from 
the 10,000-house Connecticut study 
could be used to identify high- and 
low-risk areas. “We could measure 
the radon in every house in the high- 
risk area, and every one in the low- 
risk area, and use the results to verify 
the accuracy of the geologists’ 
predictions.” 
With or without radon, some 
buildings apparently are not healthy 
for the people who work within them. 
Dr. Stolwijk, with Dr. Leaderer, has 
been examining the air quality 
problems popularly known as “sick 
building syndrome.” 
“The design is rarely at fault — 
it’s usually due to mismanagement of 
the building or to neglecting the 
human needs of the workers,” says 
Dr. Stolwijk. Modern ventilation 
systems are usually adequate for a 
building as built, but, because of the 
turnover of tenants and the continual 
rearrangement of partitions, painting 
and refurbishment, the air may be 
overloaded with contaminants. Fumes 
from the glue used to secure carpets 
are particularly troublesome. 
"Psychological and social factors 
enter in,” Dr. Stolwijk adds. “If an 
office is crowded with an eager bunch 
of stockbrokers making millions, the 
place can smell terrible and they 
won’t notice it. But if the same space 
is used for the same number of 
people, who are doing boring work 
and don't want to be there, you'll 
have problems.” 
On Air Quality 
Dr. Leaderer works with a small 
army of collaborators on an array of 
air quality problems. His research 
moves back and forth between field 
work from the EPA's own buildings in 
Washington, D.C., to the highlands of 
Guatemala, but it always comes back 
to the three “chambers” in the Pierce 
basement. These airtight, metal- 
walled rooms are used to test the 
effects of highly controlled quantities 
of airborne substances on human 
volunteers. The temperature, humid¬ 
ity and content of the air inside a 
chamber can be orchestrated to mimic 
that of the Alaskan tundra to a steamy 
rain forest, from a suburban kitchen 
to a tannery. 
Drs. Leaderer, Cometto-Muniz 
and William S. Cain, Ph.D., professor 
of epidemiology (environmental 
health) and psychology, are collabo¬ 
rating in chamber studies on the 
anosmic patients, testing chemical 
families: one alcohol, one ketone, one 
acetate at a time, to arrive at the 
threshold concentration of each. The 
next step is mixing various compounds 
to see whether a particular substance 
makes another more irritating, or 
whether small amounts of several can 
cause irritation at lower concentrations 
than when each acts alone. 
“We can add up to nine different 
ingredients to the pure air, in what¬ 
ever proportions we want,” says Dr. 
Leaderer, who participated in the 
design of the system, the most ad¬ 
vanced anywhere in the world. Re¬ 
designed and rebuilt just this spring, it’s 
already being scrutinized by envious 
investigators from other institutions. 
Inside a chamber, the person 
whose reactions are under study may 
be at rest or exercising on a stationary 
bicycle, breathing the air as it’s 
pumped into the chamber, or using a 
face mask to confine it to the nose 
and mouth. He or she records subjec¬ 
tive reactions to the changing atmo¬ 
sphere on a computer inside the 
chamber, which also collects physi¬ 
ological data. This chamber system is 
currently being used to evaluate the 
odor and sensory irritation potential 
of pollutant emissions from common 
building materials and furnishings. 
Last summer, Drs. Leaderer and 
Cain set other work aside to chart the 
effects of an additive a major oil 
company wanted to put into its 
gasoline to reduce carbon monoxide 
emissions. Environmental scientists 
were concerned whether gas station 
employees, or motorists at self- 
service pumps, would be affected 
adversely by the chemical, and 
whether the ambient temperature or 
humidity would have an impact. They 
measured the material for odor, 
irritation, neurological effects and 
pharmacokinetics of the compound. 
“We didn’t detect any sensory or 
neurological effects from exposure to 
the compound in our chamber studies, 
which was in itself an important 
finding. The protocols we developed 
for this study will allow us to more 
effectively evaluate proposed gaso¬ 
line additives in the future,” Dr. 
Leaderer explains. 
Dr. Leaderer also is studying an 
increasingly important public health 
concern, the effects of passive 
tobacco smoke. “Carcinogenicity gets 
publicity, but it isn’t the major effect 
of sidestream cigarette smoke. The 
real problem is irritation to the 
respiratory lining,” he says. “Children 
are especially vulnerable. They get an 
incredibly potent exposure if their 
parents smoke, leading to an in¬ 
creased risk for respiratory infections.” 
Studying this highly sensitive 
population of children indoors, where 
most pollutants concentrate at higher 
levels, can show which contaminants 
need to be regulated more tightly 
outdoors. So, Dr. Leaderer, under a 
National Institute of Environmental 
Health Sciences grant, developed a 
study which will screen more than 
30,000 newborn children in Connecti¬ 
cut. Lrom this screening, approxi¬ 
mately 1,000 children exposed to 
various environmental factors will be 
selected and followed intensively for 
one year. Their houses will be 
monitored for a variety of air con¬ 
taminant exposure, the families 
interviewed, and each infant followed 
for respiratory symptoms every other 
week for a year. 
The federally funded, $4 million 
study, to last five years, will relate 
household air contaminant exposures 
to respiratory symptoms in the babies 
and respiratory symptoms and lung 
function changes in their mothers. “If 
we find that common indoor sources 
and their pollutant emissions are 
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associated with increased symptoms, 
then we will have obtained valuable 
information in the setting of outdoor 
air quality standards,” Dr. Leaderer 
explains. 
Working with the WHO 
In environmental health, simple 
solutions can have profound effects. 
Under the auspices of the World 
Health Organization (WHO), Dr. 
Leaderer and a multi-university team 
are working on a public health 
problem with members of the Mam 
tribe in the highlands of Guatemala, 
who live in windowless houses and 
traditionally cook their tortillas over 
open, unvented fires on dirt floors of 
their single rooms. The smoky air is 
thought to be associated with the 
development of repeated respiratory 
infections in the Indian children and 
with the women giving birth to 
underweight infants. In developing 
countries, acute respiratory infections 
are the leading cause of death for 
children under 5 years. 
WHO is installing a simple 
vented stove called a plancha, made 
locally, in the homes of selected 
women in their first trimester. 
Through this intervention study, we 
hope to determine if an improvement 
in indoor air quality will result in 
higher birth weights and fewer and 
less severe respiratory infections. 
Early findings show that the little 
planchas vastly improve indoor air 
quality. At the study’s end, every 
home will have a plancha, and Dr. 
Leaderer expects that more children 
will be born at normal weight and, as 
they grow, they’ll have fewer infections. 
New NO Studies 
In contrast, other environmental 
health research at Yale is extremely 
subtle. The seemingly rarefied work 
of James S. Douglas, Ph.D., a fellow 
at the Pierce laboratory and senior 
research scientist and lecturer in 
epidemiology (environmental health), 
and Arthur B. DuBois, M.D., fellow at 
the Pierce laboratory, and professor of 
epidemiology and physiology at Yale, 
on the role of nitric oxide in the nose 
is breaking new ground in pulmonary 
physiology. In time, it might lead to 
better treatment for asthma. 
Highly reactive, nitric oxide (NO) 
produced in endothelial cells is crucial 
in keeping blood vessels properly 
dilated, but not until recently did any¬ 
one consider its role in the respiratory 
system — except as an air pollutant 
originating in automobile exhaust. 
Dr. Douglas recalls the cascade 
of collegial thinking — typical of the 
Pierce laboratory — when a former 
postdoctoral fellow (Dr. Ralph Altieri, 
now at the University of Colorado) 
returned to give a talk in which he 
suggested that NO might be the neuro¬ 
transmitter that regulates one type of 
smooth muscle function in the airway. 
Another investigator remembered 
hearing at a meeting a report that 
asthmatics exhaled much more NO than 
subjects with normal lung function. 
“This triggered something in me, 
and I wondered whether this could be 
an indication of inflammation,” says 
the Welsh-born Dr. Douglas. “Dr. 
Leaderer and I had been discussing 
EPA interest in biomarkers of envi¬ 
ronmental effects. We recruited some 
asthmatics and confirmed that the 
worse their asthma, the more NO they 
exhaled. Everybody exhales some 
NO, but asthmatics exhale much more.” 
Dr. DuBois wondered where the 
NO might be coming from. Dr. 
Douglas recalls. That night. Dr. 
DuBois quietly went to the lab, did 
NO measurements on himself, and 
called Dr. Douglas to tell him that the 
NO levels in the nose are 20 to 30 
times higher than the 20 parts per 
billion found in the lung. 
“This finding generates all sorts 
of questions,” says Dr. Douglas. 
"There’s so much NO in the nose one 
would expect the cells would be 
killed, but they’re not. What protects 
them? Is the NO generated there — 
and if so, why? What’s its physiologi¬ 
cal function? Could it be an early 
indicator of inflammation?” 
To questions like these, the Pierce 
laboratory scientists prefer hard data 
to the most imaginative speculations, 
and have just acquired a new instru¬ 
ment to measure the very low, but 
critical concentrations of NO in¬ 
volved. When Dr. DuBois is not 
measuring his own NO levels, he’s 
recruiting subjects whose levels can 
be measured. One of his favorites is a 
flute player, whose formidable 
control over his breathing allows Dr. 
DuBois to do measurements impos¬ 
sible on ordinary folks. 
The coming series of experiments 
will be done in the chambers. 
Background levels of NO in the 
atmosphere vary greatly from day to 
day (as high as 150ppB on a foggy 
morning to undetectable the next day, 
which is bright and clear). “We 
couldn’t possibly measure the small 
amounts we’re interested in against 
such high background levels, so 
we’re tremendously lucky to have 
these unique chambers where experi¬ 
ments can be done in the complete 
absence of NO,” says Dr. Douglas. 
Only then can they begin to ask what 
a high atmospheric concentration of 
NO does to the natural production of 
the compound in the body. Is this 
important? “We don’t know yet,” says 
Dr. Douglas, who clearly means to 
find out. 
The Pierce laboratory might be 
regarded as a splendid special 
environment for select scientific 
intellects until you recall that it’s 
surrounded by the Yale School of 
Medicine and the city of New Haven. 
For the students on their way to 
becoming physicians and public 
health practitioners, and for the 
patients who will come to them and 
the communities who will depend of 
them, discoveries that may be made 
tomorrow, whose importance may 
seem obscure today, could be the keys 
to longer and healthier life on earth. 
They can’t happen soon enough 
for Dr. Beckett, an associate fellow at 
the Pierce laboratory who not only is 












treating patients two days a week at 
the Occupational Health Clinic but 
also is collaborating in research with 
Pierce laboratory scientists. 
One topic is occupational 
asthma, which can be caused by 
more than 200 different substances. 
“Typically, it occurs in someone 
who’s never had asthma before who 
starts a new job,” says Dr. Beckett. 
“Everything goes well for a few 
months, then he develops a cough, 
wheezing, tightness in the chest — 
all the symptoms of asthma, except 
that the patient feels better at home, 
and the problem may disappear 
entirely while he’s on a vacation.” 
The most effective treatment is to 
separate the worker from the 
asthma-triggering environment as 
quickly as possible. With early 
diagnosis and intervention the 
problems usually disappear. Dr. 
Beckett tells his students. "But some 
workers are stoic and put up with 
the symptoms for too long, and 
remain asthmatic for many years.” 
Would the better understanding of 
NO, being pursued so energetically 
by Drs. DuBois and Douglas, lead to 
an early-warning test to identify 
workers at risk of developing work- 
related asthma? No one can say as 
yet. But Dr. Beckett believes, "Before 
20 years have passed, we’ll probably 
be able to identify different groups of 
people who are at higher risk for 
asthma from a broad range of aller¬ 
gens and irritants.” 
Then there are the well-publi¬ 
cized and still controversial patients 
with "multiple chemical sensitivity” 
or “environmental illness.” In col¬ 
laboration with the Pierce laboratory. 
Dr. Beckett is beginning studies of 
patients, previously well, who have 
arrived at his clinic, seemingly 
“allergic to everything.” 
“Many clinicians who haven’t seen 
these patients are skeptical — they 
believe it's psychogenic, or a conscious 
bid for attention, but at Yale, we see 
them as patients, and I think they’re 
worth a serious investment on our part,” 
he declares. “No abnormality in their 
immune system has been detected, and 
yet they have respiratory, neurological, 
gastrointestinal and skin symptoms 
severe enough to affect their lives, and 
their symptoms fall into some kind of 
pattern with certain environments.” 
For as long as people live on the 
planet, there will be no end to the 
pathway of questions and answers 
about their responses to environmen¬ 
tal factors. And along that pathway, 
many of the milestones that lie ahead 
are being carved, at this moment, in 
New Haven. YM 
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YM INTERVIEW: 
Rebeca Rico-Hesse, PH.D. 
Rebeca Rico-Hesse, Pli.D. 
Rebeca Rico-Hesse, Ph.D., associate 
professor of epidemiology and public 
health at Yale School of Medicine, 
travels throughout the Americas, 
identifying emerging viruses and 
developing vaccines for them. As part 
of the World Health Organization/Yale 
Arbovirus Research Unit, Dr. Rico- 
Hesse, who concentrates her research 
on equine encephalitis, has aided in 
controlling epidemic viruses in 
countries such as Venezuela, Brazil, 
Mexico and Colombia. She is coun¬ 
cilor of the American Society of 
Tropical Medicine and Hygiene, and 
chairperson of the American Commit¬ 
tee on Arthropod-borne Viruses. Dr. 
Rico-Hesse received a M.P.H. degree 
from the University of Minnesota and 
a Ph.D. degree from Cornell Univer¬ 
sity. Recently, Rosalind D’Eugenio, 
media specialist for the Yale School of 
Medicine Office of Public Informa¬ 
tion, interx’iewed Dr. Rico-Hesse 
about world epidemics in general and 
virology research, specifically. 
Q. Tell us about some of your 
field work. 
A. My work has led me to collabora¬ 
tions with researchers in Colombia, 
Venezuela and other areas in Latin 
America. In Venezuela, one of my 
collaborators provided me with a 
sample of an unidentified virus strain 
that I brought back, studied and helped 
discover as a new virus. 
We recently received another new 
virus from Brazil. Within the last three 
years, we’ve discovered two emerging 
viruses, transmitted from rodents to 
humans, that are extremely danger¬ 
ous. The mortality rates in humans 
are very high, around 30 percent. 
I have traveled to many other 
countries to visit the sites where 
diseases occur to see infected humans 
or animals and the ecological condi¬ 
tions. I try to communicate with them, 
see what the clinics look like and 
what type of samples we should 
expect to get, and what the actual 
situation is in terms of numbers. 
Because each branch of the arbovirus 
unit at Yale has different areas of 
expertise, several of us have visited 
different countries. For example, for 
the new virus we discovered in 
Venezuela, Robert E. Shope, M.D., 
Yale Arbovirus Research Unit 
(YARU) director and professor of 
epidemiology, did preliminary 
identification of the virus using 
antibodies made in mice. Robert B. 
Tesh, M.D.. professor of epidemiol¬ 
ogy and public health, conducted the 
population biology studies, and Mark 
L. Wilson, Sc.D., assistant professor 
of epidemiology, studied the rodent 
reservoir population biology and the 
epidemiology of the disease in 
humans. I'm beginning research on 
the molecular evolution and biology 
of the virus to make a recombinant 
vaccine. Jean-Paul Gonzalez, M.D., 
Ph.D., a visiting scientist from France, 
is assisting me with this project. 
Q. How do you set your priority 
for providing assistance? 
A. The priority is how much of an 
opportunity there is for us to do 
research. We need the political 
infrastructure — whether it's danger¬ 
ous or not to work in a country. For 
example, I can't work in Colombia 
anymore. It’s too dangerous in terms 
of guerilla warfare, drug dealers and 
things like that. This is in the jungle, 
and that’s where they are occupying 
territory. Mainly, it depends on the 
political situation and how well we 
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know the people. We get to know 
researchers little by little as we meet 
them at scientific gatherings and by 
visiting laboratories. 
Q. How do you decide which 
viruses to research? 
A. We get a lot of samples from labs 
around the world. If public health 
officials isolate the virus from a 
human and that person dies, then it 
has enough priority for us to help 
them identify it because it may be the 
beginning of a big epidemic. Then we 
follow up by making that country’s 
clinicians diagnostic tools and having 
people come from these countries to 
our labs for training. They go back 
and do the epidemiology, and try to 
define the infection rate, the geo¬ 
graphic distribution, and find out how 
many people are really dying of the 
virus, because usually it’s unknown 
with a new disease. Because the 
clinicians are not used to seeing this 
disease, the doctors can't make a 
diagnosis and need tools to detect and 
identify the virus. In Venezuela, the 
public health officials thought the 
country had a big epidemic of 
Dengue fever, which they did, but 
simultaneously they had a small 
epidemic caused by a new virus. So 
far, it has killed about 30 persons. It’s 
dangerous, and there’s a lot of 
potential there for spread. We work 
up the research part, but we train the 
people of the country to do their own 
epidemiology. 
Q. What is the process after you 
identify the virus? 
A. I do the molecular work. I try to 
establish the genetic relationships 
between new viruses and ones that 
have already been identified. Then we 
make rapid diagnostic tools and new 
systems in which people of the 
country can detect the virus circulat¬ 
ing on their own, so they’re not 
entirely dependent on us. We're 
basically transferring technology. 
Q. What countries have partici¬ 
pated in Yale’s arbovirus 
training program, and why 
aren’t more researchers in¬ 
volved in this field? 
A. This year, I have a woman from 
Brazil here, and I’ve had people from 
Australia, Venezuela, Africa and 
England. We also collaborate with 
researchers at the University of 
California, the National Centers for 
Disease Control and some researchers 
on Plum Island in New York. These 
are the only three centers we work 
with that continue studies on endemic 
and epidemic research, which points 
The map above shows the location of a Venezuelan haemorrhagic fever outbreak that was the focus of one of Dr. Rico-Hesse's studies. The 
larger portion of the map of Portuguesa State, Venezuela, shows the shaded area of the Guanarito municipality’ as the concentrated area for 
the fever outbreak. Her research findings were published in the Oct. 26, 1991 issue of The Lancet. 
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out the problem of the lack of re¬ 
searchers in this area. If an epidemic 
occurs, there’s not going to be enough 
vaccines and there aren’t going to be 
enough people who know how to 
detect the virus. 
Arbovirus research is not a trendy 
field, although it may become one 
soon. We do applied research where 
we work things up from the beginning 
to help foreign countries control 
viruses. We carry it through basic 
research to vaccine development and 
public health policy formation. 
However, in the United States, 
arboviruses are not considered 
important right now because they 
haven’t caused an epidemic. 
It’s underfunded research. It’s 
only when we go out and discover 
some major disease that the work 
becomes politically important. 
Meanwhile, we’re doing a very 
important service to people in 
developing countries because we’re 
helping them understand their 
potential for virus epidemics. For us 
to visit a country is very good 
because it helps to have an Ameri¬ 
can university interested, and Yale 
is highly respected. 
Q. So, when an epidemic actually 
hits the United States you ’re 
saying we won’t be ready? 
A. Exactly. We know that the potential 
is there. It could be AIDS all over 
again. We know that an epidemic is 
going to happen eventually, especially 
when it comes to Dengue because the 
mosquitoes are all over the world, 
including the Caribbean. We have 
mosquitoes in the United States which 
transmit these viruses, and it’s just a 
matter of time before we have enough 
immigrants who are viremic and 
enough sites that are infected to have 
actual native transmission of that 
virus in the United States. 
Q. What research are you 
presently conducting? 
A. Describing a source of emerging 
viruses. At the YARU, we looked up 
the relationship of endemic, or native, 
equine encephalitis virus in subtropi¬ 
cal and tropical areas in Colombia 
and found that these viruses are 
genetically very similar to the viruses 
that had been isolated during previous 
epidemics throughout northern South 
America. Before we realized that the 
two viruses may be related, we 
believed that they were two separate 
strains and that the source may be 
someplace in the jungle where no one 
had yet been. Now we know where 
the viruses originate. By showing that 
the epidemic viruses are related to the 
viruses that are latent in the jungle, 
the emergence of epidemic viruses 
can be controlled, and we can inter¬ 
rupt the natural cycles that generate 
epidemic viruses. 
We are still trying to find out 
what exactly makes these latent 
viruses evolve and what generates the 
epidemic viruses that spread through¬ 
out the equine population and af¬ 
fected humans. 
Q. When was the last large-scale 
encephalitis epidemic? 
A. In the 1970s, an equine encepha¬ 
litis epidemic spread to all the 
countries in Central America, through 
Mexico and stopped in Texas. The 
origin of this major epidemic was 
never really defined; however, some 
researchers think the cause may have 
been an insufficiently inactivated 
vaccine that was in use. So, instead of 
vaccinating animals, the animal health 
officials were basically infecting 
them. But there is no absolute proof. 
We’re seeing that even though that 
one epidemic that started in '69 and 
went through ’71 might have been 
caused by insufficiently inactivated 
vaccines, the potential still exists to 
cause more epidemics. 
There was an epidemic last 
summer in the southern part of 
Mexico in the state of Chiapas. This 
was the first time in more than 20 
years that an epidemic occurred. 
Virus samples were sent to me for 
Dr Rico-Hesse studies a virus in her labor¬ 
atory in the Yale Arbovirus Research Unit. 
identification and determination of 
evolutionary origin. 
Q. What influenced you to choose 
equine encephalitis as your 
field of study? 
A. I was raised in northern Mexico 
and lived through the epidemic in the 
1970s. I remember seeing a photo¬ 
graph on the front page of the paper 
showing bulldozers in Texas dumping 
carcasses of dead horses in a large pit. 
We had to round-up all of the animals 
in the surrounding area and herd them 
down the highway into the city to get 
them vaccinated. There were hun¬ 
dreds, probably even thousands, of 
animals lined up to get vaccinated; 
people were mobilizing all of these 
animals and we didn’t know how 
many of them were already sick. I 
was really amazed by that. I was only 
in high school then, but I knew I 
wanted to study virology. 
Q. Are there any vaccines 
in use now? 
A. Yes, but only for experimental 
purposes. There’s a vaccine that was 
used for the first time during the ’70s 
epidemic. The only reason so many 
horses were able to be vaccinated 
then was because the army had 




stockpiled vaccines, the military 
thought that encephalitis could be 
used for biological warfare. 
Q. Are horses infected the same 
way as humans? 
A. Yes, but the equines are always 
infected by both the epidemic and 
non-epidemic viruses in the jungle. 
They become infected with the non¬ 
epidemic virus but they don't get that 
sick, whereas humans are infected 
and develop encephalitis with both 
virus types. 
To infect humans, encephalitis 
needs to be transmitted from a sick 
animal that has a very high amount of 
virus circulating through its blood to a 
mosquito and subsequently to a 
human. Transmission does happen. 
When a virus evolves into an epi¬ 
demic type not only does the virus 
become more virulent, but it also 
changes in transmission method so 
almost any mosquito can transmit it. 
In humans, encephalitis starts out 
with a flu-like syndrome and then, 
within a week, fever and headaches 
become more intense. In the early 
stages, the person is usually hospital¬ 
ized to control the severe flu symp¬ 
toms. If the disease goes into the 
brain, it produces many different 
neurological symptoms for which 
there are no treatments. Depending on 
the epidemic, the number of patients 
that progress from the flu-like 
symptoms to the encephalitis is 
usually around 10 percent — not a 
very large number — but in equines 
it's very high, up to 80 percent. 
Q. Could encephalitis invade the 
United States? 
A. Yes. There is a natural reservoir 
in the Florida Everglades where 
encephalitis is silently transmitted by 
certain types of mosquitoes which can 
infect humans. The virus in the 
Everglades is not as dangerous as 
those in South America, but if this 
mechanism that leads the latent 
endemic virus to produce the more 
virulent form were to occur then you 
would have an epidemic in Florida. 
There have been outbreaks of en¬ 
cephalitis in Florida, caused by 
related viruses, but we have not been 
able to study this area yet. 
We have concentrated on Colom¬ 
bia because this seems to be a hot 
spot for the generation of epidemic 
viruses, and we go to the place where 
most of the virus is transmitted and 
look for anything unusual. We know 
where most of the small ecological 
niches or jungle areas are that have 
their own little cycle of the virus and 
have studied these areas for more 
than a decade, monitoring them for 
more epidemic virus activity. Until 
we recently conducted the work, no 
one had done a detailed genetic study 
of the virus. 
Q. What has this genetic study 
revealed? 
A. We can detect differences in the 
external structure of the virus by 
using antibodies and can tell where 
the virus in the non-epidemic form is 
very different from the epidemic 
virus. People think that there are two 
different viruses, even though they 
are genetically very similar. This is 
the first time we've been able to 
generate a family tree of these 
endemic and epidemic viruses. That’s 
why we’re now able to say, geneti¬ 
cally, that the epidemic virus comes 
from the endemic virus cycle. 
Q. Will understanding the molecu¬ 
lar structure enable you to 
create a new vaccine? 
A. It will enable us to create a 
vaccine to interrupt the jungle cycle 
of endemic viruses, the origin or root 
of the problem. If we can understand 
the genetic mechanism by which the 
endemic virus is switched to the 
virulent epidemic form, we can block 
its evolution biologically. For ex¬ 
ample, we can introduce a population 
of mosquitoes that do not transmit the 
mutant, epidemic virus. The vaccine 
that’s used right now is made with a 
virus isolated in the 1940s, and is now 
extinct. That vaccine was used to 
inoculate horses in Venezuela and 
Mexico. 
Those of us who work in labora¬ 
tories also have to be vaccinated 
because we work with high concen¬ 
trations of virus. It's less dangerous to 
us if we are vaccinated with an 
experimental vaccine. So we get this 
vaccine that also has been given to 
horses; however, in humans, the 
vaccine is considered to be experi¬ 
mental and it does cause some illness. 
Some of us have gotten sick from the 
vaccine. 
Therefore, I want to make a 
better, recombinant vaccine, and also 
to make sure that the vaccine protects 
against all the strains of viruses. We 
would use a virus that presently 
circulates in one of these jungles in 
South America throughout the year to 
update the vaccine. It’s a matter of 
doing things in a more systematic 
way — really thinking about what it 
is that we’re using to vaccinate and to 
make it more protective. 
Q. What do the next two or three 
years of research hold for you? 
A. I’m looking into the area of 
molecular evolution to help expedite 
the process of discovering the genetic 
mechanisms by which epidemic 
viruses originate. If we can under¬ 
stand the mechanisms by which new 
viruses are being generated, then we 
can control them. Mostly, I plan to 
conduct more research with emerging 
viruses, always with the endpoint to 
create a better vaccine or a better way 
to biologically control a virus. YM 
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J.K. Lavater, the father of physiognomy, was born into a family of physicians in Zurich, Switzerland. Although he chose to become 
a Protestant pastor and writer, health and healing played a major role in the philosophies he taught. Physiognomy, the judging of one’s 
character and temperament by analyzing facial features, was used in the 17th and 18th centuries by Lavater and his followers to assist in 
the mind/body healing process that Lavater professed. By “reading” a person’s face, Lavater believed ailments and diseases could be 
discovered along with the person’s true personality. — Rosalind D'Eugenio 
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Study on Bone Disorder 
Treatment Underway 
Researchers at Yale School of Medi¬ 
cine, in collaboration with colleagues 
at the University of Connecticut 
Health Center, have begun evaluating 
a medication currently approved to 
treat Paget’s disease in Europe. 
Paget's disease, the second most 
common bone disorder in the United 
States after osteoporosis, is character¬ 
ized by abnormal bone growth which 
leaves the effected areas of bone 
thicker but less dense, therefore, 
easier to break or fracture. The 
effected bone is also more vascular, 
with increased blood which causes 
extensive bleeding during injuries. 
Alison A. Moy, M.D., 
postdoctoral fellow in endocrinology 
and metabolism at Yale and assistant 
coordinator of the studies, explains 
that most Paget’s patients are not 
diagnosed until the disease cycle is 
well established, so finding the 
fastest, most effective medication is 
important. The medication being 
evaluated slows down the bone 
deformation process and may even 
arrest the progression of the disease. 
"We are studying the best effec¬ 
tive dose to which patients respond in 
an effort to define the optimum dose 
and how frequently to give the 
medication,” Dr. Moy states. With 
this study. Dr. Moy says that Yale 
researchers hope to establish a 
protocol for the medication that will 
support its use for treatment of 
Paget’s disease in the United States. 
“One reason for the mystery 
surrounding Paget’s disease was the 
lack of an animal model for 
O 
research,” says Nancy H. Ruddle, 
Ph.D., acting chair of epidemiology 
and public health. Last year, however. 
Dr. Ruddle and her colleagues 
designed the first mouse model for 
Paget’s disease that replicates the 
same features as a person with the 
bone disorder. 
The three-year study, led by 
William J. Burtis, M.D., Ph.D., 
associate professor of medicine, is 
conducted in the school’s General 
Clinical Research Center. 
Yale, Einstein Join 
To Form Genetic Center 
Yale School of Medicine and the 
Albert Einstein College of Medicine 
of Yeshiva University have joined 
together to establish a new Human 
Genome Science and Technology 
Center. Scientists at the center will 
focus on mapping a key chromosome 
known to carry genes involved in 
several major diseases. 
The new center, based at Albert 
Einstein College, was created with 
funds from the National Institutes of 
Health’s National Center for Human 
Genome Research. David C. Ward, 
Ph.D., professor of genetics and of 
molecular biophysics and biochemis¬ 
try at Yale, will co-direct the center, 
with Dr. Raju Kucherlapati of 
Einstein College. The center has been 
funded through 1996. 
The project’s overall goal is to 
identify all genes present in the human 
genome and to prepare a high-resolu- 
tion map of chromosome number 12. 
Chromosome 12 is known to include 
genes involved in cancers, such as 
P E 
leukemia, lymphoma, neurological 
conditions and clotting disorders. 
International scientists participating 
in the genetic project have divided 
research to unravel remaining genetic 
mysteries such as preparing genetic 
maps that show the locations of key 
genes on chromosomes. 
Vegetables Reduce 
Lung Cancer Risk 
The largest study conducted to date of 
dietary factors and lung cancer in 
non-smokers has found that raw fruits 
and vegetables and vitamin E supple¬ 
ments reduce lung cancer risk in non¬ 
smoking men and women, according 
to findings published in the Jan. 5 
issue of the Journal of the National 
Cancer Institute. 
Susan T. Mayne, Ph.D., assistant 
professor of epidemiology and public 
health at Yale School of Medicine and 
program director for prevention at the 
Yale Cancer Center, and her col¬ 
leagues conducted this study, the first 
of its type to include non-smoking 
men with lung cancer. The study, 
funded by the National Cancer 
Institute, is based on dietary inter¬ 
views with 413 lung cancer patients 
and an equal number of control 
subjects. Forty-four percent of the 
lung cancer patients and study 
subjects never smoked, and 56 
percent of which had not smoked for 
at least 10 years before the interview. 
Dr. Mayne notes that the protec¬ 
tive effect of raw fruits and veg¬ 
etables rose with increased consump¬ 
tion of these foods. If people were to 
add one-and-a-half servings of raw 
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fruits and vegetables to their normal 
diet, they could reduce their risk of 
lung cancer by 40 percent. 
The Yale findings suggest that 
further research is needed on the 
effects of food preparation on the risk 
of cancer. Cooking or processing may 
destroy beta-carotene and other 
compounds in fruits and vegetables, 
which could explain why raw foods, 




Through Brain Project 
Neuroscientists at the School of 
Medicine will electronically exchange 
complex scientific data with col¬ 
leagues as far away as Italy and Japan 
through an information infrastructure 
for the brain and behavioral sciences 
being developed at Yale. 
Scientists who are studying the 
brain face an array of knowledge 
from a multiplicity of increasingly 
sophisticated experimental ap¬ 
proaches, ranging from studies into 
the molecular basis of the functions 
of nerve membranes to scanning 
techniques for monitoring thought 
processes of the human brain. 
“We are bringing neuroscientists 
together with experts in databases and 
electronic networking to facilitate the 
rapid exchange of information 
between laboratories and the synthe¬ 
sis of models of brain function,” 
explains Gordon M. Shepherd, M.D., 
D.Phil., professor of neurobiology. 
This project is funded by a $1 
million grant from the National 
Institute of Mental Health and the 
National Aeronautics and Space 
Administration. The grant is one of 
the first six pilot projects awarded as 
part of the federal Human Brain 
Project, a broad-based, long-term 
initiative supporting research and 
development of advanced technolo¬ 
gies for neuroscience and behavioral 
sciences in the 21st century. 
Dr. Shepherd and other Yale 
neuroscientists will work with Perry 
L. Miller, M.D., Ph.D., professor of 
anesthesiology and director of Yale’s 
Center for Medical Informatics, to 
build the information infrastructure. 
The new funding will allow Yale 
biomedical scientists and computer 
specialists to interact and develop 
improved means of acquiring, storing 
and exchanging data generated in 
laboratories worldwide and also to 
use new types of object-oriented 
databases to facilitate the analysis and 
exchange of ideas. 
Cancer Center Offers 
Stem-Cell Transplantation 
The Yale Cancer Center has launched 
a peripheral stem-cell transplant 
program, a technology currently 
available for patients with Hodgkin’s 
disease and non-Hodgkin’s 
lymphoma. Later, it will be offered to 
certain breast cancer patients. 
Peripheral stem-call transplants 
permit patients to receive extremely 
high doses of chemotherapy or 
radiation. Cells are collected from 
patients prior to their cancer therapy 
and then transplanted back into the 
patients, resuscitating the severely 
suppressed immune system. 
According to program director 
Dennis Cooper, M.D., associate 
director for community research at 
the Cancer Center and assistant 
professor of medicine, “the stem-cell 
procedure offers a number of advan¬ 
tages over bone marrow transplant: it 
is easier for patients to tolerate and 
less risky, with shorter hospitaliza¬ 
tions and potentially lower costs.” 
Dr. Cooper notes that because 
stem-cell transplants make high-dose 
therapy safer, they will allow re¬ 
searchers to test the concept that in 
many types of responsive — but not 
currently curable — tumors, higher 
doses of therapy give better results. 
School Crisis Prevention 
Team Established 
A School Crisis Prevention and 
Response Team to provide critical 
mental health services for children and 
adolescents and their schools in the 
greater New Haven area will be estab¬ 
lished with a $65,000 grant from the 
Community Foundation for Greater 
New Haven to the Yale Child Study 
Center and The Consultation Center. 
Co-directors of the program are 
David J. Schonfeld, M.D., assistant 
professor of pediatrics and in the Yale 
Child Study Center, and Marsha L. 
Kline, Ph.D., director of The Consul¬ 
tation Center’s child and adolescent 
programs, and research scientist in 
psychiatry at Yale. 
The program was established to 
help assist local schools in developing 
skills to enable them to respond more 
effectively in crisis situations. Such 
situations include murders of students 
and their relatives, automobile and 
bus accidents involving major injuries 
and deaths, fires and suicides. 
With the funds more in-depth 
training for school administrators, 
teachers and support staff will be 
provided, along with on-site support 
and consultation during crises and 
their aftermath, and direct assistance 
to school-based and district-level 
teams during and after crises. 
“We plan to identify and enhance 
community resources to respond to 
unexpected needs inherent in crisis 
situations by anticipating them 
through organized, collaborative 
planning,” explains Dr. Schonfeld. 
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Faculty 
News 
Yusuf Haroon Ahmad, M.D., has 
been named to receive the first 
Richard D. Frisbee III Foundation 
fellowship in bone marrow transplan¬ 
tation at Yale-New Haven Hospital 
(YNHH) and the School of Medicine. 
Dr. Ahmad, who trained at the Cook 
County Hospital in Chicago, served 
fellowships in medical oncology and 
hematology at YNHH. 
John C. Baldwin. M.D., profes¬ 
sor and chief of cardiothoracic 
surgery, was one of three surgeons 
from the United States selected to 
speak at the International Symposium 
on Coronary Artery Surgery in 
November in Buenos Aires, Argen¬ 
tina. He also outlined Yale research, 
involving supercooling of organs for 
extended preservation, at the Decem¬ 
ber meeting of the International 
Society for Organ Transplantation in 
Bangkok, Thailand. 
Emile L. Boulpaep. M.D., 
professor of cellular and molecular 
physiology, was presented the 1993 
Christophe Plantin Award on Nov. 25 in 
Belgium. The award honors a native 
of Belgium whose activities abroad in 
the fields of education, science or the 
arts deserve to be noted. Dr. Boulpaep 
was honored for his scientific work in 
kidney physiology and his work with 
the fellowships program of the Belgian 
American Educational Foundation, 
based in New Haven. 
David L. Coleman. M.D., was 
named chief of the medical service at 
the Department of Veterans Affairs 
Medical Center in West Haven and 
associate professor of medicine at 
Yale. Dr. Coleman, who served at the 
medical center from 1983 to 1992 as 
staff physician and as chief of the 
infectious disease section, was chief 
of infectious disease at the Denver 
VAMC until September when he was 
appointed to his new positions. 
A tribute honoring James 
Comer, M.D., M.P.H., the Maurice 
Falk Professor in the Child Study 
Center and Psychiatry, was given by the 
Yale Child Study Center in December 
to recognize his work to improve the 
American educational system. 
Comedian Bill Cosby hosted the event, 
which included letters from President 
Clinton and Hillary Rodham Clinton. 
Charles B. Cuono, M.D., Ph.D., 
professor of surgery and director of 
the Yale Burn Center and Skin Bank, 
presented three scientific papers in 
November at the V Congreso Argentino 
de Quemaduras (Fifth Argentine Burn 
Congress) in Buenos Aires. 
Mary McCrea Curnen, M.D., 
Dr.P.H., clinical professor of epidemi¬ 
ology and pediatrics, was honored 
with Belgium’s Officer of the Order 
of the Crown decoration, recognizing 
her work abroad. Dr. Curnen received 
the award from the Belgian ambassa¬ 
dor on Feb. 22 in Washington, D.C., 
where her outstanding research and 
teaching in the field of cancer epide¬ 
miology were lauded. Upon accepting 
the award. Dr. Curnen noted that her 
father had also been decorated with 
the same award. 
Erol Fikrig, M.D., associate 
professor of medicine, has been 
awarded a $49,000 Apollos Kinsley 
Collaborative Grant for his project, 
Lyme Disease: Improved Serologic 
Tests Using Recombinant B. 
Burgdorferi Antigens. The grant is 
awarded under the Yankee Ingenuity 
Initiative, administered by the 
Connecticut Department of Higher 
Education. This initiative promotes 
technological innovation through 
partnerships between business and 
higher education, as well as through 
research and instruction at colleges 
and universities. 
Charles A. Janeway Jr., M.D., 
professor of immunobiology and 
biology and an investigator in the 
Howard Hughes Medical Institute, 
was the Boehringer-Ingelheim 
Distinguished Lecturer in Biomedical 
Sciences at Vanderbilt University 
School of Medicine in February in 
Nashville, Tenn. Dr. Janeway deliv¬ 
ered a series of lectures on the 
development and activation of the T- 
cell receptor and the problem of 
autoimmune diseases. 
Robert W. Makuch, Ph.D., 
associate professor of public health 
and director of the biostatistics 
consulting unit, spoke in September 
on the reliability of published data 
from older colorectal cancer trials at 
the Colorectal Cancer Collaborators’ 
meeting in Oxford, England. 
Marvin Moser, M.D., clinical 
professor of medicine, is a member of 
the newly formed Coalition for 
Hypertension Education and Control 
(CHEC) which has launched the 
Empowering America to Control the 
Pressure program, a national cam¬ 
paign of high blood pressure aware¬ 
ness, education and screening activi¬ 
ties. CHEC is comprised of the 
Association of State and Territorial 
Health Officials, Lederle Laborato¬ 
ries, National Council on Aging, 
National Medical Association, and 
Proctor & Gamble Pharmaceuticals. 
American Heart Association and the 
American Medical Association have 
also endorsed the initiative. 
Pasko Rakic, M.D., Sc.D., Dorys 
McConnell Duberg Professor of 
Neuroscience and section chief of 
neurobiology, has received the 1993 
Weinstein-Goldenson Scientific Award, 
presented by the United Cerebral 
Palsy Research and Educational 
Foundation for his contributions to 
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understanding the brain's develop¬ 
ment and organization. He received 
the award March 19 in Chicago. 
The American Society of Tropical 
Medicine and Hygiene has awarded 
Robert E. Shope, M.D., professor of 
epidemiology and director of the Yale/ 
WHO Arbovirus Research and Refer¬ 
ence Centre, the Walter Reed Medal 
for his distinguished accomplishments 
in the field of tropical medicine. The 
award was presented in November at 
the society’s annual meeting in Atlanta. 
George A. Silver, M.D., M.P.H., 
professor emeritus of public health 
(international health), has been 
honored by the University of Miami 
School of Medicine, office of health 
services research, development and 
policy studies with the establishment of 
The First Annual George A. Silver, M.D., 
Health Policy Lecture. He 
also was elected to the Johns Hopkins 
University Society of Scholars. 
Burton H. Singer, Ph.D., the Ira 
V. Hiscock Professor of Epidemiology 
and Public Health, has been elected to 
the National Academy of Sciences, a 
private organization of scientists and 
engineers dedicated to science and its 
use for the general welfare. 
Frans J. Wackers, M.D., Ph.D., 
professor of diagnostic radiology and 
medicine at the School of Medicine 
and an attending physician at Yale- 
New Haven Hospital, was elected to a 
one-year term as president of the 
American Society of Nuclear Cardiol¬ 
ogy on March 13 in Atlanta. 
Edward F. Zigler, Ph.D., Sterling 
Professor of Psychology and director 
of the Bush Center in Child Develop¬ 
ment and Social Policy, was presented 
the Distinguished Service Award by 
the Council of Chief State School 
Officers during the organization’s 
annual meeting in November in 
Columbus, Ohio, for his contributions 
to education and leadership in 
improving opportunities for children. 
Student 
News 
High School Students 
Offered Anatomy Course 
Thirty-five students from New Haven’s 
Career High School have started to 
enrich their knowledge of gross 
anatomy in an innovative program 
established at the School of Medicine. 
The juniors and seniors and their 
biology teacher, Shirley M. Neighbors, 
come twice a month to the school’s 
gross anatomy laboratory, where 
William B. Stewart, Ph.D., associate 
professor of surgery (anatomy), and 
his colleagues are helping the students 
learn more about human anatomy. 
The Yale experience supplements 
textbook and classroom bone studies 
for the students who have demonstrated 
a strong interest in science. Approxi¬ 
mately 70 percent are minorities, and 
80 percent are young women. 
“One of the program’s strongest 
points, though, is the role modeling 
which occurs,” Dr. Stewart points out. 
More than 20 first- and second-year 
medical students volunteer as mentors 
and tutors. 
The high school course is some¬ 
what parallel to the medical curricu¬ 
lum. Medical students teach the high 
school students in small groups and 
lead them through what they recently 
have learned. The high school 
students receive Dr. Stewart’s anatomy 
lecture notes and a lab manual. 
Under faculty and student guid¬ 
ance, “the high school students can 
touch, feel and look at the cadavers, 
but they don’t actively dissect their 
own cadavers during the 90-minute 
labs,” Dr. Stewart explains. “These 
students see everything that the medical 
students see, but they aren’t as account¬ 
able for learning as much information.” 
Student response has been 
“overwhelmingly positive,” both Mrs. 
Neighbors and Dr. Stewart report. 
“The students benefit from real hands- 
on work and improve their knowledge 
of anatomy,” Mrs. Neighbors notes. 
“Their experiences cannot be dupli¬ 
cated in a public school classroom.” 
Planning began last summer 
when Mrs. Neighbors worked in Dr. 
Curtis Patton’s laboratory in epidemi¬ 
ology and public health and also 
coordinated the development of her 
students’ gross anatomy curriculum 
with Dr. Stewart. School officials and 
board of education members re¬ 
viewed and accepted the program; 
before it started. Dr. Stewart and 
several medical students met with the 
high school students’ parents. 
According to Maxine I. Whitehead, 
director of minority affairs, this 
program will become part of the 
medical school’s commitment to the 
Association of American Medical 
College’s Project 3000 by 2000, 
designed to increase the number of 
minority students enrolled in bio¬ 
medical studies by the year 2000. 
School Honors Students 
for Community Service 
The School of Medicine presented the 
third annual Distinguished Community 
Service Awards to nine medical students 
and two second-year epidemiology 
and public health students, recognizing 
their outstanding service in New Haven. 
“We are delighted to honor our 
students for their exemplary commit¬ 
ment, leadership and dedication toward 
community service at the medical 
school and within New Haven,” com¬ 
ments Dean Gerard N. Burrow. 
The students, who were honored 
during school events on Martin Luther 
King Jr. Day, take leadership roles in 
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many programs, ranging from 
Adolescent Substance Abuse Preven¬ 
tion (ASAP) to Buddies Just for Kids, 
which pairs more than 100 Yale medi¬ 
cal, nursing, public health and graduate 
students with children who have 
chronic illnesses or who have extended 
hospital stays, supporting children 
during their medical experiences. 
The outstanding students and 
their community service projects are: 
• Kelly Buller of Woodbridge, 
Conn., public health. She founded an 
alumni association for graduates of the 
Grant Street Partnership, a substance 
abuse program for homeless cocaine 
addicts. She has done distinguished 
work in the field of AIDS and HIV 
prevention and education. 
• Tina M. Harris, a fourth-year 
medical student from Indianapolis, Ind. 
She founded Just For Kids, which 
enables Yale students to help meet 
social, emotional and psychological 
needs of pediatric inpatients at Yale- 
New Haven Hospital. The program 
subsequently combined with Medical 
Buddies, a similar program for children 
with chronic illnesses who may be 
outpatients. She serves as project 
leader of Buddies Just For Kids. 
• Abike T. James, a second-year 
medical student from Guyana. She is 
project leader of Buddies Just For 
Kids and co-coordinator of the 
Maternal and Child Health Interest 
Group, which promotes education and 
organizes outreach days. 
• Larry T. Khoo, a fourth-year 
medical student from Houston, Texas. 
He founded Asian Americans in Yale 
Medicine and has organized related 
community projects. 
• Heather Lauver of Sutton, Mass., 
public health. She is program director 
for the New Haven/Leon Sister City 
Project, which facilitates mutual 
community development between 
New Haven and the Nicaraguan city. 
She founded the Alternate Break 
Program, which provides health-care 
students the opportunity to visit 
various non-profit agencies and 
volunteer with them. 
• David M. Lee, a second-year 
medical student from Sandy, Utah. 
He helped organize and participates 
in the New Haven Care voucher 
program and weekly works in the 
Downtown Evening Soup Kitchen. 
• Jeffrey A. Meyerhardt, a second- 
year medical student from Closter, 
N.J. He serves as coordinator of the 
medical school's student volunteer 
program and chair-person of the 
Committee Overseeing Volunteer 
Services, and volunteers at the 
Downtown Evening Soup Kitchen. 
• Farzad Mostashari, a third-year 
medical student from Brookline, Mass. 
He founded the Medical Buddies 
program and serves as project leader 
of Buddies Just For Kids. 
• Joshua M. Rosenow, a second- 
year medical student from Plainview, 
N.Y. He is the primary adviser to the 
newly rechartered Yale chapter of 
Alpha Phi Omega Service Fraternity 
and is an active member of the 
Graduate and Professional Student 
Community Action Network. 
• Julie A. Rothstein, a second-year 
medical student from Highland Park, 
Ill. She founded the program Coach¬ 
ing Adolescents toward Careers in 
Health, which brings interested 
seventh graders to the medical school 
to encourage their interest in science 
and teach them about health occupa¬ 
tions. She also serves as a project 
leader of the Adolescent Substance 
Abuse Prevention (ASAP) program. 
• Rachael Villanueva, a second-year 
medical student from Holliswood, 
N.Y. She serves as an ASAP project 
leader, a national board member of 
the Student National Medical Asso¬ 
ciation, and a counselor for the 
Minority Student Research Program. 
§§§ 
The Life and Health Insurance 
Medical Research Fund has awarded 
Matthew Hieu Tran Bui, an M.D., 
Ph.D. student, a scholarship of 
$ 16,000 a year, for up to five years, to 
continue his research on the cell 
biology of viruses. 
Bradley Peterson, M.D., 
postdoctoral fellow, was given the 
Robinson-Cunningham Award in July 
by the American Academy of Child and 
Adolescent Psychiatry in July for his 
paper. Reduced Basal Ganglia Volumes 
in Tourette’s Syndrome Using 3-Dimen- 
sional Reconstruction Techniques 
from Magnetic Resonance Images. 
Book 
News 
Histopathology of the Liver, by 
Gerald Klatskin, M.D. and Harold O. 
Conn, M.D. '12, professor emeritus 
of medicine, Oxford University Press 
(N.Y.) 1993. Editor’s note: Dr. 
Klatskin had started this volume 
before his death in 1986. 
How We Die: Reflections on Life's 
Final Chapter, by Sherwin B. Nuland, 
M.D. '55, associate clinical professor 
of surgery, Alfred A. Knopf, Inc. 
(N.Y.) 1994. 
Hyperbaric Medicine Practice, edited 
by Eric P. Kindwall, M.D. '60, Best 
Publishing Co. (Ariz.) 1994. 
Everyone’s Guide to Cancer Therapy, 
by Malin Dollinger, M.D. ’60, et al. 
Somerville House (Toronto) Second 
Edition, 1994. 
Raising the Dead, by Richard Selzer, 
M.D., HS '61, Whittle/Viking 
(Tenn./N.Y.) 1994. 
Therapeutic change: an object 
relations perspective, by Sidney J. 
Blatt, Ph.D. professor of psychiatry 
and psychology, and Richard Q. Ford, 
Ph.D., Plenum Press (N.Y.) 1994. 
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“Med TV, Med TV, now the students they will see 
All the talent and charisma that is in the faculty 
All those shows, all that jazz. Bathroom break, Here’s your chance! 
Get the spotlights hot and glowing and the tape lets start a ‘rolling!” 
Second-Year Show 
For more than 50 years, second-year medical students at the Yale 
University School of Medicine have written, produced and 
directed an annual show. This year’s show, entitled “Med TV, " was 
presented on Feb. 25 and 26. The show's poster, above, was 
designed by Jack Maypole. 
More than 20 original skits and musical numbers, based on a 
variety of TV shows and movies, were included in the production. 
All of the show’s choreography and staging were created by the 
students. More than 90 percent of the class are involved in some 
aspect of the production. 
This year's play was produced by Jonathan Grauer and 
Jerome Zink and directed by Jeremy Miller. The show’s videotape, 
produced by Lisa Sanders, is available for $25. Checks may be 
made payable to the Class of ’96 and sent by Aug. 1 to Jeff 
Meyerhardt, 301 Humphrey St., New Haven, CT 06511. 
A final run-through of “Dr. John Forrest,” to the tune of 
“Officer Krupke, ” before opening night. Student 
performers are, left to right: Rachel Villanueva, Carole 
Smarth, Peter Ferren and Janel Hackney. 
“One, sterling education, every single class we take. 
One, thrilling kind of lecture, sorry if we were late. 
One test and suddenly no other school will do. 
We’ll always love the Yale System old or new. 
One thrilling combination Giff and Burrow at Yale. 
For the place is second best to none. 
So Duke, Hopkins, give us your attention 
Do we really have to mention 
Yale’s the one!” 
Dress rehearsal. 















The Health Intervention Focus group, started with medical school 
input, held an open meeting, focusing on a variety of community 
health topics. Speakers were, from right to left, former Mayor John 
Daniels, Carlos Ceballos, coordinator of the city’s School-Based 
Health Care Program; and Brian W. Forsyth, M.D., associate 




Dean Gerard N. Burrow spoke on physicians in 
the future and finite clinical care at a special 
meeting of the Medical School Council. 
Community members who enjoyed themselves at the 
reception include, from left to right, Barbara Geller, 
director of the city’s Fighting Back initiative, State 
Rep. William R. Dyson and Tomas Reyes, president 
of the New Haven Board of Aldermen. 
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The national debate on health-care reform and its impact on the 
underserved was the theme for the school’s 1994 observance. 
Sharing their views at a symposium on Financing Tomorrow’s Health 
Care: Not as a Privilege were Dr. Miriam Rossi, assistant dean for 
student affairs at the University of Toronto School of Medicine; and 
L. Jerome Ashford, vice president of the Kaiser Foundation Health 




A student ensemble from New Haven's Lincoln 
Bassett School presented several musical 
selections at the convocation, Dealing with 
Socio-Cultural Barriers in Health Care. 
At the afternoon convocation, Thomas W. Chapman, 
M.P.H. ’71, chief executive officer of George Washington 
University Hospital and senior associate vice president 
of the George Washington University Medical Center's 
network development, left, discussed the massive 
challenges of health-care reform. Here, he talks with 
Lawrence S. Cohen, M.D., deputy dean and chair of the 
day’s activities, far right, and Dr. Burrow. 
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Alumni 
News 
J. Karl Poppe, M.D.. HS ’38-’41, 
of Portland, Ore., has retired from his 
40-year practiee of thoracic surgery. 
Raymond A. Gagliardi, M.D. 
'45, HS '48-’51 of Bloomfield Hills, 
Mich., spoke at the January meeting 
of the Beaumont Medical Club of 
Connecticut. His topic was Radiol¬ 
ogy: Its Early Years Searching for an 
Identity. Dr. Gagliardi had a distin¬ 
guished career in radiology, which 
included his Yale training and his 
subsequent tenure at Wayne State 
University. He was president of the 
American Roentgen Ray Society from 
1988 to 1989 and continues to play an 
official role in the society. 
David E. Morton, M.D. ’48, HS 
’49-’55, who resides in Pueblo, Colo., 
retired in July from the practice of 
internal medicine. 
Francis R. Coughlin Jr., M.D. 
'52, J.D., of New Canaan, Conn., is a 
medical/legal affairs attorney concen¬ 
trating on legislative changes to the 
medical malpractice system. He also 
serves as vice chairman of the 
Connecticut Commission of Medi¬ 
colegal Investigations. 
R. John C. Pearson, M.P.H. 60, 
HS '61-’62, has resigned as chairman 
of the department of community 
medicine at West Virginia University 
Health Science Center after 17 years 
but continues as a professor in that 
department. In October, he was a 
visiting professor at Zhejiang Medical 
University, Hangzhou, People’s 
Republic of China. 
Capt. Walter W. Karney, USN, 
M.D. '62, will retire from active duty 
in the Navy in July after 30 years of 
service. He plans to work for the 
Montgomery County Health Depart¬ 
ment in Maryland. 
Ward E. Bullock Jr„ M.D., HS 
'62-'63, postdoctoral fellow '63-'64, 
of Cincinnati, Ohio, has been named 
dean of the University of 
Connecticut’s School of Medicine in 
Farmington, effective May 1. Dr. 
Bullock previously was the Arthur 
Russell Morgan Professor of Medi¬ 
cine and director of the infectious 
diseases division of the department of 
medicine at the University of Cincin¬ 
nati College of Medicine. 
Ward E. Bullock Jr., M.D. 
David R. Chase, D.D.S., M.D. 
'66, HS ’66-’68, is a practicing oral 
surgeon in Willimantic, Conn. 
Richard P. Mills, M.D. '68, was 
named president-elect of the Ameri¬ 
can Academy of Ophthalmology in 
January, becoming president in 1995. 
He is professor and vice chair of the 
department of ophthalmology at the 
University of Washington and was in 
the private practice of comprehensive 
ophthalmology in Olympia, Wash., 
for 11 years. 
Kendall A. Smith, M.D., HS ’68- 
'70, has been appointed chief of the 
division of allergy-immunology in the 
department of medicine at The New 
York Hospital-Cornell Medical Center. 
Irene Trowell-Harris, M.P.H. 
Irene Trowell-Harris, M.P.H. 
'73, nursing assistant to the director. 
Directorate of Nursing Services, 
Office of the Surgeon General, 
Headquarters, USAF, Bolling Air 
Force Base, Washington. D.C., is the 
first African-American woman 
promoted by the Air National Guard 
to the grade of brigadier general. The 
promotion caps a 30-year career in 
the nursing field. In 1963, she was 
first commissioned as a flight nurse, 
and in 1986 she was appointed 
commander of the 105th USAF clinic 
in Newburgh, N.Y., becoming the first 
nurse in Air National Guard history to 
command a medical clinic. 
David N. Bailey, M.D. ’73, HS 
’75-’77, professor and chairman of 
the department of pathology at the 
University of California, San Diego, 
received the Gerald T. Evans Award 
of the Academy of Clinical Labora¬ 
tory Physicians and Scientists at its 
national meeting in June at Yale. This 
award recognizes leadership and 
service to the academy in the field of 
laboratory medicine. 
Michael Crade, M.D., HS ’76- 
’78, of Seal Beach, Calif., spoke at 
the King’s College London Meeting 
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Special December 50th Reunion Held in Scottsdale 
Eleven members of the Yale School of Medicine Class of 1943 December 
celebrated their 50th reunion in Scottsdale, Ariz., during the first weekend of 
December. Classmates enjoyed the treasures of the Heard Museum and the 
private collection of California impressionist paintings at the Fleischer 
Museum. 
The reunion banquet at the Hyatt Regency Scottsdale provided opportu¬ 
nity for much reminiscing and an update on the state of Yale medical school 
by Arthur Crovatto, M.D. '54, director of the office of alumni affairs. 
In the photo seated, left to right, are Brownlee Brinkley, Henry H. Jones 
and Henry B. Bruyn; standing are Benjamin R. Robinson Jr., Hunter H. 
Comly, Hoyt B. Miles, Frank R. (Barney) Hurlbutt Jr., John R. Almklov, 
Thomas F. Bucky, Richard N. Abbott and Robert H. Furman. 
in July on Ovarian Cancer: Diagno¬ 
sis and Screening. 
Robert V. Levine, M.RH. '80, 
formerly senior vice president for 
administration at Flushing Hospital 
Medical Center, has been appointed 
one of the vice presidents for opera¬ 
tions at Lenox Hill Hospital in New 
York. He is past president of the 
Metropolitan Health Administrators 
Association. 
Jack D. Barchas, M.D. '81, has 
been named editor of the American 
Medical Association's Archives of 
General Psychiatry, succeeding the late 
Daniel X. Freedman, M.D. ’51, HS '58- 
'66. Dr. Barchas is the Barklie McKee 
Henry Professor and chair of the 
department of psychiatry at Cornell 
University Medical College, and 
psychiatrist-in-chief at New York 
Hospital. 
Robert C. Langdon, M.D., HS 
'82-'84, is using a Q-switched laser 
primarily for tattoo removal at his 
Shoreline Dermatology practice in 
Madison, Conn. He also is a clinical 
professor of dermatology at the 
Department of Veterans Affairs 
Medical Center in West Haven. 
Gregory R. Huth, M.P.H. '84, of 
Hamden, Conn., is managing editor at 
Appleton and Lange, the textbook 
division of Simon and Schuster 
Publishing, in Norwalk. He also 
continues his free-lance writing, 
editing and publishing. 
Sabina O’Laughlin, M.D., HS 
’86-’89, a pathology specialist at the 
Baptist Medical Center laboratory in 
Jacksonville, Fla. 
Andrew N. Bazos, M.D. '87, has 
joined the staff of New Milford 
Orthopedic Associates in Litchfield 
County, Conn. He has completed his 
orthopedic surgery and sports medi¬ 
cine training at Columbia-Presbyte- 
rian Medical Center and The Hospital 
for Joint Diseases in New York City. 
He will specialize in sports medicine 
and continue in his role as medical 
director of Yankee Stadium and 
Madison Square Garden. 
Paul Jaconette, M.P.H. '88, was 
appointed vice president of opera¬ 
tions, quality and utilization for the 
Santa Barbara Medical Foundation 
Clinic, a 100-physician multispecialty 
group practice serving the central 
coast of California. 
Robert M. Spillane, M.D. '91, of 
Winchester, Mass., has been named to 
a one-year term as chief resident in the 
department of diagnostic radiology at 
Massachusetts General Hospital. 
John Franklin Williams Jr., 
M.D., M.P.H. ’75, of Washington, 
D.C., has been named associate vice 
president for graduate medical 
education and special projects of The 
George Washington University 
Medical Center. He also will continue 
in his current position as dean of 
admissions and as an associate 
professor of anesthesiology. 




















Yale Alumni in Japan 
When Dr. Luke M. Kitahata, profes¬ 
sor and former chairman of anesthesi¬ 
ology, addressed the 15th annual 
meeting of the Japanese Society of 
Pharmaco-anesthesiology last July 2 
in Tokyo, he also reunioned with his 
former trainees. 
Yale anesthesiology has gained 
international recognition for its 
leadership in pain research; in fact, 
the department is the leading recipient 
of National Institutes of Health funds 
to study the causes and management 
of pain. 
Much of the groundbreaking 
work led by Dr. Kitahata during the 
past decades was shared by the active 
participation of those Japanese 
anesthesiologists, whom Dr. Kitahata 
trained in the clinical program as well 
as basic science research. 
In the past three decades, 46 
Japanese anesthesiologists have 
trained with Dr. Kitahata and also 
participated in his research. 
They returned to Japan after their 
training at Yale, and have occupied 
leading positions in various universi¬ 
ties in Japan. Among the trainees, 13 
have become professors and chairmen 
of various departments in Japan. 
During Dr. Kitahata’s visit, the 
anesthesiologists, shown in the 
photograph above, held their first 
alumni gathering. Attending were first 
row, left to right: Drs. Maki 
Matsumoto, Sapporo University; Itsuo 
Sato, Dokkyo University; Yoshihiro 
Kosaka, Shimane University; Luke 
M. Kitahata, Yale; Kazuo Hanaoka, 
Tokyo University; Mrs. Wakako 
Hanaoka. Second row, left to right: 
Drs. Hiroshi Yuwasaki, Sapporo 
University; Osafumi Yuge, Hiroshima 
University; Kikuo Nio, Hiroshima 
Transportation Hospital; Akiyoshi 
Namiki, Sapporo University; Shuji 
Dohi, Gifu University; Hidenori 
Toyooka, Tokyo Medical Dental 
University; Minako Otani, Hiroshima 
University. Last two rows, left to 
right: Drs. Keiichi Omote, Sapporo 
University, Yuji Yamamori, Shimane 
University; Kengo Nishioka, 
Kitakyushu Hospital; Yoji Saito, 
Tottori Hospital; Hiroshi Uchida, 
Masuda Red Cross Hospital; Masaki 
Senami, Onomichi Hospital; 
Kazuhiro Kishikawa, Sapporo 
University; Masayuki Suzukawa, 
Zichi University; and Hirosato 
Kikuchi, Toho University. 
1993-1994 Association 
of Yale Alumni in Medicine 
Marie-Louise T. Johnson, M.D., Ph.D. ’56 
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Lycurgus M. Davey, M.D. ’43 
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Gilbert F. Hogan, M.D. ’57 
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Muriel D. Wolf, M.D. '59 
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Harold D. Bornstein Jr., M.D. ’53 
Leo M. Cooney Jr. , M.D. ’69 
Lee Goldman, M.D., M.P.H. ’73 
Michael Kashgarian, M.D. ’58 
Ellen B. Milstone, M.D. ’69 
Gioacchino S. Parrella, M.D. ’41 
Barbara A. Ross, M.D. '81 
Charles F. Scholhamer Jr., M.D. ’72 
Arne S. Youngberg, M.D. ’66 
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Alumni R eport 
Strengthening the organization of 
individual classes continues to engage 
our efforts. This will increase mean¬ 
ingful involvement of our alumni/ae 
in reunion and educational affairs. 
Class secretaries are encouraged to 
strengthen their roles as archivists and 
organizers of class activities to 
motivate increased participation. The 
Office of Alumni Affairs acts as 
advisor, helper and local organizer for 
the classes. Connie Tolliver and Patty 
DiNatale, experienced staff members, 
assist the secretaries and local 
chairpersons in coordinating each 
class’ activities. This continuing 
communication and interaction with 
class officers remain a high priority 
and source of pride to our office. 
Muriel Wolf said, “Happy 
students make happy alumni/ae.” 
Because she is right, we continue to 
work closely with our students to 
establish a strong class structure 
while they are still in New Haven. 
Potential class secretaries and class 
agents are identified with other 
leaders and are encouraged to estab¬ 
lish a class organization before 
graduation. The process of nurturing 
students as future alumni/ae is 
catalyzed by active Student Council 
meetings, being an active member of 
the Medical School Council and 
serving on the Committee for the Well 
Being of Students. The alumni office 
annually sponsors a student/faculty 
tea and assists in solicitation of 
alumni/ae support for the Second-Year 
Show and the annual “Cadaver Ball.” 
Our office assisted the Yale Alumni 
Fund in Medicine with its annual 
phonathon in March. The Office of 
Alumni Affairs, with assistance from 
student council and class officers, 
coordinated the evening. Local 
alumni/ae volunteers assisted the 
students with their solicitations. 
Response was impressive, and the 
students always look forward to the 
opportunity to “give back.” 
Students have responded favor¬ 
ably to the curriculum change, now in 
its second year. Teaching is organ- 
based, and the quality is consistently 
improving. Our students are academi¬ 
cally gifted and socially aware. Their 
contributions to improve the condi¬ 
tion of the disadvantaged in New 
Haven are impressive, both in volume 
and effect. First- and second-year 
students are teaching gross anatomy 
to high school students in our dissect¬ 
ing labs. Both teacher and student are 
learning and benefiting. (See Student 
News, Page 41.) 
Dean Gerard N. Burrow, M.D. 
’58, spoke on “Medicine in the 21st 
Century” on March 16 in Hartford 
and on March 23 at the Commons in 
Woolsey Hall. Medical and general 
Yale alumni/ae attended. Previous 
talks in Philadelphia and Chicago also 
were well received. His vision is one 
of continuing excellence for the 
school, educating leaders of medicine 
in the 21st century. Alumni affairs 
supports the dean in his endeavors to 
maintain and enhance these goals. 
Reunion Plans 
Plans for the 1994 June Reunion 
Weekend are complete, and my staff 
and I anticipate an outstanding 
reunion. A strong program has been 
arranged, which will highlight the 
Yale Cancer Center. 
Dr. Leo M. Cooney Jr., M.D. ’69, 
Humana Foundation Professor of 
Medicine, chaired this year’s Class 
Reunion Activities Planning Committee, 
urging individual anniversary class 
leaders to arrange a class program 
and/or other activity on that Friday to 
kick off the weekend. Dean Burrow 
will offer official greetings and a 
much-anticipated State of the School 
address. Vincent T. DeVita Jr., M.D., 
HS ’66, director, will discuss the Yale 
Cancer Center; Ronald C. Merrell, M.D., 
will present his first surgical grand 
rounds to a reunion group since his 
appointment as chairman of surgery. 
The Alumni in Medicine Distinguished 
Service Award will be presented at 
the annual meeting of the Association 
of Yale Alumni in Medicine. (See 
complete schedule. Page 50.) 
A mini reunion of the Class of 
1943 (December) in Scottsdale, Ariz., 
on Dec. 3-5 was attended by 11 class 
members. It was my pleasure to 
represent the Office of Alumni 
Affairs. Robert H. Furman, M.D. '43, 
HS ’44-’45, planned and organized 
the event. There was much reminisc¬ 
ing; I had the opportunity to discuss 
the present state of the school and its 
future. Class members appreciated 
their Yale education and will support 
efforts to insure the school’s future. I 
was pleased to be invited to attend 
this most enthusiastic tribute to Yale 
by the Class of 1943 December. 
The Office of Alumni Affairs 
again emphasizes the need to assist 
the alumni fund. Drive efforts have 
resulted in pledges and receipts of 
more than $1 million for each of the 
last two years. John W. Foster, M.D. 
’71, and his staff hope to improve on 
his splendid record. Coordinated 
effort by all alumni/ae groups will be 
needed to help attain this goal. 
Arthur C. Crovatto, M.D. '54 
Director of alumni affairs 
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Highlights: Alumni Weekend 
June 3 and 4 
Friday, June 3 
8:00 a.m. Registration 
1:00 p.m. Class reunion seminars (concurrent) 
1939, 1944 
4:00 Special presentation 
Overview of Yale Cancer Center: 
Technology Transfer and Cancer Treatment 
Vincent T. DeVita Jr., M.D., HS '66 
Director, Yale Cancer Center 
5:00 Dean’s reception 
Saturday, June 4 
8:00 a.m. Registration 
9:00 Surgical grand rounds 
9:00 Faculty seminars 
I. Yale Cancer Center 
II. Women’s Health Initiative at Yale 
III. Update on the Medical Curriculum 
10:30 Annual meeting of the Association 
of the Yale Alumni in Medicine (AYAM) 
State of the School Address 
Gerard N. Burrow, M.D. ’58 
Dean, School of Medicine 
AYAM Distinguished Service Award presentations 
12:15 p.m. Sherry and buffet luncheon 
2:45 Guided tours: Yale Center for British Art 
Historic sections of New Haven 
Children’s Hospital at Yale-New Haven 
CushingAVhitney Medical Library 
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Obituaries 
Mary F. McClure 
Mary Fahey (Engel) McClure. PA-C. 
died Oct. 10 at Norwalk Hospital in 
Connecticut at the age of 56. 
Bom in Springfield. Mass., Mrs. 
McClure graduated from the Yale 
University School of Medicine’s 
Physician Associate Program in 1979 
and practiced at Yale-New Haven 
Hospital in the emergency department 
until 1980. She was in the department 
of pediatric neurosurgery at Yale 
medical school from 1980 to 1985. 
when she joined the Eastern Con¬ 
necticut Emergency Medical Sendees 
Council, where she served as director 
until 1988. 
Mrs. McClure returned to Yale in 
1988 as assistant director for clinical 
affairs for the physician associate 
program. She was in clinical practice 
at Newington Children’s Hospital in 
1989 and at Norwalk Hospital, 
department of pediatrics at the time of 
her death. 
She leaves her husband. William: 
two daughters. Kristin and Melissa: 
and two sons, Leonard and Thomas. 
Memorial contributions can be made 
to the Connecticut Physician Assistant 
Foundation, c/o Connecticut Acad¬ 
emy of Physician Assistants. 524 
Main St., Cromwell. CT 06416. 
David M. Carter 
David Martin Carter, M.D.. Ph.D., a 
resident of Guilford. Conn., and New 
York City, died Nov. 7 at the age of 57. 
Dr. Carter attended Dartmouth 
and received his medical degree from 
Harvard. In 1967, he entered the 
clinical research training program at 
Yale as a postdoctoral fellow and 
obtained a Ph.D. degree in develop¬ 
ment biology. 
He was a professor of dermatology 
at Yale medical school where he 
helped establish the photochemotherapy 
unit for the treatment of psoriasis and 
initiated studies on epidermolysis 
bullosa. In 1981. he joined the 
Rockefeller University where he 
became the Carl J. Herzog Professor 
of Clinical Investigation and director 
of the laboratory for investigative 
dermatology. He retained the title of 
clinical professor of dermatology at 
Yale from 1981 to 1986. Dr. Carter 
also was professor of medicine in 
dermatology and co-head of the 
division of dermatology at Cornell 
University Medical Center. 
Besides his wife, Anne (Jill), he 
leaves two daughters. Anna and 
Elizabeth: a son. Christopher: his 
father. Joseph: and a grandson. 
Memorial contributions may be made 
to the American Skin Association. 
32nd floor. 150 E. 58th St., New 
York. NY 10155. 
M. Dawson Tyson 
M. Dawson Tyson. M.D.. professor of 
clinical surgery emeritus at Dartmouth 
Medical School, died Nov. 8 at his 
home in West Lebanon, Mass. 
A 1927 graduate of Yale School 
of Medicine, Dr. Tyson interned at 
Johns Hopkins and trained in surgery 
and pathology at Yale. Louisville City 
Hospital and Massachusetts General 
Hospital. During World War II. he 
served as chief of medical sendees in 
McKinney. Texas, and in Osaka. 
Japan, for the U.S. Army. He joined 
the Hitchcock Clinic at Dartmouth 
Medical Center in 1935 and brought 
chest surgery to northern New 
England. He continued to practice 
general and thoracic surgery until his 
retirement from the Mary Hitchcock 
Memorial Hospital in 1964. 
Dr. Tyson became chief of staff at 
the White River Junction Department 
of Veterans Affairs (VA) in Vermont 
and also wras director of the VA from 
1968 to 1971. After retiring from those 
positions, he served as educational 
coordinator of the VA until 1974 and 
worked on the state rating board. 
He is survived by his wife, Jean; 
and two sons. William and James. He 
was predeceased by his son. M. 
Dawson Tyson Jr. 
John C. Parker 
John Curtis Parker. M.D.. Kenan 
Professor of Medicine at the Univer¬ 
sity of North Carolina at Chapel Hill, 
died at his home on Nov. 22. 
Bom in Boston. Dr. Parker 
graduated from Yale School of 
Medicine in 1961. During his career, 
he served in the U.S. Public Health 
Service at the National Institutes of 
Health and as a hematology fellow at 
Washington University in St. Louis. 
He joined the University of North 
Carolina School of Medicine faculty 
in 1967. 
He leaves his wife. Margaret: a 
son. Benjamin: a daughter, Claire: 
and his father. John A. Parker. 
Jay B. Cohn 
Jay Binswanger Cohn. M.D.. Ph.D., 
J.D.. died on Nov. 29 in Los Angeles 
Bom in Pelham. N.Y.. Dr. Cohn 
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Jay Binswanger Cohn, M.D., Ph.D., J.D. 
graduated from Yale School of 
Medicine in 1945. Following an 
internship at St. Elizabeth's Hospital 
in Washington, D.C., he served as a 
psychiatrist in the U.S. Army in Japan 
from 1946 to 1948. He continued his 
training in psychiatry and neurology 
in Cleveland and was certified by the 
American Board of Psychiatry and 
Neurology in 1952. Dr. Cohn held 
academic appointments at Case 
Western Reserve University in 
Cleveland, University of Southern 
California, and University of Califor¬ 
nia at Irvine and at Los Angeles. 
He was the founder of the 
Pharmacology Research Institute, 
with offices in Long Beach, Irvine 
and Northridge, where he directed 
numerous research studies on new 
medications for such conditions as 
depression, anxiety and Alzheimer's 
disease. He was recognized as an 
expert in psychopharmacology and in 
medical/legal psychiatry. 
He is survived by his wife, Sally; 
two daughters, Laurie and Jodi; and 
two grandsons. Memorial contributions 
may be made to the International 
Myeloma Loundation, 2120 Stanley 
Hills Drive, Los Angeles, CA 90046. 
Edward R. Harvey 
Edward R. Harvey, M.D.. died Dec. 1 
at Griffin Hospital in Derby, Conn. 
He was 78. 
A native of Connecticut, Dr. 
Harvey graduated in 1941 from Yale 
School of Medicine. He served in the 
U.S. Army during World War II and 
was a family physician in the 
Naugatuck Valley for 51 years. 
He is survived by his wife, Linda; 
a daughter. Kathleen; a son, Edward 
III; and a granddaughter. Memorial 
contributions may be made to 
Merrimack College Student Lund, 
North Andover, MA 01845. 
Roy N. Barnett 
Roy N. Barnett, M.D., of Westport, 
Conn., died Dec. 3 at the age of 78. 
Born in Woodmere, N.Y.. Dr. 
Barnett graduated from Yale College 
in 1935 and obtained a Yale medical 
degree in 1938. His medical training 
was interrupted by service with the 
U.S. Army Medical Coips, and after 
leaving as a lieutenant colonel in 
1945, he completed residencies at 
Yale-New Haven and Mt. Sinai, N.Y., 
hospitals. 
Dr. Barnett was an internationally 
recognized pioneer and architect in 
the development of modern labora¬ 
tory medicine and pathology. He 
served as chairman of the department 
of pathology and director of laborato¬ 
ries at Norwalk Hospital from 1947 
until he retired in 1982. Since his 
retirement, he had been a consultant 
with the Mt. Sinai Center, where he 
was co-director of the laboratory 
medicine conference. 
In addition to his wife, Margaret, 
he is survived by a daughter, Edith; 
two sons. John and Ted; and four 
grandchildren. Memorial contribu¬ 
tions may be made to the Westport 
Nature Center for Environmental 
Activities, 100 Woodside Lane, 
Westport, CT 06880. 
Lewis Thomas 
Lewis Thomas. M.D., poet-philoso¬ 
pher, doctor, administrator and 
educator, died Dec. 3 at New York 
Hospital in Manhattan. He was 80. 
A graduate of Princeton Univer¬ 
sity and Harvard Medical School, Dr. 
Thomas served in the U.S. Navy 
during World War II. After working at 
the Rockefeller Institute, Johns 
Hopkins, Tulane and the University of 
Minnesota, in 1966 he was appointed 
dean of the New York University 
School of Medicine. 
Dr. Thomas came to Yale in 1969 
and served as professor and chairman 
of the department of pathology, 
moving it into the modern era. Prom 
1972 to 1973 he was dean of Yale 
University School of Medicine. 
Dr. Thomas went on to become 
president and chief executive officer 
of Memorial Sloan-Kettering Cancer 
Center for seven years until 1980, 
when he was named chancellor. In 
1983, he became president emeritus. 
Although he held many administra¬ 
tive positions. Dr. Thomas always 
kept a laboratory and conducted 
experiments. 
Dr. Thomas was probably best 
known outside the medical profession 
for his lucid essays in which he 
translated the mysteries of biology for 
the general public. The essays that 
brought him renown were first written 
for The New England Journal of 
Lewis Thomas, M.D. 
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Medicine and later collected in best¬ 
selling books, including The Lives of 
a Cell and The Medusa and the Snail. 
He also was a tireless champion of 
financing for basic research, which he 
[| saw as the key to progress in medicine. 
He was awarded more than 20 honor¬ 
ary degrees, for literature and music 
as well as for his scientific work. 
He is survived by his wife, Beryl; 
three daughters, Abigail, Judith and 
Eliza; five grandchildren; and two 
great-grandchildren. 
Michael A. Puzak 
Michael A. Puzak, M.D., a Connecti¬ 
cut native, died Dec. 16 at Naples 
Community Hospital, Fla., at the age 
of 78. 
Dr. Puzak was a 1941 graduate of 
the Yale School of Medicine. Follow¬ 
ing a rotating internship in the District 
of Columbia General Hospital, he 
served a residency in urology and 
genito-urinary surgery. Dr. Puzak 
began his practice in Arlington, Va., 
in 1947 and retired in 1989. During 
that time, he was president of the 
Arlington County Medical Society 
and received the society’s Welburn 
Award for service to medicine and the 
community. In 1975, Georgetown 
University Medical School awarded 
him the Vicennial Medal for 20 years 
of devoted teaching. 
With a special interest in medical 
politics, he was a member of the 
Medical Society of Virginia, chairman 
of the Virginia council delegation to 
the American Medical Association 
(AMA), and a member of the AMA’s 
Council of Ethical and Judicial Affairs. 
Dr. Puzak, whose passion for golf 
balanced his passion for medicine, 
was an original benefactor of the Yale 
University Golf Course. 
He is survived by his wife, 
Elizabeth (Betty) Kurtz Puzak, YSN 
’41; a daughter, Gail; and a grand¬ 
daughter. Memorial contributions 
may be made to the Puzak-Kurtz 
Loan Fund for medical students of the 
Yale University School of Medicine, 
c/o Gerard N. Burrow, M.D., Dean, 
Yale University School of Medicine, 
P.O. Box 3333, New Haven, CT 
06510-8055. 
Frederick F. Boyce 
Frederick Fitzherbert Boyce, M.D., 
born in Barbados, West Indies, died 
Dec. 19. He was 90. 
A resident of New Orleans for 61 
years. Dr. Boyce was a 1930 graduate 
of Yale School of Medicine. He was 
professor of surgery at the Tulane and 
Louisiana State University medical 
schools and was senior surgeon at 
Mercy and Hotel Dieu hospitals. 
During his career, he wrote 
numerous medical books and articles. 
In 1940, the Philadelphia Academy of 
Surgery presented Dr. Boyce the S.D. 
Gross prize for surgical research for 
his book. The Role of the Liver in 
Surgery. 
Survivors include his wife, 
Thelma; a daughter, Hazel; two sons, 
Richard and Michael; and a grandchild. 
Ernest M. Izumi 
Ernest M. Izumi, M.D., of Pacific 
Grove, Calif., died Dec. 25 at his 
home. He was 75. 
Dr. Izumi was a World War II 
Army veteran. He graduated from the 
Yale School of Medicine in 1950, 
where he was an associate professor 
until 1957. He lived in Colebrook, 
Conn., for 31 years and served as 
medical examiner and a Litchfield 
County physician. 
He is survived by a daughter, 
Susan; two sons, Ronald and Ray; and 
two grandchildren. Memorial contri¬ 
butions may be sent to the Monterey 
Bay Aquarium Foundation, 886 
Cannery Row, Monterey, CA 93940. 
Morris Tager 
Morris Tager, M.D., died Jan. 10 at 
Knollwood Terrace, in Atlanta. 
Born in Riga, Latvia, he received 
a bachelor’s degree. Phi Beta Kappa, 
and in 1936 a medical degree from 
Yale University. Dr. Tager taught at 
Yale and at Western Reserve universi¬ 
ties before joining Emory University 
where he was chairman of the 
microbiology department. While at 
Emory, he also served as a member 
and chairman of the microbiology 
panel at the Office of Naval Research 
and at the microbiology and mycol¬ 
ogy study section of the National 
Institutes of Health. 
Dr. Tager was a fellow of the 
New York Academy of Science, the 
International Society of Hematology, 
the American Academy of Microbiol¬ 
ogy and the American Association for 
the Advancement of Science. 
Ralph E. Knutti 
Ralph Eddy Knutti, M.D., of Kennett 
Square, Penn., died Jan. 19 at 
Chester-Crozier Hospital in Upland, 
Penn. He was 92. 
He graduated from Yale School 
of Medicine with the Class of 1928M 
and taught pathology at the universi¬ 
ties of Rochester and Southern 
California before joining the U.S. 
Public Health Service in 1951. Dr. 
Knutti was director of the National 
Heart Institute of the National 
Institutes of Health in 1961 until he 
retired in 1965. After his retirement, 
he served as executive officer of 
Universities Associated for Research 
and Education in Pathology in 
Bethesda until 1972. 
He is survived by his wife, Sarah. 
George K. Hirst 
George Keble Hirst, M.D., of Palo Alto, 
Calif., died Jan. 22 at the age of 84. 
Born in Eau Claire, Wise., Dr. 
Hirst attended Hobart College in 
Geneva, N.Y., before receiving a 
bachelor’s degree from Yale Univer¬ 
sity, where he also received a medical 
degree in 1933. He was a member of 
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the Rockefeller Foundation’s Interna¬ 
tional Health Division studying 
influenza, including its prevention by 
vaccination. He found that red blood 
cells clump together when mixed with 
influenza viruses, leading him to 
develop the hemagglutination assay. 
Dr. Hirst was elected to the 
National Academy of Sciences and 
the American Academy of Arts and 
Sciences. From 1956 to 1980 he was 
director of the Public Health Research 
Institute in New York City. 
He leaves a daughter, Margaret; 
four sons, Robert, John. James and 
Thomas; and 11 grandchildren. 
Memorial contributions may be 
made to Lifeline, Hospital of St. 
Raphael, 1450 Chapel St., New 
Haven. CT 06511. 
Paul L. Saffo 
Paul L. Saffo, M.D., died Feb. 28 at 
his home in Rolling Hills, Calif. He 
was 88. 
Born in Bridgeport, Conn., Dr. 
Saffo graduated in 1933 from the Yale 
School of Medicine and received a 
fellowship from the Institute of 
International Education to study 
surgery at the Jirasek Clinic of 
Charles University in Prague, 
Czechoslovakia. 
During his medical career Dr. 
Saffo served as chief of staff and 
member of the board of trustees of the 
Robert F. Kennedy Medical Center in 
Hawthorne, Calif, and in 1964, he 
was appointed as the first Director 
Emeritus of the center. 
He also chaired the Southern 
California Yale Medical Alumni 
group and served on their board and 
scholarship committee. 
He is survived by his wife, Joan; 
a son. Paul; a daughter. Mary Beth; 
and a grandson. 
Fred M. Haddad 
Fred M. Haddad, M.D., M.P.H.. died 
Jan. 29 at Griffin Hospital in Derby, 
Conn., at the age of 76. 
A native of Connecticut, Dr. 
Haddad graduated in 1943 from the 
Yale School of Medicine and 
received a master’s degree in public 
health in 1957. He practiced for 50 
In Memoriam 
He leaves his wife, Maisie; a 
daughter, Nance; three sons, Fred, 
Louis K. Alpert 
October 29, 1993 
M.D. ’32 John A. Knapp 
December 5, 1993 
M.D. ’45 
Robert and Kenneth; and 11 grand¬ 
children. Roy N. Barnett M.D. ’38 R. Harold Lockhart M.D. ’28 
December 3, 1993 March 22, 1993 
Jean Hippolitus Celentano 
Joseph P. Carson 
August 17, 1992 
M.D. '41 Omieri Mitoko 
August 8, 1993 
M.D. ’73 
Jean Hippolitus, M.D.. who retired 
from the New Haven Health Depart¬ Edgar S. Childs M.D. ’35 Robert H. Ostberg M.D. ’59 
ment, died Feb. 5 at Laurel Woods October 15, 1992 December 9, 1992 
Health Care Center, in East Haven, 
Conn. She was 95. Jay B. Cohn M.D. ’45 John Curtis Parker M.D. ’61 
Dr. Hippolitus was the first November 29, 1993 November 22, 1993 
Italian-American woman admitted 
to the Yale University School of Benjamin F. Hoopes M.D. ’37 Majic S. Potsaid M.D. ’51 
Medicine and one of only four 
women to graduate with a medical 
August 24, 1993 January 13, 1994 
degree in the Class of 1925. She Sheldon A. Jacobson M.D. ’28 Michael A. Puzak Med. ’42 
was an obstetrics and pediatrics 
resident at St. Francis Hospital in 
May 23, 1992 December 16, 1993 
San Francisco before she embarked Martha P. Jayne M.P.H. ’50 Louis E. Young Jr. M.D. ’47 
on a 30-year career with the New October 27, 1993 April 21, 1991 
Haven Health Department. She also 
served as physician to Albertus Katharine A. Keppel M.P.H. ’60 Robert Zeppa M.D. ’52 
Magnus College and the YWCA. November 5, 1993 September 2, 1993 
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Development Report 
Yale Alumni Fund Board Member 
Issues 25th Reunion Challenge to Classmates 
It is never too early “to begin plan¬ 
ning for the future.” Doctors give 
this advice to their patients every day, 
and Alumni Fund board member M. 
Felix Freshwater, M.D. ’72 is using 
this important motto to challenge his 
classmates to raise money to endow a 
class scholarship to mark their 25th 
reunion in 1997. 
M. Felix Freshwater, M.D. 
A hand surgeon who lives and 
practices in Miami, Dr. Freshwater 
has pledged $125,000 to launch the 
class effort in anticipation of its 25th 
reunion. 
Like so many alumni/ae. Dr. 
Freshwater is grateful for the oppor¬ 
tunity that he had to attend Yale. He 
believes that enrolling the best and 
the brightest students requires a 
continuing and strong commitment to 
financial aid. “Recently, I heard that 
the school’s endowment ranks 16th 
among the country’s medical 
schools,” says Dr. Freshwater. “We 
must do better.” 
A drive of this kind is unprec¬ 
edented in reunion giving at Yale 
School of Medicine. Gerard N. 
Burrow, M.D. ’58, dean, remarks, 
“The importance of scholarship 
assistance for our future generations 
of physicians and scientists cannot be 
overemphasized.” 
1959 Graduate Sets Up 
Trust to Honor Her Father 
Lisa A. Steiner, M.D. ’59 has estab¬ 
lished a charitable remainder trust to 
fund scholarships at Yale University 
School of Medicine and Swarthmore 
College, her undergraduate alma 
mater. For the remainder of her life. 
Dr. Steiner will derive income from 
the trust. When the trust terminates, 
upon her death, the principal will be 
divided between the two educational 
institutions. 
At Yale School of Medicine, the 
assets of the trust will be used to 
create the Herman Steiner Endowed 
Scholarship, named in honor of Dr. 
Steiner’s late father. 
In appreciation of Dr. Steiner’s 
support, Gerard N. Burrow, M.D. ’58, 
dean, has written, “You are ensuring 
that the Yale University School of 
Medicine will continue to underwrite 
the education of future generations of 
young physicians. Because of the 
splendid foundation with which you 
are providing Yale University, I am 
assured that this school will retain, 
and even further advance, its position 
of leadership.” 
Dr. Steiner was 5-years-old when, 
together with her parents and brother, 
she left her birthplace in Vienna, 
Austria, after the Nazi “Anschluss.” 
Although establishing life in a new 
country was not easy, her parents 
were “extremely supportive and 
encouraged me to obtain the best 
education possible and to embark on 
a career,” she says. 
Dr. Steiner received scholarships 
that enabled her to attend Swarthmore 
and then Yale medical school. Be¬ 
cause of her deep sense of indebted¬ 
ness to these schools for their gener¬ 
ous support. Dr. Steiner notes that she 
has established the trust “so other 
students can benefit from the same 
wonderful educational opportunities I 
experienced.” 
After medical school. Dr. Steiner 
remained at Yale for an internship in 
internal medicine and residency 
training in dermatology. She recalled 
that there were very few women 
either at the medical school or on the 
house staff in those days. She then 
conducted post-doctoral work in 
immunology and, since 1967, has 
been a faculty member in the depart¬ 
ment of biology at Massachusetts 
Institute of Technology (MIT). In 
addition to teaching and research, she 
heads MIT’s pre-medical advisory 
committee. 









New Development Director Appointed 
For Medical School and Yale-New Haven Hospital 
Robert Feldman, vice president for 
development and alumni relations at 
Hahnemann University, has returned 
to New Haven to serve as director of 
development at the School of Medi¬ 
cine and Yale-New Haven Hospital 
(YNHH). 
Mr. Feldman, a New York City 
native who received a bachelor’s 
degree in 1960 and a law degree in 
1963 from Yale University, previously 
served as deputy director of The 
Campaign for Yale University and 
director of leadership gifts from 1977 
to 1979. 
After working as executive 
director of the Columbia- 
Presbyterian Medical Center Fund 
Inc., he joined Boston University as 
vice president for development, a post 
he held from 1981 to 1991. 
During his career, Mr. Feldman 
also has gained experience in diverse 
employment situations, ranging from 
income tax consulting and tax 
preparation to urban renewal project 
analysis. 
Mr. Feldman’s appointment, 
effective this spring, was announced 
by Gerard N. Burrow, M.D., dean, 
and Joseph A. Zaccagnino, YNHH 
president and chief executive officer. 
Comments Dr. Burrow, “We are 
pleased that Bob Feldman has agreed 
to direct our expanded development 
efforts. His experience and dedication 
will be invaluable at this crucial time 
for the School of Medicine. As 
research funding and clinical income 
become more tenuous, the need for 
support from philanthropy becomes 
increasingly important.” 
Mr. Zaccagnino states, “Bob 
Feldman’s appointment should 
assure the hospital's continued strong 
performance in philanthropy, 
following our successful Building for 
Health Campaign. His joint assign¬ 
ment is an excellent example of the 
symbiotic relationship between the 
hospital and the medical school.” 
While at Hahnemann, Mr. 
Feldman was instrumental in obtain¬ 
ing philanthropic support for minority 
medical student education, in gaining 
funds for medical students who 
provided health care at shelters for 
homeless people, and in instituting 
new fund-raising programs. 
In New Haven, Mr. Feldman will 
direct efforts to meet the medical 
school’s $285 million goal, part of the 
$1.5 billion capital campaign “...and 
for Yale.” Campaign funds will 
support important school needs, 
including improvements to campus 
facilities, endowments for faculty and 
for financial aid, and programmatic 
priorities. 
At Yale-New Haven Hospital, he 
also will help bring the Building for 
Health Campaign to its conclusion. 































































































































EDUCATION AT YALE 
Tuesday-Saturday 
August 2-6,1994 
Reverence for Life: Albert Schweitzer and Global Health from (A) 
Lambarene to The 21st Century 
Course Director: Howard Spiro, M.D. 
The Shubert Performing Arts Center, New Haven, CT 
Friday 
August 19,1994 
Annual Yale Sports Medicine Seminar (B) 
Course Director: Peter JokI, M.D. 
Yale University School of Medicine, New Haven, CT 
Jane Ellen Hope Building, Room 110 
Wednesday-Thursday 
September 28-29,1994 
Child Abuse Conference (C) 
Course Director: John Leventhal, M.D. 




2nd Annual Burn Camp Workshop (D) 
Course Director: Jeff Heinrich, P.A., Ecl.D. 
Mt. Washington, MA 
Thursday 
October 13,1994 
Ophthalmology Alumni Meeting (E) 
Course Director: Richard Casden, M.D. 
Old Saybrook Pointe Inn 
Old Saybrook, CT 
Wednesday 
October 26,1994 
6th Annual Cardiology Update (F) 
Course Director: Lawrence S. Cohen, M.D. 
Yale University School of Medicine, New Haven, CT 
Brady Auditorium 
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Alumni Bulletin of the School of Medicine Summer 1994; Volume 28, Number. 
A Student’s Second Year 
The year began with a vow and commitment to discipline. By the time Mary Kathlta 
Figaro finished her second year, she felt almost ready for life on the wards. 
New Ideas, Old Tradition 
Student Research Day is a well-established tradition at Yale, where medical students 
have been required to complete a thesis since 1839. Among those in the audience to 
hear the five outstanding theses was Nobel Prize-winner Joseph A. Goldstein, M.D. 
Down to Basics 
The tools of molecular biology are providing unprecedented 
glimpses into the workings of the human vascular system. 
Yale scientists at the Boyer Center for Molecular Medicine 
are among the first to see this unknown world. 
19 
33 
Heart of the Matter 
Cardiologists have made major strides in the last few decades, adding vigorously to their 
repertoire of strategies to fight heart disease. Now, as modern biology provides more 
powerful and specific tools, even greater advances are likely. 
The Modern Way of Dying 
It seems that death — or at least a preoccupation with life’s final hours — 
is everywhere. The voices of Yale physicians are clearly heard in this discussion. 
Also: How medical students here learn about death and dying. 
1 Letters 51 Faculty News 59 Alumni News 
41 Physicians as Authors 53 Student News 61 Obituaries 
43 Commencement 54 Residency Placements 63 In Memoriam 
47 Gallery 57 New Books 64 Development Report 
48 Scope 58 Alumni Report 65 Continuing Education 
On the cover: Edouard Daher, M.D., a postdoctoral fellow in nuclear cardiology, runs a stress test on patient John Thompson 
in the cardiovascular medicine exercise laboratory. (Photograph by Don Cousey) 
Dr. Michael Kashgarian, professor of pathology and biology, is editor of 
Yale Medicine. The tri-annual magazine is designed and produced by the Yale 
University School of Medicine Office of Public Information: Helaine Patterson, 
director; Michael Fitzsousa, publications editor; Rosalind D’Eugenio, media 
specialist; Claire M. Bessinger, office manager, editorial assistant; and Cheryl R. 
Violante, senior administrative assistant. JfX. 
Please recycle 
Yale Medicine is distributed to members of the Association of Yale Alumni i 
Medicine and faculty, students and friends of the School of Medicine. Commun 
cations may be addressed to Dr. Michael Kashgarian, editor, c/o the Office of Publi 
Information. P.O. Box 7612, New Haven, CT 06519-0612. (203) 785-5824 
Printing by E.H. Roberts Co. 
















Z — <NI |J 








































































More About Career 
of Former Dean 
To the editor: 
Your spring issue was, as always, 
most interesting. I talked to Dr. Arthur 
Ebbert about his letter on Stanhope 
Bayne-Jones, M.D., on Page 1. It is 
interesting to note that Dr. Bayne- 
Jones was co-editor of an outstanding 
textbook of bacteriology with Hans 
Zinsser of Harvard that was used by 
all Yale medical students and in most 
other medical schools. During Dr. 
Bayne-Jones’ career, the science was 
called bacteriology. I do not know 
when the name was changed to 
microbiology, but possibly in the late 
1950s or 1960s. 
Regarding the feature on the 
, second-year show, I graduated 51 
years ago and do not recall any 
second-year shows — especially 
during the war years 1941 through 
' 1945. I have been in New Haven 
since 1946 and think the second-year 
shows began around 1950. My 
T E R S 
memory is quite poor, however, but I 
know there were none between 1939 
and 1947. 
Dorothea R. Peck, M.D. ’43 March 
Associate clinical professor 
of diagnostic radiology 
Yale School of Medicine 
‘Induced Dementia’ 
Strikes a Chord 
To the editor: 
Dean Gifford’s poem in the 
spring issue of Yale Medicine 
reminds me of my first day in medical 
school. Dr. Thomas Forbes, the 
assistant dean, introduced himself, 
and greeted us with the following: 
Question: What is the definition 
of an assistant dean? 
Answer: A mouse, studying to 
be a rat. 
Times haven’t changed. 
Robert N. Melnick, M.D. '53 
Larchmont, N.Y. 
Ornamental grill work greets visitors to the Sterling Hall of Medicine. 
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Mary Kathleen Figaro rides the Yale shuttle the day after taking her National Board Examinations in June. 






by Mary Kathleen Figaro, 
Class of '96 
I sat near the front of the Yale 
shuttle bus, gazing out a grimy 
window onto a gray winter landscape. 
Sooty mounds of snow rose here and 
there from the pavement and a 
crimson sky stretched up over the 
horizon behind a few patchy clouds. 
As the shuttle lurched forward toward 
Science Park gate, I closed my eyes 
and daydreamed, using my energy to 
return to memories of the warm, 
Christmas vacation in Florida that had 
just ended. Only five months re¬ 
mained until the National Board 
Examinations at the end of my second 
year of medical school, and there 
would be no more vacations. I sighed. 
I had never traveled to a sunny 
place during winter break before, so I 
was not prepared for the intense 
disappointment I felt as I hurried in 
the harsh New Haven wind of early 
January. As I settled into my warm 
apartment, I considered another drastic 
adjustment that loomed ahead: After 
the boards, I would be forced to emerge 
from the measured, solitary life of the 
first two years of medical school and 
enter the hectic and collegial environ¬ 
ment of hospital wards. I wondered, 
with some apprehension, whether I 
could gain enough clinical skill, 
social grace, discipline (or even an 
appropriate wardrobe) for the abrupt 
transformation my classmates and I 
would soon have to make. 
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Throughout adolescence, when 
my future seemed only a prayer that 
my parents and I whispered to God, I 
spent hours refining my grand ideas 
about being a successful adult. In the 
midst of the real work required to 
achieve my life’s goal, I knew that 
only two traits were required to 
achieve those adolescent dreams: 
discipline and tenacity. In September, 
invigorated by the importance of my 
second year, I spent time pondering 
my faults and strengths and asking 
God to direct me as I discovered the 
kind of physician I should become. 
Medical school gives students 
little time to ponder, or even to read 
much apart from the volumes of 
lecture notes, articles and other 
handouts. After a few weeks of 
reading pamphlets on medical 
specialties and arriving at no final 
decision, I succumbed to an attitude 
of acceptance, both of the person I am 
and of the physician I will eventually 
become. After all, I believe that only 
God knows what I can and should 
accomplish with my life. My primary 
responsibility, I reason, is to make the 
most of my present opportunities by 
acquiring discipline. 
We started the second year with a 
new curriculum designed to integrate 
pathology, microbiology, laboratory 
medicine and pathophysiology into 
modules or body systems. While each 
course had its own syllabus, it was 
introduced as it became relevant to the 
hematologic or other system being 
discussed. Pharmacology proved 
harder to integrate and remained much 
more separate. Although the new Yale 
curriculum is the only one I have been 
exposed to, it makes good sense to me. 
It was easier to learn facts and under¬ 
stand them in this integrated fashion 
than it would have been had they been 
separated by time and context. 
Second year is a time to adjust to 
a new world. By next year, I will 
assume responsibility to others as 
well as to myself. The wards will take 
me onto a stage where I will begin 
performing for both the attending 
physicians and patients. Instead of 
remaining on the periphery while 
others interact as I have during my 
first two years, I will become an 
acknowledged actor on the scene. 
This requires me to assume a role. 
Now I need to learn the essentials; 
slowly, I will master them. 
First Things First 
The most exciting of the essen¬ 
tials we learn in our second year is 
taught in our clinical examination 
course, which was also the best- 
attended class at the beginning of the 
semester. The afternoon of the first 
lecture, students streamed into Hope 
216, by now a familiar place. Some I 
had not seen for months; others were 
dressed in ties and starched white 
shirts or in heels, ready for this new 
experience. A few, unsure of what to 
expect, wore their short, white coats 
and fresh haircuts. 
Our role was still that of an 
audience. We watched, excited and 
amused, as a skilled pediatrician 
examined an infant and discussed the 
developmental milestones of a 
growing child. I began to understand 
the goal of this course: to assure that 
we were prepared to perform each 
task related to the examination and 
interview of the patient. 
A few weeks later, we met our 
gynecological teaching assistants and 
were introduced to the examination of 
the female pelvis. A physician began 
the morning’s lectures by explaining 
the need for extreme sensitivity and 
professional conduct. We were, he 
said, to recognize the delicacy of the 
patient’s situation and always to 
consider her comfort and dignity. We 
had already been given a similar 
lecture by Dr. Alvan Feinstein so I 
wondered about the reason for this 
repetition. I soon found out. 
The first speaker, one of dozens 
of clinical lecturers we meet in the 
course of our education, began by 
discussing the normal female 
anatomy, the relationship between 
organs, nerves and vessels, and the 
means of examining each of the 
primary spaces in the genital area. 
His attitude was aloof and his dis¬ 
tance from patients was reflected 
even in his slides, which were 
exclusively of the genital area. His 
words showed little consideration of 
the patient as a person, in my opinion. 
This started to disturb me and I 
noticed others near me shifting 
uncomfortably in their seats. 
Eight years ago, one of the 
teaching assistants had said, Yale 
medical students had decided that 
they wanted a formal course on pelvic 
examination. They no longer wanted 
to examine patients under anesthesia 
because they felt this was inappropri¬ 
ate, undignified and inadequate 
training. The lecturer dissented. 
“How else would you be able to 
stretch the muscle to its fullest 
length?” he asked. Never mind, I 
thought, that most patients one 
examines are not anesthetized but are 
alert and require consideration. 
Later, as I thought about that 
lecture, I realized that as medical 
professionals we are all susceptible to 
this type of conduct; we all probe, 
examine, palpate and auscultate until 
we can mistake the patient’s body 
for a machine, a wondrous and 
miraculous one, but a machine, 
nonetheless. Only our sense of 
professional discipline as caregivers, 
even when we abhor the tasks we 
perform, protects us from this 
cynical view of patients. 
Editor’s note 
This is the second in a series of 
articles that Mary Kathleen 
Figaro is writing for Yale 
Medicine as she progresses 
through medical school. The 
series will document her 
impressions and changing 
perceptions about her education 
and training as a medical 
student and resident physician. 
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I have been assured by third-year 
students that he will not be the last 
doctor I see who offends those around 
him. This, like the other changes that 
accompany going on the wards, 
worries me. I am about to enter a 
macho world of over-stressed and 
overworked residents and physicians, 
where third-year medical students are 
sometimes referred to as grunts. 
Encountering Real Patients 
For the most part, my experiences 
at Yale-New Haven Hospital have 
been positive. In my first year, I had 
the opportunity to interact with a 
cancer patient, Noel, who taught me 
much about suffering and faith. This 
year, I was paired with a pregnant 
woman in the Women's Center at the 
medical school, as part of the prenatal 
care program. The clinical tutorial 
sessions, which began last year, 
continue to be my most interesting 
visits to the hospital. 
The clinical tutorial is considered 
essential enough to have been estab¬ 
lished as a part of our curriculum 
since the beginning of our first 
semester. Few things are required at 
Yale, and even this tutorial is not 
attended by all students. In effect, we 
were placed under the apprenticeship 
of an attending physician in groups of 
about five. Our group has since met 
each week or two to observe our 
physician in his hospital work, to 
learn some of the technical terms and 
procedures associated with his 
specialty and to absorb some prelimi¬ 
nary clinical judgment and skill. 
Our tutor, Sandip K. Mukherjee, 
M.D., is a competent and enthusiastic 
post-doctoral fellow in cardiology 
who enjoys teaching. We are so 
impressed with his patience, disci¬ 
pline and skill that we have been 
known to sing his praises at the end of 
our sessions. “We are so lucky,” we 
whisper as we leave the hospital, 
showing a contentment similar to that 
of accepted and well-loved children. 
As we near the end of our second 
We are encouraged 
to play the part 
of physicians, 
yet we are 
constantly reminded 
of our limited 
knowledge and the 
need to move 
beyond reading 
to petforming. 
year, our group’s meetings have taken 
on the urgency of rehearsals for the 
real performance. We are all acutely 
aware that our time as dabblers is 
ending. Like anxious debutantes, we 
wring our hands, hoping that our 
dress, our speech and our demeanor 
will be perfectly correct. We are 
encouraged to play the part of 
physicians, yet we are constantly 
reminded of our limited knowledge 
and the need to move beyond reading 
to performing. What one learns from 
a physical examination book, I have 
learned, can be different from what 
one sees in the hospital. 
For instance, my first attempt at 
taking a patient history during a 
clinical tutorial was a disaster. I had 
in mind the important questions to ask 
and the proper order in which to ask 
them. The patient, who clearly had 
not read my clinical physical exami¬ 
nation textbook, insisted on discuss¬ 
ing other bouts of illness, unrelated 
diagnoses and his work habits while 
he demurred on important issues such 
as the handcuffs that secured him to 
the bed and the guard who sat nearby. 
If I had begun as the director of the 
scene, I quickly lost control. He 
dominated the discussion, relegating 
me to the part of his comic foil. Dr. 
Mukherjee stood by silently, allowing 
me to continue the interview. 
After asking questions for nearly 
45 minutes, attempting to remember 
his answers without notes, and 
occasionally looking at Dr. 
Mukherjee for help, I was no closer to 
discovering the etiology of his chief 
complaint and had missed the essen¬ 
tial question I needed to ask him. By 
this time 1 was mentally fatigued and 
in no shape for the battle it would 
take to extract real answers from him. 
I eventually surrendered. 
Our group then met in the lounge 
to discuss the case. As usual. Dr. 
Mukherjee began with encouraging 
statements, showed us the patient's 
chart and outlined how I could have 
better focused the interview by 
disciplining myself to ask all the 
relevant questions. 
It is this sort of encounter that 
humbles me and causes me to wonder 
at the possibility of being an intern in 
two and a half years. I watch the 
residents at the Women’s Center — 
their smooth and confident gait, their 
ease with the patients, their graceful 
entrances — and I can only marvel at 
the miracle and mystery that produce 
this metamorphosis. I presume that 
they know the patient's vital statistics, 
have performed differential diag¬ 
noses and have technical expertise, 
but it is their fluid and masterful 
performance that I envy. If I am to 
become like them, I must learn to 
become not only competent and 
disciplined but a caregiver. 
Becoming a Caregiver 
1 had the opportunity to become 
involved with a student-run program 
that matches a patient from the 
Women’s Center or other clinic with a 
medical student who acts much like a 
concerned family member, a confi¬ 
dante and a consistent presence 
throughout the pregnancy and 
delivery. Medical students are 
responsible to the patient and are to 
be present at each appointment in 
order to ask doctors pertinent ques¬ 
tions that will help the patient under¬ 
stand all aspects of her care. 
My sense of the commitment 
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involved was twofold. It was my 
effort to learn about a young woman’s 
experience with the medical estab¬ 
lishment. It was also a way of becom¬ 
ing responsible to a patient, learning 
some aspects of primary care, and 
beginning to practice the art of care¬ 
giving. But I did not begin to under¬ 
stand the exact meaning of that term 
until this experience. It taught me not 
only about the meaning of care-giving 
but also about the limits of this 
special relationship. 
I had not expected Sandy to be 
22, just a year younger than me. 
Somehow I had anticipated ex¬ 
tremes, either a 14-year-old girl or 
an older woman with two children. 
When a nurse brought me into the 
examining room to meet Sandy, I 
stared into her blue eyes and at the 
bright red of her lipstick. I was a bit 
startled. She dressed like many of 
the teen-agers I saw walking in New 
Haven, but she had large, serious 
eyes that suggested she had experi¬ 
enced a great deal in life. 
A third-year friend had warned 
me not to become over-friendly with 
my patient. Since I had little technical 
skill and served as a liaison, it was 
possible to become so close to this 
young woman that she would regard 
me simply as a peer. But our close¬ 
ness in age attuned me to similarities, 
not differences. With mutual hesi- 
tance, we greeted each other and thus 
began a four-month relationship. 
As I got to know Sandy better, I 
learned that she had experienced 
many tragedies, including the loss of 
four of her friends to violent death in 
the past two years. Like many young 
people, she countered adversity with 
her hopes for the future. I may never 
know whether she becomes a parole 
officer or a nurse, as she said she 
might. I wonder how she can over¬ 
come the difficulties of having a 
child, little money and very little 
support in such a violent environ¬ 
ment. I do not know how much 
strength she has nor whether she 
possesses the discipline to succeed. 
She does seem to exhibit a balance 
between resignation, calm and 
control. I noticed this especially when 
she spoke of the baby’s father, who 
had not yet recognized the child as his 
own and who had ended their rela¬ 
tionship after her pregnancy. She 
could not make him “come to his 
senses,” she said. She instead cajoled 
him through a series of notes and 
messages to contact her and to take 
responsibility for his child. 
In one of our conversations, I 
asked Sandy about New Haven life 
and found that she believes half of its 
residents are involved with drugs, 
either as users or sellers. She did not 
state this judgmentally but with a kind 
of resigned acceptance. She has a 
pragmatic view of the city’s judicial, 
child-support and law-enforcement 
systems that comes from her family’s 
experiences. While I may disagree 
with her estimate of the proportion of 
the city involved with drugs, I’ve 
heard people say that the drug trade's 
yearly profits are equal to the city’s 
budget. It reminded me of the tremen¬ 
dous obstacles the New Haven 
seventh-graders I taught in Yale’s 
Adolescence Substance Abuse Preven¬ 
tion program these past two years will 
have to face as they grow up. 
Although I came to know Sandy 
very well, we did not become friends. 
She understood me, trusted me to be 
at her medical appointments, and 
introduced me to her mother as “the 
medical student.” Even with my 
Mary Kathleen Figaro 
stands on the balcony 
of Harkness auditorium 
during a break from the 
two-day National 
Board Examinations in 
early June. 
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A really big second-year show: MB 
limited skills, my title had separated 
me from her while it gave her confi¬ 
dence about my role in her life. 1 was 
relieved because I saw as well as she 
did that she would hold all the 
responsibility after her delivery and 
that our relationship was temporary. 
I was gaining an essential lesson 
about the discipline of being a 
medical professional. Whether I 
choose to subspecialize and see 
patients acutely or whether I become 
a long-term, primary caregiver, I will 
never get beyond a certain familiarity 
with my patients. And this familiarity 
will only be pertinent inasmuch as it 
allows me to take good care of them. 
In fact, the doctor-patient rela¬ 
tionship now seems to me to be a 
choreographed performance in which 
each plays a part. Gaining discipline 
over my attitudes about patients, 
learning to give care whether I like a 
patient or not, and bridging the social 
and economic gaps that separate us 
seem to be the subtext to the lessons I 
will learn about clinical judgment and 
skill. Yet there is room for empathy 
and understanding within the doctor- 
patient relationship. 
Last year, I was still focused on 
the romantic aspects of patients. I 
envisioned them as either saintly or 
devilish and as books to be opened and 
read. I have not entirely shed my naive 
opinions. But at least I understand 
that these exist only because I have 
not met many real patients. While 
patients are indeed books to be read, 
they are not novels but textbooks. 
A gulf exists even between a 
well-meaning physician and her 
patients. As one lecturer put it, 
"Patients are not your friends and 
medicine is just a profession. At the 
end of the day, it will be your family 
and your friends who will support you 
and hold you up.” I was encouraged 
to hear these wise words because if I 
expect too much of patients, I will be 
sorely disappointed. Sandy taught me 
to expect respect and trust but not 
friendship. I still display my picture 
of her newborn daughter and me on 
my bulletin board, though. It shows 
my proud, smiling face holding a 
baby I may never see again. 
A Clear Path 
These days I spend my time at 
home, studying for the boards. I am 
not worried though; I have been 
studying and I know that the path I 
am on was not only chosen by me but 
for me. My future is held up to God 
each night by my aging grandfather. 
He waits patiently until the day I 
become the first physician in the 
family. And when he talks to me, he 
reminds me to look to “the Great 
Physician” who heals our every 
wound. My mother comes to visit me 
and gives me food she has prepared. 
The journey is more than my own. YM 
My relationship with Sandy — 
like many doctor-patient relationships 
— was a series of brief, intense 
encounters fated to end. Our second- 
year show was similar. Signs went up 
at the front blackboard of the lecture 
hall months before the show an¬ 
nouncing the countdown, “68 Days 
until the Show...” When that failed to 
elicit the appropriate enthusiasm from 
our class, announcements were made 
daily asking that all those with talent 
and ability meet to discuss the show. 
All the while, I was wondering 
how to avoid becoming a part of the 
show. Not that I do not enjoy per¬ 
forming; I am an incurable ham on 
stage and I studied voice for many 
years. I just did not know how I 
would become part of a group of 
students I felt I hardly knew after two 
years. I was uncertain about being a 
part of the big, second-year show that 
had become such a tradition at Yale. 
Rehearsals were disorganized. 
Students waited all night to perform 
a half-hour’s worth of scenes and in 
revenge, cast members showed up 
late or not at all. What I did not 
fully realize was that, behind the 
scenes, people were working and 
setting up, getting a lot done regard¬ 
less of the delays. 
The show, a satire of music 
videos called MDTV, was mediocre 
until the last week of rehearsals. 
Then, like a miracle, MDTV came 
together. Videos we had not yet seen 
materialized and were spectacular. 
Several classmates installed and 
controlled the lights and sound system 
with great skill. The stage — built in 
one weekend and painted the week of 
the show — was magnificent in its 
simplicity and functionality. The 
band assembled and played very well. 
6 Yale Medicine Summer 1994 
Are You Ready for 
a Miracle Drug? 
Mary Kathleen Figaro 
sings Are You Ready for 
a Miracle Drug during the 
second-year show, MDTV. 
Ms. Figaro studied voice 
as an undergraduate at 
Princeton University, 
where she majored in 
French literature and 
civilization, and 
performed with the 
Katzenjammers, the 
Princeton Chapel Choir 
and as a soloist. 
its Harkness 
I was impressed with my class¬ 
mates. Many had amazing talent in 
areas that bore no relationship to 
medicine and possessed technical 
skills for which they could be highly 
paid in the real world. And we were 
all brought closer to one another. 
During this brief and memorable 
encounter, we all began to appreciate 
one another as humans and not just as 
fellow students. 
In the end, we performed MDTV 
twice. After two full rehearsals in 
which everything was done chrono¬ 
logically and in a timely fashion, it 
was opening night. Many profession¬ 
als would have been afraid to perform 
after so few real rehearsals, but for 
the most part we pulled it off, and the 
show was done well. Those two 
nights were another example of how 
life really is lived. There are few 
encores and few second chances. 
It is impossible not to be disap¬ 
pointed after the show since the only 
thing to look forward to — if one 
can actually say such a thing — is 
the finale of the boards. After 
watching the video of MDTV, I 
realized we were not quite as good 
as I had imagined. I had been 
carried away by the camaraderie and 
the fun involved with the show, and 
having had such low expectations, I 
could only be impressed by the 
outcome. 
Though the audience enjoyed 
the video, watching it was difficult 
because the missteps were obvious. 
If we were able to view our lives like 
this, would we? I, for one, would 
not dare to. After the big show, we 
returned to our favorite friends and 
to our cliques, but for a brief mo¬ 
ment, we were together. 
From The Pharmacological 
Hour of Power segment of 
MDTV, the second-year show. 
Lyrics: Janel Hackney and Jack Maypole 
Soloist: Mary Kathleen Figaro 
Chorus: Are you ready for a 
miracle drug? 
Ready as I can be! 
Are you ready for a 
miracle drug? 
Lilly will set your free! 
Are you ready? Ready! 
Are you ready? Ready! 
Are you ready? Ready! 
Are you ready? 
Are you ready, are you ready 
for a miracle drug? 
Soloist: Amenocil’s the drug 
you need, the only one 
to find. 
Raise the terminal from the 
dead, restore sight 
to the blind. 
It’s good for all resistant strep 
and will make your hair 
grow, too. 
You’ll lose 10 pounds'within 
the week and your teeth’ll 
look like new. 
Repeat chorus 
Amenocil’s the one you need 
to thwart the devil’s plan. 
Its half-life lasts the longest 
day, absorbs at your 
command. 
No contraindications here, 
take it with what you choose. 
And blessed be those who 
comply, for they shall 
see the truth. 
Repeat chorus 
Blessed be those who are sick, 
for they shall all be cured. 
Blessed be those who 
prescribe, for they shall 
make a mint. 
Blessed be the wheelchair 
bound, for they shall 
all be free. 
And blessed be the miracle 
that’s great for you and me. 
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Student 
Research Day 
Yale's tradition of the student thesis 
brings Nobel Prize-winner, wealth of ideas 
to medical school ceremony 
It was the day that the Class of 
1994 had been anticipating for nearly 
four years: not commencement, but a 
Monday afternoon three weeks 
earlier when the results of their thesis 
work were scrutinized by their 
classmates, faculty and visitors. 
Yale has required a thesis of 
its medical students for 155 
years. This year, the topics 
ranged from Treatment of Full- 
Thickness Retinal Holes with 
Autologous Serum in an Experi¬ 
mental Model to Cocaine: Media 
Coverage and Medical Opinion. 
Posters explaining the research 
projects and their conclusions 
lined the halls of the Jane Ellen 
Hope Building’s first floor. 
Nobel Prize-winner Joseph 
Goldstein, M.D., delivered the 
seventh annual Lee E. Farr, M.D., 
Lecture, titled How to Solve a 
Scientific Problem: Clues from 
Stockholm and Broadway. Dr. 
Goldstein shared the 1985 Nobel 
Prize in physiology for the discovery 
of the LDL receptor and its implica¬ 
tions for cholesterol regulation. 
The day culminated with the 
presentaion of five outstanding 
theses, delivered under the watchful 
eye — and timeclock — of John N. 
Forrest Jr, M.D., director of 
student research and professor of 
medicine. Following are Dr. 
Forrest’s remarks on the occasion: 
In the midst of national attention 
on the crisis of health care we 
celebrate the research accomplishments 
of Yale medical school students. The 
scientific quality and vigor of the 
medical student research you have 
just seen in 52 posters and in the 
prize-winning oral presentations is a 
testament to the creative accomplish¬ 
ments of Yale medical students and 
graduates to improve the health of our 
nation by outstanding individual basic 
and clinical research in the biological 
sciences. The 52 posters set a new 
record for participation in this event 
by Yale medical students and we 
congratulate the Class of 1994 for 
their research effort and productivity. 
Many of you came to this medical 
school with little experience in 
research and with the anxiety of 
learning a great deal of our existing 
medical knowledge. But by your 
research accomplishments, which go 
far beyond the minimal requirements 
of the traditional Yale thesis, you are 
contributing important new knowl¬ 
edge that will improve the health of 
our nation and begin, we hope, a 
lifelong practice of contributing new 
information to medicine. 
As the posters vividly display, the 
research done by Yale medical 
students is a national resource. As 
you go through residency training we 
hope that thesis and research experi¬ 
ence that you have had here will 
Above: Posters describing the thesis 
work of fourth-year medical students 
line the halls of the Jane Ellen Hope 
Building on Student Research Day 
on May 9. 
Right: Victoria L. Holloway tells Farr 
lecturer Joseph L. Goldstein, M.D., 
about her thesis, a study of delinquent 
children. With them is Vincent T. 
Marchesi, M.D., Ph.D., director of the 
Boyer Center for Molecular Medicine. 
encourage you to a lifelong commit¬ 
ment to contribute to new knowledge. 
Five outstanding presentations of 
prize-winning theses will be pre¬ 
sented from the platform. I want to 
tell you that if we had taken the next 
five highest ranked papers of theses 
recommended for honors the program 
would have been of similar outstand¬ 
ing quality. These presentations are 
truly representative of all of the 
outstanding accomplishments by 
members of the Class of 1994. 
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Anuj Gupta explains his thesis topic, 
Fluoroscopic Evaluation of the Scaphoid Shift 
Test, to Robert H. Gifford, M.D., associate 
dean for education and student affairs. 






Peter S. Aronson, M.D. 
Emile L. Boulpaep, M.D. 
Dennis L. Cooper, M.D. 
Anne McB. Curtis, M.D. 
John N. Forrest Jr., M.D. (chair) 
Robert H. Gifford, M.D. 
James D. Jamieson, M.D. 
Barry Kacinski, M.D. 
M. Stephen Meyn, M.D. 
I. George Miller Jr., M.D. 
Irvin M. Modlin, M.D. 
Andrew Stewart, M.D. 
Coralie Shaw, M.D. 
Frederick J. Suchy, M.D. 
Barbara Ward, M.D. 
by Debra H. Howard 
Faculty adviser: Joann Elmore, M.D., 
assistant professor of medicine 
(Primary Care Center) 
Faculty discussant: Ralph Horwitz, M.D., 
professor of medicine 
(epidemiology and public health) 
Despite widespread use of mammograms 
as a screening tool for breast cancer, variabil¬ 
ity in mammogram interpretation has not been 
extensively studied. For this project, 10 
radiologists were ‘blinded’ to the research 
hypothesis. Using a standardized coding 
form, they interpreted identical sets of 150 
mammograms, on two occasions, separated by 
a five month ‘wash-out’ period. There was a 
wide range of variability among the 10 
radiologists in their use of diagnostic catego¬ 
ries for the 150 patients (‘normal,’ 16%-61%; 
‘abnormal-probably benign,’ 13%-47%; 
‘indeterminate,’ 8%-33%; and ‘abnormal- 
suspicious for cancer,’ 9%-25%). The 
radiologists’ recommendation to biopsy also 
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The image of a hand is projected on 
the screen as David Aghassi makes 
his presentation on scleroderma 
on Student Research Day. 
varied, from 9% to 31%. For diag¬ 
nostic interpretations there was 
moderate agreement, with a median 
pairwise weighted kappa of 0.47 and 
a median weighted percent agreement 
of 78%. Diagnostic sensitivity ranged 
from 37% for one radiologist to 85% 
for another. High sensitivity values 
were often accompanied by frequent 
recommendations for immediate 
work-up in patients who did not have 
cancer. When noting the most 
suspicious lesion on a mammogram, 
the radiologists disagreed on side 
(right vs. left) in 42% of patients, 
with variability declining as interpre¬ 
tations became increasingly more 
suspicious. Major interpretive 
disagreements, in which a 
mammogram was called 'normal' by 
one radiologist and 'abnormal- 
suspicious for cancer' by another, 
occurred in 19% of the 150 patients. 
Major management disagreements, 
defined as a recommendation for 
'routine follow-up only' by one 
radiologist compared to a biopsy 
recommendation by another, occurred 
in 25% of patients. When the same 
set of 150 mammograms was re¬ 
interpreted five months later, intra¬ 
observer readings showed better 
consistency. Later, when assembled 
in a conference to review disagree¬ 
ments, the radiologists found that the 
main problems arose from differences 
in visual perceptions, characterization 
of abnormalities and thresholds of 
concern. Active measures to reduce 
this variability are warranted and will 
likely necessitate extensive collabora¬ 
tive efforts for a goal of standardiza¬ 
tion coordinated with accuracy. 
Reproducible Physical 
Measurements to Quantify 
Dermal Sclerosis 
in Scleroderma 
by David Aghassi 
Faculty adviser: Irwin M. Braverman, 
M.D. '55. HS '55-'56. professor of 
dennatology and in the Cancer Center 
Faculty discussant: Joseph Craft, 
M.D., associate professor of 
medicine (rheumatology) 
Because the current assessment 
of scleroderma skin through clinical 
skin scoring is subjective and impre¬ 
cise, we investigated fully quantita¬ 
tive, physical measures of cutaneous 
involvement in the disease. 
First, we developed image 
analysis software for calculating the 
dermal density of collagen from 58 
scleroderma and 327 control biopsies 
scanned onto our computer. Second, 
using a durometer guage, we obtained 
measurements of skin hardness over 
12 prespecified body regions for 13 
scleroderma patients and 100 con¬ 
trols; we also obtained ultrasonic 
measurements of skin thickness for 
the same 13 scleroderma patients and 
4 controls. At 2 cm intervals over the 
dorsal and ventral arms of 4 
scleroderma patients, we obtained 
serial durometer and ultrasound 
measurements, correlating them with 
independent and blinded assessments 
of skin score at each point. Third, we 
acquired two-dimensional laser 
Doppler maps of cutaneous blood 
flow over the dorsal hands of 10 
scleroderma patients and 16 controls. 
We developed software to abstract 
mean blood flow, arteriolar islands, 
and avascular areas from the images. 
Finally, with continuous laser Doppler 
point measurement of blood flow, we 
assessed the hyperemic response to 
occlusion in 8 scleroderma hands, 3 
scleroderma forearms, and 15 con¬ 
trols (both sites). 
Average dermal collagen densite 
was significantly higher in sclero¬ 
derma at 88.5% ±6.9, compared with 
75% ±9.3 in controls (p < .001). 
Durometer measurements were 
significantly greater for scleroderma 
patients (p < .05) over the finger, 
hand, wrist, forearm, and ventral arm, 
although differences in ultrasonic 
thickness did not reach significance. 
While skin scores of 0 and 1 were 
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associated significantly different (p < .05) 
durometer readings in all four 
patients, the durometer fared less 
well in distinguishing among more 
severe degrees of sclerosis, where 
skin thickness showed the greatest 
differences. In scleroderma, mean 
blood flow at 483.2 ±421.2 mV and 
arteriolar island density at 1.4 ±0.5/ 
cm2 were significantly greater than the 
control averages of 276.3 ±146.3 and 
1.0 ±0.5 respectively (p < .05). We did 
not detect any abnormalities in reflex 
hyperemic response in scleroderma. 
Dermal collagen density and 
durometer measurements of skin 
hardness accurately quantify skin 
sclerosis in scleroderma. Moreover, 
increased cutaneous blood flow and 
1 greater use of microvascular reserve 
reflect defects in vascular regulation 
inherent to the disease. These 
reproducible, physical measurements 
will allow us to more precisely 
monitor the progression of 
scleroderma and evaluate its response 
to experimental treatments. 
Central Adiposity and Its 
Metabolic Correlates 
in Obese Adolescent Girls 
by Lauren D. Hyman 
Faculty adviser: Sonia Caprio, M.D., 
research scientist, department of 
pediatrics (endocrinology) 
Faculty discussant: Gerald Shulman, 
M.D., associate professor of 
medicine (endocrinology) 
Hyperinsulinemia and insulin 
resistance, key features of adult 
obesity, are strongly influenced by 
central adiposity. To determine 
whether such associations are 
present early in the course of 
obesity, a sequential 8 and 40 mU/ 
m2»min euglycemic insulin clamp 
with l-13C-Glucose and indirect 
calorimetry, and a 2 hour 
hyperglycemic clamp (+7mM) were 
performed in 14 obese adolescent 
girls (age 13; BMI 32), 14 non- 
obese adolescent girls (age 12; BMI 
21), and 10 young, lean women (age 
22; BMI 21). Visceral and subcuta¬ 
neous fat masses were measured by 
magnetic resonance imaging. While 
during the low dose insulin infu¬ 
sion, insulin stimulated glucose 
metabolism was not significantly 
different among the groups, during 
the 40 mU/m2»min euglycemic 
clamp, compared to the lean women 
(334±27 mg/m2»min), glucose 
uptake was significantly reduced by 
30% in the non-obese girls 
(230±20 mg/m2#min, p<0.05) and by 
an additional 25% in the obese girls 
(16± 15 mg/m2«min, p<0.01). 
Insulin infusion failed to stimulate 
glucose oxidation and to suppress 
lipid oxidation only in the obese 
adolescents. Suppression of free 
fatty acid levels was also decreased 
in the obese adolescents as com¬ 
pared to controls. As shown below, 
during the hyperglycemic clamp, 
basal, first, and late phase insulin 
responses were greater in the obese 
adolescents than in the non-obese 
adolescents who, in turn, had 
greater responses than the lean adult 
women. Insulin-stimulated glucose 
metabolism was similar in all three 
groups. However, this occurred 
in the face of marked hyper¬ 
insulinemia in both adolescent 
groups. Therefore, the index of 
insulin sensitivity, the glucose 
metabolized per unit of plasma 
insulin concentration, in the obese 
adolescents was 50% that of the 
non-obese adolescents and only 
25% that of the lean adults. See 
table below. 
Of note, in the obese girls, 
visceral fat, but not waist to hip 
ratio, was highly correlated with 
basal insulin secretion (r=0.89, 
p<0.001), stimulated insulin secre¬ 
tion (r=0.61, p<0.05), and insulin 
resistance (r=0.87, p<0.02). Con¬ 
clusion: Increased visceral fat, 
hyper-insulinemia, and insulin 
resistance are closely linked abnor¬ 
malities that are expressed early in 
the natural history of obesity. 
















85±7** 56±9* 29±4 
155±20** 81±10* 39±6 
307126 306131 320192 
1.910.2** 3.71.05* 7.311.7 
**p<0.001 vs both non-obese adolescents and lean women 
*p<0.02 vs lean women 
YM 
Yale Medicine Summer 1994 11 
Fee E. Farr, M.D., speaks to Joseph L. Goldstein, M.D., the Nobel Prize-winning 
professor and chairman of molecular genetics at the University of Texas 
Southwestern Medical Center at Dallas. Dr Goldstein delivered the Farr lecture. 
Differential Properties 
of Amino Acid Transmitter 
Receptors in Subtypes 
of Spinal Cord Astrocytes 
by Karen M. Rosewater 
Faculty adviser: Harald Sontheimer, 
M.D., assistant professor 
of neurology 
(neurology and neurobiology) 
Faculty discussant: Bruce Ransom, 
M.D., associate professor of 
neurology and cellular 
and molecular physiology 
This study examined properties 
of y-aminobutyric acid (GABA) and 
glutamate receptors of spinal cord 
astrocytes in order to determine 
subtype differences and the influence 
of development. Using whole-cell 
patch clamp electrophysiology, 
receptors of fibrous and protoplasmic 
astrocytes were characterized phar¬ 
macologically by comparing current 
responses in the presence of specific 
agonists and antagonists at 1-20 days 
in vitro (DIV). 
Both astrocyte subtypes ex¬ 
pressed GABA and glutamate recep¬ 
tors. Their activation resulted in 
inward currents at the cell’s resting 
potential. After pooling the mean 
values for all cells, the subtypes 
differed significantly in current 
densities for both neurotransmitters 
tested. See table below. 
The developmental changes 
observed were as follows: Glutamate 
current density gradually increased in 
both subtypes between 1-14 DIV, 
whereas GABA current density in 
protoplasmic cells appeared to exhibit 
a step-like increase during the second 
week in vitro but was less variable in 
fibrous cells with time. 
Experiments using Li+as the 
major extracellular cation revealed no 
contribution of this electrogenic Na7 
glutamate uptake to the transmitter- 
induced currents. In addition, the 
existence of a current reversal 
potential and the ability of the 
receptor agonist kainate to generate 
similar responses to glutamate 
indicate that the astrocytic glutamate 
response is due to activation of the 
Quisqualate/Kainate (Q/K) receptor. 
Astrocyte GABA responses 
displayed most of the hallmarks of 
neuronal GABAl receptors: Currents 
reversed near the Cl - equilibrium 
potential, were blocked by picrotoxin, 
and pentobarbital and diazepam both 
enhanced GABA-induced currents. 
However, while the convulsant 
methyl-4-ethyl-6,7-dimethoxy-B- 
carboline-3-carboxylate (DMCM), 
an inverse benzodiazepine agonist, 
reduced GABA-induced currents in 
fibrous astrocytes and in neurons by 
approximately 50%, GABA currents 
in protoplasmic astrocytes were 
enhanced by up to 150%. Mean 
effects of DMCM were: -46.2% ± 
3.9%, N=40 for fibrous cells vs. 
+65.9% ± 16.7%, N=12 for protoplas¬ 
mic cells; pcO.OOOl. 
These results suggest that astro¬ 
cyte subtypes manifest distinct 
neurotransmitter receptors whose 
expression is developmentally 
regulated. The GABA receptor 
expressed by protoplasmic astrocytes 
appears to be glial specific, producing 
enhancement of the GABA response 
never seen in neurons. 
Current Density Current Density 
for GABA in pA/pF for glutamate in pA/pF 
Fibrous 25.52 ± 1.06 4.95 ± 0.15 
n = 91 n = 71 
Protoplasmic 11.04 ± 1.4 1.26 ± 0.08 
n = 99 n = 117 
P value <0.0001 <0.0001 
YM 
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Development 
of Melanophore-Based 
Bioassays for the 
Study of G-Protein Coupled 
Receptors 
by Marc Nicholas Potenza 
Faculty adviser: Michael Lerner, 
M.D. Ph.D., associate professor 
of medicine and pharmacology 
Faculty discussant: Eric J. Nestler, 
M.D., Ph.D., Elizabeth Mears and 
House Jameson Associate Professor 
of Psychiatry and Pharmacology 
The family of G-protein coupled 
receptors (GRs) is comprised of 
hundreds, if not thousands, of 
individual members. GRs mediate 
numerous important cellular pro¬ 
cesses by “transferring” information 
across the plasma membrane. 
Specifically, GRs bind ligands (such 
as hormones or neurotransmitters) 
in the extracellular environment to 
initiate intracellular cascades which 
alter cellular responses. The recent 
isolation of approximately one 
hundred cDNA clones encoding 
distinct GRs and their biological 
and medical relevance has necessi¬ 
tated the development of a rapid, 
functional assay for the study of 
these receptors. 
In order to design a strategy for 
the rapid quantitation of the effects 
of ligands upon GRs, we employed 
a cell line of Xenopus laevis mel- 
anophores as the basis for a func¬ 
tional bioassay. Pigment transloca¬ 
tion in these cells is controlled by 
GRs: activation of GRs leading to 
generation of cAMP or IP3 and 
diacyl glycerol induces pigment 
dispersion, and receptor activation 
resulting in the inhibition of cAMP 
accumulation induces pigment 
aggregation. The pigment translo¬ 
cation produces a visible change 
which can be discerned within 
minutes and becomes obvious 
within a half hour. This dissertation 
begins with a description of the 
development of a microtiter-based 
bioassay for quantitating pigment 
dispersion, and its use to evaluate 
the effects of ligands upon a B 
adrenergic receptor (AR) and a 
serotonergic receptor (SR) endog¬ 
enous to the melanophores. Sec¬ 
ond, a method employing vaccinia 
virus infection for the introduction 
of recombinant DNA into the 
melanphores is described. Third, 
the microtiter-based pigment 
dispersion assay is applied to study 
a human B2 AR expressed in the 
melanophores. Fourth, the develop¬ 
ment of a microtiter-based pigment 
aggregation assay is described, and 
the assay is employed to study 
human D2 and D3 dopamine 
receptors. Additionally, the use of 
the melanophores as the basis of a 
functional screen for the isolation 
of novel cDNA clones encoding 
GRs is discussed. The bioassays 
employing the melanophores 
provide an efficient means to 
perform structure/function analy¬ 
ses, “orphan” GR characterization, 
cDNA clone isolation, and drug 




at Student Research 
Day pose with 
faculty. From left: 
Debra H. Howard; 
Dean Gerard N. 
Burrow, M.D.; 
Marc N. Potenza, 
Student Research 
Director John N. 
Forrest Jr., M.D.; 
Lauren D. Hyman; 
Associate Dean 
Robert H. Gifford, 
M.D.; David 
Aghassi; Fan- 
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Goldstein, M.D.; 
and Karen M. 
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Down to Basics 
Yale s new molecular cardiobiology program 
plumbs the depths of the human vasculature 
Jordan S. Pober, M.D., Ph.D, looks at a slide 
while conferring with Rebecca Palmer-Crocker 
in his laboratory on the fourth floor of the 
foyer Center for Molecular Medicine at Yale. 
)r. Pober’s studies may lead to better, more 
Specific therapies against transplant rejection. 







by Michael Fitzsousa 
In a fourth-floor laboratory at the 
Boyer Center for Molecular Medi¬ 
cine, Allan G. Murray, M.D., and 
Diane Epperson are halfway through 
the day’s work for an experiment 
involving mice and human skin grafts. 
The experiment will show how 
the cells lining blood vessels of the 
human skin interact with white blood 
cells from a second human. Dr. 
Murray and Ms. Epperson, research¬ 
ers in the laboratory of Jordan S. 
Pober, M.D. ’77, Ph.D., hope to use 
the results as a model to study the 
rejection of transplanted hearts, 
kidneys and other organs. 
“We’re hoping this will prove to 
be a tool we can use to discover new 
drugs or new ways of modifying 
transplant rejection so that people’s 
grafts can survive indefinitely,” Dr. 
Murray, a postdoctoral fellow in 
pathology and nephrologist, says on 
this May afternoon. “That’s the goal: 
the acceptance of grafts without any 
host immune response to it.” 
Under Dr. Pober’s supervision, 
Dr. Murray and another postdoctoral 
fellow spent an entire year setting up 
the experiment, getting the procedure 
to the point where the results were 
reproducible. Two weeks ago, one- 
inch-square grafts of human skin 
were attached to a dozen immunode- 
ficient mice that lack T and B cells. 
Earlier today, a donor provided a 
blood sample for the human T cells 
needed to run the experiment. The 
white-blood-cell fraction was sepa¬ 
rated, then refined in one of several 
centrifuges that line the walls of the 
laboratory. Now Dr. Murray and Ms. 
Epperson, a doctoral candidate, are 
using a solution of magnetized beads 
to remove certain types of T cells 
thought to be most vigorous in the 
rejection process. At last, the cells are 
Michael Fitzsousa is publications 
editor in the medical school’s Office 
of Public Information. 
injected into the mice and the re¬ 
searchers begin a six-day wait for 
signs of inflammation. 
A Broad View 
Their project is one of two dozen 
in progress in the molecular 
cardiobiology program at the Boyer 
Center. Inaugurated in October 1992 
with a five-year, $6 million grant from 
the American Cyanamid Corp. and 
other funding, the molecular cardio¬ 
biology program has filled its space 
rapidly. Dario C. Altieri, M.D., the 
sixth faculty member, arrived in July 
from the Scripps Research Institute in 
La Jolla, Calif. All told, about 50 
scientists, technicians and students 
work on the floor. 
Molecular cardiobiology, a term 
coined by former medical school dean 
Leon E. Rosenberg, M.D., occupies 
the center’s entire fourth floor and 
combines the research of Dr. Pober, 
an immunologist and pathologist, and 
that of cardiologists, pharmacologists, 
and cellular and molecular biologists. 
What links all of the work is relevance 
to the vascular system, especially the 
endothelium — the single layer of 
cells lining the blood vessels. 
In addition to studying the 
interaction between the blood vessels 
and the immune system, the 
program’s six faculty scientists are 
exploring problems as diverse as how 
ion channels in cell membranes 
regulate cellular functions, how 
second-messenger pathways transmit 
signals in cells, and how a specific 
enzyme produces nitric oxide and 
ultimately causes the walls of the 
blood vessels to relax. Dr. Altieri’s 
lab is gearing up to study cells that 
appear to play a dual role in both 
immune response and blood clotting. 
The rapidly growing field of 
vascular biology is an area where 
basic laboratory research is quickly 
making its way into clinical medicine, 
Dr. Pober says. Studies under way 
today may lead to better, more 
specific drugs or engineered proteins 
to fight hypertension, arteriosclerosis 
and other heart diseases, as well as 
prevent the rejection of transplanted 
organs. Advances over the past 
decade have come hand-in-hand with 
huge strides in molecular biology, 
says Dr. Pober. “Molecular biology 
Jeffrey Bender, M.D., associate professor of medicine, discusses a 
series of photographs of endothelial cells during a conference with 
Michael Blum, M.D., and Teresa Caulin-Glaser, M.D., both post¬ 
doctoral fellows in medicine (cardiology). The photos show the seal 
between cells being penetrated. 
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and its tools have revolutionized the 
way we can do vascular biology. The 
days of looking at vague phenomena 
with poorly defined factors are over.” 
Dr. Pober, who returned to New 
Haven from Harvard three years ago 
to establish the molecular cardio- 
biology program, says the Boyer 
Center’s premise has strengthened 
research into targeted areas by 
encouraging scientific collaboration. 
The principal investigators at the 
center all hold appointments in 
departments at the medical school and 
some have clinical duties as well. 
"Because we are not limited by 
department,” says Dr. Pober, “it 
allows us to conceive of these 
programs in the broadest sense and 
bring in individuals trained in any 
sub-specialty that might bring to bear 
some interest in a problem and lead to 
novel kinds of interactions.” 
Until a decade ago, scholars 
thought that this layer of cells lining 
the blood vessels interacted very little 
with other parts of the body. Now the 
endothelium is understood to be on 
the front lines of many illnesses. For 
example, the plaque that lines the 
coronary arteries of most heart-attack 
sufferers turns out to be a result of 
inflammation of the blood vessels that 
begins with changes in the endothe¬ 
lium. Endothelial cells also express 
mediators that affect the tone of the 
smooth-muscle cells of the vessels, 
contributing to hypertension. And 
when a transplant fails, the blood 
vessels are the first tissue that the 
leukocytes attack. 
“What inspired Yale to commit 
to a program focused on endothelial 
cells was a body of work that started 
in the mid-1980s that made it clear 
that endothelial cells were dynamic 
or changeable — because there’s 
nothing more boring than an endo¬ 
thelial cell in its normal state,” says 
Dr. Pober. 
“That’s actually good, because an 
endothelial cell that is doing some¬ 
thing is probably doing something 
bad,” he adds. “What you want to do 
is control when that bad thing hap¬ 
pens. If they’re doing it all over the 
body, you're dead.” That extreme 
case — known clinically as septic 
shock — is fairly rare. But control¬ 
ling inflammation is likely to be a 
major benefit of the program as the 
research finds clinical applications. 
Postdoctoral 
fellow 
Allan G. Murray, 
M.D., is helping 
to develop a 




A Kinder Host 
Thirty years ago, the idea of a 
heart transplant was practically 
unthinkable. Now one is performed 
once or twice a month at Yale alone. 
Dr. Pober's research may lead to 
medications that will turn the immune 
system off to a transplanted organ 
without major side effects and 
without leaving the rest of the body 
vulnerable to attack — not only at the 
time of transplant but in the ensuing 
weeks and months. 
“Most heart transplants that fail 
now don’t fail because of the acute 
rejection process,” says Dr. Pober, 
professor of pathology, biology and 
immunobiology. “Most fail because 
the coronary arteries on the heart get 
involved in a more chronic kind of 
immunologic response. Our studies 
suggest that the primary target in that 
process is, in fact, the endothelial 
lining of the coronary arteries. That’s 
what triggers this immunologic 
response, which eventually leads the 
artery to become scarred off and 
closed down. In six months to a year, 
the heart fails because it can’t get 
enough blood.” 
To understand that interaction 
between endothelium and the circu¬ 
lating blood. Dr. Pober and his 
colleagues are looking closely at why 
some endothelial cells and not others 
attract the attention of T cells. 
They’re also trying to better under¬ 
stand the mechanism by which the T 
cells attack and how both mecha¬ 
nisms could be interrupted by drugs or 
macro-molecules from biotechnology. 
Help for Hearts 
Like Dr. Pober, colleague Jeffrey 
Bender, M.D., is interested in the 
relationships between endothelial 
cells and the immune system. A 
cardiologist who is active clinically. 
Dr. Bender has focused much of his 
research on natural killer cells and 
their mechanisms. He and his fellows 
are pursuing evidence that natural 
killer cells actually trigger the actions 
of the more deadly T cells by setting 
off a chain of events. 
In exploring how inflammation of 
the blood vessels occurs, researchers 
in Dr. Bender’s lab have identified a 
sequence of occurrences, starting 
with the interaction of certain mol¬ 
ecules that promote white-blood-cell 
adherence to the endothelium. They 
have demonstrated how the binding 
occurs and how endothelial cells are 
subsequently activated. One of the 
latest efforts is defining the process 
by which the leukocyte migrates 
through the endothelial wall, without 
destroying it and almost without a 
trace. Photographs from the micro¬ 
scope clearly show the seal between 
endothelial cells being broken, then 
reconstituting itself. 
“There is a thought that as the 
leukocytes are migrating through they 
are creating their own seal,” says Dr. 
Bender, associate professor of medicine 
and director of the cardiovascular 
medicine immunology laboratory. 
“There is a zippering effect whereby 
the leukocytes displace the original 
zipper but make their own zipper with 
the face of the endothelium.” 
“We believe that the avidity of 
some of these leukocyte-endothelial 
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interactions is determined at the genetic 
level,” says Dr. Bender. Because the 
genetic predisposition to cardiovascular 
disease is an incompletely solved 
mystery, this may be an additional, 
previously unrecognized risk factor. 
Dr. Bender’s laboratory deter¬ 
mined that endothelial cells from 
different individuals have tremen¬ 
dously different activation thresholds 
to inflammatory mediators. These 
substances, secreted in inflammatory 
or immune responses, turn on the 
endothelial-cell proteins that promote 
white-blood-cell adherence, thereby 
leading to damage to the vascular 
wall. Dr. Bender and his colleagues 
are attempting to define those suscep¬ 
tibility differences at the molecular 
level and perform family studies to 
evaluate a correlation with cardiovas¬ 
cular disease. 
“As with any puzzle, every piece 
is vital to the overall, complete 
picture,” says Dr. Bender. “We hope 
that this is an important part of the 
cardiovascular disease puzzle.” 
Other investigators in the molecular 
cardiobiology program include: 
• Steve A.N. Goldstein, M.D., 
Ph.D., assistant professor of pediat¬ 
rics and cellular and molecular 
physiology. Dr. Goldstein and his 
team are studying the proteins that 
form ion channels, which selectively 
allow certain molecules to pass 
through cell membranes. Because ion 
channels mediate all electrical 
activity in the body, they are ex¬ 
tremely important in a broad range of 
functions — from the contracting of 
heart muscle to the mechanism of 
sight. “Each heartbeat is the carefully 
orchestrated opening and closing of 
ion channels,” says Dr. Goldstein. 
Despite their importance, he 
adds, very little is understood about 
how ion channels work. That is 
changing, though, as researchers at 
Yale use the tools of electrophysiol¬ 
ogy, molecular biology and protein 
biochemistry to probe their structure 
and function. 
Dr. Goldstein’s laboratory is 
studying the functions of certain 
components of the proteins that 
compose ion channels. Researchers in 
the Goldstein lab use the methods of 
molecular biology to place naturally 
occurring channel proteins or cloned 
channel proteins into cells. Isolating 
the channel proteins from their native 
tissue and reconstituting them in 
special cells — frog oocytes, for 
example — provides a cellular 
environment where ion channels can 
be studied in remarkable detail. 
“Recent advances in molecular 
biology and high-resolution tech¬ 
niques for studying channels have 
combined to kindle an ongoing 
explosion of new information about 
how channel structure leads to 
function,” says Dr. Goldstein. 
• William C. Sessa, Ph.D., assistant 
professor of pharmacology. Dr. 
Sessa’s work is centered on the 
endothelial enzyme that produces 
nitric oxide, a substance that has been 
recognized in recent years to relax the 
smooth muscle cells that make up the 
blood vessel walls. “It’s constantly 
/<-' 
/ 
T cells appear as small, dark spots in 
this Pober lab image, showing 
inflammation of human skin that has 
been attached to an immunodeficient 
mouse. The clustering of spots show 
that the transplanted endothelial tissue 
has clearly come under attack. 
being made in low levels,” says Dr. 
Pober, “but you can increase the 
amount that’s being made.” It turns 
out that nitroglycerine, which physi¬ 
cians have used for decades to treat 
angina, works by releasing nitric 
oxide into the bloodstream. 
• Henrik G. Dohlman. Ph.D.. 
assistant professor of pharmacology. 
Dr. Dohlman studies hormone and 
neurotransmitter messenger systems 
that communicate information into 
cells. An example is the way in which 
an injection of the hormone epineph¬ 
rine makes the heart beat faster: 
Receptors on the surface of heart- 
muscle cells detect an increase in the 
level of the hormone in the blood; the 
receptor communicates that through 
the cell membrane to a protein, which 
activates enzymes inside the cell and 
sets off a cascade of biochemical 
events that increases the heart rate. In 
Dr. Dohlman’s lab. most of the 
studies are conducted in baker's 
yeast, which has pathways remark¬ 
ably similar to humans. 
Dr. Dohlman and his researchers 
believe a better understanding of 
these “second-messenger” systems 
ultimately can explain why patients 
become desensitized to medication 
and how this might be countered: 
“What we’re trying to do is under¬ 
stand how the signaling is regulated. 
Why does the heart cell stop respond¬ 
ing to epinephrine in the blood?” By 
studying the process in yeast. Dr. 
Dohlman may be able to draw some 
conclusions about human signaling. 
“Our long-term goal is to find new 
proteins that regulate desensitization 
in humans,” he says. 
Adds Dr. Pober: “Drugs that relax 
blood vessels or relax the heart do so 
through these transduction pathways. 
If you can make the patient more 
sensitive to some of these drugs, or 
less sensitive to some of these drugs 
— or to harmful substances they 
produce themselves — you can 
improve their treatment. You can 
change the gain control.” 
• Dario C. Altieri, M.D., associate 
professor of pathology. Dr. Altieri, the 
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newest member of the program, is 
continuing research into white blood 
cells and endothelial cells that are 
involved in both inflammation and 
blood clotting. In previous work, he 
discovered that one of the most 
important leukocyte proteins involved 
in the recognition and binding of 
endothelial cells turns out to be a 
critical molecule in the regulation of 
blood clots. 
"I think we don't appreciate fully 
the extent to which the coagulation 
system interacts with the inflamma¬ 
tory system,” says Dr. Pober. One 
target of the research is likely to be 
sepsis, an overwhelming inflamma¬ 
tion of the body. “One of the real 
problems with sepsis is not only the 
inflammation that destroys organs like 
the liver and the lungs but a massive 
activation of the clotting system. 
“In fact, you clot so much that 
you use up all your clotting factors 
and can bleed to death,” he says. “If 
therapy for these patients is ever 
going to be effective, it is going to 
have to deal with both aspects of this 
problem, both coagulation and 
inflammation.” 
Growth Ahead 
Where is the field of molecular 
cardiobiology heading? Because it is 
so new, it is hard for researchers to 
predict where they will be devoting 
the most energy in the coming decade. 
But based on promising results so far, 
they expect dramatic growth. 
“In the next five years, we’re 
going to be translating more of the 
laboratory findings in clinical trials,” 
says Dr. Pober. “Which diseases are 
going to be most amenable to 
control? I really don't know. These 
attempts to interfere with biological 
processes are often really hit or 
miss. But in five years the targets of 
opportunity are not going to dry up. 
I think what we’re going to see are 
more targets of opportunity.” 
Vincent T. Marchesi, M.D. '63, 
Ph.D., director of the Boyer Center 
Michael Blum, M.D., measures reagent 
in a pipette while at work in the 
laboratory of Jeffrey Bender, M.D. 
and Anthony N. Brady Professor of 
Pathology and professor of cell 
biology and biology, says the medical 
school’s decision to launch the 
molecular cardiobiology program five 
years ago was fortunate. 
“The one thing we can say now, 
at this early stage, is that the molecu¬ 
lar approaches have been really 
critical in the study of vascular 
biology, in a way no one ever antici¬ 
pated,” says Dr. Marchesi, who 
launched the program and recruited 
Dr. Pober to head it. “You just 
couldn’t study blood vessels in this 
way before the molecular probes 
came into being.” 
Dr. Pober is concerned, however, 
about declining federal funding from 
the National Institutes of Health 
(NIH), which awards the majority of 
grants to American biomedical 
researchers. From his own observa¬ 
tions as a member of a committee that 
reviews proposals for NIH, the 
percentage of investigator-initiated 
applications approved and funded has 
fallen from about 25 percent four 
years ago to the 10 percent range this 
year. “It is very difficult to sustain the 
enterprise with that level of support,” 
he says. Dr. Pober is hopeful that a 
tax on health care contained in some 
of the health-care reform proposals 
now before Congress will boost the 
funded grant ratio to 25 percent. 
Back in Dr. Pober’s lab, Ms. 
Epperson and Dr. Murray will 
examine the mice and skin grafts over 
several intervals during the next three 
weeks. Each time, they will be 
counting T cells to measure the 
degree of inflammation in the tissue. 
They suspect that the white blood 
cell samples deprived of certain 
classes of T cells — CD4 and CDS, 
as they are referred to in the lab — 
will not attack the vasculature with 
the same ferocity. 
"Part of the difficulty in solving 
the problem of rejection in humans 
has been there really hasn’t been a 
model where you can look at human 
lymphocyte interactions with human 
donor tissue,” says Dr. Murray. “In 
this system, we think that we have 
just such a model so that you can look 
at different strategies for interrupting 
the rejection.” 
It will be months before the 
results of the experiment are firm. Dr. 
Pober says in early June, as he looks 
over the first group of slides at the 
end of the three weeks. “In general, 
we’re getting less reaction with some 
of the T cells missing, but it’s too 
soon to say definitively which ones. 
So the short answer is it’s too early to 
tell.” The Yale scientists will repeat 
the experiment three or four times in 
the weeks ahead to see if the results 
are consistent and to gain enough data 
to draw real conclusions. 
For Dr. Murray, who is pursuing a 
career as an academician and clini¬ 
cian in nephrology, the basic scien¬ 
tific research conducted today may 
someday have real practical value. At 
the end of his three-and-a-half-year 
fellowship in December, he will seek 
an academic position and funding to 
continue his research. As a practicing 
physician. Dr. Murray will also care 
for transplant patients — in his case 
those with kidney transplants — some 
of whom will need better medications 
than are currently available. Twenty 
years from now, he might even 
prescribe a drug that he helped 
develop. It’s far from a certainty but 
then again, he says, “It’s not impos¬ 
sible.” YM 












Yale cardiologists attack coronary disease on many fronts 
Heart of the Matter 
Interventional cardiologists in the cardiac catherization laboratory at Yale-New 
Haven Hospital examine the arteries of a patient at risk for a heart attack. 
by Joyce Baldwin 
A generation ago, heart-attack 
patients who lived long enough to be 
admitted to the hospital usually spent 
the next four to six weeks in bed. If 
they survived, they went home to a 
new life and a different lifestyle. 
But many didn’t survive. 
Three decades later, the land¬ 
scape of cardiology has changed. An 
explosion of new knowledge has 
added dramatically to the tools 
available to physicians who diagnose 
and treat cardiovascular disease. 
Cardiologists have learned that heart 
muscle tissue doesn’t die instantly 
after a heart attack. They also know 
that heart attacks are caused by blood 
clots, which now can be dissolved 
with thrombolytic drugs. 
Patients have options unheard of, 
until recently, for correcting many of 
the problems that constitute their 
heart disease. Angioplasty, the 
removal of plaque from the arteries, 
has developed from an experimental 
technique to a routine procedure 
credited with saving thousands of 
lives a year. Lifestyle changes, too, 
are often enough to make a large 
difference in the health of coronary 
patients. Physicians and much of the 
general public are now aware of the 
risk factors that contribute to cardio¬ 
vascular disease: cholesterol intake, 
hypertension, smoking and lack of 
Joyce Baldwin is a free-lance writer 
in Oceanside, N. Y. Her latest book, 
DNA Pioneer: James Watson and the 
Double Helix, was published in April 
by Walker and Company. 
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Frans J. 77?. 
Wackers, M.D., 
Ph.D., left, is 
director of the 
nuclear cardiology 
and exercise 
laboratories at Yale. 
Cardiologists there 
are testing a new 
generation of 
radionuclide agents 
that provide more 
detailed information 
about blood flow in 
the heart than was 
previously available. 







exercise, along with genetic factors. 
Entirely new classes of drugs have 
been developed to treat heart patients: 
In the mid-1960s, beta blockers gave 
cardiologists new avenues to combat 
hypertension and angina pectoris. In 
the 1980s, calcium channel blockers 
and angiotensin converting enzyme 
(ACE) inhibitors improved treatment. 
Now, genetic engineering promises to 
create even more specific drugs with 
fewer side effects. 
Researchers in vascular biology 
are starting to understand the impor¬ 
tant role that blood vessels play in the 
condition of the heart, and their 
approach is already pointing to 
possible breakthroughs. It is becoming 
increasingly clear that a heart attack is 
one event in a long and complex 
process involving the arteries, which 
supply the heart with blood. 
At Yale, where cardiovascular 
medicine has expanded enormously 
during the last two decades, research¬ 
ers and clinicians are on the forefront 
of many of the advances. And they 
are looking ahead: “In this era of 
molecular biology, the new informa¬ 
tion that is derived will be critical for 
developing new strategies for treat¬ 
ment,” says Barry L. Zaret, M.D.. 
chief of Yale’s section of cardiovascu¬ 
lar medicine. 
§§§ 
“You can do a density count of 
white coats,” Dr. Zaret says laugh¬ 
ingly as he looks at a display of 
photographs of faculty members. The 
series of photographs shows how 
significantly the section has grown. 
“When I first started here in 1973, 
there were about six full-time faculty, 
and now we're about 25,” he says. 
“Cardiology itself has grown dramati¬ 
cally as a field during that time.” The 
growth also is reflected in the number 
of postdoctoral fellows in the section 
— 10 in 1973 and at least 20 today. 
Dr. Zaret, the Robert W. Berliner 
Professor of Medicine and professor of 
diagnostic radiology, became chief of 
the cardiovascular medicine section in 
1978. He is the third person to hold 
that post, having succeeded Lawrence 
S. Cohen, M.D., HS '58-'60, ’64-'65, 
now deputy dean of the medical school 
and Ebenezer K. Hunt Professor of 
Medicine, and under whom the clinical 
fabric of cardiology at Yale first 
developed. The first section chief was 
the late Allan V.N. Goodyer. M.D. ’42, 
an eminent physiologist and clinician. 
The field has grown so much that 
even the name of the section has 
changed — from cardiology, when 
Dr. Zaret arrived at Yale, to cardio¬ 
vascular medicine in July 1990. "The 
name cardiovascular medicine is not 
just a semantic issue,” Dr. Zaret says. 
“It reflects that the field now deals 
not only with the heart as a pump but 
also recognizes the fundamental 
importance of the blood vessels, the 
components of the vessel wall, and 
circulating blood in the development 
of cardiovascular disease, in particu¬ 
lar arteriosclerosis.” 
Ask the faculty about their work at 
Yale-New Haven Hospital (YNHH), 
their laboratories at the medical school 
or at the Department of Veterans Affairs 
Medical Center in West Haven and the 
discussion can range from advances in 
nuclear cardiology to the immunologic 
mechanisms involved in injury of 
blood-vessel walls, or a new theory 
about heart muscle degeneration. The 
scope of interests reflects a commit¬ 
ment to research, clinical work and 
education. In a field where high 
compensation can quickly lure many to 
clinical practice, Yale trains a large 
number of skilled researchers. Forty to 
50 percent of postdoctoral fellows here 
go on to academic posts, says Dr. Zaret. 
Yale's research is directed 
toward improving the imaging of 
hearts and the treatment of plaque 
buildup in arteries, as well as 
answering fundamental questions 
about heart metabolism and vascular 
and molecular biology. Faculty 
members are also active clinically 
and provide a wide range of diagnos¬ 
tic services and therapies. 
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Barry L. Zaret, M.D., 
chief of cardiovascular medicine, 
sees a greater emphasis on basic 
research as cardiology 
progresses as a field. 
Imaging Hearts 
Dr. Zaret, a pioneer in the use of 
radiotracers for imaging and diagnos¬ 
ing heart disease, instituted the 
nuclear cardiology program at Yale, 
which has become one of the largest 
and most productive of its kind in the 
world. As a postdoctoral fellow at the 
Johns Hopkins University, Dr. Zaret 
was the first physician to use electro¬ 
cardiogram gating and radionuclide 
imaging to measure the ventricular 
function of the heart. Radionuclide 
gating is a technique that safely and 
non-invasively shows how well the 
heart pumps blood. Before Dr. Zaret’s 
contribution, physicians had to insert 
catheters into the heart to measure 
ejection fraction, the quantity of 
blood pumped out. 
Dr. Zaret was also the first to 
merge the concepts of exercise stress 
and perfusion imaging, testing that 
shows the pattern of blood flow in the 
heart by use of radionuclide scanning. 
Because most heart symptoms occur 
during exertion, it made sense to study 
heart function and blood flow while 
the patient was exercising. Dr. Zaret’s 
innovations in this area as a physician 
in the Air Force were the basis for 
further work by faculty at Yale. 
In the early 1970s, the first 
nuclear cardiology studies at the 
medical school used radioactive 
potassium to image blood-flow 
patterns in the myocardia of patients 
and of animals during heart attacks. 
These crude images were followed 
several years later by animal studies 
that used thallium-201 to examine the 
uptake of the radioactive material in 
heart tissue and relate this informa¬ 
tion to measurements of blood flow 
and tissue viability. Thallium-201 is 
deposited in heart tissue in proportion 
to blood flow and provides informa¬ 
tion about areas of the heart that are 
adequately perfused with blood and 
those that are not. 
When details of the procedure had 
been perfected, clinical trials were 
initiated in patients who were studied 
as they exercised and in patients who 
had suffered heart attacks. Perfusion 
imaging is now widely performed 
throughout the world to locate areas of 
heart-muscle damage. In addition to 
thallium-201, new radiopharma¬ 
ceuticals are being developed. Three 
of them are undergoing or have 
undergone a portion of their basic and 
clinical research testing at Yale. 







Frans J. Th. Wackers, M.D., 
Ph.D., professor of diagnostic radiol¬ 
ogy and medicine and director of the 
nuclear cardiology and exercise 
laboratories at Yale, was the first 
physician to inject thallium-201 into a 
patient during a heart attack. That was 
in the 1970s, when Dr. Wackers was 
still a cardiology fellow in his native 
Holland. Now, nearly 20 years later. 
Dr. Wackers and his colleagues are 
using newer radionuclide agents, such 
as technetium-99m sestamibi. that 
provide information about the heart’s 
functional capacity. 
“With these newer agents, we can 
also look at the transit of the tracer as 
it passes through the heart and com¬ 
pute the ejection fraction, and after¬ 
ward we can then look at blood flow,” 
says Albert J. Sinusas, M.D., assistant 
professor of medicine and diagnostic 
radiology, who evaluates the potential 
clinical usefulness of radionuclide 
agents using animal models. 
To monitor blood flow in the 
heart and the condition of heart tissue, 
cardiologists at Yale use a gamma 
camera with three heads to detect 
radiotracer distribution in a patient 
suspected of heart disease. The 
camera rotates around a patient who 
has received an injection of a radio¬ 
nuclide and tracks blood flow by 
showing where the tracer has been 
taken up by heart muscle. The com¬ 
puter displays sharp, color images — 
either a heart in motion or a still 
picture that can be rotated three- 
dimensionally for detailed analysis. 
On the screen, areas of the heart 
are color-coded according to the 
degree of blood flow. The images 
show not only flow through the heart 
but also give information about tissue 
viability and how the heart carries out 
metabolic functions. They are 
extremely useful tools for diagnosing 
heart disease and evaluating patients 
at risk, including those who have 
blockages but show few or no 
symptoms. These images also help 
predict which patients will benefit 
from bypass surgery. 
The nuclear cardiology labora- 
Diwakar Jain, M.D., is the principal 
investigator for the VEST project, 
which allows ambulatory monitoring 
of left-ventricular function. 
tory is also studying use of an ambu¬ 
latory monitoring device called the 
VEST. This technique uses a small 
radiation detector to monitor left 
ventricular function for several hours. 
The device is worn by a patient, after 
injection of a radioisotope, while he 
or she carries out daily activities. The 
VEST may reveal abnormalities not 
apparent in an electrocardiogram and 
holds promise for diagnosing 
asymptomatic myocardial ischemia. 
According to Diwakar Jain, M.D., 
assistant professor of medicine and the 
principal investigator for the VEST 
project, the device may give investiga¬ 
tors a more detailed understanding of 
the heart’s performance under varied 
conditions. They, too, are using the 
VEST in a study to gauge the effect of 
mental stress on the heart. 
“Now we are working on the 
concept (of mental stress) in patients 
with known heart disease,” he says. 
“Certain factors can trigger a heart 
attack or arrhythmia and cause 
mortality or morbidity. We’re investi¬ 
gating the possibility that mental 
stress acts as a trigger for adverse 
cardiac events in patients with 
coronary artery disease.” 
Another tool used by nuclear 
cardiologists is positron emission 
tomography, or PET, an imaging 
technique that reveals blood flow and 
metabolic activity in the heart. 
Results of PET studies indicate that 
areas of the myocardium once 
thought to be dead tissue are, in fact, 
"hibernating," waiting to come alive 
again if only they could be provided 
with sufficient blood. The PET center 
at the Department of Veterans Affairs 
Medical Center in West Haven, 
directed by Robert Soufer, M.D. ’78, 
HS ’82-’85, associate professor of 
diagnostic radiology and medicine, is 
the only one in Connecticut. The $6 
million facility, which opened in 
1991, is also used to study the brain 
and has applications to research into 
the causes of schizophrenia and other 
mental illness, stroke, and the effec¬ 
tiveness of anti-cancer drugs. 
Ridding Arteries of Plaque 
Arteriosclerotic plaque builds up 
in the walls of coronary arteries 
slowly, insidiously and insistently. It 
can cause significant narrowing of the 
vessels; if the artery is then com¬ 
pletely blocked by a blood clot, a 
heart attack occurs. Balloon 
angioplasty, a procedure first used in 
the late 1970s to crush plaque against 
an artery wall, is a life-saving treat¬ 
ment for patients, opening the pas¬ 
sage to blood flow and obviating the 
need for bypass surgery. But 
restenosis, or reblocking of the 
coronary artery, occurs about a third 
of the time within six months after the 
initial procedure. 
Henry S. Cabin, M.D. ’75, HS 
’75-’78, professor of medicine and 
pathology, and other members of the 
interventional cardiac catheterization 
group are looking for new ways to 
open blocked arteries that both reduce 
risks to the patient and keep the 
lumen — the interior passageway of 
the vessel — from closing again. 
One of these research projects 
involves inserting a stainless steel 
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device, called a stent, into an artery. 
After angioplasty, the stent is 
mounted on a second balloon and 
inserted into the coronary artery to 
support the artery walls. “The balloon 
is inflated, the stent is stretched and 
deployed,” says Dr. Cabin. “Then we 
deflate the balloon and remove it.” 
Initial results look promising for 
lowering the restenosis rate. 
Until recently, Yale cardiologists 
were the only physicians in Connecticut 
using stents; they have been at the 
forefront in testing new interventional 
devices for approval by the U.S. Food 
and Drug Administration (FDA). 
Interventional cardiologists on Yale’s 
team include Michael W. Cleman, 
M.D., professor of medicine and 
director of the cardiac catheter-ization 
laboratory; Michael S. Remetz, M.D., 
associate professor of medicine; Joseph 
J. Brennan, M.D., assistant professor of 
medicine; John Setaro, M.D., HS '86, 
assistant professor of medicine; and 
William J. Farrell, M.D., assistant 
clinical professor of medicine. 
Two new methods for ridding 
arteries of plaque altogether are also 
being evaluated. One uses a dia¬ 
mond-studded, high-speed drill to cut 
through heavily calcified plaque and 
pulverize it into particles smaller than 
red blood cells. It may also prove 
useful in patients who have blockages 
at certain branch points in their 
arteries. Directional coronary 
atherectomy provides yet another way 
to deal with plaque by removing it 
and temporarily placing it in a small 
storage chamber within the catheter. 
When the catheter is removed, the 
plaque comes out, too. The FDA has 
approved both of these atherectomy 
devices, the first with restrictions. 
Lawrence I. Deckelbaum, M.D., 
associate professor of medicine and 
director of the West Haven VA 
cardiac catheterization laboratory, 
and his colleagues are exploring the 
use of laser-induced fluorescence 
spectroscopy as a safer technique for 
vaporizing plaque without risk of 
damaging the underlying vessel wall. 
They are exploiting the fact that 
normal and arteriosclerotic tissue 
have different florescence spectra. 
If the arterial florescence emission 
points more toward the blue end of the 
spectrum, then the material tends to be 
plaque; if it moves more toward the 
green range, it tends to be normal 
tissue. Laser-induced fluorescence 
spectroscopy holds the promise of 
being able to guide vaporization of all 
the plaque to completely open the blood 
vessel. The technique has been devel¬ 
oped using animals as a model; more 
than 25 patients have been treated both 
at YNHH and the West Haven VA. The 
results: a high success rate and a 
low incidence of repeat procedures. 
In exploring other refinements of 
angioplasty, the laser research faculty 
have developed a technique that 
flushes saline solution into the artery 
during a laser procedure to remove 
the blood from the immediate field. 
This procedure allows better laser 
irradiation of the field and thus may 
decrease damage to the vessel wall. 
Michael Cleman, M.D., outside the cardiac catheterization laboratory at Yale-New 
Haven Hospital, where interventional cardiologists examine patients. 







Multi-Center Clinical Trials 
In the early 1980s. Yale was one 
of the original sites for the Coronary 
Artery Surgery Study (CASS). Dr. 
Cohen, the principal investigator and 
then-chief of cardiology, and his 
colleagues participated in this impor¬ 
tant study, which concluded that for 
patients witli coronary artery disease 
whose symptoms could be controlled 
well with medication and who had less 
than three diseased coronary arteries, a 
strategy of continuing medical therapy 
was as satisfactory as immediate 
surgical intervention with coronary 
bypass surgery. 
Dr. Cohen, along with former 
faculty member Charles K. Francis, 
M.D., and other colleagues, contrib¬ 
uted to the multi-center Thrombolysis 
in Myocardial Infarction (TIMI) 
studies in the mid-1980s. The second 
TIMI trial showed that after throm¬ 
bolytic therapy, routine angioplasty 
was not necessary unless there were 
continuing symptoms or evidence of 
continuing ischemia on exercise 
testing. This finding is of major 
importance to the health- delivery 
system, as it meant that patients could 
be cared for at their own community 
hospitals without the need for transfer 
to a tertiary center. 
“Participation in multi-center 
trials remains an important aspect of 
the clinical research program in the 
section and involves several investi¬ 
gators in a variety of areas in clinical 
cardiology,” says Dr. Zaret. 
Correcting Heart 
Arrhythmias 
Advances in electrophysiology 
have revolutionized the treatment of 
arrhythmias, the aberrant beating of 
the heart that can result in sudden 
death. At Yale-New Haven Hospital, 
several hundred automatic implant¬ 
able cardioverter-defibrillators, or 
AICDs, have been provided to 
patients with ventricular arrhythmias. 
Previously, this device was implanted 
only at the time of heart surgery. Now 
the electrical leads can be inserted 
into the subclavian vein near the 
collarbone and tunneled into an area 
in the abdomen where they are 
connected with the pulse generator, 
eliminating the need for chest surgery 
and speeding recovery. When the 
device detects an arrhythmia, it 
shocks or paces the heart into a 
normal beating pattern. 
For patients with an extra electri¬ 
cal pathway in the heart and conse¬ 
quently very fast heart rhythms, open- 
heart surgery was once the only way 
to eradicate the redundant electrical 
signals. Now, this can be accom¬ 
plished under local anesthesia with a 
technique known as radiofrequency 
catheter ablation. A catheter is 
introduced via a vein or artery and 
advanced to the heart under X-ray 
guidance. It delivers intense heat to 
the site of the rhythm disturbance, in 
muscular tissue connecting the upper 
and lower chambers of the heart. “If 
you burn the correct tissue, it 
eliminates the pathway,” says 
William P. Batsford, M.D., professor 
of medicine and director of the 
arrhythmia service. 
Now researchers are looking 
ahead to develop preventive strate¬ 
gies for arrhythmia. "We know fairly 
well how to manage patients who 
have had a life-threatening event,” 
says Dr. Batsford. “The big question 
is, ‘How do we anticipate who is 
going to have a life-threatening 
event before it happens?”’ Clinical 
trials in progress at the medical 
center are identifying the risk factors 
that can predict arrhythmias and the 
most effective treatments for various 
subgroups of patients. 
Lynda E. Rosenfeld, M.D., 
associate professor of medicine and 
director of the pediatric arrhythmia 
service, encounters a wide range of 
clinical challenges. “I see fetuses with 
arrhythmias and at the same time I see 
an 80-year-old (with arrhythmias), so 
the problems are different, which 
makes my job interesting,” she says. 
A sonogram can detect the heart 
rhythm problems of a fetus that 
cause total body edema, a condition 
known as hydrops. When a fetus is 
diagnosed with an arrhythmia, the 
mother often is given a medication, 
such as digoxin or a beta blocker, 
that passes into the fetus by way of 
the maternal circulation. 
The electrophysiology group also 
includes Craig A. McPherson, M.D., 
associate professor of medicine; and 
Richard J. Lewis, M.D., assistant 
professor of medicine. 
New Uses 
for Photochemotherapy 
Dermatologists have used ultravio¬ 
let light and psoralen to successfully 
treat psoriasis. Two projects at Yale are 
adapting the photochemotherapy 
technique for thwarting arterial block¬ 
age and for dampening the rejection 
reaction and reducing the infection rate 
following transplantation. 
In one of these studies. Dr. 
Deckelbaum and collaborators in the 
surgery and dermatology departments 
are using psoralen and ultraviolet 
(UV) or visible light to block growth 
of smooth muscle cells, a factor that 
is thought to contribute to reblockage 
of arteries. Dr. Deckelbaum’s col¬ 
leagues in this project are Bauer E. 
Sumpio, M.D., Ph.D., HS '81-’86, 
associate professor of surgery; and 
Francis P. Gasparro, Ph.D., research 
scientist in dermatology. 
Yale also is one of 12 centers 
participating in a clinical trial to test 
the usefulness of photochemotherapy 
for controlling rejection in heart- 
transplant patients. White blood cells 
are removed from the body and 
treated with the UV light and the drug 
before being reinfused into the 
patient. Several patients have already 
received the photochemotherapy, and 
it is expected that five to 10 patients 
who have received transplants will be 
treated with the UV light and psoralen 
regimen during the next year. 
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Molecular Cardiobiology: 
A New Era 
What prompts the adherence of 
plaque to the endothelial cells lining a 
blood vessel? 
Jeffrey R. Bender, M.D., HS 
’79-’83, associate professor of 
medicine and director of the cardio¬ 
vascular immunology laboratory, is 
using the tools of molecular 
cardiobiology to peer ever more 
closely at the intricate workings of 
cells to learn about the signaling 
that precedes vascular injury. 
Some of the hypotheses being 
examined offer surprising answers 
about several cardiovascular dis¬ 
eases. “We believe the interactions 
between the white blood cells and 
vascular endothelial cells are a form 
of immunity which plays a role in a 
lot of vascular diseases, anywhere 
from the obvious rejection of an 
organ transplant to atherosclerosis 
and strokes,” he says. 
The details of this immune 
reaction are being teased from the 
cells by Dr. Bender and his col¬ 
leagues. Their studies show that the 
seals between endothelial cells 
become loose when an immune 
reaction occurs. Leukocytes then 
seize the moment, pass through the 
seal and produce inflammation that 
can injure the vessel wall and lay the 
groundwork for plaque to develop. 
Dr. Bender and other researchers 
on the fourth floor of the Boyer 
Center for Molecular Medicine are 
studying mechanisms that explain 
how circulating cells in the blood 
adhere to the cells that line blood 
vessels. Estrogen seems to protect 
these cells from becoming “pro¬ 
adhesive” to blood cells. The rela¬ 
tionship between these two types of 
cells may explain why post-meno¬ 
pausal women, who secrete little 
estrogen, lose their shield from heart 
disease. See Down to Basics: Yale’s 
New Molecular Cardiobiology 
Program Plumbs the Depths of the 
Human Vasculature on Page 14. 
Exploring How Insulin 
Affects Heart Metabolism 
Most people think of the heart as 
a static muscle, a mechanical pump 
that provides the force needed to 
propel blood throughout the body. 
New information from studies in the 
cardiac laboratory shows that the 
heart is a structurally dynamic organ 
that constantly breaks down and 
rebuilds protein. One could almost 
say that each of us gets a new heart 
every 28 days. 
A new hypothesis about heart 
metabolism and the role of insulin in 
heart growth is being tested by 
Lawrence H. Young, M.D. ’80, HS 
’80-’83, associate professor of 
medicine, and Patrick H. McNulty, 
M.D., assistant professor of medicine, 
of the cardiology metabolism pro¬ 
gram. They have found evidence that 
conditions associated with high levels 
of insulin due to insulin resistance — 
such as obesity, aging, diabetes and 
high blood pressure — may contrib¬ 
ute to cardiac hypertrophy. 
“We have several pieces of data 
now which show that insulin is a 
factor which regulates heart growth. 
It does this not by increasing protein 
synthesis in the heart, but rather by 
inhibiting protein degradation,” says 
Dr. Young, who adds that they are 
now hoping to elucidate this process 
at a molecular level. 









noticed a connection 
between estrogen 
levels and the 
activities of the cells 
lining the blood 
vessels. Dr. Bender’s 
research may help 
explain why post¬ 
menopausal women 
lose their shield from 
heart disease. 
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Preventing Artery-Clogging 
Blood Clots 
Michael D. Ezekowitz, M.B.Ch.B., 
Ph.D., professor of medicine and 
chief of the cardiology service at the 
Department of Veterans Affairs 
Medical Center, and colleagues are 
seeking ways to prevent heart attacks 
caused when an artery is blocked by a 
blood clot. Two targets are human 
tissue factor, a protein abundantly 
associated with arteriosclerotic 
plaque that triggers blood clotting, 
and Ilbllla, a receptor that regulates 
the clumping of platelets. 
Yale scientists have produced a 
monoclonal antibody against tissue 
factor that inhibits blood clotting in a 
rabbit model and may provide the 
foundation for the development of an 
entirely new class of anticoagulants. 
Working with Dr. Ezekowitz are 
William H. Konigsberg, Ph.D., 
professor of molecular biophysics and 
biochemistry and genetics; Alan 
Garen, Ph.D., professor of molecular 
biophysics and biochemistry; and 
Aruna B. Pawashe, Ph.D., a post¬ 
doctoral associate in medicine and 
molecular biophysics and biochemistry. 
The team has also developed an 
antibody against the Ilbllla receptor 
in rabbits. “There are clinical trials in 
progress using the human version of 
this,” says Dr. Ezekowitz, “and this 
work may lead to the development of 
a more effective aspirin — a super¬ 
aspirin — to treat a whole variety of 
vascular diseases.” 
Synthetic forms of both anti¬ 
bodies will soon be tested in large 
clinical trials to determine their 
effectiveness in blocking the forma¬ 
tion of clots that can cause a heart 
attack, says Dr. Ezekowitz. 
Transplantation 
and Heart Failure 
In one of the newest components 
of the clinical research program, each 
year approximately 100 patients from 
Connecticut and nearby areas of New 
York are evaluated for either a heart 
transplant or a heart-lung transplant. 
“Only people seriously ill with heart 
disease who have a life expectancy of 
less than one year without a trans- 
Forrester A. Lee, M.D., is medical 
director of Yale’s cardiopulmonary 
transplant program. 
plant and for whom there is no other 
treatment option are candidates,” says 
Forrester A. Lee, M.D. ’79, associate 
professor of medicine and medical 
director of the cardiopulmonary 
transplant program. Approximately 
Patrick H. McNulty, M.D., 
left, and Lawrence H. 
Young, M.D., of the 
cardiology metabolism 
program have found 
evidence that conditions 
associated with high levels 
of insulin due to insulin 
resistance may contribute 
to cardiac hypertrophy. 
New evidence shows that 
insulin helps regulate 
heart growth ‘'not by 
increasing protein 
synthesis in the heart, but 
rather by inhibiting 


















20 to 25 of these candidates receive 
transplants. 
A substantial clinical and research 
program also is developing to treat that 
much larger group of heart-failure 
patients who will not receive a trans¬ 
plant. A variety of new drugs and 
therapeutic strategies may result from 
the program, under the direction of Dr. 
Lee, James H. Revkin, M.D., assistant 
clinical professor of medicine; and 
Tarik M. Ramahi, M.D. ’87, HS ’87- 
’90, instructor in medicine. Dr. Lee also 
serves as director of the post-graduate 
fellowship program in cardiology. 
What Lies Ahead 
As a discipline, cardiology contin¬ 
ues to grow rapidly, especially as the 
tools of molecular biology open new 
doors. Dr. Zaret predicts a host of 
molecular and vascular studies over the 
next decade and the development of new 
therapies based on modem biology. 
Ultimately, he says, gene therapy may 
bring major changes: “The injection of 
genes that would change the genetic 
makeup of the heart could lead to the 
regeneration of muscle cells.” 
Cardiologists will be better able to 
identify patients at high risk for cardiac 
problems and treat them before a heart 
attack or other problem occurs. Out¬ 
comes research, including studies by 
Harlan M. Krumholz, M.D., assistant 
professor of medicine and epidemiol¬ 
ogy, will give cardiologists a better 
understanding of treatment strategies 
— “not just in terms of life and death 
but in quality of life, cost-effectiveness 
and other factors,” says Dr. Zaret. 
“At Yale, there's likely to be more 
focus on basic research and more 
emphasis on a larger clinical net¬ 
work of patients entering the system 
through referrals,” he adds. “As we 
move into a new era of health-care 
reform and changing policies involv¬ 
ing health care, it is critical that we 
are positioned to continue to have 
that patient base so necessary for our 
research, our teaching and our 
clinical practice.” YM 
Literature of the heart 
In addition to their extensive 
research, clinical and educa¬ 
tional activities, faculty of the 
Yale cardiovascular medicine 
section publish more than 100 
articles and reviews in profes¬ 
sional journals every year. 
Several of the faculty 
helped launch a new publica¬ 
tion, The Journal of Nuclear 
Cardiology. Dr. Zaret serves as 
editor-in-chief, Drs. Wackers 
and Sinusas are two of the four 
associate editors, and Dr. 
Soufer is a member of the 
international editorial board. 
The journal is the primary 
publication of the American 
Society of Nuclear Cardiology; 
Dr. Wackers serves as the 
society’s current president. 
Among the recent books 
emanating from the section are: 
Yale University School of 
Medicine Heart Book (Hearst 
Books, New York, 1992), edited 
by Dr. Zaret, Marvin Moser, 
M.D., and Lawrence S. Cohen, 
M.D., with editorial director 
Genell J. 
Subak- 
Sharpe, is a 
comprehen¬ 
sive guide 





tests and treatments. It also 
includes advice on nutrition, 
prevention and rehabilitation. 
Special sections focus on heart 
disease in women, children and 
the elderly. More than two 
dozen Yale faculty have written 
a practical reference book that 
answers the public’s questions 
about cardiovascular disease and 
how to prevent it. 
JOURNAL OF 
NUCLEAR CARDIOLOGY 
Volume I • Number 3 May / |une 1994 
American Society ol Nuclear Cardiology 
M Mosby 
Nuclear Cardiology: State 
of the Art and Future Direc¬ 
tions (Mosby, St. Louis, 1993), 
edited by Dr. Zaret and George 
A. Beller, M.D., head of the 
division of cardiology at the 
University of Virginia Health 
Sciences Center in 
Charlottesville. The book is 
considered to be the most up- 
to-date reference in the field of 
nuclear cardiology and assesses 
the state of the art of the 
discipline and considers future 
directions. 
Systemic Cardiac Embo¬ 
lism (Marcel Decker, New 
York, 1994) was edited by 
Michael D. Ezekewitz, 
M.B.Ch.B., Ph.D., who also 
contributed many of the 
chapters. It is the first book to 
discuss cardiac causes of strokes. 
Frontiers in Cardiovascu¬ 
lar Imaging, (Raven Press, 
1993), edited by Dr. Zaret, Leon 
Kaufman, Alan S. Berson and 
Rosalie A. Dunn. The book 
provides a comprehensive 
overview of techniques for 
imaging the heart, based on a 
1992 workshop sponsored by the 
National Institutes of Health. 
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My Three Valves 
by John T. Harrington, M.D. '62 
"Whatever you say, you say 
nothing.” When I was asked to write 
an editorial on my personal experi¬ 
ences with heart-valve surgery, that 
pithy phrase of Seamus Heaney, 
succinctly expressing the Catholic 
code of silent speech in Northern 
Ireland, came to mind. That code had 
leapt from Belfast to the town where I 
grew up, a working-class community 
of hills, mills, and churches in 
Massachusetts. The code was strong 
enough that during the time I pos¬ 
sessed my native aortic valve (which 
1 will here term the era of valve I), 
few people other than my family 
knew of my illness. I had had rheu¬ 
matic fever at the age of eight, just 
before penicillin became available. I 
don't remember much about the acute 
episode, except that I couldn't move 
my knees for a week and that I was 
hospitalized alone in a 10-bed ward. 
The code of my culture said you don't 
complain about illness — you simply 
do what is necessary. 
I did what was necessary. I 
wasn’t allowed to play sports (not a 
great loss to my high-school team, 
since I couldn’t hit curveballs any¬ 
way). After swimming 1 had to 
change my bathing suit immediately 
because wet bathing suits promoted 
John T. Harrington, M.D. '62, 
is professor of medicine 
at Tufts University School of Medicine 
and co-editor of Nephrology Forum. 
disease. I wasn't even allowed to be 
an altar boy. For the most part, I went 
quietly along my way ignoring my 
silent murmuring valve. In college, I 
remember monthly injections of 1.2 
million units of Bicillin, which would 
leave me with a limp for a few days 
as I climbed the hills of Holy Cross 
College. In medical school, fellow 
students learned from listening to my 
“interesting” aortic diastolic blow and 
some years later remembered that 
murmur as my most impressive asset. 
Valve I was a hindrance to getting 
affordable insurance — I still have 
minimal life insurance — but I’ve 
beaten the insurance companies. I’m 
delighted to say. Valve I also made 
me 4-F in the early 1960s, which 
disappointed me then but in the late 
1960s had the advantage of prevent¬ 
ing me from going to Vietnam. 
By the late 1970s and early 
1980s, I was cocky. Yes, 1 had the 
murmur of aortic insufficiency, but I 
had no symptoms, and periodic 
electrocardiograms and 
echocardiograms showed no change 
in cardiac structure or function. I 
knew I would need a new valve 
someday, but I had convinced myself 
that such an operation lay 10 years 
away from whatever day it was. Most 
of the people I worked with on a daily 
basis did not know I had a leaky 
valve. That is not too surprising, 
because for the most part I denied it 
to myself, and even when I was aware 
of it, I wouldn't have told others 
about it. For the psychiatrists who 
read this, I know it was denial, but 
wait till you read the next paragraph. 
John T. Harrington, M.D. 
The era of valve II began in late 
1983 or early 1984. I had begun one 
of my infrequent attempts at aerobic 
exercise by running a mile or so three 
nights a week. I would run a half-mile 
down the road and then the half-mile 
back, up a gentle incline. I began to 
notice that when I reached my home, 
I had a peculiar sensation, centered 
dead in the middle of my sternum, 
which I called "windburn.” The 
windburn would disappear after I 
rested for a few minutes on my front 
steps. At about the same time, my 
aortic-insufficiency murmur disap¬ 
peared, leaving me with the murmur 
of aortic stenosis. The windburn 
lasted three or four months — until I 
told my cardiologist about it. To his 
credit, he didn’t hit me over the head 
with a hammer, but he suggested that 
I stop running and begin to think 
about getting a “valve job” (my 
phrase, not his). 
That was in 1984. I was 47 years 
old, I assumed that I would always be 
47, and suddenly I had to decide 
which type of artificial valve I 
wanted. I first checked mortality 
figures (I spent many years doing 
acid-base physiology, and I remain 
obsessive about “hard” data). Fortu- 
28 Yale Medicine Summer 1994 
nately, the mortality associated with 
elective aortic-valve replacement had 
dropped from 10 percent in the early 
1970s to about 1 percent by Novem¬ 
ber 1, 1984 (All Saints’ Day), the date 
of my first valve surgery. Unfortu¬ 
nately, I couldn’t get what I wanted. 
What did I want? I wanted the best 
of both worlds — the low incidence 
of complications of a bioprosthetic 
valve and the longevity of a mechani¬ 
cal valve. But I didn’t want to take 
any medicine, particularly that nasty 
warfarin, which I knew would make 
me bleed in my head. I was most 
worried about an intraoperative 
stroke, an unlikely event, but one that 
terrified me because of my obliga¬ 
tions to my wife and seven children, 
only two of whom had graduated 
from college at that time. 
I chose a bioprosthetic valve for 
valve II (fashioned from bovine 
pericardial tissue, which I liked to 
think of as a “valve from a bull”), 
mainly because of my fear of 
anticoagulation. I knew the valve 
would not last as long as a mechani¬ 
cal valve, but to me it was simple; I 
didn’t want anticoagulation. I didn't 
bleed into my brain, I had no impor¬ 
tant complications, and I was back at 
work four weeks later. The first 
several years went well. I went back 
into the denial mode that allows me to 
make my way in life. I did, however, 
begin to ask my cardiologist how the 
valve would fall apart, how I would 
know, and what I should do. And I 
again began negotiating with God to 
put off valve surgery, this time not for 
10 years, but for two years from 
whatever day it was. 
My bioprosthetic valve and I 
nevertheless got along famously for 
eight years and almost two months. I 
saw my cardiologist once a year and 
had a cardiac echocardiogram, as I 
did in mid-November of 1992. My 
anxiety titer would go up during the 
My wife, however, 
read my silence, 
followed me upstairs, 
and said, “What's 
going on?” / 
confessed. One hour 
later I was receiving 
intravenous 
nitroglycerin in the 
emergency room of a 
Boston hospital. 
month or so before the visit and wane 
thereafter. I’ve always been a lucky 
guy (for you youngsters reading 
this, that phrase is adapted from 
Lou Gehrig), so I simply assumed 
that at some time, always fairly far 
in the future, there would be a 
“little” calcification of the valve 
and, over weeks to months, the 
valve would deteriorate. 
It didn’t happen that way. The 
valve III era began abruptly. Two 
days after Christmas 1992, at 7:30 
a.m., I was healthy and hardy, having 
breakfast with my wife, my twin 
three-and-a-half-year-old grandsons, 
and my son-in-law. At 7:31 a.m., I 
had the world’s worst chest pain, 
causing me to double up. One cusp of 
the valve had torn, rendering the 
valve suddenly totally incompetent. I 
tried to debate for a millisecond 
whether it was better to have a heart 
attack or to have the valve blow, but I 
didn’t believe that I could have a 
heart attack because my coronaries 
had been clean eight years earlier. 
Remaining true to the code, I didn’t 
say anything. And being brilliant, I 
walked up a flight of stairs to get 
away from the kids. My wife, how¬ 
ever, read my silence, followed me 
upstairs, and said, “What’s going 
on?” I confessed. One hour later I 
was receiving intravenous nitroglyc¬ 
erin in the emergency room of a 
Boston hospital, with a worried 
cardiologist and a cardiac surgeon 
hovering over me. Valve III was 
installed the next day. 
I don’t remember much of the 
first two or three days after surgery. In 
fact, I had a cardiac catheterization 
just before surgery, now lost in the fog 
of retrograde amnesia. Valve III is a 
mechanical valve — a Saint Jude 
valve, to be precise. I had talked that 
decision over a bit with my cardiolo¬ 
gist in the year or so before surgery. I 
can't say I gave fully informed 
consent before surgery; I sort of 
waved, and my wife, cardiologist and 
cardiac surgeon ran the show. After 
the operation, I was delighted it was a 
Saint Jude valve. Beforehand, it 
probably would have worried me. To 
a traditional Catholic, Saint Jude is the 
patron saint of hopeless causes, and 
although things were desperate, my 
denial would not have permitted me to 
believe they were hopeless. 
For some reason, I never thought 
I was going to die, despite having 
wide-open aortic regurgitation. I had 
great confidence in the cardiologist 
who had been seeing me for more 
than 25 years, since I came to Boston, 
and in my cardiac surgeon — he’s 
been in my heart twice. Now I am 
anticoagulated and I still don’t like 
that. But, in this era of valve III, it 
looks like something I will have to 
tolerate. I am told Saint Jude and I can 
last 30 years or more. I will try not to 
have my head hit by the boom of my 
sailboat, but I’ll be damned if I’ll 
wear a helmet while sailing! Carpe 
Diem. (Did you notice I didn’t 
mention endocarditis — or sex?) 
Reprinted by permission 
of The New England Journal of Medicine, 
Vol. 328 No. 18, pages 1345-6. 
Copyright 1993 
Massachusetts Medical Society. 
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Ruminations of a 
Teaching Surgeon 
by Robert A. Chase, M.D. '47, 
HS '47-’54 
I would like to take a rather 
lighthearted approach to reviewing 
my world of medical education. A 
good friend of mine has a credo that 
goes: “It is not so important to be 
serious as it is to be serious about 
what's important.’’ 
One of the strong memories in 
my career was coming to California 
and Stanford University in 1963 as 
chairman of the department of 
surgery. My vision over the years had 
been that, except for the captain of an 
ocean-going liner, the last reigning 
monarch was the chairman of a 
department of surgery. “Power, power 
at last,” I thought to myself. So as an 
early initiative, I phoned the emer¬ 
gency department, the intensive care 
unit, the recovery room, and various 
areas to check on their facilities and 
readiness. I called the operating room 
and got the doctors' dressing room 
orderly. “Doctors’ dressing room,” 
said he. I said, “I would like to 
inquire about locker facilities for 
surgeons.” “Well,” he responded, 
“we have some open half singles for 
students and residents, some slightly 
rusty back lockers for attending and 
Robert A. Chase, M.D. '47, HS ’47- 
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visitors, and for the fat-assed profes¬ 
sors, we have some new combination, 
secured full-length lockers.” “Do you 
know who this is?” I questioned. 
“Nope,” was his response. "This is 
Professor Chase, new chairman of the 
department of surgery,” said I au¬ 
thoritatively. "Do you know who this 
is?” he inquired. “Well, no,” I an¬ 
swered. “Well, good-bye, fat ass,” he 
retorted as the phone clicked off. 
Memories 
I would like to go back 47 years 
to 1943 when I started in the study of 
medicine. It was, in Dickens’s words, 
. .the best of times and the worst of 
times,” before ball point pens, 
pantyhose and credit cards. Before 
hair dryers, second opinions and 
touch-tone telephones. We didn't dare 
say condom out loud but had no fear 
of referring to hearts as young and 
gay. It was an age when Madonna 
was a statue at the local Catholic 
church, third-party carriers helped 
with your luggage, and marketing was 
something you did with a basket. 
It was an era when TLC didn't 
mean thin-layer chromatography and 
HMO was Haley’s famous laxative. 
MR meant mister and medically 
indigent adults were not MIAs. MIA 
had the jarring and depressing 
meaning that it had again during the 
Persian Gulf War. APCs were not 
armored personnel carriers. In those 
days, physicians knew who Osier and 
Halsted were and fear of malpractice 
was not a driving force in medical 
decisions. Podiatrists did podiatry, 
general surgeons were general, and 
the only treatment in gastroenterology 
was some variation of the Sippy diet, 
whereas today's fiberoptic endoscopy 
presents endless opportunities to look 
into oneself. Less than a radical 
mastectomy would have been mal¬ 
practice — if there had been malprac¬ 
tice. A hand-held calculator was a 
slide rule and AIDS identified people 
who helped nurses or wore pink 
frocks. Closets were not for coming 
out of. Gallbladders were removed by 
incision and dissection. 
It was before “thank you” was 
said by flashing lights at the toll booth 
and when “have a nice day” meant 
have a nice day. Affirmative action 
was a vote at the town meeting. 
It was before MRI, RVS, CME and 
PPO. Oncology wasn’t even a word. 
We surgeons didn’t know we 
were in non-cognitive specialty. 
There were no lasers, surgical staples, 
vascular grafts or joint prostheses. 
Digital subtraction meant finger 
amputation, lithotripsy was a tech¬ 
nique for jumping rope, and ultra¬ 
sound came from jukeboxes. 
A hospital day cost $65, and an 
appendectomy brought $125 maxi¬ 
mum. Free care was freely given and 
Robin Hood ordered the behavior of 
administrators. Now it’s rob the rich 
and pay the lawyers. It now costs 
more to go to the hospital than it did 
then to go to medical school. We 
didn’t call firing people downsizing 
or being de-selected, outplaced or non- 
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positively terminated, and a set of 
objectives was not a paradigm. 
Quality assurance was the wear 
guarantee that came with interwo¬ 
ven socks. 
I would have thought a suppres¬ 
sor oncogene was an auto part or a 
radio tube. There were no contact 
lenses, throw-away syringes, 
cyclosporins, monoclonal antibodies 
or recertifications. A chromosomal 
short arm could have been misinter¬ 
preted by us Army docs. 
Come and gone in my years have 
been Wangensteen’s gastric freezing, 
Smithwick’s total sympathectomy. 
Gillies’ tubed pedical flap, and a 
whole host of procedures now dealt 
with medically or radiologically. 
In our days, kids played doctor — 
now they play specialist and their little 
doctors’ kits come with a malpractice 
insurance policy. In the ER they used 
to take your vital signs — now they 
take your Blue Cross number. 
We were grossly deficient in 
what we could do physically for our 
patients — no open-heart surgery, no 
endoscopic surgery, no microsurgery, 
no transplant surgery, but medical 
care meant caring for the patient. In 
many ways — the best of times. 
What has continued as best for 
me is the privilege of teaching. There 
is real pleasure in watching and 
helping students develop from 
freshman who think the Caesarean 
section is a district in Rome to seniors 
who understand the details of genetic 
recombinant DNA therapy far better 
than I. 
It has been fun to observe the 
cyclic changes in medical school 
related to: 
• Grading versus pass/fail 
• Core curriculum versus electives 
• Honors versus no honors 
• The early introduction to clinical 
medicine 
• Organ systems approaches 
• Problem-oriented learning 
• Thesis requirements 
• Attitudes towards the National 
Board Examinations 
Robert A. Chase, M.D. 
There are lots of experimental 
curricula as at Case Western Re¬ 
serve, McMaster University, Miami 
and Harvard and their “New Path¬ 
way.” Our generation can be 
characterized as one offering 
French in kindergarten and remedial 
English in college. In academic 
medicine, we see evidence of this 
when reading histories. Here are 
some entertaining chart entries: 
This gentleman urinates around 
the clock every four hours. 
A 54-year-old woman arrived 
with abdominal distress — she has 
constipation on the one hand and 
diarrhea on the other. 
This 30-year-old male is married 
— no other serious illness. 
Or a prescription I saw that read, 
“Tenactin suppositories, dispense 24 
(such) Sig: Insert one every four 
hours until exhausted.” 
What incredible satisfaction I 
have had in watching the unfolding of 
the careers of students and trainees. 
Recommending them for the next step 
in their careers is generally one of the 
pleasures. Yet, in today’s era of 
freedom of information, letters are 
available to the student or trainee. 
This has led to what Lederer calls the 
“mangled modifier” strategy for 
letters of recommendation. Watch for 
varying interpretations in letters 
describing students. For example: 
For the lazy student: “You'll be 
lucky to get Harvey to work for you,” 
or “I can't recommend him too highly.” 
For the person in trouble with 
the law: “He is a man with many 
convictions.” 
For the heavy drinker: “I spent 
many happy hours with Hubert.” 
Participating as a CME instruc¬ 
tor is always profitable education¬ 
ally, since one learns from the 
participants. Although ours has been 
identified as a learned profession, 
its proudest attribute is that it is a 
learning profession. 
As a teacher, do I have concerns? 
Of course I do. I have noted with 
some alarm the drop in the number of 
applications to medical school — 
about 31 percent over the last decade 
with an applicant-to-billet ratio going 
from 3.5 applications to one position 
in 1950 to 1.6 to one in 1990. Fortu¬ 
nately, this year’s application num¬ 
bers have started to rise. Disturbing, 
however, were data from the Associa¬ 
tion of American Medical Colleges 
survey of students who took the 
MCAT, then did not apply to medical 
school. Of these, a half had chosen 
alternative careers, and 30 percent of 
these were advised against medicine 
by physicians predominately from the 
older generation. 
I am concerned at the growing 
average indebtedness of our gradu¬ 
ates. In 1989, the average debt for 
medical school graduates was 
$42,374 — nearly twice what it was 
in 1987. 
I worry that medical schools 
have become more dependent upon 
faculty-earned practice funds. In 
1971, practice funds furnished 12 
percent of total school revenues, 
whereas in 1990, 43 percent of 
revenues came from faculty prac¬ 
tice earnings. 
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The Future 
In the years ahead, our profession 
generally has enormous new prob¬ 
lems to solve. A simple listing of a 
few of the issues might include: 
• The continuing struggle to meet 
the health-care needs of our citizens 
versus the reality of budget con¬ 
straints and deficit reduction 
• Over 30 percent of babies 
admitted to inner-city intensive care 
units are born to “crack” abusing 
mothers, and 2 percent or 3 percent 
are positive for the human immuno¬ 
deficiency virus, HIV 
• An estimated 1 million people in 
the United States are HIV-positive 
• 37 health-care workers are 
thought to have contracted HIV 
infections on the job, largely from 
needle sticks 
• 14 percent of medical schools 
report medical students or residents 
who are HIV-positive 
• 40 surgeons and 144 dentists are 
known to have the acquired immuno¬ 
deficiency syndrome, and the Centers 
for Disease Control estimates at least 
10 times this many are HIV-positive 
• Old diseases such as measles are 
reappearing — 13,000 cases in the 
United States in 1989 
• The whole issue of positive 
euthanasia 
• The problem of physician 
participation in executions for capital 
punishment 
• Sex between physicians and 
patients, said to have an incidence of 
5 percent to 10 percent among 
psychiatrists 
• The need for guidelines on ethics 
of various drug house gifts and favors 
• The growing evidence of fraudu¬ 
lent research 
And the list goes on. 
Above all, we must not let 
problems, challenges and advances 
cloud those wonderful attributes of 
our profession and its activities that 
are changeless. Quantitatively, most 
clinical medicine is straightforward. 
It is our privilege to help most 
patients because they have simple 
curable disorders, and it is equally 
important that we offer effective 
reassurance to the one-third to one- 
half of patients coming to us who 
have no physical or biomedical 
ailment. In academia we are inclined 
to search for zebras. 
Responsibility at a distance as in 
“managed care” will never substitute 
for a physician’s responsibility for his 
or her patient. I find that the apparent 
ease with which a problem may be 
solved is directly proportional to 
one’s distance from the problem. 
Since a physician knows more than 
anyone else about his or her patient, 
he or she is, by definition, captain of 
the health care team. 
Next to being shot at and missed, 
nothing is really as satisfactory 
professionally as a good surgical 
outcome recognized by both the 
patient and the surgeon. A poor 
result makes one wish that the shot 
had not missed. 
Despite the fact that we may all 
become salaried employees with rules 
based on cost, faced with ethical 
issues of monumental proportions 
because of emerging technologies, 
and despite the specter of malpractice 
litigation and diminishing public 
respect, as well as demands of society 
through third-party carriers and 
government, despite all of these, the 
most precious gift of all — the 
relationship between physician and 
patient — remains and always will 
remain in our hands. 
Reprinted by permission of The Western 
Journal of Medicine, March 1992, 
Vol. 156 No. 3, pages 314-315. 
The following poem is reprinted 
from the spring 1994 issue 
of Diverticulum, the medical 
school literary magazine. 
The Long Visit 
With a smile 
She pulls a secret from her pocket 
and sneaks it into mine, 
soft and weathered 
like the clay she walks on 
sits against my chest and 
weighs 
speckling my complexion 
weaned from daisy’s white milk, 
and throws a strand of hair astray 
cameras shutter. 
After the rains 
my shoe lodges in her mud 
and mends the callus on my heel, 
past prayers that clash to call 
in sixths and minor fourths, 
retreating like late afternoon 
toward fruit from the vines that fall 
... and trip my thoughts. She sees 
in me a glimpse of time, 
now her morning tea 
too dark for just 
one mug. 
— James Ahn 
Class of '95 
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The Modern 
Way of Dying 
Yale physicians 
look closely at the 
dilemmas of 
a patient's final days 
by Carolyn Battista 







In a crowded, big-city university 
hospital with no empty beds, a cancer 
patient lies on a stretcher outside the 
emergency room, passing in and out of 
a coma. Experimental chemotherapy 
has not halted his disease and the toxic 
effects have become unmanageable. 
Another cancer patient is at 
home, welcoming two dozen guests to 
a Christmas Eve dinner, one of the 
annual rituals that have defined and 
brightened his adult life. His progno¬ 
sis is terrible and this year, he knows, 
he will enter a hospice as soon as the 
holiday ends. But he has chosen his 
own epitaph, a line from Dickens that 
will be engraved on his tombstone: 
"And it was always said of him that 
he knew how to keep Christmas well.” 
Stories like these fill the pages of 
How We Die: Reflections on Life's 
Final Chapter, the best-selling book 
by Sherwin B. Nuland, M.D. ’55, HS 
'55-'61, clinical professor of surgery 
at Yale. The stories grew from his 
practice and his personal experience 
(the first patient was his brother) and 
they address some of the most vexing 
human questions confronting physi¬ 
cians at the turn of a new millennium. 
How can doctors best help their 
dying patients? How can they deal 
with "the modern way of death” 
created by late 20th-century medi¬ 
cine? Does such a thing as “a good 
death” exist? 
At a time when America seems 
spellbound by death — from the 
passing of Jacqueline Kennedy 
Onassis and Richard M. Nixon to the 
suicides assisted by Dr. Jack 
Kevorkian — Yale physicians are 
looking at modern death as well, 
examining doctors’ attitudes, patients’ 
fears and the dilemmas faced by 
physicians, patients and families. 
They, too, see ways in which 
doctors can help dying patients find 
genuine hope, like that embodied in 
an observation of Diane M. Komp, 
Carolyn Battista is a free-lance writer 
who lives in Waterford, Conn. 
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M.D.: “Separation and isolation in 
the valley of the shadow of death are 
preventable disorders.” 
Six physicians — including Drs. 
Nuland and Komp, professor of 
pediatrics at Yale — talk here about 
what they have learned. They also point 
to areas where they know that they and 
their colleagues need to keep working. 
"Doctors are afraid of death, 
unconsciously, more than anybody 
else,” says Howard M. Spiro, M.D., 
a gastroenterologist and professor of 
medicine at Yale. "They have 
deconstructed death into a series of 
events which can be handled medically. 
For them, death is not the end of life; 
it’s the failure of the physician. They 
never talk about what a good death 
could be, about the right time to die.” 
Doctors need to ponder these 
issues and discuss them, says Dr. 
Spiro, editor of the anthology Empa¬ 
thy and the Practice of Medicine, 
(Yale University Press, 1993) and the 
author of two of its chapters. See 
Doctors, Death and Discourse: 
Physicians as Authors, Page 41. 
“‘Empathy’ is the feeling that I 
might be you,” Dr. Spiro writes. He 
believes that doctors must have 
empathy if they are to treat disease — 
and provide compassionate care. 
Talking, he says, helps them recog¬ 
nize and develop empathy. 
As director of the Program for 
Humanities in Medicine at Yale, Dr. 
Spiro recently co-chaired a Yale 
colloquium titled Ars Moriendi: The 
Art of Dying. Now he and faculty 
from other disciplines are starting an 
informal discussion group to examine 
death and dying and other important 
issues facing physicians from many 
perspectives. "We doctors need to get 
advice from historians, philosophers, 
the clergy,” he says. 
He sees hope in the spread of 
ideas and information. Recently, he 
observes, “the whole notion of futility 
has been highlighted in medical 
literature. Doctors are becoming more 
aware that they have to decide ‘What 
am I trying to do? To prolong life, or 
to prolong dying?”’ 
The public should know more 
about what is futile and what is 
reasonable, he adds. Though he was 
no fan of the late President Nixon 
while he was in office (“I marched in 
Washington to protest the Vietnam 
War,” he recalls), he admired him 
later for drawing up a living will. 
“That made an impression on many 
people,” he says. 
Dr. Spiro sees hope in changing 
an impression that he thinks too many 
of his colleagues hold. “Doctors see 
the dying patient as ‘someone I can’t 
help,’ but that is exactly the patient 
that doctors can help,” he says. “They 
can comfort them, make sure they’re 
not in pain.” 
Dr. Nuland’s How We Die, which 
has received wide attention in the 
national press, is opening many eyes 
to the concept that even in the 1990s 
— and perhaps especially today — 
doctors need to reach out to patients 
in ways they cannot learn from 
medical texts and journals. 
“People are talking; they need 
and want to hear more. Every effort 
like this increases the dialogue,” says 
Dr. Nuland. He expected many of his 
colleagues to be angered by his 
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insistence that hope often lies outside 
modem, high-tech medicine but 
instead has found them to be supportive. 
“They’re saying, ‘Well, it’s about time.’” 
Dr. Nuland entered medicine 
inspired by the general practitioner 
who looked after his family when he 
was growing up in the Bronx. But like 
many of his colleagues he experi¬ 
enced a change in attitude during the 
course of his education. “There’s a 
subtle progression,” he observes, in 
which young medical students who set 
out to help the sick become “biomedi¬ 
cal problem-solvers,” fascinated by — 
and driven to solve — what he calls 
“The Riddle of Disease.” 
“To medicine’s absorption with 
the Riddle, we owe the great clinical 
advances of which all patients are the 
beneficiaries,” he says. But that 
absorption has also produced expecta¬ 
tions that doctors cannot fulfill. When 
his brother, Harvey, was found to 
have a cancer he knew to be beyond 
any treatment, he kept elements of the 
full truth from him. With desperation 
replacing better judgment, he per¬ 
suaded his brother to be treated with 
experimental, highly toxic drugs. 
The crux of medicine is the relief 
of pain and suffering, says Dr. Nuland. 
Hope lies there, not in efforts that are 
misguided, unrealistic, often drastic. 
“We must never let patients lose 
hope, but there is arrogance in the 
message that hope can come only 
from us — that the only important 
hope is that successful treatment will 
be found,” he says. “There are many 
kinds of hope that doctors can help 
patients to find at the end of life.” 
Physicians can give dying 
patients and their families assurance 
that there will be no unreasonable 
efforts, he says, and help them find 
the hope that comes from under¬ 
standing there is only futility in 
fighting death beyond a certain point. 
They can give patients the hope that 
they will not be abandoned by a 
medical staff that no longer has a 
riddle to solve. 
“A promise we can keep, and a 
hope we can give, is the certainty that 
is the hope that what a person’s life 
meant will not die. He has never 
forgotten Bob DeMatteis, the patient 
whose last celebration of Christmas 
was part of being who he was and 
being remembered that way. “Death 
belongs to the dying,” Dr. Nuland 
says, and doctors who understand that 
can offer hope. 
Dr. Komp, in her 27-year career 
as a pediatric oncologist, has seen the 
great hope that solving the Riddle of 
Diane M. Komp, M.D. 
no man or woman will be left to die 
alone,” he says, adding that “of the 
many ways to die alone, the most 
comfortless and solitary must surely 
be when the knowledge of death's 
certainty is withheld.” For then, he 
says, the dying person is deprived of 
any final consummation with loved 
ones, and of the hope that comes from 
“the promise of spiritual companion¬ 
ship near the end.” 
Perhaps most important, he adds. 







Death of the King, on anonymous 16th-century woodcut print from the Clements 
C. Fry Collection at the Historical Library’ of Harvey Cushing/John Hay Whitney 
Medical Library at Yale. 
Disease offers. She has seen the 
percentage of children dying from 
cancer drop by 68 percent. But she 
has learned — often from her dying 
young patients and their families — 
about other kinds of hope as well. 
“Hope is something that can be 
used to explore things other than 
survival. It’s not denial or wishful 
thinking; it's grounded in reality.” 
says Dr. Komp, the author of two 
books on children with cancer. A 
Window to Heaven and A Child Shall 
Lead Them. Her newest book. Hope 
Springs from Mended Places, to be 
released in October, focuses on the 
experiences of mothers. 
She says physicians need to 
“support families without suggesting 
that a 'good death’ cannot happen 
unless we are running the show.” She’s 
found that it’s best when doctors and 
nurses stand as advisers, “helping 
parents listen to their own children.” 
Physicians need to retune their 
ears, to listen to whispers, she says. 
They need to “hear not what they 
want to hear, but what the patient has 
to say. That starts with taking time.” 
To those who say doctors don't 
have time, her reply is: “We seem to 
find time to do the technical things. If 
listening is necessary and valuable 
and accomplishes what needs to be 
accomplished, we must take the 
time." She adds that when doctors 
consider the doctor-patient relation¬ 
ship a covenant — an agreement in 
which parties work together toward a 
mutual goal — they can establish a 
foundation upon which to build hope. 
Yale is a center for high-tech 
solutions to the Riddle. But, says Dr. 
Komp, “the compassionate 
companioning of the dying — envi¬ 
sioned by humanists and religionists, 
yearned for by the sick, wished for by 
health-care professionals if they could 
only learn how — is not in conflict with 
the mission of an institution like ours.” 
Just how to provide that compas¬ 
sionate companioning is a daily 
concern for Alan B. Astrow, M.D. 
'80, program director of the hematol¬ 
ogy/oncology section at St. Vincent’s 
Hospital and Medical Center in New 
York City. Dr. Astrow, who knows 
well the importance of helping 
patients reach an understanding that 
replaces false expectations, finds 
direction in the biblical passage. 
“Come, let us reason together.” 
He describes a patient who knows 
that her cancer is advanced yet talks of 
seeing her children marry and have 
children — a patient who “cannot hear 
the brutal truth.” He knows that with 
such patients, doctors must build a 
foundation for reasoning together, 
toward hope for genuine possibilities. 
“You have to combine truth with 
sensitivity, to who the person is and 
where the person is. You cannot lie, 
but you can speak in a way they will 
listen to. You're trying to reach an 
understanding,” says Dr. Astrow, who 
began by advising his patient to take 
care of any business, to not postpone 
a trip to see her son. to “take each day 
as a blessing.” 
Dr. Astrow notes that as people 
address such topics as euthanasia, 
“close attention to what the patient 
needs may avert some moral dilem¬ 
mas.” He cites progress in his field 
toward good pain management or 
palliative care. "There’s more attention 
than in the past,” he says. But he knows 
more could be done, and he would 
particularly like to see legislative 
changes that would help doctors to 
provide narcotics for suffering patients. 
Doctors need to keep educating the 
public and themselves as well, says Dr. 
Astrow. He points out that oncologists' 
meetings regularly include sessions on 
pain management but don't devote time 
to the issues related to talking with 
patients about dying. 
“Medicine appropriately focuses 
on living,” he says, “but somehow, 
we have to acknowledge that part of 
living is dying. And we have to ask 
ourselves, ‘Are we doing better?’” 
It is necessary to do better, says 
Eric Krakauer, M.D., Ph.D. His views 
reflect his interest in ethics and his 
current residency in internal medicine 
at Yale-New Haven Hospital. 
“In Western science, there’s been 
a belief that nature can be mastered, 
its secrets discovered — including the 
secrets of life and death,” says Dr. 
Krakauer. “But we need, in medicine 
and as a culture, to think about this. ... 
It certainly needs revision in medi¬ 
cine, or we risk doing harm to people 
rather than helping them.” 
One way for doctors to offer hope. 
36 Yale Medicine Summer 1994 
he adds, is to get out the word that 
sometimes patients’ interests are best 
served not by the most modem treat¬ 
ment, but by real comfort care. Medical 
schools can help greatly by taking end- 
of-life care seriously, by such means as 
teaching good palliative care. 
Dr. Krakauer cites the hope 
offered by the hospice movement. 
“That needs to be expanded,” he 
says. He also points to such efforts 
as the AIDS care program at Yale, 
where helpful staff and close coordi¬ 
nation of inpatient and outpatient 
services allow physicians to give 
their patients hope that at the end of 
life they can be where they want to 
be (at home, usually), with the 
people they care about, and with the 
services they need. 
It is in dealing with AIDS that 
many physicians see clearly that they 
cannot fulfill unrealistic hopes, but 
they can indeed provide the kinds of 
hope of which Dr. Nuland writes. 
“With AIDS, the doctor fills the 
role of caregiver, as opposed to the 
“You have to combine 
truth with sensitivity, to 
who the person is and 
where the person is. You 
cannot lie, but you can 
speak in a way 
they will listen to. ” 
Alan B. Astrow, M.D. ’80 
role of conqueror of disease. With 
AIDS, although certainly for other 
diseases as well, caring for patients 
literally means caring for them,” says 
Peter A. Selwyn, M.D., associate 
director of the AIDS care program at 
Yale-New Haven Hospital and 
associate professor of medicine and 
epidemiology at the medical school. 
Dr. Selwyn adds that doctors can 
best help their patients when they 
recognize their own emotions, 
including feelings of frustration, 
anger or loss that are triggered by 
dealings with patients. He recom¬ 
mends reflecting, talking, maybe 
writing, at some later time. “It’s a gift 
patients give you, to remind you of 
your own unfinished business, so that 
you can be a better care-provider,” 
says Dr. Selwyn, who says that early 
in his practice he needed to come to 
terms with his own grief, over his 
father — who died young — and 
over his patients. 
For patients living with AIDS, 
the disease can mean “clearing away 
distractions and illusions — like the 
illusion that you’ll live forever,” says 
Dr. Selwyn. It can mean not putting 
off what’s important to you, like a 
reconciliation. Hope lies in seeing 
that “the process is as important as 
the outcome. Everybody has a 
limited life span; everybody’s future 
is uncertain,” he says. “It’s in how 
you approach that, not how much 
time there is.” YM 
Eric Krakauer, M.D., Ph.D, left, and Alan B. Astrow, M.D. 
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Mortal Lessons 
How Yale medical 
students learn 
to deal with death 
by Carolyn Battista 
How do you tell someone he or 
she is dying? 
As a doctor, how do you deal with 
your own feelings about death? How do 
you treat those who certainly will die? 
As a medical student, how do you 
learn about helping patients prepare 
for death? 
There was a time when you 
didn't, at least not in any formal 
manner. But today at Yale, professors 
and students are talking about life’s 
final days and hours in an effort to 
better care for their patients. 
With lectures, workshops and 
special programs, the Yale School of 
Medicine introduces future physicians 
to issues related to death and dying 
that they will face throughout their 
careers. The focus is not only on 
medical matters, but the personal, 
ethical and legal ramifications of 
death as well. 
“It’s very important to have 
didactic lessons as a preliminary, but I 
really believe that the hands-on 
interpersonal relationships that you 
have to develop are what’s critical,” 
says Robert H. Gifford, M.D., HS 
'66-'67, associate dean for education 
and student affairs and professor of 
medicine. Doctors do not always have 
— and must learn — the communica¬ 
tion skills they need when their 
patients face death, he says. 
“Everyone recognizes that there 
is a need to deal with these issues, 
and not just in a few separate 
Robert H. Gifford, M.D., associate 
dean for education and student affairs 
and professor of medicine. 
courses,” says Mary Anne Johnston, 
Ph.D.. director of the office of 
education at the medical school. 
Many medical students. Dr. 
Johnston notes, have dealt with 
losing someone — a grandparent, for 
instance. “It’s so hard, so painful. 
They work out ways of dealing with 
loss that may not be best for them¬ 
selves or their patients,” she says. 
David G. Greenfeld, M.D., HS 
’68-’72, clinical professor of psychia¬ 
try, gives a lecture on death and dying 
in the first-year Life Cycle course. He 
stresses the need to come to terms 
with one’s feelings about death. 
“There’s a danger that you'll 
avoid dealing directly and intimately 
with dying patients because of fear of 
your own death,” says Dr. Greenfeld. 
“I tell students, ‘It’s troubling to deal 
with your own feelings, but it’s 
worthwhile. Dealing with dying 
patients and their families will be an 
important part of what you do.”’ 
He says students “appreciate the 
opportunity to talk about this; they’re 
hungry for it.” When he attended the 
Johns Hopkins School of Medicine in 
the early 1960s, “nobody talked about 
this. You were on your own.” 
Shih-Yin Ho, who will start her 
third year of medical school in 
September, recalls two first-year 
lectures on issues relating to death 
and dying that she and her fellow 
students attended. The lectures helped 
them “to start thinking about these 
issues, and about the role we would 
play as healers,” she says. 
Stephen V. Jackman, M.D. ’94, 
recalls his experience, just weeks 
before graduation, in a workshop on 
ways to help patients with potentially 
terminal illnesses. “What I realized out 
of the workshop was that when and 
what you tell patients and their families 
needs to be tailored to them,” he says. 
Ethical considerations regarding 
death and dying are the focus of a 
lecture by Robert J. Levine, M.D., HS 
’62-'63, professor of medicine, 
during the first-year course Profes¬ 
sional Responsibility. “I hope students 
will develop a working understanding 
they can put to use,” says Dr. Levine, 
also chairman of the Human Investi¬ 
gation Committee. He steers students 
to such reading as an essay on ethical 
views of death and dying, Yale-New 
Haven Hospital’s policy on limiting 
life-sustaining treatment, and several 
relevant case studies. 
“Ethics is not just the touchy- 
feely stuff that some people think; it’s 
a rigorous discipline. I want to make 
students aware that there are re¬ 
sources they can draw on,” he says. 
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“If anyone knows the need for compassionate care, 
and how to provide it, it is the patient 
who is seriously ill. The patient is the teacher. ” 
Alan C. Mermann, M.D., M.Div., 
the medical school chaplain, talks 
in his office with a student, 
Nicole Ullrich, 
an M.D./Ph.D. candidate. 
The Professional Responsibility 
course, dealing with many ethical and 
legal issues, is directed by John S. 
Hughes, M.D., associate clinical 
professor of medicine, and Angela 
Holder, LLM. Ms. Holder, clinical 
professor of pediatrics (law), says the 
course stresses “that it’s the patient’s 
body, not the doctor’s, even unto death.” 
Alan C. Mermann, M.D., M.Div., 
leads a seminar. Caring For the 
Seriously III Patient, in which stu¬ 
dents are paired with “teacher- 
patients,” many of whom are dying. 
“If anyone knows the need for 
compassionate care, and how to 
provide it, it is the patient who is 
seriously ill. The patient is the 
teacher,” says Dr. Mermann, clinical 
professor of pediatrics and the 
medical school’s chaplain. 
The students meet regularly with 
their patient-teachers; they also gather 
weekly to talk with Dr. Mermann and 
one another. 
With the patient-teachers, says 
Dr. Mermann, “the students are very 
anxious at first, but they can move 
into talking about serious issues.” The 
teacher-patients tell the students about 
the care they’re getting, the concerns 
they have, the ways in which they’re 
coping. “Students are surprised that 
dying patients focus on life, and they 
learn from these patients about the 
resources that can support us as we 
approach death,” says Dr. Mermann. 
Mark L. Rubinstein, who will be 
a second-year student this fall, 
remembers how concerned his 
patient-teacher was about keeping 
much of his own distress from his 
family. “When they left the room, he 
opened up more,” he says. 
Shelagh A. Houghton, another 
second-year student, worked with a 
patient-teacher whose illness ap¬ 
peared suddenly. “We talked about 
her life being thrown into turmoil,” 
says Ms. Houghton, who added that 
the seminar got students thinking “of 
what it’s like to be a patient.” 
Associate Dean Gifford calls the 
seminar “one of the most valuable 
things that we do.” He also points to 
“the real teaching” that occurs in 
clinical rotations, where students can 
observe how well — or how poorly 
Alan C. Mermann, M.D., M.Div. 
— the physicians in charge deal with 
dying patients and their families. 
Dr. Johnston says that plans are 
under way to incorporate more formal 
discussion of ethical issues, including 
those relating to death and dying, into 
the clinical years of medical educa¬ 
tion. Meanwhile, students find that 
professors offer much informal 
guidance. “In my internal medicine 
rotation, Dr. (Thomas R) Duffy was a 







Thomas P. Duffy, M.D., who sen’es on the ethics committee at Yale-New Haven 
Hospital, believes patients should be well-informed. “We want to know patients’ 
desires, recognize their wishes, outside of emergency situations.” 
tremendous source for me,” says 
Lawrence W. Solomon, now entering 
his fourth year. 
Thomas P. Duffy, M.D., professor 
of medicine in the hematology section, 
stresses the need to talk with patients 
early on. “We want to know patients’ 
desires, recognize their wishes, outside 
of emergency situations.” 
He adds that students may have 
considered death and similar issues 
only in the abstract before beginning 
their clerkships. At that stage, they 
get "to see how things are applied in 
practice, with a care team that has 
ongoing conversations with patients 
and patients' families, and to act 
upon those discussions.” Dr. Duffy 
writes of bio-ethical issues and 
serves on the ethics committee at 
Yale-New Haven Hospital. 
Many note that rotations in Yale’s 
AIDS care program offer ready 
exposure to end-of-life issues. Those 
rotations are “medically oriented, 
because there’s a lot of medicine that 
students need to know,” says Peter 
Selwyn. M.D., associate director of 
the program. “But there’s also a lot of 
interaction with nurses and social 
workers, more than in many other 
areas, and students are confronted 
with a lot of issues related to death and 
dying, like palliative or comfort care, 
withdrawal of care, advance directives 
and do-not-resuscitate orders.” 
Karen J. Jubanyik, M.D. ’94, 
says, “I got a lot of training there. ... 
We talked a lot about palliative care; 
the AIDS Care team is superb at 
palliation.” 
A fourth-year workshop led by 
Lawrence R. Solomon, M.D., on 
Caring For the Terminally III Patient 
focuses on palliative care. “The goal 
of the workshop is to acquaint 
students with the problems and care- 
management of people who have 
terminal illnesses, and to help stu¬ 
dents become comfortable with the 
use of palliation as opposed to 
curative therapy,” says Dr. Solomon, 
associate clinical professor of medicine, 
who was the medical director of 
Connecticut Hospice from 1990 to 1993. 
“In many ways, palliative care is 
a specialty. Students need to become 
familiar with what we can offer,” says 
Dr. Solomon. 
Dr. Solomon’s workshop is part 
of the medical school’s new fourth- 
year clerkship in primary care, 
directed by Frederick Haeseler, M.D., 
associate clinical professor of medicine. 
Also included in that clerkship is 
a workshop on care for patients 
whose illnesses are potentially 
terminal, led by Nancy R. Angoff, 
M.D. ’90, M.RH. '81, assistant 
director of the clerkship, and 
Susanne J. Goldie, M.D., clinical 
instructor of medicine, who served a 
residency in internal medicine at 
Yale-New Haven Hospital and is 
now medical director at the Hospital 
of St. Raphael in New Haven. 
Dr. Angoff says that she and Dr. 
Goldie tell students that “when there 
is no cure, palliative care is intensive 
care; it needs to be pursued aggres¬ 
sively.” They stress, however, that 
it’s always important to consider the 
patient’s comfort, and that all care — 
including palliative care — requires 
that doctors fully understand the 
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disease process. “So, there’s no shift 
in thinking when you come to 
terminal care,” says Dr. Angoff, 
clinical instructor of medicine 
(infectious diseases). 
She and Dr. Goldie address such 
topics as the need for doctors to 
respect patients’ wishes and values, 
and they offer guidelines for choosing 
in-patient or out-patient care. “We 
can do more outside the hospital than 
students realize,” notes Dr. Angoff. 
The primary-care clerkship also 
includes sessions in which students 
practice doctor-patient conversations 
with “standardized patients” who are 
trained actors. In some sessions. Dr. 
Haeseler notes, “the students are 
called upon to tell patients that they 
are seriously ill, perhaps terminally ill. 
They have an opportunity to develop 
the skills required for transmitting 
difficult news in ways that are com¬ 
passionate and considerate.” 
He adds that the sessions help 
students to “recognize their own 
feelings and be respectful of each 
patient's way of dealing with bad 
news.” He also stresses that such 
sessions do not replace clinical 
practice, but complement it. 
Yale is considering other ways to 
give future physicians more opportu¬ 
nity in the later years of medical 
school to focus on issues — including 
death and dying — that will always 
be important to them. Plans include 
the development of a fourth-year 
component of the Medicine, Society 
and Public Health series. 
“We are working to create a 
required fourth-year course integrat¬ 
ing biomedical and psychosocial 
issues, including those related to 
death and dying. We hope to have a 
pilot program in place by 1995,” says 
Dr. Johnston. 
Associate Dean Gifford says that 
“it makes sense; it’s meaningful for 
students” to address such issues after 
they have had considerable clinical 
experience. YM 
Doctors, Death and Discourse: 
Physicians as Authors 
In September 1993, Yale University School of Medicine hosted the 
annual Ivy/Hopkins/NYU Medical Editors' Alumni Retreat. The following 
are excerpts from a panel discussion during the retreat entitled The 
Agony and The Ecstasy: Writing about the Fine Art of Medicine. 
Lawrence S. Cohen, M.D., the Ebenezer K. Hunt Professor of Medicine, 
deputy' dean, and co-editor of the Yale University School of Medicine 
Heart Book, served as the panel's moderator. 
The panelists were: Howard M. Spiro, M.D., professor of medicine, 
and author o/When Doctors Get Sick and Doctors, Patients and Place¬ 
bos, and co-editor of Empathy and the Practice of Medicine; 
Diane M. Komp, M.D., professor of pediatrics and author of A 
Window to Heaven, A Child Shall Lead Them and Hope Springs from 
Mended Places, to be released in October; 
Richard Selzer, M.D., former surgeon at Yale-New Haven Hospital 
and author of several books, including Coming Down from Troy and 
Raising the Dead. 
Lawrence S. Cohen, M.D.: 
Tell us a bit about how you 
became interested in writing 
books and why you write. 
Howard M. Spiro, M.D. 
I’m not a writer of books, 
I’m simply a stomach doctor. I 
write little pieces of my every¬ 
day experiences. Writing allows 
me to reshape the world in a 
way that makes it more conge¬ 
nial for me. It gives me the 
opportunity to reframe experi¬ 
ences in one variety or another. 
I do that in my clinical practice, 
where I see a lot of people with 
existential pain. I find one thing 
I can do for them is to help 
them to resee their lives, 
experiences and sorrows. I 
think that’s part of what a 
doctor does, certainly that’s 
what a writer does. That sense 
of control is important in 
writing because life is not 
controllable. But, when you put 
something down on paper you 
have something under control, 
reframed, you have recreated 
the world. 
Why don’t all doctors 
write? As far as I can see, we 
Howard M. Spiro, M.D. 
put on that white coat, which 
armors us against feeling and 
which has always been the thing 
that sets the doctor off from the 
patient. It also tells us we have to 
be trained in emotional privacy. 
Suddenly, we are to keep our 
emotions and our feelings away 
from the patients. I was asked 
about two years ago to give a talk 
to the Medical School Council on 
empathy and because I like to 
write, I prepared it as an essay. 
When it was done, I sent it to the 
editor of a medical journal. He sent 
it back to me saying that he 
couldn’t accept the paper because 
he did not think that empathy was I 
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anything that belonged in clinical 
practice. That we were in an era of 
technology and empathy only got 
in the way. 
Many doctors don’t write because 
they don’t allow themselves to feel 
any emotion. We are trained to 
generalize. We have abstracted the 
patient and take credit or pride in that. 
Diane M. Komp, M.D. 
I’ve had 20 years of successful 
scientific writing, which is a very 
different style. The experience of 
writing outside of medicine is a little 
like finally getting out of the whale¬ 
bone corset and taking a deep breath. 
When I started writing my 
books, I thought I was writing 
outside of medicine. I think it relates 
to our “cultic” belief in privacy in 
medicine that overextends the 
boundary of confidentiality. There is 
this tension between sharing how we 
practice medicine and how we 
process things as human beings 
ourselves. In the process of writing, I 
learned our patients wish we would 
give up this artificial boundary 
between medicine and non-medicine. 
The medicine we practice is the 
medicine they experience and 
receive in their own bodies. 
An agony for me has been 
dealing with how to properly deal 
with issues of privacy and confiden¬ 
tiality while using the stories of real 
people. I shared the early drafts of 
my stories with the parents of the 
children, not for permission but to 
share the way I lived through these 
experiences with them. This has 
been the most rewarding thing for 
me as a physician/author, partly 
because the family and I live through 
the same experience but the way we 
process it may be completely differ¬ 
ent. I think we have to recognize that 
in some ways, reliving these experi¬ 
ences of our patients affirms that 
their physician thought enough about 
them to write about it. Patients find 
that a very healing experience. It 
was an incredible struggle for me to 
write that first essay, but once it was 
written the stories started to flow 
out. I get letters from people around 
the country who have read my books 
and share their own stories. These 
stories don’t belong to me. They 
belong to the people who lived them. 
If there are experiences from our 
practice that will help other people 
make decisions in their lives to bring 
them health, happiness and healing, 
then we have to find ways to share 
those things despite how we were 
brought up medically. 
Richard Selzer, M.D. 
I began to write when I was 40, 
and I had already been a surgeon for 
many years before that. I decided 
that I would try to master the craft of 
writing much as I had mastered the 
craft of surgery in the first half of 
my life. I don’t think that compas¬ 
sion or empathy has anything to do 
with being a writer. It is not entirely 
so that good heart makes good art. It 
is rarely so. I think writing is a skill 
and I do not intentionally try to 
infuse my writing with the spiritual 
or the emotional but it does come 
out. ... I am not out to make a cause 
for anything. I like to tell stories. I 
find a lot of similarities between 
surgery particularly, and writing. It 
seems to me that there is a kind of 
odd similarity. I write in long hand. I 
like to watch the word issuing forth 
from my finger like a secretion from 
my body. It’s that intimate and close. 
I am a writer who happens to have 
been a doctor, and every writer 
makes the literary most of what 
happens to her or him and so it 
happens that my writing is infused 
with my medical experience, with 
the human body and those who tend 
to it. Yes, I was a doctor so it is very 
difficult for me to kill off my charac¬ 
ters. I tend to rescue them from the 
fate that I have decreed for them. 
When I finished Poe’s story The 
Lighthouse, I ended up giving the 
character La Tourette’s syndrome 
because it seemed an appropriate 
reason for someone to have exiled 
himself to a lighthouse in the middle 
of the ocean. My most recent book, 
Raising The Dead, is posthumous 
because I was sick two years ago 
with Legionnaire’s disease and spent 
23 days in a state of coma. I began to 
tell the story of my illness. I dwelt 
on that stage of coma. It was a 
strange experience because little bits 
of sensation were retrievable and I 
snatched them, grasped at them, and 
I reconstructed the stage of coma in 
language. Anyone who reads my 
book with the idea that he’s going to 
learn about Legionnaire’s disease or 
even what coma is like will be 
mistaken. Mine is a literary treat¬ 
ment of this condition. It’s an 
imaginary work that implies a 
different kind of truth. YM 
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Members of the 
Class of 1994 
make their way 
from the steps 
of Sterling Hall 
of Medicine 
on May 23 
after having 
their photo¬ 





Yale medical students, like their 
counterparts around the world, make 
a commencement vow based on the 
Hippocratic oath of antiquity. For the 
first time, the Yale Physician’s Oath 
has been adapted to include the words 
“gender" and “sexual orientiation” 
in the oath's statement of non¬ 
discrimination, in accordance with a 
1993 AM A policy decision and the 
ongoing policies of Yale University. 
“No matter what specialty we 
choose, we will be responsible for the 
health of gay, lesbian and bisexual 
people, ” Peter Ferren, Class of '95, of 
the Lambda Health Alliance, wrote in 
a letter to students signed by the class 
presidents and other student leaders. 
“Pediatricians will treat the 
children of gay parents, Ob/Gyns will 
deliver babies of lesbian couples, 
psychiatrists will help teen-agers who 
are struggling with issues of sexual 
orientation. ... By affirming our 
commitment to care for every patient 
without prejudice, each of us will 
enable health care to be delivered in a 
safe and welcome environment which 
respects the diversity of our society 
and the dignity of our patients. ” 
The Yale Oath 
Now being admitted to the high calling 
of the physician, I solemnly pledge to 
consecrate my life to the care of the 
sick, the promotion of health, and the 
service of humanity. 
I will practice medicine with conscience 
and in truth. The health and dignity of 
my patients will be my first concern. 
I will hold in confidence all that my 
patients relate to me. I will not permit 
considerations of gender, race, religion, 
sexual orientation, nationality, or social 
standing to influence my duty to care 
for those in need of my services. 
I will respect the moral right of 
patients to participate fully in the 
medical decisions that affect them. 
I will assist my patients to make 
choices that coincide with their own 
values and beliefs. 
I will try to increase my competence 
constantly and respect those who teach 
and those who broaden our knowledge 
by research. I will try to prevent, as 
well as cure, disease. 
When I am qualified to instruct, I will 
impart my knowledge gladly, hold my 
students and colleagues in affectionate 
esteem, and encourage mutual critical 
evaluation of our work. 
In the spirit of those who have 
inspired and taught me, I will seek 
constantly to grow in knowledge, 
understanding, and skill and will 
work with my colleagues to promote 
all that is worthy in the ancient and 
honorable profession of medicine. 
I will maintain the honor and the 
noble traditions of the medical 
profession. My behavior will be 
honorable and thoughtful and reflect 
justice toward all. 
If I fulfill this Oath and do not violate 
it, may it be granted to me to enjoy life 
and the practice of the Art. This pledge 
I make freely and upon my honor. May 
my faith strengthen my resolve. 










Frances K. Conley, M.D., sits next to Deputy Dean 
Lawrence S. Cohen, M.D., before delivering the 
commencement address at the School of Medicine. 
Excerpt from commencement address 
by Stanford’s Frances K. Conley, M.D. 
The most important decisions you will make as physicians 
will be in choosing the leadership of your profession. My career 
as a female neurosurgeon has been made possible virtually 
entirely through the support and guidance of some wonderful, 
compassionate, decent, honest white males who also happen to be 
physicians and academicians — men who are “too nice” to have 
been appointed to positions of authority. The process by which 
leaders are chosen needs revamping; power cannot continue to be 
defined as simply as "power over others.” Along with the tradi¬ 
tional evaluation of technical talent and academic acumen, 
leaders need to be assessed for their degree of behavioral de¬ 
cency. Only with leaders in place who are passionately commit¬ 
ted to developing the careers of others based on their ability and 
resolve, rather than simply on the basis of gender or race, will the 
medical profession enter the 21st century maximally prepared for 
the challenges presented by such aspects as managed health-care 
systems, cost containment, rationing of medical resources and 
ever increasing technology. In addition, our leaders of this 
wonderful profession need to help each of us rediscover the 
intriguing quality of the art in medicine, an important element 
that must again become a part of our everyday practice. 
Frances K. Conley, M.D. 
professor of surgery (neurosurgery) 
Stanford University School of Medicine 
John C. Landed, M.D. '94, and 
Andrea L. Landed, M.D.'94, celebrate 
another milestone with hats. 
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Left: Sylvia F. Garcia, M.D. '94, waves 
to a friend as she and classmates pose 
on the steps of Sterling Hall of 
Medicine for their commencement 
photograph. 
Johnson Loh, M.D. '94, gives his 
daughter, Amanda, a ride inside 
Harkness lounge after the 
commencement ceremony. 
U.S. health official Judith Feder, speaker at the Epidemiology and 
Public Health ceremony, talks with state health commissioner Susan 
S. Addiss, M.P.H. '69, acting EPH vice chair Martine Y. Armstrong, 
M.D., and Rosemary Johnson-Hurzeler, M.P.H. '75, president of the 
EPH alumni organization. 
University honors 
Robert Cooke, Maxine Singer 
This May, two distinguished Yale alumni/ae 
affiliated with the School of Medicine were 
among eight individuals selected by the Yale 
Corporation to receive honorary degrees in 
recognition of outstanding achievements in their 
respective fields. 
The Honorary Degee of Medical Sciences 
was given to Robert E. Cooke, M.D., a national 
leader in health care and child development, 
who graduated from Yale’s Sheffield Scientific 
School in 1941 and from the School of Medicine 
in 1944. He then joined the Yale medical faculty 
as associate professor of pediatrics and physiol¬ 
ogy, conducting research in salt and water 
metabolism on which the modern treatment of 
dehydration in infants, children and adults is 
based. In 1956, Dr. Cooke became pediatrician- 









in-chief at Johns Hopkins Hospital 
and chairman of the pediatrics 
department at its medical school. He 
served as president of the Medical 
College of Pennsylvania. 
During his career. Dr. Cooke was 
the guiding force behind a series of 
health and child development initia¬ 
tives, including the founding of the 
National Institute of Child Health and 
Human Development, part of the 
National Institutes of Health. He 
chaired the original planning commit¬ 
tee for Head Start and was instrumen¬ 
tal in the adoption of Public Law 88- 
164, which established community 
mental health centers and centers for 
research in mental retardation. 
The Honorary Degree of Science 
was awarded to Maxine Singer, who 
received her Ph.D. degree from Yale 
in 1957, and who currently serves as 
president of the Carnegie Institution of 
Washington and as scientist emeritus 
in the division of cancer biology and 
diagnosis of the National Cancer Institute. 
In the mid-1970s, Dr. Singer 
helped organize the Asilomar confer¬ 
ence which developed safety guide¬ 
lines to regulate and monitor the new 
discipline known as genetic engineer¬ 
ing. Her most recent research focuses 
on the role of "movable elements” 
within human DNA. 
In 1988, Dr. Singer received a 
Distinguished Presidential Rank 
Award, the nation’s highest civil- 
service prize. 
From 1975 through 1990, Dr. 
Singer served as a fellow of the 
Yale Corporation, during which 
time she advocated strengthening 
science requirements for under¬ 
graduates and improving the stand¬ 
ing of Yale’s science faculty. She 
also serves as a member of the 
University Council and the Dean’s 
Council of the School of Medicine. 
In 1991, Dr. Singer was awarded the 
Wilbur Cross Medal of Honor by 
the Yale Graduate Association. 
Dean Burrow and the School 
of Medicine’s new standard, 
a gold-headed cane. 
At the University’s commencement 
ceremony, Dean Gerard N. Burrow 
assisted Gladys Iola Tantaquidgeon, the 
Mohegan medicine woman who founded 
the Tantaquidgeon Indian Museum in 
Monh’iile, Conn. She received an 
honorary Yale degree. An anthropologist 
and cultural leader. Miss Tantaquidgeon 
learned herbal medicine from three older 
women, and in 1972 published the 
monograph, Folk Medicine of the 
Delaware and Related Algonkian Indians. 
explains. So he presented to the 
school his own gold-headed 
cane, a gift from his chief 
residents when he left Toronto 
General Hospital. This cane was 
first carried May 23 at the Yale 
University commencement, and 
Dr. Burrow shared news of this 
new tradition with alumni/ae at 
reunion weekend in June. 
The original cane was 
carried by John Radcliffe, an 
outstanding British physician. A 
year before he died in 1714, Dr. 
Radcliffe passed the cane on as a 
token of friendship to Dr. Richard 
Mead, a rising physician. The 
tradition of passing the cane 
continued until 1823, when the widow 
of Dr. Matthew Baillie presented the 
cane to the College of Physicians in 
London. Two years later, it was 
displayed in the college’s new library. 
Interestingly, the physician’s cane 
symbolized the wand of Aesculapius. 
During the late 17th century, the 
physician’s cane generally had a knob 
or bar, containing a vinaigrette, which 
he held to his nose to ward off “the 
noxious vapours arising from the 
sickroom.” But it is believed that Dr. 
Radcliffe’s cane, in the form of a 
crutch, was used for support. 
A New Tradition 
Arrives at Yale 
At a medical school so steeped 
in tradition. Dean Gerard N. Burrow, 
M.D. '58, knows full well how 
difficult it is to start a new one. But 
with the dean's gift of a replica of 
John Radcliffe’s gold-headed cane, 
the school now has another tradition. 
"After my first Yale com¬ 
mencement as dean last year, I 
realized that we were the only 
school within the University not to 
have a standard to carry,” the dean 
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Gallery 
The facility above, in the former 
Czechoslovakia, is representative of 
the elaborate European “houses of 
bath ” patronized during the 16th and 
17th centuries. 
Bathing 
appliances of the 




Back to the days when a bath was a luxury\ a cure 
Spa treatments, while popular today, no longer claim 
many of the medicinal benefits once attributed to thera¬ 
peutic baths. Bath therapy, dating back to Roman civili¬ 
zation in A.D. 60, was believed to expedite the healing 
process of digestive, skin and respiratory diseases, as 
well as anemia, lumbago, metallic poisoning and cer¬ 
tain stages of paralysis. Baths 60 feet wide bubbled with 
60,000 gallons of sparkling, colorless mineral water 
warmed to 100 degrees Fahrenheit. 
The bathhouses also provided medical appliances 
then touted as state of the art. Vapor baths, commonly 
used for weight reduction, also were said to be effective 
for eczema and gout; inhalation and pulverization rooms 
were used to spray fine mists of water on sensitive sur¬ 
faces, such as the eyes or throat. Nervous exhaustion 
was treated with a medical bath, and a special thermal 
treatment was devised for cardiac problems. 
Rosalind D ’Eugenio 




Jr., director of 






from the porch 




New Haven Debuts 
Lead Safe Home 
A ceremony to debut New 
Haven's first lead-safe home was held 
May 31 on the front porch of the 
Davenport Avenue building. Featured 
speakers at the event included Ted 
Kennedy Jr., director of the New 
Haven Lead Safe Home and Commu¬ 
nity Project; Rosa L. DeLauro, U.S. 
Representative, 3rd Congressional 
District; and Lowell P. Weicker Jr., 
governor of Connecticut. 
The Lead Safe Home, located in 
the Hill neighborhood, will serve as a 
temporary residence and out-patient 
treatment site and address the housing, 
medical and social service needs of 
lead-poisoned children and their 
families. Scheduled to open Oct. 1, the 
Lead Safe Home will accommodate up 
to four families at a time and approxi¬ 
mately 24 families per year. 
David J. Schonfeld, M.D., assis¬ 
tant professor of pediatrics, director of 
Yale’s lead clinic, and medical director 
for the New Haven Lead Safe Home 
and Community Project, explains the 
concern of lead-poisoning: “An 
estimated 55 percent of New Haven 
children under six years of age have 
blood lead levels over 10 micrograms 
per deciliter of whole blood, the 
‘concern threshold’ established by the 
Centers for Disease Control and 
Prevention. Currently, more than 200 
children with severe lead poisoning 
are being followed by Yale-New 
Haven Hospital’s Lead Clinic.” 
The project is a collaborative 
effort between the department of 
pediatrics at Yale-New Haven 
Hospital and the Yale School of 
Medicine; the city of New Haven’s 
Departments of Housing and of 
Health; and HOME, Inc., a local non¬ 
profit housing and development 
organization, as well as other commu¬ 
nity-based organizations. 
Also dedicated was the Lead 
Resource Center, located next to the 
Lead Safe Home. Supported by the 
medical school and the hospital, the 
center will house administrative and 
social service offices for the home, as 
well as family and community 
meeting space. 
Medical School Dean 
Visits White House 
Medical school Dean Gerard N. 
Burrow, M.D. ’58, and some 40 medical 
school leaders from across the country 
discussed the importance of universal 
coverage as the highest priority of the 
health-care debate with President Bill 
Clinton, First Lady Hillary Rodham 
Clinton and Secretary of Health and 
Human Services Donna Shalala. 
Meeting in the White House’s 
East Room on June 27, Dr. Burrow 
and his colleagues, including repre¬ 
sentatives from the Association of 
American Medical Colleges, stressed 
the need for health-care reform and 
urged that a responsible financial 
mechanism will ensure needed health 
security for all. 
In urging guaranteed health-care 
coverage for the entire nation, they 
called for the highest quality health care, 
consumer choice and a system that 
provides appropriate benefits and ready 
access to primary and preventive care. 
"There was also an opportunity to 
impress upon the White House policy¬ 
makers once again the extreme 
fragility of the financial infrastructure 
of medical schools and how they are 
at particular risk during this transi¬ 
tional period,” Dr. Burrow comments. 
"What was apparent was that 
over the past year. President and Mrs. 
Clinton have come to understand the 
importance of academic health 
centers to U.S. health care, and they 
are supportive.” 
Sperm Test Predicts 
Fertilization Ability 
A procedure designed by re¬ 
searcher Gabor B. Huszar, M.D., HS 
’76-’79, director of the Sperm Physiol¬ 
ogy Laboratory, aims to eliminate 
some of the guesswork couples face in 














their attempts to bear children. 
Physicians routinely measure the 
concentration and speed of sperm to 
test a male’s ability to bear children, 
but Dr. Huszar’s new test enables 
physicians to predict which sperm 
will penetrate and fertilize the female 
egg. Results of the test can help 
couples who are trying to conceive a 
child decide whether to pursue in 
vitro fertilization or other options. 
“Because a man may have low 
sperm concentration and low motility 
does not necessarily mean that he will 
have diminished fertility,” explains Dr. 
Huszar, who also is senior research 
scientist in obstetrics and gynecology. 
“Diminished fertility is caused when 
sperm do not mature properly. With 
the creatine kinase (CK) test, we can 
tell whether a man has a sufficient 
number of mature sperm.” 
Dr. Huszar’s research showed that 
men with normal concentrations of 
sperm may still have a fertility prob¬ 
lem if the majority of their sperm are 
immature. With former sperm analy¬ 
ses, Dr. Huszar says men would never 
know this, and the women would be 
tested for reproductive problems. 
He explains that sperm start 
manufacturing a different type of 
creatine kinase during the matura¬ 
tion process, a change that can be 
noted through the CK Test. By 
observing the ratio of old and new 
CKs, physicians can determine the 
maturity and fertility of the ejacu¬ 
lated sperm. 
Yale was the first facility to 
implement the CK Test, which now 
is being used at several medical 
centers throughout the United States 
and Europe. 
A visit from Washington 
Tipper Gore, mental health adviser to President Clinton and wife of Vice President 
Al Gore, visited New Haven on April 5 to observe model programs for improving 
inner-city children’s education and mental health. Mrs. Gore, second from right, 
met with reporters and James P. Comer, M.D., far left, who pioneered a nationally 
recognized model for school reform; U.S. Rep. Rosa DeLauro, D-Conn.; and 
Donald J. Cohen, M.D., director of the Yale Child Study Center. Mrs. Gore toured 
the children's psychiatric in-patient sendee at the Children's Hospital and visited a 
city school that has implemented the Comer program. 
Twin Study Indicates 
Genetic Susceptibility 
to Disease 
A Yale study, based on data from 
the Swedish Twin Registry, suggests 
that genetic factors influence death 
from coronary heart disease in both 
men and women at early ages. 
The study shows that genetic 
influences continue to play a role, 
although not as strongly, after the age 
of 65, according to Marjorie 
Marenberg, Ph.D., first author of an 
article published in the April issue of 
the New England Journal of Medi¬ 
cine. Dr. Marenberg, a third-year 
medical student who received her 
Ph.D. degree in epidemiology and 
public health from Yale in 1992, 
conducted this research for her 
doctoral dissertation. 
These findings are based on a 
review of 10,502 pairs of twins born 
between 1886 and 1925. Dr. 
Marenberg and her colleagues looked 
at both identical and fraternal twins in 
the Swedish Twin Registry. Because 
identical twins share 100 percent of 
their genes, and fraternal twins share, 
on average, 50 percent of their genes, 
differences in twin similarity for heart 
disease point to genetic factors. 
“We found that if one twin died 
of coronary heart disease, the prob¬ 
ability that the other twin also died of 
this disease was greater among 
identical than fraternal twins,” she 
adds. “But, other behavior risk 
factors, such as smoking, were still 
important influences.” 
This study is one of the few which 
takes family history of women into 
consideration and also reviews data on 
individuals over the age of 65. 
Pepper Candy Used 
in Cancer Treatment 
The Yale Pain Management 
Center/Supportive Care Services has 
found immediate success using hot 
pepper candy to literally burn away 
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Ann M. Berger, M.D., right, director of supportive care services at the Yale Cancer 
Center, distributes capsaicin candies to cancer patients to ease the pain caused by 
mouth sores that develop during treatment. 
pain caused by mouth sores during 
chemotherapy and radiation treat¬ 
ment. Used in a taffy candy form, 
researchers at the School of Medicine 
discovered that capsaicin, the active 
ingredient in chili peppers, provides a 
means to control pain through 
repeated applications which desensi¬ 
tize chemical pain receptors. 
Ann M. Berger. M.D., director of 
supportive care services at the Yale 
Cancer Center, says the taffy was an 
instant success with the patients. “It is 
very exciting for us to be able to provide 
immediate relief to oncology patients.” 
The candy idea was conceived a 
year ago by Wolffe Nadoolman, then 
a first-year medical student working 
in the School of Medicine’s taste 
laboratory. He created a butterscotch 
brittle with several levels of cayenne 
pepper. Linda M. Bartoshuk, Ph.D., 
professor of surgery (otolaryngology) 
and director of the taste laboratory, 
commented, “The candy is the perfect 
means to get the right level of capsai¬ 
cin in the mouth for enough time to 
desensitize pain receptors.” 
Because chemotherapy kills the 
cells in mucous membranes, the mouth 
and esophagus usually develop many 
painful sores during treatment, explains 
Dr. Berger. With the pepper candy, the 
patient feels an initial burning 
sensation, then the tongue becomes 
desensitized to the bum as well as other 
pain, without any numbing affect. 
Dr. Bartoshuk says that because 
the threshold for pain differs with each 
individual, studies continue to adjust 
both the level of capsaicin in the candy 
and the frequency of treatment to meet 
each patient’s need. Researchers at 
Yale are also looking into making a 
capsaicin mouthwash or popsicle for 
mouth, head and neck cancer patients 
who find swallowing difficult. 
Yale is the first to use the candy 
in cancer treatment but has shared the 
recipe with health-care facilities and 
dentists throughout the country. 
Findings from capsaicin candy 
used at Yale were published in the May 
issue of the Proceedings of the Ameri¬ 
can Association of Clinical Oncology. 
Membrane Transport 
Research Funded 
The department of cellular and 
molecular physiology has been 
awarded a five-year, program project 
grant from the National Institute of 
Diabetes and Digestive and Kidney 
Disorders to support research on 
membrane transport. This is the 
fourth renewal of the grant, which is 
in its 21st year. 
Gerhard H. Giebisch. M.D., 
Sterling Professor of Cellular and 
Molecular Physiology, is the principal 
investigator for this research which 
concentrates on the transport mecha¬ 
nisms for salt and water and their 
responsibility in regulating the human 
body’s water and ion excretion. The 
team of scientists also studies the 
molecular mechanisms by which cells 
transport the ions. 
Using biochemical, electrophysi- 
ological and cell biological tech¬ 
niques, as well as studies of organ 
function, members of several depart¬ 
ments participate in this strongly 
interactive research project. 
Dr. Giebisch says that through 
this continuous funding, the Yale 
researchers have acquired an ex¬ 
panded optical imaging unit with 
confocal microscopy and methods to 
visualize elements involved in 
transport within single cells. 
"We also now have methods that 
allow us to measure the activity of 
single-ion channels with the patch-clamp 
technique, with which we can isolate 
electrically tiny bits of membrane and 
study their function,” states Dr. Giebisch. 
Clinical applications for this 
research have also improved, particu¬ 
larly in regard to understanding the 
cellular mechanism of action of 
diuretics and other drugs. 
Other investigators include: 
Peter S. Aronson, M.D.; Walter F. 
Boron, M.D., HS ’78-’80; Emile L. 
Boulpaep, M.D.; Michael J. Caplan, 
M.D. ’87, Ph.D. ’87; Bliss 
Forbush III, Ph.D.; John P. Geibel, 
Ph.D.; and Michael Kashgarian, M.D. 
'58, HS ’59-’63 











The Dean’s Medical Education 
Prize was presented for the first time 
this year to Michael L. Schwartz, 
Ph.D., associate professor of neurobi¬ 
ology. The annual award recognizes a 
faculty member who has made 
significant contributions to medical 
students’ education. 
Alice Bohmfalk Prizes were 
awarded to A. Brian West, M.D., 
associate professor of pathology and 
medicine, and Leo M. Cooney Jr., 
M.D. ’69, the Humana Foundation 
Professor of Geriatric Medicine. 
These prestigious prizes are awarded 
annually to individuals who have 
made outstanding contributions to the 
teaching program, one each in the 
basic and clinical sciences. 
The Leah M. Lowenstein Award 
was presented to Coralie Shaw, M.D., 
professor of diagnostic radiology, by 
the Office of Women in Medicine in 
recognition of a full-time faculty 
member whose work represents the 
highest degree of excellence in non¬ 
sexist education. 
The Francis Gilman Blake 
Award, established in 1952 by Nu 
Sigma Nu, was presented to Peter W. 
Heald, M.D., associate professor of 
dermatology, to recognize the medical 
faculty member, designated by the 
senior class, as the most outstanding 
teacher of the medical sciences. 
The Betsy Winters House Staff 
Award, established by the Class of 
1972, was presented to Steven J. 
Ralston, M.D., chief resident in 
obstetrics and gynecology at Yale- 
New Haven Hospital for making the 
most significant contribution to the 
medical students’ education. 
Thomas H.G. Aitken. M.D.. 
research affiliate in epidemiology at 
the Yale Arbovirus Research Unit, 
was awarded the John N. Belkin 
Memorial Award by the American 
Mosquito Control Association in April 
at its 60th annual meeting in San 
Diego. The award recognizes Dr. 
Aitken's more than 50 years of 
outstanding contributions to the field 
of mosquito biosystematics. 
On behalf of the American 
Committee of Medical Entomology, 
Dr. Aitken has been designated as the 
seventh recipient of the Harry 
Hoogstrall Medal for Outstanding 
Achievement in Medical Entomology. 
The medal was presented at the 
annual meeting of the American 
Society of Tropical Medicine and 
Hygiene on Nov. 1 in Atlanta. Also, 
the Caribbean Epidemiology Centre, 
a division of the World Health 
Organization in Spain, has dedicated 
the newly rebuilt Parasitology/ 
Entomology Laboratories in his name. 
Frank J. Bia, M.D., M.P.H., 
professor of medicine and laboratory 
medicine, and Margaret Bia. M.D., 
professor of medicine and director of 
renal transplant medicine, were 
invited in March to Georgetown 
University Medical Center as the 
Laura J. Hadad Visiting Professors of 
At commencement, 
Leo M. Cooney Jr., 









presented the Alice 
Bohmfalk Prizes 
for their outstand¬ 
ing contributions 
to teaching. 
Medicine to present the Third Annual 
Laura J. Hadad Lectureship. 
Walter F. Boron. M.D., Ph.D., 
HS ’78-’80, professor and chairman 
of the cellular and molecular physiol¬ 
ogy, has been appointed editor-in- 
chief of the journal of Physiological 
Reviews. Gerhard Giebish. M.D.. 
will be associate editor, and Leisa 
Strohinaier, administrative associate, 
will be the managing editor. Physi¬ 
ological Reviews is a publication of 
the American Physiological Society. 
Michael B. Bracken. Ph.D.. 
M.P.H., professor of epidemiology 
and public health; Ralph I. Horwitz, 
M.D. '73, HS '15-11, the Harold H. 
Himes, Jr. Professor of Medicine and 
Epidemiology; and Burton Singer, 
Ph.D.. professor of epidemiology, 
economics and statistics, have been 
elected to the Connecticut Academy 
of Science and Engineering. 
James S. Duncan. Ph.D.. associate 
professor of diagnostic radiology and 
of electrical engineering, has been 
presented a Fulbright Research Scholar 
Award. With this grant, he performed 
research in medical image processing at 
the universities of Amsterdam and 
Utrecht in the Netherlands. 
Matthew J. During, M.D., 
assistant professor of surgery 
(neurosurgery) and medicine, has 
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been awarded a three-year. $225,000 
grant by the Johnson & Johnson Focused 
Giving Program for research on the role 
of certain neurological receptors in 
causing temporal lobe epilepsy. 
Myron Genel, M.D., professor of 
pediatrics and associate dean for 
government and community affairs, 
was elected to serve a three-year term 
on the American Medical Association 
Council on Scientific Affairs. Dr. 
Genel has represented the medical 
school to the AMA Medical Schools 
Section since 1985, has served on the 
House of Delegates of the Connecti¬ 
cut State Medical Society, and has 
belonged to the board of governors of 
the New Haven County Medical 
Association since 1990. 
Gerhard Giebisch, M.D., 
Sterling Professor of Cellular and 
Molecular Physiology, has been 
named the 1994 recipient of the 
Robert W. Berliner Award for Excel¬ 
lence in Renal Physiology by the 
American Physiological Society. The 
award, sponsored by Abbott Labora¬ 
tories, was presented in April at the 
Renal Dinner in Anaheim, Calif. 
Frederick S. Gorelick, M.D., 
professor of medicine and cell 
biology at Yale and staff physician at 
Department of Veterans Affairs in 
West Haven, was one of seven 
honored with a Distinguished Alumni 
Award in June at Drury College in 
Springfield, Mo. Dr. Gorelick was 
recognized for his discoveries in two 
potentially deadly diseases, 
pancreatitis and cystic fibrosis. 
Nora E. Groce, Ph.D., assistant 
professor of public health and 
anthropology, has been awarded a 
grant from the Yale Program on Non- 
Profit Organizations to pursue 
research on the topic Parent Advo¬ 
cacy for Disabled Children and the 
Disability Rights Movement: Why 
Do Two National Movements on the 
Same Issue Rarely Associate with 
One Another? 
Dorothy M. Horstmann, M.D., 
John Rodman Paul Professor Emeri¬ 
tus of Epidemiology and Pediatrics 
and senior research scientist in 
epidemiology, serves as a member of 
the International Commission of the 
Certification of Poliomyelitis Eradi¬ 
cation. She recently visited Havana 
to certify the success of Cuba in 
eliminating the virus and the disease. 
Joshua R. Korzenik, M.D., and 
Satish Kumar Singh, M.D., both 
associate research scientists in 
medicine, are among the 22 scientific 
researchers and physician-scientists 
who have been awarded one-year 
grants from the Glaxo Institute for 
Digestive Health to pursue medical 
research on topics in gastrointestinal 
disease. 
William Lieber, M.D., associate 
professor of obstetrics and gynecol¬ 
ogy, has been appointed staff gyne¬ 
cologist at the Department of Veter¬ 
ans Affairs in West Haven. 
James R. Merikangas, M.D. ’69, 
assistant clinical professor of psychia¬ 
try, has been elected to fellowship in 
the American Psychiatric Association. 
Dr. Merikangas is also a member of 
the committee which develops the 
questions for the specialty examina¬ 
tions administered by the American 
Board of Psychiatry and Neurology 
and is a board examiner. 
William Rosenblatt, M.D., 
assistant professor of anesthesia and 
director of the REMEDY (Recovered 
Medical Equipment for Developing 
World), has received the $5,000 
Cost-Effectiveness Award from 
Stuart Labs. 
Mark J. Shlomchik, M.D., 
assistant professor of laboratory 
medicine and immunobiology, has 
been named a Hulda Irene Duggan 
Investigator by the National Arthritis 
Foundation. Dr. Shlomchik was also 
awarded an Arthritis Foundation 
Investigator Award. 
Gerald I. Shulman, M.D., Ph D., 
associate professor of medicine, 
associate director of the Yale-Diabe- 
tes Endocrine Research Center and 
associate director of the Yale M.D./ 
Ph.D. training program, was awarded 
the 1994 Young Investigator Award 
from the American Federation for 
Clinical Research Foundation at its 
annual meeting in May in New 
Orleans. In March, Dr. Shulman also 
received the Albert Weinstein Visiting 
Lectureship at Vanderbilt University 
School of Medicine. 
Joan A. Steitz, Ph.D., the Henry 
Ford II Professor of Molecular 
Biophysics and Biochemistry, was 
presented the first Weizmann Woman 
and Science Award by the Weizmann 
Institute of Science in Rehovot, Israel. 
The award, presented in June at the 
New York Academy of Sciences, 
includes a $25,000 research grant. 
Frans J. Wackers, M.D., Ph.D., 
professor of diagnostic radiology and 
medicine, was elected on March 13 to a 
one-year term as president of the Ameri¬ 
can Society of Nuclear Cardiology. 
Theodore Zanker, M.D., 
associate clinical professor of 
psychiatry and 
in the Child Study 
Center, was in¬ 
stalled as president 
of the Connecticut 
State Medical 
Society at the 
society's 202nd 
annual meeting in 
Meriden. 
Barry L. Zaret, M.D., the 
Robert W. Berliner Professor of 
Medicine, professor of diagnostic 
radiology and chief, section of 
cardiovascular medicine, has been 
appointed to serve for two years on 
an Institute of Medicine committee 
to evaluate the United States Nuclear 
Regulatory Commission in medical 
use program. 
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Student 
News 
Yale Student Elected 
President of Student 
National Medical 
Association 
Rachel Villanueva, a third-year 
student, has been named president¬ 






SNMA, the nation’s 
oldest and largest 
student organiza¬ 
tion focused on the 
needs and concerns of medical students 
of color and minority communities. 
At the SNMA 29th Annual Medical 
Education Conference March 31-April 
3 in Atlanta, Ms. Villanueva was 
awarded the Chairperson’s Award for 
outstanding service to SNMA and the 
Presidential Award for outstanding 
service to the board of directors as 
community affairs co-chair. 
Ms. Villanueva received a B.S. 
degree from Yale in 1992, and expects 
to receive an M.D. degree in May 
1996. For her medical school thesis, 
she is working in the department of 
anesthesiology, testing the efficacy of 
a pulse oximeter in states of low 
perfusion in children. She recently 
presented her work at the annual 
meeting of the Society for Technology 
in Anesthesiology and was awarded 
Best Clinical Poster and Presentation. 
Ms. Villanueva has been a group 
leader and project coordinator for the 
Adolescent Substance Abuse Preven¬ 
tion Program and presented this 
successful venture at a 1993 Ameri¬ 
can Medical Student Association 
national convention seminar. She has 
been a leader in the Careers in 
Medicine program in the New Haven 
high schools and a member of the 
Forum on Education and Society at the 
Yale Child Study Center. She is the 
Yale representative elected to the 
Association of American Medical 
College organization of student 
representatives and was co-coordinator 
of the Minority Summer High School 
Research Program sponsored by Yale. 
Commencement Awards 
The Parker Prize was awarded to 
David Shaun Aghassi for best qualifica¬ 
tion for a successful physician. The 
faculty selects the recipient of this annual 
award, established in 1914 by bequest 
from Frank J. Parker, Ph.D., M.D. 1898. 
The Miriam Kathleen Dasey 
Award, in honor of Ms. Dasey, regis¬ 
trar from 1921 to 1950, was presented 
to Tina Marie Harris as the student 
who, by strength of character, personal 
integrity and academic achievement, 
gives promise of fulfilling the ideal of 
the compassionate physician. 
The Norma Bailey Berniker 
Prize, established in 1970 by bequest 
of John H. Bailey, M.D. ’03, was 
awarded to Kevin Elisabeth Bishoff, 
the graduating student who, in the 
faculty’s judgment, gives promise of 
best exemplifying the disciplines and 
precepts of the Oath of Hippocrates 
and Maimonides Prayer. 
The Upjohn Award was presented to 
Victoria Lynne Holloway for outstand¬ 
ing service to the School of Medicine. 
The William U. Gardner Thesis 
Prize, established in 1989 by Dr. 
Gardner’s widow, was awarded to 
Lauren Davida Hyman for having the 
most outstanding thesis. 
The degree of Doctor of Medi¬ 
cine cum laude was conferred on the 
following students: David Shaun 
Aghassi, Juan Carlos Bartolomei, 
Kevin Elizabeth Bishoff, Alexandra 
F. Boer, Millicent Mina Chung, 
Sylvia F. Garcia, Tina Marie Harris, 
Nicole Hausman, Sunil Ram 
Hingorani, Victoria Lynne Holloway, 
Lauren Davida Hyman, Wendy Wei- 
Yue Lou, Constantino Santiago Pena, 
Elizabeth Ann Quattrocki and Karen 
M. Rosewater. 
§§§ 
Second-year student Winifred 
Agard served as The Family Van’s 
first program assistant. The Family 
Van is a community-based mobile 
unit providing reproductive and 
prenatal care screening, education, 
referrals and outreach to individuals 
at risk for poor health outcomes. 
Monica Chacon and Marcoli 
Cyriile, both second-year students, 
were presented McGraw Hill Awards 
in recognition of their dedication and 
hard work during their first year of 
medical school. 
The American Cancer Society has 
awarded 1994 postdoctoral fellowships 
to three Yale medical school research¬ 
ers to continue studies and training in 
their respective departments. Recipients 
include: Scott E. Erdman, biology; 
Grace Gray, cell biology; and 
Matthew Junker, molecular biophys¬ 
ics and biochemistry. 
Anu R. Gupta, who will begin 
her second year in September, was 
awarded the Lerner Award for 
creative writing by a first-year 
medical student. Her entry was a 
short fiction story, entitled Storytime, 
a young woman’s perceptions on 
growing up in India. 
Third-year student Jeff 
Meyerhardt was presented the Ciba- 
Geigy Award, given to a second-year 
medical student who has performed 
laudable, extracurricular activities 
within the community. 
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Matthew Mayr, Steven Chough, Emil Engels and Jae Lin, from left, celebrate after receiving 
the news of their residency placements on March 16. Results of the National Resident 
Matching Program were released simultaneously around the nation at noon EST on that date. 
California 
California Pacific Medical 







Cedars-Sinai Medical Center, 
Los Angeles 
John Kirk, obstetrics 
and gynecology 
Kaiser Permanente 
Medical Center, Oakland 








Christine Lydon, orthopaedics 
Stanford University Hospital 
Sylvia Garcia, medicine 
Mike Yao, otolaryngology 
University of California, Irvine 
Medical Center 
Lauren Hyman, obstetrics and 
gynecology 
University of California, Los Angeles 
Medical Center 
Belinda Chan, internal medicine 
Jae Lim, neurosurgery 
Katherine Martin, diagnostic 
radiology 
University of California, San Diego 
Medical Center 
Marsha Roberts, diagnostic 
radiology 
University of California, San 
Francisco 
Kirk Essenmacher, internal 
medicine 
Dina Strachan, medicine 
Sang-Wook Yoon, 
orthopaedics 
University of Southern 
California, Los Angeles 
Millicent Chung, 
ophthalmology 
Ventura County Medical Center 




Millicent Chung, medicine 
Ann Hoff, internal medicine 
Susie Kim, medicine 
Andrea Lundell, medicine 
John Lundell, medicine 
Katherine Martin, medicine 














Yale-New Haven Hospital 
Juan Bartolomei, 
neurosurgery, surgery 
Terrence Geiger, laboratory 
medicine 
Bonnie Gould, obstetrics and 
gynecology 
Karen Jubanyik, medicine 
Mark Meyer, internal medicine 
Robert Nolfo, pediatrics 
Parwane Parsa, 
anesthesiology 
Lanford Peck, obstetrics and 
gynecology 
Constantino Pena, medicine 
Marc Potenza, psychiatry 
District of Columbia 
Georgetown University Hospital 
Heather Christian, obstetrics 
and gynecology 
Florida 
University of (Vliami/Bascom 
Palmer 
Daniel Roth, ophthalmology 
University Miami School of Medicine 
Marvin Young, urology 
Georgia 
Emory University School of Medi¬ 
cine, Atlanta 
Matthew Mayr, neurosurgery 
Illinois 
McGaw Medical Center - North¬ 
western University, Chicago 
Amy Kaissar, medicine/primary 
Indiana 
Saint Vincent Hospital, Indianapolis 
Tina Harris, transitional 
Iowa 
University of Iowa Hospitals & 




Alton Oschner Medical Foundation, 
New Orleans 
David Alieva, diagnostic 
radiology 
Maryland 
Johns Hopkins Hospital, Baltimore 
Tina Harris, diagnostic 
radiology 
Robert lannone, pediatrics 
Stephen Jackman, surgery, 
urology 
Peter Jay, orthopaedics 
Brian Lee, emergency 
medicine 
Beverly Naiman, pediatrics 
National Naval Hospital, Bethesda 
George Cole, general surgery 
Sinai Hospital, Baltimore 
Anthony Burns, physical 
medicine and rehabilitation 
Massachusetts 
Baystate Medical Center, Springfield 
Katherine Dee, medicine 
Beth Israel Hospital, Boston 
Alexandra Boer, medicine 
Michelle Ng, medicine 
Boston University Medical 
Research Program, Boston 
Ray Buchmann, internal 
medicine 
Brigham and Women’s 
Hospital, Boston 
David Aghassi, medicine 
Kevin Bishoff, medicine/ 
primary 
Felix Brown, pathology 
Scott Dessain, internal medicine 
Emil Engels, anesthesiology 
Sunil Hingorani, internal 
medicine 
Michelle Ng, anesthesiology 
Stephen Okon, diagnostic radiology 
Children’s Hospital, Boston 
Emily Davidson, pediatrics 
Karen Rosewater, pediatrics 
Jan Steckel, pediatrics 
Lahey Clinic Medical Center, 
Burlington 
Parwane Parsa, medicine 
Mike Yao, Tim 
Yoon, Armen 
Khachatryan 
and Susie Kim, 
from left, talk 
over the match 
results. Mr. 
Khachatryan 
is a member 
of the Class 
of ’95. 
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Massachusetts General Hospital, 
Boston 
Karen Broder, pediatrics 
Lee Goldstein, psychiatry 
Victoria Holloway, medicine 
Susie Kim, diagnostic 
radiology 
Constantino Pena, diagnostic 
radiology 
David Scott, internal medicine 
McLean Hospital, Belmont 
Lisa Quattrocki, psychiatry 
Mount Auburn Hospital, Cambridge 
Lee Goldstein, medicine 
New England Deaconess, Boston 
Emil Engels, medicine 
New England Medical Center, Boston 
Anuj Gupta, orthopaedics 









Christian and her 
husband, Mike 
Christian, right, 
look over the 
match results. 
Barnes Hospital, St. Louis 
John Curci, general surgery 
New York 
Columbia University, New York 
Michael Kaiser, neurosurgery 
Einstein Affiliated Hospitals, Bronx 
Shaheed Kalloo, internal 
medicine 
Manhattan Eye, Ear & Throat, New York 
Ho-Sheng Lin, otolaryngology 
New York University Medical Center, 
New York 
G. Rick Bruno, emergency 
medicine 
New York Hospital, New York 
Debra Howard, internal medicine 
Leonard Landesberg, internal 
medicine 
Ho-Sheng Lin, surgery 
North Shore University Hospital, 
Manhasset 
Khursheed Imam, medicine 
Presbyterian Hospital, New York 
Himi Kim, psychiatry 
Wendy Lou, medicine 
J. Adrian Lunn, internal 
medicine 
Stony Brook Teaching Hospitals, 
Stony Brook 




Marie Eason, medicine 
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Beverly Naiman and Brian Lee read 
of their placements. 
North Carolina 
Bowman Gray/NC Baptist Hospital, 
Winston-Salem 
Andrea lundell, diagnostic 
radiology 
John Lundell, anesthesiology 
University of North Carolina Hospitals, 
Chapel Hill 
David Levy, medicine 
Pennsylvania 
Children’s Hospital, Philadelphia 
Peter Langmuir, pediatrics 
Harrisburg Hospital 
Ronald Thibou, family practice 
Hospital of University of Pennsylvania, 
Philadelphia 
Fabian Chen, internal 
medicine 
Steven Chough, internal 
medicine 
Gabriella Gosman, obstetrics 
and gynecology 
Nicole Hausman, obstetrics 
and gynecology 
Thomas Jefferson University, 
Philadelphia 
Marie Eason, diagnostic 
radiology 
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University Health Center, Pittsburgh 




Rhode Island Hospital, Providence 
Khursheed Imam, diagnostic 
radiology 
Tennessee 
University of Tennessee College of 
Medicine, Memphis 
Daniel Roth, medicine 
Utah 
University of Utah Affiliated Hospitals, 
Salt Lake City 
Annika Wisniewski, family 
practice 
Virginia 
University of Virginia, 
Charlottesville 
David Levy, diagnostic 
radiology 
Washington 
University of Washington Affiliated 
Hospitals, Seattle 
Katherine Dee, diagnostic 
radiology 
Johnson Loh, internal medicine 
Rajendran Naidoo, 
orthopaedics 
University of Washington, Seattle 
Ramsey Alsarraf, 
otolaryngology 
Virginia Mason Hospital, Seattle 
Benjamin Haslund, general 
surgery 
Residency placement information 
is provided courtesy of the 
Yale University School of Medicine 
Office of Education and Student Affairs. 
Implantation Biology: The 
Host Response and Biomedical 
Devices, edited by Ralph S. Greco, 
M.D. ’68, CRC Press (Fla.) 1994. 
Hsiang’s Diagnostic Virology: 
As Illustrated by Light and Elec¬ 
tron Microscopy, by Gueh-Djen 
Hsiung, Ph.D., professor emeritus 
of laboratory medicine, Carolyn 
K.Y. Fong-Cheng, Ph.D., research 
scientist in laboratory medicine, 
and Marie L. Landry, M.D., associ¬ 
ate professor of laboratory medicine 
and medicine, Yale University 
Press, Fourth Edition, 1994. 
Families, Illness, and Disabil¬ 
ity: An Integrative Treatment 
Model, by John S. Rolland, M.D., 
lecturer in psychiatry, Basic 
Books (N.Y.) 1994. 
Medicine’s Dilemmas: Infinite 
Needs versus Finite Resources, by 
William L. Kissick, M.D. ’57, HS 
’58-’61, M.PH. ’59, Yale Univer¬ 
sity Press, 1994. 
Doc: Then and Now with a 
Montana Physician, by Ronald E. 
Losee, M.D. '44, Lyons and 
Burford (N.Y), 1994. To be 
published in November. 
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Director of Alumni Affairs Arthur C. Crovatto, M.D. '54, speaks with Michael 
DeNicola Jr, M.D. '54, and his wife, Jean DeNicola, during Alumni Reunion 
Weekend in early June. 
June in New Haven: 
A Time to Be Young, 
Together Once Again 
Organizing the class secretaries — 
of both current and future alumni/ae 
— presents the keenest challenges and 
greatest rewards for me and my staff. 
Class solidarity and cohesion, rein¬ 
forced in innovative ways by these 
devoted alumni/ae, are the engine that 
drives the Association of Yale Alumni 
in Medicine and the magnet that brings 
us back to New Haven. 
My group, the Class of 1954, 
returned this year for our 40th 
reunion. More than half of the 
surviving class members were here 
and we all were magically young 
again. Some of us had not attended a 
reunion since graduation, but we fell 
into place once again as a class. We 
could evaluate ourselves and our 
class as we were, as we are, and as 
we hope to be. Yale can be proud of 
us, and we can be grateful for the 
superb preparation provided by the 
Yale System. 
In addition, there were three other 
reunion classes attended by more than 
half of the surviving members. The 
consensus was that returning has a 
magic quality of renewal. 
The alumni/ae weekend program 
began on June 3 with individual class 
reunion programs presented by the 
Classes of 1939, 1944 and 1954. The 
50th reunion class program featured a 
videotape titled Company C and 
Friends; The Yale School of Medicine 
During World War //, provided by 
Nicholas P.R. Spinelli, M.D. ’44, to 
enthusiastic praise. Reunion program 
chairs included Joseph B. Forman, 
M.D. ( for the Class of 1939); Edith 
M. Jurka, M.D. (Class of 1944); and 
John K. Rose, M.D. (Class of 1954). 
Alumni/ae were greeted by Marie- 
Louise T. Johnson, Ph.D., M.D. ’56, 
president of the AYAM. Our dean, 
Gerard N. Burrow, M.D. ’58, also 
welcomed those assembled. Vincent 
T. DeVita Jr., M.D., HS '66, director, 
Yale Cancer Center (YCC), presented 
a talk titled Overview of the Yale 
Cancer Center: Technology Transfer 
and Cancer Treatment. 
When the program of faculty 
seminars was completed on June 4, 
the annual meeting of the Association 
of Yale Alumni in Medicine was 
called to order by Dr. Johnson. Linda 
Koch Lorimer, B.A., J.D. ’77, 
secretary of the University, gave 
warm and special greetings to all 
attendees. She then spoke of the 
University/Medical School relation¬ 
ship. Dr. Burrow delivered a stimulat¬ 
ing State of the School Address. 
Following the address, he awarded 
the initial Peter Parker Prize to John 
B. Ogilvie, M.D. ’34, and Dr. Spinelli 
for long and distinguished service to 
the medical school. 
Jean Bolognia, M.D. ’80, chaired 
this year’s Association of Yale 
Alumni in Medicine Nominating 
Committee. Dr. Johnson and Dr. 
Gilbert Hogan remain as president 
and secretary, respectively. The 1994 
candidates to replace retiring mem¬ 
bers of the executive committee are 
David Astrachan, M.D. ’84; Leo M. 
Cooney Jr., M.D. ’69; Joseph F.J. 
Curi, M.D. ’64; Peter N. Herbert, 
M.D. ’67; Donald E. Moore, M.D. 






’81, and Lynn W. Reiser, 
M.D. ’70. Nominated as representa¬ 
tives to the Association of Yale 
Alumni are Harold D. Bornstein Jr., 
M.D. ’53, and Alfredo Axtmayer, 
M.D. ’76. Retiring members of the 
executive committee were thanked 
for a job well done. Gioacchino 
“Jack” S. Parrella, M.D. ’41, passed 
away suddenly before completing his 
term on the committee. His faithful 
attendance and wise counsel will be 
missed. We extend our condolences to 
his wife, Lucy, and his family. 
The Distinguished Alumni 
Service Award was presented to 
Dorothea R. Peck, M.D. ’43 March 
and Muriel D. Wolf, M.D. ’59, (who 
was celebrating her 35th reunion). 
Citations and remarks were delivered 
by Lycurgus Davey, M.D. ’43 March; 
and Arthur C. Crovatto, M.D. ’54, to 
the honorees. Each was honored for 
support to the school by devoted 
participation in alumni affairs, and is 
richly deserved. Congratulations are 
also in order for Dr. Cooney, Humana 
Foundation Professor of Geriatric 
Medicine and a member of the AYAM 
Executive Committee, who received 
the Bohmfalk Prize for teaching in the 
clinical sciences at the school’s 
commencement ceremony in May. 
Our medical students and future 
alumni/ae are aware of the concern of 
the association for their well-being 
(academically, socially, and finan¬ 
cially). We continue to support their 
efforts — student council meetings, 
second-year show performances, the 
annual cadaver ball, faculty-student 
teas — with yours truly as an instruc¬ 
tor in physical diagnosis classes. The 
students are on track to become the 
kind of alumni/ae who attend re¬ 
unions and continue to support the 
school. Their record at our telethons 
speaks well for their future. Thirty- 
two students from all classes joined 
alumni/ae and the fund staff on March 
29 and 30 to solicit pledges for the 
annual campaign. Lively “then and 
now” interchange between students 
and alumni bond the generations in a 
common cause. Significant pledges 
David Robinson, M.D. '69, ties a 
balloon on the wrist of his son, David, 
outside Harkness hall after lunch on 
the Saturday of reunion weekend. 
were again obtained and our finan¬ 
cially harried students benefit from 
the effort. 
This report would be incomplete 
if I did not take this opportunity to 
congratulate John W. Foster Jr., M.D. 
’71; chair. Medical School Alumni 
Fund, and his committee for their 
efforts to again successfully exceed 
the goal set for the year. The final 
tally is not available at this writing. 
However, it shows increasing aware¬ 
ness of the alumni/ae to financial 
needs of the school. 
Plans are in place for June 2 and 
3, 1995. A reunion-planning commit¬ 
tee will meet in early September, and 
we welcome your suggestions. 
Classes ending in 5s and Os will be 
hearing from the Office of Alumni 
Affairs in the very near future, and 
we encourage you to participate. 
Arthur C. Crovatto, M.D. ’54 
Director of alumni affairs 
Alumni 
News 
Horace E. Thomas, M.D., HS 
’36-’40, retired surgeon, received one 
of three service awards given by the 
University of Missouri-Columbia 
Medical Alumni Organization. Since 
his retirement. Dr. Thomas has been 
working with Habitat for Humanity, 
building houses for families in need. 
He was also honored in 1993 as 
Doctor of the Year by the Boone 
County Medical Society. 
John J. McGillieuddy, M.D. ’38, of 
South Orleans, Mass., has retired from 
the practice of orthopaedic surgery. 
Fitzhugh C. Pannill Jr., M.D. 
’45, was awarded a mastership by 
the American College of Physicians 
at its annual meeting in April in 
recognition of his lifelong commit¬ 
ment to medical education. Dr. 
Pannill retired from Erie County 
Medical Center in 1990 but contin¬ 
ues as an attending physician at the 
Maine Medical Center in Portland. 
Herbert S. Sacks, M.D. ’52, 
clinical professor of child and adoles¬ 
cent psychiatry in the Yale Child Study 
Center, was elected vice president of 
the American Psychiatric Association 
(APA) in March. Since 1990, he has 
chaired of the APA Committee on 
Universal Access to Health Care. 
Daniel M. Divack, M.D., HS 
’56-'57, is practicing obstetrics and 
gynecology at Long Island Jewish 
Hospital in New Hyde Park, N.Y. and 
in private practice in Bayside and 
East Hills, N.Y. 
Eiji Yanagisawa, M.D., HS ’56- 
’59, clinical professor of otolaryn¬ 
gology at Yale, was installed as 
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president of the American Broncho- 
Esophagological Association at its 
annual meeting in May in Palm Beach, 
Fla. In this capacity, he will organize 
the association’s 1995 scientific 
meeting in Palm Desert, Calif. 
Edward L. Eyerman, M.D. ’57, 
neurologist and assistant professor of 
clinical neurology at St. Louis 
University Medical School, is con¬ 
tributing editor of sports medicine for 
Pony Expres magazine. Dr. Eyerman 
is in private practice in St. Louis and 
is writing a book on common sense 
diet and nutrition. 
Harold J. Fallon Jr.. M.D. 57, 
dean of the University of Alabama 
School of Medicine and former 
professor and chairman of internal 
medicine at the Medical College of 
Virginia, has been elected to a second 
term on the American College of 
Physicians’ board of regents. 
John Harrington, M.D. ’62, 
chief of staff at Newton-Wellesley 
Hospital in Massachusetts, has been 
awarded the Tufts University School 
of Medicine Distinguished Faculty 
Award. Dr. Harrington, professor of 
medicine at Tufts, has been recog¬ 
nized by the students for excellence 
in teaching on seven occasions. 
Edgar G. Sanner Jr., M.D., HS 
'62-’65, is staff urologist at St. Francis 
Medical Center in Pittsburgh, Penn. 
Fred M. Rosenbloom, M.D., HS 
'62-'67, of Miami Beach, has been in 
the practice of internal medicine for 
25 years. Dr. Rosenbloom recently 
was appointed a trustee of Mt. Sinai 
Hospital Medical Center and elected 
vice president of the Foundation 
Board at Mt. Sinai Hospital. 
Thomas J. Spackman, M.D., HS 
'64-'69, clinical professor of radiol¬ 
ogy at the University of Connecticut 
School of Medicine, was appointed 
president and chief executive officer 
Out of the 
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of pediatrics — 
shown here in a 
1989 photo — 
has retired from 
private practice 
and is hosting a 
new cable 





of Elscint, Inc. and senior vice 
president of its parent organization, 
Elscint, Ltd., a medical imaging 
equipment company. 
Sidney C. Smith Jr., M.D. ’67, 
clinical cardiologist and president¬ 
elect of the 
American Heart 
Association 
(AHA), has been 
named chief of 
cardiology and 
professor of 
medicine at the 
University of 
North Carolina at 
Chapel Hill School 
of Medicine. Dr. Smith also is the 
director of the academic center for 
cardiovascular disease at the univer¬ 
sity and has served the AHA for 
nearly two decades. 
Joseph L. Renda, M.D. '68, HS 
’68-'74, chairman of the nephrology 
department at Waterbury Hospital in 
Connecticut, has won the Yale School 
of Medicine’s George F. Thornton 
Teaching Award for his outstanding 
achievements in teaching medical 
residents. Dr. Renda is the first 
recipient of the award, which will be 
given annually in honor of Dr. 
Thornton, who is known throughout 
the country for being one of the 
leading teachers of medical residents. 
Steven M. Shoum, M.D. ’78, 
director of the department of anesthe¬ 
siology at South Nassau Communities 
Hospital, Oceanside, N.Y., was 
certified as a fellow of the American 
College of Pain Medicine. 
Shirley M. McCarthy, M.D. ’79, 
HS ’80-’83, associate professor of 
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diagnostic radiology at Yale, has been 
elected to a two-year term as chair of 
the Medical School Council at Yale. 
Robert V. Levine, M.P.H. ’80, 
vice president of operations at Lenox 
Hill Hospital, has been elected to the 
board of directors of the American 
Lung Association of New York. 
Before joining Lenox Hill, Dr. 
Levine was senior vice president for 
administration at Flushing Hospital 
Medical Center. 
Heide Boersler, M.P.H. 81, 
Ph.D. ’87, J.D., is associate professor 
and department chair of health 
administration, law and ethics at the 
University of Colorado. 
Michael P. Krusch, M.D., P.A. 
’86, received the Doctor of Medicine 
degree from the Chicago Medical 
School in June. He is starting resi¬ 
dency training in obstetrics and 
gynecology in Chicago. 
Michael D. Miller, M.D. ’86, has 
been named director of federal 
relations for Pfizer Inc.’s Washington 
office. He formerly was legislative 
assistant in the office of U.S. Rep. 
Sander Levin. 
Patrick A. Ruwe, M.D. ’87, has 
joined the faculty of the department 
of orthopaedics and rehabilatation at 
Yale. He completed his orthopaedic 
surgery training at Yale-New Haven 
Hospital and his sports medicine 
training at the Kerlan-Jobe 
Orthopaedic Clinic in Los Angeles, 
Calif. Dr. Ruwe specializes in sports 
medicine and shoulder problems, and 
also is the orthopaedic consultant for 
the Yale University athletic teams. 
Jonathan J. Lewis, M.D., Ph D., 
HS ’90-’92, is attending surgeon of 
the Gastric and Mixed Tumor Service, 
Department of Surgery, at Memorial 
Sloan-Kettering Cancer Center and 
assistant professor of surgery at 
Cornell University Medical College. 
Obituaries 
Wilbur P. McNulty 
Wilbur P. McNulty, M.D., died 
on Nov. 7, 1991, at his home in 
Beaverton, Ore. He was 66. 
Dr. McNulty graduated from the 
medical school in 1952 and com¬ 
pleted a fellowship in biophysics at 
Yale. He served as a captain in the 
U.S. Army at Walter Reed Army 
Institute of Research and later on the 
staff of the Armed Forces Institute of 
Pathology. He was director of clinical 
and anatomical pathology at Griffin 
Hospital in Derby, Conn., and assis¬ 
tant professor of pathology at Yale 
before becoming chairman of pathol¬ 
ogy at the Oregon Regional Primate 
Research Center in Beaverton from 
1963 until his retirement in 1989. 
He is survived by his wife, 
Maureen; a son, Ian; four daughters, 
Carol, Ellen, Alison and Jennifer; and 
a grandson. 
George S. Bascom 
George S. Bascom, M.D., died 
Aug. 7, 1993, at his home in Manhat¬ 
tan, Kan., at the 






cal residency at 
New Haven 
Hospital and the 
Yale School of Medicine in 1957, 
followed by a surgical fellowship at 
the Massachusetts General Hospital. 
He returned to Yale for three more 
years of surgical residency and then 
on to the Denver Veterans Affairs 
Hospital for his final year of training. 
He returned to Kansas to join 
his father in practice. He retired 
after 45 years of private surgical 
practice. In addition to his accom¬ 
plishments as a surgeon. Dr. Bascom 
left a legacy of literary work, most 
of which was poetry. 
Survivors include his wife, 
Jane; four sons, George, John, 
Charles and James; and nine grand¬ 
children. He was predeceased by a 
son, Harry, in 1970. 
John A. Knapp 
John A. Knapp, M.D.. died Dec. 5. 
He was 72. 
Dr. Knapp was a radiologist on 
Long Island and in Pennsylvania 
before he retired 15 years ago to 
Cheshire, Conn. 
He is survived by a daughter, 
Wendy. 
Memorial contributions can be 
made to the Cheshire Public Library, 
104 Main St., Cheshire, CT, or to the 
Cheshire Senior Center, Maple 
Avenue, Cheshire, CT 06410. 
Clement C. Clarke 
Clement C. Clarke, M.D., of 
Woodbridge, Conn., died Feb. 17 at 
the age of 90. 
Dr. Clarke graduated from the 
Yale School of Medicine in 1932. He 
was in private practice as an ophthal¬ 
mologist in New Haven and was 
associated with the clinical program 
at Yale until 1969. 
He was a member of the New 
Haven County Medical Association, 
the Connecticut State Medical 
Society and the American Medical 
Association. 
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Thomas J. Murphy 
Thomas J. Murphy, M.D., of 
North Easton. Mass., died March 26 
in the Good Samaritan Medical 
Center-Cushing Campus in Brockton. 
He was 72. 
A 1946 graduate of Yale School 
of Medicine, Dr. Murphy served in 
the Navy for three years at Quonsett 
Naval Air Base Hospital in Rhode 
Island before completing a pediatric 
residency at Children’s Hospital in 
Boston. In 1952, he opened his 
medical practice in Brockton and was 
on the staff of Goddard Hospital in 
Stoughton. When Cardinal Cushing 
Hospital (now the Good Samaritan 
Medical Center) opened in 1968, he 
became chief of pediatrics. He retired 
from that position in 1992. 
Survivors include his wife, Muriel; 
three daughters, Caryl, Colleen and 
Karyn; three sons, Colin, Kevin and 
Kenan; and 10 grandchildren. 
Elizabeth C. Beilis 
Elizabeth Costenbader Beilis, 
M.P.H., M.U.S., died April 11 in 
Connecticut Hospice. She was 72. 
Mrs. Beilis obtained a master of 
public health degree in 1964 and a 
master of urban studies degree in 
1968, both from Yale. She came to 
work for the Yale Department of 
Epidemiology and Public Health as a 
research assistant. Eventually, in part, 
because of her concern for the 
welfare of students, she became 
associate dean for public health. 
Always active in the medical 
school and the community, by serving 
on many committees, including the 
Minority Affairs Committee and the 
Committee on the Status of Women, 
and by working with city of New 
Haven's Human Resources Adminis¬ 
tration on an agreement between the 
city and Yale, she was awarded the 
Connecticut Public Health 
Association’s highest honor, the C.- 
E.A. Winslow Award, in 1989. She 
retired in 1992. 
She is survived by a son, James; 
and a granddaughter. 
Memorial contributions may be 
made to the EPH Internship Fund at 
Yale University or to the Erasmus 
Scholarship Fund, care of the Philoso¬ 
phy Department, University of 
Montana, Missoula, MT 59812. 
Daniel J. Levinson 
Daniel J. Levinson, a resident of 
New Haven, died April 12 at Yale- 
New Haven Hospital. He was 73. 
Born in New York City, Dr. 
Levinson received a bachelor’s 
degree in psychology and master’s 
and Ph.D. degrees, all from the 
University of California at Los 
Angeles and at Berkeley. He was 
assistant professor of clinical psy¬ 
chology in the department of social 
relations at Harvard University and 
served in the psychology departments 
at Harvard Medical School and the 
Massachusetts Mental Health Center 
in the 1950s. 
In 1966, Dr. Levinson came to 
Yale as a professor of psychology in 
the department of psychiatry and also 
became director of the research unit 
for social psychology at the Connecti¬ 
cut Mental Health Center, where he 
later served as director of psychology 
from 1976 to 1979. Dr. Levinson was 
the author of the best-selling book 
The Seasons of a Man's Life, which 
provided a framework for understand¬ 
ing the developmental stages of men. 
In 1990, he retired from Yale and was 
named professor emeritus. 
He is survived by his wife, Judy; 
and two sons, Mark and Douglas. 
Gioacchino S. Parrella 
Gioacchino S. “Jack” Parrella, 
died April 12 at Milford Hospital at 
the age of 77. 
Dr. Parrella was a 1941 graduate 
of the Yale School of Medicine and 
served as a captain in the Army 
Medical Corps during World War II. 
He was chairman of surgery at 
Milford Hospital from 1957 to 1985 
and retired in 1986. He was elected to 
the New England Surgical Society 
and was a fellow of both the Ameri¬ 
can Medical Association and the 
American College of Surgeons. 
During his career he also served 
as president of the Connecticut 
Medical Society, the New Haven 
Medical Association and as a member 
of the board of directors of the Yale 
Medical Alumni Association. Dr. 
Parrella was active in the community 
as well, having been a former Milford 
Police commissioner and former 
president of the New Haven Chapter 
of the American Cancer Society. 
Survivors include his wife, Lucy; 
two sons, John and David; a daughter, 
Licia, and three grandchildren. 
Donations may be made to 
Milford Hospital Memorial Fund, 
2047 Bridgeport Ave., Milford, CT 
06460; Yale Medical School Scholar¬ 
ship Fund; or St. Peter’s Church 71 
River St., Milford, CT. 
Daniel Rudman 
Daniel Rudman, M.D., died April 
17 at Froedtert Memorial Lutheran 
Hospital in Milwaukee. He was 67. 
Dr. Rudman was professor of 
medicine at the Medical College of 
Wisconsin and associate chief of staff 
for extended care at the Veterans 
Affairs Medical Center in Milwaukee. 
A native of Boston, he received a 
medical degree in 1949 from Yale and 
has held faculty appointments at 
Columbia University College of 
Physicians and Surgeons, Emory 
University School of Medicine, and 
the University of Health Sciences/ 
Chicago Medical School before 
joining the Medical College of 
Wisconsin in 1988. 
A pioneer in the field of aging. 
Dr. Rudman’s research spanned four 
decades. He published more than 
270 scientific articles in the fields of 
metabolism, endocrinology and 
nutrition. 
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He is survived by his wife, Inge; a 
daughter, Nancy; and a son, Richard. 
Norman P. Rindge 
Norman Pember Rindge, M.D., 
died April 21 in Sun City Center, Fla. 
He was 86. 
A native of Connecticut, Dr. 
Rindge was born in Madison, re¬ 
ceived a Yale medical degree in 1935, 
and served as housestaff from 1935 to 
1936. He was a medical officer in the 
82nd Airborne Division during World 
War II. Dr. Rindge was a general 
practitioner whose practice was based 
in Clinton and when he retired in 
1977, the town celebrated “Dr. Rindge 
Day” in his honor. 
He is survived by his wife, Ruth; 
two daughters, Mrs. Robert Bell and 
Mrs. Janice York; a stepdaughter, 
Mrs. Rolf Jeker; a stepson, James 
Robinson; and a number of grandchil¬ 
dren, great-grandchildren and great, 
great-grandchildren. 
William S. Elliott 
William S. Elliott, M.D., died at 
his home in Greenville, Ohio, May 3 
at the age of 67. 
A graduate of Miami University, 
Yale School of Medicine in 1955 and 
Ohio State University, Dr. Elliott 
served as coroner in Greenville from 
1962 until February 1994, when he 
retired. He also was a surgeon and 
family practice physician from July 
1961 until December 1993. 
Survivors include his second 
wife, Julie; three sons, Jonathan, 
Geoffrey and Daniel; a daughter, 
Rebecca; and four grandchildren. 
Memorial contributions may be 
made to Hospice of Darke County or 
The American Cancer Society. 
Horace C. Stansel Jr. 
Horace C. Stansel Jr., M.D., of 
Woodbridge, Conn., died on May 7 in 
Yale-New Haven Hospital. He was 67. 
Born in Tampa, Fla., Dr. 
Stansel received a medical degree 
from Washington University School 
of Medicine in St. Louis. He was 
an instructor on surgery at the 
University of Illinois prior to 
joining the Yale faculty in 1962. 
Since coming to Yale he had been 
successively an instructor, assistant 
professor and associate professor 
of surgery; associate professor of 
pediatrics; professor of surgery and 
In Me 
E. St George Anderson, M.P.H. '56 
July 11, 1990 
Jeanette Averill, M.P.H. ’53 
December 1, 1993 
Elizabeth C. Beilis, M.P.H. ’64 
April 11, 1994 
Jean Celentano, M.D. ’25 
February 5, 1994 
Clement C. Clarke, M.D. ’32 
February 17, 1994 
Jack Greenberg, M.D. ’33 
October 16, 1993 
Fred M. Haddad, M.D. ’43, M.P.H. ’58 
January 29, 1994 
Edward R. Harvey Jr., M.D. ’41 
December 1, 1993 
Carlos E. Alvarez Herrera, M.P.H. ’67 
November 16, 1991 
George K. Hirst, M.D. ’33 
January 22, 1994 
John B. Joseph, M.P.H. ’53 
February 17, 1994 
Ralph E. Knutti, M.D. ’28 
January 19, 1994 
Leonard F. Menczer, M.P.H. ’51 
January 30, 1994 
Rosa Frances Montgomery, M.P.H. ’47 
February 17, 1993 
of pediatrics; and, since 1990, 
professor emeritus of surgery. Dr. 
Stansel developed the Stansel 
surgical procedure for transposition 
of great arteries. 
Survivors include his wife, Doris; 
two sons, David and Matthew; and 
two daughters, Pamela and Carolyn. 
Memorial contributions may be 
made to the Pediatric Cardiac Surgi¬ 
cal Department, Yale University 
School of Medicine, 333 Cedar St., 
New Haven, CT 06511. 
M O R I A M 
Thomas J. Murphy, M.D. ’46 
March 26, 1994 
Gioacchino S. Parrella, M.D. ’41 
April 12, 1994 
Henry M. Parrish, M.D., M.P.H. ’56 
February 16, 1992 
Laurence K. Rainsford, M.P.H. '53 
December 3, 1993 
Carole R. Robbins, M.P.H. ’91 
March 18, 1994 
Robert I. Roy, M.D. '67 
September 28, 1993 
Paul L. Saffo, M.D. ’33 
February 19, 1994 
Norman M. Schlossberger, M.P.H. '80 
December 10, 1993 
Morris Tager, M.D. ’36 
January 10, 1994 
J. Champneys Taylor, M.D. "40 
December 29, 1993 
Alexander J. Tutles, M.P.H. ’51 
July 25, 1989 
M. Dawson Tyson, M.D. ’27 
November 8, 1993 
Agnes E. Vaughn, M.P.H. ’40 
October 13, 1990 
John B. Wells, M.D. '40 
October 28, 1993 
Yale Medicine Summer 1994 63 
Developm 
R E P O R 
Jockers Professorship 
Established to Encourage 
Clinical Excellence 
The Yale University School of 
Medicine has received a major gift 
that will encourage excellence in 
patient care and compassionate 
communication between physicians 
and patients. In memory of her late 
husband. Mrs. Harold W. Jockers has 
endowed a junior professorship to 
reward the teaching of the special 
skills of clinical medicine through 
selection and support of outstanding, 
young academic clinicians. 
The professorship is intended to 
provide a role model to inspire 
students and demonstrate the effec¬ 
tiveness of bedside acumen, insightful 
communication and knowledgeable 
physical assessment, along with the 
judicious selection of laboratory and 
radiographic studies to formulate 
effective, efficient and compassionate 
diagnostic and therapeutic regimens. 
The endowment commemorates 
Harold W. Jockers, who died in 
November 1991. Mr. Jockers began 
his extraordinarily long and success¬ 
ful business career as a runner at the 
New York Stock Exchange, culminat¬ 
ing with his election to the positions 
of president, and later chairman of the 
board of Mercantile Stores Co., Inc. 
During his 57-year career with 
the company, he built success on a 
strong sense of simplicity and belief 
in the basics, respect for the impor¬ 
tance of consumer relations, and 
faith in the integrity of his custom¬ 
ers. If a customer complained about 
merchandise, Mr. Jockers would 
often simply ask. “What do you 
think is right?” He would accept the 
Harold W. Jockers 
customer's answer as the basis for 
resolution. It is fitting that an endow¬ 
ment in memory of a merchant who 
esteemed his customers should 
emphasize the parallel relationship 
between a doctor and patient. 
Mr. and Mrs. Jockers’ interest in 
the Yale School of Medicine began in 
1955 with the matriculation of their 
younger daughter, Carol. She attained 
her medical degree in 1959 and began 
her residency training in pathology. 
This has been her full-time profes¬ 
sional career, and she is presently 
chief of pathology at Lemuel 
Shattuck Hospital in Boston. During 
medical school, she married Robert 
Amick, M.D.’59. They reside in 
Brookline, MA. 
Mrs. Jockers’ interest in medi¬ 
cine, however, antedates Carol’s 
admission to the School of Medicine. 
It received its fullest expression when 
she served as a volunteer ambulance 
ENT 
driver and helped staff the Norwalk 
Hospital emergency room during 
World War 11. Both Mr. and Mrs. 
Jockers maintained a strong interest 
in the Yale School of Medicine after 
their daughter’s graduation. 
Mrs. Jockers says that she is 
“well aware of the need to support 
clinical medicine, particularly in 
primary care, by encouraging dedi¬ 
cated faculty members to serve as 
inspiring role models for medical 
students.” It is critically important 
that students be able to observe and 
emulate clear, precise and compas¬ 
sionate clinicians early in their 
careers. She emphasizes the need for 
students to learn the skill of listening 
to their patients. 
Both Carol and the Jockers' older 
daughter, Helen Bradley, are 
Wellesley graduates. Helen resides in 
central New Hampshire. Both share 
in their parents’ recognition of the 
benefits and effectiveness of philan¬ 
thropy and believe that private 
institutions often are best able to 
establish and maintain excellence. 
According to Dean Gerard N. 
Burrow, M.D. ’58, Mrs. Jockers’ 
extraordinary support will help the 
medical school maintain its excel¬ 
lence in clinical education. Her gift 
also will enable Yale to explore new 
directions in medicine at a time when 
health care is in transition. 





n n W W 

































































































































Course Director: Paul Webster, Ph.D. 
Yale University School of Medicine 
Jane Ellen Hope Building. Room 110 
Annual Yale Sports Medicine Seminar 
Course Director: Peter Jokl, M.D. 
Yale University School of Medicine 
Jane Ellen Hope Building, Room 110 
Thrombosis, Thromboembolism and Thrombolysis Symposium 
Course Director: Michael D. Ezekowitz, M.D. 
Yale University School of Medicine 
Jane Ellen Hope Building. Room 110 
Immunocytochemistry & Cryosections ’94: 
A Practical Course 
Course Director: Paul Webster, Ph.D. 
Yale Lhiiversity School of Medicine 
Jane Ellen Hope Building. Room 110 
Child Abuse Conference 
Course Director: John Leventhal, M.D. 
Sheraton Hotel and Conference Center 
Waterbury, Connecticut 
New Frontiers in Child Psychological Assessment: 
Attention, Memory and Learning 
Course Director: Lawrence Vitulano, Ph.D. 
Yale University School of Medicine 
Mary S. Harkness Auditorium 
Second International Burn Camp Workshop 
Course Director: Jeff Heinrich, P.A., Ed.D. 
Camp Hi-Rock/Bear Rock 
Mt. Washington. Massachusetts 
6th Annual Cardiology Update 
Course Directors: Lawrence S. Cohen, M.D. and Barry L. Zaret, M.D. 
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